Citrus Sinensis ID: 007088
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 618 | 2.2.26 [Sep-21-2011] | |||||||
| Q9ASS4 | 620 | Probably inactive leucine | yes | no | 0.936 | 0.933 | 0.622 | 0.0 | |
| O04567 | 601 | Probable inactive recepto | no | no | 0.891 | 0.916 | 0.454 | 1e-141 | |
| C0LGI5 | 591 | Probable LRR receptor-lik | no | no | 0.885 | 0.925 | 0.449 | 1e-141 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.800 | 0.415 | 0.371 | 1e-87 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.765 | 0.406 | 0.378 | 2e-87 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.775 | 0.396 | 0.386 | 2e-87 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.775 | 0.396 | 0.386 | 3e-87 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.778 | 0.412 | 0.370 | 3e-86 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.765 | 0.395 | 0.375 | 2e-85 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.757 | 0.458 | 0.397 | 8e-84 |
| >sp|Q9ASS4|Y5838_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g48380 OS=Arabidopsis thaliana GN=At5g48380 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 758 bits (1957), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/591 (62%), Positives = 456/591 (77%), Gaps = 12/591 (2%)
Query: 36 DIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLK 95
+I+CL++ K+ +EDP YL+T W F N T G+IC+F+GV CWH DEN+VL+I+LS GL+
Sbjct: 31 NIDCLRTFKSQVEDPNRYLST-WVFGNETAGYICKFSGVTCWHDDENRVLSIKLSGYGLR 89
Query: 96 GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCT 155
G FP ++ C LTGLDLS NN SG +P++IS+ + VT LDLS NS SGEIP ++N T
Sbjct: 90 GVFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSGEIPMLISNIT 149
Query: 156 FLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF-ANVNFTAEDFANNSGL 214
FLN L L +N+FTG +PPQL L R+KTFSV+ N L GP+P+F + F E FANN L
Sbjct: 150 FLNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFKQELFANNLDL 209
Query: 215 CGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMRGV-YVKKKEDDPEGNK 273
CGKPL+ C SR ++ AA G+T ALVVG+ LF + R + V+KK+DDPEGN+
Sbjct: 210 CGKPLDDCKSA-SSSRGKVVIIAAVGGLTAAALVVGVVLFFYFRKLGAVRKKQDDPEGNR 268
Query: 274 WAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFI 333
WAK +KG KG+KV F+KSV KM+LSDLMKAT F K+NII TGRTG Y L G +
Sbjct: 269 WAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKGRLEDGSLL 328
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH 393
MIKRL+DSQ SEKEF +E+ TLGSV++RNLVPLLG+CVA KERLL+Y Y+ NG LYD+LH
Sbjct: 329 MIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMANGYLYDQLH 388
Query: 394 PAEHEVMH-MDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
PA+ E +DWP RL+IAIG+A+GLAWLHH+CNPRIIHRNISSKCILL +FEPK+SDF
Sbjct: 389 PADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLTAEFEPKISDF 448
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPT 512
GLARLMNP+DTHLSTFVNGEFGD GYVAPEY RT+VATPKGDVYSFGVVLLEL+TG++ T
Sbjct: 449 GLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVLLELVTGQKAT 508
Query: 513 HLTNA------PESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCV 566
+T E+FKG+LVEWIT L++ S L+ AID+SLLGNG D E+ + L+VACNCV
Sbjct: 509 SVTKVSEEKAEEENFKGNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIFKVLKVACNCV 568
Query: 567 LP-TPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPDELIVA 616
LP K+R TMFEVYQLLRAI E Y+FT DD+I++PS +G+ +F +ELIVA
Sbjct: 569 LPEIAKQRPTMFEVYQLLRAIGESYNFTADDDILIPSESGEGDFIEELIVA 619
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O04567|Y1719_ARATH Probable inactive receptor kinase At1g27190 OS=Arabidopsis thaliana GN=At1g27190 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1295), Expect = e-141, Method: Compositional matrix adjust.
Identities = 256/563 (45%), Positives = 371/563 (65%), Gaps = 12/563 (2%)
Query: 35 NDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGL 94
+D+ CL+ +KNSL DP + L+ SW+F N++ IC+ TGV CW+ EN++++++L M L
Sbjct: 26 DDVLCLQGLKNSLIDPSSRLS-SWSFPNSSASSICKLTGVSCWNEKENRIISLQLQSMQL 84
Query: 95 KGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANC 154
G+ P ++ C SL LDLS N+LSGSIPS I S L Y+ +LDLS N L G IP+ + C
Sbjct: 85 AGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLSGNKLGGSIPTQIVEC 144
Query: 155 TFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGL 214
FLN L L++N+ +G IP QL L+R++ S+A N L+G +PS F +DF+ N+GL
Sbjct: 145 KFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPS-ELARFGGDDFSGNNGL 203
Query: 215 CGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMR-------GVYVKKKED 267
CGKPL+ C + ++ + II A V + + IF + F+R G K +D
Sbjct: 204 CGKPLSRCGALNGRNLSIIIVAGVLGAVGSLCVGLVIFWWFFIREGSRKKKGYGAGKSKD 263
Query: 268 DPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAML 327
D + W ++ K ++V+ F+K + K++L DLM ATN+FS NI + RTG +Y A L
Sbjct: 264 DSD---WIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDVSSRTGVSYKADL 320
Query: 328 PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT 387
P G + +KRL EK+F SE+N LG +RH NLVPLLG+CV + ERLLVY ++ NGT
Sbjct: 321 PDGSALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDERLLVYKHMVNGT 380
Query: 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447
L+ +LH +DWP R I +G+A+GLAWLHH C P +H+ ISS ILLD DF+
Sbjct: 381 LFSQLHNGGLCDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFISSNVILLDDDFDA 440
Query: 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
+++D+GLA+L+ D++ S+F NG+ G+LGYVAPEY T+VA+ KGDVY FG+VLLEL+T
Sbjct: 441 RITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDVYGFGIVLLELVT 500
Query: 508 GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVL 567
G++P + N E FKGSLV+W++ + AID+S+ G D E+ QFL++AC+CV+
Sbjct: 501 GQKPLSVINGVEGFKGSLVDWVSQYLGTGRSKDAIDRSICDKGHDEEILQFLKIACSCVV 560
Query: 568 PTPKERHTMFEVYQLLRAIAERY 590
PKER TM +VY+ L+ +A+++
Sbjct: 561 SRPKERPTMIQVYESLKNMADKH 583
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGI5|Y1699_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g69990 OS=Arabidopsis thaliana GN=At1g69990 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 502 bits (1293), Expect = e-141, Method: Compositional matrix adjust.
Identities = 256/570 (44%), Positives = 367/570 (64%), Gaps = 23/570 (4%)
Query: 35 NDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGL 94
+D+ CLK K+SL+DP N L T W+F N++ IC+ TGV CW+ EN++L+++L M L
Sbjct: 20 DDVLCLKGFKSSLKDPSNQLNT-WSFPNSSSS-ICKLTGVSCWNAKENRILSLQLQSMQL 77
Query: 95 KGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANC 154
GQ P ++ C SL LDLS N+ SG IPS I S L Y+ +LDLS N LSG IPS + +C
Sbjct: 78 SGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPYLVTLDLSGNKLSGSIPSQIVDC 137
Query: 155 TFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGL 214
FLN L LN N+ TG IP +L LNR++ S+A N L+G +PS + ++ + F N GL
Sbjct: 138 KFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLSGSIPSELS-HYGEDGFRGNGGL 196
Query: 215 CGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMR--------GVYVKKKE 266
CGKPL+ C K+ I+ A V + G+F + F+R G K +
Sbjct: 197 CGKPLSNCGSFNGKNLTIIVTAGVIGAVGSLCVGFGMFWWFFIRDRRKMNNYGYGAGKCK 256
Query: 267 DDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAM 326
DD + W ++ K ++V+ F+K + K++L DL++ATN F NI+ + R+G +Y A
Sbjct: 257 DDSD---WIGLLRSHKLVQVTLFQKPIVKIKLVDLIEATNGFDSGNIVVSSRSGVSYKAD 313
Query: 327 LPGGCFIMIKRLED-SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385
LP G + +KRL + SEK+F SEIN LG +RH NLVPLLGFCV + E LLVY ++ N
Sbjct: 314 LPDGSTLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLVPLLGFCVVEDEILLVYKHMAN 373
Query: 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445
GTLY +L + +DWP R+R+A+G+ARGLAWLHH C P +H+ ISS ILLD DF
Sbjct: 374 GTLYSQLQQWD-----IDWPTRVRVAVGAARGLAWLHHGCQPLYMHQYISSNVILLDEDF 428
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
+ ++ D+GL +L++ D+ S+F NG+F GYVAPEY T+VA+ GDVY FG+VLLE+
Sbjct: 429 DARVIDYGLGKLVSSQDSKDSSFSNGKF---GYVAPEYSSTMVASLSGDVYGFGIVLLEI 485
Query: 506 ITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNC 565
+TG++P + N E FK SLVEW++ +N + AID+ + G G+D E+ Q LR+AC+C
Sbjct: 486 VTGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDRRIFGKGYDDEIMQVLRIACSC 545
Query: 566 VLPTPKERHTMFEVYQLLRAIAERYHFTTD 595
V+ PKER M +VY+ L+ + +++ F ++
Sbjct: 546 VVSRPKERPLMIQVYESLKNLGDQHGFFSE 575
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 204/549 (37%), Positives = 309/549 (56%), Gaps = 54/549 (9%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
K+ + L++ L G P SL L+L+ N L G +P+ + + L+ +T +DLS N+
Sbjct: 653 KLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGN-LKELTHMDLSFNN 711
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS----F 198
LSGE+ S L+ L L + N+FTG+IP +LG L +++ V+ NLL+G +P+
Sbjct: 712 LSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGL 771
Query: 199 ANVNF----------------TAED-----FANNSGLCGKPL-NPCPGVPKKSRAGIIAA 236
N+ F +D + N LCG+ + + C K R+ A
Sbjct: 772 PNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIA 831
Query: 237 AAAAGVTFTALVVGIFLFCFMRGVYVK--KKEDDPEGNKWAK---------------RIK 279
G T ++V +F+F R K K+ DDPE + ++ R +
Sbjct: 832 GLMLGFT---IIVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSR 888
Query: 280 GTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLE 339
I ++ FE+ + K+RL D+++AT+ FSK NIIG G G Y A LPG + +K+L
Sbjct: 889 EPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLS 948
Query: 340 DSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHE 398
+++ +EF++E+ TLG V+H NLV LLG+C +E+LLVY Y+ NG+L L
Sbjct: 949 EAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGM 1008
Query: 399 VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458
+ +DW RL+IA+G+ARGLA+LHH P IIHR+I + ILLDGDFEPK++DFGLARL+
Sbjct: 1009 LEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLI 1068
Query: 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAP 518
+ ++H+ST + G F GY+ PEY ++ AT KGDVYSFGV+LLEL+TG+ PT +
Sbjct: 1069 SACESHVSTVIAGTF---GYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTG-PDFK 1124
Query: 519 ESFKGSLVEW-ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577
ES G+LV W I +N +++ ID L+ + L++A C+ TP +R M
Sbjct: 1125 ESEGGNLVGWAIQKINQGKAVDV-IDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNML 1183
Query: 578 EVYQLLRAI 586
+V + L+ I
Sbjct: 1184 DVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (829), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 192/507 (37%), Positives = 291/507 (57%), Gaps = 34/507 (6%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166
S+ LDLS N +SGSIP + + Y+ L+L N L+G IP + VL L++N
Sbjct: 640 SMIYLDLSYNAVSGSIPLGYGA-MGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHND 698
Query: 167 FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN-FTAEDFANNSGLCGKPLNPCPGV 225
G +P LG L+ + V++N LTGP+P + F +ANNSGLCG PL PC
Sbjct: 699 LQGFLPGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPLPPCSSG 758
Query: 226 PKKSRAGI------IAAAAAAGVTFTALVVGIFLFCFMRGVYVKKKEDDPEGNKWAKRIK 279
+ +R+ IA +AG+ F+ + + + + R V+KKE E K+ + +
Sbjct: 759 SRPTRSHAHPKKQSIATGMSAGIVFSFMCIVMLIMALYRARKVQKKEKQRE--KYIESLP 816
Query: 280 GTK-------------GIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAM 326
+ I V+ FEK + K+ + L++ATN FS +++IG+G G Y A
Sbjct: 817 TSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAK 876
Query: 327 LPGGCFIMIKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385
L G + IK+L + + ++EF++E+ T+G ++HRNLVPLLG+C +ERLLVY Y++
Sbjct: 877 LADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKY 936
Query: 386 GTLYDKLHPAEHEV-MHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD 444
G+L LH + + +DW R +IAIG+ARGLA+LHH+C P IIHR++ S +LLD D
Sbjct: 937 GSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQD 996
Query: 445 FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLE 504
F ++SDFG+ARL++ +DTHLS V+ G GYV PEY ++ T KGDVYS+GV+LLE
Sbjct: 997 FVARVSDFGMARLVSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLE 1054
Query: 505 LITGERPTHLTNAPESF--KGSLVEWITLLNTNSSLETAIDKSLLGN-GFDGELHQFLRV 561
L++G++P PE F +LV W L +D L+ + D EL +L++
Sbjct: 1055 LLSGKKPID----PEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKI 1110
Query: 562 ACNCVLPTPKERHTMFEVYQLLRAIAE 588
A C+ P +R TM +V + + + +
Sbjct: 1111 ASQCLDDRPFKRPTMIQVMTMFKELVQ 1137
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 201/520 (38%), Positives = 295/520 (56%), Gaps = 41/520 (7%)
Query: 100 RGIERCT-----SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANC 154
RGI + T S+ LDLS N L GSIP ++ + + Y++ L+L N LSG IP L
Sbjct: 652 RGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGA-MYYLSILNLGHNDLSGMIPQQLGGL 710
Query: 155 TFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN-FTAEDFANNSG 213
+ +L L+ NRF G IP L L + +++N L+G +P A + F FANNS
Sbjct: 711 KNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNS- 769
Query: 214 LCGKPLN-PCPGVPKKS---------RAGIIAAAAAAGVTFTALVV-GIFLFCFMRGVYV 262
LCG PL PC PK R +A + A G+ F+ + G+ +
Sbjct: 770 LCGYPLPLPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRR 829
Query: 263 KKKEDDPEG------------NKWA-KRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFS 309
+KKE E + W + I ++AFEK + K+ +DL++ATN F
Sbjct: 830 RKKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFH 889
Query: 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
++++G+G G Y A L G + IK+L S ++EF +E+ T+G ++HRNLVPLLG
Sbjct: 890 NDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLG 949
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
+C +ERLLVY Y++ G+L D LH + + ++WP R +IAIG+ARGLA+LHHNC P
Sbjct: 950 YCKVGEERLLVYEYMKYGSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPH 1009
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV 488
IIHR++ S +LLD + E ++SDFG+ARLM+ +DTHLS V+ G GYV PEY ++
Sbjct: 1010 IIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFR 1067
Query: 489 ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548
+ KGDVYS+GVVLLEL+TG++P T++ + +LV W+ L+ + D+ LL
Sbjct: 1068 CSTKGDVYSYGVVLLELLTGKQP---TDSADFGDNNLVGWVK-LHAKGKITDVFDRELLK 1123
Query: 549 N--GFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
+ EL Q L+VAC C+ +R TM +V + + I
Sbjct: 1124 EDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEI 1163
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 201/520 (38%), Positives = 295/520 (56%), Gaps = 41/520 (7%)
Query: 100 RGIERCT-----SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANC 154
RGI + T S+ LDLS N L GSIP ++ + + Y++ L+L N LSG IP L
Sbjct: 652 RGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGA-MYYLSILNLGHNDLSGMIPQQLGGL 710
Query: 155 TFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN-FTAEDFANNSG 213
+ +L L+ NRF G IP L L + +++N L+G +P A + F FANNS
Sbjct: 711 KNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANNS- 769
Query: 214 LCGKPLN-PCPGVPKKS---------RAGIIAAAAAAGVTFTALVV-GIFLFCFMRGVYV 262
LCG PL PC PK R +A + A G+ F+ + G+ +
Sbjct: 770 LCGYPLPIPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIETKKRR 829
Query: 263 KKKEDDPEG------------NKWA-KRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFS 309
+KKE E + W + I ++AFEK + K+ +DL++ATN F
Sbjct: 830 RKKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAAFEKPLRKLTFADLLEATNGFH 889
Query: 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
++++G+G G Y A L G + IK+L S ++EF +E+ T+G ++HRNLVPLLG
Sbjct: 890 NDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLG 949
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
+C +ERLLVY Y++ G+L D LH + + ++WP R +IAIG+ARGLA+LHHNC P
Sbjct: 950 YCKVGEERLLVYEYMKYGSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPH 1009
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV 488
IIHR++ S +LLD + E ++SDFG+ARLM+ +DTHLS V+ G GYV PEY ++
Sbjct: 1010 IIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFR 1067
Query: 489 ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548
+ KGDVYS+GVVLLEL+TG++P T++ + +LV W+ L+ + D+ LL
Sbjct: 1068 CSTKGDVYSYGVVLLELLTGKQP---TDSADFGDNNLVGWVK-LHAKGKITDVFDRELLK 1123
Query: 549 N--GFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
+ EL Q L+VAC C+ +R TM +V + + I
Sbjct: 1124 EDASIEIELLQHLKVACACLDDRHWKRPTMIQVMAMFKEI 1163
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 3e-86, Method: Compositional matrix adjust.
Identities = 191/516 (37%), Positives = 287/516 (55%), Gaps = 35/516 (6%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166
S+ D+S N +SG IP + + Y+ L+L N ++G IP + VL L++N
Sbjct: 640 SMIYFDISYNAVSGFIPPGYGN-MGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNN 698
Query: 167 FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN-FTAEDFANNSGLCGKPLNPCPGV 225
G +P LG L+ + V++N LTGP+P + F +ANNSGLCG PL PC
Sbjct: 699 LQGYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSA 758
Query: 226 PKK-------SRAGIIAAAAAAGVTFTALVVGIFLFCFMRGVYVKKKEDDPEGNKWAKRI 278
P++ ++ +A A AG+ F+ + + + R V+KKE E +
Sbjct: 759 PRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPT 818
Query: 279 KGT-----------KGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAML 327
G+ I V+ FEK + K+ + L++ATN FS ++G+G G Y A L
Sbjct: 819 SGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQL 878
Query: 328 PGGCFIMIKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386
G + IK+L + ++EF++E+ T+G ++HRNLVPLLG+C +ERLLVY Y++ G
Sbjct: 879 RDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWG 938
Query: 387 TLYDKLHPAEHEV--MHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD 444
+L LH + ++++W R +IAIG+ARGLA+LHH+C P IIHR++ S +LLD D
Sbjct: 939 SLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDED 998
Query: 445 FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLE 504
FE ++SDFG+ARL++ +DTHLS V+ G GYV PEY ++ T KGDVYS+GV+LLE
Sbjct: 999 FEARVSDFGMARLVSALDTHLS--VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLE 1056
Query: 505 LITGERPTHLTNAPESF--KGSLVEWITLLNTNSSLETAIDKSLLGN-GFDGELHQFLRV 561
L++G++P P F +LV W L +D L+ + D EL +L++
Sbjct: 1057 LLSGKKPID----PGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKI 1112
Query: 562 ACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDE 597
A C+ P +R TM QL+ E T +DE
Sbjct: 1113 ASQCLDDRPFKRPTMI---QLMAMFKEMKADTEEDE 1145
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (812), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 192/511 (37%), Positives = 290/511 (56%), Gaps = 38/511 (7%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166
S+ LD+S N LSG IP +I S + Y+ L+L N +SG IP + + LN+L L++N+
Sbjct: 655 SMMFLDMSYNMLSGYIPKEIGS-MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 713
Query: 167 FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN-FTAEDFANNSGLCGKPLNPCP-- 223
G+IP + L + +++N L+GP+P F F NN GLCG PL C
Sbjct: 714 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 773
Query: 224 ---GVPKKSRA-----GIIAAAAAAGVTFTALVV-GIFLFCFMRG-----------VYVK 263
G R+ +A + A G+ F+ + + G+ L +Y +
Sbjct: 774 NADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAE 833
Query: 264 KKED--DPEGNKWAKRIKGTK---GIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGR 318
+ D N ++ G K I ++AFEK + K+ +DL++ATN F +++IG+G
Sbjct: 834 GHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGG 893
Query: 319 TGATYIAMLPGGCFIMIKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377
G Y A+L G + IK+L S ++EF++E+ T+G ++HRNLVPLLG+C ERL
Sbjct: 894 FGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERL 953
Query: 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437
LVY +++ G+L D LH + + ++W R +IAIGSARGLA+LHHNC+P IIHR++ S
Sbjct: 954 LVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSS 1013
Query: 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYS 497
+LLD + E ++SDFG+ARLM+ +DTHLS V+ G GYV PEY ++ + KGDVYS
Sbjct: 1014 NVLLDENLEARVSDFGMARLMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGDVYS 1071
Query: 498 FGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGN--GFDGEL 555
+GVVLLEL+TG+RP T++P+ +LV W+ + + D L+ + EL
Sbjct: 1072 YGVVLLELLTGKRP---TDSPDFGDNNLVGWVK-QHAKLRISDVFDPELMKEDPALEIEL 1127
Query: 556 HQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
Q L+VA C+ R TM +V + + I
Sbjct: 1128 LQHLKVAVACLDDRAWRRPTMVQVMAMFKEI 1158
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (798), Expect = 8e-84, Method: Compositional matrix adjust.
Identities = 194/488 (39%), Positives = 273/488 (55%), Gaps = 20/488 (4%)
Query: 111 LDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGK 170
+DLS N+L+GSI + L+ + L+L +N+LSG IP+ L+ T L VL L++N +G
Sbjct: 538 IDLSYNSLNGSIWPEFGD-LRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGN 596
Query: 171 IPPQLGLLNRIKTFSVASNLLTGPVPSFANVN-FTAEDFANNSGLCGKPLNPCP------ 223
IPP L L+ + TFSVA N L+GP+P+ F F N GLCG+ +PC
Sbjct: 597 IPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHASPCHITDQSP 656
Query: 224 -GVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMRGVYVKKKEDDPEGNKWAKRIK-GT 281
G KS+ I A A T V + + + + E DPE A I+ G+
Sbjct: 657 HGSAVKSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKADADEIELGS 716
Query: 282 KGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLE-D 340
+ + + + S ++ L D++K+T+SF++ NIIG G G Y A LP G + IKRL D
Sbjct: 717 RSVVLFHNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLSGD 776
Query: 341 SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVM 400
+ ++EF +E+ TL +H NLV LLG+C K ++LL+YSY++NG+L LH
Sbjct: 777 TGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVDGPP 836
Query: 401 HMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460
+DW RLRIA G+A GLA+LH +C P I+HR+I S ILL F L+DFGLARL+ P
Sbjct: 837 SLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHLADFGLARLILP 896
Query: 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPES 520
DTH++T + G LGY+ PEY + VAT KGDVYSFGVVLLEL+TG RP +
Sbjct: 897 YDTHVTTDL---VGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPMDVCKP--- 950
Query: 521 FKGS--LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFE 578
+GS L+ W+ + T D + E+ L +AC C+ PK R T +
Sbjct: 951 -RGSRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENPKTRPTTQQ 1009
Query: 579 VYQLLRAI 586
+ L I
Sbjct: 1010 LVSWLENI 1017
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 618 | ||||||
| 296083399 | 625 | unnamed protein product [Vitis vinifera] | 0.987 | 0.976 | 0.735 | 0.0 | |
| 359495880 | 621 | PREDICTED: probably inactive leucine-ric | 0.987 | 0.982 | 0.735 | 0.0 | |
| 224101263 | 605 | predicted protein [Populus trichocarpa] | 0.967 | 0.988 | 0.731 | 0.0 | |
| 224109168 | 612 | predicted protein [Populus trichocarpa] | 0.967 | 0.977 | 0.721 | 0.0 | |
| 359497728 | 625 | PREDICTED: probably inactive leucine-ric | 0.974 | 0.963 | 0.700 | 0.0 | |
| 296083571 | 619 | unnamed protein product [Vitis vinifera] | 0.974 | 0.972 | 0.700 | 0.0 | |
| 147766948 | 619 | hypothetical protein VITISV_037939 [Viti | 0.975 | 0.974 | 0.692 | 0.0 | |
| 358248884 | 592 | probably inactive leucine-rich repeat re | 0.943 | 0.984 | 0.682 | 0.0 | |
| 356531854 | 617 | PREDICTED: probably inactive leucine-ric | 0.957 | 0.959 | 0.664 | 0.0 | |
| 357507899 | 615 | Probably inactive leucine-rich repeat re | 0.957 | 0.962 | 0.661 | 0.0 |
| >gi|296083399|emb|CBI23354.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2348), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/620 (73%), Positives = 520/620 (83%), Gaps = 10/620 (1%)
Query: 1 MALMNKDATIFAHTLTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNF 60
MAL +K + AH+L VV++ + + AT DI CLK++KNSL+DP NYL SWNF
Sbjct: 1 MALTSKYLVVVAHSLIWVVLLSYSS---VCYATETDIYCLKTIKNSLQDPNNYLNFSWNF 57
Query: 61 NNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSG 120
NNNTEGFIC+F G+DCWHPDEN+VLNIRLSDMGLKGQFPRGI C+SLTGLDLS+N LSG
Sbjct: 58 NNNTEGFICKFAGIDCWHPDENRVLNIRLSDMGLKGQFPRGIRNCSSLTGLDLSNNKLSG 117
Query: 121 SIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNR 180
SIPSDIS L++VT+L+LSSNS +G+IP LANC+FLNVLKL+NNR TG IP QL LNR
Sbjct: 118 SIPSDISELLKFVTTLELSSNSFAGDIPPSLANCSFLNVLKLDNNRLTGTIPLQLSQLNR 177
Query: 181 IKTFSVASNLLTGPVPSFANVNFTA-EDFANNSGLCGKPL-NPCPGVPKKSRAGIIAAAA 238
+KTFSVA+NLLTG +P N+N T ED+ANN GLCGKP + C PKK R GIIA AA
Sbjct: 178 LKTFSVANNLLTGQIP---NINSTTREDYANNPGLCGKPFFDLCQASPKKFRIGIIAGAA 234
Query: 239 AAGVTFTALVVGIFLFCFMRGVYVKKK--EDDPEGNKWAKRIKGTKGIKVSAFEKSVEKM 296
GVT T +VV I L+ RGV +KKK EDDP+GNKW K IKG KG+KVS FEKS+ KM
Sbjct: 235 VGGVTITVIVVVIILYYISRGVVIKKKKKEDDPDGNKWTKSIKGLKGLKVSMFEKSISKM 294
Query: 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLG 356
RLSDLMKATN+F+KNNIIG GRTG+ Y A+LP GC +M+KRL+DSQ SEKEF+SE+NTLG
Sbjct: 295 RLSDLMKATNNFNKNNIIGDGRTGSVYKAVLPDGCSLMVKRLQDSQRSEKEFVSEMNTLG 354
Query: 357 SVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR 416
+V+HRNLVPL+GFC+AKKERLLVY ++ NG LYD+LHP E E M+WPLRLRIAIG+A+
Sbjct: 355 TVKHRNLVPLMGFCMAKKERLLVYKHMANGNLYDQLHPLEPEAKGMEWPLRLRIAIGTAK 414
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
GLAWLHH+CNPRIIHRNISSKCILLD +FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL
Sbjct: 415 GLAWLHHSCNPRIIHRNISSKCILLDENFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 474
Query: 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536
GYVAPEY RTLVATPKGDVYSFG VLLELITGERPTH++NAP+ FKGSLVEWIT L++NS
Sbjct: 475 GYVAPEYLRTLVATPKGDVYSFGTVLLELITGERPTHVSNAPDGFKGSLVEWITDLSSNS 534
Query: 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDD 596
L+TAIDKSLLG GFDGEL QFLRVAC CV TPKER TMFEVYQLLRAI ERYHFTTDD
Sbjct: 535 LLQTAIDKSLLGKGFDGELMQFLRVACKCVSETPKERPTMFEVYQLLRAIGERYHFTTDD 594
Query: 597 EIMLPSNTGDPNFPDELIVA 616
EI +PSNT D + PDELIVA
Sbjct: 595 EIFVPSNTADADLPDELIVA 614
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495880|ref|XP_002267164.2| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2347), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/620 (73%), Positives = 520/620 (83%), Gaps = 10/620 (1%)
Query: 1 MALMNKDATIFAHTLTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNF 60
MAL +K + AH+L VV++ + + AT DI CLK++KNSL+DP NYL SWNF
Sbjct: 1 MALTSKYLVVVAHSLIWVVLLSYSS---VCYATETDIYCLKTIKNSLQDPNNYLNFSWNF 57
Query: 61 NNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSG 120
NNNTEGFIC+F G+DCWHPDEN+VLNIRLSDMGLKGQFPRGI C+SLTGLDLS+N LSG
Sbjct: 58 NNNTEGFICKFAGIDCWHPDENRVLNIRLSDMGLKGQFPRGIRNCSSLTGLDLSNNKLSG 117
Query: 121 SIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNR 180
SIPSDIS L++VT+L+LSSNS +G+IP LANC+FLNVLKL+NNR TG IP QL LNR
Sbjct: 118 SIPSDISELLKFVTTLELSSNSFAGDIPPSLANCSFLNVLKLDNNRLTGTIPLQLSQLNR 177
Query: 181 IKTFSVASNLLTGPVPSFANVNFTA-EDFANNSGLCGKPL-NPCPGVPKKSRAGIIAAAA 238
+KTFSVA+NLLTG +P N+N T ED+ANN GLCGKP + C PKK R GIIA AA
Sbjct: 178 LKTFSVANNLLTGQIP---NINSTTREDYANNPGLCGKPFFDLCQASPKKFRIGIIAGAA 234
Query: 239 AAGVTFTALVVGIFLFCFMRGVYVKKK--EDDPEGNKWAKRIKGTKGIKVSAFEKSVEKM 296
GVT T +VV I L+ RGV +KKK EDDP+GNKW K IKG KG+KVS FEKS+ KM
Sbjct: 235 VGGVTITVIVVVIILYYISRGVVIKKKKKEDDPDGNKWTKSIKGLKGLKVSMFEKSISKM 294
Query: 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLG 356
RLSDLMKATN+F+KNNIIG GRTG+ Y A+LP GC +M+KRL+DSQ SEKEF+SE+NTLG
Sbjct: 295 RLSDLMKATNNFNKNNIIGDGRTGSVYKAVLPDGCSLMVKRLQDSQRSEKEFVSEMNTLG 354
Query: 357 SVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR 416
+V+HRNLVPL+GFC+AKKERLLVY ++ NG LYD+LHP E E M+WPLRLRIAIG+A+
Sbjct: 355 TVKHRNLVPLMGFCMAKKERLLVYKHMANGNLYDQLHPLEPEAKGMEWPLRLRIAIGTAK 414
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
GLAWLHH+CNPRIIHRNISSKCILLD +FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL
Sbjct: 415 GLAWLHHSCNPRIIHRNISSKCILLDENFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 474
Query: 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536
GYVAPEY RTLVATPKGDVYSFG VLLELITGERPTH++NAP+ FKGSLVEWIT L++NS
Sbjct: 475 GYVAPEYLRTLVATPKGDVYSFGTVLLELITGERPTHVSNAPDGFKGSLVEWITDLSSNS 534
Query: 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDD 596
L+TAIDKSLLG GFDGEL QFLRVAC CV TPKER TMFEVYQLLRAI ERYHFTTDD
Sbjct: 535 LLQTAIDKSLLGKGFDGELMQFLRVACKCVSETPKERPTMFEVYQLLRAIGERYHFTTDD 594
Query: 597 EIMLPSNTGDPNFPDELIVA 616
EI +PSNT D + PDELIVA
Sbjct: 595 EIFVPSNTADADLPDELIVA 614
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224101263|ref|XP_002312207.1| predicted protein [Populus trichocarpa] gi|222852027|gb|EEE89574.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 897 bits (2319), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/606 (73%), Positives = 508/606 (83%), Gaps = 8/606 (1%)
Query: 18 VVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCW 77
+V++L + L AT DIECLKS+K+SL DP+NYL T+W+FNNNTEGF+C+F GV+CW
Sbjct: 1 MVLVLLSSRITLIDATATDIECLKSIKDSLVDPYNYLNTTWDFNNNTEGFLCRFMGVECW 60
Query: 78 HPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLD 137
HPDEN+VLNIRLSD+ LKGQFP GI++CTSLTGLDLS N L GSIP++IS L YVT+LD
Sbjct: 61 HPDENRVLNIRLSDLSLKGQFPLGIQKCTSLTGLDLSRNKLFGSIPANISKLLPYVTNLD 120
Query: 138 LSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
LS N+ SG IP LANC+FLN LKL+NNR TG IP + GLL+RIK F+V +NLL+GP+P+
Sbjct: 121 LSFNNFSGGIPLNLANCSFLNDLKLDNNRLTGNIPLEFGLLDRIKIFTVTNNLLSGPIPN 180
Query: 198 FANVNFTAEDFANNSGLCGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFM 257
F + N + FANN LCGKPL CPGV +KS G+IAAAAA G+TFT+++ GIFL+
Sbjct: 181 FIHSNIPVDSFANNLDLCGKPLKLCPGVQRKSHVGVIAAAAAGGITFTSIICGIFLYYLS 240
Query: 258 RGVYVKKKEDDPEGNKWAKRIKGTKGIK-------VSAFEKSVEKMRLSDLMKATNSFSK 310
RGV K+K DDPEGN+WAK IKGTKGIK VS FEKSV KMRLSDLMKATN FS
Sbjct: 241 RGV-AKRKADDPEGNRWAKSIKGTKGIKASYLTHLVSMFEKSVSKMRLSDLMKATNDFSN 299
Query: 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC 370
NNIIG GRTG Y A+ GCF+M+KRL+DSQ EKEF+SE+NTLG+V+HRNLVPLLGFC
Sbjct: 300 NNIIGAGRTGPMYKAVFSEGCFLMVKRLQDSQRLEKEFVSEMNTLGNVKHRNLVPLLGFC 359
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRII 430
VAKKER LVY ++ENGTLYDKLHP E E+ +MDWPLRL+IAIG+ARGLAWLHHNCNPRII
Sbjct: 360 VAKKERFLVYKFIENGTLYDKLHPLEPEIRNMDWPLRLKIAIGTARGLAWLHHNCNPRII 419
Query: 431 HRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT 490
HRNISSKCILLDGDFEPKLSDFGLARLMNP+DTHLSTFVNGEFGDLGYVAPEY RTLVAT
Sbjct: 420 HRNISSKCILLDGDFEPKLSDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYLRTLVAT 479
Query: 491 PKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNG 550
PKGDVYSFGVVLLELITGE+PTH+ NAPESFKGSLVEWI L+ L TAIDK L GNG
Sbjct: 480 PKGDVYSFGVVLLELITGEKPTHVANAPESFKGSLVEWIKQLSHGPLLHTAIDKPLPGNG 539
Query: 551 FDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFP 610
+D EL+QFL+VACNCV+ KER TMFEV+QLLRAI ERYHFTTDD+IMLPS+TGD FP
Sbjct: 540 YDHELNQFLKVACNCVVENAKERPTMFEVHQLLRAIGERYHFTTDDDIMLPSDTGDTAFP 599
Query: 611 DELIVA 616
DELIVA
Sbjct: 600 DELIVA 605
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224109168|ref|XP_002315108.1| predicted protein [Populus trichocarpa] gi|222864148|gb|EEF01279.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2298), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/607 (72%), Positives = 508/607 (83%), Gaps = 9/607 (1%)
Query: 18 VVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCW 77
+V++L + +S AT D+ CLKS+K SL DP NYL T+WNFNNNTEGFIC+F G+DCW
Sbjct: 1 MVLVLLSSRISVSNATETDLACLKSIKASLVDPNNYLNTTWNFNNNTEGFICRFMGIDCW 60
Query: 78 HPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLD 137
HPDEN+VLNIRLSD+GL+GQFP GI+ CTSLTGLDLS N LSGSIP +IS + Y+T+LD
Sbjct: 61 HPDENRVLNIRLSDLGLEGQFPLGIKNCTSLTGLDLSHNKLSGSIPDNISDLIPYITNLD 120
Query: 138 LSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
LS N+ SG IP LANC+FLN LKL+NNR TGKIPP+LGLL+RIK F+V +NLL+G +PS
Sbjct: 121 LSFNNFSGGIPQNLANCSFLNDLKLDNNRLTGKIPPELGLLDRIKEFTVTNNLLSGQIPS 180
Query: 198 FANVNFTAEDFANNSGLCGKPLNP-CPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCF 256
F + N A+ FANN LCGKPLN CP V +KS G+IAA+AA G+TFT+++VG+FLF
Sbjct: 181 FVHNNIPADSFANNLDLCGKPLNSSCPAVARKSHVGVIAASAAGGITFTSIIVGVFLFYL 240
Query: 257 MRGVYVKKKEDDPEGNKWAKRIKGTKGIK-------VSAFEKSVEKMRLSDLMKATNSFS 309
RG KKK +DPEGN+WAK IKGTKGIK VS FEKSV KMRLSDLMKATN FS
Sbjct: 241 SRGA-AKKKAEDPEGNRWAKSIKGTKGIKASYLAHHVSMFEKSVSKMRLSDLMKATNDFS 299
Query: 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGF 369
NNIIG GRTG Y A++ GCF+M+KRL+DSQ EKEF+SE+ TLG+V+HRNLVPLLGF
Sbjct: 300 NNNIIGAGRTGPMYKAVISDGCFLMVKRLQDSQRLEKEFVSEMKTLGNVKHRNLVPLLGF 359
Query: 370 CVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRI 429
CVAK+ER LVY ++ENGTLYDKLHP E E+ +MDW LRL+IAIG+ARGLAWLH+NCNPRI
Sbjct: 360 CVAKRERFLVYKFMENGTLYDKLHPVEPEIRNMDWSLRLKIAIGAARGLAWLHYNCNPRI 419
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA 489
IHRNISSKCILLD DFEPKLSDFGLARLMNP+DTHLSTFVNGEFGD+GYVAPEY RTLVA
Sbjct: 420 IHRNISSKCILLDNDFEPKLSDFGLARLMNPIDTHLSTFVNGEFGDMGYVAPEYLRTLVA 479
Query: 490 TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGN 549
TPKGDVYSFGVVLLELITGE+PTH+ NAPESFKGSLVEWI L L T+IDK LLGN
Sbjct: 480 TPKGDVYSFGVVLLELITGEKPTHVANAPESFKGSLVEWIRQLTDGPLLHTSIDKPLLGN 539
Query: 550 GFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNF 609
GFD EL+QFL+VACNCV+ KER TMFEV+QLLRAI ERYHFTT+D+IMLP++TGD +F
Sbjct: 540 GFDHELNQFLKVACNCVVENAKERPTMFEVHQLLRAIGERYHFTTEDDIMLPTDTGDTDF 599
Query: 610 PDELIVA 616
PDELIVA
Sbjct: 600 PDELIVA 606
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497728|ref|XP_003635622.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2289), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/605 (70%), Positives = 503/605 (83%), Gaps = 3/605 (0%)
Query: 15 LTVVVVILFC--GNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFT 72
LTV + I+ C LS AT +D+ CLK +KNSL+DP+ YL +SW+FNN TEGFIC+FT
Sbjct: 14 LTVAIAIMLCLLWCSSLSYATESDLYCLKGIKNSLDDPYRYLNSSWDFNNKTEGFICRFT 73
Query: 73 GVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY 132
G++CWHPDEN+VLNI+L+DMGLKGQFPR I+ CTSLTGLDLSSN+L GSIPSDI+ +++
Sbjct: 74 GIECWHPDENRVLNIKLADMGLKGQFPRAIKNCTSLTGLDLSSNDLYGSIPSDINDIIKF 133
Query: 133 VTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+T+LDLSSN+ SG IP GL+NC++LNVLKL+NN+ +G IP +LGLLNR+KTFSV++NLLT
Sbjct: 134 MTTLDLSSNNFSGPIPLGLSNCSYLNVLKLDNNQLSGTIPLELGLLNRMKTFSVSNNLLT 193
Query: 193 GPVPSFANVNFTAEDFANNSGLCGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIF 252
GPVP FA+VN TA+ +ANN GLCG NPC KK AGIIA AA VT +ALVVG+
Sbjct: 194 GPVPQFASVNVTADSYANNPGLCGYASNPCQAPSKKMHAGIIAGAAMGAVTISALVVGLG 253
Query: 253 LFCFMRGVYVK-KKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKN 311
L + R V VK KKE+DPEGNKWA+ IKGTKGIKVS FEKS+ KMRLSDLMKATN+FSK+
Sbjct: 254 LSFYYRNVSVKRKKEEDPEGNKWARSIKGTKGIKVSMFEKSISKMRLSDLMKATNNFSKD 313
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
NIIG+GRTG Y A+L G +M+KRL+DSQHSEKEF+SE+ TLGSV+HRNLVPLLGFCV
Sbjct: 314 NIIGSGRTGTMYKAVLEDGTSLMVKRLQDSQHSEKEFMSEMATLGSVKHRNLVPLLGFCV 373
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
AKKERLLVY + NG L+D+LHP + ++WPLRL+I IG+AR AWLHHNCNPRI+H
Sbjct: 374 AKKERLLVYRNMPNGNLHDQLHPMDGGDKTLEWPLRLKIGIGAARAFAWLHHNCNPRILH 433
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
RNISSKCILLD DFEPK+SDFGLARLMNP+DTHLSTFVNGEFGDLGYVAPEY RTLVATP
Sbjct: 434 RNISSKCILLDADFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTRTLVATP 493
Query: 492 KGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGF 551
KGDVYSFG VLLEL+TGERP H+ APE FKG+LVEWIT L++N+ L AID+SL+G GF
Sbjct: 494 KGDVYSFGTVLLELVTGERPIHVAKAPEDFKGNLVEWITQLSSNNKLHDAIDESLVGKGF 553
Query: 552 DGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPD 611
D EL QFL+VAC CVLP PKER TMFE++Q LRAI ERY+FT DD+I PS+TG + D
Sbjct: 554 DSELFQFLKVACTCVLPEPKERPTMFELFQFLRAIGERYNFTVDDDIGAPSDTGGEDNMD 613
Query: 612 ELIVA 616
ELIVA
Sbjct: 614 ELIVA 618
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296083571|emb|CBI23562.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/605 (70%), Positives = 503/605 (83%), Gaps = 3/605 (0%)
Query: 15 LTVVVVILFC--GNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFT 72
LTV + I+ C LS AT +D+ CLK +KNSL+DP+ YL +SW+FNN TEGFIC+FT
Sbjct: 8 LTVAIAIMLCLLWCSSLSYATESDLYCLKGIKNSLDDPYRYLNSSWDFNNKTEGFICRFT 67
Query: 73 GVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY 132
G++CWHPDEN+VLNI+L+DMGLKGQFPR I+ CTSLTGLDLSSN+L GSIPSDI+ +++
Sbjct: 68 GIECWHPDENRVLNIKLADMGLKGQFPRAIKNCTSLTGLDLSSNDLYGSIPSDINDIIKF 127
Query: 133 VTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+T+LDLSSN+ SG IP GL+NC++LNVLKL+NN+ +G IP +LGLLNR+KTFSV++NLLT
Sbjct: 128 MTTLDLSSNNFSGPIPLGLSNCSYLNVLKLDNNQLSGTIPLELGLLNRMKTFSVSNNLLT 187
Query: 193 GPVPSFANVNFTAEDFANNSGLCGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIF 252
GPVP FA+VN TA+ +ANN GLCG NPC KK AGIIA AA VT +ALVVG+
Sbjct: 188 GPVPQFASVNVTADSYANNPGLCGYASNPCQAPSKKMHAGIIAGAAMGAVTISALVVGLG 247
Query: 253 LFCFMRGVYVK-KKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKN 311
L + R V VK KKE+DPEGNKWA+ IKGTKGIKVS FEKS+ KMRLSDLMKATN+FSK+
Sbjct: 248 LSFYYRNVSVKRKKEEDPEGNKWARSIKGTKGIKVSMFEKSISKMRLSDLMKATNNFSKD 307
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
NIIG+GRTG Y A+L G +M+KRL+DSQHSEKEF+SE+ TLGSV+HRNLVPLLGFCV
Sbjct: 308 NIIGSGRTGTMYKAVLEDGTSLMVKRLQDSQHSEKEFMSEMATLGSVKHRNLVPLLGFCV 367
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
AKKERLLVY + NG L+D+LHP + ++WPLRL+I IG+AR AWLHHNCNPRI+H
Sbjct: 368 AKKERLLVYRNMPNGNLHDQLHPMDGGDKTLEWPLRLKIGIGAARAFAWLHHNCNPRILH 427
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
RNISSKCILLD DFEPK+SDFGLARLMNP+DTHLSTFVNGEFGDLGYVAPEY RTLVATP
Sbjct: 428 RNISSKCILLDADFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTRTLVATP 487
Query: 492 KGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGF 551
KGDVYSFG VLLEL+TGERP H+ APE FKG+LVEWIT L++N+ L AID+SL+G GF
Sbjct: 488 KGDVYSFGTVLLELVTGERPIHVAKAPEDFKGNLVEWITQLSSNNKLHDAIDESLVGKGF 547
Query: 552 DGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPD 611
D EL QFL+VAC CVLP PKER TMFE++Q LRAI ERY+FT DD+I PS+TG + D
Sbjct: 548 DSELFQFLKVACTCVLPEPKERPTMFELFQFLRAIGERYNFTVDDDIGAPSDTGGEDNMD 607
Query: 612 ELIVA 616
ELIVA
Sbjct: 608 ELIVA 612
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147766948|emb|CAN63265.1| hypothetical protein VITISV_037939 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/604 (69%), Positives = 502/604 (83%), Gaps = 1/604 (0%)
Query: 14 TLTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTG 73
T+ + +++ + LS AT +D+ CLK++K SL+DP+ YL +SW+FNN TEGFIC+FTG
Sbjct: 9 TVAIAIMLCLLWSSSLSYATESDLYCLKAIKKSLDDPYRYLNSSWDFNNKTEGFICRFTG 68
Query: 74 VDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYV 133
++CWHPDEN+VLNI+L+DMGLKGQFPR I+ CTSLTGLDLSSN+L GSIPSDI+ ++++
Sbjct: 69 IECWHPDENRVLNIKLADMGLKGQFPRAIKNCTSLTGLDLSSNDLYGSIPSDINDIIKFM 128
Query: 134 TSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
T+LDLSSN+ SG IP L+NC++LNVLKL+NN+ +G IP +LGLLNR+KTFSV++NLLTG
Sbjct: 129 TTLDLSSNNFSGPIPLXLSNCSYLNVLKLDNNQLSGTIPLELGLLNRMKTFSVSNNLLTG 188
Query: 194 PVPSFANVNFTAEDFANNSGLCGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFL 253
PVP FA+VN TA+ +ANN GLCG NPC KK AGIIA AA VT +ALVVG+ L
Sbjct: 189 PVPQFASVNVTADSYANNPGLCGYASNPCQAPSKKMHAGIIAGAAMGAVTISALVVGLGL 248
Query: 254 FCFMRGVYVK-KKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNN 312
+ R V VK KKE+DPEGNKWA+ IKGTKGIKVS FEKS+ KMRLSDLMKATN+FSK+N
Sbjct: 249 SFYYRNVSVKRKKEEDPEGNKWARSIKGTKGIKVSMFEKSISKMRLSDLMKATNNFSKDN 308
Query: 313 IIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
IIG+GRTG Y A+L G +M+KRL+DSQHSEKEF+SE+ TLGSV+HRNLVPLLGFCVA
Sbjct: 309 IIGSGRTGTMYKAVLEDGTSLMVKRLQDSQHSEKEFMSEMATLGSVKHRNLVPLLGFCVA 368
Query: 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR 432
KKERLLVY + NG L+D+LHP + ++WPLRL+I IG+AR AWLHHNCNPRI+HR
Sbjct: 369 KKERLLVYRNMPNGNLHDQLHPMDGGDKXLEWPLRLKIGIGAARAFAWLHHNCNPRILHR 428
Query: 433 NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPK 492
NISSKCILLD DFEPK+SDFGLARLMNP+DTHLSTFVNGEFGDLGYVAPEY RTLVATPK
Sbjct: 429 NISSKCILLDADFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTRTLVATPK 488
Query: 493 GDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFD 552
GDVYSFG VLLEL+TGERP H+ APE FKG+LVEWIT L++N+ L AID+SL+G GFD
Sbjct: 489 GDVYSFGTVLLELVTGERPIHVAKAPEDFKGNLVEWITQLSSNNKLHDAIDESLVGKGFD 548
Query: 553 GELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPDE 612
EL QFL+VAC CVLP PKER TMFE++Q LRAI ERY+FT DD+I PS+TG + DE
Sbjct: 549 SELFQFLKVACTCVLPEPKERPTMFELFQFLRAIGERYNFTVDDDIGAPSDTGGEDNMDE 608
Query: 613 LIVA 616
LIVA
Sbjct: 609 LIVA 612
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248884|ref|NP_001239701.1| probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Glycine max] gi|223452311|gb|ACM89483.1| leucine-rich repeat family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/586 (68%), Positives = 483/586 (82%), Gaps = 3/586 (0%)
Query: 32 ATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSD 91
T +DI CLKSVK +L+DP+NYL SWNFNNNTEG+IC+FTGV+CWHPDENKVLN++LS+
Sbjct: 4 GTDSDIFCLKSVKRTLDDPYNYLQ-SWNFNNNTEGYICKFTGVECWHPDENKVLNLKLSN 62
Query: 92 MGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL 151
MGLKG FPRGI+ C+S+TGLD S N LS +IP+DIS+ L +VT+LDLSSN +GEIP+ L
Sbjct: 63 MGLKGPFPRGIQNCSSMTGLDFSLNRLSKTIPADISTLLTFVTTLDLSSNDFTGEIPASL 122
Query: 152 ANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANN 211
+NCT+LN ++L+ N+ TG+IP L L R+K FSVA+NLLTG VP FAN +A +ANN
Sbjct: 123 SNCTYLNTIRLDQNQLTGQIPANLSQLPRLKLFSVANNLLTGQVPIFANGVASANSYANN 182
Query: 212 SGLCGKPL-NPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMRGVYVKKKEDDPE 270
SGLCGKPL + C KS +IA AA GVT AL +GI +F ++R + +KKE+DPE
Sbjct: 183 SGLCGKPLLDACQAKASKSNTAVIAGAAVGGVTVAALGLGIGMFFYVRRISYRKKEEDPE 242
Query: 271 GNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGG 330
GNKWA+ +KGTK IKVS FEKS+ KM L+DLMKAT++F K+NIIGTGR+G Y A+L G
Sbjct: 243 GNKWARSLKGTKTIKVSMFEKSISKMNLNDLMKATDNFGKSNIIGTGRSGTVYKAVLHDG 302
Query: 331 CFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390
+M+KRL++SQHSEKEFLSE+N LGSV+HRNLVPLLGFCVAKKER LVY + NGTL+D
Sbjct: 303 TSLMVKRLQESQHSEKEFLSEMNILGSVKHRNLVPLLGFCVAKKERFLVYKNMPNGTLHD 362
Query: 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
+LHP + MDWPLRL+IAIG+A+GLAWLHH+CNPRIIHRNISSKCILLD DFEPK+S
Sbjct: 363 QLHP-DAGACTMDWPLRLKIAIGAAKGLAWLHHSCNPRIIHRNISSKCILLDADFEPKIS 421
Query: 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGER 510
DFGLARLMNP+DTHLSTFVNGEFGDLGYVAPEY +TLVATPKGD+YSFG VLLEL+TGER
Sbjct: 422 DFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTKTLVATPKGDIYSFGTVLLELVTGER 481
Query: 511 PTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTP 570
PTH++ APE+FKG+LVEWI ++N+ L AID+SL+G G D EL QFL+VACNCV P
Sbjct: 482 PTHVSKAPETFKGNLVEWIQQQSSNAKLHEAIDESLVGKGVDQELFQFLKVACNCVTAMP 541
Query: 571 KERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPDELIVA 616
KER TMFEVYQLLRAI Y+FTT+DEIMLP +TGD + +ELIVA
Sbjct: 542 KERPTMFEVYQLLRAIGINYNFTTEDEIMLPMDTGDADNLEELIVA 587
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531854|ref|XP_003534491.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g48380-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2130), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/597 (66%), Positives = 482/597 (80%), Gaps = 5/597 (0%)
Query: 20 VILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHP 79
+++ CG V T +D+ CLKSVK++LEDP+NYL SWNFNNNTEG+IC+F GV+CWHP
Sbjct: 21 LLILCGMV---CGTESDLFCLKSVKSALEDPYNYLQ-SWNFNNNTEGYICKFIGVECWHP 76
Query: 80 DENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLS 139
DENKVLN++LS+MGLKG FPRGI+ CTS+TGLD S N LS +IP+DIS+ L +VT+LDLS
Sbjct: 77 DENKVLNLKLSNMGLKGPFPRGIQNCTSMTGLDFSLNRLSKTIPADISTLLTFVTTLDLS 136
Query: 140 SNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA 199
SN +GEIP+ L+NCT+LN L+L+ N+ TG IP L L R+K FSVA+NLLTGPVP F
Sbjct: 137 SNDFTGEIPASLSNCTYLNTLRLDQNQLTGHIPANLSQLPRLKLFSVANNLLTGPVPPFK 196
Query: 200 NVNFTAEDFANNSGLCGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMRG 259
A+++ANNSGLCG PL C KS +IA AA GVT AL +GI +F ++R
Sbjct: 197 PGVAGADNYANNSGLCGNPLGTCQVGSSKSNTAVIAGAAVGGVTVAALGLGIGMFFYVRR 256
Query: 260 VYVKKKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRT 319
+ +KKE+DPEGNKWA+ +KGTK IKVS FEKS+ KM L+DLMKAT++FSK+NIIGTGR+
Sbjct: 257 ISYRKKEEDPEGNKWARSLKGTKKIKVSMFEKSISKMNLNDLMKATDNFSKSNIIGTGRS 316
Query: 320 GATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379
G Y A+L G +M+KRL++SQ+SEKEFLSE+N LGSV+HRNLVPLLGFCVAKKERLLV
Sbjct: 317 GIVYKAVLHDGTSLMVKRLQESQYSEKEFLSEMNILGSVKHRNLVPLLGFCVAKKERLLV 376
Query: 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCI 439
Y + NGTL+D+LHP + MDWPLRL+IAIG+A+GLAWLHH+CNPRIIHRNISSKCI
Sbjct: 377 YKNMPNGTLHDQLHP-DAGACTMDWPLRLKIAIGAAKGLAWLHHSCNPRIIHRNISSKCI 435
Query: 440 LLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFG 499
LLD DFEP +SDFGLARLMNP+DTHLSTFVNGEFGDLGYVAPEY +TLVATPKGD+YSFG
Sbjct: 436 LLDADFEPTISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTKTLVATPKGDIYSFG 495
Query: 500 VVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFL 559
VLLEL+TGERPTH+ APE+FKG+LVEWI ++N+ L ID+SL+G G D EL QFL
Sbjct: 496 TVLLELVTGERPTHVAKAPETFKGNLVEWIQQQSSNAKLHEVIDESLVGKGVDQELFQFL 555
Query: 560 RVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPDELIVA 616
+VA NCV PKER TMFEVYQ L+AI Y+FT +DEIMLP +TGD + +ELIVA
Sbjct: 556 KVASNCVTAMPKERPTMFEVYQFLKAIGINYNFTIEDEIMLPIDTGDADNLEELIVA 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357507899|ref|XP_003624238.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|124361026|gb|ABN08998.1| Protein kinase [Medicago truncatula] gi|355499253|gb|AES80456.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/599 (66%), Positives = 480/599 (80%), Gaps = 7/599 (1%)
Query: 19 VVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWH 78
++++ CG ++ T DI CLK VK SL+DP NYL +W+FNN TEG IC+FTGV+CWH
Sbjct: 18 LLVISCG---ITYGTETDILCLKRVKESLKDPNNYLQ-NWDFNNKTEGSICKFTGVECWH 73
Query: 79 PDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDL 138
PDEN+VLN++LS+MGLKG+FPRGI+ C+SLTGLD S N+LS SIP+D+S+ + +VT+LDL
Sbjct: 74 PDENRVLNLKLSNMGLKGEFPRGIQNCSSLTGLDFSLNSLSKSIPADVSTLIGFVTTLDL 133
Query: 139 SSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
SSN +GEIP LANCT+LN +KL+ N+ TG+IP + G L R+KTFSV++NLL+G VP+F
Sbjct: 134 SSNDFTGEIPVSLANCTYLNSIKLDQNQLTGQIPLEFGGLTRLKTFSVSNNLLSGQVPTF 193
Query: 199 ANVNF-TAEDFANNSGLCGKPLNPCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFM 257
TA+ FANNSGLCG PL C K + A +IA AA G T AL VG+ L F+
Sbjct: 194 IKQGIVTADSFANNSGLCGAPLEACSKSSKTNTA-VIAGAAVGGATLAALGVGVGLLFFV 252
Query: 258 RGVYVKKKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTG 317
R V +KKE+DPEGNKWA+ +KGTK IKVS FEKS+ KM LSDLMKATN+FSK+N+IGTG
Sbjct: 253 RSVSHRKKEEDPEGNKWARILKGTKKIKVSMFEKSISKMNLSDLMKATNNFSKSNVIGTG 312
Query: 318 RTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377
R+G Y A+L G +M+KRL +SQHSE+EF +E+ TLG+VRHRNLVPLLGFC+AKKERL
Sbjct: 313 RSGTVYKAVLDDGTSLMVKRLLESQHSEQEFTAEMATLGTVRHRNLVPLLGFCLAKKERL 372
Query: 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437
LVY + NGTL+DKLHP E M+W +RL+IAIG+A+G AWLHHNCNPRIIHRNISSK
Sbjct: 373 LVYKNMPNGTLHDKLHPDAGECT-MEWSVRLKIAIGAAKGFAWLHHNCNPRIIHRNISSK 431
Query: 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYS 497
CILLD DFEPK+SDFGLARLMNP+DTHLSTFVNGEFGDLGYVAPEY TLVATPKGDVYS
Sbjct: 432 CILLDVDFEPKISDFGLARLMNPIDTHLSTFVNGEFGDLGYVAPEYTTTLVATPKGDVYS 491
Query: 498 FGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQ 557
FG VLLEL+TGERPTH+ APE+FKG+LVEWI L+ NS L+ AID+SL+G G D EL Q
Sbjct: 492 FGTVLLELVTGERPTHIAKAPETFKGNLVEWIMQLSVNSKLKDAIDESLVGKGVDHELFQ 551
Query: 558 FLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPDELIVA 616
FL+VACNCV TPKER TMFEVYQ LR I RY+F T+DEIM+ ++ GD +ELIVA
Sbjct: 552 FLKVACNCVSSTPKERPTMFEVYQFLRDIGSRYNFITEDEIMILTDNGDAGKLEELIVA 610
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 618 | ||||||
| TAIR|locus:2165981 | 620 | BIR1 "AT5G48380" [Arabidopsis | 0.936 | 0.933 | 0.598 | 8.8e-189 | |
| TAIR|locus:2088937 | 605 | AT3G28450 [Arabidopsis thalian | 0.927 | 0.947 | 0.430 | 2.8e-128 | |
| TAIR|locus:2205834 | 601 | AT1G27190 [Arabidopsis thalian | 0.938 | 0.965 | 0.425 | 2.9e-126 | |
| TAIR|locus:2020558 | 591 | AT1G69990 [Arabidopsis thalian | 0.925 | 0.967 | 0.419 | 1.7e-123 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.700 | 0.429 | 0.403 | 3.9e-87 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.524 | 0.289 | 0.423 | 8.5e-79 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.490 | 0.253 | 0.432 | 7e-78 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.477 | 0.469 | 0.390 | 1.4e-76 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.506 | 0.500 | 0.384 | 2.2e-76 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.731 | 0.387 | 0.356 | 9.3e-76 |
| TAIR|locus:2165981 BIR1 "AT5G48380" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1830 (649.3 bits), Expect = 8.8e-189, P = 8.8e-189
Identities = 354/591 (59%), Positives = 440/591 (74%)
Query: 36 DIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLK 95
+I+CL++ K+ +EDP YL+T W F N T G+IC+F+GV CWH DEN+VL+I+LS GL+
Sbjct: 31 NIDCLRTFKSQVEDPNRYLST-WVFGNETAGYICKFSGVTCWHDDENRVLSIKLSGYGLR 89
Query: 96 GQFPRGIERCXXXXXXXXXXXXXXXXIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCT 155
G FP ++ C +P++IS+ + VT LDLS NS SGEIP ++N T
Sbjct: 90 GVFPPAVKLCADLTGLDLSRNNFSGPLPANISTLIPLVTILDLSYNSFSGEIPMLISNIT 149
Query: 156 FLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF-ANVNFTAEDFANNSGL 214
FLN L L +N+FTG +PPQL L R+KTFSV+ N L GP+P+F + F E FANN L
Sbjct: 150 FLNTLMLQHNQFTGTLPPQLAQLGRLKTFSVSDNRLVGPIPNFNQTLQFKQELFANNLDL 209
Query: 215 CGKPLNPCPGVPKKSRXXXXXXXXXXXVTFTALVVGIFLFCFMRGV-YVKKKEDDPEGNK 273
CGKPL+ C SR +T ALVVG+ LF + R + V+KK+DDPEGN+
Sbjct: 210 CGKPLDDCKSA-SSSRGKVVIIAAVGGLTAAALVVGVVLFFYFRKLGAVRKKQDDPEGNR 268
Query: 274 WAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFI 333
WAK +KG KG+KV F+KSV KM+LSDLMKAT F K+NII TGRTG Y L G +
Sbjct: 269 WAKSLKGQKGVKVFMFKKSVSKMKLSDLMKATEEFKKDNIIATGRTGTMYKGRLEDGSLL 328
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH 393
MIKRL+DSQ SEKEF +E+ TLGSV++RNLVPLLG+CVA KERLL+Y Y+ NG LYD+LH
Sbjct: 329 MIKRLQDSQRSEKEFDAEMKTLGSVKNRNLVPLLGYCVANKERLLMYEYMANGYLYDQLH 388
Query: 394 PAEHEVMH-MDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
PA+ E +DWP RL+IAIG+A+GLAWLHH+CNPRIIHRNISSKCILL +FEPK+SDF
Sbjct: 389 PADEESFKPLDWPSRLKIAIGTAKGLAWLHHSCNPRIIHRNISSKCILLTAEFEPKISDF 448
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPT 512
GLARLMNP+DTHLSTFVNGEFGD GYVAPEY RT+VATPKGDVYSFGVVLLEL+TG++ T
Sbjct: 449 GLARLMNPIDTHLSTFVNGEFGDFGYVAPEYSRTMVATPKGDVYSFGVVLLELVTGQKAT 508
Query: 513 HLTNAPE------SFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCV 566
+T E +FKG+LVEWIT L++ S L+ AID+SLLGNG D E+ + L+VACNCV
Sbjct: 509 SVTKVSEEKAEEENFKGNLVEWITKLSSESKLQEAIDRSLLGNGVDDEIFKVLKVACNCV 568
Query: 567 LPT-PKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDPNFPDELIVA 616
LP K+R TMFEVYQLLRAI E Y+FT DD+I++PS +G+ +F +ELIVA
Sbjct: 569 LPEIAKQRPTMFEVYQLLRAIGESYNFTADDDILIPSESGEGDFIEELIVA 619
|
|
| TAIR|locus:2088937 AT3G28450 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
Identities = 253/588 (43%), Positives = 365/588 (62%)
Query: 15 LTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGV 74
L ++ + FC +V A +DI CL+ +K SL DP N L SWNF+N T GF+C F GV
Sbjct: 14 LCFIIFLCFCSSVMA--ADEDDIRCLRGLKASLTDPQNALK-SWNFDNTTLGFLCNFVGV 70
Query: 75 DCWHPDENKVLNIRLSDMGLKGQFPRGIERCXXXXXXXXXXXXXXXXIPSDISSRLQYVT 134
CW+ EN+V+N+ L DMGL G+ P ++ C IP+++ + L ++
Sbjct: 71 SCWNNQENRVINLELRDMGLSGKIPDSLQYCASLQKLDLSSNRLSGNIPTELCNWLPFLV 130
Query: 135 SLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP 194
SLDLS+N L+GEIP LA C+F+N L L++NR +G+IP Q L R+ FSVA+N L+G
Sbjct: 131 SLDLSNNELNGEIPPDLAKCSFVNSLVLSDNRLSGQIPVQFSALGRLGRFSVANNDLSGR 190
Query: 195 VPSF-ANVNFTAEDFANNSGLCGKPLNP-CPGVPKKSRXXXXXXXXXXXVTFTALVVGIF 252
+P F ++ +++++DF+ N GLCG+PL+ C G+ KK+ L GI+
Sbjct: 191 IPVFFSSPSYSSDDFSGNKGLCGRPLSSSCGGLSKKNLGIIIAAGVFGAAASMLLAFGIW 250
Query: 253 LFCFMRGVYVKKKEDDPEG-NKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKN 311
+ ++ ++ G + A+R++ K +VS F+K + K++L DLM ATN+F+
Sbjct: 251 WYYHLKWTRRRRSGLTEVGVSGLAQRLRSHKLTQVSLFQKPLVKVKLGDLMAATNNFNSE 310
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
NII + RTG TY A+LP G + +K L + E+EF E+N L +RH NL PLLGFCV
Sbjct: 311 NIIVSTRTGTTYKALLPDGSALAVKHLSTCKLGEREFRYEMNQLWELRHSNLAPLLGFCV 370
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
++E+ LVY Y+ NGTL+ L E +DW R RI +G+ARGLAWLHH C P I+H
Sbjct: 371 VEEEKFLVYKYMSNGTLHSLLDSNRGE---LDWSTRFRIGLGAARGLAWLHHGCRPPILH 427
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
+NI S IL+D DF+ ++ D GLARLM P D + S+F+ G+ G+ GYVAPEY T++A+
Sbjct: 428 QNICSSVILIDEDFDARIIDSGLARLMVPSDNNESSFMTGDLGEFGYVAPEYSTTMLASL 487
Query: 492 KGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGF 551
KGDVY GVVLLEL TG + E FKGSLV+W+ L ++ + D+++ G G
Sbjct: 488 KGDVYGLGVVLLELATGLKAV----GGEGFKGSLVDWVKQLESSGRIAETFDENIRGKGH 543
Query: 552 DGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER--YHFTTDDE 597
D E+ +F+ +A NCV PKER +MF+ YQ L+AIAE+ Y F+ D+
Sbjct: 544 DEEISKFVEIALNCVSSRPKERWSMFQAYQSLKAIAEKQGYSFSEQDD 591
|
|
| TAIR|locus:2205834 AT1G27190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1240 (441.6 bits), Expect = 2.9e-126, P = 2.9e-126
Identities = 251/590 (42%), Positives = 369/590 (62%)
Query: 21 ILFCGNVRLSLATL-NDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHP 79
+LF + S ++ +D+ CL+ +KNSL DP + L+ SW+F N++ IC+ TGV CW+
Sbjct: 11 LLFISSFLCSSSSAEDDVLCLQGLKNSLIDPSSRLS-SWSFPNSSASSICKLTGVSCWNE 69
Query: 80 DENKVLNIRLSDMGLKGQFPRGIERCXXXXXXXXXXXXXXXXIPSDISSRLQYVTSLDLS 139
EN++++++L M L G+ P ++ C IPS I S L Y+ +LDLS
Sbjct: 70 KENRIISLQLQSMQLAGEIPESLKLCRSLQSLDLSGNDLSGSIPSQICSWLPYLVTLDLS 129
Query: 140 SNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA 199
N L G IP+ + C FLN L L++N+ +G IP QL L+R++ S+A N L+G +PS
Sbjct: 130 GNKLGGSIPTQIVECKFLNALILSDNKLSGSIPSQLSRLDRLRRLSLAGNDLSGTIPSEL 189
Query: 200 NVNFTAEDFANNSGLCGKPLNPCPGVPKKSRXXXXXXXXXXXVTFTALVVGIFLFCFMRG 259
F +DF+ N+GLCGKPL+ C + ++ V + + IF + F+R
Sbjct: 190 -ARFGGDDFSGNNGLCGKPLSRCGALNGRNLSIIIVAGVLGAVGSLCVGLVIFWWFFIRE 248
Query: 260 VYVKKKE----DDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIG 315
KKK + + W ++ K ++V+ F+K + K++L DLM ATN+FS NI
Sbjct: 249 GSRKKKGYGAGKSKDDSDWIGLLRSHKLVQVTLFQKPIVKIKLGDLMAATNNFSSGNIDV 308
Query: 316 TGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375
+ RTG +Y A LP G + +KRL EK+F SE+N LG +RH NLVPLLG+CV + E
Sbjct: 309 SSRTGVSYKADLPDGSALAVKRLSACGFGEKQFRSEMNKLGELRHPNLVPLLGYCVVEDE 368
Query: 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNIS 435
RLLVY ++ NGTL+ +LH +DWP R I +G+A+GLAWLHH C P +H+ IS
Sbjct: 369 RLLVYKHMVNGTLFSQLHNGGLCDAVLDWPTRRAIGVGAAKGLAWLHHGCQPPYLHQFIS 428
Query: 436 SKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDV 495
S ILLD DF+ +++D+GLA+L+ D++ S+F NG+ G+LGYVAPEY T+VA+ KGDV
Sbjct: 429 SNVILLDDDFDARITDYGLAKLVGSRDSNDSSFNNGDLGELGYVAPEYSSTMVASLKGDV 488
Query: 496 YSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT-LLNTNSSLETAIDKSLLGNGFDGE 554
Y FG+VLLEL+TG++P + N E FKGSLV+W++ L T S + AID+S+ G D E
Sbjct: 489 YGFGIVLLELVTGQKPLSVINGVEGFKGSLVDWVSQYLGTGRSKD-AIDRSICDKGHDEE 547
Query: 555 LHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTD-DEIMLPSN 603
+ QFL++AC+CV+ PKER TM +VY+ L+ +A+++ + DE L N
Sbjct: 548 ILQFLKIACSCVVSRPKERPTMIQVYESLKNMADKHGVSEHYDEFPLVFN 597
|
|
| TAIR|locus:2020558 AT1G69990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1214 (432.4 bits), Expect = 1.7e-123, P = 1.7e-123
Identities = 252/601 (41%), Positives = 366/601 (60%)
Query: 14 TLTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTG 73
T+++ VI+ + +D+ CLK K+SL+DP N L T W+F N++ IC+ TG
Sbjct: 3 TISIFFVIILMSSSHAE----DDVLCLKGFKSSLKDPSNQLNT-WSFPNSSSS-ICKLTG 56
Query: 74 VDCWHPDENKVLNIRLSDMGLKGQFPRGIERCXXXXXXXXXXXXXXXXIPSDISSRLQYV 133
V CW+ EN++L+++L M L GQ P ++ C IPS I S L Y+
Sbjct: 57 VSCWNAKENRILSLQLQSMQLSGQIPESLKLCRSLQSLDLSFNDFSGLIPSQICSWLPYL 116
Query: 134 TSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
+LDLS N LSG IPS + +C FLN L LN N+ TG IP +L LNR++ S+A N L+G
Sbjct: 117 VTLDLSGNKLSGSIPSQIVDCKFLNSLALNQNKLTGSIPSELTRLNRLQRLSLADNDLSG 176
Query: 194 PVPSFANVNFTAEDFANNSGLCGKPLNPCPGVPKKSRXXXXXXXXXXXVTFTALVVGIFL 253
+PS + ++ + F N GLCGKPL+ C K+ V + G+F
Sbjct: 177 SIPSELS-HYGEDGFRGNGGLCGKPLSNCGSFNGKNLTIIVTAGVIGAVGSLCVGFGMFW 235
Query: 254 FCFMR--------GVYVKKKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKAT 305
+ F+R G K +DD + W ++ K ++V+ F+K + K++L DL++AT
Sbjct: 236 WFFIRDRRKMNNYGYGAGKCKDDSD---WIGLLRSHKLVQVTLFQKPIVKIKLVDLIEAT 292
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLV 364
N F NI+ + R+G +Y A LP G + +KRL + SEK+F SEIN LG +RH NLV
Sbjct: 293 NGFDSGNIVVSSRSGVSYKADLPDGSTLEVKRLSSCCELSEKQFRSEINKLGQIRHPNLV 352
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
PLLGFCV + E LLVY ++ NGTLY +L + +DWP R+R+A+G+ARGLAWLHH
Sbjct: 353 PLLGFCVVEDEILLVYKHMANGTLYSQLQQWD-----IDWPTRVRVAVGAARGLAWLHHG 407
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
C P +H+ ISS ILLD DF+ ++ D+GL +L++ D+ S+F NG+FG YVAPEY
Sbjct: 408 CQPLYMHQYISSNVILLDEDFDARVIDYGLGKLVSSQDSKDSSFSNGKFG---YVAPEYS 464
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
T+VA+ GDVY FG+VLLE++TG++P + N E FK SLVEW++ +N + AID+
Sbjct: 465 STMVASLSGDVYGFGIVLLEIVTGQKPVLINNGEEGFKESLVEWVSKHLSNGRSKDAIDR 524
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTD--DEIMLPS 602
+ G G+D E+ Q LR+AC+CV+ PKER M +VY+ L+ + +++ F ++ DE L
Sbjct: 525 RIFGKGYDDEIMQVLRIACSCVVSRPKERPLMIQVYESLKNLGDQHGFFSEYSDEFPLIF 584
Query: 603 N 603
N
Sbjct: 585 N 585
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 3.9e-87, Sum P(2) = 3.9e-87
Identities = 182/451 (40%), Positives = 248/451 (54%)
Query: 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
DL N+LSG IPS L+ T L L L+NNR +G IP L L+ + FSVA N L+G +P
Sbjct: 553 DLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVIP 612
Query: 197 SFANVN-FTAEDFANNSGLCGKPLNPCP-GVP----KKSRXXXXXXXXXXX-VTFTALVV 249
S F F +N LCG+ PC G K+SR + F ++ +
Sbjct: 613 SGGQFQTFPNSSFESNH-LCGEHRFPCSEGTESALIKRSRRSRGGDIGMAIGIAFGSVFL 671
Query: 250 GIFLFCFMRGVYVKKKEDDPE---GNKWAKRIKGTKGIK-VSAFEKSVEKMRLSDLMKAT 305
L + + E DPE ++ G G K V F+ + +++ DL+ +T
Sbjct: 672 LTLLSLIVLRARRRSGEVDPEIEESESMNRKELGEIGSKLVVLFQSNDKELSYDDLLDST 731
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLV 364
NSF + NIIG G G Y A LP G + IK+L D E+EF +E+ TL +H NLV
Sbjct: 732 NSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLV 791
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
L GFC K +RLL+YSY+ENG+L LH + W RLRIA G+A+GL +LH
Sbjct: 792 LLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEG 851
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
C+P I+HR+I S ILLD +F L+DFGLARLM+P +TH+ST + G LGY+ PEY
Sbjct: 852 CDPHILHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDL---VGTLGYIPPEYG 908
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
+ VAT KGDVYSFGVVLLEL+T +RP + P+ + L+ W+ + S D
Sbjct: 909 QASVATYKGDVYSFGVVLLELLTDKRPVDMCK-PKGCR-DLISWVVKMKHESRASEVFDP 966
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHT 575
+ D E+ + L +AC C+ PK+R T
Sbjct: 967 LIYSKENDKEMFRVLEIACLCLSENPKQRPT 997
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 8.5e-79, Sum P(3) = 8.5e-79
Identities = 142/335 (42%), Positives = 204/335 (60%)
Query: 258 RGVYVKKKEDDPEGNK-WAKRIKGTK--GIKVSAFEKSVEKMRLSDLMKATNSFSKNNII 314
R +Y+ + N W + + GT I ++AFEK ++ + L+DL++ATN F I
Sbjct: 754 RDIYIDSRSHSATMNSDWRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQI 813
Query: 315 GTGRTGATYIAMLPGGCFIMIKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
G+G G Y A L G + IK+L S ++EF +E+ T+G ++HRNLVPLLG+C A
Sbjct: 814 GSGGFGDVYKAQLKDGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKAG 873
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ERLLVY Y++ G+L D LH + ++W R +IA+G+ARGLA+LHHNC P IIHR+
Sbjct: 874 EERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLHHNCIPHIIHRD 933
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+ S +L+D E ++SDFG+ARLM+ VDTHLS V+ G GYV PEY ++ T KG
Sbjct: 934 MKSSNVLIDEQLEARVSDFGMARLMSVVDTHLS--VSTLAGTPGYVPPEYYQSFRCTTKG 991
Query: 494 DVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGN--GF 551
DVYS+GVVLLEL+TG+ PT + E +LV W+ +T + D LL
Sbjct: 992 DVYSYGVVLLELLTGKPPTDSADFGED--NNLVGWVKQ-HTKLKITDVFDPELLKEDPSV 1048
Query: 552 DGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
+ EL + L++AC C+ P R TM +V + + I
Sbjct: 1049 ELELLEHLKIACACLDDRPSRRPTMLKVMAMFKEI 1083
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 7.0e-78, Sum P(2) = 7.0e-78
Identities = 135/312 (43%), Positives = 200/312 (64%)
Query: 278 IKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKR 337
+K I ++AFEK + K+ +DL++ATN F +++IG+G G Y A+L G + IK+
Sbjct: 853 VKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKK 912
Query: 338 L-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAE 396
L S ++EF++E+ T+G ++HRNLVPLLG+C ERLLVY +++ G+L D LH +
Sbjct: 913 LIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHDPK 972
Query: 397 HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
+ ++W R +IAIGSARGLA+LHHNC+P IIHR++ S +LLD + E ++SDFG+AR
Sbjct: 973 KAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMAR 1032
Query: 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516
LM+ +DTHLS V+ G GYV PEY ++ + KGDVYS+GVVLLEL+TG+RPT +
Sbjct: 1033 LMSAMDTHLS--VSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPT---D 1087
Query: 517 APESFKGSLVEWITLLNTNSSLETAIDKSLLGN--GFDGELHQFLRVACNCVLPTPKERH 574
+P+ +LV W+ + + D L+ + EL Q L+VA C+ R
Sbjct: 1088 SPDFGDNNLVGWVKQ-HAKLRISDVFDPELMKEDPALEIELLQHLKVAVACLDDRAWRRP 1146
Query: 575 TMFEVYQLLRAI 586
TM +V + + I
Sbjct: 1147 TMVQVMAMFKEI 1158
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 118/302 (39%), Positives = 180/302 (59%)
Query: 293 VEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH--SEKEFLS 350
+++ L +L AT+SFS NI+G G G Y L G + +KRL++ + E +F +
Sbjct: 290 LKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQT 349
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
E+ + HRNL+ L GFC+ ERLLVY Y+ NG++ L + + W +R +I
Sbjct: 350 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQI 409
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
A+GSARGL++LH +C+P+IIHR++ + ILLD +FE + DFGLARLM+ DTH++T V
Sbjct: 410 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAVR 469
Query: 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT 530
G +G++APEY T ++ K DV+ +G++LLELITG+R L L++W+
Sbjct: 470 GT---IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 526
Query: 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA--IAE 588
L LE +D L N + E+ Q ++VA C +P ER M EV ++L +AE
Sbjct: 527 GLLKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 586
Query: 589 RY 590
++
Sbjct: 587 KW 588
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 559 (201.8 bits), Expect = 2.2e-76, Sum P(2) = 2.2e-76
Identities = 123/320 (38%), Positives = 184/320 (57%)
Query: 293 VEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH--SEKEFLS 350
+++ L +L A++ FS NI+G G G Y L G + +KRL++ + E +F +
Sbjct: 287 LKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQT 346
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
E+ + HRNL+ L GFC+ ERLLVY Y+ NG++ L +DWP R RI
Sbjct: 347 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKRI 406
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
A+GSARGL++LH +C+P+IIHR++ + ILLD +FE + DFGLA+LM+ DTH++T V
Sbjct: 407 ALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 466
Query: 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT 530
G +G++APEY T ++ K DV+ +G++LLELITG+R L L++W+
Sbjct: 467 GT---IGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVK 523
Query: 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA--IAE 588
L LE +D L N + EL Q ++VA C +P ER M EV ++L +AE
Sbjct: 524 GLLKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLEGDGLAE 583
Query: 589 RYHFTTDDEIMLPSNTGDPN 608
++ EI+ PN
Sbjct: 584 KWDEWQKVEILREEIDLSPN 603
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 667 (239.9 bits), Expect = 9.3e-76, Sum P(2) = 9.3e-76
Identities = 175/491 (35%), Positives = 262/491 (53%)
Query: 122 IPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRI 181
IP L+ + LDLS N+L G +P L + +FL+ L ++NN TG IP G ++
Sbjct: 679 IPDSFGG-LKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIP--FG--GQL 733
Query: 182 KTFSVASNLLTGPVPSFANVNFTAEDFANNSGLCGK-PLNPCPG-VPKKSRXXXXXXXXX 239
TF PV +AN N CG P P + K +
Sbjct: 734 TTF---------PVSRYAN-NSGLCGVPLRP--CGSAPRRPITSRIHAKKQTVATAVIAG 781
Query: 240 XXVTFTALVVGIFLFCFMRGVYVKKKEDD------P-EGN-KWA-KRIKGTKGIKVSAFE 290
+F V+ + +R V K+++ + P G+ W + I V+ FE
Sbjct: 782 IAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCSWKLSSVPEPLSINVATFE 841
Query: 291 KSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRL-EDSQHSEKEFL 349
K + K+ + L++ATN FS ++G+G G Y A L G + IK+L + ++EF+
Sbjct: 842 KPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFM 901
Query: 350 SEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEV--MHMDWPLR 407
+E+ T+G ++HRNLVPLLG+C +ERLLVY Y++ G+L LH + ++++W R
Sbjct: 902 AEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAAR 961
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467
+IAIG+ARGLA+LHH+C P IIHR++ S +LLD DFE ++SDFG+ARL++ +DTHLS
Sbjct: 962 KKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLS- 1020
Query: 468 FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527
V+ G GYV PEY ++ T KGDVYS+GV+LLEL++G++P E +LV
Sbjct: 1021 -VSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGED--NNLVG 1077
Query: 528 WITLLNTNSSLETAIDKSLLGN-GFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
W L +D L+ + D EL +L++A C+ P +R TM QL+
Sbjct: 1078 WAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMI---QLMAMF 1134
Query: 587 AERYHFTTDDE 597
E T +DE
Sbjct: 1135 KEMKADTEEDE 1145
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9ASS4 | Y5838_ARATH | No assigned EC number | 0.6226 | 0.9368 | 0.9338 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.VIII.1410.1 | hypothetical protein (605 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 618 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-34 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-28 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-28 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-24 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-18 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-07 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 0.002 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.002 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.003 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 208 bits (530), Expect = 3e-57
Identities = 156/514 (30%), Positives = 250/514 (48%), Gaps = 56/514 (10%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
N+ LS G PR + + L L LS N LSG IP ++SS + V SLDLS N LSG
Sbjct: 479 NLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV-SLDLSHNQLSG 537
Query: 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS---FANVN 202
+IP+ + L+ L L+ N+ +G+IP LG + + +++ N L G +PS F +N
Sbjct: 538 QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAIN 597
Query: 203 FTAEDFANNSGLCG----KPLNPCPGVPK-KSRAGIIAAAAAAGVTFTALVVGIFLFCFM 257
+A A N LCG L PC V K S I A F L + F F F+
Sbjct: 598 ASA--VAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGA---FLVLALVAFGFVFI 652
Query: 258 RG---VYVKKKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNII 314
RG + +K+ E+ E W + +K KS+ ++D++ + + N+I
Sbjct: 653 RGRNNLELKRVEN--EDGTWELQFFDSK------VSKSIT---INDILSSLK---EENVI 698
Query: 315 GTGRTGATYIA-MLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
G+ GA+Y + G ++K + D +++ +G ++H N+V L+G C ++
Sbjct: 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSE 755
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
K L++ Y+E L + L ++ W R +IAIG A+ L +LH C+P ++ N
Sbjct: 756 KGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+S + I++DG EP L L + T F++ YVAPE T T K
Sbjct: 809 LSPEKIIIDGKDEPHL----RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKS 859
Query: 494 DVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGF-- 551
D+Y FG++L+EL+TG+ P +A GS+VEW ++ L+ ID S+ G+
Sbjct: 860 DIYGFGLILIELLTGKSP---ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 552 DGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585
E+ + + +A +C P R +V + L +
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 69/197 (35%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 314 IGTGRTGATYIAMLPG-GCFIMIKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC 370
+G G G Y+A G + IK + EDS +E L EI L + H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRII 430
+ LV Y E G+L D L E + + LRI + GL +LH N II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114
Query: 431 HRNISSKCILLD-GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-YPRTLV 488
HR++ + ILLD + + KL+DFGL++L+ + L T V G Y+APE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV----GTPAYMAPEVLLGKGY 170
Query: 489 ATPKGDVYSFGVVLLEL 505
+ K D++S GV+L EL
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 72/206 (34%), Positives = 103/206 (50%), Gaps = 20/206 (9%)
Query: 313 IIGTGRTGATYIAMLPG-GCFIMIKRLE-DSQHSEKE--FLSEINTLGSVRHRNLVPLLG 368
+G+G G Y A G G + +K L+ S+ S+K+ EI L + H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMH--MDWPLRLRIAIGSARGLAWLHHNCN 426
K LV Y E G L+D L + +IA+ RGL +LH N
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL------SRGGPLSEDEAKKIALQILRGLEYLHSN-- 117
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-YPR 485
IIHR++ + ILLD + K++DFGLA+ + + L+TFV G Y+APE
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV----GTPWYMAPEVLLG 172
Query: 486 TLVATPKGDVYSFGVVLLELITGERP 511
PK DV+S GV+L EL+TG+ P
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 66/217 (30%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIM----IKRL-EDSQHSE-KEFLSEINTLGSVRHRNLVP 365
+G G G Y L G +K L ED+ E K+FL E + + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKL-----HPAEHEVMHMDWPLRLRIAIGSARGLAW 420
LLG C ++ LV Y+E G L D L E + L AI A+G+ +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV- 479
L + +HR+++++ L+ D K+SDFGL+R + D G +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD-------YYRKKTGGKLP 170
Query: 480 ----APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
APE + + T K DV+SFGV+L E+ T G P
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 11/180 (6%)
Query: 335 IKRL-EDSQHSEK-EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+K L E + E+ EFL E + + + H N+V LLG C + +V Y+ G L D L
Sbjct: 33 VKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL 92
Query: 393 HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
+H + L++A+ A+G+ +L +HR+++++ L+ + K+SDF
Sbjct: 93 R--KHG-EKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDF 146
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
GL+R + D + G + ++APE + T K DV+SFGV+L E+ T GE+P
Sbjct: 147 GLSRDIYEDDYYRKR--GGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 16/182 (8%)
Query: 335 IKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+K L + S+ +EFL E + + H N+V LLG C ++ +V Y+E G L L
Sbjct: 33 VKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL 92
Query: 393 HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
++ L A+ ARG+ +L IHR+++++ L+ + K+SDF
Sbjct: 93 RKNRPKL---SLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDF 146
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGY--VAPEYPRTLVATPKGDVYSFGVVLLELIT-GE 509
GL+R + D + G L +APE + T K DV+SFGV+L E+ T GE
Sbjct: 147 GLSRDLYDDDYYRKR-----GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGE 201
Query: 510 RP 511
+P
Sbjct: 202 QP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 309 SKNNIIGTGRTGATYIAML---PGGCFIM--IKRLEDSQHSE--KEFLSEINTLGSVRHR 361
+ +G G G Y L G + +K L++ + +EFL E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
N+V LLG C ++ ++V Y+ G L D L + + + L A+ ARG+ +L
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSL--SDLLSFALQIARGMEYL 119
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV-- 479
IHR+++++ L+ + K+SDFGL+R + D + G +
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV--------KGGKLPI 168
Query: 480 ---APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
APE + T K DV+SFGV+L E+ T GE P
Sbjct: 169 RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 66/215 (30%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLV 364
+ +G G G Y+A G + IK + + + + L EI L ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
L + + LV Y E G L+D L + + D L +LH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK--KRGRLSEDE--ARFYLRQILSALEYLHSK 116
Query: 425 CNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
I+HR++ K ILLD D KL+DFGLAR ++P L+TFV G Y+APE
Sbjct: 117 ---GIVHRDL--KPENILLDEDGHVKLADFGLARQLDP-GEKLTTFV----GTPEYMAPE 166
Query: 483 ------YPRTLVATPKGDVYSFGVVLLELITGERP 511
Y D++S GV+L EL+TG+ P
Sbjct: 167 VLLGKGY------GKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-25
Identities = 62/194 (31%), Positives = 104/194 (53%), Gaps = 16/194 (8%)
Query: 12 AHTLTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQF 71
++ +LF + S+ ++E L S K+S+ DP YL+ +WN + + +C +
Sbjct: 6 PQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLS-NWNSSAD----VCLW 60
Query: 72 TGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDI---SS 128
G+ C + ++V++I LS + G+ I R + ++LS+N LSG IP DI SS
Sbjct: 61 QGITC--NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSS 118
Query: 129 RLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVAS 188
L+Y L+LS+N+ +G IP G L L L+NN +G+IP +G + +K +
Sbjct: 119 SLRY---LNLSNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173
Query: 189 NLLTGPVP-SFANV 201
N+L G +P S N+
Sbjct: 174 NVLVGKIPNSLTNL 187
|
Length = 968 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 4e-24
Identities = 80/310 (25%), Positives = 114/310 (36%), Gaps = 21/310 (6%)
Query: 314 IGTGRTGATYIAMLPGGCFI--MIKRLEDSQHSEKEFLSEINTLGSVRH-RNLVPLLGFC 370
+G G G Y+A + + K+LE + FL EI L S+ H N+V L F
Sbjct: 8 LGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF 67
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRII 430
+ LV Y++ G+L D L + L I L +LH II
Sbjct: 68 QDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEYLHSK---GII 123
Query: 431 HRNISSKCILLDGD-FEPKLSDFGLARLMNPVDTHLST--FVNGEFGDLGYVAPEYPRTL 487
HR+I + ILLD D KL DFGLA+L+ + S + G GY+APE L
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 488 V---ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
A+ D++S G+ L EL+TG P + ++ I L T S +
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-QTLKIILELPTPSLAS-PLSP 241
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNT 604
S L+ + PK R + L + D L
Sbjct: 242 SNPELISK-AASDLLK---KLLAKDPKNRLSSSSD--LSHDLLAHLKLKESDLSDLLKPD 295
Query: 605 GDPNFPDELI 614
L
Sbjct: 296 DSAPLRLSLP 305
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 307 SFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRN 362
+++ ++G G G+ Y+A+ G + +K +E S SE+E EI L S++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 363 LVPLLGFCVAKKERLLVYSYLE---NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR--- 416
+V G +E+ + +LE G+L ++ L + R
Sbjct: 61 IVRYYGSER-DEEKNTLNIFLEYVSGGSLSS--------LLKKFGKLPEPVIRKYTRQIL 111
Query: 417 -GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
GLA+LH N I+HR+I IL+D D KL+DFG A+ + ++T T G
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT--GSVRGT 166
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
++APE R D++S G ++E+ TG+ P
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 6e-21
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 14/209 (6%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSE-KEFLSEINTLGSVRHRNLVPLL 367
N IG G G Y A+ L G + +K R++D+ KE E+ L ++H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 368 GFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNP 427
G V +++ + Y GTL + L H+ +R + GLA+LH +
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---IR-VYTLQLLEGLAYLHSH--- 118
Query: 428 RIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
I+HR+I I LD + KL DFG A + T + V G Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 488 VATPKG---DVYSFGVVLLELITGERPTH 513
G D++S G V+LE+ TG+RP
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-21
Identities = 58/150 (38%), Positives = 79/150 (52%), Gaps = 17/150 (11%)
Query: 110 GLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTG 169
GL L + L G IP+DIS +L+++ S++LS NS+ G IP L + T L VL L+ N F G
Sbjct: 422 GLGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480
Query: 170 KIPPQLGLLNRIKTFSVASNLLTGPVPSF--------ANVNFTAEDFANNSGLCGKP-LN 220
IP LG L ++ ++ N L+G VP+ A+ NFT +N+GLCG P L
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFT-----DNAGLCGIPGLR 535
Query: 221 PCPGVPKKSRAGIIAAAAAAGVTFTALVVG 250
C P S I A V F LV+
Sbjct: 536 ACG--PHLSVGAKIGIAFGVSVAFLFLVIC 563
|
Length = 623 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-20
Identities = 67/218 (30%), Positives = 115/218 (52%), Gaps = 24/218 (11%)
Query: 306 NSFSKNNIIGTGRTGATYIAML--PGG--CFIMIKRLEDSQHSEKE---FLSEINTLGSV 358
+ +K +IG G G + +L PG + IK L+ ++EK+ FLSE + +G
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASIMGQF 63
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTL--YDKLHPAEHEVMHMDWPLRLRIAIGSAR 416
H N++ L G K +++ Y+ENG L Y + H E + LR G A
Sbjct: 64 SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAA 118
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM--NPVDTHLSTFVNGEFG 474
G+ +L + +HR+++++ IL++ + E K+SDFGL+R++ +P T+ ++ G
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS---GGKI 172
Query: 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ + APE T DV+SFG+V+ E+++ GERP
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEF-LSEINTLGSVRHRNLVP 365
F IG G G Y A G + IK ++ +KE ++EI L +H N+V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 366 LLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLR----IAIGSARGLAW 420
G KK+ L +V + G+L D L L + +GL +
Sbjct: 62 YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQ-------TLTESQIAYVCKELLKGLEY 113
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA-RLMNPVDTHLSTFVNGEFGDLGYV 479
LH N IIHR+I + ILL D E KL DFGL+ +L + + T V G ++
Sbjct: 114 LHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN--TMV----GTPYWM 164
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELITGERPTH 513
APE K D++S G+ +EL G+ P
Sbjct: 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 17/194 (8%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
IG G G + G + +K L+D + + FL+E + + ++RH NLV LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+V Y+ G+L D L V+ + +L A+ G+ +L +HR+
Sbjct: 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL--GYVAPEYPRTLVATP 491
++++ +L+ D K+SDFGLA+ + G L + APE R +
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 492 KGDVYSFGVVLLEL 505
K DV+SFG++L E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 11/182 (6%)
Query: 335 IKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLENGTLYD 390
+K L S +F EI L ++ H N+V G C R L+ YL +G+L D
Sbjct: 38 VKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD 97
Query: 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
L H ++ L + +G+ +L + R IHR+++++ IL++ + K+S
Sbjct: 98 YLQ--RHRD-QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKIS 151
Query: 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGER 510
DFGLA+++ + GE Y APE RT + DV+SFGV L EL T
Sbjct: 152 DFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGD 210
Query: 511 PT 512
P+
Sbjct: 211 PS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 306 NSFSKNNIIGTGRTGATYIAML--PGG--CFIMIKRLEDSQHSEKE---FLSEINTLGSV 358
+ + +IG G G L PG + IK L+ S+K+ FL+E + +G
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQF 62
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL-RIAIGSARG 417
H N++ L G + +++ Y+ENG+L L + + +L + G A G
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT----VGQLVGMLRGIASG 118
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
+ +L +HR+++++ IL++ + K+SDFGL+R + + +T G +
Sbjct: 119 MKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIR 173
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ APE T DV+SFG+V+ E+++ GERP
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 22/223 (9%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE---DSQHSEKEFLSEINTLGSVRHRNL 363
+ ++IG G G Y + L G F+ IK++ + + K + EI+ L +++H N+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSA---RGLAW 420
V +G ++ Y ENG+L + +P L +A+ +GLA+
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKK------FGPFPESL-VAVYVYQVLQGLAY 114
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
LH +IHR+I + IL D KL+DFG+A +N V ++ V G ++A
Sbjct: 115 LH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV----GTPYWMA 167
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERPTH-LTNAPESFK 522
PE A+ D++S G ++EL+TG P + L F+
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR 210
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
S +G G+ G ++ G + +K L+ S + FL E + +RH LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L C ++ +V Y+ G+L D L E + + + P + +A A G+A+L
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLESR- 122
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
IHR+++++ IL+ + K++DFGLARL+ D + +F + + APE
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIE--DDEYTAREGAKF-PIKWTAPEAAN 177
Query: 486 TLVATPKGDVYSFGVVLLELIT 507
T K DV+SFG++L E++T
Sbjct: 178 YGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 58/215 (26%), Positives = 109/215 (50%), Gaps = 23/215 (10%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGG---CF-IMIKRLED--SQHSEKEFLSEINTLGSVRH 360
K ++G+G G Y + +P G + IK L + S + KE L E + SV H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTL--YDKLHPAEHEVMHM-DWPLRLRIAIGSARG 417
++V LLG C++ + L+ + G L Y + H ++ +W +++ A+G
Sbjct: 69 PHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
+++L R++HR+++++ +L+ K++DFGLA+L++ + G +
Sbjct: 122 MSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH--AEGGKVPIK 176
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
++A E + T K DV+S+GV + EL+T G +P
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 9e-18
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 59/226 (26%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQH-------------SEKEF-LSEINTLGSVR 359
IG G G Y+ +R D + E+E L+E+ L +
Sbjct: 8 IGKGSFGKVYLV----------RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN 57
Query: 360 HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL--------HPAEHEVMHMDWPLRLRIA 411
H N++ K + +V Y + G L K+ E +++ DW ++L +A
Sbjct: 58 HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL--DWFVQLCLA 115
Query: 412 IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNG 471
L +LH +I+HR+I + I L + KL DFG++++++ T V
Sbjct: 116 ------LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-- 164
Query: 472 EFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERP 511
G Y++PE Y K D++S G VL EL T + P
Sbjct: 165 --GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 9/195 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G+G+ G ++ G + IK + + SE +F+ E + + H NLV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ +V Y+ NG L + L + + +W L + + + +L N IHR+
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDV--CEAMEYLESNG---FIHRD 125
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
++++ L+ D K+SDFGLAR + +D ++ +F + + PE + K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV--LDDQYTSSQGTKF-PVKWAPPEVFDYSRFSSKS 182
Query: 494 DVYSFGVVLLELITG 508
DV+SFGV++ E+ +
Sbjct: 183 DVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 84/297 (28%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 290 EKSVEKMR----LSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHS 344
E+ +EK+R + D K F K IG G +G Y AM + G + I+++ Q
Sbjct: 3 EEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 345 EKEFL-SEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMD 403
+KE + +EI + ++ N+V L + E +V YL G+L D + MD
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMD 114
Query: 404 WPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463
+ + L +LH N ++IHR+I S ILL D KL+DFG + P +
Sbjct: 115 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523
ST V + ++APE PK D++S G++ +E+I GE P +L P
Sbjct: 172 KRSTMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE-PPYLNENP----- 221
Query: 524 SLVEWITLLNTNSSLE-------TAIDKSLLGNGFDGEL-----------HQFLRVA 562
+ + L+ TN + E +AI + L D ++ HQFL++A
Sbjct: 222 --LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 80/260 (30%), Positives = 107/260 (41%), Gaps = 46/260 (17%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIKR--LEDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
+IG G T Y A+ LP + IKR LE Q S E E+ + H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMH-------MDWPLRLRIAIGSARGLAWL 421
V E LV YL G+L D +M +D + + +GL +L
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLD--------IMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL-ARLMNPVD-THLS--TFVNGEFGDLG 477
H N IHR+I + ILL D K++DFG+ A L + D T TFV G
Sbjct: 119 HSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV----GTPC 171
Query: 478 YVAPEYPRTLVATP------KGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531
++APE V K D++SFG+ +EL TG P + V +TL
Sbjct: 172 WMAPE-----VMEQVHGYDFKADIWSFGITAIELATGAAPYS------KYPPMKVLMLTL 220
Query: 532 LNTNSSLETAIDKSLLGNGF 551
N SLET D F
Sbjct: 221 QNDPPSLETGADYKKYSKSF 240
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 290 EKSVEKMR----LSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHS 344
E+ +EK+R + D K F K IG G +G Y A+ + G + IK++ Q
Sbjct: 2 EEILEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQP 58
Query: 345 EKEFL-SEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMD 403
+KE + +EI + +H N+V L + E +V YL G+L D + MD
Sbjct: 59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MD 113
Query: 404 WPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463
+ + L +LH N ++IHR+I S ILL D KL+DFG + P +
Sbjct: 114 EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170
Query: 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523
ST V + ++APE PK D++S G++ +E++ GE P +L P
Sbjct: 171 KRSTMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE-PPYLNENP----- 220
Query: 524 SLVEWITLLNTNSSLE-------TAIDKSLLGNGFDGEL-----------HQFLRVA 562
+ + L+ TN + E +AI + L + ++ H FL++A
Sbjct: 221 --LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 22/235 (9%)
Query: 290 EKSVEKMR----LSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHS 344
E+ +EK+R + D K F K IG G +G Y A+ + G + IK++ Q
Sbjct: 2 EEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQP 58
Query: 345 EKEFL-SEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMD 403
+KE + +EI + ++ N+V L + E +V YL G+L D + MD
Sbjct: 59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMD 113
Query: 404 WPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463
+ + L +LH N ++IHR+I S ILL D KL+DFG + P +
Sbjct: 114 EGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170
Query: 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAP 518
ST V + ++APE PK D++S G++ +E++ GE P +L P
Sbjct: 171 KRSTMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE-PPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 53/128 (41%), Positives = 68/128 (53%), Gaps = 8/128 (6%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
L G P + +L L L N LSG IP I S LQ + SLDLS NSLSGEIP +
Sbjct: 248 LTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQ 306
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV----NFTAEDFA 209
L +L L +N FTGKIP L L R++ + SN +G +P N+ N T D +
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP--KNLGKHNNLTVLDLS 364
Query: 210 NNSGLCGK 217
N+ L G+
Sbjct: 365 TNN-LTGE 371
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 312 NIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC 370
+ +G G+ G Y + + +K L++ +EFL E + ++H NLV LLG C
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRII 430
+ ++ ++ G L D L + ++ + L +A + + +L I
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQE--VNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 431 HRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT 490
HR+++++ L+ + K++DFGL+RLM DT+ T G + + APE +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTG-DTY--TAHAGAKFPIKWTAPESLAYNKFS 183
Query: 491 PKGDVYSFGVVLLELIT 507
K DV++FGV+L E+ T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 57/189 (30%), Positives = 89/189 (47%), Gaps = 12/189 (6%)
Query: 328 PGGCFI--MIKRLEDSQHSE--KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383
GG I +K L+ + S+ +FL E + S+ H NL+ L G V ++V
Sbjct: 19 SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGV-VLTHPLMMVTELA 77
Query: 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG 443
G+L D+L + + H A+ A G+ +L R IHR+++++ ILL
Sbjct: 78 PLGSLLDRLR--KDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLAS 132
Query: 444 DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLL 503
D + K+ DFGL R + + H + + + APE RT + DV+ FGV L
Sbjct: 133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGVTLW 191
Query: 504 ELIT-GERP 511
E+ T GE P
Sbjct: 192 EMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 73/297 (24%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHR 361
+ + ++G G +G Y P G +K++ D + K+ L E+ TL S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF-RKQLLRELKTLRSCESP 59
Query: 362 NLVPLLG-FCVAKKERL-LVYSYLENGTLYDKLHPAEH--EVMHMDWPLRLRIAIGSARG 417
+V G F K+ + +V Y++ G+L D L E + IA +G
Sbjct: 60 YVVKCYGAFY--KEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA------YIARQILKG 111
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L +LH IIHR+I +L++ E K++DFG+++++ +TFV G +
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVT 165
Query: 478 YVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531
Y++PE Y D++S G+ LLE G+ P G + L
Sbjct: 166 YMSPERIQGESYSY------AADIWSLGLTLLECALGKFPF-------LPPGQPS-FFEL 211
Query: 532 LNTNSSLETAIDK----SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584
+ AI SL F E F+ C+ PK+R + +LL+
Sbjct: 212 MQ-------AICDGPPPSLPAEEFSPEFRDFISA---CLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 308 FSKNNIIGTGRTGATYIAMLPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVPL 366
F+ +G+G G + + + IK L+ D +++F E+ L +RH++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
C + ++ +E G+L L E +V+ + L + +A A G+A+L
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVA-SL-IDMACQVAEGMAYLEEQ-- 123
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLM-NPVDTHLSTFVNGEFGDLGYVAPEYPR 485
IHR+++++ IL+ D K++DFGLARL+ V + + APE
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-----PYKWTAPEAAS 177
Query: 486 TLVATPKGDVYSFGVVLLELIT 507
+ K DV+SFG++L E+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G G+ G ++ G + +K L+ S + FL E + +RH LV L V++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVSE 72
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ +V Y+ G+L D L E + + P + +A A G+A++ IHR+
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIERM---NYIHRD 127
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+ S IL+ K++DFGLARL+ D + +F + + APE T K
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE--DNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184
Query: 494 DVYSFGVVLLELITGER 510
DV+SFG++L EL+T R
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 9/197 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G G G ++ G + IK L+ + FL E + +RH LVPL V++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVSE 72
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ +V ++ G+L D L E + ++ P + +A A G+A++ IHR+
Sbjct: 73 EPIYIVTEFMGKGSLLDFLK--EGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRD 127
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+ + IL+ + K++DFGLARL+ D + +F + + APE T K
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIE--DNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184
Query: 494 DVYSFGVVLLELITGER 510
DV+SFG++L EL+T R
Sbjct: 185 DVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 12/207 (5%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G G+ G + + + +K L+ K+FL+E + +RH L+ L C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH-HNCNPRIIHR 432
+ +V ++ G+L + L + + P + +A A G+A+L N IHR
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQN----YIHR 127
Query: 433 NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPK 492
+++++ +L+ + K++DFGLAR++ + +F + + APE + K
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI--KEDIYEAREGAKF-PIKWTAPEAALYNRFSIK 184
Query: 493 GDVYSFGVVLLELIT-GERP-THLTNA 517
DV+SFG++L E++T G P +TNA
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNA 211
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 5e-16
Identities = 58/210 (27%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 313 IIGTGRTGATYIAML--PGG--CFIMIKRLED--SQHSEKEFLSEINTLGSVRHRNLVPL 366
+IG G G L PG F+ IK L+ ++ ++FLSE + +G H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 367 LGFCVAKKERLLVYSYLENGTL--YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
G + +++ ++ENG L + + + + V+ + LR G A G+ +L
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYL--- 122
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM--NPVDTHLSTFVNGEFGDLGYVAPE 482
+HR+++++ IL++ + K+SDFGL+R + + D ++ + G+ + + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI-PIRWTAPE 181
Query: 483 YPRTLVATPKGDVYSFGVVLLELIT-GERP 511
T DV+S+G+V+ E+++ GERP
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 10/207 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+GTG+ G G + IK +++ SE EF+ E + + H LV L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ +V Y+ NG L + L L + G+A+L + + IHR+
Sbjct: 72 RPIYIVTEYMSNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
++++ L+D K+SDFGL+R + +D ++ V +F + + PE + K
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKF-PVRWSPPEVLLYSKFSSKS 182
Query: 494 DVYSFGVVLLELIT-GERPTHLTNAPE 519
DV++FGV++ E+ + G+ P N E
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G G+ G ++ G + IK L+ S + FL+E N + ++H LV L V +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VVTQ 72
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ ++ Y+ENG+L D L E + + + +A A G+A++ IHR+
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGIKLTI--NKLIDMAAQIAEGMAFIERK---NYIHRD 127
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+ + IL+ K++DFGLARL+ D + +F + + APE T K
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKF-PIKWTAPEAINYGTFTIKS 184
Query: 494 DVYSFGVVLLELITGER 510
DV+SFG++L E++T R
Sbjct: 185 DVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-15
Identities = 42/103 (40%), Positives = 61/103 (59%), Gaps = 1/103 (0%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
L G P I L LDLS N+LSG IP ++ +LQ + L L SN+ +G+IP L +
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
L VL+L +N+F+G+IP LG N + +++N LTG +P
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 16/190 (8%)
Query: 333 IMIKRLEDSQHSEKE--FLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390
+++K L S +++ FL E+ + H N++ LG C+ LLV + G L +
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 391 KLHPA-EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449
L + R+A A GL WLH IH +++ + L D K+
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKI 141
Query: 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-----YPRTLVA--TPKGDVYSFGVVL 502
D+GLA P D +++ + L ++APE L T K +++S GV +
Sbjct: 142 GDYGLALEQYPEDYYITK--DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199
Query: 503 LELIT-GERP 511
EL T ++P
Sbjct: 200 WELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
IG G G Y +L G + +K R +++FL E L H N+V L+G CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH-HNCNPRII 430
K+ +V + G+L L ++ + L++++ +A G+ +L NC I
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEYLESKNC----I 115
Query: 431 HRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF-VNGEFGDL--GYVAPEYPRTL 487
HR+++++ L+ + K+SDFG++R + + V+ + + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 488 VATPKGDVYSFGVVLLELITG 508
T + DV+S+G++L E +
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 55/184 (29%), Positives = 80/184 (43%), Gaps = 29/184 (15%)
Query: 336 KRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL--H 393
K ED + +K L E+ L +RH N+V L K LV+ Y+E TL + L
Sbjct: 35 KESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEAS 93
Query: 394 PA---EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
P V W L + +A+ H + IIHR+I + IL+ KL
Sbjct: 94 PGGLPPDAVRSYIWQL--------LQAIAYCHSH---NIIHRDIKPENILVSESGVLKLC 142
Query: 451 DFGLARLMN-PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPK----GDVYSFGVVLLEL 505
DFG AR + + L+ +V + Y APE LV DV++ G ++ EL
Sbjct: 143 DFGFARALRARPASPLTDYVATRW----YRAPE---LLVGDTNYGKPVDVWAIGCIMAEL 195
Query: 506 ITGE 509
+ GE
Sbjct: 196 LDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 5e-15
Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 16/232 (6%)
Query: 290 EKSVEKMR-LSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE 347
E+ +EK+R + + +++ IG G +G + A+ + G + IK++ + +KE
Sbjct: 2 EEIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE 61
Query: 348 FL-SEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL 406
+ +EI + +++ N+V L + E +V YL G+L D + MD
Sbjct: 62 LIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-----CMDEAQ 116
Query: 407 RLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466
+ + L +LH N ++IHR+I S +LL D KL+DFG + P + S
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173
Query: 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAP 518
T V + ++APE PK D++S G++ +E++ GE P +L P
Sbjct: 174 TMVGTPY----WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE-PPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 63/209 (30%), Positives = 109/209 (52%), Gaps = 20/209 (9%)
Query: 313 IIGTGRTGATYIAML--PGG--CFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNLVP 365
+IG G G L PG + IK L+ + ++EK+ FLSE + +G H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 366 LLGFCVAKKERLLVYSYLENGTL--YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
L G K ++V Y+ENG+L + + H + V+ + LR G A G+ +L
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR-----GIASGMKYL-- 122
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY 483
+ +HR+++++ IL++ + K+SDFGL+R++ T G+ + + APE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI-PIRWTAPEA 180
Query: 484 PRTLVATPKGDVYSFGVVLLELIT-GERP 511
T DV+S+G+V+ E+++ GERP
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 38/269 (14%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE--KEFLSEINTLGSVRHRNLVPLLGFC 370
+G G +G + P G + +K + + K+ L E++ L +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL--RIAIGSARGLAWLHHNCNPR 428
+ + Y++ G+L DK+ + P R+ +IA+ +GL +LH
Sbjct: 69 YNNGDISICMEYMDGGSL-DKILKEVQGRI----PERILGKIAVAVLKGLTYLHEKHK-- 121
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV 488
IIHR++ IL++ + KL DFG++ + V++ TFV G Y+APE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFV----GTSSYMAPERIQGND 175
Query: 489 ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI---DKS 545
+ K D++S G+ L+EL TG P + + L I
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFP---------YPPENDPPDGIF----ELLQYIVNEPPP 222
Query: 546 LLGNG-FDGELHQFLRVACNCVLPTPKER 573
L +G F + F+ C++ P+ER
Sbjct: 223 RLPSGKFSPDFQDFV---NLCLIKDPRER 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 51/199 (25%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
IG+G+ G ++ + IK + + SE++F+ E + + H LV L G C +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
LV+ ++E+G L D L + L + + G+A+L + +IHR+
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
++++ L+ + K+SDFG+ R + +D ++ +F + + +PE + K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV--LDDQYTSSTGTKF-PVKWSSPEVFSFSKYSSKS 182
Query: 494 DVYSFGVVLLELIT-GERP 511
DV+SFGV++ E+ + G+ P
Sbjct: 183 DVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 314 IGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
IG G +G Y A G + IK++ + +++ ++EI + +H N+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 373 KKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
+ L +V Y++ G+L D + + M+ P + +GL +LH +IH
Sbjct: 86 VGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIH 139
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
R+I S ILL D KL+DFG A + + ++ V G ++APE + P
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYWMAPEVIKRKDYGP 195
Query: 492 KGDVYSFGVVLLELITGERP 511
K D++S G++ +E+ GE P
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 314 IGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFL-SEINTLGSVRHRNLVPLLGFCV 371
IG G TG IA + G + +K+++ + +E L +E+ + +H N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
E +V +LE G L D + H M+ + + +A+ + L+ LH +IH
Sbjct: 88 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAV--LKALSVLHAQ---GVIH 139
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
R+I S ILL D KLSDFG ++ + V + ++APE L P
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY----WMAPELISRLPYGP 195
Query: 492 KGDVYSFGVVLLELITGERP 511
+ D++S G++++E++ GE P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 33/193 (17%)
Query: 330 GCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386
G + IK+ ED +K L EI L ++H NLV L+ K++ LV+ Y ++
Sbjct: 26 GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH- 84
Query: 387 TLYDKL--HPA---EHEVMHMDWPLRLRIAIGSARGLAWLH-HNCNPRIIHRNISSKCIL 440
T+ ++L +P EH + + W + + + H HNC IHR++ + IL
Sbjct: 85 TVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNFCHKHNC----IHRDVKPENIL 132
Query: 441 LDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT----PKGDVY 496
+ + KL DFG AR++ + +V + Y APE LV P DV+
Sbjct: 133 ITKQGQIKLCDFGFARILTGPGDDYTDYVATRW----YRAPEL---LVGDTQYGPPVDVW 185
Query: 497 SFGVVLLELITGE 509
+ G V EL+TG+
Sbjct: 186 AIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 21/187 (11%)
Query: 330 GCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386
G + IK+ ED + +K + EI L +RH NLV L+ KK LV+ ++++
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH- 84
Query: 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446
T+ D L E +D + RG+ + H + IIHR+I + IL+
Sbjct: 85 TVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGV 138
Query: 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG----DVYSFGVVL 502
KL DFG AR + + +V + Y APE LV K D+++ G ++
Sbjct: 139 VKLCDFGFARTLAAPGEVYTDYVATRW----YRAPEL---LVGDTKYGRAVDIWAVGCLV 191
Query: 503 LELITGE 509
E++TGE
Sbjct: 192 TEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 308 FSKNNIIGTGRTGATYIAM--LPGGCFIMIKRLEDSQHSEK---EFLSEINTLGSVRHRN 362
F N IG G G + + + M K+++ S+ + + E + E L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAM-KQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMD--WPLRLRIAIGSARGLAW 420
++ + K + +V Y ENG L+ L + D W ++I +G LA
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
LH +I+HR+I S + LD K+ D G+A+L++ + F N G Y++
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----TNFANTIVGTPYYLS 169
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERP 511
PE K DV++ GVVL E TG+ P
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 16/184 (8%)
Query: 330 GCFIMIKRLEDSQHSEKE----FLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYL 383
G + +K+L QHS E F EI L S++H N+V G C + R LV YL
Sbjct: 33 GEVVAVKKL---QHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89
Query: 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG 443
G+L D L + H L A +G+ +L + R +HR+++++ IL++
Sbjct: 90 PYGSLRDYLQKHRERLDH---RKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVES 143
Query: 444 DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLL 503
+ K+ DFGL +++ P D + + APE + DV+SFGVVL
Sbjct: 144 ENRVKIGDFGLTKVL-PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
Query: 504 ELIT 507
EL T
Sbjct: 203 ELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 28/221 (12%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNLVPLL 367
IG G G G ++ K ++ +EKE +SE+N L ++H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 368 GFCVAKKERLL--VYSYLENGTL--------YDKLHPAEHEVMHMDWPLRLRIAIGSARG 417
+ + + L V Y E G L ++ + E + RI
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI--------WRILTQLLLA 117
Query: 418 LAWLHH--NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
L H+ + ++HR++ I LD + KL DFGLA+++ + T+V G
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV----GT 173
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516
Y++PE + K D++S G ++ EL P N
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G G G ++ G + IK L+ S + FL E + +RH LV L V++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 72
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ +V Y+ G+L D L + + + P + +A A G+A++ +HR+
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NYVHRD 127
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+ + IL+ + K++DFGLARL+ D + +F + + APE T K
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKF-PIKWTAPEAALYGRFTIKS 184
Query: 494 DVYSFGVVLLELITGER 510
DV+SFG++L EL T R
Sbjct: 185 DVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 10/210 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G G+ G ++A + +K ++ S + FL+E N + +++H LV L V K
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 72
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ ++ ++ G+L D L E + P + + A G+A++ IHR+
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIHRD 127
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+ + IL+ K++DFGLAR++ D + +F + + APE T K
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184
Query: 494 DVYSFGVVLLELIT-GERPTHLTNAPESFK 522
DV+SFG++L+E++T G P + PE +
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 67/298 (22%), Positives = 122/298 (40%), Gaps = 56/298 (18%)
Query: 313 IIGTGRTGATYIAMLPGGC------FIMIKRLE--DSQHSEKEFLSEINTLGSVRHRNLV 364
+G G G ++A G +++K L+ ++ + EF E++ + H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWP-----LRLRIAIGSARGLA 419
LLG C + ++ Y + G L L + + + P ++ + A G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF--VNGEFGDLG 477
L N R +HR+++++ L+ E K+S L++ D + S + + L
Sbjct: 132 HLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK-----DVYNSEYYKLRNALIPLR 183
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP-THLTNAPESF-----KGSLVEWIT 530
++APE + + K DV+SFGV++ E+ T GE P L++ E G L E
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--EEVLNRLQAGKL-ELPV 240
Query: 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588
S L ++ C PK+R + E L+ A+ E
Sbjct: 241 PEGCPSRLY--------------------KLMTRCWAVNPKDRPSFSE---LVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 8/194 (4%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G G+ G ++ + +K L+ S + FL E N + +++H LV L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
+ ++ Y+ G+L D L E + + P + + A G+A++ IHR+
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+ + +L+ K++DFGLAR++ D + +F + + APE T K
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIE--DNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185
Query: 494 DVYSFGVVLLELIT 507
DV+SFG++L E++T
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 1/104 (0%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
G+ P + L L L SN SG IP ++ +T LDLS+N+L+GEIP GL +
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH-NNLTVLDLSTNNLTGEIPEGLCS 378
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
L L L +N G+IP LG ++ + N +G +PS
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 41/103 (39%), Positives = 58/103 (56%), Gaps = 1/103 (0%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
L GQ PR + + SL + L NNLSG IP +I L + LDL N+L+G IPS L N
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG-GLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
L L L N+ +G IPP + L ++ + ++ N L+G +P
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 53/206 (25%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 321 ATYIAMLPGGCFIMIKRL-EDSQHSE-KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378
A + G + +K L E++ SE ++ LSE N L V H +++ L G C LL
Sbjct: 21 AFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80
Query: 379 VYSYLENGTLYD------KLHPA------EHEVMHMDWPLRLRIAIGSARGLAW-----L 421
+ Y + G+L K+ P+ ++D P + +G AW +
Sbjct: 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGM 140
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
+ +++HR+++++ +L+ + K+SDFGL+R + D+++ G + ++A
Sbjct: 141 QYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKR-SKGRI-PVKWMAI 198
Query: 482 EYPRTLVATPKGDVYSFGVVLLELIT 507
E + T + DV+SFGV+L E++T
Sbjct: 199 ESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 41/225 (18%)
Query: 310 KNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-----DSQHSEKE------FLSEINTLGS 357
K +IG G G Y+A+ + G + +K++E +H ++ SEI TL
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 358 VRHRNLVPLLGFCVAKKERLLVYS-YLEN------GTLYDKLHPAEHEVMHMDWPLRLRI 410
+ H N+V LGF + S +LE G+ E +++
Sbjct: 65 LDHLNIVQYLGF----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF-------F 113
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
GLA+LH + I+HR++ + +L+D D K+SDFG+++ D + +
Sbjct: 114 TEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNM 168
Query: 471 GEFGDLGYVAPE----YPRTLVATPKGDVYSFGVVLLELITGERP 511
G + ++APE Y + A K D++S G V+LE+ G RP
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSA--KVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 28/217 (12%)
Query: 313 IIGTGRTG----ATYIAM--LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSV-RHRN 362
+G G G A + + + +K L+D EK+ +SE+ + + +H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKN 77
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLH----PAEHEVMHMDWPLRLRI-------- 410
++ LLG C + +V Y +G L D L P E+ P +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
A ARG+ +L + + IHR+++++ +L+ D K++DFGLAR ++ +D + T N
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT-TN 193
Query: 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
G + ++APE V T + DV+SFGV+L E+ T
Sbjct: 194 GRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 42/234 (17%)
Query: 308 FSKNNI-----IGTGRTGATYIAMLPG------GCFIMIKRLED--SQHSEKEFLSEINT 354
+ +NNI IG G G + A PG + +K L++ S + +F E
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 355 LGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHP----AEHEVMHMDWPLR--- 407
+ H N+V LLG C K L++ Y+ G L + L A+ + H R
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 408 -----------LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
L IA A G+A+L + +HR+++++ L+ + K++DFGL+R
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 457 LMNPVDTHLSTFVNGEFGDLGYVAPE---YPRTLVATPKGDVYSFGVVLLELIT 507
+ D + ++ + + ++ PE Y R T + DV+++GVVL E+ +
Sbjct: 179 NIYSADYYKAS--ENDAIPIRWMPPESIFYNRY---TTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 314 IGTGRTGATYIA--MLPGGCF----IMIKRLEDSQHSEK---EFLSEINTLGSVRHRNLV 364
+G G G Y P + IK L+++ K EF E + ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKL-----------HPAEHEVMHMDWPLR-LRIAI 412
LLG C ++ +++ YL +G L++ L + V L IAI
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 413 GSARGLAWL--HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
A G+ +L HH +HR+++++ L+ K+SDFGL+R + D + +
Sbjct: 132 QIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY--RVQS 184
Query: 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
+ ++ PE T + D++SFGVVL E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 13/163 (7%)
Query: 344 SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHM 402
+ + FL+E + + +RH NLV LLG V +K L +V Y+ G+L D L V+
Sbjct: 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG 101
Query: 403 DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462
D L+ ++ + +L N +HR+++++ +L+ D K+SDFGL + +
Sbjct: 102 D--CLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156
Query: 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
V + APE R + K DV+SFG++L E+
Sbjct: 157 DTGKLPVK-------WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 314 IGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFL-SEINTLGSVRHRNLVPLLGFCV 371
IG G TG IA G + +K+++ + +E L +E+ + H N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
E +V +LE G L D + H M+ + + +++ R L++LH N +IH
Sbjct: 90 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSV--LRALSYLH---NQGVIH 141
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
R+I S ILL D KLSDFG ++ + V + ++APE L
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY----WMAPEVISRLPYGT 197
Query: 492 KGDVYSFGVVLLELITGERP 511
+ D++S G++++E+I GE P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 24/186 (12%)
Query: 335 IKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+K L E +KEFL E + + + H +V L+G C + +LV G L L
Sbjct: 28 VKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYL 86
Query: 393 ----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448
++ + A A G+A+L +HR+++++ +LL + K
Sbjct: 87 KKRREIPVSDLKEL--------AHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAK 135
Query: 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE--YPRTLVATPKGDVYSFGVVLLELI 506
+SDFG++R + + G + L + APE + K DV+S+GV L E
Sbjct: 136 ISDFGMSRALGAGSDYYRATTAGRW-PLKWYAPECINYGKF--SSKSDVWSYGVTLWEAF 192
Query: 507 T-GERP 511
+ G +P
Sbjct: 193 SYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 48/204 (23%)
Query: 345 EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHP----AEHEV 399
EKE L+ +N H ++ L + +E L V Y NG L + E
Sbjct: 51 EKEVLTRLN-----GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT 104
Query: 400 MHMDWPLRLRIA-IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458
R A I A L +LH IIHR++ + ILLD D K++DFG A+++
Sbjct: 105 -------RFYAAEILLA--LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152
Query: 459 NPVD--------------------THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSF 498
+P ++FV G YV+PE A D+++
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFV----GTAEYVSPELLNEKPAGKSSDLWAL 208
Query: 499 GVVLLELITGERPTHLTNAPESFK 522
G ++ +++TG+ P +N +F+
Sbjct: 209 GCIIYQMLTGKPPFRGSNEYLTFQ 232
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 38/222 (17%)
Query: 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL------EDSQHSEKEFLSEINTLGSVR 359
+ K ++G+G G+ Y + L G F +K + + Q + K+ EI L ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 360 HRNLVPLLGFCVAKKERLLVYSYLENG----TLYDKLHPAEHEVMHMDWPLRLRIAIGSA 415
H N+V LG +++ L ++ L G L K V+ + L
Sbjct: 61 HPNIVQYLG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------ 113
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
GL +LH +HR+I IL+D + KL+DFG+A+ + S F +
Sbjct: 114 -GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPY-- 166
Query: 476 LGYVAPEYPRTLVATPKG------DVYSFGVVLLELITGERP 511
++APE V +G D++S G +LE+ TG+ P
Sbjct: 167 --WMAPE-----VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 44/279 (15%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFL-SEINTLGSVRHRNLVPLLGFCV 371
IG G TG IA G + +K+++ + +E L +E+ + +H N+V + +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
E +V +LE G L D + M+ + + + L++LH +IH
Sbjct: 87 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLH---AQGVIH 138
Query: 432 RNISSKCILLDGDFEPKLSDFGL-ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT 490
R+I S ILL D KLSDFG A++ V S G ++APE L
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL-----VGTPYWMAPEVISRLPYG 193
Query: 491 PKGDVYSFGVVLLELITGERPTHL------------TNAPESFKGS------LVEWITLL 532
+ D++S G++++E++ GE P + N P K L ++ +
Sbjct: 194 TEVDIWSLGIMVIEMVDGE-PPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252
Query: 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACN--CVLPT 569
+ A LL H FL A ++P
Sbjct: 253 LVRDPAQRATAAELLN-------HPFLAKAGPPSSIVPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 308 FSKNNIIGTGRTGATYIAMLPGGCFIMIKRLE----DSQHSEKEF---LSEINTLGSVRH 360
++K ++G G G Y + G I +K++E + +EKE+ E++ L S++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
N+V LG C+ + ++ G++ L+ + P+ + G+A+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAY 117
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL--STFVNGEFGDLGY 478
LH+NC ++HR+I ++L + KL DFG AR + V H S + G +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+APE K D++S G + E+ TG+ P
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-12
Identities = 45/116 (38%), Positives = 61/116 (52%), Gaps = 5/116 (4%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISS--RLQYVTSLDLSS 140
K++++ LSD L G+ P + + +L L L SNN +G IP ++S RLQ L L S
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV---LQLWS 341
Query: 141 NSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
N SGEIP L L VL L+ N TG+IP L + + SN L G +P
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-12
Identities = 38/104 (36%), Positives = 59/104 (56%), Gaps = 1/104 (0%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
G+ P+ + + +LT LDLS+NNL+G IP + S + L L SNSL GEIP L
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS-GNLFKLILFSNSLEGEIPKSLGA 402
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
C L ++L +N F+G++P + L + +++N L G + S
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 23/207 (11%)
Query: 333 IMIKRLEDSQHSEKEF---LSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTL 388
+ +K L+ S +EK+ +SE+ + + +H+N++ LLG C ++ Y G L
Sbjct: 53 VAVKMLK-SDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 389 YDKL------------HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISS 436
+ L +P + + + + A ARG+ +L + + IHR++++
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 437 KCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVY 496
+ +L+ D K++DFGLAR ++ +D + T NG + ++APE + T + DV+
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKT-TNGRL-PVKWMAPEALFDRIYTHQSDVW 226
Query: 497 SFGVVLLELIT-GERPTHLTNAPESFK 522
SFGV+L E+ T G P E FK
Sbjct: 227 SFGVLLWEIFTLGGSPYPGVPVEELFK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 50/182 (27%), Positives = 91/182 (50%), Gaps = 12/182 (6%)
Query: 333 IMIKRLED--SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390
+ IK ++D + + +E + +GS+ H +V LLG C +L V G+L D
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLD 97
Query: 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
H +H +D L + A+G+ +L + ++HRN++++ ILL D +++
Sbjct: 98 --HVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIA 151
Query: 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GE 509
DFG+A L+ P D F + + ++A E T + DV+S+GV + E+++ G
Sbjct: 152 DFGVADLLYPDDKKY--FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA 209
Query: 510 RP 511
P
Sbjct: 210 EP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 333 IMIKRLED--SQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389
+ +K L+D ++ + +SE+ + + +H+N++ LLG C ++ Y G L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 390 DKLH---PAEHEVMH-----MDWPLRLRIAIGS----ARGLAWLHHNCNPRIIHRNISSK 437
+ L P E + D + + + ARG+ +L + + IHR+++++
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYS 497
+L+ + K++DFGLAR +N +D + T NG + ++APE V T + DV+S
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKT-TNGRL-PVKWMAPEALFDRVYTHQSDVWS 224
Query: 498 FGVVLLELIT-GERPTHLTNAPESFK 522
FGV++ E+ T G P E FK
Sbjct: 225 FGVLMWEIFTLGGSPYPGIPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 59/228 (25%), Positives = 88/228 (38%), Gaps = 55/228 (24%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-----FLSEINTLGSVRHR 361
+ K IG G G Y A G + +K++ +EKE + EI L +RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 362 NLVPLLGFCV--AKKERLLVYSYLE---NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR 416
N+V L K +V+ Y++ G L + +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV---------------KFTESQIK 103
Query: 417 --------GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468
GL +LH N I+HR+I IL++ D KL+DFGLAR + + +
Sbjct: 104 CYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR--NSADY 158
Query: 469 VNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
N L Y PE Y P+ D++S G +L EL G+
Sbjct: 159 TNRVI-TLWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 308 FSKNNIIGTGRTGATYIAM---LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLV 364
F+K IG G G Y + I I LE+++ ++ EI L +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
G + + ++ YL G+ D L P E ++ LR + +GL +LH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLH-- 118
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+ R IHR+I + +LL + KL+DFG+A + +TFV F ++APE
Sbjct: 119 -SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF----WMAPEVI 173
Query: 485 RTLVATPKGDVYSFGVVLLELITGERP 511
+ K D++S G+ +EL GE P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 13/182 (7%)
Query: 330 GCFIMIKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLEN 385
G + +K L E Q + + EIN L ++ H N+V G C + + L+ Y+
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445
G+L D L +H++ + L A G+A+LH + IHR+++++ +LLD D
Sbjct: 93 GSLRDYL--PKHKL---NLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDR 144
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
K+ DFGLA+ + + +G+ + + A E + + DV+SFGV L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGD-SPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 506 IT 507
+T
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
+G+G+ G ++ + IK + + SE++F+ E + + H LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
K +V ++ENG L L+ + + L + G+ +L N IHR+
Sbjct: 72 KPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRD 125
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
++++ L+ K+SDFG+ R + +D ++ +F + + PE + K
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKS 182
Query: 494 DVYSFGVVLLELIT-GERP 511
DV+SFGV++ E+ T G+ P
Sbjct: 183 DVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 67/294 (22%), Positives = 123/294 (41%), Gaps = 48/294 (16%)
Query: 314 IGTGRTGATYIA----MLPGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVRHRNLVP 365
+G G G ++ + P + +K L++ S + K+F E L + +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLR----------LRIAIGSA 415
G C ++V+ Y+E+G L L + + P L+IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE-FG 474
G+ +L + +HR+++++ L+ D K+ DFG++R + D + V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---VGGHTML 186
Query: 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLN 533
+ ++ PE T + DV+SFGVVL E+ T G++P W L N
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP----------------WYGLSN 230
Query: 534 TNSSLETAIDKSLLG--NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585
E LL E++ + C P++R + ++++ L+
Sbjct: 231 EEVI-ECITQGRLLQRPRTCPSEVYDIML---GCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 16/181 (8%)
Query: 340 DSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH---PAE 396
S EFL+E + + ++V LLG + L+V + G L L P
Sbjct: 48 ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEA 107
Query: 397 HEVMHMDWPLRLRI---AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453
+ P + A A G+A+L + +HR+++++ ++ D K+ DFG
Sbjct: 108 ENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFG 164
Query: 454 LARLMNPVDTHLSTFVNGEFGDLG--YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GER 510
+ R + D + G G L ++APE + V T K DV+SFGVVL E+ T E+
Sbjct: 165 MTRDIYETDY----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQ 220
Query: 511 P 511
P
Sbjct: 221 P 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 18/167 (10%)
Query: 348 FLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
FL E + + H+NLV LLG + +V + G L + L ++ +
Sbjct: 46 FLEETAVMTKLHHKNLVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSV--IQL 102
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP--VDTHL 465
L+ ++ A G+ +L + +++HR+++++ IL+ D K+SDFGLAR + VD
Sbjct: 103 LQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSK 158
Query: 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ + APE + + K DV+S+GV+L E+ + G P
Sbjct: 159 LP--------VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 56/210 (26%), Positives = 110/210 (52%), Gaps = 23/210 (10%)
Query: 313 IIGTGRTGATYIAM-LPGG----CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVP 365
++G+G G Y + +P G + IK L ++ + EF+ E + S+ H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEV---MHMDWPLRLRIAIGSARGLAWLH 422
LLG C++ +L V + +G L D +H + + + ++W +++ A+G+ +L
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
R++HR+++++ +L+ K++DFGLARL+ + + +G + ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--DGGKMPIKWMALE 181
Query: 483 YPRTLVATPKGDVYSFGVVLLELIT-GERP 511
T + DV+S+GV + EL+T G +P
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 310 KNNIIGTGRTGATYIAM-LPGGCFIMIKRLE------DSQHSEKEFLS----EINTLGSV 358
K +IG+G G+ Y+ M G + +K++E S+ ++ L EI L +
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL--HPAEHEVMHMDWPLRLRIAIGSAR 416
+H N+V LG + + Y+ G++ L + A E L +
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE------TLVRNFVRQILK 117
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM--NPVDTHLSTFVNGEFG 474
GL +LH N IIHR+I IL+D K+SDFG+++ + N + T + G
Sbjct: 118 GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+ ++APE + T K D++S G +++E++TG+ P
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/220 (27%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 301 LMKATNSFSKNNIIGTGRTGATYIAM-LPGG----CFIMIKRLED--SQHSEKEFLSEIN 353
++K T F K ++G+G G Y + +P G + IK L + S + KE L E
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 354 TLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEH-EVMHMDWPLRLRIAI 412
+ SV + ++ LLG C+ +L + + G L D + EH + + + L + I
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQI 118
Query: 413 GSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE 472
A+G+ +L R++HR+++++ +L+ K++DFGLA+L+ + G
Sbjct: 119 --AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--EGG 171
Query: 473 FGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ ++A E + T + DV+S+GV + EL+T G +P
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 313 IIGTGRTGATYIAML--PGGCFIMIK----RLEDSQHSE-KEFLSEINTLGSVRHRNLVP 365
I+G G G+ L G + + +L+ +SE +EFLSE + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 366 LLGFCVAKKER------LLVYSYLENGTLYDKLHPAEHEVMHMDWPLR--LRIAIGSARG 417
L+G C +++ ++++G L+ L + + PL+ L+ + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD----THLSTFVNGEF 473
+ +L N IHR+++++ +L D ++DFGL++ + D ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM----- 177
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ ++A E V T K DV++FGV + E+ T G+ P
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
+ +G G G+ L I + + + +K+ L E+ S + +V G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 369 FCVAKKERLL--VYSYLENGTL---YDKLHP-----AEHEVMHMDWPLRLRIAIGSARGL 418
+ + + Y E G+L Y K+ E L +IA +GL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-------VL-GKIAESVLKGL 118
Query: 419 AWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA-RLMNPVDTHLSTFVNGEFGDLG 477
++LH +IIHR+I ILL + KL DFG++ L+N + TF F
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSF---- 168
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
Y+APE + + DV+S G+ LLE+ P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 333 IMIKRLED--SQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389
+ +K L+D + + +SE+ + + +H+N++ LLG C + ++ Y G L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 390 DKLH-------------PAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISS 436
+ L E + + + A ARG+ +L + R IHR++++
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQ-LSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAA 162
Query: 437 KCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVY 496
+ +L+ D K++DFGLAR ++ +D + T NG + ++APE V T + DV+
Sbjct: 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKT-SNGRL-PVKWMAPEALFDRVYTHQSDVW 220
Query: 497 SFGVVLLELIT-GERPTHLTNAPESFK 522
SFG+++ E+ T G P E FK
Sbjct: 221 SFGILMWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 314 IGTGRTGA-TYIAMLPGGCFIMIKR---LEDSQHSEKEFLSEINTLGSVRHRNLVPLLGF 369
+G G G+ + + +P G M K+ + K+ L E+ + R +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTV-MAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 370 CVAKKERLLVYSYLENGTL---YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
+ + + +++ G+L Y K P E++ IA+ GL +L++
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK-------IAVAVVEGLTYLYNV-- 122
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLA-RLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
RI+HR+I IL++ + KL DFG++ L+N + TFV G Y++PE +
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---ADTFV----GTSTYMSPERIQ 175
Query: 486 TLVATPKGDVYSFGVVLLELITGERP 511
T K DV+S G+ ++EL G+ P
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 56/185 (30%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDK 391
I+ ++ + +E+ LS IN H +V L + +E+L LV Y G L+
Sbjct: 31 IIKRKEVEHTLTERNILSRIN------HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSH 83
Query: 392 LHPA----EHEVMHMDWPLRLRIA-IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446
L E R A I A L +LH + II+R++ + ILLD D
Sbjct: 84 LSKEGRFSEERA-------RFYAAEIVLA--LEYLH---SLGIIYRDLKPENILLDADGH 131
Query: 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELI 506
KL+DFGLA+ ++ + +TF G Y+APE D +S GV+L E++
Sbjct: 132 IKLTDFGLAKELSSEGSRTNTFC----GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML 187
Query: 507 TGERP 511
TG+ P
Sbjct: 188 TGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 57/182 (31%), Positives = 93/182 (51%), Gaps = 18/182 (9%)
Query: 333 IMIKRLEDSQH-SEKEFL-SEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389
+ +K L+ + H SE+E L SE+ + + H N+V LLG C L++ Y G L
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPK 448
+ L + E L L + A+G+A+L NC IHR+++++ +LL K
Sbjct: 128 NFLR-RKRESFLTLEDL-LSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVK 181
Query: 449 LSDFGLAR-LMNPVDTHLSTFV--NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
+ DFGLAR +MN S +V + ++APE V T + DV+S+G++L E+
Sbjct: 182 ICDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 506 IT 507
+
Sbjct: 237 FS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 12/190 (6%)
Query: 333 IMIKRLEDSQHSEKE---FLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389
++ K + ++ SEKE L+EI L ++H N++ + L+ Y GTLY
Sbjct: 28 VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLY 87
Query: 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449
DK+ + + + L ++++H I+HR+I + I L KL
Sbjct: 88 DKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKL 142
Query: 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE 509
DFG+++++ + T V G Y++PE + + K D+++ G VL EL+T +
Sbjct: 143 GDFGISKILGSEYSMAETVV----GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198
Query: 510 RPTHLTNAPE 519
R TN
Sbjct: 199 RTFDATNPLN 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 30/208 (14%)
Query: 321 ATYIAMLPGGCF-IMIKRLED--SQHSEKEFLSEINTLGSVRHRNLVPLLGFCV---AKK 374
I PG + +K ++D S+ L E L + H+N++P+L C+
Sbjct: 25 GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84
Query: 375 ERLLVY-------SYLENGTLYDKLHP---AEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
L Y +L+ L + +P + +++HM AI A G+++LH
Sbjct: 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM--------AIQIACGMSYLH-- 134
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+IH++I+++ ++D + + K++D L+R + P+D H + E + ++A E
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH--CLGDNENRPVKWMALESL 191
Query: 485 RTLVATPKGDVYSFGVVLLELIT-GERP 511
+ DV+SFGV+L EL+T G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 310 KNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-------FLSEINTLGSVRHR 361
K +GTG + Y A + G + +K++ +++ E EI + + H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHP--AEHEVMHMDWPLRLRIAIGSARGLA 419
+++ +LG L ++ G++ L A E + +++ +L RGL+
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLS 117
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEP-KLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+LH N +IIHR++ +L+D + +++DFG A + T F G + +
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+APE R DV+S G V++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 23/183 (12%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD---- 390
IK +S+ K L EI L + H N++ LL K + LV+ +++ LY
Sbjct: 32 IKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD 90
Query: 391 -KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449
+ E + + L +GLA+ H + I+HR++ + +L++ + KL
Sbjct: 91 RQRGLPESLIKSYLYQL--------LQGLAFCHSH---GILHRDLKPENLLINTEGVLKL 139
Query: 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-YPRTLVATPKGDVYSFGVVLLELITG 508
+DFGLAR + +V + Y APE + D++S G + EL++
Sbjct: 140 ADFGLARSFGSPVRPYTHYVVTRW----YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR 195
Query: 509 ERP 511
RP
Sbjct: 196 -RP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 24/216 (11%)
Query: 314 IGTGRTGATYIAMLPGGC------FIMIKRLED-SQHSEKEFLSEINTLGSVRHRNLVPL 366
+G G G ++A C + +K L+D S ++ K+F E L +++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 367 LGFCVAKKERLLVYSYLENGTL--YDKLHPAEHEVMHMDWP-------LRLRIAIGSARG 417
G CV ++V+ Y+++G L + + H + +M L IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE-FGDL 476
+ +L + +HR+++++ L+ + K+ DFG++R + D + V G +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPI 186
Query: 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
++ PE T + DV+S GVVL E+ T G++P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 291 KSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFL 349
+S++ + LS L F ++G G G Y + G IK ++ ++ E+E
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIK 60
Query: 350 SEINTLGSV-RHRNLVPLLGFCVAKK------ERLLVYSYLENGTLYDKLHPAEHEVMHM 402
EIN L HRN+ G + K + LV + G++ D + + +
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 403 DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462
DW + I RGLA LH + ++IHR+I + +LL + E KL DFG++ ++
Sbjct: 121 DWIAYICREI--LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175
Query: 463 THLSTFVNGEFGDLGYVAPEYPRTLVATP---------KGDVYSFGVVLLELITGERP 511
+TF+ + ++APE ++A + D++S G+ +E+ G P
Sbjct: 176 GRRNTFIGTPY----WMAPE----VIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 17/179 (9%)
Query: 337 RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAE 396
RL S + ++ E L ++H N+V A +V Y + G L K+
Sbjct: 34 RLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR 93
Query: 397 ----HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
E + W +++ + + H R++HR+I SK I L + + KL DF
Sbjct: 94 GKLFPEDTILQWFVQMCLGV---------QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
G ARL+ + T+V + YV PE + K D++S G +L EL T + P
Sbjct: 145 GSARLLTSPGAYACTYVGTPY----YVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-11
Identities = 41/111 (36%), Positives = 61/111 (54%), Gaps = 5/111 (4%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGE 146
LS+ L G+ P I +SL LDL N L G IP+ ++ + L+++T L+SN L G+
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT---LASNQLVGQ 203
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
IP L L + L N +G+IP ++G L + + N LTGP+PS
Sbjct: 204 IPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 312 NIIGTGRTG----ATYIAMLPGGCFIMIK---RLEDSQHSEKEFLSEINTLGSVRHRNLV 364
+IG G G T I +K R+ D + E+ FL E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 365 PLLGFCVAKK-ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIG--SARGLAWL 421
LLG C+ + L+V Y+++G L + + H D I G A+G+ +L
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL--GYV 479
+ + +HR+++++ +LD F K++DFGLAR + D + N L ++
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI--YDKEYYSVHNHTGAKLPVKWM 169
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELIT 507
A E +T T K DV+SFGV+L EL+T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 66/298 (22%), Positives = 132/298 (44%), Gaps = 56/298 (18%)
Query: 314 IGTGRTGATYIA----MLPGG--CFIMIKRLED-SQHSEKEFLSEINTLGSVRHRNLVPL 366
+G G G ++A +LP + +K L++ S+ + ++F E L ++H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 367 LGFCVAKKERLLVYSYLENGTL--YDKLHPAEHEVM---------HMDWPLRLRIAIGSA 415
G C + L+V+ Y+ +G L + + H + +++ + L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE-FG 474
G+ +L + +HR+++++ L+ K+ DFG++R + D + V G
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTML 186
Query: 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLN 533
+ ++ PE T + D++SFGVVL E+ T G++P W L N
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP----------------WYQLSN 230
Query: 534 TNSSLETAIDKSLLGNGFD------GELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585
T AI+ G + E++ ++ C P++R + +++ L+A
Sbjct: 231 TE-----AIECITQGRELERPRTCPPEVYAIMQ---GCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 8e-11
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 26/169 (15%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL 408
L EI+ L ++H N+V LL +++ LV+ Y + D + + L
Sbjct: 46 LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD----MDLKKYLDKRPGPLSPNLIK 101
Query: 409 RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR-LMNPVDTHLST 467
I RGLA+ H + RI+HR++ + IL++ D KL+DFGLAR P+ T+
Sbjct: 102 SIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158
Query: 468 FVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
V L Y APE Y + D++S G + E+ITG+
Sbjct: 159 VVT-----LWYRAPEILLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 27/209 (12%)
Query: 333 IMIKRLEDSQHSE--KEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTL- 388
+ +K L+D + + +SE+ + + +H+N++ LLG C ++ Y G L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 389 --------------YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNI 434
+D E ++ D + A ARG+ +L + + IHR++
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDL---VSCAYQVARGMEYL---ASQKCIHRDL 160
Query: 435 SSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGD 494
+++ +L+ D K++DFGLAR ++ +D + T NG + ++APE V T + D
Sbjct: 161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKT-TNGRL-PVKWMAPEALFDRVYTHQSD 218
Query: 495 VYSFGVVLLELIT-GERPTHLTNAPESFK 522
V+SFGV+L E+ T G P E FK
Sbjct: 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV-RHRNLVP 365
++IG G G A + M IKR+++ S+ ++F E+ L + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLH--------PA---EHEVMH-MDWPLRLRIAIG 413
LLG C + L Y +G L D L PA + + L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 414 SARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
ARG+ +L + IHR+++++ IL+ ++ K++DFGL+R +V
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTM 170
Query: 474 GDLG--YVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
G L ++A E V T DV+S+GV+L E+++
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLS---EINTLGSVRHRNL 363
+ K ++G G G ++ ++IK++ Q ++ E L+ E L + H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
+ + K ++V Y GTL + + + ++ D L + I L LHH
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI-----LLALHH 116
Query: 424 NCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
I+HR++ ++ ILLD K+ DFG++++++ + T V G Y++PE
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVV----GTPCYISPE 171
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAP 518
K D+++ G VL EL + +R N P
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV-R 359
N ++IG G G A + M IKR+++ S+ ++F E+ L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 360 HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLR------------ 407
H N++ LLG C + L Y +G L D L + V+ D
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR--VLETDPAFAIANSTASTLSSQ 124
Query: 408 --LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465
L A ARG+ +L + IHR+++++ IL+ ++ K++DFGL+R
Sbjct: 125 QLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ------- 174
Query: 466 STFVNGEFGDLG--YVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
+V G L ++A E V T DV+S+GV+L E+++
Sbjct: 175 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 308 FSKNNIIGTGRTGATYIAM---LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLV 364
F+K IG G G + + I I LE+++ ++ EI L +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
G + + ++ YL G+ D L P + + LR + +GL +LH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-----KGLDYLH-- 118
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+ + IHR+I + +LL E KL+DFG+A + +TFV F ++APE
Sbjct: 119 -SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF----WMAPEVI 173
Query: 485 RTLVATPKGDVYSFGVVLLELITGERP 511
+ K D++S G+ +EL GE P
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 30/216 (13%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV-RHRNLVP 365
++IG G G AM+ M IK L++ S++ ++F E+ L + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLH--------PA---EHEVMH-MDWPLRLRIAIG 413
LLG C + + Y G L D L PA EH + L+ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 414 SARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
A G+ +L + IHR+++++ +L+ + K++DFGL+R +V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKTM 177
Query: 474 GDLG--YVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
G L ++A E V T K DV+SFGV+L E+++
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDS--QHSEK--EFLSEINTLGSVRHRNLVPLLG 368
IG G GA Y A + + IK++ S Q +EK + + E+ L +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH-HNCNP 427
+ + LV Y G+ D L + + ++ + G+ +GLA+LH HN
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AVTHGALQGLAYLHSHN--- 135
Query: 428 RIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
+IHR++ + ILL KL DFG A +M P + FV + ++APE +
Sbjct: 136 -MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----XFVGTPY----WMAPE---VI 183
Query: 488 VATPKG------DVYSFGVVLLELITGERPTHLTN 516
+A +G DV+S G+ +EL ER L N
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL--AERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 314 IGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFL-SEINTLGSVRHRNLVPLLGFCV 371
IG G TG IA G + +K ++ + +E L +E+ + +H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 372 AKKERLLVYSYLENGTLYD---KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
+E ++ +L+ G L D + E ++ + + L +LH
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTRLNEEQIA--------TVCESVLQALCYLHSQ---G 137
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGL-ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
+IHR+I S ILL D KLSDFG A++ V S G ++APE
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL-----VGTPYWMAPEVISRT 192
Query: 488 VATPKGDVYSFGVVLLELITGERPTHLTNAP 518
+ D++S G++++E++ GE P + +++P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGE-PPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 48/195 (24%), Positives = 95/195 (48%), Gaps = 21/195 (10%)
Query: 332 FIMIKRLEDSQHS-EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL-- 388
+ +K L+D + K+F E L +++H ++V G C ++V+ Y+++G L
Sbjct: 37 LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 96
Query: 389 YDKLHPAEHEVMHMDWPLR----------LRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438
+ + H + ++ P + L IA A G+ +L + +HR+++++
Sbjct: 97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRN 153
Query: 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE-FGDLGYVAPEYPRTLVATPKGDVYS 497
L+ + K+ DFG++R + D + V G + ++ PE T + DV+S
Sbjct: 154 CLVGANLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWS 210
Query: 498 FGVVLLELIT-GERP 511
FGV+L E+ T G++P
Sbjct: 211 FGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 15/175 (8%)
Query: 347 EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL 406
+F+ EI+ L +H N+V L + + ++ + + G L + E + P
Sbjct: 48 DFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG---LTEPQ 104
Query: 407 RLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466
+ L +LH + ++IHR++ + ILL D + KL+DFG++
Sbjct: 105 IRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161
Query: 467 TFVNGEFGDLGYVAPEYP--RTLVATP---KGDVYSFGVVLLELITGERPTHLTN 516
TF+ G ++APE T P K D++S G+ L+EL E P H N
Sbjct: 162 TFI----GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 37/219 (16%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDS--QHSEK--EFLSEINTLGSVRHRNLVPLLG 368
IG G GA Y A + + IK++ S Q +EK + + E+ L +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLR-LRIAI---GSARGLAWLHHN 424
+ + LV Y G+ D L EV PL+ + IA G+ +GLA+LH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDIL-----EVHKK--PLQEVEIAAICHGALQGLAYLHSH 134
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
IHR+I + ILL KL+DFG A L++P + +FV + ++APE
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN----SFVGTPY----WMAPE-- 181
Query: 485 RTLVATPKG------DVYSFGVVLLELITGERPTHLTNA 517
++A +G DV+S G+ +EL + P NA
Sbjct: 182 -VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 45/202 (22%)
Query: 335 IKRLEDSQ-------------HSEKE-FLSEINTLGSVRHRNLVP-----LLG--FCV-- 371
+KRL D+Q E+E ++EI L SV H N++ L G C+
Sbjct: 19 VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78
Query: 372 --AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRI 429
A L + KL P + W RI I RGL LH +I
Sbjct: 79 EYAPFGDL--SKAISKRKKKRKLIPEQ-----EIW----RIFIQLLRGLQALHEQ---KI 124
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA 489
+HR++ S ILL + K+ D G+++++ + G Y+APE +
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVLK------KNMAKTQIGTPHYMAPEVWKGRPY 178
Query: 490 TPKGDVYSFGVVLLELITGERP 511
+ K D++S G +L E+ T P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 30/189 (15%)
Query: 333 IMIKRLEDSQHSEKE-FLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391
+++K L+ S + E F + + + H++LV G CV E ++V Y++ G+L D
Sbjct: 30 VLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSL-DT 88
Query: 392 LHPAEHEVMHMDWPLRLRIAIGSARGLAW-LHHNCNPRIIHRNISSKCILL--DGDFEP- 447
++++ W L + A+ LAW LH + + H N+ +K +LL + D +
Sbjct: 89 YLKKNKNLINISWKLEV------AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTG 142
Query: 448 -----KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE---YPRTLVATPKGDVYSFG 499
KLSD G++ + P + L + +V PE P+ L + D +SFG
Sbjct: 143 NPPFIKLSDPGISITVLPKEILLER--------IPWVPPECIENPQNL--SLAADKWSFG 192
Query: 500 VVLLELITG 508
L E+ +G
Sbjct: 193 TTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 313 IIGTGRTGATYIA--MLPGG--CFIMIKRLED--SQHSEKEFLSEINTLGSVRHRNLVPL 366
I+GTGR G LP + I L S + FL+E TLG H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
G ++V Y+ NG L L E +++ + + G A G+ +L
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPGLASGMKYL---SE 125
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
+H+ +++ +L++ D K+S F RL + T ++G+ L + APE +
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL-WAAPEAIQY 182
Query: 487 LVATPKGDVYSFGVVLLELIT-GERP 511
+ DV+SFG+V+ E+++ GERP
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 56/182 (30%), Positives = 93/182 (51%), Gaps = 26/182 (14%)
Query: 345 EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDW 404
+KEFL E + + + H N+V LLG C+ + + ++ +E G L L A E
Sbjct: 43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGP-- 100
Query: 405 PL-----RLRIAIGSARGLAWLHHNCNPRIIHRNISSK-CILLDGDFEP----KLSDFGL 454
PL L I + A+G +L IHR+++++ C++ + ++ K+ DFGL
Sbjct: 101 PLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157
Query: 455 ARLMNPVDTHLSTF--VNGEFGDLG--YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GE 509
AR D + S + GE G L ++APE T + DV+SFGV++ E++T G+
Sbjct: 158 AR-----DIYKSDYYRKEGE-GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211
Query: 510 RP 511
+P
Sbjct: 212 QP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 55/222 (24%), Positives = 103/222 (46%), Gaps = 33/222 (14%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE---DSQHSEKEFLS---EINTLGSV 358
++ + ++G G G Y+ + G + +K++ DS ++KE + EI L ++
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 359 RHRNLVPLLGFCVAKKERLLVY-SYLENGTLYD--KLHPAEHEVMHMDWPLRLRIAIGSA 415
+H +V G C+ E L ++ Y+ G++ D K + A E + + ++
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------L 114
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
G+ +LH N I+HR+I IL D KL DFG ++ + + + T + G
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS-GTGMKSVTGT 170
Query: 476 LGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERP 511
+++PE Y R K DV+S G ++E++T + P
Sbjct: 171 PYWMSPEVISGEGYGR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 62/223 (27%), Positives = 86/223 (38%), Gaps = 41/223 (18%)
Query: 308 FSKNNIIGTG----------RTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGS 357
F +IG G R AM M K+ + S + L+E L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMK-----YMNKQKCVEKGSVRNVLNERRILQE 56
Query: 358 VRHRNLVPL-LGFCVAKKERL-LVYSYLENGTL-Y---DKLHPAEHEVMHMDWPLRLRIA 411
+ H LV L F +E + LV L G L Y K+ +E +V + I
Sbjct: 57 LNHPFLVNLWYSFQ--DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV-------KFWIC 107
Query: 412 -IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
I A L +LH + IIHR+I ILLD ++DF +A + P T
Sbjct: 108 EIVLA--LEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-----DTLTT 157
Query: 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTH 513
G GY+APE + D +S GV E + G+RP
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 58/219 (26%), Positives = 104/219 (47%), Gaps = 18/219 (8%)
Query: 301 LMKATNSFSKNNIIGTGRTGATYIAM-LPGG------CFIMIKRLEDSQHSEKEFLSEIN 353
++K T K ++G+G G Y + +P G I + R S + KE L E
Sbjct: 3 ILKET-ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 354 TLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIG 413
+ V + LLG C+ +L V + G L D + + + D L +
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL---LNWCVQ 117
Query: 414 SARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
A+G+++L R++HR+++++ +L+ K++DFGLARL++ +T +G
Sbjct: 118 IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA--DGGK 172
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ ++A E T + DV+S+GV + EL+T G +P
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSE-KEFLSEINTLGSVRH---R 361
+ + +IG G GA Y +P G + +K + D+ + + E+ L +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 362 NLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR-LRIAIGSARGLA 419
N+ G K RL ++ Y E G++ + ++ +R + +A L
Sbjct: 63 NITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA------LK 115
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
++H +IHR+I + IL+ KL DFG+A L+N + STFV G ++
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV----GTPYWM 168
Query: 480 APEYPRTLVA-TPKGDVYSFGVVLLELITGERP 511
APE K D++S G+ + E+ TG P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 49/181 (27%), Positives = 73/181 (40%), Gaps = 24/181 (13%)
Query: 342 QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL-VYSYLENGTLYDKLH-----PA 395
+H F E + H N+V LL A L V+ Y+ TL + L PA
Sbjct: 19 EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPA 78
Query: 396 EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDF 452
M L LA H+ I+HR++ + I++ K+ DF
Sbjct: 79 GETGRLMLQVLD---------ALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDF 126
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLG---YVAPEYPRTLVATPKGDVYSFGVVLLELITGE 509
G+ L+ V + LG Y APE R TP D+Y++G++ LE +TG+
Sbjct: 127 GIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
Query: 510 R 510
R
Sbjct: 187 R 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 24/182 (13%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+++K L F + + + H++LV L G CV E ++V Y++ G L L
Sbjct: 33 VVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFL 91
Query: 393 HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL-----DGDFEP 447
H ++ V + W +L +A A L +L +++H N+ K IL+ + + P
Sbjct: 92 HREKNNV-SLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145
Query: 448 --KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPK--GDVYSFGVVLL 503
KLSD G+ + + + + ++APE R A+ D +SFG LL
Sbjct: 146 FIKLSDPGIPITVLSREERVE--------RIPWIAPECIRNGQASLTIAADKWSFGTTLL 197
Query: 504 EL 505
E+
Sbjct: 198 EI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-----FLSEINTLGSVRHR 361
F K N IG G G Y A G + +K++ E++ L EI L ++RH
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLNLRHP 66
Query: 362 NLVPLLGFCVAKK--ERLLVYSYLEN--GTLYDKLHP--AEHEVMHMDWPLRLRIAIGSA 415
N+V L V K LV Y E +L D + +E +V + +
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC--------LMLQLL 118
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL +LH N IIHR++ +LL K++DFGLAR ++ V
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV----T 171
Query: 476 LGYVAPEYP-RTLVATPKGDVYSFGVVLLELITGE 509
L Y APE T D+++ G +L EL+ +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 307 SFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNL 363
SF K ++ + G Y+ IK + S+ S KE E+ L +++H N+
Sbjct: 12 SFGKAILVKSKEDGKQYV----------IKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHP------AEHEVMHMDWPLRLRIAIGSARG 417
V +V Y E G LY K++ E +++ DW +++ +A
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL--DWFVQICLA------ 113
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L H + +I+HR+I S+ I L D KL DFG+AR++N T + +
Sbjct: 114 ---LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY---- 166
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
Y++PE K D+++ G VL E+ T
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 308 FSKNNIIGTGRTGATYIAM---LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLV 364
F+K IG G G + + I I LE+++ ++ EI L +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
G + + ++ YL G+ D L + + L+ + +GL +LH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLH-- 118
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+ + IHR+I + +LL + KL+DFG+A + +TFV F ++APE
Sbjct: 119 -SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF----WMAPEVI 173
Query: 485 RTLVATPKGDVYSFGVVLLELITGERP 511
+ K D++S G+ +EL GE P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 38/120 (31%), Positives = 58/120 (48%), Gaps = 13/120 (10%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
GL +LH II+R++ +LLD D K++DFG+ + + STF G
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC----GTP 160
Query: 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE------WIT 530
Y+APE + D +SFGV+L E++ G+ P H + E F L + WI+
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWIS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVP 365
F ++G G G Y + G IK ++ + E+E EIN L HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 366 LLGFCVAKK------ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
G + K + LV + G++ D + + + +W + I RGL+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI--LRGLS 125
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
LH + ++IHR+I + +LL + E KL DFG++ ++ +TF+ + ++
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY----WM 178
Query: 480 APEYPRTLVATP---------KGDVYSFGVVLLELITGERP 511
APE ++A K D++S G+ +E+ G P
Sbjct: 179 APE----VIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 41/121 (33%), Positives = 61/121 (50%), Gaps = 13/121 (10%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
GL +LH II+R++ ++LD D K++DFG+ + D STF G
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC----GTP 160
Query: 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE------WIT 530
Y+APE + L T D +SFGV+L E++ G+ P H + E F+ V+ WIT
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWIT 220
Query: 531 L 531
Sbjct: 221 K 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 31/222 (13%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS--QHSEK--EFLSEINTLGSVRHRN 362
F+ IG G GA Y A + + IK++ S Q +EK + + E+ L ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
+ G + + LV Y G+ D L + + ++ I G+ +GLA+LH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLH 142
Query: 423 -HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
HN +IHR+I + ILL + KL+DFG A + +P + +FV + ++AP
Sbjct: 143 SHN----MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN----SFVGTPY----WMAP 190
Query: 482 EYPRTLVATPKG------DVYSFGVVLLELITGERPTHLTNA 517
E ++A +G DV+S G+ +EL + P NA
Sbjct: 191 E---VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 50/192 (26%), Positives = 78/192 (40%), Gaps = 43/192 (22%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLL-----GFCVAKKERLLVYSYLENGT 387
+ ++RLE + L EI L + +H +V LL G LV Y+
Sbjct: 33 VALRRLEGG--IPNQALREIKALQACQHPYVVKLLDVFPHGSGFV-----LVMEYMP-SD 84
Query: 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GLAWLHHNCNPRIIHRNISSKCILLDG 443
L + L E PL R G+A++H N I+HR++ +L+
Sbjct: 85 LSEVLRDEER-------PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISA 134
Query: 444 DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-------YPRTLVATPKGDVY 496
D K++DFGLARL + + L + + Y APE Y P D++
Sbjct: 135 DGVLKIADFGLARLFSEEEPRLYSH---QVATRWYRAPELLYGARKY------DPGVDLW 185
Query: 497 SFGVVLLELITG 508
+ G + EL+ G
Sbjct: 186 AVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 45/190 (23%), Positives = 91/190 (47%), Gaps = 22/190 (11%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+ I R + ++++ +FL E+ L ++ N++ LLG CV + ++ Y+ENG L L
Sbjct: 51 VKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL 110
Query: 393 H---------------PAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437
P H + + + L +A+ A G+ +L + +HR+++++
Sbjct: 111 SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATR 167
Query: 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE-FGDLGYVAPEYPRTLVATPKGDVY 496
L+ + K++DFG++R + D + + G + ++A E T DV+
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYR---IQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 497 SFGVVLLELI 506
+FGV L E++
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 6e-09
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 2/132 (1%)
Query: 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSS 140
N + + LS L G+ P G+ +L L L SN+L G IP + + + + + L
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA-CRSLRRVRLQD 413
Query: 141 NSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP-SFA 199
NS SGE+PS + L ++NN G+I + + ++ S+A N G +P SF
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473
Query: 200 NVNFTAEDFANN 211
+ D + N
Sbjct: 474 SKRLENLDLSRN 485
|
Length = 968 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 29/215 (13%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDS--QHSEK--EFLSEINTLGSVRHRNLVPLLG 368
IG G GA Y A + +K++ S Q +EK + + E+ L ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
+ + LV Y G+ D L + + ++ I G+ +GLA+LH +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA---AITHGALQGLAYLHSHN--- 141
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV 488
+IHR+I + ILL + KL+DFG A +P + +FV + ++APE ++
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN----SFVGTPY----WMAPE---VIL 190
Query: 489 ATPKG------DVYSFGVVLLELITGERPTHLTNA 517
A +G DV+S G+ +EL + P NA
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 12/96 (12%)
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL---- 476
+HH + +IHR+I S ILL + KL DFG ++ + V+ + G
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-------MYAATVSDDVGRTFCGT 208
Query: 477 -GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
YVAPE R + K D++S GV+L EL+T +RP
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 38/225 (16%)
Query: 304 ATNSFS---KNNIIGTGRTGATYIAM-LPGGCFIMIKRL----EDSQHSEKEFLSEINTL 355
A S S + N IG+G G Y + P G +K + ED+ ++ EI L
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT--VRRQICREIEIL 126
Query: 356 GSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSA 415
V H N+V E ++ +++ G+L E + +A
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD--------VARQIL 178
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL----MNPVDTHLSTFVNG 471
G+A+LH I+HR+I +L++ K++DFG++R+ M+P N
Sbjct: 179 SGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--------CNS 227
Query: 472 EFGDLGYVAPEYPRTLVATPK-----GDVYSFGVVLLELITGERP 511
G + Y++PE T + GD++S GV +LE G P
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 6e-09
Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 27/202 (13%)
Query: 313 IIGTGRTGATYIAMLPGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFC 370
++G G G + L + +K ++ Q + +FLSE L H N+V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH-HNCNPRI 429
++ +V + G L + E+ ++ A+ +A G+A+L NC
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL---VKFALDAAAGMAYLESKNC---- 114
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG-------YVAPE 482
IHR+++++ L+ + K+SDFG++R + +G + G + APE
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQED----------DGIYSSSGLKQIPIKWTAPE 164
Query: 483 YPRTLVATPKGDVYSFGVVLLE 504
+ + DV+S+G++L E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 313 IIGTGRTGATYIAMLPGG---CFIMIKRLEDSQHSEKEF-LSEINTLGSVRHRNLVPLLG 368
IG G G Y+A C I L EKE E+ L ++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMH-----MDWPLRLRIAIGSARGLAWLHH 423
+V Y + G L +++ + V+ + W ++I++G L H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRIN-RQRGVLFSEDQILSW--FVQISLG-------LKH 116
Query: 424 NCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
+ +I+HR+I S+ I L + KL DFG+AR +N T V + Y++PE
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY----YLSPE 172
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ K D++S G VL EL T + P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHR 361
F +G G G+ Y A+ G + IK + ED Q KE I+ L
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSP 58
Query: 362 NLVPLLGFCVAKKERL-LVYSYLENGTLYD-------KLHPAEHEVMHMDWPLRLRIAI- 412
+V G K L +V Y G++ D L E IA
Sbjct: 59 YIVKYYG-SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE-------------IAAI 104
Query: 413 --GSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
+ +GL +LH N + IHR+I + ILL+ + + KL+DFG++ + +T +
Sbjct: 105 LYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIG 161
Query: 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
F ++APE + + K D++S G+ +E+ G+ P
Sbjct: 162 TPF----WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 49/174 (28%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 347 EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHP----AEHEVMHM 402
EFL+E + + ++V LLG + L++ + G L L E+ +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 403 DWPLRLRIAIGS--ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460
L+ I + A G+A+L+ N + +HR+++++ ++ DF K+ DFG+ R +
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 461 VDTHLSTFVNGEFGDLG--YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
D + G G L +++PE + V T DV+SFGVVL E+ T E+P
Sbjct: 172 TDY----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRN 362
+F K IG G G Y A G + +K++ +E + EI+ L + H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 363 LVPLLGFCVAKKERLLVYSYLENG--TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
+V LL + + LV+ +L D + + PL +GLA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG-----IPLPLIKSYLFQLLQGLAF 115
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN-PVDTHLSTFVNGEFGDLGYV 479
H + R++HR++ + +L++ + KL+DFGLAR PV T+ V L Y
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVT-----LWYR 167
Query: 480 APE------YPRTLVATPKGDVYSFGVVLLELIT 507
APE Y T V D++S G + E++T
Sbjct: 168 APEILLGCKYYSTAV-----DIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 48/188 (25%), Positives = 74/188 (39%), Gaps = 45/188 (23%)
Query: 341 SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVM 400
S+ E +FL E + H+N+V L+G + R ++ + G L L
Sbjct: 49 SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFL---RENRP 105
Query: 401 HMDWPLRLR------IAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSD 451
+ P L A A+G +L N IHR+I+++ LL K++D
Sbjct: 106 RPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIAD 162
Query: 452 FGLAR-------------LMNPVD-THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYS 497
FG+AR M P+ F++G F T K DV+S
Sbjct: 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF----------------TSKTDVWS 206
Query: 498 FGVVLLEL 505
FGV+L E+
Sbjct: 207 FGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 45/169 (26%), Positives = 66/169 (39%), Gaps = 26/169 (15%)
Query: 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH--HNCNPRIIHRNIS 435
LV YL G L L + D I A + L H+ IIHR++
Sbjct: 70 LVMEYLPGGDLASLLE--NVGSLDEDV-----ARIYIAEIVLALEYLHSNG--IIHRDLK 120
Query: 436 SKCILLDGDFEPKLSDFGLARL--------MNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
IL+D + KL+DFGL+++ +N + V G Y+APE
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV----GTPDYIAPEVILGQ 176
Query: 488 VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL---VEWITLLN 533
+ D +S G +L E + G P H E F+ L +EW +
Sbjct: 177 GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 47/189 (24%), Positives = 92/189 (48%), Gaps = 17/189 (8%)
Query: 337 RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAE 396
R + ++ + +FL EI + +++ N++ LLG CV+ ++ Y+ENG L L E
Sbjct: 53 RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQRE 112
Query: 397 --------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448
+ + + L +A+ A G+ +L + +HR+++++ L+ + K
Sbjct: 113 IESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIK 169
Query: 449 LSDFGLARLMNPVDTHLSTFVNGE-FGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
++DFG++R + D + + G + ++A E T DV++FGV L E+ T
Sbjct: 170 IADFGMSRNLYSGDYYR---IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
Query: 508 --GERPTHL 514
E+P L
Sbjct: 227 LCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 313 IIGTGRTGATYIAM-LPGGCFIMIKRLE--DSQHSEKEFLSEINTLGSVRHRNLVPLLGF 369
++G G G Y A L I IK + DS++ + EI ++HRN+V LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP-LHEEIALHSYLKHRNIVQYLGS 73
Query: 370 CVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDW-PLRLR---IAIGSAR---GLAWLH 422
+ + G+L L W PL+ I + + GL +LH
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRS--------KWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 423 HNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
N +I+HR+I +L++ K+SDFG ++ + ++ TF G L Y+AP
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT----GTLQYMAP 178
Query: 482 EY----PRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPES 520
E PR D++S G ++E+ TG+ P P++
Sbjct: 179 EVIDKGPRGY--GAPADIWSLGCTIVEMATGKPPFIELGEPQA 219
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
GL +LH IHR+I + ILL + + KL+DFG++ + + +TFV F
Sbjct: 109 LGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF-- 163
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
++APE + K D++S G+ +EL GE P
Sbjct: 164 --WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 320 GATYIAMLPGGCFIMIKRLEDSQHSEK--EFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377
G Y+ + + IK L+D + ++ EF E + + + H N+V LLG ++
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 378 LVYSYLENGTLY----------------DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
+++ YL G L+ D+ + + H D+ L IAI A G+ +L
Sbjct: 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF---LHIAIQIAAGMEYL 140
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
+ +H++++++ IL+ K+SD GL+R + D + + ++ P
Sbjct: 141 SSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPP 195
Query: 482 EYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
E + D++SFGVVL E+ + G +P
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 55/190 (28%), Positives = 86/190 (45%), Gaps = 16/190 (8%)
Query: 333 IMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390
+++K L S + +FL E S++H NL+ LG C LLV + G L
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 391 KLHPAEH-EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449
L E+M D R+A A GL LH N IH +++ + LL D K+
Sbjct: 85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKI 141
Query: 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-----YPRTLVA--TPKGDVYSFGVVL 502
D+GL+ D +++ + + L ++APE + LV T + +V+S GV +
Sbjct: 142 GDYGLSHNKYKEDYYVTP--DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199
Query: 503 LELIT-GERP 511
EL G +P
Sbjct: 200 WELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 28/174 (16%)
Query: 344 SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHM 402
+EK+ L ++N+ V L + K+ L LV + + G L K H + HM
Sbjct: 49 NEKQILEKVNS-------RFVVSLAYAYETKDALCLVLTLMNGGDL--KFH-----IYHM 94
Query: 403 -----DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457
+ + A GL LH RI++R++ + ILLD ++SD GLA
Sbjct: 95 GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA-- 149
Query: 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
V + G G +GY+APE + T D ++ G +L E+I G+ P
Sbjct: 150 ---VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 38/249 (15%)
Query: 347 EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHP----AEHEVMHM 402
EFL+E + + ++V LLG + L+V + +G L L AE+
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 403 DWPLRLRIAIGS--ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460
L+ I + + A G+A+L+ + +HR+++++ ++ DF K+ DFG+ R +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 461 VDTHLSTFVNGEFGDL--GYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNA 517
D + G G L ++APE + V T D++SFGVVL E+ + E+P
Sbjct: 172 TDY----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP------ 221
Query: 518 PESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGE--LHQFLRVACNCVLPTPKERHT 575
++G L+ L+ +D L + + +R+ C PK R T
Sbjct: 222 ---YQG--------LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPT 267
Query: 576 MFEVYQLLR 584
E+ LL+
Sbjct: 268 FLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 32/170 (18%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG--------TLYDKLHPAEHEVMHM 402
EI+ + ++H N+V L + + +LV+ Y++ + L P V
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT--VKSF 105
Query: 403 DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN-PV 461
+ L +G+A+ H N R++HR++ + +L++ E KL+DFGLAR PV
Sbjct: 106 TYQL--------LKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154
Query: 462 DTHLSTFVNGEFGDLGYVAPEY---PRTLVATPKGDVYSFGVVLLELITG 508
+TF N E L Y AP+ RT + D++S G ++ E+ITG
Sbjct: 155 ----NTFSN-EVVTLWYRAPDVLLGSRTY--STSIDIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 20/140 (14%)
Query: 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGS-ARGLAWLHHNCNPRIIHRNISS 436
L+ Y+ G L+ L+ EH +R+ I L LH II+R+I
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-----EVRVYIAEIVLALDHLHQL---GIIYRDIKL 133
Query: 437 KCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG--- 493
+ ILLD + L+DFGL++ + + G + Y+APE R G
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERA---YSFCGTIEYMAPEVIRG---GSGGHDK 187
Query: 494 --DVYSFGVVLLELITGERP 511
D +S GV+ EL+TG P
Sbjct: 188 AVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
E + L V H +V L + + L+ +L G L+ +L EVM + ++ +
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYL 104
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
A A L LH + II+R++ + ILLD + KL+DFGL++ +D +
Sbjct: 105 A-ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAY-- 156
Query: 471 GEF-GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTH 513
F G + Y+APE T D +SFGV++ E++TG P
Sbjct: 157 -SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 8e-08
Identities = 66/244 (27%), Positives = 95/244 (38%), Gaps = 35/244 (14%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLE----DSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
I G G+ Y+A G + IK L+ +++ +E + V L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 369 FCVAKKERL-LVYSYLENG---TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
+ K+ L LV YL G +L L + DW + IA G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGG-----LPEDW-AKQYIA-EVVLGVEDLHQR 116
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLAR--LMNPVDTHLSTFVNGEFGDLGYVAPE 482
IIHR+I + +L+D KL+DFGL+R L N FV G Y+APE
Sbjct: 117 ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFV----GTPDYLAPE 163
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL---VEWITLLNTNSSLE 539
+ D +S G V+ E + G P H F L + W + S E
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223
Query: 540 TAID 543
A+D
Sbjct: 224 -AVD 226
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKE-----FLSEINTLGSVRHRNLVP 365
IG G G Y A G + +K RLE +E E + EI+ L + H N+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLE----TEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
LL ++ + LV+ +L+ L K + + +D PL +G+A+ H +
Sbjct: 63 LLDVVHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN-PVDTHLSTFVNGEFGDLGYVAPE-- 482
R++HR++ + +L+D + KL+DFGLAR PV T+ V L Y APE
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVT-----LWYRAPEIL 171
Query: 483 -----YPRTLVATPKGDVYSFGVVLLELITGERP 511
Y +TP D++S G + E++ RP
Sbjct: 172 LGSRQY-----STPV-DIWSIGCIFAEMVNR-RP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 32/209 (15%)
Query: 314 IGTGRTGATYIA--MLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR------HRNLVP 365
IG G G + A + GG F+ +KR+ E LS I + +R H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 366 LLGFC-VAKKER----LLVYSYLENG--TLYDKL-HPAEHEVMHMDWPLRLRIAIGSARG 417
L C V++ +R LV+ +++ T DK+ P D +L RG
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------LRG 122
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L +LH + R++HR++ + IL+ + KL+DFGLAR+ + S V L
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT-----LW 174
Query: 478 YVAPE-YPRTLVATPKGDVYSFGVVLLEL 505
Y APE ++ ATP D++S G + E+
Sbjct: 175 YRAPEVLLQSSYATPV-DLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 314 IGTGRTGAT---YIAMLPGGCFIMIKRLEDSQHSEK---EFLSEINTLGSVRHRNLVPLL 367
+G+G G M + +K L++ + E L E N + + + +V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 368 GFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNP 427
G C A+ +LV E G L L +H L ++++G + +L
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG----MKYLEET--- 114
Query: 428 RIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
+HR+++++ +LL K+SDFGL++ + + + +G++ + + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW-PVKWYAPECMNYY 173
Query: 488 VATPKGDVYSFGVVLLELIT-GERP 511
+ K DV+SFGV++ E + G++P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 59/224 (26%), Positives = 93/224 (41%), Gaps = 20/224 (8%)
Query: 301 LMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV- 358
L T F +IG G G Y A G + IK ++ + E+E E N L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 359 RHRNLVPLLGFCVAKKERL------LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAI 412
H N+ G + K LV G++ D + + + I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 413 GSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE 472
+ RGLA+LH N ++IHR+I + ILL + E KL DFG++ ++ +TF+
Sbjct: 121 ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTP 177
Query: 473 FGDLGYVAPE-----YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ ++APE + DV+S G+ +EL G+ P
Sbjct: 178 Y----WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 43/183 (23%), Positives = 86/183 (46%), Gaps = 30/183 (16%)
Query: 346 KEFLSEINTLGSVRHRNLVPLLGFCVAKKER------LLVYSYLENGTLYDKLHPAEHEV 399
++FLSE + H N++ L+G C+ E +++ ++++G L+ L +
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104
Query: 400 MHMDWPLRLRIAIGS--ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457
P ++ + + A G+ +L + IHR+++++ +L+ + ++DFGL++
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK- 160
Query: 458 MNPVDTHLSTFVNGEFGDLG--------YVAPEYPRTLVATPKGDVYSFGVVLLELIT-G 508
NG++ G ++A E V T K DV+SFGV + E+ T G
Sbjct: 161 ---------KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211
Query: 509 ERP 511
+ P
Sbjct: 212 QTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 34/111 (30%), Positives = 61/111 (54%), Gaps = 8/111 (7%)
Query: 409 RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468
+++I RGLA+L +I+HR++ IL++ E KL DFG++ + +D+ ++F
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF 162
Query: 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519
V G Y++PE + + + D++S G+ L+EL G P +A E
Sbjct: 163 V----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 17/178 (9%)
Query: 337 RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAE 396
RLE + + + E++ L +++H N+V L ++ LV+ YL++ +
Sbjct: 39 RLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGN 98
Query: 397 HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
MH ++ RGL++ H +I+HR++ + +L++ E KL+DFGLAR
Sbjct: 99 LMSMHNVKIFMFQLL----RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151
Query: 457 LMN-PVDTHLSTFVNGEFGDLGYVAPE--YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ P T+ + V L Y P+ T +TP D++ G +L E+ TG RP
Sbjct: 152 AKSVPTKTYSNEVVT-----LWYRPPDVLLGSTEYSTPI-DMWGVGCILYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 11/176 (6%)
Query: 336 KRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPA 395
KRL+ + E+ L+E L V R +V L K + LV + + G L K H
Sbjct: 29 KRLKKRK-GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL--KYHIY 85
Query: 396 EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455
+ A GL LH RI++R++ + +LLD ++SD GLA
Sbjct: 86 NVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLA 142
Query: 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
V+ + G G GY+APE + V D ++ G L E+I G P
Sbjct: 143 -----VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 41/174 (23%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 348 FLSEINTLGSVRHRNLVPLLGFCVAKKERL----LVYSYLENGTLYDKLHPAEHEVMHMD 403
+EI L + N++ + GF + + L L+ Y G L + L + +
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD----LS 120
Query: 404 WPLRLRIAIGSARGLAWLHHNCN-PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462
+ +L +AI +GL L+ N P ++N++S L+ +++ K+ GL ++++
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILS--- 174
Query: 463 THLSTFVNGEFGDLGYVAPEYPRTLVA-----TPKGDVYSFGVVLLELITGERP 511
+ F ++ ++ + L T K D+YS GVVL E+ TG+ P
Sbjct: 175 -------SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 45/277 (16%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLVP-LLGF 369
+G G G+ Y + P G + +K RLE + + + E++ L H+ + P ++ F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYIVDF 64
Query: 370 CVAKKERLLVY---SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
A VY Y++ G+L DKL+ + + RI +GL +L N
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
IIHR++ +L++G+ + KL DFG++ + +++ G Y+APE ++
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPERIKS 175
Query: 487 LVATPKG------DVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540
DV+S G+ +LE+ G P PE++ N + L
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPY----PPETYA----------NIFAQLSA 221
Query: 541 AIDKS--LLGNGFDGELHQFLRVACNCVLPTPKERHT 575
+D L +G+ + F+ C+ P R T
Sbjct: 222 IVDGDPPTLPSGYSDDAQDFVA---KCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 23/228 (10%)
Query: 298 LSDLMKATNSFSKNNIIGTGRTGATY-IAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLG 356
L L T+++ IG G G Y + G +K L+ ++E +E N L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 357 SV-RHRNLVPLLG-FCVAKK----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
S+ H N+V G F A K + LV G++ + + +D + I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
G+ GL LH+N RIIHR++ ILL + KL DFG++ + +T V
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190
Query: 471 GEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGERP 511
F ++APE Y + A + DV+S G+ +EL G+ P
Sbjct: 191 TPF----WMAPEVIACEQQYDYSYDA--RCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L +LH RI+HR+++ I+L D + ++DFGLA+ P ++ L++ V G +
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVV----GTIL 178
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516
Y PE + K DV++FG +L ++ T + P + TN
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 32/103 (31%), Positives = 57/103 (55%), Gaps = 8/103 (7%)
Query: 409 RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468
+I+I RGL +L +I+HR++ IL++ E KL DFG++ + +D+ ++F
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF 158
Query: 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
V G Y++PE + T + D++S G+ L+E+ G P
Sbjct: 159 V----GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 47/198 (23%)
Query: 332 FIMIKRLEDSQHSEK---EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE---- 384
+ IK+ +DS+ +E+ L E+ L +++ N+V L + + LV+ Y+E
Sbjct: 28 IVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87
Query: 385 -------NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437
NG +K+ ++++ + + W H N I+HR+I +
Sbjct: 88 ELLEEMPNGVPPEKVRSYIYQLI---------------KAIHWCHKN---DIVHRDIKPE 129
Query: 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY---PRTLVATPKG- 493
+L+ + KL DFG AR +LS N + + YVA + P L+ P G
Sbjct: 130 NLLISHNDVLKLCDFGFAR-------NLSEGSNANYTE--YVATRWYRSPELLLGAPYGK 180
Query: 494 --DVYSFGVVLLELITGE 509
D++S G +L EL G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 13/180 (7%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
L+E L V +VPL F E+L LV +++ G L+ H + E R
Sbjct: 41 LAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELF---HHLQREGRFDLSRAR 96
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467
+A L L + +I+R++ + ILLD L DFGL +L D +T
Sbjct: 97 FY----TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
Query: 468 FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527
F G Y+APE T D ++ GV+L E++TG P + N E ++ L E
Sbjct: 153 FC----GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEK--EFLSEINTLGSVRHRNLVPLLGFCV 371
+G G G Y A + ++ D++ E+ +++ EI+ L S H N+V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL---RLRIAIG-SARGLAWLHHNCNP 427
+ ++ + G + + ++ ++ PL ++R+ + L +LH N
Sbjct: 73 YENNLWILIEFCAGGAV-------DAVMLELERPLTEPQIRVVCKQTLEALNYLHEN--- 122
Query: 428 RIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP--R 485
+IIHR++ + IL D + KL+DFG++ +F+ + ++APE
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY----WMAPEVVMCE 178
Query: 486 TLVATP---KGDVYSFGVVLLELITGERPTHLTN 516
T P K DV+S G+ L+E+ E P H N
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 8/158 (5%)
Query: 347 EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL 406
+FL E L H N+V L+G C K+ +V ++ G D L E +
Sbjct: 39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKE 95
Query: 407 RLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466
+++ +A G+ +L IHR+++++ L+ K+SDFG++R D +
Sbjct: 96 LIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYA 150
Query: 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLE 504
+ + + + APE + + DV+SFG++L E
Sbjct: 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 52/191 (27%), Positives = 80/191 (41%), Gaps = 34/191 (17%)
Query: 340 DSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHE 398
+ +EK L+ +H L L C K+RL V Y+ G L
Sbjct: 40 ECTMTEKRVLALAG-----KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDL---------- 83
Query: 399 VMHM------DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
+ H+ D P A GL +LH II+R++ +LLD + K++DF
Sbjct: 84 MFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADF 140
Query: 453 GLAR--LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGER 510
G+ + ++ V T STF G Y+APE P D ++ GV+L E++ G+
Sbjct: 141 GMCKEGILGGVTT--STFC----GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQS 194
Query: 511 PTHLTNAPESF 521
P + E F
Sbjct: 195 PFEGDDEDELF 205
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 7e-07
Identities = 56/191 (29%), Positives = 84/191 (43%), Gaps = 42/191 (21%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLE---NGTL 388
I+ ++ SEKE L E N V+ +R K++ +Y +E G L
Sbjct: 31 IVETGQQEHIFSEKEILEECNHPFIVKLYRTF----------KDKKYIYMLMEYCLGGEL 80
Query: 389 YDKLHPAEHEVMHMD-WPLRLRIA-IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446
+ L + D + R IA + A +LH+ II+R++ + +LLD +
Sbjct: 81 WTILR----DRGLFDEYTARFYIACVVLA--FEYLHNR---GIIYRDLKPENLLLDSNGY 131
Query: 447 PKLSDFGLAR-LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGV 500
KL DFG A+ L + T TF G YVAPE + KG D +S G+
Sbjct: 132 VKLVDFGFAKKLKSGQKTW--TFC----GTPEYVAPE-----IILNKGYDFSVDYWSLGI 180
Query: 501 VLLELITGERP 511
+L EL+TG P
Sbjct: 181 LLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 26/134 (19%)
Query: 390 DKLHPAEHEVMHMDWPLRL--RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447
DK + +EV+ P + +IA+ + + L +L IIHR++ ILLD +
Sbjct: 90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNI 147
Query: 448 KLSDFGLA-RLMNPV-DTHLSTFVNGEFGDLG---YVAPEYPRTLVATPKG-----DVYS 497
KL DFG++ +L++ + T D G Y+APE R + G DV+S
Sbjct: 148 KLCDFGISGQLVDSIAKTR----------DAGCRPYMAPE--RIDPSARDGYDVRSDVWS 195
Query: 498 FGVVLLELITGERP 511
G+ L E+ TG+ P
Sbjct: 196 LGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 34/95 (35%), Positives = 45/95 (47%), Gaps = 15/95 (15%)
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLA-RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
+IHR++ ILLD KL DFG++ RL VD+ T G Y+APE R
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRL---VDSKAKT---RSAGCAAYMAPE--RID 187
Query: 488 VATPKG------DVYSFGVVLLELITGERPTHLTN 516
P DV+S G+ L+EL TG+ P
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 51/218 (23%), Positives = 100/218 (45%), Gaps = 17/218 (7%)
Query: 306 NSFSKNNIIGTGRTGATY-IAMLPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHR 361
+ F K + +G G G + ++ P G IM ++L E + + E+ L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
+V G + E + +++ G+L L A + + +++I +GL +L
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYL 119
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
+I+HR++ IL++ E KL DFG++ + +D+ ++FV G Y++P
Sbjct: 120 REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV----GTRSYMSP 171
Query: 482 EYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519
E + + + D++S G+ L+E+ G P +A E
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
I+G G G Y A L + +K L+ + +K+ +SE+ L ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 369 FCVAKKERLLVYSYLENGTL--YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
+ + +++ G+L Y K+ EH + RIA+ +GL +L +
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKI--PEHVLG--------RIAVAVVKGLTYL---WS 113
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
+I+HR++ +L++ + KL DFG++ + V++ T+V G Y+APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYV----GTNAYMAPERISG 167
Query: 487 LVATPKGDVYSFGVVLLELITGERP 511
DV+S G+ +EL G P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 9e-07
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 32/192 (16%)
Query: 333 IMIKRLEDSQHSE---KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389
I +K++ Q E + EI+ L ++H N+V L ++K LV+ YL+
Sbjct: 30 IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD----- 84
Query: 390 DKLHPAEHEVMHMDWPLRLRIAIGS-----ARGLAWLHHNCNPRIIHRNISSKCILLDGD 444
L +H D+ R+ I + RG+A+ H + R++HR++ + +L+D
Sbjct: 85 --LDLKKHMDSSPDFAKNPRL-IKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRR 138
Query: 445 FEP-KLSDFGLARLMN-PVDTHLSTFVNGEFGDLGYVAPEY---PRTLVATPKGDVYSFG 499
KL+DFGLAR PV T V L Y APE R +TP D++S G
Sbjct: 139 TNALKLADFGLARAFGIPVRTFTHEVVT-----LWYRAPEILLGSRHY-STPV-DIWSVG 191
Query: 500 VVLLELITGERP 511
+ E++ ++P
Sbjct: 192 CIFAEMVN-QKP 202
|
Length = 294 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 35/213 (16%)
Query: 314 IGTGRTGATYIA-MLPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC 370
IG+G G Y A + G + IK +LE + EI+ L RH N+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP-GDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL-RLRIAI---GSARGLAWLHHNCN 426
+ + + +V Y G+L D PL L+IA + +GLA+LH
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTRG-------PLSELQIAYVCRETLKGLAYLHET-- 120
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
IHR+I ILL D + KL+DFG++ + +F+ G ++APE
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI----GTPYWMAPE---- 171
Query: 487 LVA--------TPKGDVYSFGVVLLELITGERP 511
VA K D+++ G+ +EL + P
Sbjct: 172 -VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 61/221 (27%), Positives = 88/221 (39%), Gaps = 27/221 (12%)
Query: 313 IIGTGRTGATYIAMLPG-GCFIMIKRLE----------DSQHSEKEFLSEINTLGSVRHR 361
++G G G ++A L G F IK L+ + EK LS + H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL-----AWEHP 56
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
L L K+ V YL G L + D P A GL +L
Sbjct: 57 FLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFL 112
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
H + I++R++ ILLD D K++DFG+ + D TF G Y+AP
Sbjct: 113 H---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAP 165
Query: 482 EYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
E D +SFGV+L E++ G+ P H + E F+
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-FLSEINTLGSVRHRNLVPLLGFCV 371
+G G G Y A G K +E E E ++ EI L + H +V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL-RIAIGSARGLAWLHHNCNPRII 430
+ ++ + G + + ++ +D L +I + + L L + + +II
Sbjct: 80 WDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII 132
Query: 431 HRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP--RTLV 488
HR++ + +LL D + KL+DFG++ +F+ + ++APE T+
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY----WMAPEVVMCETMK 188
Query: 489 ATP---KGDVYSFGVVLLELITGERPTHLTN 516
TP K D++S G+ L+E+ E P H N
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 12/97 (12%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
R + +LH N RIIHR+I ++ I ++ + L DFG A PVD + N +G
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDIN----ANKYYGW 243
Query: 476 LGYVAPEYPRTLVATPKG---DVYSFGVVLLELITGE 509
G +A P L P G D++S G+VL E+ T
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 67/227 (29%), Positives = 95/227 (41%), Gaps = 50/227 (22%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKE-----FLSEINTLGSVRHRNL 363
IG G G Y A G + +K RL++ EKE + EI L + HRN+
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDN----EKEGFPITAIREIKILRQLNHRNI 68
Query: 364 VPLLGFCVAKKERL----------LVYSYLEN---GTLYDKL--HPAEHEVMHMDWPLRL 408
V L K++ L LV+ Y+++ G L L +H M L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE- 127
Query: 409 RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468
GL + H +HR+I ILL+ + KL+DFGLARL N ++ T
Sbjct: 128 --------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT- 175
Query: 469 VNGEFGDLGYVAPEYPRTLVA----TPKGDVYSFGVVLLELITGERP 511
+ L Y PE L+ P DV+S G +L EL T ++P
Sbjct: 176 --NKVITLWYRPPEL---LLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 55/267 (20%), Positives = 93/267 (34%), Gaps = 37/267 (13%)
Query: 328 PGGCFIMIKR--LEDSQHSEKEFL-SEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384
P + +K+ L+ + + L EI T ++H N++P + + E +V +
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD 444
G+ D L H + I L ++H IHR++ + ILL GD
Sbjct: 83 YGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGD 137
Query: 445 FEPKLSDFGLARLMNPVDTH------LSTFVNGEFGDLGYVAPE--YPRTLVATPKGDVY 496
+ LS R + H + F +L +++PE K D+Y
Sbjct: 138 GKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIY 194
Query: 497 SFGVVLLELITGERP---THLTNA-PESFKG---SLVEWITLLNTNSSLETAIDKSLLGN 549
S G+ EL G P T E +G L++ T S+ + + N
Sbjct: 195 SVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN 254
Query: 550 G-----------FDGELHQFLRVACNC 565
F HQF+ +
Sbjct: 255 NRDSVDHPYTRTFSEHFHQFVELCLQR 281
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 39/116 (33%), Positives = 64/116 (55%), Gaps = 14/116 (12%)
Query: 403 DWPLR----LRIAIGSARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR- 456
WPL LR + A+G+ +L NC IHR+++++ +LL K+ DFGLAR
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARD 261
Query: 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+MN D++ N + ++APE V T + DV+S+G++L E+ + G+ P
Sbjct: 262 IMN--DSNYVVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE---DSQHSEKEFLS---EINTLGSVR 359
++ + ++G G G Y+ + G + K+++ +S + KE + EI L +++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 360 HRNLVPLLGFCVAKKERLLV--YSYLENGTLYDKL--HPAEHEVMHMDWPLRLRIAIGSA 415
H +V G + E+ L Y+ G++ D+L + A E + + ++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------L 116
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
G+++LH N I+HR+I IL D KL DFG ++ + + T + G
Sbjct: 117 EGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI-CMSGTGIRSVTGT 172
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+++PE K DV+S G ++E++T + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 25/206 (12%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
L+E L + RH L L + K+RL V Y+ G L+ H + V D
Sbjct: 43 LTESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRF 99
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467
I SA L +LH +I++R++ + ++LD D K++DFGL + + T
Sbjct: 100 YGAEIVSA--LDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154
Query: 468 FVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521
F G Y+APE Y R + D + GVV+ E++ G P + + + F
Sbjct: 155 FC----GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPFYNQDHEKLF 204
Query: 522 KGSLVEWITLLNTNSSLETAIDKSLL 547
+ L+E I T S+ ++ LL
Sbjct: 205 ELILMEDIKFPRTLSADAKSLLSGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 41/162 (25%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL 408
EI L ++ H N+V G C L+ +L +G+L + L ++ +L
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQL 112
Query: 409 RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468
+ A+ +G+ +L + +HR+++++ +L++ + + K+ DFGL + + D T
Sbjct: 113 KYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE-TDKEYYTV 168
Query: 469 VNGEFGDLGYVAPE---YPRTLVATPKGDVYSFGVVLLELIT 507
+ + + APE + +A+ DV+SFGV L EL+T
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIAS---DVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 46/171 (26%), Positives = 72/171 (42%), Gaps = 36/171 (21%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL 408
L EI L ++H N++ LL K LV+ ++E L E + D + L
Sbjct: 50 LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDL---------EKVIKDKSIVL 99
Query: 409 R------IAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462
+ + RGL +LH N I+HR++ +L+ D KL+DFGLAR +
Sbjct: 100 TPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156
Query: 463 THLSTFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELI 506
++ V + Y APE Y D++S G + EL+
Sbjct: 157 RKMTHQVVTRW----YRAPELLFGARHY------GVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/212 (25%), Positives = 83/212 (39%), Gaps = 19/212 (8%)
Query: 307 SFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHR 361
+F + ++G G G + G KRLE + E L+E L V +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWP--LRLRIAIGSARGLA 419
+V L K LV + + G L K H + +M P R +A L
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDL--KFH-----IYNMGNPGFEEERALFYAAEILC 113
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
L ++R++ + ILLD ++SD GLA V + G G +GY+
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA-----VKIPEGESIRGRVGTVGYM 168
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELITGERP 511
APE T D + G ++ E+I G+ P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 24/136 (17%)
Query: 387 TLYDKLHPAEHEV-MHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445
T DK + ++ + + + +IA+ + L +LH + +IHR++ +L++ +
Sbjct: 84 TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNG 141
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG---YVAPEY--PRTLVATPKG-----DV 495
+ KL DFG++ VD+ T D G Y+APE P KG DV
Sbjct: 142 QVKLCDFGISG--YLVDSVAKTI------DAGCKPYMAPERINPEL---NQKGYDVKSDV 190
Query: 496 YSFGVVLLELITGERP 511
+S G+ ++EL TG P
Sbjct: 191 WSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 314 IGTGRTGATYIAML---PGGCFIMIKRLEDSQHS--EKEFLSEINTLGSVRHRNLVPLLG 368
IG G G ++ + G +++K L+ + S + EFL + + ++H N++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL--RIAIGSARGLAWLH-HNC 425
CV LLV+ Y E G L K + ++ + + L L R+A A G+ +H HN
Sbjct: 63 QCVEAIPYLLVFEYCELGDL--KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN- 119
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE--- 482
+H +++ + L D K+ D+G+ + ++ T + + L ++APE
Sbjct: 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIET-EDDKCVPLRWLAPELVG 174
Query: 483 --YPRTLVA--TPKGDVYSFGVVLLEL 505
+ + A T +V++ GV L EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 45/196 (22%), Positives = 96/196 (48%), Gaps = 27/196 (13%)
Query: 337 RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL---- 392
R + ++++ +FL EI + ++ N++ LL C+ ++ Y+ENG L L
Sbjct: 55 REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE 114
Query: 393 ---HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449
+ +V+ + + + +A A G+ +L + +HR+++++ L+ ++ K+
Sbjct: 115 PQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKI 171
Query: 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP----EYPRTLVA--TPKGDVYSFGVVLL 503
+DFG++R + D + + G V P + L+ T DV++FGV L
Sbjct: 172 ADFGMSRNLYSGDYYR---IQGR-----AVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 504 ELIT--GERP-THLTN 516
E++T E+P + L++
Sbjct: 224 EILTLCKEQPYSQLSD 239
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 23/101 (22%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL ++H + IIHR++ I ++ D E K+ DFGLAR D ++ +V +
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTGYVATRW-- 180
Query: 476 LGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
Y APE Y +T+ D++S G ++ EL+TG+
Sbjct: 181 --YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 51/224 (22%)
Query: 300 DLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV 358
D+ KA N + TG A I L PG F +I++ EI +
Sbjct: 24 DVYKARN-------LHTGELAAVKIIKLEPGDDFSLIQQ-------------EIFMVKEC 63
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL-RLRIAI---GS 414
+H N+V G +++++ + Y G+L D + H+ PL L+IA +
Sbjct: 64 KHCNIVAYFGSYLSREKLWICMEYCGGGSLQD--------IYHVTGPLSELQIAYVCRET 115
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
+GLA+LH +HR+I ILL + + KL+DFG+A + +F+ +
Sbjct: 116 LQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY- 171
Query: 475 DLGYVAPEYPRTLVATPKG-------DVYSFGVVLLELITGERP 511
++APE + A K D+++ G+ +EL + P
Sbjct: 172 ---WMAPE----VAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 39/190 (20%)
Query: 337 RLEDSQHSEKEF-LSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE----------N 385
RL+D L EI L ++H+N+V L + K+ LV+ Y + N
Sbjct: 34 RLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCN 93
Query: 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH-HNCNPRIIHRNISSKCILLDGD 444
G + + E++ + +L +GLA+ H HN ++HR++ + +L++ +
Sbjct: 94 GDI-------DPEIVK-SFMFQL------LKGLAFCHSHN----VLHRDLKPQNLLINKN 135
Query: 445 FEPKLSDFGLARLMN-PVDTHLSTFVNGEFGDLGYVAPE--YPRTLVATPKGDVYSFGVV 501
E KL+DFGLAR PV + + V L Y P+ + L +T D++S G +
Sbjct: 136 GELKLADFGLARAFGIPVRCYSAEVVT-----LWYRPPDVLFGAKLYSTSI-DMWSAGCI 189
Query: 502 LLELITGERP 511
EL RP
Sbjct: 190 FAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 39/219 (17%)
Query: 313 IIGTGRTGATYIAMLPGG-----CFIM--------IKRLEDSQHSEKEFLSEINTLGSVR 359
++GTG G ++ G + M +++ + +H+ +E N L VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR----TERNVLEHVR 62
Query: 360 HRNLVPLLGFCVAKKERL-LVYSYLENGT----LYDKLHPAEHEVMHMDWPLRLRIAIGS 414
+ L + + +L L+ Y+ G LY + + +E EV R G
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV---------RFYSGE 113
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR-LMNPVDTHLSTFVNGEF 473
+ L H I++R+I + ILLD + L+DFGL++ ++ +F
Sbjct: 114 I--ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---- 167
Query: 474 GDLGYVAPEYPRTLVATPKG-DVYSFGVVLLELITGERP 511
G + Y+APE R K D +S G+++ EL+TG P
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 16/159 (10%)
Query: 370 CVAKKERLL-VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
C K+RL V Y+ G L ++ + D P A L +LH +
Sbjct: 64 CFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRH---G 116
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLAR--LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
+I+R++ ILLD + KL+DFG+ + ++N V T +TF G Y+APE +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFC----GTPDYIAPEILQE 170
Query: 487 LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525
L P D ++ GV++ E++ G+ P N + F+ L
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 35/196 (17%)
Query: 341 SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL--YDKLHPAEHE 398
S ++ ++FL E+ L + N+ LLG C ++ Y+ENG L + + H AE
Sbjct: 59 SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 399 VMHMDWP-----LRLRIAIGSARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
+ + L +A A G+ +L N +HR+++++ L+ ++ K++DF
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADF 174
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA---------TPKGDVYSFGVVLL 503
G++R + + ++ + AP P +A T K DV++FGV L
Sbjct: 175 GMSRNL----------YSSDYYRVQGRAP-LPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 504 ELIT--GERP-THLTN 516
E++T E+P HLT+
Sbjct: 224 EILTLCREQPYEHLTD 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 41/213 (19%)
Query: 314 IGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVR------HRNLVPL 366
IG G G Y A P G F+ +K + + + LS + + ++ H N+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 367 LGFCV-AKKER----LLVYSYLENG--TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
+ C ++ +R LV+ +++ T DK+ P + +R + RGL
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL-----RGLD 122
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL------MNPVDTHLSTFVNGEF 473
+LH NC I+HR++ + IL+ + KL+DFGLAR+ + PV
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV---------- 169
Query: 474 GDLGYVAPE-YPRTLVATPKGDVYSFGVVLLEL 505
L Y APE ++ ATP D++S G + E+
Sbjct: 170 -TLWYRAPEVLLQSTYATPV-DMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 24/168 (14%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG-TLYDKLHPA---EHEVMHMDW 404
+ E + L ++H N+V L K+ V+ Y+ Y HP + V +
Sbjct: 51 IREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMF 110
Query: 405 PLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN-PVDT 463
L RGLA++H I+HR++ + +L+ E KL+DFGLAR + P T
Sbjct: 111 QL--------LRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT 159
Query: 464 HLSTFVNGEF--GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE 509
+ S V + D+ A +Y L D++ G + +E++ G+
Sbjct: 160 YSSEVVTLWYRPPDVLLGATDYSSAL------DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 58/204 (28%), Positives = 86/204 (42%), Gaps = 55/204 (26%)
Query: 342 QHSEKEF-----LSEINTLGSVRHRNLVPLLGFCV-----AKKERLLVYS---YLE---N 385
H+EK+ L EI L ++H N+VPL+ V +K++R VY Y++ +
Sbjct: 43 MHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS 102
Query: 386 GTLYD---KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442
G L + KL ++ + M L G+ +LH N I+HR+I + IL+D
Sbjct: 103 GLLENPSVKLTESQIKCY-MLQLLE---------GINYLHEN---HILHRDIKAANILID 149
Query: 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG----------YVAPEYPRTLVA--- 489
K++DFGLAR P D G G Y PE L+
Sbjct: 150 NQGILKIADFGLAR---PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE----LLLGER 202
Query: 490 --TPKGDVYSFGVVLLELITGERP 511
T D++ G V E+ T RP
Sbjct: 203 RYTTAVDIWGIGCVFAEMFTR-RP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 67/227 (29%), Positives = 99/227 (43%), Gaps = 33/227 (14%)
Query: 313 IIGTGRTGATYIAMLPGG-CFIMIKRLEDS----QHSEKEFLSEINTL-GSVRHRNLVPL 366
+IG G G +A F +K L+ + EK +SE N L +V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 367 LGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIA-IGSARGLAWLHHN 424
F ++L V Y+ G L+ L + E ++ R A I SA L +LH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASA--LGYLH-- 113
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-- 482
+ I++R++ + ILLD L+DFGL + + STF G Y+APE
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC----GTPEYLAPEVL 168
Query: 483 ----YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525
Y RT+ D + G VL E++ G P + N E + L
Sbjct: 169 HKQPYDRTV------DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 54/194 (27%), Positives = 90/194 (46%), Gaps = 25/194 (12%)
Query: 337 RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAE 396
RLE + + + E++ L ++H N+V L +K LV+ YL+ L L
Sbjct: 40 RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG 98
Query: 397 HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
+ + + L L + RGL + H +++HR++ + +L++ E KL+DFGLAR
Sbjct: 99 NSINMHNVKLFLFQLL---RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
Query: 457 LMN-PVDTHLSTFVNGEFGDLGYVAPE--YPRTLVATPKGDVYSFGVVLLELITGERPTH 513
+ P T+ + V L Y P+ T +T + D++ G + E+ TG RP
Sbjct: 153 AKSIPTKTYSNEVVT-----LWYRPPDILLGSTDYST-QIDMWGVGCIFYEMSTG-RPL- 204
Query: 514 LTNAPESFKGSLVE 527
F GS VE
Sbjct: 205 -------FPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRN 362
+S+ K +G G Y G + +K RL++ + + + E + L ++H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTL-YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
+V L K+ LV+ Y+ Y HP +H + ++L + RGL+++
Sbjct: 65 IVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGG---LHPE-NVKLFL-FQLLRGLSYI 119
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
H I+HR++ + +L+ E KL+DFGLAR V +H T+ N E L Y P
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSH--TYSN-EVVTLWYRPP 172
Query: 482 -------EYPRTLVATPKGDVYSFGVVLLELITG 508
EY L D++ G + +E+I G
Sbjct: 173 DVLLGSTEYSTCL------DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 313 IIGTGRTGATYIAMLPG-GCFIMIKRLE---DSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
IG+G G A+ G + IK++ D K L E+ L +H N++ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 369 FCVAK----KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL---RIAIGSA-RGLAW 420
K+ +V +E+ H ++H D PL R + RGL +
Sbjct: 72 ILRPPGADFKDVYVVMDLMESDL---------HHIIHSDQPLTEEHIRYFLYQLLRGLKY 122
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
+H +IHR++ +L++ D E ++ DFG+AR ++ T F+ Y A
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 481 PEYPRTLVA-TPKGDVYSFGVVLLELITGERP 511
PE +L T D++S G + E++ G R
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 29/171 (16%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG-TLYDKLHPAEHEVMHMDWPLRLR 409
E + L ++H N+V L KK LV+ YL+ Y + M +R
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGG---GLSMH---NVR 106
Query: 410 IAIGS-ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468
+ + RGLA+ H R++HR++ + +L+ E KL+DFGLAR V + T+
Sbjct: 107 LFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSK--TY 160
Query: 469 VNGEFGDLGYVAP-------EYPRTLVATPKGDVYSFGVVLLELITGERPT 512
N E L Y P EY +L D++ G + E+ TG RP
Sbjct: 161 SN-EVVTLWYRPPDVLLGSTEYSTSL------DMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 39/216 (18%)
Query: 313 IIGTGRTGATYIAMLPG-GCFIMIKRLEDS----QHSEKEFLSEINTL-GSVRHRNLVPL 366
+IG G G +A G F +K L+ + +K ++E N L +V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 367 LGFCVAKKERL-LVYSYLENGTLYDKLHPAEH--EVMHMDWPLRLRI-AIGSARGLAWLH 422
+ ++L V Y+ G L+ L E R R A A L +LH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-------RARFYAAEIASALGYLH 113
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGDLGYVAP 481
+ II+R++ + ILLD L+DFGL + + T STF G Y+AP
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFC----GTPEYLAP 165
Query: 482 E------YPRTLVATPKGDVYSFGVVLLELITGERP 511
E Y RT+ D + G VL E++ G P
Sbjct: 166 EVLRKQPYDRTV------DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
R L ++H + HR++ K IL + D + K+ DFGLAR+ DT + F
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVAT 169
Query: 476 LGYVAPEYPRTLVA--TPKGDVYSFGVVLLELITGE 509
Y APE + + TP D++S G + E++TG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 35/121 (28%), Positives = 59/121 (48%), Gaps = 8/121 (6%)
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLAR--LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
II+R++ +LLD + KL+DFG+ + + N T STF G Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFC----GTPDYIAPEILQE 170
Query: 487 LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546
++ P D ++ GV+L E++ G P N + F+ L + + S I K+
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230
Query: 547 L 547
+
Sbjct: 231 M 231
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 62/219 (28%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 308 FSKNNIIGTGRTGATYIA--MLPGGCFIMIK-RLEDSQHSEKE-----FLSEINTLGSVR 359
++K IG G G Y G M K RLE SE+E + EI+ L ++
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE----SEEEGVPSTAIREISLLKELQ 57
Query: 360 HRNLVPLLGFCVAKKERLLVYSYL--ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARG 417
H N+V L + + L++ +L + D L ++ MD L +G
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY----MDAELVKSYLYQILQG 113
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN-PVD--THLSTFVNGEFG 474
+ + H R++HR++ + +L+D KL+DFGLAR PV TH E
Sbjct: 114 ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH-------EVV 163
Query: 475 DLGYVAPE--YPRTLVATPKGDVYSFGVVLLELITGERP 511
L Y APE +TP D++S G + E+ T ++P
Sbjct: 164 TLWYRAPEVLLGSPRYSTPV-DIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 29/163 (17%)
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR--LMNPVDTHLSTFVNGE 472
A GL +LH + II+R++ ++LD + K++DFG+ + + T TF
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT--RTFC--- 162
Query: 473 FGDLGYVAPEYPRTLVATPKG---DVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529
G Y+APE + P G D ++FGV+L E++ G+ P + E F+ + +
Sbjct: 163 -GTPDYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218
Query: 530 TLLNTNSSLETAIDKSL--------LGNGFDGE----LHQFLR 560
+ + S +I K L LG G GE H F R
Sbjct: 219 SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 37/183 (20%)
Query: 340 DSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHE 398
+S EK T S RH LV L C ++ + V Y G L +H
Sbjct: 44 ESLMCEKRIFE---TANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLM--MH----- 92
Query: 399 VMHMDWPLRLRIAIGSAR---GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455
+H D R +A GL +LH N +I++R++ +LLD + K++DFGL
Sbjct: 93 -IHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLC 148
Query: 456 RL-MNPVDTHLSTFVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITG 508
+ M D STF G ++APE Y R + D + GV++ E++ G
Sbjct: 149 KEGMGFGDR-TSTFC----GTPEFLAPEVLTETSYTRAV------DWWGLGVLIYEMLVG 197
Query: 509 ERP 511
E P
Sbjct: 198 ESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 48/229 (20%)
Query: 314 IGTGRTGATYIAML---PGGCFIMIKRLEDSQHSEKEFLS-----EINTLGSVRHRNLVP 365
IG G G Y A G IK+ + + + +S EI L ++H N+V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVS 66
Query: 366 LLGFCVAKKERL--LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR------- 416
L+ + ++ L++ Y E +D + H R+ I +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAE----HDLWQIIKF---HRQ-AKRVSIPPSMVKSLLWQIL 118
Query: 417 -GLAWLHHNCNPRIIHRNISSKCILLDGDFEP----KLSDFGLARLMNPVDTHLSTFVNG 471
G+ +LH N ++HR++ IL+ G+ K+ D GLARL N L+ ++
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD-LDP 174
Query: 472 EFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGERPTH 513
+ Y APE Y T D+++ G + EL+T E
Sbjct: 175 VVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 348 FLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
F + + V H+++V L G CV E ++V ++E G L D + +V+ W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL-DLFMHRKSDVLTTPW--K 107
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL-----DGDFEP--KLSDFGLARLMNP 460
++A A L++L + ++H N+ +K ILL DG+ P KLSD G+ P
Sbjct: 108 FKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI-----P 159
Query: 461 VDTHLSTFVNGEFGDLGYVAPE-YPRTLVATPKGDVYSFGVVLLEL-ITGERP 511
+ T LS E + ++APE + + D +SFG L E+ GE P
Sbjct: 160 I-TVLSRQECVE--RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 56/206 (27%), Positives = 89/206 (43%), Gaps = 28/206 (13%)
Query: 370 CVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
C +RL V Y+ G L ++ +V P + A A GL +LH +
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLH---SKG 121
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLAR--LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
II+R++ ++LD + K++DFG+ + + + V T TF G Y+APE
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT--KTFC----GTPDYIAPEIIAY 175
Query: 487 LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546
D ++FGV+L E++ G+ P + E F+ + + + S AI K L
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL 235
Query: 547 --------LGNGFDGEL----HQFLR 560
LG G +GE H F R
Sbjct: 236 MTKHPGKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 28/84 (33%), Positives = 44/84 (52%), Gaps = 5/84 (5%)
Query: 428 RIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
RI++R++ + ILLD ++SD GLA + +T V G G +GY+APE
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAPEVINNE 176
Query: 488 VATPKGDVYSFGVVLLELITGERP 511
T D + G ++ E+I G+ P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 49/176 (27%), Positives = 73/176 (41%), Gaps = 8/176 (4%)
Query: 336 KRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPA 395
KRL+ + E + E L V R +V L K + LV + + G L ++
Sbjct: 29 KRLKKRKGYEGAMV-EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNV 87
Query: 396 EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455
+ E P GL LH RII+R++ + +LLD D ++SD GLA
Sbjct: 88 DEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLA 144
Query: 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+ D T G G G++APE + D ++ GV L E+I P
Sbjct: 145 --VELKDGQSKT--KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 20/183 (10%)
Query: 336 KRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYD 390
K+LE + E L+E L V R +V L + K+ L LV + + G L
Sbjct: 31 KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDL-- 87
Query: 391 KLHPAEHEVMHMDWP--LRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448
K H + +M P R +A L RI++R++ + ILLD +
Sbjct: 88 KFH-----IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIR 142
Query: 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITG 508
+SD GLA V+ + G G +GY+APE + T D + G ++ E+I G
Sbjct: 143 ISDLGLA-----VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197
Query: 509 ERP 511
+ P
Sbjct: 198 KSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 50/229 (21%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRNLVPLLGF 369
+G+G G A+ G + IK+L SE K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 370 CVAKK------ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSA-RGLAWLH 422
+ LV ++ GT KL +HE + D R++ + +GL ++H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFM--GTDLGKL--MKHEKLSED---RIQFLVYQMLKGLKYIH 135
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
IIHR++ + ++ D E K+ DFGLAR D+ ++ +V + Y APE
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRW----YRAPE 185
Query: 483 -------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS 524
Y +T+ D++S G ++ E++TG +P FKG
Sbjct: 186 VILNWMHYTQTV------DIWSVGCIMAEMLTG-KPL--------FKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 18/114 (15%)
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM--NPVDTHLSTFVNGE 472
ARG+ +L + + IHR+++++ ILL + K+ DFGLAR + +P +V
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------DYVRK- 232
Query: 473 FGD----LGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521
GD L ++APE V T + DV+SFGV+L E+ + G P E F
Sbjct: 233 -GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 26/107 (24%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL +LH + N +IHR++ IL++ + + K+ DFGLAR ++P +
Sbjct: 114 RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------ 164
Query: 476 LGYV------APEYPRTLVATPKG-----DVYSFGVVLLELITGERP 511
YV APE L+ + D++S G + EL+T +P
Sbjct: 165 -EYVVTRWYRAPE----LLLSSSRYTKAIDIWSVGCIFAELLTR-KP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 36/116 (31%), Positives = 62/116 (53%), Gaps = 4/116 (3%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
++L LDLS N +S +P +I L + LDLS+NS+ E+ S L+N L+ L+L+N
Sbjct: 185 LSNLNNLDLSGNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSN 241
Query: 165 NRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGLCGKPLN 220
N+ +P +G L+ ++T +++N ++ + N D + NS PL
Sbjct: 242 NKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLI 296
|
Length = 394 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL ++H + ++HR++ IL++ + + K+ DFGLAR+ +P ++ +V+ +
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRY-- 170
Query: 476 LGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGE 509
Y APE T + D++S G + E++ G+
Sbjct: 171 --YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 66/243 (27%), Positives = 108/243 (44%), Gaps = 21/243 (8%)
Query: 313 IIGTGRTGATYIAM--LPGGCF---IMIKRLEDSQHSEKEFLSEINTL-GSVRHRNLVPL 366
+IG G G +A L G C+ ++ K++ ++ +K ++E N L +V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 367 LGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIA-IGSARGLAWLHHN 424
+ E+L V ++ G L+ L + E + R A I SA L +LH
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAEIASA--LGYLH-- 113
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+ I++R++ + ILLD L+DFGL + +TF G Y+APE
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC----GTPEYLAPEVI 168
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
R D + G VL E++ G P + + E + L + + L S +I +
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILE 228
Query: 545 SLL 547
LL
Sbjct: 229 ELL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 65/249 (26%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 313 IIGTGRTGATYIAMLPG-GCFIMIKRLEDS----QHSEKEFLSEINTL-GSVRHRNLVPL 366
+IG G G +A G F +K L+ + + ++E N L +++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 367 LGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
+ E+L V Y+ G L+ L + E ++ R A A + +LH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARF-YAAEVASAIGYLH--- 113
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGDLGYVAPE-- 482
+ II+R++ + ILLD L+DFGL + + P +T STF G Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET-TSTFC----GTPEYLAPEVL 168
Query: 483 ----YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538
Y RT+ D + G VL E++ G P + + + + L + + L +
Sbjct: 169 RKEPYDRTV------DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA 222
Query: 539 ETAIDKSLL 547
+ LL
Sbjct: 223 ACDLLVGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 4e-05
Identities = 51/191 (26%), Positives = 80/191 (41%), Gaps = 33/191 (17%)
Query: 330 GCFIMIKRLEDSQHSEKEF--LSEINTLGSVR-HRNLVPLLGFCVAKKE-RLLVYSYLEN 385
G + IK ++ S ++ L EI L + H N++ L+ +K RL + L +
Sbjct: 24 GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83
Query: 386 GTLYD-----KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCIL 440
LY+ K E V + L + L +H N I HR+I + IL
Sbjct: 84 MNLYELIKGRKRPLPEKRVKSYMYQL--------LKSLDHMHRN---GIFHRDIKPENIL 132
Query: 441 LDGDFEPKLSDFGLARLMN---PVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVY 496
+ D KL+DFG R + P ++ST Y APE T PK D++
Sbjct: 133 IKDD-ILKLADFGSCRGIYSKPPYTEYIST--------RWYRAPECLLTDGYYGPKMDIW 183
Query: 497 SFGVVLLELIT 507
+ G V E+++
Sbjct: 184 AVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 25/91 (27%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA 489
+HR+++++ +LL K+SDFGL++ + D++ G++ L + APE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKW-PLKWYAPECINFRKF 175
Query: 490 TPKGDVYSFGVVLLELIT-GERPTHLTNAPE 519
+ + DV+S+G+ + E + G++P PE
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 35/199 (17%)
Query: 337 RLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAE 396
RLE + + + E++ L ++H N+V L K LV+ YL+
Sbjct: 40 RLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGN 99
Query: 397 HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
MH +I RGLA+ H +++HR++ + +L++ E KL+DFGLAR
Sbjct: 100 IMSMHNVKIFLYQIL----RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
Query: 457 LMN-PVDTHLSTFVNGEFGDLGYVAP-------EYPRTLVATPKGDVYSFGVVLLELITG 508
+ P T+ + V L Y P EY + D++ G + E+ +G
Sbjct: 153 AKSVPTKTYSNEVVT-----LWYRPPDVLLGSSEYSTQI------DMWGVGCIFFEMASG 201
Query: 509 ERPTHLTNAPESFKGSLVE 527
RP F GS VE
Sbjct: 202 -RPL--------FPGSTVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 65/292 (22%), Positives = 116/292 (39%), Gaps = 61/292 (20%)
Query: 300 DLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV 358
D+ KA N + TG A + L PG F ++++ EI +
Sbjct: 24 DVYKARN-------VNTGELAAIKVIKLEPGEDFAVVQQ-------------EIIMMKDC 63
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL-RLRIAIGSARG 417
+H N+V G + + + + + G+L D + H+ PL +IA S
Sbjct: 64 KHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD--------IYHVTGPLSESQIAYVSRET 115
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L L++ + +HR+I ILL + KL+DFG++ + +F+ +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY---- 171
Query: 478 YVAPEYPRTLVATPKG------DVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531
++APE KG D+++ G+ +EL + P + +
Sbjct: 172 WMAPE---VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---------F 219
Query: 532 LNTNSSLETA--IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
L T S+ + DK N F H F+++A + PK+R T ++ Q
Sbjct: 220 LMTKSNFQPPKLKDKMKWSNSF----HHFVKMA---LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 28/231 (12%)
Query: 306 NSFSKNNIIGTGRTGATYIAM--LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRH 360
F +++G G G + G + M K ++ S +E F E + S+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAM-KVMKKSVLLAQETVSFFEEERDILSISN 59
Query: 361 RNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAE---HEVMHMDWPLRLRIAIGSAR 416
+P L + K+ L LV Y G L L+ E E M + L +AI S
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
+ + +HR+I + +L+D KL+DFG A + S G
Sbjct: 120 QMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL---PVGTP 167
Query: 477 GYVAPEYPRTLVATPKG------DVYSFGVVLLELITGERPTHLTNAPESF 521
Y+APE T+ KG D +S GV+ E+I G P H + +++
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 340 DSQHSEKEFLS---EINTLGSVRHRNLVPLLGFCVAKKERLL--VYSYLENGTLYDKL-- 392
DSQ + KE + EI L ++RH +V G +E+ L Y+ G++ D+L
Sbjct: 40 DSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA 99
Query: 393 HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
+ A E + + ++ +G+++LH N I+HR+I IL D KL DF
Sbjct: 100 YGALTENVTRRYTRQI------LQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 150
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
G ++ + + T + G +++PE K DV+S ++E++T + P
Sbjct: 151 GASKRIQTICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 18/104 (17%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
+ L ++H + +IHR++ ILL+ D KL+DFGLAR ++ ++ N E
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE------NPENPV 168
Query: 476 LG-YVAPEY---PRTLVATP---KG-DVYSFGVVLLELITGERP 511
L YVA + P L+ + KG D++S G +L E++ G +P
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 15/98 (15%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT-HLSTFVNGEFG 474
RGL +LH + I+HR+I +L++ + K+ DFGLAR+ P ++ H++ V ++
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 475 DLGYVAPEYPRTLVATP----KGDVYSFGVVLLELITG 508
Y APE L+ + D++S G + EL+
Sbjct: 170 ---YRAPE---ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 51/193 (26%), Positives = 83/193 (43%), Gaps = 39/193 (20%)
Query: 346 KEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENGT-LYDKLHPAE-HEVMHM 402
K L E+ L R H+N+ L + +V+ N LY++L A+ H+++
Sbjct: 46 KRALRELKLLRHFRGHKNITCLY-------DMDIVFPGNFNELYLYEELMEADLHQIIRS 98
Query: 403 DWPLRLRIAIGSA----------RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
PL A GL ++H + ++HR++ +L++ D E K+ DF
Sbjct: 99 GQPL------TDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDF 149
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-DVYSFGVVLLELITGERP 511
GLAR + + F+ Y APE + + K DV+S G +L EL+ G +P
Sbjct: 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP 208
Query: 512 THLTNAPESFKGS 524
FKG
Sbjct: 209 V--------FKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 6e-05
Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 64/233 (27%)
Query: 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-F----LSEINTLGSVRH 360
+ K N I G G Y A G + +K+L+ EKE F L EIN L ++H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQH 63
Query: 361 RNLVPLLGFCVAKKER--LLVYSYLENG--TLYDKLHP--AEHEVMHMDWPLRLRIAIGS 414
N+V + V +V Y+E+ +L + + + EV + L
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL-------- 115
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
G+A LH N I+HR++ + +LL+ K+ DFGLAR E+G
Sbjct: 116 LSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR---------------EYG 157
Query: 475 D-----------LGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
L Y APE Y + D++S G + EL+T +
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEY------STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 47/158 (29%), Positives = 70/158 (44%), Gaps = 25/158 (15%)
Query: 370 CVAKKERL-LVYSYLENGTLYDKLH-----PAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
C RL LV Y+ G L + P EH + I I L +LH
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA-----AEICIA----LNFLHE 114
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGDLGYVAPE 482
II+R++ +LLD D KL+D+G+ + + P DT STF G Y+APE
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-TSTFC----GTPNYIAPE 166
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERPTH-LTNAPE 519
R D ++ GV++ E++ G P +T+ P+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 65/302 (21%), Positives = 114/302 (37%), Gaps = 51/302 (16%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-----DSQHSEKEFLSEINTLGSV 358
+F IG G+ Y A+ L G + +K+++ D++ + L EI+ L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEIDLLKQL 59
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLY---------DKLHPAEHEVMHMDWPLRLR 409
H N++ L + E +V + G L +L P E + W ++
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTI----WKYFVQ 114
Query: 410 IAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV 469
+ L +H RI+HR+I + + KL D GL R + T + V
Sbjct: 115 LC----SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 167
Query: 470 NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529
G Y++PE K D++S G +L E+ + P F G +
Sbjct: 168 ----GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---------FYGDKMNLY 214
Query: 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589
+L + L + + EL + C+ P P++R + V Q +A+
Sbjct: 215 SLCKKIEKCDY---PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ----VAKE 264
Query: 590 YH 591
H
Sbjct: 265 MH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 370 CVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
C +RL V Y+ G L + +V P + A + GL +LH
Sbjct: 69 CFQTVDRLYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---G 121
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLAR--LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
II+R++ ++LD + K++DFG+ + +++ V T TF G Y+APE
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR--TFC----GTPDYIAPE---I 172
Query: 487 LVATPKG---DVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543
+ P G D +++GV+L E++ G+ P + E F+ + ++ + S +I
Sbjct: 173 IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSIC 232
Query: 544 KSL--------LGNGFDGEL----HQFLR 560
K L LG G +GE H F R
Sbjct: 233 KGLMTKHPSKRLGCGPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 9e-05
Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 21/182 (11%)
Query: 334 MIKRLEDSQHSEKEFLS---EINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLY 389
+IK+L S +E + E L ++H N+V + L +V + E G LY
Sbjct: 29 VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLY 88
Query: 390 DKLHPAEHEVMH----MDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445
KL + +++ ++W +++ +A L +LH I+HR++ ++ + L
Sbjct: 89 HKLKEQKGKLLPENQVVEWFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTN 139
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
K+ D G+AR++ ST + + Y++PE K DV++ G + E+
Sbjct: 140 IIKVGDLGIARVLENQCDMASTLIGTPY----YMSPELFSNKPYNYKSDVWALGCCVYEM 195
Query: 506 IT 507
T
Sbjct: 196 AT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 43/175 (24%), Positives = 86/175 (49%), Gaps = 14/175 (8%)
Query: 346 KEFLSEINTLGSVRHRNLVPLLGFCVAK--KERL----LVYSYLENGTLYDKLHPAEHEV 399
+EFL E + H N++ L+G + K RL ++ ++++G L+ L +
Sbjct: 46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE 105
Query: 400 MHMDWPLR--LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457
PL+ +R I A G+ +L + IHR+++++ +L+ + ++DFGL++
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
Query: 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ D + + + ++A E V T DV++FGV + E++T G+ P
Sbjct: 163 IYSGDYYRQGCASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 28/87 (32%), Positives = 44/87 (50%), Gaps = 3/87 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
T+LT LDL +NN++ IP I + LDLS N + +PS L N L L L+ N
Sbjct: 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ +P L L+ + ++ N ++
Sbjct: 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS 199
|
Length = 394 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 23/100 (23%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL ++H + IIHR++ + ++ D E K+ DFGLAR H + G
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVAT 180
Query: 476 LGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITG 508
Y APE Y +T+ D++S G ++ EL+TG
Sbjct: 181 RWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 14/102 (13%)
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
A+G+ +L + + IHR+++++ ILL + K+ DFGLAR + ++ G
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK------G 239
Query: 475 D----LGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
D L ++APE V T + DV+SFGV+L E+ + G P
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 313 IIGTGRTGATYIAM-LPGGCFIMIKRLE---DSQHSEKEFLS---EINTLGSVRHRNLVP 365
++G G G Y+ G + +K+++ +S + KE + EI L ++ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 366 LLGFCVAKKERLL--VYSYLENGTLYDKL--HPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
G ER L ++ G++ D+L + A E + + ++ G+++L
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGVSYL 122
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
H N I+HR+I IL D KL DFG ++ + + T + G +++P
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS-GTGMKSVTGTPYWMSP 178
Query: 482 EYPRTLVATPKGDVYSFGVVLLELITGERP 511
E K D++S G ++E++T E+P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLT-EKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 41/185 (22%), Positives = 80/185 (43%), Gaps = 28/185 (15%)
Query: 336 KRLEDSQHSEKEFLSEINTLGSVRHRNLV--------PLLGFCVAKKERLLVYSYLENGT 387
KR++ + + +EI LG + H N++ + + +K +YS++ +
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA 257
Query: 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447
K P + R I + ++H + ++IHR+I + I L+ D +
Sbjct: 258 FDWKDRP-------LLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKI 306
Query: 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPK---GDVYSFGVVLLE 504
L DFG A P + F ++G +G VA P L D++S G++LL+
Sbjct: 307 VLGDFGTA---MPFEKEREAF---DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360
Query: 505 LITGE 509
+++ +
Sbjct: 361 MLSHD 365
|
Length = 501 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 6/98 (6%)
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
ARG+ +L + + IHR+++++ ILL + K+ DFGLAR + D +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGSARL- 238
Query: 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
L ++APE V T + DV+SFGV+L E+ + G P
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 8/99 (8%)
Query: 415 ARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
A+G+++L NC IHR+++++ ILL K+ DFGLAR + D++ N
Sbjct: 224 AKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIR-NDSNYVVKGNARL 278
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ ++APE V T + DV+S+G++L E+ + G P
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 23/171 (13%)
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
L H + R++HR+I + + KL D GL R + T + V + Y++
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY----YMS 174
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540
PE K D++S G +L E+ + P F G + + L + +E
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP---------FYG---DKMNLYSLCKKIEQ 222
Query: 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591
L + + EL Q + + C+ P P++R + VY +A+R H
Sbjct: 223 CDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVY----DVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR--LMNPVDTHLSTFVNGEF 473
GL +LH RIIHR++ ++ I ++ + + D G A+ ++ P L+
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA------- 217
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPES 520
G + APE K D++S G+VL E++ P+ + P S
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YPSTIFEDPPS 262
|
Length = 357 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 333 IMIKRLEDSQHS-EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391
+++K L+ S F + + V H +L + G CV E ++V ++E+G L D
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DV 105
Query: 392 LHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL------DGDF 445
E + + W ++ +A A L++L + ++H N+ +K ILL +G
Sbjct: 106 CLRKEKGRVPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGT- 159
Query: 446 EP--KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-YPRTLVATPKGDVYSFGVVL 502
P KLSD G++ T LS E + ++APE P + D +SFG L
Sbjct: 160 SPFIKLSDPGVSF------TALSREERVE--RIPWIAPECVPGGNSLSTAADKWSFGTTL 211
Query: 503 LEL-ITGERPTHLTNAPE 519
LE+ GE P E
Sbjct: 212 LEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 30/221 (13%)
Query: 314 IGTGRTGATYIAMLPGGC------FIMIKRLEDSQHS--EKEFLSEINTLGSVRHRNLVP 365
+G R G Y L G + IK L+D +EF E ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKL--HPAEHEVMHMD----------WPLRLRIAIG 413
LLG ++ +++SY + L++ L +V D + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 414 SARGLAWL--HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNG 471
A G+ +L HH ++H++++++ +L+ K+SD GL R + D + +
Sbjct: 133 IAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY--KLMGN 185
Query: 472 EFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ +++PE + D++S+GVVL E+ + G +P
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 45/217 (20%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVR---HRNLV 364
IG G G Y A L G F+ +K++ + L EI L + H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 365 PLLGFCVAKK-ER----LLVYSYLEN--GTLYDKLHPA---EHEVMHMDWPLRLRIAIGS 414
LL C + +R LV+ +++ T K + + L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL-------- 116
Query: 415 ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
RG+ +LH + RI+HR++ + IL+ D + K++DFGLAR+ + + L++ V
Sbjct: 117 LRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV---- 168
Query: 475 DLGYVAPE------YPRTLVATPKGDVYSFGVVLLEL 505
L Y APE Y ATP D++S G + EL
Sbjct: 169 TLWYRAPEVLLQSSY-----ATPV-DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 25/206 (12%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
++E L + RH L L + +RL V Y G L+ H + V +
Sbjct: 43 VTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARF 99
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467
I SA L +LH + +++R+I + ++LD D K++DFGL + + T
Sbjct: 100 YGAEIVSA--LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154
Query: 468 FVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521
F G Y+APE Y R + D + GVV+ E++ G P + + F
Sbjct: 155 FC----GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPFYNQDHERLF 204
Query: 522 KGSLVEWITLLNTNSSLETAIDKSLL 547
+ L+E I T S ++ LL
Sbjct: 205 ELILMEEIRFPRTLSPEAKSLLAGLL 230
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 52/240 (21%)
Query: 290 EKSVEKMRLSDL-MKATNSFSKNNIIGTGRTGATYIAMLPG-GCFIMIK--------RLE 339
+ +LSD M T +GTG G IA G G + IK +++
Sbjct: 9 KPDTSSWKLSDFEMGET--------LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK 60
Query: 340 DSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEH 397
QH EK L E++ H +V ++ + + ++ G L+ L A
Sbjct: 61 QVQHVAQEKSILMELS------HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR 114
Query: 398 EVMHMDWPLRLRIAIGSARGLAWLH-HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
+P + + LA+ + H+ + II+R++ + +LLD K++DFG A+
Sbjct: 115 ------FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAK 166
Query: 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVLLELITGERP 511
V T G Y+APE V KG D ++ GV+L E I G P
Sbjct: 167 ---KVPDRTFTLC----GTPEYLAPE-----VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 33/104 (31%), Positives = 58/104 (55%), Gaps = 20/104 (19%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH---LSTFVNGE 472
RGL ++H + N ++HR++ +LL+ + + K+ DFGLAR+ +P H L+ +V
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 473 FGDLGYVAPEYPRTLVATPKG-----DVYSFGVVLLELITGERP 511
+ Y APE ++ KG D++S G +L E+++ RP
Sbjct: 174 W----YRAPE----IMLNSKGYTKAIDIWSVGCILAEMLSN-RP 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 21/203 (10%)
Query: 314 IGTGRTG---ATYIAMLPGGCFIMIKRL----EDSQHSEKEFLSEINTLGSVRHRNLVPL 366
IG+G G A + +L G + +K+L ++ H+++ + E+ L V H+N++ L
Sbjct: 29 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEH-EVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L +K ++ L +L A +V+HM+ R++ + L + H
Sbjct: 86 LNVFTPQKS----LEEFQDVYLVMELMDANLCQVIHMELDHE-RMSYLLYQMLCGIKHLH 140
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+ IIHR++ I++ D K+ DFGLAR + ++ +V + Y APE
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC-TNFMMTPYVVTRY----YRAPEVIL 195
Query: 486 TLVATPKGDVYSFGVVLLELITG 508
+ D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 39/109 (35%), Positives = 52/109 (47%), Gaps = 12/109 (11%)
Query: 410 IAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV 469
I G+ RGL +LH N IHRNI + IL+ GD LS GL+ L + V V
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 470 NGEFGD-----LGYVAPEYPRTLVA--TPKGDVYSFGVVLLELITGERP 511
+F L +++PE R + K D+YS G+ EL TG P
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 4e-04
Identities = 46/189 (24%), Positives = 82/189 (43%), Gaps = 33/189 (17%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKL 392
++++ + ++H+ +E L +R + L + +L L+ Y+ G L+ L
Sbjct: 41 IVQKAKTTEHTR----TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL 96
Query: 393 HP----AEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448
E EV +I G + L H II+R+I + ILLD +
Sbjct: 97 SQRERFKEQEV---------QIYSGEI--VLALEHLHKLGIIYRDIKLENILLDSNGHVV 145
Query: 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG------DVYSFGVVL 502
L+DFGL++ + + + G + Y+AP+ +V G D +S GV++
Sbjct: 146 LTDFGLSKEFHEDEVERAYSF---CGTIEYMAPD----IVRGGDGGHDKAVDWWSMGVLM 198
Query: 503 LELITGERP 511
EL+TG P
Sbjct: 199 YELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 23/182 (12%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH 393
+++ +D+ H++ +E N L +V+H +V L+ + L+ YL G L+ L
Sbjct: 37 IVRNQKDTAHTK----AERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL- 91
Query: 394 PAEHEVMHMDWPLRLRIA-IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
E E + M+ ++ I A L LH II+R++ + ILLD KL+DF
Sbjct: 92 --EREGIFMEDTACFYLSEISLA--LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDF 144
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG---DVYSFGVVLLELITGE 509
GL + T TF G + Y+APE L+ + G D +S G ++ +++TG
Sbjct: 145 GLCKESIHEGTVTHTFC----GTIEYMAPE---ILMRSGHGKAVDWWSLGALMYDMLTGA 197
Query: 510 RP 511
P
Sbjct: 198 PP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEV--------M 400
L EI L ++H N+V L+ C K Y G+ Y EH++ +
Sbjct: 59 LREIKILQLLKHENVVNLIEICRTKATPYNRY----KGSFYLVFEFCEHDLAGLLSNKNV 114
Query: 401 HMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
++ GL ++H N +I+HR++ + IL+ D KL+DFGLAR
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 19/210 (9%)
Query: 314 IGTGRTGATY-IAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCV 371
IG G G + + G +K L+ ++E +E N L ++ H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 372 AKKER-----LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
K + LV G++ D + M+ P+ I + GL LH N
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-- 143
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY--- 483
+ IHR++ ILL + KL DFG++ + +T V F ++APE
Sbjct: 144 -KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF----WMAPEVIAC 198
Query: 484 PRTLVAT--PKGDVYSFGVVLLELITGERP 511
+ L +T + DV+S G+ +EL G+ P
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
L H N +++R++ ILLD ++SD GLA + H S G GY+A
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMA 163
Query: 481 PEYPRTLVA-TPKGDVYSFGVVLLELITGERP 511
PE + VA D +S G +L +L+ G P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 11/96 (11%)
Query: 415 ARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN--G 471
ARG+ +L NC +HR+++++ +LL K+ DFGLAR + H S +V+
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDI----MHDSNYVSKGS 298
Query: 472 EFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
F + ++APE + T DV+S+G++L E+ +
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 8/99 (8%)
Query: 428 RIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
+HR+I +LLD + +L+DFG MN T S+ G Y++PE + +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA---VGTPDYISPEILQAM 178
Query: 488 -----VATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521
P+ D +S GV + E++ GE P + + E++
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 60/256 (23%), Positives = 98/256 (38%), Gaps = 50/256 (19%)
Query: 288 AFEKSVEKMR------LSDLMKATNSFSKNN----------IIGTGRTGATYIAMLPG-- 329
AFEK + DL + NN ++G T A ++A
Sbjct: 33 AFEKYCADLDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRGSDP 92
Query: 330 -----GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384
F+M+ + ++ SE++ L + H +V + + LL+ Y
Sbjct: 93 KEKVVAKFVMLNDERQAAYAR----SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148
Query: 385 NGTL--------YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISS 436
G L + L E+EV + + + L L +H ++HR++ S
Sbjct: 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVL--------ALDEVHSRK---MMHRDLKS 197
Query: 437 KCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF-GDLGYVAPEYPRTLVATPKGDV 495
I L KL DFG ++ + +S V F G Y+APE + K D+
Sbjct: 198 ANIFLMPTGIIKLGDFGFSKQYS---DSVSLDVASSFCGTPYYLAPELWERKRYSKKADM 254
Query: 496 YSFGVVLLELITGERP 511
+S GV+L EL+T RP
Sbjct: 255 WSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 32/113 (28%), Positives = 45/113 (39%), Gaps = 30/113 (26%)
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE------ 482
IHR++ + L+D KL+DFGL+ + T+ N G Y+APE
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLS-------KGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE--WITLLN 533
Y T+ D +S G +L E + G P F GS W L
Sbjct: 175 YDFTV------DYWSLGCMLYEFLCGFPP---------FSGSTPNETWENLKY 212
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 49/248 (19%), Positives = 95/248 (38%), Gaps = 40/248 (16%)
Query: 344 SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMD 403
+ ++ + EI+ L + H N++ L + E +V + G L + +
Sbjct: 45 ARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDL-------SQMIKYFK 97
Query: 404 WPLRL---------RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454
RL + + SA + H + R++HR+I + + KL D GL
Sbjct: 98 KQKRLIPERTVWKYFVQLCSA-----VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
Query: 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHL 514
R + T + V + Y++PE K D++S G +L E+ + P
Sbjct: 153 GRFFSSKTTAAHSLVGTPY----YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--- 205
Query: 515 TNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH 574
F G + + L + +E L + +L + + + C+ P P +R
Sbjct: 206 ------FYG---DKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM---CIYPDPDQRP 253
Query: 575 TMFEVYQL 582
+ V+Q+
Sbjct: 254 DIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 42/214 (19%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRNLVPLLGF 369
+G+G G+ A+ G + IK+L SE K E+ L ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 370 CVAK------KERLLVYSYLENGTLYDKLHP-AEHEVMHMDWPLRLRIAIGSARGLAWLH 422
+ ++ LV Y++ HP +E +V ++ + + GL ++H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--------LCGLKYIH 134
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
+ IIHR++ + ++ D E K+ DFGLAR D ++ +V + Y APE
Sbjct: 135 ---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVVTRW----YRAPE 184
Query: 483 -------YPRTLVATPKGDVYSFGVVLLELITGE 509
Y +T+ D++S G ++ E++TG+
Sbjct: 185 VILNWMHYNQTV------DIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 57/236 (24%), Positives = 97/236 (41%), Gaps = 28/236 (11%)
Query: 292 SVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCF--IMIKRLEDS----QHSE 345
S ++ + + MK + F+ +GTG G +A F + IKR E S Q
Sbjct: 17 STKEPKRKNKMKYED-FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV 75
Query: 346 KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWP 405
SE L + H V L G + LV ++ G + L +
Sbjct: 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--------- 126
Query: 406 LRLRIAIG---SARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462
R +G +A+ + + + I++R++ + +LLD D K++DFG A++ VD
Sbjct: 127 -RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---VD 182
Query: 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAP 518
T T G Y+APE + D ++ G+ + E++ G P + N P
Sbjct: 183 TRTYTLC----GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFY-ANEP 233
|
Length = 340 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 52/223 (23%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 311 NNIIGTGRTG----ATYIAMLPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLV 364
IG G+ G Y++ + +K + S ++FL E + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSA----RGLAW 420
L+G V+ +E L + ++ L L I + LA+
Sbjct: 71 KLIGVITENP----VWIVME---LAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAY 122
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL--GY 478
L + R +HR+I+++ +L+ KL DFGL+R + ++ G L +
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL-----EDESYYKASKGKLPIKW 174
Query: 479 VAPE---YPRTLVATPKGDVYSFGVVLLE-LITGERPTH-LTN 516
+APE + R A+ DV+ FGV + E L+ G +P + N
Sbjct: 175 MAPESINFRRFTSAS---DVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
L H N +++R++ ILLD ++SD GLA + H S G GY+A
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------GTHGYMA 163
Query: 481 PEYPRTLVA-TPKGDVYSFGVVLLELITGERP 511
PE + A D +S G +L +L+ G P
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 30/169 (17%)
Query: 345 EKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEH------ 397
E + LS+++ V+ H + + FC+ + Y E L KL +H
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCI-------ITEYCEGRDLDCKLEELKHTGKTLS 104
Query: 398 EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR- 456
E +W ++L + G+ ++H RI+HR++ +K I L + K+ DFG++R
Sbjct: 105 ENQVCEWFIQLLL------GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL 154
Query: 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
LM D +TF G Y++PE + K D++S G +L E+
Sbjct: 155 LMGSCDL-ATTFT----GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 9e-04
Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 20/91 (21%)
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
II+R++ +LLD + KL+D+G+ + + P DT STF G Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT-TSTFC----GTPNYIAPEILR-- 169
Query: 488 VATPKGDVYSF-------GVVLLELITGERP 511
G+ Y F GV++ E++ G P
Sbjct: 170 -----GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 30/101 (29%), Positives = 52/101 (51%), Gaps = 23/101 (22%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL ++H + IIHR++ + ++ D E ++ DFGLAR D ++ +V +
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMTGYVATRW-- 180
Query: 476 LGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
Y APE Y +T+ D++S G ++ EL+ G+
Sbjct: 181 --YRAPEIMLNWMHYNQTV------DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 24/193 (12%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
L+E L + RH L L + +RL V Y G L+ H + V D
Sbjct: 43 LTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARF 99
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467
I SA L +LH N +++R++ + ++LD D K++DFGL + + T
Sbjct: 100 YGAEIVSA--LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155
Query: 468 FVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521
F G Y+APE Y R + D + GVV+ E++ G P + + + F
Sbjct: 156 FC----GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPFYNQDHEKLF 205
Query: 522 KGSLVEWITLLNT 534
+ L+E I T
Sbjct: 206 ELILMEEIRFPRT 218
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 415 ARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
A G+ +L NC +HR+++++ +L+ K+ DFGLAR + ++S F
Sbjct: 249 ANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTF 302
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
L ++APE + T DV+SFG++L E+ T
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 31/173 (17%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
L+E L + RH L L + +RL V Y G L+ H + V D R
Sbjct: 43 LTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSED---R 96
Query: 408 LRI---AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464
R I SA L +LH +C+ +++R++ + ++LD D K++DFGL +
Sbjct: 97 ARFYGAEIVSA--LGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT 151
Query: 465 LSTFVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ TF G Y+APE Y R + D + GVV+ E++ G P
Sbjct: 152 MKTFC----GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.002
Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 48/183 (26%)
Query: 345 EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD-----KLHP-AEHE 398
E + L ++N H N+V L E V+ Y+E G LY K P +E
Sbjct: 47 EVKSLRKLN-----EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESV 100
Query: 399 VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR-- 456
+ + + + +GLA +H + HR++ + +L+ G K++DFGLAR
Sbjct: 101 IRSIIYQI--------LQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREI 149
Query: 457 -LMNPVDTHLSTFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITG 508
P ++ST Y APE Y + D+++ G ++ EL T
Sbjct: 150 RSRPPYTDYVST--------RWYRAPEILLRSTSY------SSPVDIWALGCIMAELYTL 195
Query: 509 ERP 511
RP
Sbjct: 196 -RP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 51/223 (22%), Positives = 85/223 (38%), Gaps = 33/223 (14%)
Query: 313 IIGTGRTGATYIAMLPG-GCFIMIKR----LEDSQHSEKEFLSEINTLGSVRHRNLVPLL 367
+IG G G Y+A P + +K+ L ++ +K FL E + H +VP+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 368 GFCVAKKERLLVYSYLENGTLYDKLH--------PAEHEVMHMDWPLRLRIAIGSARGLA 419
C Y+E TL L E L I +
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE-KTSVGAFLSIFHKICATIE 127
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMN-------------PVDTHL 465
++H + ++HR++ ILL G F E + D+G A +
Sbjct: 128 YVH---SKGVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 466 STFVNGEF-GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
S + G+ G Y+APE + A+ D+Y+ GV+L +++T
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 31/105 (29%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
L +LH II+R++ +LLD + KL+D+G+ + + P DT STF G
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC----GT 159
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPES 520
Y+APE R D ++ GV++ E++ G P + + ++
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 16/107 (14%)
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
LH I++R++ + ILLD L DFGL++ + +TF G Y+A
Sbjct: 112 LHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC----GTTEYLA 164
Query: 481 PEYPRTLVATPKG-----DVYSFGVVLLELITGERPTHLTNAPESFK 522
PE ++ KG D +S GV++ E+ G P + + + ++
Sbjct: 165 PE----VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR 207
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166
+L LDLS+N L+ IP L + LDLS N+L+ P + L L L+ N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 167 F 167
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 18/168 (10%)
Query: 345 EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMD 403
EKE L ++N+ V L + K L LV S + G L ++ + M+
Sbjct: 43 EKEILEKVNSPFIVN-------LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME 95
Query: 404 WPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463
R+ SA+ + H + I++R++ + +LLD +LSD GLA V+
Sbjct: 96 -----RVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-----VEL 145
Query: 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+ G GY+APE + + D ++ G + E++ G P
Sbjct: 146 KDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 22/153 (14%)
Query: 378 LVYSYLENG---TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNI 434
LV Y G TL K E M + + IAI S L + +HR+I
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---------VHRDI 128
Query: 435 SSKCILLDGDFEPKLSDFG-LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT--- 490
IL+D + +L+DFG +LM S V G Y++PE + +
Sbjct: 129 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV----GTPDYISPEILQAMEDGKGK 184
Query: 491 --PKGDVYSFGVVLLELITGERPTHLTNAPESF 521
P+ D +S GV + E++ GE P + + E++
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 27/151 (17%), Positives = 55/151 (36%), Gaps = 15/151 (9%)
Query: 313 IIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNL-VP-LLGFC 370
++ G T Y+ +++ ++ S+ + E+ L + + L VP +L
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVL--KINPSREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRII 430
+ L+ ++E G D++ E E + + LA LH +
Sbjct: 63 ESDGWSYLLMEWIE-GETLDEVSEEEKE--------DIAEQLAEL--LAKLHQLPLLVLC 111
Query: 431 HRNISSKCILLDGDFEPKLSDFGLARLMNPV 461
H ++ IL+D + D+ A P
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 20/101 (19%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL ++H + ++HR++ +LL+ + + K+ DFGLAR + ++ +V +
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW-- 173
Query: 476 LGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
Y APE Y T DV+S G + EL+ +
Sbjct: 174 --YRAPELLLNCSEY------TTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 31/109 (28%), Positives = 42/109 (38%), Gaps = 29/109 (26%)
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV-------------------- 469
IHR+I IL+D D KL+DFGL + MN +
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMN--KAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 470 -------NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
N G Y+APE R + D +S GV+L E++ G P
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 618 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.3 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.19 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.18 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.08 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.05 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.04 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.95 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.92 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.83 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.8 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.78 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.71 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.69 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.65 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.57 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.56 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.51 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.5 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.47 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.46 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.45 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.42 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.4 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.39 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.3 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.24 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.2 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.09 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.08 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=573.01 Aligned_cols=471 Identities=30% Similarity=0.543 Sum_probs=360.4
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|+++|.+|..+.++++|+.|+|++|++.|.+|..+.. +++|++|+|++|.++|.+|..++++++|+.|+
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 553 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSS-CKKLVSLDLSHNQLSGQIPASFSEMPVLSQLD 553 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcC-ccCCCEEECCCCcccccCChhHhCcccCCEEE
Confidence 56889999999999999999999999999999999999999999876 99999999999999999999999999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCCCCCCCCC----CCCCCCCCCCchhHHHH
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNSGLCGKPL----NPCPGVPKKSRAGIIAA 236 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~~c~~~~----~~C~~~~~~~~~~~ii~ 236 (618)
|++|+++|.+|..+..+++|+.|++++|+++|.+|.... ..+....+.+|+.+|+.+. ++|...........+++
T Consensus 554 Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~ 633 (968)
T PLN00113 554 LSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYIT 633 (968)
T ss_pred CCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehh
Confidence 999999999999999999999999999999999997543 2567788999999998642 56754222222222222
Q ss_pred HhhhhhHHHHHHHHhhheeeeecceecccCCCCCCcccchhccCCCcceeeeecc-cccccCHHHHHHhhccCCCCcEEe
Q 007088 237 AAAAGVTFTALVVGIFLFCFMRGVYVKKKEDDPEGNKWAKRIKGTKGIKVSAFEK-SVEKMRLSDLMKATNSFSKNNIIG 315 (618)
Q Consensus 237 ~v~~~v~~~~lvv~ii~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~y~~~~~lG 315 (618)
++++++ +++++++++++++++++..+.++.+.....|. ...+.. ....++++++. ..|...+.||
T Consensus 634 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~---~~~~~~~~ig 699 (968)
T PLN00113 634 CTLGAF-LVLALVAFGFVFIRGRNNLELKRVENEDGTWE----------LQFFDSKVSKSITINDIL---SSLKEENVIS 699 (968)
T ss_pred HHHHHH-HHHHHHHHHHHHHHhhhccccccccccccccc----------ccccccccchhhhHHHHH---hhCCcccEEc
Confidence 222222 22222222222222221111111110001111 111111 11234444443 4577888999
Q ss_pred ecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCccccccCC
Q 007088 316 TGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHP 394 (618)
Q Consensus 316 ~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 394 (618)
+|+||.||+|+. .++..||+|+++...... ..|++.+++++|||||+++++|.+++..++||||+++|+|.++++
T Consensus 700 ~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~- 775 (968)
T PLN00113 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR- 775 (968)
T ss_pred cCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-
Confidence 999999999995 678999999987543222 356889999999999999999999999999999999999999984
Q ss_pred CCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCC
Q 007088 395 AEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474 (618)
Q Consensus 395 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~g 474 (618)
.++|..+.+|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.+....... ...+
T Consensus 776 ------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~--------~~~~ 840 (968)
T PLN00113 776 ------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT--------KCFI 840 (968)
T ss_pred ------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC--------Cccc
Confidence 27899999999999999999997666699999999999999999888875 66554322111 1237
Q ss_pred cccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCC--CCH
Q 007088 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGN--GFD 552 (618)
Q Consensus 475 t~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~ 552 (618)
|+.|+|||++.+..++.++|||||||++|||+||+.||+... .....+.+|.............+|+.+... ...
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 899999999999999999999999999999999999995432 223457777776555555555666655332 245
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 553 GELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 553 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
++..++.+++.+|++.||++||+|+||++.|+++.+.
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 6777889999999999999999999999999998663
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=456.12 Aligned_cols=291 Identities=47% Similarity=0.761 Sum_probs=255.9
Q ss_pred cccccCHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccC-HHHHHHHHHHHhcCCCCCccceeEEE
Q 007088 292 SVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS-EKEFLSEINTLGSVRHRNLVPLLGFC 370 (618)
Q Consensus 292 ~~~~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~ 370 (618)
....|++.|+..||++|+..++||+|+||.||+|.+++|+.||||++...... .++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998776554 67799999999999999999999999
Q ss_pred EeCC-eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 371 VAKK-ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 371 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
.+.+ +.+|||||+++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.|+|+||||||+|||+|+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999986643 7999999999999999999999999889999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
+|||+|+............. .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+.... .....+..|.
T Consensus 219 sDFGLa~~~~~~~~~~~~~~---~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~ 293 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTV---MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWA 293 (361)
T ss_pred cCccCcccCCccccceeeec---CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHH
Confidence 99999976543111111110 489999999999999999999999999999999999998876542 2233489999
Q ss_pred HHHhcCCccchhcccccc-CCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 530 TLLNTNSSLETAIDKSLL-GNGFD-GELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
........+.+++|+.+. ..... +++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 888888899999999987 55544 6899999999999999999999999999999766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=391.81 Aligned_cols=256 Identities=30% Similarity=0.447 Sum_probs=211.3
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccC---HHHHHHHHHHHhcCCCCCccceeEEEEeCC-eeEEEEeecCCC
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS---EKEFLSEINTLGSVRHRNLVPLLGFCVAKK-ERLLVYSYLENG 386 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~g 386 (618)
.+.||+|+||+||+|.+.+...||||++...... .++|.+|+.+|.+++|||||+++|+|.++. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4569999999999999977666999999764422 568999999999999999999999999987 789999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCCeeeCCCC-ceEEcccCcccccCCCCCc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR-IIHRNISSKCILLDGDF-EPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 464 (618)
+|.++++... ...+++..+++++.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++........
T Consensus 126 sL~~~l~~~~--~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKKR--KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred cHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 9999998742 25699999999999999999999999 7 99999999999999997 9999999999876543211
Q ss_pred ccccccCCCCcccccCCCCCC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPR--TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.....||+.|||||++. ...|+.|+||||||+++|||+||+.||......+ .... . +
T Consensus 201 ----~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~-----~~~~---v---------~ 259 (362)
T KOG0192|consen 201 ----MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ-----VASA---V---------V 259 (362)
T ss_pred ----ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH-----HHHH---H---------H
Confidence 11234999999999999 5699999999999999999999999998754311 1111 1 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
....+...+......+..++.+||..||..||++.|++..|+.+...+..
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 11111222233566788888899999999999999999999999886654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=371.88 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=207.2
Q ss_pred ccCHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEecc--CccCHHHHHHHHHHHhcCCCCCccceeEEEE
Q 007088 295 KMRLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLED--SQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 371 (618)
..+++|+++ .+.||+|..|+||++.+ .+++.+|+|.+.. +....+++.+|++++++++||+||++||.|.
T Consensus 75 ~i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~ 147 (364)
T KOG0581|consen 75 GISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY 147 (364)
T ss_pred ccCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence 345566655 67899999999999995 5789999999943 3456788999999999999999999999999
Q ss_pred eCC-eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEE
Q 007088 372 AKK-ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 372 ~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
.+. ...++||||++|+|++++...+ .+++...-+|+.++++||.|||+ + +||||||||+|||++..|++||
T Consensus 148 ~~~~~isI~mEYMDgGSLd~~~k~~g----~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKi 220 (364)
T KOG0581|consen 148 SNGEEISICMEYMDGGSLDDILKRVG----RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKI 220 (364)
T ss_pred eCCceEEeehhhcCCCCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEe
Confidence 999 5999999999999999997664 38999999999999999999996 6 9999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
+|||.++.+... ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.||...... .....+.+
T Consensus 221 cDFGVS~~lvnS------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~~~~~Ll 291 (364)
T KOG0581|consen 221 CDFGVSGILVNS------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YLDIFELL 291 (364)
T ss_pred ccccccHHhhhh------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CCCHHHHH
Confidence 999999887653 233455999999999999999999999999999999999999999764211 11222222
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.....+. .+.+....++++ +..++..||++||.+||+++|+++
T Consensus 292 ~~Iv~~p------pP~lP~~~fS~e---f~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 292 CAIVDEP------PPRLPEGEFSPE---FRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HHHhcCC------CCCCCcccCCHH---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222111 122322234444 555555999999999999999975
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=390.11 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=208.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEecc----CccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLED----SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.+|...+.||+|||+.||.++. ..|..||+|++.+ .....+.+.+|+++.++|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 8999999999976 3456678999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
|+|+.|+|.++++.+ .++++.++..+++||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999844 4699999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.+....+ .+|||.|+|||++.....+..+||||+||+||.|++|++||+...- .+-....... +
T Consensus 171 ~~Erk~T----lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~----~ 234 (592)
T KOG0575|consen 171 DGERKKT----LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLN----E 234 (592)
T ss_pred cccccce----ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhc----C
Confidence 5444333 4599999999999999999999999999999999999999986432 2222111111 1
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..- +........+||.++|+.||.+|||+++|+.
T Consensus 235 Y~~-------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YSM-------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccc-------ccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1122234455666999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=370.77 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=202.7
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc--------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ--------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
.+.|.+.+.||+|+||.|-+|. ..+|+.||||++++.. .....+++|+++|++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3467888999999999999999 6789999999997532 122346799999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC---CceEEccc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD---FEPKLSDF 452 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df 452 (618)
.||||||++||+|.+.+-.++. +.+...+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999977654 77888899999999999999999 99999999999999766 77999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCC---CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA---TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
|+|+..+. ...+...+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||....... .+.+.+
T Consensus 324 GlAK~~g~-----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----sl~eQI 394 (475)
T KOG0615|consen 324 GLAKVSGE-----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----SLKEQI 394 (475)
T ss_pred chhhcccc-----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----cHHHHH
Confidence 99998753 234556679999999999876543 348899999999999999999998643321 122221
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .++.. .....+.+...+.+++|.+||..||++|||+.|+++
T Consensus 395 ~----~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 L----KGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred h----cCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1 11110 001123445566777777999999999999999976
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=382.26 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=216.1
Q ss_pred CCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCccc
Q 007088 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 389 (618)
..+.||+|.||.||.|.+++...||+|.++......++|.+|+++|++|+|+|||+++++|..++..+||||||+.|+|.
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 35789999999999999988889999999988788889999999999999999999999999988999999999999999
Q ss_pred cccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccc
Q 007088 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV 469 (618)
Q Consensus 390 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 469 (618)
++|..... ..+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||+|+...+......
T Consensus 290 ~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~--- 361 (468)
T KOG0197|consen 290 DYLRTREG--GLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS--- 361 (468)
T ss_pred HHhhhcCC--CccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec---
Confidence 99987433 5689999999999999999999999 999999999999999999999999999996544332221
Q ss_pred cCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 470 NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 470 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
.+..-+..|.|||.+..++++.|||||||||+||||+| |+.||..... .+.+.. ++...+.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~----------le~GyRl 423 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLEL----------LERGYRL 423 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHH----------HhccCcC
Confidence 12224678999999999999999999999999999999 8888875432 222222 2333333
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
..+..++..+.+|+..||+.+|++|||++.+...|+++..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 4456677888899999999999999999999998888754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=362.47 Aligned_cols=200 Identities=28% Similarity=0.407 Sum_probs=179.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
..+|...+.||+|+||+||+|++ +++..||||.+.... ...+.+..|+.+|+.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45788888999999999999994 568999999996543 44566789999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC------CceEEcccCc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD------FEPKLSDFGL 454 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfG~ 454 (618)
|||.||+|.+|++..+. +++..++.++.|||.||++||++ +||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999987754 99999999999999999999999 99999999999999764 4589999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
|+.+.... .....+|++.|||||++..++|+.|+|+||+|+|+|++++|+.||+...
T Consensus 162 AR~L~~~~-----~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 162 ARFLQPGS-----MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhhCCchh-----HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 99987432 2234569999999999999999999999999999999999999998644
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=355.77 Aligned_cols=257 Identities=21% Similarity=0.310 Sum_probs=207.5
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeE-EEEeCCe-eEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLG-FCVAKKE-RLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV~ 380 (618)
+|.+.++||+|.||+||++. +.+|..||.|.++-.. ...+++..|+.+|++++|||||++++ .+.++.+ .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 47778899999999999999 7899999999997533 44566889999999999999999998 4555555 78999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|||..|+|.+.++..+.....+++..+++++.|+++||.++|++.. + |+||||||.||+++.+|.+||+|||+++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999998766666789999999999999999999999432 4 999999999999999999999999999988
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
...... ..+.+|||.||+||.+.+.+|+.||||||+||++|||..-++||...+ +.+..+.... ++.
T Consensus 179 ~s~~tf----A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~q-gd~ 245 (375)
T KOG0591|consen 179 SSKTTF----AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQ-GDY 245 (375)
T ss_pred cchhHH----HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHc-CCC
Confidence 754433 334559999999999999999999999999999999999999998742 2221111111 111
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
+.+.. .-...++..|+..|+..||+.||+...++..+..
T Consensus 246 -----~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 -----PPLPD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -----CCCcH---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 01111 3355677777889999999999996555555444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=352.50 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=200.1
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||.++ .++++.+|+|++++.. ...+...+|..+|.+++||.||+++..|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4579999999999999999999 4568999999998743 3456688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
+||+.||.|+.+|+..+. +++..+.-++..|+.||.|||++ +||||||||+|||+|.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999987654 99999999999999999999999 99999999999999999999999999998644
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ...+||+.|||||++.+..|+.++|.||+|+++|||++|.+||...+. .++........
T Consensus 177 ~~~~~t----~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~~k--- 241 (357)
T KOG0598|consen 177 KDGDAT----RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILKGK--- 241 (357)
T ss_pred cCCCcc----ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhcCc---
Confidence 332222 235699999999999999999999999999999999999999986442 33333332221
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH 574 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 574 (618)
........+.+..++++ +.+..||++|-
T Consensus 242 ----~~~~p~~ls~~ardll~---~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLK---KLLKRDPRQRL 269 (357)
T ss_pred ----CCCCCccCCHHHHHHHH---HHhccCHHHhc
Confidence 01112223445554444 99999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=340.35 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=206.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccC---HHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHS---EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
+.|+...++|+|+||.||+++. ++|+.||||++..++.+ .+-..+|+++|++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688889999999999999994 56999999999775532 3456899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
||+. ++.+-+.... ..++...+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+||+|||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 5555555444 3488999999999999999999999 9999999999999999999999999999988743
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-------cCHHHHHHHHh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK-------GSLVEWITLLN 533 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~-------~~l~~~~~~~~ 533 (618)
....+. .+.|..|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+.++-+... ..+.+....+.
T Consensus 155 gd~YTD----YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 GDNYTD----YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred cchhhh----hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 333333 347999999999877 789999999999999999999999987765432211 11112222222
Q ss_pred cCCccchhccccc-----cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 007088 534 TNSSLETAIDKSL-----LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVY 580 (618)
Q Consensus 534 ~~~~~~~~~d~~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 580 (618)
.+.....+.-+.. ..........-+++++..||+.||.+|++.+|++
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 2222222211111 1122333445788899999999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=358.06 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=208.1
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHH--HHHHHHHhcCC-CCCccceeEEEEeCC-eeEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEF--LSEINTLGSVR-HRNLVPLLGFCVAKK-ERLL 378 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 378 (618)
..++|...++||.|.||.||+|+ ...|..||||++++.-...++. .+|+..|++++ ||||+++.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 34678889999999999999999 6779999999998755444443 68999999998 999999999999988 8999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|||||+. +|.++++.+. ..+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+..
T Consensus 88 VfE~Md~-NLYqLmK~R~---r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999976 9999998874 6899999999999999999999999 9999999999999998889999999999987
Q ss_pred CCCCCcccccccCCCCcccccCCCCC-CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYP-RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
...... ...+.|..|+|||++ ..+.|+.+.|+||+|||++|+.+-++.|.+.++.+.... +.+.........+
T Consensus 161 ~SkpPY-----TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K-Ic~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSKPPY-----TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK-ICEVLGTPDKDSW 234 (538)
T ss_pred ccCCCc-----chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH-HHHHhCCCccccc
Confidence 654332 233479999999975 467899999999999999999999999987654322111 0111000000100
Q ss_pred -----cchhcc---ccccC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 538 -----LETAID---KSLLG----NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 538 -----~~~~~d---~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
+...+. +...+ ........+.++++.+|+++||.+|||++|+++.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 001111 00001 1122356678888889999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=357.09 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=205.5
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 375 (618)
.+..++|...+.||+|+|++|++|+ ...++.||||++.+.. ...+-+..|-++|.+| .||.|++++..|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445678889999999999999999 5679999999996632 3334577888999999 89999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.|+|+||+++|+|.++|++.+. +++.....++.+|+.||+|||++ |||||||||+|||+|+++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999988754 99999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCc-----cc----ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH
Q 007088 456 RLMNPVDTH-----LS----TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 456 ~~~~~~~~~-----~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~ 526 (618)
+.+.+.... .. ......+||..|.+||++.+...+..+|+|+||||+|+|+.|++||...++.-.+ .
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF----q 297 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF----Q 297 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH----H
Confidence 988653322 11 1112356999999999999999999999999999999999999999875532111 1
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVY 580 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 580 (618)
+... ++-. .+...+....+|+.+.|..||.+|+|++||-
T Consensus 298 kI~~-----------l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk 336 (604)
T KOG0592|consen 298 KIQA-----------LDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIK 336 (604)
T ss_pred HHHH-----------hccc----CCCCCCHHHHHHHHHHHccCccccccHHHHh
Confidence 1000 1111 1122224556666699999999999996653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=324.51 Aligned_cols=282 Identities=21% Similarity=0.264 Sum_probs=215.2
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.+|...+++|+|.||.||+|+ ..+|+.||||+++..+. ......+|++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468889999999999999999 67899999999976432 24567899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++. +|+..+++.. ..++..++..++.++++|++|+|++ .|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9987 9999998765 5799999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh---cCCc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN---TNSS 537 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~---~~~~ 537 (618)
....... +-|..|+|||.+.| +.|+...|+||.|||+.||+-|.+-|.+.++-+.. ......+- .+.|
T Consensus 155 ~~~~~~~----V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL----~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 155 NRIQTHQ----VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL----SKIFRALGTPTPDQW 226 (318)
T ss_pred Ccccccc----eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH----HHHHHHcCCCCcccC
Confidence 5443322 36899999998775 57999999999999999999998777665432211 11111000 0000
Q ss_pred -----cchh-----ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCCCC
Q 007088 538 -----LETA-----IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSN 603 (618)
Q Consensus 538 -----~~~~-----~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 603 (618)
+.+. +..............+.++++..|+..||.+|++++|+++. ..+...-..+.....+.|..
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~yf~~~P~pt~~~~lp~p~~ 301 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH-PYFKSLPLPTPPSKLPIPST 301 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc-hhhhcCCCCCChhhCcCCcc
Confidence 0000 01111111234455667899999999999999999999764 23333233333444444444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=378.39 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=217.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
.+....+.||+|.||.||+|... +...||||.+++.. ...++|++|++++..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 33445678999999999999943 35789999998754 35788999999999999999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCC----------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 378 LVYSYLENGTLYDKLHPAEHE----------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
||+|||..|||.++|...... ..+++..+.+.||.|||.|+.||-++ .+|||||..+|+|+.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 999999999999998754321 23488999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++..-..+..... ....-+.+|||||.+..+++|.+||||||||+|||+++ |+.||....+.+..
T Consensus 643 KIsDfGLsRdiYssDYYk~~--~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI----- 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVR--GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI----- 715 (774)
T ss_pred Eecccccchhhhhhhhhccc--CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-----
Confidence 99999999976554433211 11224679999999999999999999999999999998 99999876543211
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
.....+. + -..++.++.++.+|+..||+.+|++||+++||-..|+.+.+...
T Consensus 716 ----e~i~~g~--------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 716 ----ECIRAGQ--------L-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ----HHHHcCC--------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 1111111 1 23456678899999999999999999999999999999876543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=341.31 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=209.0
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.+.|+..+.||.|..++||+|+ .+.+..||||++.-+. ...+.+++|+..|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4678899999999999999999 6778999999996533 345789999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
||.+|++.+++...-. ..+++..+..|++++++||.|||++ |.||||||+.||||+.+|.+||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999976654 3499999999999999999999999 9999999999999999999999999988776554
Q ss_pred CCcccccccCCCCcccccCCCCCC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPR--TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
............||+.|||||++. ...|+.|+||||||++..||.+|..||....+-. -....+.......
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLLLTLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCCCCc
Confidence 432222224557999999999854 3568999999999999999999999998643311 1111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. -..+..+......+.+.+++..||+.||++|||++++++
T Consensus 253 ~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 L--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred c--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0 001111112223457788888999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=351.79 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=203.4
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 378 (618)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+. ....-..+|+.+|++|+||||+++.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457778899999999999999 6789999999997543 3344568999999999999999999998877 68999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|+|||+. +|..++.... ..+++.++..+++|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999998 9998887654 4699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... ...++-|..|+|||++.| ..|+.+.|+||.||||.||++|++.|....+.+....+. +.......+.|
T Consensus 269 ~~~~~~~---~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf-klcGSP~e~~W 344 (560)
T KOG0600|consen 269 TPSGSAP---YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF-KLCGSPTEDYW 344 (560)
T ss_pred cCCCCcc---cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH-HHhCCCChhcc
Confidence 6544322 334557999999998776 479999999999999999999999998755422211110 00000000011
Q ss_pred c----c--hhcccccc-----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 L----E--TAIDKSLL-----GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~----~--~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. . ..+.+.-. .+.........++|+..+|..||.+|.|+.++++
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 0 00000000 0001112345667788999999999999998864
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=370.80 Aligned_cols=272 Identities=23% Similarity=0.372 Sum_probs=226.3
Q ss_pred ccccCHHHHHHhhccC---------CCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccC--ccCHHHHHHHHHHHhc
Q 007088 293 VEKMRLSDLMKATNSF---------SKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDS--QHSEKEFLSEINTLGS 357 (618)
Q Consensus 293 ~~~~~~~~l~~~~~~y---------~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~E~~~l~~ 357 (618)
.+.++++|-.+|...| .+.++||.|.||.||+|+++ ....||||.++.. +....+|+.|..+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 3456666655554444 45789999999999999954 2468999999874 3556789999999999
Q ss_pred CCCCCccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 007088 358 VRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437 (618)
Q Consensus 358 l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 437 (618)
++||||+++.|+.......++|.|||++|+|+.+|+.+.+ .+.+.+..-++++|+.|++||-+. ++|||||.++
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG---qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAAR 760 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG---QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAAR 760 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC---ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhh
Confidence 9999999999999999999999999999999999988774 488999999999999999999999 9999999999
Q ss_pred CeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 007088 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTN 516 (618)
Q Consensus 438 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~ 516 (618)
|||++.+..+|++|||+++.+.+......+ ..+.--+.+|.|||.+...+++.+||||||||+|||.++ |.+||.+..
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~~yt-t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYT-TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred heeeccceEEEeccccceeecccCCCcccc-ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 999999999999999999987654422222 122223579999999999999999999999999999887 999998754
Q ss_pred CCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 517 APESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 517 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
+. +....+....+-..+.+++..|.+|+..||++|-.+||.+.||+..|+++...
T Consensus 840 NQ------------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 840 NQ------------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred hH------------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 42 12233333444445667888999999999999999999999999999998654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=352.83 Aligned_cols=247 Identities=30% Similarity=0.451 Sum_probs=204.9
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCH-HHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE-KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
..|....+||+|..|.||.|. ..+++.||||++....... +-+.+|+.+|+..+|+|||++++.|...++.|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 457778899999999999999 5678999999998765544 44789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
+||+|.+.+.... +++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999987654 89999999999999999999999 999999999999999999999999999988876555
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
...+ .+||+.|||||+.....|++|.||||||++++||+-|.+||...+. +.. ......++.
T Consensus 425 KR~T----mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrA-lyLIa~ng~------ 486 (550)
T KOG0578|consen 425 KRST----MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRA-LYLIATNGT------ 486 (550)
T ss_pred cccc----ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHH-HHHHhhcCC------
Confidence 4443 3499999999999999999999999999999999999999975332 111 111111111
Q ss_pred cccc-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLL-GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+. .+..+.+.++|++ +||..||++|+++.|+|+
T Consensus 487 P~lk~~~klS~~~kdFL~---~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLD---RCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCcCCccccCHHHHHHHH---HHhhcchhcCCCHHHHhc
Confidence 1111 1123344455555 999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=356.08 Aligned_cols=263 Identities=24% Similarity=0.370 Sum_probs=203.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC-
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK- 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 374 (618)
.++|.+.++||+|+||.||+|.. .++..||+|+++... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999973 235789999997533 2345688999999999 8999999999987654
Q ss_pred eeEEEEeecCCCccccccCCCCCC--------------------------------------------------------
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHE-------------------------------------------------------- 398 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 398 (618)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999888643210
Q ss_pred --CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcc
Q 007088 399 --VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476 (618)
Q Consensus 399 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~ 476 (618)
..++++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......... .....++.
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~--~~~~~~~~ 240 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGSARLPL 240 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhc--ccCCCCCc
Confidence 13488889999999999999999999 999999999999999999999999999986543221111 11223567
Q ss_pred cccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHH
Q 007088 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGEL 555 (618)
Q Consensus 477 ~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 555 (618)
.|+|||++.+..++.++|||||||++|||++ |..||......+ ....... ..... .......
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~-~~~~~---------~~~~~~~ 303 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLK-DGTRM---------RAPENAT 303 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHh-cCCCC---------CCCCCCC
Confidence 8999999999999999999999999999997 999997543211 1111111 11100 0111233
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 556 HQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 556 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 4677888899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=340.24 Aligned_cols=257 Identities=27% Similarity=0.400 Sum_probs=197.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC--eeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK--ERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e 381 (618)
.++...+.||+|+||.||++... +|...|||...... ...+.+.+|+.+|.+++|||||+++|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667889999999999999954 59999999886542 11456899999999999999999999855554 5889999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~ 460 (618)
|+++|+|.+++...+. .+++..+.++..||++||+|||++ ||+||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999987653 499999999999999999999999 9999999999999999 79999999999987763
Q ss_pred CCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.. ..........||+.|||||++..+ ....++||||+||++.||+||++||... .....+.-........
T Consensus 171 ~~-~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~- 241 (313)
T KOG0198|consen 171 KG-TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDSL- 241 (313)
T ss_pred cc-ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCCC-
Confidence 11 111111234599999999999853 3345999999999999999999999753 1111222111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
+.+ ....+++.+ +++.+|++.||++|||++|+++.---
T Consensus 242 ----P~i-p~~ls~~a~---~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 242 ----PEI-PDSLSDEAK---DFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred ----CCC-CcccCHHHH---HHHHHHhhcCcccCcCHHHHhhChhh
Confidence 111 111334444 45559999999999999999876543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=349.52 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=206.5
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCH---HHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|.+.+.||+|+||.||||+ ..+.+.||+|.+.+....+ +.+++|++++++++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888999999999999999 4568999999997765444 558899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+.| +|+.++...+. ++++.+..++.|++.||.|||+. +|+|||+||.|||++..+.+|++|||+|+-+...
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 99999987764 99999999999999999999999 9999999999999999999999999999987653
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.... ....||+-|||||+..++.|+..+|.||+|||+||+++|++||... .+.+.++....+..
T Consensus 154 t~vl----tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~v---- 217 (808)
T KOG0597|consen 154 TSVL----TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDPV---- 217 (808)
T ss_pred ceee----eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCCC----
Confidence 3222 2334999999999999999999999999999999999999999753 23333333322211
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..++.....+..++...|.+||.+|.+..+++.
T Consensus 218 -------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 -------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 112234456677777999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=324.43 Aligned_cols=198 Identities=25% Similarity=0.363 Sum_probs=179.3
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..+.||.|+||.|.+++ ..+|..+|+|++.+.. ...+...+|..+|+.+.||.++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 457778999999999999999 4578999999997654 23455788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||++||.|+.+++..+. +++..++-++.||+.||+|||+. +|++|||||+|||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999987654 99999999999999999999999 999999999999999999999999999998764
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
. + ...+||+.|+|||.+.+..+..++|.|||||++|||+.|.+||...+.
T Consensus 197 r-T------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 R-T------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred c-E------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3 1 234599999999999999999999999999999999999999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=348.21 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=205.2
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC----c--cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS----Q--HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKE 375 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 375 (618)
..++|...+.||+|+||.|+.|. ..++..||+|++... . ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 45689999999999999999998 557899999977553 1 23456778999999999 9999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGL 454 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~ 454 (618)
.++||||+.||+|.+++... .++.+..+.+++.|++.|++|+|++ ||+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999874 3488899999999999999999999 99999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCC-CC-CccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV-AT-PKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+......+ ......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.... .-....
T Consensus 168 s~~~~~~~----~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--------~l~~ki 235 (370)
T KOG0583|consen 168 SAISPGED----GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--------NLYRKI 235 (370)
T ss_pred ccccCCCC----CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--------HHHHHH
Confidence 99874111 2233456999999999999877 75 7899999999999999999999873321 111111
Q ss_pred hcC-CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 533 NTN-SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 533 ~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
... -.+.. ... ..++..++.+|+..||.+|+++.||+ .-..+..
T Consensus 236 ~~~~~~~p~---------~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 236 RKGEFKIPS---------YLL--SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred hcCCccCCC---------CcC--CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 110 01111 110 34566777799999999999999999 4444444
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=343.37 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=203.4
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
..++|+....||+|+||.||+|+ ..+|..+|+|+++++. ...+.++.|-.+|...++|.||+++..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 56789999999999999999999 5679999999998864 344668899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||++||++..+|...+ .|++..+..++.+++.|+..||+. |+|||||||+|+|||..|++||+|||++.-+
T Consensus 219 iMEylPGGD~mTLL~~~~----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHhcC----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999998765 499999999999999999999999 9999999999999999999999999999543
Q ss_pred CCC----------------------CCc-----cc----------------ccccCCCCcccccCCCCCCCCCCCCccch
Q 007088 459 NPV----------------------DTH-----LS----------------TFVNGEFGDLGYVAPEYPRTLVATPKGDV 495 (618)
Q Consensus 459 ~~~----------------------~~~-----~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV 495 (618)
... +.. .. ......+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 000 00 00112459999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 007088 496 YSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT 575 (618)
Q Consensus 496 wS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 575 (618)
||+|||+|||+.|.+||......+. ...+..|...+..... .....+..+||.+|+. ||++|--
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQET-YRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999997665432 3345555543322111 1112455666669998 9999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.12 Aligned_cols=247 Identities=19% Similarity=0.252 Sum_probs=198.4
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccC----HHHHHHHHHHHhcCCCCCccceeEEEEe----CCeeEEEEee
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS----EKEFLSEINTLGSVRHRNLVPLLGFCVA----KKERLLVYSY 382 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 382 (618)
...||+|++|.||+|.. +|+.||||+++..... .+.+.+|+.++.+++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 46899999999999998 6889999999765433 3567899999999999999999999877 3467899999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++.... .+++.....++.|++.||.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999997643 4889999999999999999999732 78899999999999999999999999998654321
Q ss_pred CcccccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +...........
T Consensus 178 ~-------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~-- 240 (283)
T PHA02988 178 F-------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------EIYDLIINKNNS-- 240 (283)
T ss_pred c-------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcCCC--
Confidence 1 2237889999999876 68899999999999999999999999754321 111111111100
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
. ..+......+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 241 ---~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 ---L----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---C----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0 0111234467778889999999999999999999998754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=351.11 Aligned_cols=267 Identities=26% Similarity=0.394 Sum_probs=211.2
Q ss_pred HHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 007088 298 LSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK 374 (618)
Q Consensus 298 ~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 374 (618)
.++.+...+.+.....||+|+||+||+|.+.+ .||||+++.+. ...+.|++|+..+++-+|.||+-+.|+|..+.
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 34455555667778999999999999999755 59999997543 34567999999999999999999999999887
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
. .+|+.+|+|.+|+.+++..+ ..++..+.+.|+.||++|+.|||.+ +|||||||..||++.++++|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 7 99999999999999999876 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT---LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
+..-...... .......|...|||||++.. .+|++++||||||+++|||+||..||......+.....
T Consensus 535 atvk~~w~g~--~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV------- 605 (678)
T KOG0193|consen 535 ATVKTRWSGE--QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV------- 605 (678)
T ss_pred eeeeeeeccc--cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------
Confidence 9754322111 11122237789999998764 47899999999999999999999999843322211110
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..+.. ..|. ........+++.+|+..||..++++||.+.+|+..|+++...
T Consensus 606 --GrG~l--~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 --GRGYL--MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred --ccccc--Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00000 0011 111234566788888899999999999999999999888663
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=335.91 Aligned_cols=256 Identities=22% Similarity=0.241 Sum_probs=200.8
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc---------------cCHHHHHHHHHHHhcCCCCCccc
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ---------------HSEKEFLSEINTLGSVRHRNLVP 365 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~ 365 (618)
.+..++|++.+.||+|.||.|-+|+ ..+++.||||++.+.. ...+.+++|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456789999999999999999999 5679999999996432 12357899999999999999999
Q ss_pred eeEEEEeC--CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC
Q 007088 366 LLGFCVAK--KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG 443 (618)
Q Consensus 366 l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 443 (618)
++++..+. +..|||+|||..|.+...=... ..+++.++++++.+++.||+|||.+ |||||||||+|+|+++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 99999875 4789999999988776543222 2389999999999999999999999 9999999999999999
Q ss_pred CCceEEcccCcccccCCCC-CcccccccCCCCcccccCCCCCCCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 007088 444 DFEPKLSDFGLARLMNPVD-THLSTFVNGEFGDLGYVAPEYPRTLV----ATPKGDVYSFGVVLLELITGERPTHLTNAP 518 (618)
Q Consensus 444 ~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~Gvil~elltG~~Pf~~~~~~ 518 (618)
+|++||+|||.+....... ...........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999999998764321 11122233467999999999877632 357899999999999999999999864321
Q ss_pred CccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 519 ESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 519 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+ .+++...+......+.-..+.+|+.++|++||++|.+..+|..
T Consensus 326 ~l~-----------------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 326 ELF-----------------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHH-----------------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 111 1222223322223344556777788999999999999988854
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=348.68 Aligned_cols=246 Identities=23% Similarity=0.291 Sum_probs=203.7
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+-|..++.||.|+.|.|.+|+ ..+|+.+|||++.+. ......+.+|+-+|+-+.||||+++|++++++.+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 346668889999999999999 578999999999664 233456789999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|.|++++-.++ ++++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999998765 499999999999999999999999 999999999999999999999999999976433
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
. ......||.+.|.|||++.|.+| +.++||||+|||||.|+||+.||++++ +........... .
T Consensus 165 g-----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------ir~LLlKV~~G~--f 229 (786)
T KOG0588|consen 165 G-----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------IRVLLLKVQRGV--F 229 (786)
T ss_pred C-----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCc--c
Confidence 2 23345679999999999999988 479999999999999999999998543 222222221110 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
+-++....+..+|+.+|+..||++|.|++||++.
T Consensus 230 ---------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 ---------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1122333455666669999999999999999764
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=329.56 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=204.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|+..+.||+|+||.||++...++..+|+|.+.......+++.+|++++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45788899999999999999988888999999887666677899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999987543 2489999999999999999999999 99999999999999999999999999988654322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+........... ..+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~---~~~ 223 (256)
T cd05114 158 ---SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRL---YRP 223 (256)
T ss_pred ---cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCC---CCC
Confidence 112224568999999988889999999999999999999 8999865332 1111111111110 001
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
......+.+++.+||+.+|++||+++|+++.|
T Consensus 224 -------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 -------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11234678888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=331.88 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=207.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|++.++||+|++|.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 56888999999999999999988888999999876655667899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..........
T Consensus 86 ~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 86 GSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 999999865432 4588999999999999999999999 99999999999999999999999999998764322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....++..|+|||+..+..++.++|||||||++|||++ |+.||...... ..... .......
T Consensus 161 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~---~~~~~~~------ 223 (261)
T cd05072 161 ---REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-----DVMSA---LQRGYRM------ 223 (261)
T ss_pred ---cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-----HHHHH---HHcCCCC------
Confidence 112235678999999988889999999999999999998 99998653211 11111 1111000
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
.........+.+++.+|+..+|++||+++++.+.|+++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112234677888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=319.98 Aligned_cols=265 Identities=23% Similarity=0.212 Sum_probs=199.8
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccC---HHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHS---EKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 378 (618)
.++|+..+.|++|.||.||+|+ .++++.||+|+++-+... .-.-.+|+.+|.+++|||||.+..+.... +..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4568889999999999999999 567899999999765421 12357999999999999999999988654 57899
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|||||+. +|..++.... .++...++..+..|+++|++|||.. .|+|||||++|+|+++.|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999988 9999988765 4689999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
+......+.. +-|..|+|||++.+ ..|+++.|+||+|||+.||+++++.|.+..+.+....+... ........|
T Consensus 228 gsp~k~~T~l----VVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l-lGtPte~iw 302 (419)
T KOG0663|consen 228 GSPLKPYTPL----VVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL-LGTPSEAIW 302 (419)
T ss_pred cCCcccCcce----EEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH-hCCCccccC
Confidence 7654333332 36899999998775 56999999999999999999999999876543222111110 000000000
Q ss_pred c----chhc---------cccccCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 L----ETAI---------DKSLLGNGFDG-ELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~----~~~~---------d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ...+ ...+...+... -...-.+++...+..||.+|.|+.|.++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 0000 00000000000 1134456667999999999999999865
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=328.56 Aligned_cols=256 Identities=22% Similarity=0.359 Sum_probs=208.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|++.+.||+|++|.||+|...+++.||+|.++......+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 45688899999999999999998788899999998766667789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 85 YGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred CCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999876542 4589999999999999999999999 9999999999999999999999999999876532111
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. ..+...+..|+|||+..+..++.++||||||+++|||++ |+.||...... .+. ........
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~---~~~~~~~~------ 222 (261)
T cd05068 160 A---REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-----EVL---QQVDQGYR------ 222 (261)
T ss_pred c---cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-----HHH---HHHHcCCC------
Confidence 1 111123457999999998899999999999999999999 99998653211 011 11111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
..........+.+++.+|++.+|.+||+++++.+.|+++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 ----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011122345678888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=338.41 Aligned_cols=264 Identities=20% Similarity=0.320 Sum_probs=201.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC-----------------CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccce
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG-----------------GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPL 366 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l 366 (618)
++|.+.++||+|+||.||++..++ +..||+|.+.... ....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 568889999999999999997532 3479999987642 334678999999999999999999
Q ss_pred eEEEEeCCeeEEEEeecCCCccccccCCCCC---------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 007088 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEH---------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431 (618)
Q Consensus 367 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 431 (618)
++++.+.+..++||||+++|+|.+++..... ....+++..+++++.||+.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999998754321 113478899999999999999999999 9999
Q ss_pred cCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh--CC
Q 007088 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT--GE 509 (618)
Q Consensus 432 ~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt--G~ 509 (618)
|||||+|||++.++.+||+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++ +.
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR--IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeE--ecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999998654332211 1112235788999999988889999999999999999987 55
Q ss_pred CCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 510 RPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 510 ~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
.||...... ................ .........+..+.+++.+||+.||++|||+.||.+.|++
T Consensus 240 ~p~~~~~~~-----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 240 QPYGELTDE-----QVIENAGEFFRDQGRQ------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCcCCHH-----HHHHHHHHHhhhcccc------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 677643221 1111111111110000 0000112234567888889999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=310.87 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=211.2
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Cee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-----KER 376 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 376 (618)
..++|.+.+.+|+|||+-||+++ ..++..||+|++.-.. ...+...+|++..++++|||+++++++...+ ...
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34679999999999999999999 7789999999986544 6677889999999999999999999887543 358
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
|++++|+..|+|.+.+.....+...+++.++++|+.++++||++||+. .|+++||||||.||++.+++.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999987776667899999999999999999999997 3459999999999999999999999999987
Q ss_pred ccCCCC-----CcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 457 LMNPVD-----THLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 457 ~~~~~~-----~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
...-.- ...-........|..|+|||.+. +...++++|||||||++|+|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 653211 11111112233689999999875 45678999999999999999999999975322
Q ss_pred HHHHhcCCccc-hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 529 ITLLNTNSSLE-TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 529 ~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
..+.+. .+....+.....+.....+.+++..|++.||.+||++.+++..++.+
T Consensus 247 -----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 247 -----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111 11111222122223566788888899999999999999999998875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.87 Aligned_cols=250 Identities=24% Similarity=0.279 Sum_probs=197.8
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.|+..+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999994 678999999986432 223457889999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999888754332 3589999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||........ ........ ....
T Consensus 156 ~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~-~~~~---- 221 (285)
T cd05631 156 ET-----VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRV-KEDQ---- 221 (285)
T ss_pred Ce-----ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHh-hccc----
Confidence 21 1233489999999999999999999999999999999999999986433111 01111110 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
..........+.+++.+||+.||++||+ ++|+++
T Consensus 222 ------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 ------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0011122345667777999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=335.82 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=204.2
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
..|+..++||+|.||.||+|. ...++.||+|++.-. ....+++++|+.++.+++++||.++|+.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 357777899999999999999 467899999999754 34567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+.||++.+.+..... +++..+.-|+++++.|+.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999986642 57788888999999999999999 99999999999999999999999999998876544
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
....+ .+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+..... -+.+-.
T Consensus 166 ~rr~t----fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--------------lIpk~~ 227 (467)
T KOG0201|consen 166 KRRKT----FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--------------LIPKSA 227 (467)
T ss_pred hcccc----ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--------------eccCCC
Confidence 43333 349999999999998899999999999999999999999997654321100 011111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.|.+.+ .+ .+.+.+++..||..||+.||++.++++
T Consensus 228 PP~L~~-~~---S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 228 PPRLDG-DF---SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCcccc-cc---CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222322 23 344556666999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=348.24 Aligned_cols=260 Identities=23% Similarity=0.345 Sum_probs=202.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 375 (618)
.++|+..+.||+|+||.||+|+. .++..||+|+++... ...+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999973 345689999997543 3345688999999999 89999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCC----------------------------------------------------------
Q 007088 376 RLLVYSYLENGTLYDKLHPAEH---------------------------------------------------------- 397 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 397 (618)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988864321
Q ss_pred -------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 398 -------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 398 -------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 012578999999999999999999999 9999999999999999999999999999866432211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+ ......
T Consensus 271 ~--~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~----~~~~~---~~~~~~------ 335 (375)
T cd05104 271 V--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS----KFYKM---IKEGYR------ 335 (375)
T ss_pred c--ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH----HHHHH---HHhCcc------
Confidence 1 1111224668999999999999999999999999999998 888886532211 11111 111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
...+.....++.+++.+||+.||++||+++||++.|++.
T Consensus 336 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 ----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000111234677888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=330.69 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=202.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.+.||+|+||.||+|... .+..||+|.++... .....+.+|+..+.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999842 46789999997643 2345688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 3589999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...... +..........
T Consensus 159 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~- 226 (266)
T cd05064 159 SEAIY---TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFR- 226 (266)
T ss_pred ccchh---cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCC-
Confidence 21111 1111225678999999998999999999999999999775 99999754321 11111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
.......+..+.+++.+||+.+|.+||+++|+.+.|+++
T Consensus 227 ---------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 ---------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 011122345677888899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=328.91 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=206.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.+|+..+.||+|++|.||+|.. +.++.|++|.+.......+++.+|++++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 3577788999999999999995 458899999998766666789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999865432 4589999999999999999999999 9999999999999999999999999999876532211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.........
T Consensus 161 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~------- 222 (263)
T cd05052 161 A---HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEKGY------- 222 (263)
T ss_pred c---cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCC-------
Confidence 1 111224568999999998999999999999999999998 9999864321 11111111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
...........+.+++.+|++.||++||++.++++.|+.+
T Consensus 223 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 ---RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0111122335677788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=367.07 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=213.6
Q ss_pred cCCCCcEEeecCCeeEEEEEeCC--C----cEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPG--G----CFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~--~----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
+-+..+.||+|.||.||.|...+ | ..||||.+++. .....+|.+|..+|++++|||||+++|++.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34557789999999999999543 3 35999999874 4566789999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 379 VYSYLENGTLYDKLHPAEH---EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
++|||++|+|..+|++.+. ....++..+.+.++.|||+|+.||+++ ++|||||.++|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 9999999999999987632 235688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
+.+...+...... ...-...|||||.+..+.++.|+|||||||++||++| |..||...++.+ .+ .....
T Consensus 850 rDiy~~~yyr~~~--~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~----v~----~~~~~ 919 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHG--EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE----VL----LDVLE 919 (1025)
T ss_pred HhhhhchheeccC--ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH----HH----HHHHh
Confidence 9544333221110 1123468999999999999999999999999999999 999987654321 11 11111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
.+ +-+.+..++..+.+|+..||+.+|++||++..+++++..+.....
T Consensus 920 gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 920 GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 22 122345677788899999999999999999999999999877543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.07 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=199.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 377 (618)
..++|...++||+|.||.|+++.. .+++.+|||++++.. ...+....|-.++... +||.++.++..|...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 456799999999999999999995 468899999998854 4456677888887776 5999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+.||++..+.+.. .+++..+.-++..|+.||.|||++ +||+||||.+|||+|.+|++||+|||+++.
T Consensus 446 fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccc
Confidence 999999999976666543 399999999999999999999999 999999999999999999999999999997
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
-...+... .+.+||+.|+|||++.+..|+.++|.|||||+||||+.|..||...++++....++ .++
T Consensus 518 ~m~~g~~T----sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~--------~d~- 584 (694)
T KOG0694|consen 518 GMGQGDRT----STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV--------NDE- 584 (694)
T ss_pred cCCCCCcc----ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--------cCC-
Confidence 54333322 23469999999999999999999999999999999999999999766543322111 110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
- .++.....+.+.++.+++..+|++|--+
T Consensus 585 -------~---~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 -------V---RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------C---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 0 1122334566777779999999999765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=346.95 Aligned_cols=261 Identities=23% Similarity=0.343 Sum_probs=202.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 375 (618)
.++|++.+.||+|+||.||+|+. .++..||+|+++... ...+.+.+|+++++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 45788999999999999999873 234589999997543 2345688999999999 89999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCC----------------------------------------------------------
Q 007088 376 RLLVYSYLENGTLYDKLHPAEH---------------------------------------------------------- 397 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 397 (618)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999988753210
Q ss_pred --------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccc
Q 007088 398 --------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV 469 (618)
Q Consensus 398 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 469 (618)
...++++..+++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........ ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~ 271 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVK 271 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--eec
Confidence 113578899999999999999999999 9999999999999999999999999999865432211 111
Q ss_pred cCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 470 NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 470 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... . ...... .. ...
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----~---~~~~~~-~~---------~~~ 334 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----K---FYKMVK-RG---------YQM 334 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----H---HHHHHH-cc---------cCc
Confidence 11224668999999988899999999999999999997 999997533211 1 111111 00 000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
........++.+++.+||+.||++||++.++++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 001112346777888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=308.81 Aligned_cols=248 Identities=24% Similarity=0.336 Sum_probs=205.5
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|-||.||.|+ .+++-.||+|++.+++ ....++.+|+++-+.++||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3568889999999999999999 5678899999997754 4457899999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
+||.+.|++...|..... ..+++.....+..|+|.||.|+|.. +|+||||||+|+|++..+..|++|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999985554 4588899999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
. .... ..+||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+. .... .
T Consensus 176 ~--~kR~----tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk--------rI~k----~ 237 (281)
T KOG0580|consen 176 S--NKRK----TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK--------RIRK----V 237 (281)
T ss_pred C--CCce----eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH--------HHHH----c
Confidence 2 2222 2359999999999999999999999999999999999999998654322211 1110 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
+..+ ++.......+++.+|+..+|.+|.+..|+++.
T Consensus 238 ~~~~-------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLKF-------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccC-------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111 12233455667779999999999999998763
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.48 Aligned_cols=266 Identities=20% Similarity=0.209 Sum_probs=199.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|+||.||+++.. +++.||+|+++... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999964 68899999997542 334568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++++.+..+.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987776554322 3489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-------cCHHHHHHHHhc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK-------GSLVEWITLLNT 534 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~-------~~l~~~~~~~~~ 534 (618)
.... .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+... .....+......
T Consensus 154 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 154 SNAN---YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred cccc---ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 2111 112347899999999988889999999999999999999999997643211000 000011111111
Q ss_pred CCccchhccccccC------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLG------NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.........+.... .........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110000000000 001112346788888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=341.35 Aligned_cols=240 Identities=20% Similarity=0.242 Sum_probs=192.9
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 578999999997532 23346778999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 151 (323)
T cd05571 81 ELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc--
Confidence 9999887543 489999999999999999999999 9999999999999999999999999998754322211
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 546 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .......... ..+
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--------~~~~~~~~~~-------~~~ 214 (323)
T cd05571 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEE-------IRF 214 (323)
T ss_pred --ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--------HHHHHHHcCC-------CCC
Confidence 11234899999999999999999999999999999999999999753211 1111111110 001
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 547 LGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
+......+.+++.+||+.||++|| ++.++++
T Consensus 215 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111234566777799999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=328.55 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=209.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc-CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH-SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
...+|+..++||+|+||.||+|...++..+++|.+..... ...++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 4567888999999999999999988899999999976543 466789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999976543 4589999999999999999999999 99999999999999999999999999998764322
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
... ....++..|+|||...+..++.++||||||+++|+|++ |+.||...... +.........
T Consensus 159 ~~~----~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~----- 221 (261)
T cd05148 159 YLS----SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGY----- 221 (261)
T ss_pred ccc----cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCC-----
Confidence 111 12235778999999988889999999999999999998 89998653311 1111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
...........+.+++.+|++.||++|||++++++.|+.+
T Consensus 222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 -----RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0011122345677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.44 Aligned_cols=243 Identities=19% Similarity=0.236 Sum_probs=197.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999954 68999999986432 23456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 9999999999987543 489999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. ....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +......... .
T Consensus 154 ~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~-~-- 215 (291)
T cd05612 154 RT-------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF--------GIYEKILAGK-L-- 215 (291)
T ss_pred Cc-------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-c--
Confidence 21 1234899999999999888999999999999999999999999754321 1111111110 0
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
.+ .......+.+++.+||+.||.+||+ ++|+++
T Consensus 216 ----~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 ----EF----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ----CC----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 00 1111235667777999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.87 Aligned_cols=252 Identities=19% Similarity=0.239 Sum_probs=200.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|+.. +++.||+|+++... ...+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999964 58999999997532 23456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 9999999999996543 488999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......... .
T Consensus 154 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~---~ 215 (333)
T cd05600 154 -------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWK---E 215 (333)
T ss_pred -------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhcc---c
Confidence 1123348999999999999999999999999999999999999997543211 111110000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+..............++.+++.+||..+|.+||+++|+++.
T Consensus 216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000001223456677779999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=340.22 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=202.8
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcccc
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 390 (618)
.+-||+|+.|.||+|++. ++.||||+++.-+ ..+++-|++|+||||+.+.|+|....-+|||||||+.|-|.+
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 578999999999999984 5678999875432 257888999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccccc
Q 007088 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470 (618)
Q Consensus 391 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 470 (618)
.|+..+ ++.......|..+||.|+.|||.+ .|||||||.-||||..+..+||+|||.++......+ ..
T Consensus 202 VLka~~----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST-----kM 269 (904)
T KOG4721|consen 202 VLKAGR----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST-----KM 269 (904)
T ss_pred HHhccC----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhh-----hh
Confidence 998765 488888999999999999999999 999999999999999999999999999988765422 22
Q ss_pred CCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCC
Q 007088 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNG 550 (618)
Q Consensus 471 ~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 550 (618)
..+||..|||||++...+.++|+|||||||+||||+||..||.+.+......+ +-...+.-..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG-----------------VGsNsL~Lpv 332 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG-----------------VGSNSLHLPV 332 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe-----------------ccCCcccccC
Confidence 34599999999999999999999999999999999999999986543222111 0111122233
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 551 FDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
++.+++.|.-|+++||+..|..||++++++..|+-...+
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 455667788888899999999999999999998865544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.12 Aligned_cols=264 Identities=19% Similarity=0.258 Sum_probs=196.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.++||+|+||.||+|.. .++..||+|+++... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5688899999999999999995 468999999986532 3345678999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 8988886543 3478999999999999999999999 99999999999999999999999999997654322
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH--------HHHHHHHh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL--------VEWITLLN 533 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l--------~~~~~~~~ 533 (618)
.. .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||......+...... ..|.. ..
T Consensus 158 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 232 (288)
T cd07871 158 KT----YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG-IT 232 (288)
T ss_pred cc----ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc-cc
Confidence 11 122347899999998765 568999999999999999999999997643221110000 00000 00
Q ss_pred cCCccchhccccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........+...... ......+..+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000011111100000 0011235667888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=323.90 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=204.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|++.++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 468889999999999999999888889999999876666778999999999999999999999875 4568999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
++|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||.+..........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999875432 4589999999999999999999999 99999999999999999999999999998764322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....++..|+|||+..+..++.++||||||+++|||++ |..||..... .+.........
T Consensus 160 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~-------- 220 (260)
T cd05070 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGY-------- 220 (260)
T ss_pred ---ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC--------
Confidence 112225668999999988889999999999999999999 8889865321 11111111110
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
...........+.+++.+|++.+|++|||+.++.+.|++
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 --RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112234567888889999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=325.14 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=204.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|...+.||+|+||.||+|...++..+|+|.++......+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 45778899999999999999987777899999887666677899999999999999999999999988889999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.........
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999986543 2589999999999999999999999 99999999999999999999999999988654322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....++..|+|||+..+..++.++||||||+++|||++ |+.||...... ............
T Consensus 158 ---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~------ 220 (256)
T cd05113 158 ---SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRL------ 220 (256)
T ss_pred ---cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCC------
Confidence 112235678999999988889999999999999999998 99998653321 111111111100
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.........+.+++.+||+.||.+||++.++++.|+
T Consensus 221 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 ----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001112356778888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=337.28 Aligned_cols=243 Identities=21% Similarity=0.265 Sum_probs=196.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4688899999999999999995 468999999986532 23456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 9999999999987543 488999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
... ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ ..
T Consensus 171 ~~~-------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~-~~-- 232 (329)
T PTZ00263 171 RTF-------TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAG-RL-- 232 (329)
T ss_pred Ccc-------eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcC-Cc--
Confidence 221 124899999999999999999999999999999999999999753221 111111111 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
.+ .... ...+.+++.+||+.||.+||+ ++++++
T Consensus 233 ----~~-p~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 ----KF-PNWF---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ----CC-CCCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 0111 234567777999999999997 577653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=323.01 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=205.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|++.++||+|+||.||+|+..++..||+|.++......+++.+|++++++++|+||+++++++.+ +..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 35688999999999999999998777789999998766667789999999999999999999998754 56799999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999975432 3579999999999999999999999 9999999999999999999999999999866433221
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. .....++..|+|||+..+..++.++||||||+++|||++ |..||...... +..........
T Consensus 159 ~---~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~------ 221 (262)
T cd05071 159 A---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYR------ 221 (262)
T ss_pred c---ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCC------
Confidence 1 112235678999999988889999999999999999999 88888653221 11111111000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
.....+....+.+++.+|++.||++||++.++++.|++.
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011123445678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=341.98 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=208.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC--CC--cE-EEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP--GG--CF-IMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~--~~--~~-vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
++-...++||+|+||.||+|++. ++ .. ||||..+.+ ....++|.+|.++|++++|||||++||++......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34444589999999999999953 33 23 899998752 34567899999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++|||+|.||+|.++|..... .++..++..++.+.|.||+|||++ +++||||-++|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999987763 599999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.-......... .--+..|+|||.+....++.++|||||||++||+++ |..||...... .+..++. ..
T Consensus 311 ~~~~~~~~~~~----~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~---~~ 378 (474)
T KOG0194|consen 311 AGSQYVMKKFL----KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIV---KN 378 (474)
T ss_pred CCcceeecccc----ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHH---hc
Confidence 65421111100 013578999999999999999999999999999999 89898764421 1222221 11
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
......+...+..+..++.+|+..||++||+|.++.+.|+.+......
T Consensus 379 ---------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 379 ---------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ---------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 111112223455666777799999999999999999999999876554
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.20 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=209.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-eEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE-RLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 380 (618)
++|...+.+|+|+||.++..+. .+++.|++|.+.-.. ...+...+|+.++++++|||||.+.+.|..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788899999999999999984 467899999886433 334467899999999999999999999999988 89999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
+|++||++.+.+...++ ..++++.+..++.|++.|+.|||+. +|+|||||+.|||++.+..+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999987763 6799999999999999999999998 999999999999999999999999999999887
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
..... ....||+.|++||++.+.+|..|+||||+||++|||++-+++|...+-. .-+....
T Consensus 159 ~~~~a----~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--------~Li~ki~------- 219 (426)
T KOG0589|consen 159 EDSLA----STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--------ELILKIN------- 219 (426)
T ss_pred chhhh----heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--------HHHHHHh-------
Confidence 55322 2345999999999999999999999999999999999999999864421 1111111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
+......+..+..++..++..|++.+|..||++.+++..
T Consensus 220 ---~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 ---RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 111122234455677777779999999999999999987
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.36 Aligned_cols=199 Identities=23% Similarity=0.362 Sum_probs=174.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.+.||+|+||.||++... ++..||+|.+.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999954 68899999987532 334678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999987543 4889999999999999999999852 5999999999999999999999999998765432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
.. ....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 MA------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cc------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1234889999999999989999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=328.09 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=204.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC------CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|++.+.||+|+||.||+|...+ ...|++|.++... ....++.+|+.++.+++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998533 2679999986543 23456899999999999999999999999988999
Q ss_pred EEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC
Q 007088 378 LVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 445 (618)
++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999998865321 114588999999999999999999999 999999999999999999
Q ss_pred ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccC
Q 007088 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGS 524 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~ 524 (618)
.++|+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-----~ 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYR--VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-----E 234 (283)
T ss_pred cEEECCCcceeecccccccc--ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-----H
Confidence 99999999998654322111 1122336788999999988899999999999999999998 99998754321 1
Q ss_pred HHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 525 LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 525 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
+... .. ... ...........+.+++.+||+.||.+||+++||++.|+++
T Consensus 235 ~~~~---i~-~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEM---IR-SRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHH---HH-cCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111 11 111 0111223446778888899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.42 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=202.5
Q ss_pred cCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
+|++.+.||+|+||.||++...++..+|+|.+........++.+|++++++++||||+++++++...+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 47788999999999999999877889999998776666678899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||.++.........
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~- 157 (256)
T cd05059 85 CLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS- 157 (256)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc-
Confidence 9999987543 2589999999999999999999999 99999999999999999999999999997654322111
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....++..|+|||...+..++.++||||||+++||+++ |+.||......+ ... ...... ..
T Consensus 158 --~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~---~~~~~~------~~- 220 (256)
T cd05059 158 --SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-----VVE---SVSAGY------RL- 220 (256)
T ss_pred --cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-----HHH---HHHcCC------cC-
Confidence 111124467999999998899999999999999999999 899986532211 111 111100 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
.........+.+++.+|+..+|++|||+.|+++.|
T Consensus 221 ---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 ---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01112345677888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.07 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=210.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCC-cEEEEEEecc-CccCHHHHHHHHHHHhcCC-CCCccceeEE-EEeC------C
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGG-CFIMIKRLED-SQHSEKEFLSEINTLGSVR-HRNLVPLLGF-CVAK------K 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~------~ 374 (618)
..++++.+.|.+|||+.||.|....+ ..||+|++-. ++...+.+.+|+++|++|+ |+|||.+++. .... -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 34567789999999999999997665 9999998843 4556677899999999996 9999999993 3221 2
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
+.+|.||||+||.|-+++..+.. ..|++.++++|+.|+++|+++||.. .|+|||||||-+||||+.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 67899999999999999986654 3499999999999999999999986 67799999999999999999999999999
Q ss_pred ccccCCCCCc-c-c---ccccCCCCcccccCCCCC---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH
Q 007088 455 ARLMNPVDTH-L-S---TFVNGEFGDLGYVAPEYP---RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 455 a~~~~~~~~~-~-~---~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~ 526 (618)
|...-..... . . ........|+.|+|||++ .+...++|+|||||||+||-|+....||+.....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 8653222110 0 0 001123468999999975 5778999999999999999999999999865332
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
.+++........+.+...+.+||..||+.||.+||++-+|+..+.+++.+..
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 1222222223345677888899999999999999999999999999877533
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=332.35 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=195.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.+.||+|+||.||+|... +++.||+|+++... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999954 78999999987533 233467889999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 57877776543 3488899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC---c
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS---S 537 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~---~ 537 (618)
... .....+++.|+|||++.+ ..++.++||||+||++|||++|+.||....... ..+........... +
T Consensus 157 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 157 SHT----YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ---DQLERIFLVLGTPNEDTW 229 (303)
T ss_pred Ccc----CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHhCCCChhhc
Confidence 211 122347899999998765 457889999999999999999999997543210 01111100000000 0
Q ss_pred -----cchhcccccc---CCCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 -----LETAIDKSLL---GNGFD------GELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 -----~~~~~d~~l~---~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......... ..... .....+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000 00000 01235667888999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.76 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=199.2
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-----eEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE-----RLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lV~ 380 (618)
.|...+++|+|+||.||+|+. .++..||||+.-.+.... .+|+++|++++|||||+++-+|..... ..+||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 466688999999999999994 557999999886544321 379999999999999999988865432 24999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCcccccC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMN 459 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~ 459 (618)
||+|. +|.+.++........++...++-+..||++||+|||+. +|+||||||.|+|+|.+ |.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99987 99999885433335688888899999999999999998 99999999999999976 899999999999887
Q ss_pred CCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC---
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN--- 535 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~--- 535 (618)
......... .|..|+|||.+.+ ..|+.+.||||.||++.||+-|++.|.+.+.. ..++...+.+-..
T Consensus 178 ~~epniSYi-----cSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~----dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 178 KGEPNISYI-----CSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV----DQLVEIIKVLGTPTRE 248 (364)
T ss_pred cCCCceeEE-----EeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH----HHHHHHHHHhCCCCHH
Confidence 655543332 5789999998776 57999999999999999999999999875432 2233322221110
Q ss_pred ------CccchhccccccCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhh
Q 007088 536 ------SSLETAIDKSLLGN-----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ--LLRAIA 587 (618)
Q Consensus 536 ------~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 587 (618)
....+...+.+... .......+.++++.++++.+|.+|.++.|++. ..+++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 00011111222111 12234567788888999999999999999873 344443
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=322.61 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=206.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|++.++||+|+||.||+|...+++.||+|.+........++.+|+.++++++|+||+++++++. .+..++||||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 3568889999999999999999888999999999877767788999999999999999999999874 456899999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999865433 4689999999999999999999999 9999999999999999999999999999766532211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... +..........
T Consensus 159 ~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~------ 221 (260)
T cd05067 159 A---REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--------EVIQNLERGYR------ 221 (260)
T ss_pred c---ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--------HHHHHHHcCCC------
Confidence 1 112235678999999988889999999999999999999 99999754321 11111111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
..........+.+++.+|+..+|++||+++++.+.|+.
T Consensus 222 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ----MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 00111223467788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=336.36 Aligned_cols=240 Identities=20% Similarity=0.244 Sum_probs=192.0
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
+.||+|+||.||++.. .+|..||+|+++... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 578999999997532 23445778999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-- 151 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 151 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--
Confidence 9998886543 489999999999999999999999 9999999999999999999999999998753222111
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 546 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .......... ..+
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~~~-------~~~ 214 (323)
T cd05595 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEE-------IRF 214 (323)
T ss_pred --cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCC-------CCC
Confidence 12234899999999999999999999999999999999999999754321 1111111100 001
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 547 LGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
. ......+.+++.+||+.||++|| ++.++++
T Consensus 215 p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 P----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred C----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1 11223556777799999999998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=317.40 Aligned_cols=282 Identities=23% Similarity=0.288 Sum_probs=209.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEecc---CccCHHHHHHHHHHHhcCCCCCccceeEEEEe-----CC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLED---SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA-----KK 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 374 (618)
....|...+.||+|+||.|+.+. ..+|+.||||++.. .....++..+|+++|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34566667899999999999999 56789999999973 33456778999999999999999999999865 24
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..|+|+|+|+. +|.+.++.+. .++...+..++.|+++||+|+|+. +|+||||||+|++++.+..+||+|||+
T Consensus 100 DvYiV~elMet-DL~~iik~~~----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQ----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCc----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 68999999955 9999998764 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCC-CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH------HH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYP-RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL------VE 527 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l------~~ 527 (618)
|+..... .......+.+.|..|+|||+. ....|+.+.||||.|||+.||++|++.|.+.+.......++ .+
T Consensus 172 AR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 172 ARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred eeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9987653 223334456689999999975 46789999999999999999999999998765422111000 00
Q ss_pred HHHHHhcCCccchhccc--cccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCc
Q 007088 528 WITLLNTNSSLETAIDK--SLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDE 597 (618)
Q Consensus 528 ~~~~~~~~~~~~~~~d~--~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 597 (618)
..-...........+.. ...... ........++|+.+||..||.+|+|++|+++. --.+.++..++++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h--PYl~~~hdp~dEP 323 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH--PYLAPYHDPEDEP 323 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC--hhhhhhcCCccCC
Confidence 00000000001111100 000000 11223456677779999999999999999762 3445556555555
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=321.80 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=204.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|+..+.||+|+||.||+|... +...|++|.++... ....++.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999863 24689999987543 3345788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999987643 3589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
........ ....++..|+|||...+..++.++||||||+++|||++ |..||...... ..... .......
T Consensus 158 ~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~---~~~~~~~ 227 (266)
T cd05033 158 DSEATYTT--KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-----DVIKA---VEDGYRL 227 (266)
T ss_pred ccccceec--cCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-----HHHHH---HHcCCCC
Confidence 22221111 12235678999999998899999999999999999998 99998643211 11111 1111000
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
.........+.+++.+|++.+|++||+++|+++.|+++
T Consensus 228 ----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345677888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=339.37 Aligned_cols=261 Identities=20% Similarity=0.220 Sum_probs=196.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.++|++.+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++......++|+|++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 35799999999999999999994 5689999997532 35678999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
. ++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 68888876543 488999999999999999999999 999999999999999999999999999975432211
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc---cCHHHHHHHHhcC---C-
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK---GSLVEWITLLNTN---S- 536 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~---~~l~~~~~~~~~~---~- 536 (618)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ..+.......... .
T Consensus 238 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 N---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred c---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 1123458999999999999999999999999999999999998876433211100 0011110000000 0
Q ss_pred -----ccchhc---------cccccC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 -----SLETAI---------DKSLLG--NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 -----~~~~~~---------d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...... .+.... ........++.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 000000 001123456788899999999999999999975
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=322.94 Aligned_cols=260 Identities=18% Similarity=0.271 Sum_probs=207.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|+. .+++.||+|.++.. ......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999994 57899999987542 223456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.........+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988864333334588999999999999999999999 999999999999999999999999999887643
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+........
T Consensus 159 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~---- 224 (267)
T cd08228 159 KTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCD---- 224 (267)
T ss_pred hhHH----HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCC----
Confidence 2211 1123478899999999888899999999999999999999999865321 1112222211111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
.+. .........+.+++.+||+.+|++||++.||++.++++.
T Consensus 225 --~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 000 111233456778888999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=337.28 Aligned_cols=237 Identities=24% Similarity=0.254 Sum_probs=189.6
Q ss_pred EeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 314 IGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 314 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
||+|+||.||++.. .+++.||+|+++.. ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999995 46889999998643 23345678899999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~---- 149 (312)
T cd05585 81 FHHLQREG----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---- 149 (312)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc----
Confidence 99987543 489999999999999999999999 9999999999999999999999999999754322211
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .+
T Consensus 150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~~-------~~-- 212 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEPL-------RF-- 212 (312)
T ss_pred cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCC-------CC--
Confidence 1223489999999999999999999999999999999999999975321 122222111100 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHT---MFEVY 580 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 580 (618)
.......+.+++.+||+.||++||+ +.|++
T Consensus 213 --~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 213 --PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred --CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 1112245667777999999999985 55554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=336.65 Aligned_cols=245 Identities=22% Similarity=0.398 Sum_probs=190.2
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+|+..++||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 455678999999999999995 468999999986533 23467889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999986532 256677889999999999999999 999999999999999999999999999987643221
Q ss_pred cccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
. .....||..|+|||++.. ...+.++|||||||++|||++|+.||...... .............
T Consensus 224 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~-- 292 (353)
T PLN00034 224 P----CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-----DWASLMCAICMSQ-- 292 (353)
T ss_pred c----ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhccC--
Confidence 1 122348999999998743 23456899999999999999999999743211 1111111110000
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........++.+++.+||+.||++||++.|+++
T Consensus 293 --------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 --------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011123346777888999999999999999986
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=331.34 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=203.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCc----EEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGC----FIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.+|+..+.||+|+||.||+|++ .++. .||+|.++... ...+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4688899999999999999984 3333 48999986532 3456788999999999999999999999764 5679
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999987654 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~ 229 (316)
T cd05108 160 GADEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGER 229 (316)
T ss_pred cCCCccee--ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence 54322211 112224678999999999999999999999999999998 9999865321 111111111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
. .........+.+++.+||+.||.+||++.+++..+..+..+.
T Consensus 230 ~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 L----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 001112345778888999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.09 Aligned_cols=241 Identities=20% Similarity=0.257 Sum_probs=193.2
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
+.||+|+||.||++.. .+++.||+|++.... .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999994 568999999997532 23456788999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 151 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-- 151 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc--
Confidence 9998886543 489999999999999999999999 9999999999999999999999999998754322111
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 546 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +......... ..+
T Consensus 152 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~~~-------~~~ 214 (328)
T cd05593 152 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMED-------IKF 214 (328)
T ss_pred --cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhccCC-------ccC
Confidence 12234899999999999889999999999999999999999999753321 1111111100 001
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007088 547 LGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQL 582 (618)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 582 (618)
+.....++.+++.+||+.||++|| ++.|+++.
T Consensus 215 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 ----PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111223566777799999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.34 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=192.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe--CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcC---CCCCccceeEEEEe-----
Q 007088 306 NSFSKNNIIGTGRTGATYIAML--PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSV---RHRNLVPLLGFCVA----- 372 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 372 (618)
++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999985 347889999986432 2234566777777665 69999999999853
Q ss_pred CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 373 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
....++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 346789999996 589988865433 3589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
|+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|++||......+. +.......
T Consensus 155 g~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~----~~~i~~~~ 225 (290)
T cd07862 155 GLARIYSFQMA-----LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ----LGKILDVI 225 (290)
T ss_pred cceEeccCCcc-----cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH----HHHHHHHh
Confidence 99986543211 1223488999999999888899999999999999999999999986443211 11111100
Q ss_pred h---cCCcc------chhcccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 N---TNSSL------ETAIDKSLL---GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~---~~~~~------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ...+. .....+... ..........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 00000 000000000 0000112345667888999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.14 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=203.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|.+.+.||+|+||.||+|... ++..||+|.++.... ..+.+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 46788899999999999999853 347899999976443 3567999999999999999999999999999999
Q ss_pred EEEeecCCCccccccCCCCC----------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 378 LVYSYLENGTLYDKLHPAEH----------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
+||||+++|+|.+++..... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999865421 224588999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 162 kl~d~g~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------- 231 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------- 231 (280)
T ss_pred EECCcccceecccCccee--cCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence 999999997653322110 1112225678999999999999999999999999999998 99998654321
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
+...... ..... .........+.+++.+||+.||++||++.||++.|+
T Consensus 232 ~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECIT-QGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHH-cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 11100 011123356778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=325.53 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=201.9
Q ss_pred cC-CCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--Cee
Q 007088 307 SF-SKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KER 376 (618)
Q Consensus 307 ~y-~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 376 (618)
+| ...+.||+|+||.||++.. .++..||+|.++... ...+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7889999999999988652 457899999997543 2456788999999999999999999988664 357
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 8999999999999998643 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
........... .....++..|+|||...+..++.++||||||+++|||++|..|+....... . ....+........
T Consensus 156 ~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~-~~~~~~~~~~~~~ 231 (283)
T cd05080 156 AVPEGHEYYRV-REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--E-EMIGPKQGQMTVV 231 (283)
T ss_pred ccCCcchhhcc-CCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--h-hhhcccccccchh
Confidence 76532211100 111225667999999988889999999999999999999999986533210 0 0000000000000
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
...+.++..............+.+++.+|++.||++|||++++++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111111111112223457788888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=326.10 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=206.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|.+.+.||+|+||.||++.. .++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688889999999999999984 234678999987543 345678999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCC---------CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 379 VYSYLENGTLYDKLHPAE---------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
||||+++++|.+++.... .....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999886432 1223589999999999999999999999 9999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~ 528 (618)
+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... +.
T Consensus 162 ~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------~~ 231 (288)
T cd05093 162 GDFGMSRDVYSTDYYR--VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------EV 231 (288)
T ss_pred ccCCccccccCCceee--cCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HH
Confidence 9999998654322111 1112225678999999998899999999999999999998 89998654321 11
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
....... .... . .......+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 232 ~~~i~~~-~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQG-RVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcC-CcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111 1000 0 111234578888899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.52 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=203.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|.+.+.||+|++|.||++...++..+|+|++.......+.+.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 468888999999999999999877778999998776666678899999999999999999999875 4567899999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+..........
T Consensus 85 ~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 85 GSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999975432 4589999999999999999999999 99999999999999999999999999997654322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....++..|+|||...+..++.++||||||+++|||++ |+.||...... ....+ ......
T Consensus 160 ---~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~---~~~~~~------- 221 (260)
T cd05069 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-----EVLEQ---VERGYR------- 221 (260)
T ss_pred ---cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH---HHcCCC-------
Confidence 112235678999999988889999999999999999999 89998753221 11111 111100
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
..........+.+++.+||..||++||+++++++.|++
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 ---MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01112234567788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=319.99 Aligned_cols=245 Identities=20% Similarity=0.334 Sum_probs=204.3
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.+|++.+.||+|.||.|-+|+ ...|+.||||.++++. .+.-.+++|+++|+.++||||+.++++|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 467788899999999999999 5789999999998754 23345789999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||..+|.|.+|+...+. +++.+..++++||..|+.|+|.+ +++|||||.+|||+|.++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999987764 99999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.. +....+|++-|.+||+..+.+| ++.+|-||+||+||.|+.|..||+..+. ...+++.. .+...
T Consensus 206 ~k-----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs-~GaYr 271 (668)
T KOG0611|consen 206 KK-----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQIS-RGAYR 271 (668)
T ss_pred cc-----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhh-ccccc
Confidence 32 2334569999999999999988 4789999999999999999999986432 22222222 11111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
+ .+.+....-||++||..+|++|-|+.+|...
T Consensus 272 E-----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 E-----------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred C-----------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1 1122334556779999999999999998754
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=340.12 Aligned_cols=262 Identities=20% Similarity=0.320 Sum_probs=204.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 375 (618)
.++|.+.++||+|+||.||+|+.. .+..||||+++... ...+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567888999999999999999842 23579999997543 23456899999999996 9999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCC----------------------------------------------------------
Q 007088 376 RLLVYSYLENGTLYDKLHPAEH---------------------------------------------------------- 397 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 397 (618)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988754311
Q ss_pred ----------------------------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC
Q 007088 398 ----------------------------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG 443 (618)
Q Consensus 398 ----------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 443 (618)
....+++..+..++.|+++||+|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012478889999999999999999999 9999999999999999
Q ss_pred CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccc
Q 007088 444 DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFK 522 (618)
Q Consensus 444 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~ 522 (618)
++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYV--SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--- 347 (400)
T ss_pred CCEEEEEeCCcceecccccccc--ccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---
Confidence 9999999999998654322211 1122336788999999988899999999999999999997 999986532110
Q ss_pred cCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 523 GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 523 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
.+... .. .. ............+.+++.+||+.||++||++.+|.+.|+++.+
T Consensus 348 -~~~~~---~~-~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 -TFYNK---IK-SG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHHHH---Hh-cC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111 11 10 0001112234567888889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.83 Aligned_cols=261 Identities=22% Similarity=0.395 Sum_probs=206.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|...+.||+|+||.||++... ++..+++|.+.... ...+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999842 35678999987644 334678999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc
Q 007088 379 VYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 446 (618)
||||+++++|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999865321 123489999999999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCH
Q 007088 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSL 525 (618)
Q Consensus 447 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l 525 (618)
++|+|||++......... .......++..|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 162 ~~l~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 232 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYY--RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------- 232 (291)
T ss_pred EEECCCCcccccCCCcee--ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 999999999765432211 11112236788999999998999999999999999999999 99998654321
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
+...... ..... ......+..+.+++.+||+.||++||++++|++.|+++.+.
T Consensus 233 -~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 -EVIECIT-QGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHHh-CCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111 11111 01112345677888899999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=333.13 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=202.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC-Ce
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK-KE 375 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 375 (618)
++|++.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47888999999999999999732 34789999987543 2235677899999999 899999999988654 46
Q ss_pred eEEEEeecCCCccccccCCCCCC---------------------------------------------------------
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHE--------------------------------------------------------- 398 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 398 (618)
.+++|||+++|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999887542210
Q ss_pred CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccc
Q 007088 399 VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478 (618)
Q Consensus 399 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y 478 (618)
..++++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++.+........ .....++..|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~--~~~~~~~~~y 241 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDARLPLKW 241 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhh--ccCCCCCccc
Confidence 12689999999999999999999999 999999999999999999999999999987643221111 1122356789
Q ss_pred cCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHH
Q 007088 479 VAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQ 557 (618)
Q Consensus 479 ~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 557 (618)
+|||++.+..++.++|||||||++|||++ |..||......+ .+.. .. ..... ..........
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~~---~~-~~~~~---------~~~~~~~~~~ 304 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCR---RL-KEGTR---------MRAPEYATPE 304 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHHH---HH-hccCC---------CCCCccCCHH
Confidence 99999999999999999999999999998 999987532211 1111 11 11000 0001123356
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 558 FLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 558 l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
+.+++.+||+.+|++||++.|+++.|+++.+
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7888889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.13 Aligned_cols=199 Identities=22% Similarity=0.365 Sum_probs=173.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.++||+|+||.||++... ++..+|+|.+.... .....+.+|++++++++|+||+++++++.++++.++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999964 68899999886532 234568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999986543 4889999999999999999999742 6999999999999999999999999998765332
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
.. ....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MA------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cc------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 11 1234789999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.76 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=208.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..+.||+|++|.||+|... +|+.|++|.++.. ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999965 7899999988632 223567899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998865433335689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
..... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+........ ..
T Consensus 159 ~~~~~----~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~-- 225 (267)
T cd08224 159 KTTAA----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKC-DY-- 225 (267)
T ss_pred CCccc----ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcC-CC--
Confidence 22111 122378899999999888899999999999999999999999864321 122221111110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
+... .......+.+++.+||..+|++||++.+|++.|+++.
T Consensus 226 ---~~~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 ---PPLP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CCCC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0000 1133456778888999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.11 Aligned_cols=248 Identities=17% Similarity=0.232 Sum_probs=192.5
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||++.. .+++.||+|+++... ...+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999995 468999999997532 2334578899999888 799999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 g~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~- 152 (329)
T cd05588 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT- 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCc-
Confidence 99998886543 489999999999999999999999 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......++.......... .
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 223 (329)
T cd05588 153 ---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------R 223 (329)
T ss_pred ---cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------C
Confidence 1223489999999999999999999999999999999999999975332221111222222221111110 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHT------MFEVY 580 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl 580 (618)
+ +......+.+++.+||+.||.+||+ +++++
T Consensus 224 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 I----PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 1 1112235667777999999999998 56664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=332.81 Aligned_cols=243 Identities=20% Similarity=0.242 Sum_probs=195.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC--CcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG--GCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.+.||+|+||.||+|...+ +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998533 3689999986432 3345688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999987553 489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .
T Consensus 183 ~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~-~- 245 (340)
T PTZ00426 183 TRT-------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGI-I- 245 (340)
T ss_pred CCc-------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCC-C-
Confidence 321 1234899999999999888999999999999999999999999754321 0011111110 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
.+ ....+ ..+.+++.+|++.||++|+ +++|+++
T Consensus 246 -----~~-p~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 -----YF-PKFLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -----CC-CCCCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 00 11122 3455677799999999995 7888764
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=324.00 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=202.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
.+++|+..+.||+|+||.||+|... .+..||+|.+.... ....++.+|+.++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999743 35689999986532 234568899999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCC------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHE------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653221 23468889999999999999999999 9999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~ 528 (618)
+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 161 ~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~ 230 (277)
T cd05062 161 GDFGMTRDIYETDYYRK--GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQV 230 (277)
T ss_pred CCCCCccccCCcceeec--CCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 99999876543222111 111235778999999998889999999999999999999 7888865322 111
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
........ ... ........+.+++.+|++.||++|||+.|+++.|++
T Consensus 231 ~~~~~~~~-~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRFVMEGG-LLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHcCC-cCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111111 000 011223467788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.97 Aligned_cols=244 Identities=18% Similarity=0.229 Sum_probs=189.4
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||++.. .+++.||+|+++... ...+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 468899999997532 2334577888888776 899999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~- 152 (329)
T cd05618 81 GDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT- 152 (329)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc-
Confidence 99998886543 489999999999999999999999 9999999999999999999999999998753322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...............+.......... .
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 223 (329)
T cd05618 153 ---TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 223 (329)
T ss_pred ---cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C
Confidence 1123489999999999999999999999999999999999999964332221111222222221111110 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
.+......+.+++.+||+.||++||++
T Consensus 224 ----~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 ----IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111223456677779999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.10 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=207.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|.+.+.||+|+||.||+|..+++..|++|.+.......+++.+|+.++++++|+||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 46788899999999999999998888899999998776777889999999999999999999999998889999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... ..+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||.+.........
T Consensus 85 ~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 85 KGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999976543 4589999999999999999999999 9999999999999999999999999999876532111
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.......+..|+|||.+.+..++.++||||||+++||+++ |+.||...... ...........
T Consensus 160 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~------ 222 (261)
T cd05034 160 ---AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--------EVLEQVERGYR------ 222 (261)
T ss_pred ---hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC------
Confidence 1111224568999999998889999999999999999998 99998643211 11111111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
..........+.+++.+|++.+|++||+++++.+.|+.
T Consensus 223 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ----MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011124467788889999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=326.30 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=205.7
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
..++|+..+.||+|+||.||++... +...+|+|.+.... ....++.+|++++.++ +|+||+++++++...+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888999999999999999853 34689999987543 2335688999999999 8999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCC------------CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAE------------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
..+++|||+++|+|.+++.... .....+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 9999999999999999986432 1235689999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~ 521 (618)
+++.+||+|||+++........... ....++..|+|||...+..++.++|||||||++||+++ |..||......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--- 241 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKT--TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--- 241 (293)
T ss_pred CCCeEEeCccccccccccccceecc--CCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---
Confidence 9999999999999876543221111 11224678999999988899999999999999999997 99998643221
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
+......... ...........+.+++.+|++.||++|||+.|+++.|+++.
T Consensus 242 -----~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 -----ELFKLLKEGY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----HHHHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111110 00111223456778888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=317.73 Aligned_cols=247 Identities=21% Similarity=0.291 Sum_probs=195.1
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
+.||+|+||.||+|+. .+++.||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999995 578999999886432 3346789999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~ 152 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--ST 152 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccc--cc
Confidence 99986543 3588999999999999999999999 9999999999999999999999999998765432111 00
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccccc
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLL 547 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 547 (618)
......+..|+|||.+.+..++.++||||||+++|||++ |..||...... ......... ..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~----------~~ 214 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQG----------VR 214 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcC----------CC
Confidence 011123457999999998889999999999999999998 88888643211 111111110 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 548 GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
..........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1111223456778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.14 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=203.2
Q ss_pred cCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
+|+..+.||+|+||.||+|... +...+++|.+.... ...+++.+|+.++++++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999842 23678999886543 234578899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCC--------------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 007088 379 VYSYLENGTLYDKLHPAEH--------------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 438 (618)
|+||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999998754211 124588999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 007088 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNA 517 (618)
Q Consensus 439 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~ 517 (618)
|++++++.+||+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVK--RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhc--ccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999986543222111 111235678999999888889999999999999999998 9999864321
Q ss_pred CCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 518 PESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.+........ ............+.+++.+|++.+|++||+++|+++.|+++..+
T Consensus 236 --------~~~~~~~~~~----------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 --------ERLFNLLKTG----------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --------HHHHHHHhCC----------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111111110 00011122334677888899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=320.31 Aligned_cols=259 Identities=20% Similarity=0.305 Sum_probs=206.5
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|++|.||++. ..++..+++|.+.... ....++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467888999999999999999 4688999999886432 23457889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998864333335689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... .....++..|+|||...+..++.++||||||+++|||++|..||...... ..........
T Consensus 159 ~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~------ 222 (267)
T cd08229 159 KTTA----AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQ------ 222 (267)
T ss_pred CCcc----cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhc------
Confidence 2211 11234788999999998888999999999999999999999998643211 1111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
...+... .......+.+++.+|++.||++|||+.+|++.++++
T Consensus 223 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 223 CDYPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0011111 122344677777899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.61 Aligned_cols=248 Identities=35% Similarity=0.463 Sum_probs=191.6
Q ss_pred CcEEeecCCeeEEEEEeC-----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 311 NNIIGTGRTGATYIAMLP-----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.+.||.|.||.||+|.+. .+..|+||.++... ...+++.+|++.+.+++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 578999999999999965 36789999996533 23578999999999999999999999999888899999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..+..|+.||++||+|||+. +++|+||+++||+++.++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999987622 4589999999999999999999999 999999999999999999999999999987633222
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
. ...........|+|||.+.+..++.++||||||+++||+++ |+.||.... ..+.......... .
T Consensus 159 ~--~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~~~~~~-~--- 224 (259)
T PF07714_consen 159 Y--KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKLKQGQR-L--- 224 (259)
T ss_dssp E--EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHHHTTEE-T---
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccc-c---
Confidence 1 11112236778999999988889999999999999999999 788876432 1222222211111 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
.........+.+++.+||+.||++||+++++++.|
T Consensus 225 ------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11112345677888899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.07 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=203.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC-C--cEEEEEEeccC--ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG-G--CFIMIKRLEDS--QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.+.||+|+||.||+|...+ + ..+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999998643 3 35788888742 23346788999999999 799999999999999999999
Q ss_pred EeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 380 YSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
|||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999865321 113588999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||++......... .....+..|+|||+..+..++.++|||||||++|||++ |..||..... .
T Consensus 159 kl~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~ 225 (297)
T cd05089 159 KIADFGLSRGEEVYVKK-----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------A 225 (297)
T ss_pred EECCcCCCccccceecc-----CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 99999998643221110 01113457999999988889999999999999999997 9999965332 1
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
+........ ............+.+++.+|++.+|.+||+++++++.|+++.+.+..
T Consensus 226 ~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 226 ELYEKLPQG----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 111111111 00011112234567788899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.47 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=200.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|++.+.||+|+||.||+|.. .++..|++|.+.... .....+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999983 356889999997533 233578899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCC-------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC
Q 007088 379 VYSYLENGTLYDKLHPAEH-------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 445 (618)
||||+++|+|.+++..... ....+++.+...++.|++.||+|||+. +++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999998853211 123588999999999999999999999 999999999999999999
Q ss_pred ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccC
Q 007088 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGS 524 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~ 524 (618)
.+||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRV--QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----E 234 (283)
T ss_pred cEEeccccccccccCCcceec--ccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----H
Confidence 999999999987543221111 112235678999999988889999999999999999998 99898653211 1
Q ss_pred HHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 525 LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 525 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
+.+ ........ .........+.+++.+|++.||++||++.++.+.|..
T Consensus 235 ~~~---~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIE---MVRKRQLL----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHH---HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 11111100 0111223456777789999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=327.19 Aligned_cols=240 Identities=23% Similarity=0.253 Sum_probs=191.9
Q ss_pred cEEeecCCeeEEEEEe----CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 312 NIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+.||+|+||.||+++. .+++.||+|+++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999984 357899999986532 2334578899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++.... .+.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999986543 478889999999999999999999 99999999999999999999999999987543222
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 155 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~------ 216 (323)
T cd05584 155 TV----THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGK------ 216 (323)
T ss_pred Cc----ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC------
Confidence 11 1123489999999999988899999999999999999999999975332 11111111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
..+ +......+.+++.+||+.||++|| ++.++++
T Consensus 217 -~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 -LNL----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCC----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 001 111224566777799999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=331.43 Aligned_cols=243 Identities=22% Similarity=0.296 Sum_probs=190.6
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHH---hcCCCCCccceeEEEEeCCeeEEE
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTL---GSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
|++.+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|..++ ++++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999995 468999999997532 2234566666554 567899999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|..++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999999887542 489999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||...... +..........
T Consensus 153 ~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~-- 218 (324)
T cd05589 153 GFGDR----TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE--------EVFDSIVNDEV-- 218 (324)
T ss_pred CCCCc----ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC--
Confidence 22211 12234899999999999999999999999999999999999999754321 11111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
. .+......+.+++.+||+.||.+|| ++.++++
T Consensus 219 -----~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 -----R----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -----C----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0 0111234566778899999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=316.25 Aligned_cols=265 Identities=22% Similarity=0.258 Sum_probs=200.9
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCC-ccceeEEEEeCC------
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRN-LVPLLGFCVAKK------ 374 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 374 (618)
..|...++||+|.||+||+|+ ..+|+.||+|++.-... ......+|+.++++++|+| |+++++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 446667789999999999999 56789999999975432 3445689999999999999 999999998877
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++|+||++. +|.+++.........++...++.++.||++||+|||++ +|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999976 99999877653223477789999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH-
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL- 532 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~- 532 (618)
|+...-.... ....++|..|+|||++.+. .|+...||||+|||+.||+++++.|....+.+ .+....+..
T Consensus 167 Ara~~ip~~~----yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~----ql~~If~~lG 238 (323)
T KOG0594|consen 167 ARAFSIPMRT----YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID----QLFRIFRLLG 238 (323)
T ss_pred HHHhcCCccc----ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH----HHHHHHHHcC
Confidence 9966533222 2233478999999998876 79999999999999999999999888755421 111111111
Q ss_pred --hcCCccchh--cc-----cccc-CCCCH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 533 --NTNSSLETA--ID-----KSLL-GNGFD----GELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 533 --~~~~~~~~~--~d-----~~l~-~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
....|.... .+ +... ..... .......+++.+|++.+|.+|.|++.+++.
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 011111100 00 0000 00011 111367788889999999999999999874
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.13 Aligned_cols=254 Identities=23% Similarity=0.264 Sum_probs=201.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|.+.+.||+|+||.||+|... +++.||+|+++... .....+.+|++++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999954 78999999997532 34456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999987653 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-------------------------cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 461 VDT-------------------------HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 461 ~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 320 0001122345899999999999999999999999999999999999999764
Q ss_pred CCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 007088 516 NAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-MFEVYQL 582 (618)
Q Consensus 516 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 582 (618)
... .......... ..+...........+.+++.+|+. ||.+||+ ++|+++.
T Consensus 234 ~~~--------~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQ--------ETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHH--------HHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 321 1111111100 000000001123456677779997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=324.19 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=192.5
Q ss_pred EeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 314 IGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 314 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
||+|+||+||++.. .+++.||+|.+.... ...+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 478999999986532 1234577899999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++.........+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~---- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc----
Confidence 887754333335689999999999999999999999 9999999999999999999999999999765443221
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ...
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~---------~~~-- 218 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILN---------DSV-- 218 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcc---------cCC--
Confidence 122348899999999999999999999999999999999999997543211 01111111100 000
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
.........+.+++.+||+.||++|| +++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01122334566777799999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.06 Aligned_cols=252 Identities=19% Similarity=0.184 Sum_probs=199.4
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-C-CcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-G-GCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.|...+.||+|++|.||+|... + +..||+|.+.... .....+.+|+.++++++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999843 3 6788888765433 33345788999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++........++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999988865433335689999999999999999999999 999999999999999999999999999987653221
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+......... ..
T Consensus 225 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~-~~---- 289 (478)
T PTZ00267 225 L--DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGK-YD---- 289 (478)
T ss_pred c--ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC-CC----
Confidence 1 112234589999999999999999999999999999999999999965321 11111111110 00
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.........+.+++.+||+.||++||++.+++.
T Consensus 290 -----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 -----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 001112345677778999999999999999864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=320.21 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=199.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCc----EEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGC----FIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|++.+.||+|+||.||+|.. .++. .+++|.+.... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 4577889999999999999995 3443 57888875432 233567888889999999999999998754 45789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 3589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....++..|+|||...+..++.++||||||+++||+++ |+.||...... ...+.. .....
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~---~~~~~ 229 (279)
T cd05111 160 YPDDKKYF--YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EVPDLL---EKGER 229 (279)
T ss_pred cCCCcccc--cCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHH---HCCCc
Confidence 43222111 122336778999999988899999999999999999998 99998753221 111111 11111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.. .+ ......+.+++.+|+..||.+|||+.|+++.|..+..+
T Consensus 230 ~~---~~-------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LA---QP-------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC---CC-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00 01 11223567778899999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=316.96 Aligned_cols=254 Identities=23% Similarity=0.384 Sum_probs=205.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|...++||+|+||.||++...++..+++|.++......+.+.+|++++++++|+||+++++++.. ...+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 35788899999999999999998788889999988765556789999999999999999999999887 77899999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999976433 4588999999999999999999999 9999999999999999999999999999765432211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. .....++..|+|||++.+..++.++|+|||||++|++++ |+.||...... .+..+.. ....
T Consensus 159 ~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~~~---~~~~------ 221 (260)
T cd05073 159 A---REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIRALE---RGYR------ 221 (260)
T ss_pred c---ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHh---CCCC------
Confidence 1 112235678999999988889999999999999999999 99998653221 1111111 1100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
..........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112234567788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=309.31 Aligned_cols=250 Identities=20% Similarity=0.272 Sum_probs=198.9
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEecc---CccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLED---SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++.|++-+.||+|.|+.||++. .++|+.+|+|++.. +....+++.+|+.+.+.++||||+++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3567777889999999999998 56789999998853 3346778999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEcccCcccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSDFGLARL 457 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~ 457 (618)
|+|.|++|..-+-.+ ..+++..+-.+.+||+.+|.|.|.+ +|||||+||+|+++.. .--+||+|||+|..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999997655443 3488889999999999999999999 9999999999999953 33589999999998
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
++.. ....+..|||+|||||+....+|+..+|||+.|||||-|+.|.+||.+.+....+ + ..... .
T Consensus 163 l~~g-----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly-----e---~I~~g-~ 228 (355)
T KOG0033|consen 163 VNDG-----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY-----E---QIKAG-A 228 (355)
T ss_pred eCCc-----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-----H---HHhcc-c
Confidence 8732 2234567999999999999999999999999999999999999999874432211 1 11110 0
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
-...+..++.......+|+.+||..||.+|.|+.|.++
T Consensus 229 ------yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 229 ------YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ------cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 01111122222334445555999999999999988764
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=339.14 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=196.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4788999999999999999995 468999999997532 23355788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 9999999999987543 489999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCcc----------------------------------cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHH
Q 007088 461 VDTHL----------------------------------STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELI 506 (618)
Q Consensus 461 ~~~~~----------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ell 506 (618)
..... .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 00011235899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 007088 507 TGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT---MFEVYQ 581 (618)
Q Consensus 507 tG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 581 (618)
+|+.||...... +.............. .. ....+ ..+.+++.+|+. +|.+|++ +.|+++
T Consensus 234 ~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~-~~---~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQ--------ETYRKIINWKETLQF-PD---EVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHH--------HHHHHHHcCCCccCC-CC---CCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999754321 111111110000000 00 00122 345566668886 9999998 888866
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.10 Aligned_cols=250 Identities=22% Similarity=0.267 Sum_probs=194.9
Q ss_pred cCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 307 SFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
+|++.+.||+|+||.||+++. .+++.||+|++.... ...+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999984 367899999986432 2345678899999999 599999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 99999999999999986543 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.......... ....||..|+|||++.+. .++.++|||||||++|||++|+.||....... ............
T Consensus 154 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~ 226 (332)
T cd05614 154 EFLSEEKERT---YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILKC 226 (332)
T ss_pred cccccCCCcc---ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhcC
Confidence 6533222111 123489999999998765 47889999999999999999999997543211 111111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
++.+. ......+.+++.+||+.||++|| +++++++
T Consensus 227 -------~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 -------DPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -------CCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11111 11233456677799999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.03 Aligned_cols=240 Identities=20% Similarity=0.243 Sum_probs=191.6
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
+.||+|+||.||++.. .+++.||+|+++... .....+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999994 578999999997532 23456778999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT- 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-
Confidence 9998886543 48999999999999999999997 7 9999999999999999999999999998754322211
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......... ..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~~~~-------~~ 214 (325)
T cd05594 153 ---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEE-------IR 214 (325)
T ss_pred ---cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHhcCC-------CC
Confidence 11234899999999999989999999999999999999999999753321 1111111100 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
+ +......+.+++.+||+.||++|+ ++.++++
T Consensus 215 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 F----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred C----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1 111223566777799999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.80 Aligned_cols=203 Identities=21% Similarity=0.273 Sum_probs=174.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..+.||+|+||.||++.. .+++.||+|++.... .....+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999985 468999999996532 23356788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKD----TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 9999999999987543 489999999999999999999999 999999999999999999999999999976532
Q ss_pred CCCc-------------------------------ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCC
Q 007088 461 VDTH-------------------------------LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE 509 (618)
Q Consensus 461 ~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~ 509 (618)
.... ........+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 000012346899999999999999999999999999999999999
Q ss_pred CCCCCC
Q 007088 510 RPTHLT 515 (618)
Q Consensus 510 ~Pf~~~ 515 (618)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=320.42 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=207.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCC-----CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEe-CCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPG-----GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVA-KKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 376 (618)
.++|...+.||+|+||.||+|...+ +..|++|++.... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999655 7889999987542 334668899999999999999999998776 4678
Q ss_pred EEEEeecCCCccccccCCCCCC----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHE----VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
++++||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654321 14589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|+++.+........ .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... .++...
T Consensus 162 g~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~ 231 (280)
T cd05043 162 ALSRDLFPMDYHCL--GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAY 231 (280)
T ss_pred CCcccccCCceEEe--CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHH
Confidence 99986644322111 112235678999999988889999999999999999999 9999975322 111111
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
....... .........+.+++.+|++.||++|||+.|+++.|+++.++
T Consensus 232 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 232 LKDGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHcCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1111110 01111234677888899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=314.90 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=204.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|+..+.||+|+||.||+|... |+.||+|.+.......+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 356888999999999999999874 7889999998765556789999999999999999999999998889999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 84 KGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999876542 3589999999999999999999999 999999999999999999999999999987632211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
....+..|+|||++.+..++.++||||||+++||+++ |+.||...... .+.. .......
T Consensus 158 ------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~---~~~~~~~------ 217 (256)
T cd05039 158 ------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVP---HVEKGYR------ 217 (256)
T ss_pred ------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-----HHHH---HHhcCCC------
Confidence 1124568999999988889999999999999999997 99998643211 1111 1111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
..........+.+++.+||..+|++||++.|+++.|+.+
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 ----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 011112345677888899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.17 Aligned_cols=253 Identities=21% Similarity=0.261 Sum_probs=193.2
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.|+..+.||+|+||.||+|+. .+++.||+|++.... ...+.+.+|++++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999984 568999999996532 234568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRME----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 999999999987543 488999999999999999999999 9999999999999999999999999997643210
Q ss_pred CCc-------------------------------------------ccccccCCCCcccccCCCCCCCCCCCCccchHHH
Q 007088 462 DTH-------------------------------------------LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSF 498 (618)
Q Consensus 462 ~~~-------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~ 498 (618)
... .........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 000 0000112358999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhh--ccCCCCCCCCCH
Q 007088 499 GVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACN--CVLPTPKERHTM 576 (618)
Q Consensus 499 Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~ 576 (618)
||++|||++|+.||......+. ........... . +. .....+. ++.+++.+ |+..+|..||++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~-~-~~---~~~~~s~---~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTET-------QLKVINWENTL-H-IP---PQVKLSP---EAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHH-------HHHHHcccccc-C-CC---CCCCCCH---HHHHHHHHHccCcccccCCCCH
Confidence 9999999999999976432110 00000000000 0 00 0001223 34445545 556777779999
Q ss_pred HHHHH
Q 007088 577 FEVYQ 581 (618)
Q Consensus 577 ~evl~ 581 (618)
+|+++
T Consensus 300 ~~~l~ 304 (381)
T cd05626 300 DDIKA 304 (381)
T ss_pred HHHhc
Confidence 99976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=316.99 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=200.1
Q ss_pred CCCCcEEeecCCeeEEEEEeCC----CcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-----
Q 007088 308 FSKNNIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE----- 375 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 375 (618)
|.+.+.||+|+||.||+|.... +..||+|+++.... ....+.+|++.+++++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998532 37899999875432 24568899999999999999999999876554
Q ss_pred -eEEEEeecCCCccccccCCCCC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 376 -RLLVYSYLENGTLYDKLHPAEH--EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 376 -~~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
.++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6899999999999988854321 224689999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|+++........... ....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +....
T Consensus 158 g~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~ 227 (273)
T cd05035 158 GLSKKIYSGDYYRQG--RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDY 227 (273)
T ss_pred cceeecccccccccc--ccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH
Confidence 999876543221111 11224678999999988889999999999999999999 88888653321 11111
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
....... .........+.+++.+|++.||++||++.|+++.|+++
T Consensus 228 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 LRHGNRL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHcCCCC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111100 11122345678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=320.32 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=199.8
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeC------C
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK------K 374 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 374 (618)
.+++.|+..+.||+|+||.||+|.. .+++.||+|++.........+.+|+.++.++ +|+||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999995 4688999999977666677889999999998 799999999998753 4
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 57899999999999999876432 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
+.......... ....|+..|+|||++. +..++.++|||||||++|||++|+.||..... .....
T Consensus 158 ~~~~~~~~~~~----~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~ 226 (272)
T cd06637 158 SAQLDRTVGRR----NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALF 226 (272)
T ss_pred ceecccccccC----CcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHH
Confidence 98654322111 1234788999999875 34578899999999999999999999964321 11111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. ... . ....... .....+.+++.+||..||.+|||+.|+++
T Consensus 227 ~~-~~~-~-----~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 227 LI-PRN-P-----APRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HH-hcC-C-----CCCCCCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11 000 0 0111111 12345677888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.24 Aligned_cols=260 Identities=24% Similarity=0.364 Sum_probs=202.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCc--EEEEEEeccC--ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGC--FIMIKRLEDS--QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.+.||+|+||.||+|... ++. .+++|.++.. ....+.+.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46888899999999999999953 443 5688877643 23445788999999999 899999999999999999999
Q ss_pred EeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 380 YSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
|||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999865421 123588999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++....... . ....++..|+|||++.+..++.++|||||||++|||+| |..||......
T Consensus 164 kl~dfg~~~~~~~~~~---~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------- 230 (303)
T cd05088 164 KIADFGLSRGQEVYVK---K--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------- 230 (303)
T ss_pred EeCccccCcccchhhh---c--ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--------
Confidence 9999999864321110 0 11124567999999988889999999999999999998 99998653321
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
+.......... ..........+.+++.+|++.+|++||+++++++.|+++.+.-.
T Consensus 231 ~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 231 ELYEKLPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHHhcCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11111111000 00111123456788889999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=335.98 Aligned_cols=251 Identities=20% Similarity=0.203 Sum_probs=198.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999995 578999999997542 23456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999987653 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPR------TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ........
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~ 223 (330)
T cd05601 155 NKMVN---SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA--------KTYNNIMN 223 (330)
T ss_pred CCcee---eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH--------HHHHHHHc
Confidence 32221 11234899999999876 456789999999999999999999999754321 11111111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....... .........+.+++..|++ +|.+||++.++++
T Consensus 224 ~~~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 224 FQRFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1110000 0001123456667779997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=338.75 Aligned_cols=253 Identities=19% Similarity=0.212 Sum_probs=197.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
..++|++.++||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456899999999999999999995 468999999996432 233457889999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999988643 378888999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTL----VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .........
T Consensus 193 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~ 261 (370)
T cd05596 193 DANGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMD 261 (370)
T ss_pred cCCCccc---CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHc
Confidence 4322111 1233589999999987643 478999999999999999999999975432 111111111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKE--RHTMFEVYQL 582 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 582 (618)
.... +...........+.+++.+||+.+|.+ ||++.|+++.
T Consensus 262 ~~~~-------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 262 HKNS-------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCc-------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1000 000000112345666777999999988 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=330.11 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=193.7
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----eeE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK-----ERL 377 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 377 (618)
+|++.+.||+|+||.||+|+. .++..||+|+++... .....+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999994 578999999986432 23456889999999999999999999886432 479
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||++ ++|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhcc----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 58988886543 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-------cCHHHH
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK-------GSLVEW 528 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~-------~~l~~~ 528 (618)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .....+
T Consensus 153 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 153 AFNDTPTA-IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred cccccCcc-ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 43221111 11123458999999998765 678999999999999999999999997543211000 000000
Q ss_pred HHHHhcCCccchhc---cccccC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 529 ITLLNTNSSLETAI---DKSLLG---NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 529 ~~~~~~~~~~~~~~---d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... .......+ .+.... .........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 00000000 000000 000112345678888999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.17 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=204.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC--------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP--------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
++|.+.+.||+|+||.||++... +...+|+|.++... ....++.+|+++++++ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57889999999999999999742 23579999997542 3345688899999999 7999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
..++||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 99999999999999999975432 123589999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~ 521 (618)
.++.+||+|||.++........... ....++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----- 247 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKT--TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----- 247 (307)
T ss_pred CCCcEEECCCcccccccccchhhcc--ccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence 9999999999998765432111111 11124568999999988889999999999999999998 888885422
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..+......... ...........+.+++.+|++.+|++||++.|+++.|+++.+.
T Consensus 248 ---~~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 ---VEELFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ---HHHHHHHHHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 112221111111 0011122345677788899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=352.44 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=204.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.++||+|+||.||+|.. .+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999995 468999999997532 23457899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCC-------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 381 SYLENGTLYDKLHPAEH-------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
||++||+|.+++..... ....+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998853211 123467788899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc--------------ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 007088 454 LARLMNPVDTH--------------LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519 (618)
Q Consensus 454 ~a~~~~~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~ 519 (618)
+++........ .........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876221100 0011112358999999999999999999999999999999999999997532211
Q ss_pred ccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhhhh
Q 007088 520 SFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-TMFEVYQLLRAIAER 589 (618)
Q Consensus 520 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~ 589 (618)
. . ..... .++.- .....+.+..+.+++.+|++.||++|| +++++.+.|+...+.
T Consensus 239 i-----~-~~~~i---------~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 I-----S-YRDVI---------LSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred h-----h-hhhhc---------cChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0 00000 00000 000112334567788899999999995 677788888887653
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=323.07 Aligned_cols=261 Identities=23% Similarity=0.380 Sum_probs=205.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe--------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML--------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 373 (618)
.++|.+.+.||+|+||.||+|.. .++..||+|.+.... ...+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45688899999999999999973 124579999987532 3346788999999999 899999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
...++||||+++|+|.+++..... ....+++..+..++.||+.||+|||+. +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999875422 123588999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPES 520 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~ 520 (618)
+.++.+||+|||.++.......... .....++..|+|||++.+..++.++||||||+++||+++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred cCCCcEEECCCccceeccccccccc--ccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 9999999999999987644322111 112235678999999988889999999999999999998 778875422
Q ss_pred cccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 521 FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 521 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
..+........... .........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 245 ----~~~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 ----VEELFKLLKEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----HHHHHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 22222222211110 0111234567778889999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.58 Aligned_cols=240 Identities=20% Similarity=0.249 Sum_probs=190.2
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCC-CccceeEEEEeCCeeEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHR-NLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 380 (618)
+|++.+.||+|+||.||+|... +++.||+|+++... ...+.+..|.+++..++|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999954 57899999997532 3345678899999999765 5888999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 9999999999886543 488999999999999999999999 999999999999999999999999999875322
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +.........
T Consensus 154 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~---- 217 (324)
T cd05587 154 GGKT----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHN---- 217 (324)
T ss_pred CCCc----eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC----
Confidence 1111 12234899999999999999999999999999999999999999753321 1111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
..+ +......+.+++.+||..||.+|++.
T Consensus 218 ---~~~----~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 ---VSY----PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCC----CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 000 11123356677779999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.14 Aligned_cols=250 Identities=24% Similarity=0.270 Sum_probs=198.0
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
+|+..++||+|+||.||++.. .+++.||+|.+.... .....+.+|+.++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999995 568999999986532 223457789999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988764332 4589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.. .....|+..|+|||++.+..++.++||||+||++|||++|+.||....... .......... ..
T Consensus 156 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~-~~----- 220 (285)
T cd05605 156 ET-----IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVK-ED----- 220 (285)
T ss_pred Cc-----cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhh-hc-----
Confidence 21 122348899999999988889999999999999999999999997533211 0111111110 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
...........+.+++.+|++.||++|| +++++++
T Consensus 221 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 -----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred -----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0011122344567788899999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.77 Aligned_cols=265 Identities=24% Similarity=0.361 Sum_probs=200.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 377 (618)
++|++.+.||+|+||.||++.. .++..|++|.++... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688899999999999999974 357899999987543 3346789999999999999999999987543 4678
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999986543 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
.......... .....++..|+|||+..+..++.++|||||||++|||++|..|+...... +.........
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---------~~~~~~~~~~ 227 (284)
T cd05081 158 LPQDKEYYKV-REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---------FMRMMGNDKQ 227 (284)
T ss_pred ccCCCcceee-cCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---------hhhhcccccc
Confidence 6543221111 11112345699999998888999999999999999999998776432210 0000000000
Q ss_pred -------cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 538 -------LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 538 -------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
+.+.+...............+.+++.+||+.+|++|||++||++.|+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000000011122335677888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.55 Aligned_cols=258 Identities=21% Similarity=0.244 Sum_probs=203.2
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC---
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK--- 374 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--- 374 (618)
....++|.+.+.||+|+||.||+|. ..+++.||||++.... .....+.+|+..+..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3345789999999999999999998 4578999999986543 23456788999999999999999988775432
Q ss_pred -----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 375 -----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 375 -----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 35799999999999999876544445789999999999999999999999 9999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+..
T Consensus 185 ~DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~ 254 (496)
T PTZ00283 185 GDFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVM 254 (496)
T ss_pred EecccCeeccccccc--cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHH
Confidence 999999875432211 11123458999999999999999999999999999999999999997532 12222
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
....... . + ..+......+.+++.+||+.||.+||++.++++.
T Consensus 255 ~~~~~~~-~----~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLAGR-Y----D-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhcCC-C----C-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2211110 0 0 0111223457777889999999999999999763
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.85 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=203.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
++|...+.||+|+||.||++.. ..+..||+|+++... ...+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 5688899999999999999973 234589999987543 2345688999999999 799999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.++++|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999875432 3489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ...... . .
T Consensus 190 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~----~~~~~~---~-~ 259 (302)
T cd05055 190 DIMNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS----KFYKLI---K-E 259 (302)
T ss_pred cccCCCcee--ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH----HHHHHH---H-c
Confidence 654322111 1112235678999999988889999999999999999998 999987543211 111111 1 1
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
.. ...........+.+++.+|+..+|++||++.|+++.|+++
T Consensus 260 ~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GY---------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 0000111234677788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=314.71 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=202.0
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|++|.||+++. .+++.|++|.+... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477789999999999999995 46899999998643 23456788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999876432 4689999999999999999999999 99999999999999999999999999988765432
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....++..|+|||+..+..++.++||||||+++|||++|+.||...... ........ ...
T Consensus 156 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~---- 218 (256)
T cd08529 156 NFA----NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--------ALILKIIR-GVF---- 218 (256)
T ss_pred chh----hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHc-CCC----
Confidence 211 1234788999999999888999999999999999999999999754311 11111110 000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
..........+.+++.+|++.+|++||++.++++.
T Consensus 219 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 -----PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -----CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 01111234567888889999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.25 Aligned_cols=236 Identities=20% Similarity=0.282 Sum_probs=188.2
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.. .+++.||+|+++... ...+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468999999987532 3345567888888876 699999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~i~~~~----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~- 152 (320)
T cd05590 81 GDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT- 152 (320)
T ss_pred chHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc-
Confidence 99999886543 489999999999999999999999 9999999999999999999999999998754322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~----~--- 214 (320)
T cd05590 153 ---TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEV----V--- 214 (320)
T ss_pred ---ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCC----C---
Confidence 1223489999999999999999999999999999999999999975432 111111111100 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 577 (618)
........+.+++.+||+.||++||++.
T Consensus 215 ----~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 215 ----YPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 0111234566777799999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=316.75 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=196.1
Q ss_pred CCCCcEEeecCCeeEEEEEeCC-C--cEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC------Ce
Q 007088 308 FSKNNIIGTGRTGATYIAMLPG-G--CFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------KE 375 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 375 (618)
|.+.+.||+|+||.||+|...+ + ..||+|.++... ...+.+.+|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3457889999999999999644 3 368999886542 3345688999999999999999999987532 24
Q ss_pred eEEEEeecCCCccccccCCCC--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 376 RLLVYSYLENGTLYDKLHPAE--HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
.++||||+++|+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988774321 1224589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+++.......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||..... .+.....
T Consensus 158 ~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~ 227 (272)
T cd05075 158 LSKKIYNGDYYRQ--GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYL 227 (272)
T ss_pred cccccCcccceec--CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH
Confidence 9987654322111 111225678999999998899999999999999999999 8888865321 1111111
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
....... ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 228 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 228 RQGNRLK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111100 0112234577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=318.34 Aligned_cols=258 Identities=24% Similarity=0.375 Sum_probs=203.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCc----EEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGC----FIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|+..++||+|+||.||+|+. .++. .||+|.++... ...+++.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 5688889999999999999984 4444 58999986532 3356788999999999999999999998754 5689
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999987543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....++..|+|||...+..++.++|||||||++|||++ |..||..... ..+..+... ...
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~---~~~ 229 (279)
T cd05109 160 DIDETEYH--ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLEK---GER 229 (279)
T ss_pred ccccceee--cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHC---CCc
Confidence 53322111 112224678999999988899999999999999999998 8999864321 112222111 100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
. .........+.+++.+||+.||++||++.|+++.|+.+..+.
T Consensus 230 ~----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 L----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred C----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0 001123346778888999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=316.65 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=203.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CC---cEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GG---CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.++|+..+.||+|+||.||+|+.. ++ ..+++|.++... ...+++.+|++++++++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356888899999999999999964 23 379999986542 334678899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999986543 3589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
......... ......+..|+|||++.+..++.++|||||||++||+++ |+.||..... .+..........
T Consensus 158 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~~ 228 (268)
T cd05063 158 EDDPEGTYT-TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGFR 228 (268)
T ss_pred cccccccee-ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCCC
Confidence 432221111 111123457999999988889999999999999999997 9999865321 112222111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
..........+.+++.+|++.+|++||++.+|++.|+++
T Consensus 229 ----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ----------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112345678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=312.28 Aligned_cols=246 Identities=21% Similarity=0.309 Sum_probs=196.7
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCccc
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 389 (618)
++||+|+||.||+|...++..||+|.+.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3689999999999998889999999987543 23446889999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccc
Q 007088 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV 469 (618)
Q Consensus 390 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 469 (618)
+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~--- 151 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS--- 151 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccC---
Confidence 9886543 3478999999999999999999999 999999999999999999999999999875433211111
Q ss_pred cCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 470 NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 470 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
....++..|+|||+..+..++.++||||||+++||+++ |..||...... ........... .
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~----------~ 213 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYR----------M 213 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCC----------C
Confidence 11124567999999988889999999999999999998 99998653221 11111111100 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.........+.+++.+|+..+|++||++.|+++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111123456788888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.45 Aligned_cols=240 Identities=22% Similarity=0.286 Sum_probs=190.4
Q ss_pred cEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++||+|+||.||+|+.. +++.||+|+++... ...+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 57899999997532 2334577888888866 799999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~- 152 (321)
T cd05591 81 GDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT- 152 (321)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-
Confidence 99998886543 488999999999999999999999 9999999999999999999999999998754322211
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~--------~~~~~i~~~~~----~~-- 215 (321)
T cd05591 153 ---TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--------DLFESILHDDV----LY-- 215 (321)
T ss_pred ---ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCC----CC--
Confidence 12234899999999999989999999999999999999999999754321 11111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERH-------TMFEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 581 (618)
+......+.+++.+||+.||++|| +++++++
T Consensus 216 -----p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 -----PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -----CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 011224566777799999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.91 Aligned_cols=262 Identities=21% Similarity=0.236 Sum_probs=191.3
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeC--------C
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--------K 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~ 374 (618)
..++|+..++||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++... .
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 346799999999999999999995 568999999886533 2345799999999999999999987542 2
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFG 453 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG 453 (618)
..++||||+++ +|.+++.........+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35699999985 77776653322235689999999999999999999999 999999999999999664 69999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+++........ ....||+.|+|||++.+ ..++.++|||||||++|||++|.+||......+. +.......
T Consensus 217 la~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~----~~~i~~~~ 287 (440)
T PTZ00036 217 SAKNLLAGQRS-----VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ----LVRIIQVL 287 (440)
T ss_pred cchhccCCCCc-----ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHh
Confidence 99866432221 12347899999998765 4689999999999999999999999976443211 11111100
Q ss_pred hcC---------Cccch-----hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTN---------SSLET-----AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~---------~~~~~-----~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... ..... .....+....+.....++.+++.+||+.||.+|||+.|+++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 00000 00000000001112346778888999999999999999974
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.49 Aligned_cols=239 Identities=23% Similarity=0.297 Sum_probs=187.0
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.. .+++.||+|+++... ...+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 457899999997532 2334456677776654 899999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 g~L~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~- 152 (316)
T cd05592 81 GDLMFHIQSSG----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK- 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc-
Confidence 99999886543 489999999999999999999999 9999999999999999999999999999764332211
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +......... +.
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~-------~~ 214 (316)
T cd05592 153 ---ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDR-------PH 214 (316)
T ss_pred ---cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC-------CC
Confidence 12234899999999999989999999999999999999999999754321 1111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMF-EVY 580 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 580 (618)
+ +......+.+++.+||+.||++||++. +++
T Consensus 215 ~----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 F----PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred C----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0 111223456677799999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=314.70 Aligned_cols=269 Identities=25% Similarity=0.364 Sum_probs=199.7
Q ss_pred CCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHh--cCCCCCccceeEEEEeCC----eeEEEEee
Q 007088 309 SKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLG--SVRHRNLVPLLGFCVAKK----ERLLVYSY 382 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~lV~e~ 382 (618)
+..+.||+|+||.||+|.+. ++.||||++... ..+.|.+|-++.+ .++|+||++++++-.... +++||+||
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 33567999999999999984 489999999763 3456777766655 458999999999876655 78999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC------NPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
.+.|+|.++|..+. ++|....+|+..+++||+|||+.. +|+|+|||||++|||+.+|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999998754 899999999999999999999863 5789999999999999999999999999999
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCC------CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH----
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV------ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV---- 526 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~---- 526 (618)
.+........ ..+.+||.+|||||++.+.. .=.+.||||+|.++|||++.-.-++. .+...+.....
T Consensus 365 ~~~p~~~~~d--~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 365 RLEPGKPQGD--THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVG 441 (534)
T ss_pred EecCCCCCcc--hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhc
Confidence 8875433222 23366999999999987532 12479999999999999986554432 11111211111
Q ss_pred ------HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 527 ------EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 527 ------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
+.......+.....+ ...+.. ...+..+.+.+..||+.||+.|-|+.=|.+++.++..-...
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~-p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKI-PDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCC-hhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111111111111 111111 13566788888899999999999999999999998765543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.06 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=211.4
Q ss_pred CCCCcEEeecCCeeEEEEEeCC---C--cEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 308 FSKNNIIGTGRTGATYIAMLPG---G--CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
....++||.|-||.||+|++.+ | -.||||..+.+. ...+.|.+|..+|++++||||++++|+|.+ ...|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 4456789999999999999432 3 468999998643 456789999999999999999999999976 4689999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
|.++-|.|..|++.+. ..++......++.||+.||+|||+. ++|||||..+|||+....-+||+|||+++.+..
T Consensus 470 EL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999998776 3588899999999999999999999 999999999999999999999999999999887
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
......... .-+..|||||-+.-.+++.+||||-|||.+||++. |..||..-.+.+..
T Consensus 544 ~~yYkaS~~---kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------------------ 602 (974)
T KOG4257|consen 544 DAYYKASRG---KLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------------------ 602 (974)
T ss_pred cchhhcccc---ccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------------------
Confidence 654433321 13578999999999999999999999999999987 99999875543221
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
-.+...-+...++.++..+..|+.+||.+||.+||++.|+...|+++.+
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111111223355677788899999999999999999999999998876
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=313.72 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=193.9
Q ss_pred EEeecCCeeEEEEEe---CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 313 IIGTGRTGATYIAML---PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
.||+|+||.||+|.+ .++..+|+|+++... ...+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999974 457899999986543 23467889999999999999999999885 45678999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999986543 489999999999999999999999 999999999999999999999999999987654332211
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
. .....++..|+|||.+....++.++|||||||++|||++ |+.||..... .++......... .
T Consensus 154 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i~~~~~-~------ 217 (257)
T cd05116 154 A-KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMIESGER-M------ 217 (257)
T ss_pred e-cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHCCCC-C------
Confidence 1 111224578999999988889999999999999999998 9999975322 112222111110 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
..+.....++.+++.+|++.||++||++++|.+.|++
T Consensus 218 ---~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ---ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1111233456778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=319.27 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=201.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
..++|.+.+.||+|++|.||+|... .+..|++|.+.... .....+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3467889999999999999999964 36789999886543 334568999999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC---ceEE
Q 007088 376 RLLVYSYLENGTLYDKLHPAEH---EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF---EPKL 449 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 449 (618)
.++||||+++++|.+++..... ....+++..+++++.||+.||+|||+. +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865432 123589999999999999999999999 999999999999998654 5999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~ 528 (618)
+|||+++......... .......+..|+|||++.+..++.++|||||||++|||++ |+.||...... +.
T Consensus 161 ~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~ 230 (277)
T cd05036 161 ADFGMARDIYRASYYR--KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EV 230 (277)
T ss_pred ccCccccccCCcccee--cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence 9999998763322111 0111123568999999988899999999999999999997 99998753321 11
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.......... .........+.+++.+|++.+|++||++.+|++.|+
T Consensus 231 ~~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 MEFVTGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111110 111122356778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=313.66 Aligned_cols=251 Identities=22% Similarity=0.386 Sum_probs=203.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
.+|+..+.||+|+||.||++...++..+++|.+........++.+|++++++++|||++++++++......++||||+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 45777899999999999999987788999999987666677899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999986543 3478999999999999999999999 9999999999999999999999999998765432111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
......++..|+|||+..+..++.++||||||+++|||++ |+.||..... ........... ....+
T Consensus 157 --~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~---~~~~~ 223 (256)
T cd05112 157 --SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGF---RLYKP 223 (256)
T ss_pred --ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCC---CCCCC
Confidence 1112224678999999988889999999999999999998 9999865321 11222211110 00111
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
. .....+.+++.+||+.+|++||++.|+++.|
T Consensus 224 ~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 R-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 1235677888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.17 Aligned_cols=254 Identities=19% Similarity=0.180 Sum_probs=194.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.++||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999984 578999999986532 23356788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYD----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999987543 488999999999999999999999 999999999999999999999999999964321
Q ss_pred CCCc------------c-------------------------------cccccCCCCcccccCCCCCCCCCCCCccchHH
Q 007088 461 VDTH------------L-------------------------------STFVNGEFGDLGYVAPEYPRTLVATPKGDVYS 497 (618)
Q Consensus 461 ~~~~------------~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS 497 (618)
.... . ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 0 00001235899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCC---C
Q 007088 498 FGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKER---H 574 (618)
Q Consensus 498 ~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---P 574 (618)
|||++|||++|+.||...... +............. + .........+.+++.+|+. +|.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~-----~--p~~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLY-----F--PDDIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccC-----C--CCCCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 999999999999999754321 11111110000000 0 0000112345566669997 67665 5
Q ss_pred CHHHHHHH
Q 007088 575 TMFEVYQL 582 (618)
Q Consensus 575 s~~evl~~ 582 (618)
++.|+++.
T Consensus 298 ~~~~~l~h 305 (377)
T cd05629 298 GAHEIKSH 305 (377)
T ss_pred CHHHHhcC
Confidence 99998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=315.10 Aligned_cols=252 Identities=20% Similarity=0.253 Sum_probs=198.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999995 678999999986543 34456789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVTG----PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999886543 489999999999999999999999 999999999999999999999999999986643221
Q ss_pred cccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. ....++..|+|||.+. ...++.++|||||||++|||++|+.||......+... . . ....
T Consensus 162 ~~----~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~----~-~~~~--- 225 (267)
T cd06646 162 KR----KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----L----M-SKSN--- 225 (267)
T ss_pred cc----CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----e----e-ecCC---
Confidence 11 1223788999999874 4457889999999999999999999986433211100 0 0 0000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
...+.... .......+.+++.+||+.||++||+++++++.
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 226 FQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00001100 11223467778889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.49 Aligned_cols=202 Identities=24% Similarity=0.288 Sum_probs=172.2
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.|+..++||+|+||.||+|.. .+++.||+|++.... .....+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999994 568899999987532 234568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999986543 488899999999999999999999 9999999999999999999999999997533210
Q ss_pred CC-------------------------------------------cccccccCCCCcccccCCCCCCCCCCCCccchHHH
Q 007088 462 DT-------------------------------------------HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSF 498 (618)
Q Consensus 462 ~~-------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~ 498 (618)
.. ..........||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 00 00000112358999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 007088 499 GVVLLELITGERPTHLT 515 (618)
Q Consensus 499 Gvil~elltG~~Pf~~~ 515 (618)
||++|||++|+.||...
T Consensus 235 Gvil~elltG~~Pf~~~ 251 (382)
T cd05625 235 GVILYEMLVGQPPFLAQ 251 (382)
T ss_pred hHHHHHHHhCCCCCCCC
Confidence 99999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=313.67 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=199.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEE-eCCeeEEEEeecC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV-AKKERLLVYSYLE 384 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~ 384 (618)
++|.+.+.||+|+||.||++... |..|++|.++... ..+.+.+|+.++++++|+|++++++++. ..+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 46888899999999999999864 7789999986543 4567899999999999999999999765 4457899999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 84 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 9999999875443 3588999999999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
...++..|+|||+..+..++.++|||||||++|||++ |+.||.... ..+..........
T Consensus 158 ------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~------ 217 (256)
T cd05082 158 ------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYK------ 217 (256)
T ss_pred ------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcCCC------
Confidence 1124568999999988889999999999999999998 999986432 2222222211100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
..........+.+++.+|++.+|++|||+.++++.|+++
T Consensus 218 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 ----MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 011122345677788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=313.63 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=197.1
Q ss_pred cEEeecCCeeEEEEEeC--C--CcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLP--G--GCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++||+|+||.||+|+.. + +..||+|.+..... ..+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999842 2 37899999976543 4567899999999999999999999876 4567999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997654 489999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.. .....++..|+|||...+..++.++||||||+++|||++ |+.||..... ..+..+. ......
T Consensus 153 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~---~~~~~~------ 217 (257)
T cd05060 153 RA-TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAML---ESGERL------ 217 (257)
T ss_pred cc-ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHH---HcCCcC------
Confidence 11 111223567999999998899999999999999999998 9999865322 1111221 111110
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
.........+.+++.+|+..+|++||++.++++.|+++.
T Consensus 218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011123356778888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=314.92 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=202.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.+.||+|+||.||+|... .+..+|+|.++... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999853 23479999986533 2345789999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997543 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
........ .....++..|+|||++.+..++.++||||||+++||+++ |..||...... .... ........
T Consensus 158 ~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~---~~~~~~~~ 228 (267)
T cd05066 158 DDPEAAYT-TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIK---AIEEGYRL 228 (267)
T ss_pred cccceeee-cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHH---HHhCCCcC
Confidence 43221111 111223568999999998889999999999999999886 99998754321 1111 11111000
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
......+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 229 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 ----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01112334667888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.37 Aligned_cols=256 Identities=19% Similarity=0.215 Sum_probs=196.8
Q ss_pred HHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 301 LMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 301 l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
+....++|+..+.||+|+||.||++.. .+++.||+|++.+.. ...+.+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344567899999999999999999995 468899999986422 234557899999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 99999999999999998643 378899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL----VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
......... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......
T Consensus 190 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~ 258 (370)
T cd05621 190 MKMDETGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSK 258 (370)
T ss_pred eecccCCce---ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 876432211 11234589999999988654 378899999999999999999999975432 111111
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKE--RHTMFEVYQL 582 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 582 (618)
....... +...........+.+++.+|+..++.+ ||++.|+++.
T Consensus 259 i~~~~~~-------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 IMDHKNS-------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHhCCcc-------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111000 000000112334556666888755543 8899998774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.16 Aligned_cols=239 Identities=23% Similarity=0.301 Sum_probs=187.9
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.. .+|+.||+|.++... ...+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 468899999997532 2344567788887754 899999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 g~L~~~i~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 152 (316)
T cd05620 81 GDLMFHIQDKG----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR- 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc-
Confidence 99999886543 488999999999999999999999 9999999999999999999999999998753222111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +......... +.
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~-------~~ 214 (316)
T cd05620 153 ---ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDT-------PH 214 (316)
T ss_pred ---eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-------CC
Confidence 12234899999999999999999999999999999999999999754321 1111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMF-EVY 580 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 580 (618)
+. .. ...++.+++.+||+.||++||++. +++
T Consensus 215 ~~-~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 215 YP-RW---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CC-CC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 10 11 223456677799999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=326.23 Aligned_cols=239 Identities=24% Similarity=0.329 Sum_probs=188.1
Q ss_pred cEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|... +++.||+|+++... ...+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999954 57899999997532 2344566788888764 899999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 152 (316)
T cd05619 81 GDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK- 152 (316)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc-
Confidence 99999986543 488999999999999999999999 9999999999999999999999999998753222111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... +......... +.
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~-------~~ 214 (316)
T cd05619 153 ---TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDN-------PC 214 (316)
T ss_pred ---eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC-------CC
Confidence 11234899999999999989999999999999999999999999753321 1111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMF-EVY 580 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 580 (618)
. +......+.+++.+||+.||++||++. ++.
T Consensus 215 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 Y----PRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C----CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0 011223456777799999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=320.17 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=200.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC---------------CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG---------------GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLG 368 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~ 368 (618)
++|++.+.||+|+||.||++...+ ...||+|.++... .....+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478889999999999999987532 2358999987542 33456899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCccccccCCCCC--------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCee
Q 007088 369 FCVAKKERLLVYSYLENGTLYDKLHPAEH--------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCIL 440 (618)
Q Consensus 369 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 440 (618)
++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999998854321 113478999999999999999999999 9999999999999
Q ss_pred eCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCC
Q 007088 441 LDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT--GERPTHLTNAP 518 (618)
Q Consensus 441 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt--G~~Pf~~~~~~ 518 (618)
+++++.+||+|||++......... .......++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EcCCCcEEecccccccccccCcce--eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 999999999999999765432211 11112235678999999988889999999999999999998 56677643221
Q ss_pred CccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 519 ESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 519 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
+ .+............. .........+..+.+++.+|++.||++||++++|++.|++
T Consensus 240 ~----~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 Q----VIENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred H----HHHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1 111111111110000 0000111123578888889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=315.72 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=194.7
Q ss_pred cEEeecCCeeEEEEEeCC-Cc--EEEEEEeccC--ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLPG-GC--FIMIKRLEDS--QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|...+ +. .+++|.++.. ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999643 43 5788988753 23446788999999999 799999999999999999999999999
Q ss_pred CccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 386 GTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 386 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999865431 123588999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
++........ . .....+..|+|||++.+..++.++||||||+++|||++ |..||..... .+.....
T Consensus 158 l~~~~~~~~~---~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~ 224 (270)
T cd05047 158 LSRGQEVYVK---K--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKL 224 (270)
T ss_pred Cccccchhhh---c--cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHH
Confidence 9863221110 0 01113567999999988889999999999999999997 9999865321 1111111
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
..... ..........+.+++.+|++.||.+|||+.|+++.|+++.
T Consensus 225 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCCCC----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11100 0111122346778888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=320.10 Aligned_cols=256 Identities=21% Similarity=0.293 Sum_probs=200.2
Q ss_pred cCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
+|.+.+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|+.++.+++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4666788999999999999853 257899999975432 23568899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCC------------CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc
Q 007088 379 VYSYLENGTLYDKLHPAE------------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 446 (618)
++||+++++|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999875321 1123588999999999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCH
Q 007088 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSL 525 (618)
Q Consensus 447 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l 525 (618)
+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------- 232 (283)
T cd05091 163 VKISDLGLFREVYAADYY--KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 232 (283)
T ss_pred eEecccccccccccchhe--eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 999999998865432211 11122235778999999988889999999999999999998 8888864321
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
.++......... . .........+.+++.+|++.+|++||+++||++.|+.
T Consensus 233 ~~~~~~i~~~~~-~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 QDVIEMIRNRQV-L---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHcCCc-C---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 122222211110 0 0112234557788889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=318.51 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=203.2
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
..++|++.+.||+|+||.||+|... .+..||+|.+..... ....+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999743 245899998865432 23457889999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCC------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 376 RLLVYSYLENGTLYDKLHPAEH------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
.++||||+++|+|.+++..... .....++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864321 123457788899999999999999999 9999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~ 528 (618)
+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~ 230 (288)
T cd05061 161 GDFGMTRDIYETDYYRK--GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQV 230 (288)
T ss_pred CcCCccccccccccccc--cCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999986543221111 111224678999999988889999999999999999998 7888864321 111
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
......... . .........+.+++.+|++.||++|||+.++++.|++..
T Consensus 231 ~~~~~~~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 LKFVMDGGY-L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHcCCC-C---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111111110 0 001122356778888999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.24 Aligned_cols=248 Identities=27% Similarity=0.382 Sum_probs=200.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.+|+..+.||+|++|.||+|.. .++..|++|.+.... ...+.+.+|+.+++.++|+||+++++.+....+.++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788899999999999999994 578999999886543 33566889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998542 378999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.. ......
T Consensus 172 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~-~~~~~~------ 233 (296)
T cd06654 172 KR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYL-IATNGT------ 233 (296)
T ss_pred cc----CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHH-HhcCCC------
Confidence 11 1224788999999998888999999999999999999999999754321 11111 110000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+ .........+.+++.+||..||++||++.|+++
T Consensus 234 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 111223355777888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=332.30 Aligned_cols=262 Identities=21% Similarity=0.326 Sum_probs=203.1
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKK 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 374 (618)
..++|.+.++||+|+||.||+|+.. .+..||+|+++... ...+.+.+|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456888899999999999999853 34689999997643 22346889999999997 999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCC---------------------------------------------------------
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH--------------------------------------------------------- 397 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 397 (618)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999998864321
Q ss_pred -------------------------------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCee
Q 007088 398 -------------------------------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCIL 440 (618)
Q Consensus 398 -------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 440 (618)
....+++..+..++.|++.||+|||+. +++||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 112477888999999999999999998 9999999999999
Q ss_pred eCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 007088 441 LDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPE 519 (618)
Q Consensus 441 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~ 519 (618)
+++++.+||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYI--SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EeCCCEEEEEecCcceecccccccc--cCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999998653322111 1112236788999999988889999999999999999998 888986432211
Q ss_pred ccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 520 SFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 520 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
.......... ....+......+.+++.+||..+|.+||+++||++.|+++.
T Consensus 350 -------~~~~~~~~~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -------QFYNAIKRGY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -------HHHHHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0111111110 00111112346777777999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.15 Aligned_cols=254 Identities=20% Similarity=0.212 Sum_probs=194.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||++.. .+++.||+|++.... .....+.+|++++++++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688999999999999999994 568999999986532 23456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRLG----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 9999999999997643 488899999999999999999999 999999999999999999999999999753311
Q ss_pred CCC---------------------------------------cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHH
Q 007088 461 VDT---------------------------------------HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVV 501 (618)
Q Consensus 461 ~~~---------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvi 501 (618)
... ..........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 00000112358999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC---CHHH
Q 007088 502 LLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH---TMFE 578 (618)
Q Consensus 502 l~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~e 578 (618)
+|||++|+.||...... +.......... .+...........+.+++.+|+ .+|.+|+ ++.|
T Consensus 234 lyell~G~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPA--------ETQLKVINWET-------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHH--------HHHHHHhccCc-------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 99999999999764321 11111110000 0000000112234455555765 5999999 8888
Q ss_pred HHHH
Q 007088 579 VYQL 582 (618)
Q Consensus 579 vl~~ 582 (618)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.58 Aligned_cols=243 Identities=19% Similarity=0.227 Sum_probs=188.9
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 567899999997532 2334578899999888 699999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 152 (327)
T cd05617 81 GDLMFHMQRQR----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT- 152 (327)
T ss_pred CcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc-
Confidence 99998886543 489999999999999999999999 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...++.......... .
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~------~ 221 (327)
T cd05617 153 ---TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM--NTEDYLFQVILEKPI------R 221 (327)
T ss_pred ---eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc--ccHHHHHHHHHhCCC------C
Confidence 12234899999999999999999999999999999999999999753322111 111111111111100 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 577 (618)
+ +......+.+++.+||+.||++|+++.
T Consensus 222 ~----p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 222 I----PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 0 111223456777799999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=318.33 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=202.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|.+.+.||+|+||.||+|... .+..|++|.+.... .....+.+|+.++++++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 57888999999999999999853 24789999987543 23456889999999999999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCC------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcc
Q 007088 378 LVYSYLENGTLYDKLHPAEHE------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 999999999999998654321 23478999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWIT 530 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~ 530 (618)
||+++......... ......++..|+|||.+.+..++.++|||||||++||+++ |..||...... ....+
T Consensus 163 fg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~~-- 233 (277)
T cd05032 163 FGMTRDIYETDYYR--KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE-----EVLKF-- 233 (277)
T ss_pred cccchhhccCcccc--cCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH-----HHHHH--
Confidence 99998654332111 1112236788999999988889999999999999999998 99998643221 11111
Q ss_pred HHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 531 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.. ..... ..+......+.+++.+||+.+|++|||+.|+++.|+
T Consensus 234 -~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 -VI-DGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -Hh-cCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11 11100 011122456778888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.38 Aligned_cols=264 Identities=23% Similarity=0.361 Sum_probs=206.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC--------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP--------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
.+|.+.+.||+|+||.||++... .+..||+|.++... ...+++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999732 12478999887532 2346788999999999 7999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
..+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999865321 124588999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~ 521 (618)
.++.+||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----- 241 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----- 241 (334)
T ss_pred CCCcEEECCcccceeccccccccc--ccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-----
Confidence 999999999999986543221111 111224567999999999899999999999999999998 888886432
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
..+.......... ..........+.+++.+|++.+|++||++.|+++.|+++......
T Consensus 242 ---~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 242 ---VEELFKLLKEGHR----------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred ---HHHHHHHHHcCCC----------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 1222222211110 011122345677888899999999999999999999999754443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=319.11 Aligned_cols=246 Identities=20% Similarity=0.222 Sum_probs=191.8
Q ss_pred EeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 314 IGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 314 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
||+|+||.||++.. .+|+.||+|.+.... ...+.+..|++++++++||||+++++++.++.+.++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999995 568999999986432 2234566799999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---- 151 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---- 151 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee----
Confidence 988865432 4588999999999999999999999 9999999999999999999999999998766432211
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
....|+..|+|||++.+..++.++||||+||++|||++|+.||....... ............ .. . ...
T Consensus 152 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~-~~----~--~~~ 219 (277)
T cd05607 152 -TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLED-EV----K--FEH 219 (277)
T ss_pred -eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhcc-cc----c--ccc
Confidence 12347899999999988889999999999999999999999997532210 111111111100 00 0 001
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
. ....++.+++.+||+.||++||+++|+++.+
T Consensus 220 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 220 Q---NFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred c---cCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 1 1234566777799999999999998876433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.99 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=213.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+...+.++||+|.||.|.++...++..||||.++... ...++|.+|+++|.+++||||++++|+|..++..++|+||+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 3456788999999999999999889999999998754 44578999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++...... ...-....+|+.||+.|++||.+. ++|||||.++|+|+|.++++||+|||+++.+-..+.
T Consensus 618 EnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999887642 245566788999999999999999 999999999999999999999999999996654443
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT--GERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt--G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
+... ...+-+..|||||.+.-++++.+||||+||+++||+++ ...||....+ ...++....+.........
T Consensus 693 y~vq--gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 693 YRVQ--GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred eeee--cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHhhhhhcCCCCccee
Confidence 3221 12234679999999999999999999999999999865 7888876433 2233333333222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
+ ..+.-++..+.+++.+||..|-++||+++++...|++..
T Consensus 766 l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 L------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred c------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 113345667889999999999999999999999988754
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.17 Aligned_cols=248 Identities=19% Similarity=0.319 Sum_probs=193.9
Q ss_pred EEeecCCeeEEEEEeC---CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCc
Q 007088 313 IIGTGRTGATYIAMLP---GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT 387 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 387 (618)
.||+|+||.||+|.+. ++..||+|++.... ...+.+.+|+.++++++|+||+++++++.. +..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999753 45679999987543 234568999999999999999999998854 56799999999999
Q ss_pred cccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccc
Q 007088 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467 (618)
Q Consensus 388 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 467 (618)
|.+++.... ..+++..+++++.|++.||+|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999986533 3589999999999999999999999 9999999999999999999999999999865433221111
Q ss_pred cccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccc
Q 007088 468 FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546 (618)
Q Consensus 468 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 546 (618)
.....++..|+|||...+..++.++||||||+++||+++ |..||..... .+..........
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~--------- 216 (257)
T cd05115 155 -RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFIEQGKR--------- 216 (257)
T ss_pred -cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCC---------
Confidence 111223578999999988889999999999999999996 9999875432 111111111110
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 547 LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
.........++.+++.+||..||++||++.+|.+.|+.+
T Consensus 217 -~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 -LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011122345667788899999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.86 Aligned_cols=240 Identities=20% Similarity=0.250 Sum_probs=190.2
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+|++.+.||+|+||.||+|... +++.||+|++.... ...+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999954 57899999987532 2234566788888777 5899999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 9999999999886543 488999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 154 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~~---- 217 (323)
T cd05616 154 DGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEHN---- 217 (323)
T ss_pred CCCc----cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC----
Confidence 2211 12234899999999999999999999999999999999999999754321 1111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
. ..+.....++.+++.+|++.||.+|++.
T Consensus 218 -----~--~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -----V--AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----C--CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 0011123456677779999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.07 Aligned_cols=240 Identities=21% Similarity=0.269 Sum_probs=191.1
Q ss_pred cEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||++... +++.||+|+++... .....+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999954 57899999997532 2345567888888887 799999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~L~~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99998886543 489999999999999999999999 99999999999999999999999999987532221111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ............ .
T Consensus 154 ----~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~~-------~ 214 (318)
T cd05570 154 ----STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDEV-------R 214 (318)
T ss_pred ----cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCC-------C
Confidence 123488999999999999999999999999999999999999975331 111111111100 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTM-----FEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 581 (618)
........+.+++.+||+.||.+||++ .++++
T Consensus 215 ----~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 ----YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ----CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 011123456777789999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.89 Aligned_cols=236 Identities=24% Similarity=0.278 Sum_probs=185.9
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEIN-TLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.. .+|+.||+|++.... ...+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 478999999996532 22334555554 56789999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 152 (323)
T cd05575 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT- 152 (323)
T ss_pred CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc-
Confidence 99999886543 488999999999999999999999 9999999999999999999999999998753222111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+......... ..
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~-------~~ 214 (323)
T cd05575 153 ---TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKP-------LR 214 (323)
T ss_pred ---cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCC-------CC
Confidence 1223489999999999999999999999999999999999999975322 11111111110 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 577 (618)
+. ......+.+++.+|++.||++||++.
T Consensus 215 ~~----~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 LK----PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CC----CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 11234567777799999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.99 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=196.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|+..+.||+|+||.||+|.. .+++.||+|++.... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999984 578999999986542 3345688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 367888999999999999999999 99999999999999999999999999997654321
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
. ....++..|+|||++.+..++.++||||||+++|+|++|+.||......+... ...++........
T Consensus 150 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~------ 216 (279)
T cd06619 150 A------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDED------ 216 (279)
T ss_pred c------cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccC------
Confidence 1 12347899999999998899999999999999999999999997533221111 1111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+.+.. .....++.+++.+|++.||++||+++|+++.
T Consensus 217 ~~~~~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 011111 1123456778889999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=330.46 Aligned_cols=237 Identities=23% Similarity=0.267 Sum_probs=189.8
Q ss_pred cEEeecCCeeEEEEEe----CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 312 NIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
+.||+|+||.||++.. .+|+.||+|+++... .....+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 467999999997532 233457789999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999986543 489999999999999999999999 9999999999999999999999999999765432211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .+.........
T Consensus 155 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~-------- 214 (318)
T cd05582 155 ----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAK-------- 214 (318)
T ss_pred ----eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCC--------
Confidence 1123489999999999988899999999999999999999999975322 11111111110
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFE 578 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 578 (618)
. ..+......+.+++.+||+.||++||++.+
T Consensus 215 -~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 -L--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -C--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0 001112245667777999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.02 Aligned_cols=264 Identities=21% Similarity=0.335 Sum_probs=202.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCC-----------------CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccc
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPG-----------------GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVP 365 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~ 365 (618)
.++|++.+.||+|+||.||++...+ +..||+|.+.... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999998532 2468999987543 34567889999999999999999
Q ss_pred eeEEEEeCCeeEEEEeecCCCccccccCCCCC-------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 007088 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEH-------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438 (618)
Q Consensus 366 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 438 (618)
+++++...+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999865441 123589999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCC
Q 007088 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT--GERPTHLTN 516 (618)
Q Consensus 439 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt--G~~Pf~~~~ 516 (618)
|+++.++.++|+|||+++.......... .....++..|+|||+..+..++.++|||||||++|||++ |..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRV--QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceee--cCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999876543221111 112235678999999988889999999999999999998 677775432
Q ss_pred CCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 517 APESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 517 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.. ................ ...........++.+++.+|++.||++|||+.|+++.|+
T Consensus 239 ~~-----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 DQ-----QVIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred hH-----HHHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11 1111111111000000 000111223357888888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=319.20 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=203.3
Q ss_pred CHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEE---
Q 007088 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCV--- 371 (618)
Q Consensus 297 ~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 371 (618)
.++.+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+........++.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455666788999999999999999999985 5688999999876555556788999999999 6999999999884
Q ss_pred --eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 372 --AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 372 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 33568999999999999988754322234588999999999999999999999 9999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS 524 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~ 524 (618)
+|||+++......... ....|+..|+|||++. +..++.++||||+||++|||++|+.||.......
T Consensus 166 ~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----- 236 (286)
T cd06638 166 VDFGVSAQLTSTRLRR----NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----- 236 (286)
T ss_pred ccCCceeecccCCCcc----ccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----
Confidence 9999998764322211 1234889999999875 3457889999999999999999999987543211
Q ss_pred HHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 525 LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 525 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.... ..... .....++ ......+.+++.+||+.||++|||+.|+++.
T Consensus 237 --~~~~-~~~~~-~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 --ALFK-IPRNP-PPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --HHhh-ccccC-CCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1100 00000 0000011 1122457788889999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.27 Aligned_cols=252 Identities=19% Similarity=0.266 Sum_probs=199.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc------CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH------SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|...+.||+|++|.||++.. .++..|++|.+..... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999995 5689999999864321 23468889999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999999999886543 488999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
........ ......++..|+|||++.+..++.++||||+|+++|||++|+.||...... ..... ......
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~-~~~~~~- 224 (263)
T cd06625 155 QTICSSGT-GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFK-IATQPT- 224 (263)
T ss_pred cccccccc-cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHH-HhccCC-
Confidence 43211111 011233678999999999988999999999999999999999998653221 11111 100000
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
...........+.+++.+||..+|.+|||+.|+++.
T Consensus 225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 --------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111233456777789999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.34 Aligned_cols=264 Identities=20% Similarity=0.335 Sum_probs=201.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-----------------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccce
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-----------------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPL 366 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l 366 (618)
++|++.++||+|+||.||++... ++..||+|+++... ....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999998532 24579999997543 334678999999999999999999
Q ss_pred eEEEEeCCeeEEEEeecCCCccccccCCCCC-------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 007088 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEH-------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCI 439 (618)
Q Consensus 367 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 439 (618)
++++...+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999865432 123478889999999999999999999 999999999999
Q ss_pred eeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCC
Q 007088 440 LLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT--GERPTHLTNA 517 (618)
Q Consensus 440 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt--G~~Pf~~~~~ 517 (618)
+++.++.++|+|||+++.+....... ......++..|+|||...+..++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR--IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee--ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999998654322111 1111224578999998888889999999999999999998 7788864332
Q ss_pred CCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 518 PESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
.+ ................. ..........+.+++.+||+.||.+||++.||.+.|++
T Consensus 240 ~~-----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ-----VIENTGEFFRDQGRQVY------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH-----HHHHHHHHHhhcccccc------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111111000000000 01112233577888889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=312.13 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=199.9
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+|++.+.||+|+||.||++.. .++..||+|.++.. ....+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999995 46899999988542 234567889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999998865432 4578999999999999999999999 999999999999999999999999999976643222
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ....++..|+|||+..+..++.++||||||+++|+|++|+.||..... .......... ...
T Consensus 156 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~---- 218 (255)
T cd08219 156 YA----CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQG-SYK---- 218 (255)
T ss_pred cc----ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhcC-CCC----
Confidence 11 123378899999999888899999999999999999999999975321 1111111111 000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.........+.+++.+||+.||++||++.|++..
T Consensus 219 -----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 -----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011123456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=317.30 Aligned_cols=261 Identities=23% Similarity=0.350 Sum_probs=205.1
Q ss_pred ccCHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 007088 295 KMRLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVA 372 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 372 (618)
..++.++....+.|+..+.||+|+||.||+|.. .+++.||+|++........++..|+.++.++ +|+||+++++++..
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 346677777889999999999999999999995 5689999999876655566788999999998 69999999999853
Q ss_pred ------CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc
Q 007088 373 ------KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446 (618)
Q Consensus 373 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 446 (618)
.+..+++|||+++|+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence 3577999999999999999875443 3578888999999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007088 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521 (618)
Q Consensus 447 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~ 521 (618)
++|+|||++.......... ....|+..|+|||.+. +..++.++|||||||++|||++|+.||.........
T Consensus 160 ~~l~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 160 VKLVDFGVSAQLDRTVGRR----NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred EEEeeCcchhhhhccccCC----CcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 9999999987654322111 1234788999999875 356788999999999999999999999653321100
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .... .....+.. ......+.+++.+||+.||.+||++.|+++
T Consensus 236 -------~-~~~~------~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -------F-LIPR------NPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------h-hHhh------CCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0000 00111111 123346778888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=316.83 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=200.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|+..++||+|+||.||++.. .++..+++|.+.... ...+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4577788999999999999973 235689999886543 345679999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 379 VYSYLENGTLYDKLHPAEH-----------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
||||+++|+|.+++..... ....+++..++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999998865431 113588999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||++.......... ......+++.|+|||+..+..++.++|||||||++|||++ |+.||......
T Consensus 162 kL~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------- 231 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------- 231 (280)
T ss_pred EECCCCceeEcCCCceee--cCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH--------
Confidence 999999997654322111 1111224678999999998899999999999999999998 99998653321
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
+........... .........+.+++.+||+.||.+||++.||++.|++
T Consensus 232 ~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 232 EAIECITQGREL----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHHcCccC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111111000 0111223456778889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=319.15 Aligned_cols=260 Identities=21% Similarity=0.254 Sum_probs=191.5
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcC---CCCCccceeEEEEeC-----C
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSV---RHRNLVPLLGFCVAK-----K 374 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~ 374 (618)
+|++.+.||+|+||.||+|.. .+++.||+|.++... .....+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478889999999999999995 468999999986432 2234556777777665 799999999988652 3
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57899999975 88888865432 3489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
++........ ....+|..|+|||++.+..++.++||||+||++|||++|++||......+ .+.........
T Consensus 155 ~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~ 225 (288)
T cd07863 155 ARIYSCQMAL-----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIGL 225 (288)
T ss_pred cccccCcccC-----CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH----HHHHHHHHhCC
Confidence 9866432211 12347889999999988899999999999999999999999986543211 11111111000
Q ss_pred ---CCcc------chhcccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 ---NSSL------ETAIDKSLL---GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ---~~~~------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+. .....+... ..........+.+++.+||+.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 000000000 0001122345678888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.07 Aligned_cols=261 Identities=24% Similarity=0.376 Sum_probs=203.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC--------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP--------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
++|.+.+.||+|+||.||++... ....||+|.++... ....++.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56888999999999999999742 24579999987543 2345688999999999 6999999999999988
Q ss_pred eeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 99999999999999999865321 124589999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~ 521 (618)
.++.+||+|||.++........... ....++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---- 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKT--SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---- 242 (314)
T ss_pred CCCcEEEcccccccccccccccccc--ccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence 9999999999999876432211111 11124467999999988889999999999999999999 8888864321
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.+.......... . ........++.+++.+|++.||++||++.|+++.|+++...
T Consensus 243 ----~~~~~~~~~~~~-~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 ----EELFKLLREGHR-M---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHHHHHHHcCCC-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 111111111100 0 11122234667788899999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=318.89 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=205.9
Q ss_pred cCHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 007088 296 MRLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK 373 (618)
Q Consensus 296 ~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 373 (618)
+.+.++..++++|++.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.++.++ +|||++++++++...
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 45567777889999999999999999999995 5789999999976555567788999999999 899999999998754
Q ss_pred -----CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceE
Q 007088 374 -----KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448 (618)
Q Consensus 374 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 448 (618)
+..++||||+++|+|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 357999999999999998864332234689999999999999999999999 999999999999999999999
Q ss_pred EcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 007088 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-----VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523 (618)
Q Consensus 449 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~ 523 (618)
|+|||++.......... ....++..|+|||.+... .++.++|||||||++|||++|+.||......+
T Consensus 169 l~dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~---- 240 (291)
T cd06639 169 LVDFGVSAQLTSTRLRR----NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK---- 240 (291)
T ss_pred Eeecccchhcccccccc----cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH----
Confidence 99999988654322211 122378899999987543 36889999999999999999999997533211
Q ss_pred CHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+..+ ... ......+ .......+.+++.+|++.+|++||++.|+++
T Consensus 241 ~~~~~----~~~-~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 TLFKI----PRN-PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHH----hcC-CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 000 0001101 1123346778888999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.70 Aligned_cols=257 Identities=23% Similarity=0.392 Sum_probs=201.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CC---cEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GG---CFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
+.|.+.+.||+|+||.||+|... ++ ..|++|.++.. ....++|..|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34777899999999999999954 23 46999998753 23456799999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999987543 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCccc-ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 460 PVDTHLS-TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 460 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... ....+...+..|+|||++.+..++.++|||||||++||+++ |..||...... ....+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~~~~i~---~~~~ 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DVINAIE---QDYR 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HHHHHHH---cCCc
Confidence 3222111 10111112457999999998899999999999999999886 99998653321 1112211 1100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
. ....+.+..+.+++.+|++.+|.+||++++++..|+++
T Consensus 230 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 L----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01112334577888899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=317.88 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=201.9
Q ss_pred cCCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERL 377 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 377 (618)
.|++.+.||+|+||.||++.. .++..||+|.++... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999973 357899999986432 3345789999999999999999999998775 5678
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999986543 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC-------ccccCHHHHHH
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE-------SFKGSLVEWIT 530 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~-------~~~~~l~~~~~ 530 (618)
........ .......++..|+|||.+.+..++.++||||||+++|||++++.|+....... ........+..
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 159 IETDKEYY-TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred cccCccce-eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65432211 11122336678999999888889999999999999999999887654321100 00011111111
Q ss_pred HHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 531 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
...... ...........+.+++.+|++.||++||+++++++.|+++
T Consensus 238 ~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 0011122345678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.02 Aligned_cols=240 Identities=24% Similarity=0.276 Sum_probs=186.4
Q ss_pred cEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEIN-TLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|... +++.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 67889999986532 22234444444 56788999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~- 152 (325)
T cd05602 81 GELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT- 152 (325)
T ss_pred CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC-
Confidence 99999887543 378888999999999999999999 9999999999999999999999999999754322211
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......... . .
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~-~------~ 214 (325)
T cd05602 153 ---TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKP-L------Q 214 (325)
T ss_pred ---cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCC-c------C
Confidence 12234899999999999999999999999999999999999999753321 1111111110 0 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .......+.+++.+|++.||.+||++.+.+.
T Consensus 215 ~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 L----KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred C----CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0 0112335666777999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.86 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=202.5
Q ss_pred HhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc-----cC----HHHHHHHHHHHhcC-CCCCccceeEEEE
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-----HS----EKEFLSEINTLGSV-RHRNLVPLLGFCV 371 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~----~~~~~~E~~~l~~l-~h~niv~l~~~~~ 371 (618)
..-+.|...+.+|.|..++|-++. .++|..+|+|++.... .. .+.-.+|+.+|+++ .||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 345678888999999999999888 5678889999885321 11 23457899999998 6999999999999
Q ss_pred eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcc
Q 007088 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 372 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
.+...++|+|.|+.|.|++++... ..+++....+|++|+..|++|||.. +||||||||+|||+|++.++||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999999999865 4599999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR------TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l 525 (618)
||+|..+.+... .+..+||++|.|||.+. ...|+...|+||+|||+|.|+.|.+||..... .+
T Consensus 167 FGFa~~l~~Gek-----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ml 235 (411)
T KOG0599|consen 167 FGFACQLEPGEK-----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ML 235 (411)
T ss_pred cceeeccCCchh-----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HH
Confidence 999998865432 34456999999999765 34688899999999999999999999975221 00
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+..+.. . . ......+.+......+|+.+||+.||.+|.|++|+++
T Consensus 236 --MLR~ImeG-k-y-----qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 --MLRMIMEG-K-Y-----QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred --HHHHHHhc-c-c-----ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 01111110 0 0 1122334455566777888999999999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=323.72 Aligned_cols=264 Identities=18% Similarity=0.249 Sum_probs=195.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|.+.+.||+|+||.||+|+. .+++.||+|.++... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688899999999999999995 467899999986432 3344677899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888776543 3478999999999999999999999 99999999999999999999999999997644322
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH--------HHHHHHHh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL--------VEWITLLN 533 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l--------~~~~~~~~ 533 (618)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+...... ..|.. ..
T Consensus 159 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 233 (309)
T cd07872 159 KTY----SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG-IS 233 (309)
T ss_pred ccc----ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-hc
Confidence 211 12347889999998764 568899999999999999999999997644321110000 00100 00
Q ss_pred cCCccchhccccccCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGN----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........-.+..... .......++.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000000000 00112345667888999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.22 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=200.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC-Ce
Q 007088 306 NSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK-KE 375 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 375 (618)
++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788999999999999999973 356899999997543 2345688999999999 689999999988654 45
Q ss_pred eEEEEeecCCCccccccCCCCC----------------------------------------------------------
Q 007088 376 RLLVYSYLENGTLYDKLHPAEH---------------------------------------------------------- 397 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 397 (618)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999988764321
Q ss_pred -----CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCC
Q 007088 398 -----EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE 472 (618)
Q Consensus 398 -----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 472 (618)
....+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++........... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~ 241 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR--KGDA 241 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh--cCCC
Confidence 012478888999999999999999999 999999999999999999999999999986533221111 1112
Q ss_pred CCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCC
Q 007088 473 FGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGF 551 (618)
Q Consensus 473 ~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 551 (618)
.++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....... ...... ..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~-~~~~~~---------~~ 304 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLK-EGTRMR---------AP 304 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------HHHHHHh-ccCCCC---------CC
Confidence 25678999999988899999999999999999997 999986532210 1111111 110000 00
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 552 DGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 552 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
......+.+++.+||+.||++||++.|+++.|+.+.+
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1112357788889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.49 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=192.4
Q ss_pred cEEeecCCeeEEEEEeC----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeeEEEEeecC
Q 007088 312 NIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVA-KKERLLVYSYLE 384 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 384 (618)
+.||+|+||.||+|... +...||+|++.... ...+.+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999843 24679999985432 334678899999999999999999998764 456789999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++.... ...++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999987543 2367888899999999999999999 9999999999999999999999999999765432211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITG-ERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG-~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.........++..|+|||...+..++.++||||||+++|||++| .+||..... .............
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~----- 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRL----- 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCCC-----
Confidence 11111122356789999999888899999999999999999995 455543211 1111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
......+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 222 -----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 222 -----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 0011123467788889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.06 Aligned_cols=263 Identities=20% Similarity=0.258 Sum_probs=195.4
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----eeE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK-----ERL 377 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 377 (618)
+|+..+.||+|+||.||++.. .+++.||+|++.... ...+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999995 578999999986532 23467889999999999999999999998776 789
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+. ++|.+.+... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 4788777543 3489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc--------CHHHH
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG--------SLVEW 528 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~--------~l~~~ 528 (618)
....... ......++..|+|||++.+. .++.++||||+||++|||++|+.||......+.... ....+
T Consensus 153 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 153 EEPDESK---HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred cccCccc---cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 5432211 11223478899999988764 478999999999999999999999976443211000 00000
Q ss_pred H-------HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 529 I-------TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 529 ~-------~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
. ............. ..+ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 230 RSACEGARAHILRGPHKPPSL-PVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHhhHHHHHHHHhCCCCCCch-HHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000000000 000 00011123457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.74 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=201.5
Q ss_pred cEEeecCCeeEEEEEeCC----CcEEEEEEeccCccC--HHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQHS--EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.... +..|++|.++..... .+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999643 889999999765433 57889999999999999999999999998999999999999
Q ss_pred CccccccCCCCCC-----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 386 GTLYDKLHPAEHE-----VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 386 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
++|.+++...... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875211 25699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.... .......++..|+|||.+....++.++||||+|+++|||++ |..||..... .+..........
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~-- 225 (262)
T cd00192 158 DDYY--RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYR-- 225 (262)
T ss_pred cccc--ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 3321 11123346889999999988889999999999999999999 6999876422 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
..........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 226 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 --------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222456778888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.03 Aligned_cols=263 Identities=18% Similarity=0.202 Sum_probs=195.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
..+|.+.+.||+|+||.||++... .++.||+|.... ..+.+|++++++++|+||+++++++...+..++|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 346899999999999999999964 578999996432 34678999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
. ++|.+++.... ..+++..++.|+.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 5 68888876543 3599999999999999999999999 999999999999999999999999999986543221
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc---ccCHHHHHHHHhcC-Cccc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF---KGSLVEWITLLNTN-SSLE 539 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~---~~~l~~~~~~~~~~-~~~~ 539 (618)
.. ......||..|+|||++.+..++.++|||||||++|||++|..|+......... ...+...+...... ....
T Consensus 316 ~~--~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 316 TP--FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cc--cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 11 112335899999999999999999999999999999999988776443221111 11111111111100 0000
Q ss_pred hhc----------------cccccCCCCH---HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAI----------------DKSLLGNGFD---GELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~----------------d~~l~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .+......+. .....+.+++.+||+.||.+|||+.|+++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 0000000000 11235677888999999999999999986
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.88 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=206.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-----CCcEEEEEEeccCccC--HHHHHHHHHHHhcCCCCCccceeEEEEe--CCee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-----GGCFIMIKRLEDSQHS--EKEFLSEINTLGSVRHRNLVPLLGFCVA--KKER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 376 (618)
+.|+..+.||+|+||.||++... ++..||+|.++..... .+.+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35777889999999999999853 3689999999865543 6789999999999999999999999877 5578
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997654 2589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc-------ccCHHHHH
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF-------KGSLVEWI 529 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~-------~~~l~~~~ 529 (618)
.......... ......++..|+|||...+..++.++||||||+++|||++|+.|+......... ......+.
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 158 VLPEDKDYYY-VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccccCCccee-ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 7653222111 111123456799999998889999999999999999999999998653221100 00111111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
....... ...........+.+++.+|++.+|++||++.||+++|+.++
T Consensus 237 ~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 237 ELLKEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111111 01111223356888888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.42 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=221.0
Q ss_pred cCCCCcEEeecCCeeEEEEEeCC-CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+....++||-|.||.||.|.++. ...||||.++.+....++|..|..+|+.++|||+|+++|+|.....+|||+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 45557899999999999999765 57899999999888899999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+||..... ..++.-..+.++.||..|++||..+ ++|||||.++|.|+.++..+|++|||+++.+.......
T Consensus 348 GNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 348 GNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 999999987654 4577777899999999999999999 99999999999999999999999999999987543221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
. .+.--...|.|||-+....++.|+|||+|||+|||+.| |..||...+ +.+. ...+.+
T Consensus 423 H---AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqV----------Y~LLEk 481 (1157)
T KOG4278|consen 423 H---AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQV----------YGLLEK 481 (1157)
T ss_pred c---cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHH----------HHHHhc
Confidence 1 11123568999999999999999999999999999998 888886532 2222 223333
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTT 594 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (618)
..+.+.+..++..+.+|+++||+.+|.+||++.|+.+.++.+-..-..++
T Consensus 482 gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSisd 531 (1157)
T KOG4278|consen 482 GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSISD 531 (1157)
T ss_pred cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccccH
Confidence 44455567788899999999999999999999999999988766544444
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=326.89 Aligned_cols=198 Identities=25% Similarity=0.326 Sum_probs=175.5
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-C-----CCccceeEEEEeCCeeEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-H-----RNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~lV 379 (618)
+|++.+.||+|.||.|-+|. ..+++.||||+++....-..+-..|+.+|..++ | -|+|+++++|...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 89999999999999999999 567999999999988777777888999999996 4 4899999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC--CceEEcccCcccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD--FEPKLSDFGLARL 457 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~a~~ 457 (618)
+|.+.. +|.++++.+.. ..++...+..|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|||.|..
T Consensus 267 fELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999965 99999988766 5699999999999999999999999 99999999999999644 3699999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
..+... ...-+..|+|||++.|.+|+.+.||||||||+.||++|.+.|.+.++
T Consensus 341 ~~q~vy-------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQRVY-------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcce-------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 654332 12257889999999999999999999999999999999888876543
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=309.32 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=202.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC-CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
++|+..+.||+|++|.||+|...+ +..|++|.+..... .+++.+|++++++++|+||+++++++.+....++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 578889999999999999999654 78999999876533 6789999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 82 AGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 999999986543 4589999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
. ....++..|+|||++.+..++.++||||||+++|+|++|+.||........ .. .. .... .+
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------~~-~~-~~~~-----~~ 217 (256)
T cd06612 156 R----NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------IF-MI-PNKP-----PP 217 (256)
T ss_pred c----ccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------hh-hh-ccCC-----CC
Confidence 1 112368899999999888999999999999999999999999975332110 00 00 0000 00
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ .........+.+++.+|++.||++|||+.|+++
T Consensus 218 ~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 011122346777888999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.51 Aligned_cols=259 Identities=19% Similarity=0.220 Sum_probs=198.2
Q ss_pred HHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 007088 298 LSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372 (618)
Q Consensus 298 ~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 372 (618)
+.++....++|++.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344555678999999999999999999995 468899999986422 233457889999999999999999999999
Q ss_pred CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 373 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
.+..++||||+++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998643 378888999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL----VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
|+++......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+. ...
T Consensus 187 G~a~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~ 255 (371)
T cd05622 187 GTCMKMNKEGMVR---CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGT 255 (371)
T ss_pred CceeEcCcCCccc---ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHH
Confidence 9998764322111 1234589999999988654 378999999999999999999999975332 111
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKE--RHTMFEVYQL 582 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 582 (618)
.............. ........+.+++.+|+..++.+ ||+++|+++.
T Consensus 256 ~~~i~~~~~~~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 256 YSKIMNHKNSLTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHHcCCCcccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111111100000 01112334556666999744433 7889888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=307.85 Aligned_cols=280 Identities=24% Similarity=0.349 Sum_probs=213.6
Q ss_pred cccCHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhc--CCCCCccceeEEEE
Q 007088 294 EKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGS--VRHRNLVPLLGFCV 371 (618)
Q Consensus 294 ~~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~ 371 (618)
..+++---....++....+.||+|.||.||+|.+ .|..||||++... +++...+|.++.+. ++|+||+.+++.-.
T Consensus 199 SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 199 SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred CCchhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 3444444555667788899999999999999998 5778999999653 45567778777766 49999999998865
Q ss_pred eCC----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecCCCCCCeeeC
Q 007088 372 AKK----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN-----CNPRIIHRNISSKCILLD 442 (618)
Q Consensus 372 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~ 442 (618)
.++ +.|||++|.+.|||+|||... .++....++++..+|.||++||.. .+|.|.|||||+.|||+.
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 543 679999999999999999764 489999999999999999999975 468999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCC------CCCccchHHHHHHHHHHHhC--------
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV------ATPKGDVYSFGVVLLELITG-------- 508 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVwS~Gvil~elltG-------- 508 (618)
+++.+.|+|+|+|..............+.++||.+|||||++.... .-..+||||||.++||+...
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 9999999999999887765555555667788999999999876432 12469999999999999752
Q ss_pred --CCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 509 --ERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 509 --~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
+.||.+.-+.+.....+.+ ..=..++...++.++ ...+.+..+.++++.||..+|..|-|+=.+-+.|.++
T Consensus 431 ey~~Pyyd~Vp~DPs~eeMrk----VVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDPSFEEMRK----VVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred hhcCCcccCCCCCCCHHHHhc----ceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 3566543322111111111 000111111111111 1346888999999999999999999999999999888
Q ss_pred hh
Q 007088 587 AE 588 (618)
Q Consensus 587 ~~ 588 (618)
.+
T Consensus 504 ~~ 505 (513)
T KOG2052|consen 504 SN 505 (513)
T ss_pred hc
Confidence 64
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.97 Aligned_cols=240 Identities=24% Similarity=0.281 Sum_probs=187.3
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEIN-TLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.. .+|+.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999994 578999999996532 22344555655 46778999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|..++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~- 152 (325)
T cd05604 81 GELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT- 152 (325)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC-
Confidence 99998886543 489999999999999999999999 9999999999999999999999999998753221111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +......... . .
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~~-~------~ 214 (325)
T cd05604 153 ---TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHKP-L------V 214 (325)
T ss_pred ---cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcCC-c------c
Confidence 12234899999999999999999999999999999999999999754321 1111111110 0 0
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+. ......+.+++.+|++.||.+||++++.++
T Consensus 215 ~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 215 LR----PGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 01 112235667777999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=307.30 Aligned_cols=251 Identities=22% Similarity=0.257 Sum_probs=202.0
Q ss_pred cCCCCcEEeecCCeeEEEEEeCC-CcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.|+..+.||+|.-|+||++.+.+ +..+|+|++.+.. ....+.+.|-+||+.++||.++.+|..++.++..|+|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45557889999999999999654 5899999997643 233456789999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
||+||+|..+.+.+.. ..+++..+.-++.+++-||+|||-. |||.|||||+||||-++|++-|+||.++......
T Consensus 158 yCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999987765 6799999999999999999999999 9999999999999999999999999988654210
Q ss_pred CC------------------------------c-c---------------------cccccCCCCcccccCCCCCCCCCC
Q 007088 462 DT------------------------------H-L---------------------STFVNGEFGDLGYVAPEYPRTLVA 489 (618)
Q Consensus 462 ~~------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 489 (618)
.. . . ....+.-+||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 0 0 001112359999999999999999
Q ss_pred CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCC
Q 007088 490 TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPT 569 (618)
Q Consensus 490 ~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d 569 (618)
+.++|.|+|||++|||+.|..||...+..+.... ++-+.+...........+.+||++.|.+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N-----------------Iv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN-----------------IVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH-----------------HhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999998765433221 11222221222234456677888999999
Q ss_pred CCCCCC----HHHH
Q 007088 570 PKERHT----MFEV 579 (618)
Q Consensus 570 P~~RPs----~~ev 579 (618)
|++|.. ++||
T Consensus 376 P~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEI 389 (459)
T ss_pred hhhhhccccchHHh
Confidence 999987 6665
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=323.76 Aligned_cols=240 Identities=20% Similarity=0.244 Sum_probs=190.1
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 380 (618)
+|+..+.||+|+||.||+|.. .+++.||+|++.... ...+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467789999999999999995 568999999987532 23355778888888885 577888999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 9999999999886543 489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus 154 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~~~--- 218 (323)
T cd05615 154 DGVT----TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--------ELFQSIMEHNV--- 218 (323)
T ss_pred CCcc----ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCC---
Confidence 2211 12234899999999999889999999999999999999999999754321 11111111100
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
. .+......+.+++.+||+.||.+|++.
T Consensus 219 ----~----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 ----S----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----C----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 011123456677789999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=324.78 Aligned_cols=198 Identities=26% Similarity=0.347 Sum_probs=167.7
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK----- 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 374 (618)
..++|+..+.||+|+||.||++.. .+|..||+|++... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999995 56899999999653 233456789999999999999999999986543
Q ss_pred -eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 375 -ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 375 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999976 5666553 2378889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 169 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 169 LARTACTNFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CccccccCcc-----CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 9976432211 122347899999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=316.69 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=202.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|+..+.||+|+||.||+|... ++..||+|++.... ...+++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 46889999987543 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCC------------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 007088 377 LLVYSYLENGTLYDKLHPAEH------------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 438 (618)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999864321 123578899999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCC
Q 007088 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNA 517 (618)
Q Consensus 439 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~ 517 (618)
|+++.++.++|+|||++........... ......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKA--SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccc--cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999876543221110 111224567999999988899999999999999999997 8888864321
Q ss_pred CCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 518 PESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
.+........ ... .........+.+++.+|++.||++|||+.|+++.|++
T Consensus 239 --------~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 --------EEVIYYVRDG-NVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --------HHHHHHHhcC-CCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1222221111 110 0011233567788889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=325.91 Aligned_cols=236 Identities=23% Similarity=0.286 Sum_probs=185.3
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEIN-TLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|+. .+++.||+|++.... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 468999999986532 22334555554 57889999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET- 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc-
Confidence 99988886433 488899999999999999999999 9999999999999999999999999998753222111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ...........
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~--------- 212 (321)
T cd05603 153 ---TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHKP--------- 212 (321)
T ss_pred ---cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcCC---------
Confidence 1223489999999999988999999999999999999999999975321 11111111110
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 577 (618)
+ .........+.+++.+||+.||.+||++.
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 L--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0 01112234567778899999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.30 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=197.9
Q ss_pred cEEeecCCeeEEEEEeCC--C--cEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLPG--G--CFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|++|.||+|...+ + ..||+|.+..... ..+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998533 3 3699999976543 45678999999999999999999999988 888999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999876542 4589999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
... ....++..|+|||++.+..++.++|||||||++|||++ |+.||...... +............
T Consensus 155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~----- 220 (257)
T cd05040 155 VME-EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGERL----- 220 (257)
T ss_pred ecc-cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCcC-----
Confidence 111 12336788999999998899999999999999999998 99998643221 1111111111000
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
......+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123456778888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.10 Aligned_cols=250 Identities=25% Similarity=0.297 Sum_probs=196.7
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.|+..+.||+|+||.||++.. .+++.||+|.+.... ...+.+.+|+.++++++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999995 568999999986532 223457789999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998854332 3589999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
... ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ........... .
T Consensus 156 ~~~-----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~--~--- 220 (285)
T cd05630 156 QTI-----KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKE--V--- 220 (285)
T ss_pred ccc-----cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhh--h---
Confidence 211 12348999999999999899999999999999999999999997543211 00001100000 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
.... .......+.+++.+||+.||++||| ++|+++
T Consensus 221 -~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 -QEEY----SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhhc----CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0001 1112234667777999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=326.98 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=197.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC---CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP---GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
..+|.+.+.||+|+||.||++... .+..|++|.+... +...+|++++++++||||+++++++......++|||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 357999999999999999999743 3578999988653 235689999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+. ++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++.++.++|+|||+++.....
T Consensus 167 ~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 996 5888888433 3589999999999999999999999 9999999999999999999999999999766543
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC-----
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS----- 536 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~----- 536 (618)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+...........
T Consensus 239 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 239 PDTP--QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred cccc--cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCccccCC
Confidence 2211 1123458999999999999999999999999999999999999997654321 1111111111110000
Q ss_pred -----------------ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 537 -----------------SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 537 -----------------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.........+... ....++.+++.+||..||++|||+.|++..
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKY---GMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhcc---CcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 112456677889999999999999999764
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=318.18 Aligned_cols=274 Identities=19% Similarity=0.255 Sum_probs=200.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|.+.+.||+|+||.||+|.. .+++.||+|.++... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4688899999999999999985 468899999986432 3345678899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
++ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 58988886543 3488999999999999999999999 99999999999999999999999999997643322
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc--------CHHHHHHHHh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG--------SLVEWITLLN 533 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~--------~l~~~~~~~~ 533 (618)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+.... ....|... .
T Consensus 159 ~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 233 (301)
T cd07873 159 KT----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI-L 233 (301)
T ss_pred Cc----ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh-h
Confidence 11 112236889999998765 4578899999999999999999999975432110000 00000000 0
Q ss_pred cCCccchhccccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhhhhcC
Q 007088 534 TNSSLETAIDKSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ--LLRAIAERYH 591 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~~~ 591 (618)
........-.+....+. .......+.+++.+|++.||.+|||++|+++ .++.+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~ 297 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIH 297 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhh
Confidence 00000000000000000 0112335667888999999999999999986 5555555544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.04 Aligned_cols=249 Identities=26% Similarity=0.367 Sum_probs=200.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|++|.||++.. .+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788999999999999999994 578999999986543 3445688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999988542 378999999999999999999999 99999999999999999999999999987654332
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....+++.|+|||...+..++.++|||||||++|++++|+.||........... .....
T Consensus 170 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------~~~~~------ 231 (297)
T cd06656 170 SKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------IATNG------ 231 (297)
T ss_pred cCc----CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------eccCC------
Confidence 211 122378899999999988899999999999999999999999975432111000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+. ..........+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 232 TPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 0011222345667778999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=310.39 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=201.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC----CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|...+.||+|+||.||+|...+ ...|++|...... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998533 3578999886543 345678999999999999999999999875 457899
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999996543 3489999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
........ ...++..|+|||.+....++.++||||||+++||+++ |..||...... ....+. ......
T Consensus 159 ~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~---~~~~~~ 227 (270)
T cd05056 159 DESYYKAS---KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DVIGRI---ENGERL 227 (270)
T ss_pred cccceecC---CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHH---HcCCcC
Confidence 43221111 1224568999999988889999999999999999986 99999754321 111111 111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.........+.+++.+|+..+|.+|||+.++++.|+++..+
T Consensus 228 ----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 ----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112234677788899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=311.02 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=203.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CC----cEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GG----CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.+|++.+.||+|+||.||+|... +| ..||+|.+.... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999853 33 368999887653 234678899999999999999999999987 78899
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999987654 3489999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....++..|+|||......++.++||||||+++||+++ |+.||..... .++.........
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~ 229 (279)
T cd05057 160 DVDEKEYH--AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGER 229 (279)
T ss_pred cCccccee--cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence 54322211 112224568999999988889999999999999999998 9999875322 112211111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
. ..+......+.+++.+||..||.+||++.++++.|+++.++
T Consensus 230 ~----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 L----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 00111224567788899999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.81 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=198.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.+.||+|+||.||++.. .++..+++|.++... ....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999995 468889999886532 2345688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.... .+++..+..++.|+++||.|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997543 4889999999999999999999732 89999999999999999999999999987653321
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc----
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL---- 538 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~---- 538 (618)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+... ...+..........
T Consensus 155 ~------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 155 A------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESH 223 (308)
T ss_pred c------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCc
Confidence 1 12347889999999988889999999999999999999999986433111 11111000000000
Q ss_pred ----------------chhc-------cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 539 ----------------ETAI-------DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 539 ----------------~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+.. .+.+.. ......+.+++.+||+.||++||++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000000 0123457788889999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.95 Aligned_cols=249 Identities=23% Similarity=0.323 Sum_probs=205.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 378 (618)
...|+..+.||+|.||.||+++.+ +|+.+|+|.+.+.. .....+.+|+.+|+++. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456888899999999999999955 49999999997643 24468999999999998 9999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC----CceEEcccCc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD----FEPKLSDFGL 454 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~ 454 (618)
|||++.||.|.+.+... .+++..+..++.|++.+++|||+. ||+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999765 289999999999999999999999 99999999999999633 5799999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
+..... ... ....+||+.|+|||++....|+.++||||+||++|.|++|.+||.......... .....
T Consensus 186 a~~~~~-~~~----~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~ 253 (382)
T KOG0032|consen 186 AKFIKP-GER----LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG 253 (382)
T ss_pred ceEccC-Cce----EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC
Confidence 998765 222 234459999999999999999999999999999999999999998765322111 11111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+ .......++.......+++..|+..||.+|+|+.++++
T Consensus 254 ~--------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 254 D--------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C--------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1 01222333444455666666999999999999999998
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.71 Aligned_cols=249 Identities=23% Similarity=0.250 Sum_probs=195.6
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
|+..+.||+|+||.||++.. .+++.||+|.+.... .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999995 578999999986532 2234578899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865432 3599999999999999999999999 99999999999999999999999999987654321
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
. .....|+..|+|||++.+..++.++|+||||+++|||++|+.||....... ............. .
T Consensus 157 ~-----~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~----~~~~~~~~~~~~~---~-- 222 (285)
T cd05632 157 S-----IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV----KREEVDRRVLETE---E-- 222 (285)
T ss_pred c-----ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhhhccc---c--
Confidence 1 122348999999999988899999999999999999999999997533211 0111111111000 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
.........+.+++.+|++.||++||+ +.++++
T Consensus 223 ------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 ------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 001112335567777999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=313.07 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=196.1
Q ss_pred CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHH---HHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEK---EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
|+..+.||+|+||.||++... +++.||+|++........ ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 566789999999999999964 567999999987653332 2345999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999722 3489999999999999999999999 999999999999999999999999999976421111
Q ss_pred cccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
......++..|+|||... +..++.++||||+|+++|+|++|..||...... ............. .
T Consensus 154 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~-----~ 219 (260)
T PF00069_consen 154 ----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-----DQLEIIEKILKRP-----L 219 (260)
T ss_dssp ----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-----HHHHHHHHHHHTH-----H
T ss_pred ----ccccccccccccccccccccccccccccccccccccccccccccccccccch-----hhhhhhhhccccc-----c
Confidence 122344789999999988 888999999999999999999999999864110 0001110000000 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... .........+.+++.+||+.||++||++.++++
T Consensus 220 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSS--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHT--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccc--cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000011267888888999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.35 Aligned_cols=275 Identities=25% Similarity=0.418 Sum_probs=208.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCc----EEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGC----FIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|+..+.||+|+||.||+|.. .++. .||+|.+..... ...++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4577788999999999999985 3443 578998875432 234688999999999999999999998754 4679
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999987543 3488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ....++. .....
T Consensus 160 ~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----~~~~~~~---~~~~~ 229 (303)
T cd05110 160 EGDEKEYN--ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----REIPDLL---EKGER 229 (303)
T ss_pred cCcccccc--cCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH---HCCCC
Confidence 53222111 112335678999999998899999999999999999997 8899864321 1111211 11111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC----CCCCCcccCCCCCCCC
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH----FTTDDEIMLPSNTGDP 607 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~----~~~~~~~~~~~~~~~~ 607 (618)
.. ........+.+++.+|+..+|++||+++++++.|+++.+... ...++...+|.+...+
T Consensus 230 ~~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (303)
T cd05110 230 LP----------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSK 293 (303)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeeccCCcCCCCCCchhh
Confidence 00 011123467788889999999999999999999999875533 2334454455544443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=315.09 Aligned_cols=266 Identities=20% Similarity=0.230 Sum_probs=195.0
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|++.+.||+|++|.||+|+. .++..||+|.++... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477889999999999999995 468999999986432 2346788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
++ ++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 588888764332 24589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH-------HHHhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI-------TLLNT 534 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~-------~~~~~ 534 (618)
.. .....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||...............+. .....
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 RV----YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred cc----ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 11 112236889999998765 4578899999999999999999999975432111000000000 00000
Q ss_pred CCccchhcccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLL---GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......++.... .........++.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0000112345667888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=309.32 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=197.5
Q ss_pred HHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 301 LMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 301 l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++.+++++.....||+|+||.||+|+. .++..|++|.+.... ...+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344667777778999999999999994 567899999887543 345678999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccCcc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHM--DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLA 455 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a 455 (618)
|+||+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+|||.+
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999987543 224 7888899999999999999999 9999999999999976 678999999998
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV--ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
.......... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...+.....
T Consensus 157 ~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~~~~~~ 227 (268)
T cd06624 157 KRLAGINPCT----ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMFKVGMF 227 (268)
T ss_pred eecccCCCcc----ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHhhhhhh
Confidence 7654322111 1223788999999876543 7889999999999999999999986532210 011110000
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .+ ..+......+.+++.+||+.+|++|||+.|+++
T Consensus 228 ~~-------~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 KI-------HP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cc-------CC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 00 011122345667778999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=305.58 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=197.1
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCccc
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 389 (618)
++||+|++|.||++...+++.|++|.+..... ..+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999977799999999876432 3567899999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccc
Q 007088 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV 469 (618)
Q Consensus 390 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 469 (618)
+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+............
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~-- 152 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD-- 152 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc--
Confidence 9986543 3478999999999999999999999 9999999999999999999999999999765422111110
Q ss_pred cCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 470 NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 470 ~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||...... ........... .
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--------~~~~~~~~~~~----------~ 214 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--------QTRERIESGYR----------M 214 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--------HHHHHHhcCCC----------C
Confidence 11123567999999988899999999999999999999 88888653321 11111111100 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.........+.+++.+|+..+|++||++.|+++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 111223456788888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.59 Aligned_cols=193 Identities=22% Similarity=0.291 Sum_probs=164.8
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
...+|.+.+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++|+||+++++++...+..++||||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 3457999999999999999999964 5688999975432 235699999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+. ++|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 139 YS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred cC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 95 58888876543 4589999999999999999999999 99999999999999999999999999997543221
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTH 513 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~ 513 (618)
. .....||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 212 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 212 A-----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c-----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1 112348999999999999999999999999999999999666553
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=312.27 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=202.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.+.||+|+||.||++.. .+++.||+|++... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4677788999999999999995 46899999988643 23456789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.... .+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999886543 4899999999999999999999732 89999999999999999999999999986543221
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc---cCHHHHHHHHhcCCccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK---GSLVEWITLLNTNSSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~---~~l~~~~~~~~~~~~~~ 539 (618)
. ....|+..|+|||++.+..++.++|||||||++|++++|+.||......+... ..+.++........
T Consensus 159 ~------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 229 (284)
T cd06620 159 A------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP--- 229 (284)
T ss_pred c------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence 1 12347899999999888889999999999999999999999998644321111 11112222111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
.+.+. .......+.+++.+|++.||++|||+.|+++..
T Consensus 230 ---~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 ---PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00110 112345677888899999999999999998864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.18 Aligned_cols=204 Identities=21% Similarity=0.292 Sum_probs=174.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..+.||+|+||.||++.. .+++.||+|+++.. ......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999995 46899999999643 233456788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKD----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 9999999999987543 489999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCc-------------------------------ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCC
Q 007088 461 VDTH-------------------------------LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE 509 (618)
Q Consensus 461 ~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~ 509 (618)
.... .........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 000011245899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 007088 510 RPTHLTN 516 (618)
Q Consensus 510 ~Pf~~~~ 516 (618)
.||....
T Consensus 234 ~Pf~~~~ 240 (360)
T cd05627 234 PPFCSET 240 (360)
T ss_pred CCCCCCC
Confidence 9997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=334.54 Aligned_cols=267 Identities=16% Similarity=0.174 Sum_probs=192.8
Q ss_pred HHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCC------CCccceeEEEEe
Q 007088 300 DLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH------RNLVPLLGFCVA 372 (618)
Q Consensus 300 ~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~ 372 (618)
++...+++|++.++||+|+||.||+|.. .+++.||||+++.......++..|+.++.+++| .+++++++++..
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 3444678899999999999999999995 568899999997644444556677777777654 458889898876
Q ss_pred C-CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCC-----
Q 007088 373 K-KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDF----- 445 (618)
Q Consensus 373 ~-~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~----- 445 (618)
. .+.++|||++ +++|.+++.... .+++..+..|+.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccc
Confidence 5 4788999988 678888886543 48999999999999999999997 5 899999999999998765
Q ss_pred -----------ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 007088 446 -----------EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHL 514 (618)
Q Consensus 446 -----------~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~ 514 (618)
.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~~-------~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERHSR-------TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcccc-------ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999876432211 123489999999999999999999999999999999999999976
Q ss_pred CCCCCcccc-------CHHHHHHHH---------hcCCccchhcccc----ccC-CCC--HHHHHHHHHHHhhccCCCCC
Q 007088 515 TNAPESFKG-------SLVEWITLL---------NTNSSLETAIDKS----LLG-NGF--DGELHQFLRVACNCVLPTPK 571 (618)
Q Consensus 515 ~~~~~~~~~-------~l~~~~~~~---------~~~~~~~~~~d~~----l~~-~~~--~~~~~~l~~li~~cl~~dP~ 571 (618)
....+.... .-..|.... ..........++. +.. ... ......+.+|+.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 442111000 000111000 0000000000000 000 000 01134577899999999999
Q ss_pred CCCCHHHHHH
Q 007088 572 ERHTMFEVYQ 581 (618)
Q Consensus 572 ~RPs~~evl~ 581 (618)
+|||++|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=317.67 Aligned_cols=201 Identities=23% Similarity=0.282 Sum_probs=171.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+++. .+++.||+|++... ....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688999999999999999995 46899999998642 223455889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999986532 3488999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
...... ....||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 155 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 DGTVQS---NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCCccc---cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 222111 11248999999998763 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.50 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=198.6
Q ss_pred cCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
+|...+.||+|+||.||+|...+++.+|+|.++... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999886432 1124588899999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... ++++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 99999999999986543 478999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCc--ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 460 PVDTH--LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 460 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
..... .........++..|+|||+..+..++.++||||||+++|+|++|+.||...+.. ............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~ 226 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-------AAMFYIGAHRGL 226 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-------HHHHHhhhccCC
Confidence 21111 111112334788999999999888999999999999999999999999753221 111000000000
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+.+ .......+.+++.+||+.+|.+||++.|+++
T Consensus 227 -----~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -----MPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -----CCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0111 1122345667777999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.43 Aligned_cols=200 Identities=23% Similarity=0.329 Sum_probs=161.6
Q ss_pred CcEEeecCCeeEEEEEeC---CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeeEEEEeecCC
Q 007088 311 NNIIGTGRTGATYIAMLP---GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA--KKERLLVYSYLEN 385 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 385 (618)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 468999999999999854 46889999987643 23457789999999999999999999865 3467899999865
Q ss_pred CccccccCCCC-----CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee----CCCCceEEcccCccc
Q 007088 386 GTLYDKLHPAE-----HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL----DGDFEPKLSDFGLAR 456 (618)
Q Consensus 386 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a~ 456 (618)
+|.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 7877764321 1123589999999999999999999999 99999999999999 456789999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
......... .......+|+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 161 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccc-cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 765332111 11223458999999998876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.75 Aligned_cols=265 Identities=19% Similarity=0.216 Sum_probs=195.6
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK---- 374 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 374 (618)
...++|+..+.||+|+||.||++.. ..++.||+|++.... ...+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999984 468899999997532 23456788999999999999999999886542
Q ss_pred --eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 375 --ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 375 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
..++||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 46899999975 66666532 378899999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH-------
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL------- 525 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l------- 525 (618)
|+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||......+.....+
T Consensus 164 g~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 164 GLARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred cccccCCCccc-----cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99986543221 122347899999999999899999999999999999999999997543211100000
Q ss_pred -------HHHHHHHhc-CCccchhccc-----ccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 526 -------VEWITLLNT-NSSLETAIDK-----SLL---GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 526 -------~~~~~~~~~-~~~~~~~~d~-----~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
...+..... .........+ ... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 0000000000 000 00011123466788889999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=309.73 Aligned_cols=247 Identities=26% Similarity=0.352 Sum_probs=200.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|+..+.||.|++|.||+|.. .+++.|++|.+.... .....+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3688889999999999999995 468999999986542 3345688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++... ++++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998754 489999999999999999999999 99999999999999999999999999998775432
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...... ........ . .
T Consensus 153 ~~~----~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~-~-----~ 214 (274)
T cd06609 153 SKR----NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPK-N-----N 214 (274)
T ss_pred ccc----ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhh-c-----C
Confidence 211 1223788899999999888999999999999999999999999753321 11111110 0 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+.+... .....+.+++.+||..||++||+++++++
T Consensus 215 ~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 215 PPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111111 02345677788999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=313.78 Aligned_cols=248 Identities=25% Similarity=0.394 Sum_probs=199.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.+|+..+.||.|++|.||+|.. .+++.|++|.+.... ...+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999984 678999999986543 34567889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988643 389999999999999999999999 999999999999999999999999999886543322
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. .......... ...
T Consensus 171 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------~~~~~~~~~~-~~~--- 234 (296)
T cd06655 171 KR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNG-TPE--- 234 (296)
T ss_pred cC----CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcC-Ccc---
Confidence 11 1224788999999999888999999999999999999999999754321 1111111110 000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+ .........+.+++.+||..||++||++.++++
T Consensus 235 --~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 235 --L--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --c--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0 011122345667778999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=310.81 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=196.1
Q ss_pred cEEeecCCeeEEEEEeCC-------CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 312 NIIGTGRTGATYIAMLPG-------GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+.||+|+||.||+|+..+ +..+++|.+.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2579999886543 3456788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-----ceEEcccCc
Q 007088 383 LENGTLYDKLHPAEH---EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-----EPKLSDFGL 454 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~ 454 (618)
+++++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999865322 124488999999999999999999999 999999999999999877 899999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
++.......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||...... +......
T Consensus 158 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~ 227 (269)
T cd05044 158 ARDIYKSDYYRK--EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVT 227 (269)
T ss_pred cccccccccccc--CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHh
Confidence 976543221111 112235678999999998999999999999999999998 99998643221 1111111
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
.... ..........+.+++.+||+.+|.+||+++++++.|++
T Consensus 228 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 AGGR----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cCCc----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1100 01112234567788889999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.93 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=200.1
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 467788999999999999995 468899999986532 34467889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++... ++++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988643 378899999999999999999999 999999999999999999999999999976644322
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ....++..|+|||++.+..++.++|||||||++|||++|..||....... ......
T Consensus 157 ~~----~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~---------- 214 (277)
T cd06640 157 KR----NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIP---------- 214 (277)
T ss_pred cc----ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhhhhh----------
Confidence 11 12236788999999988889999999999999999999999987533211 000000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
..............+.+++.+||+.+|++||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 215 KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 000111223455678888889999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=313.06 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=201.5
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC------
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 374 (618)
..+++|++.+.||+|++|.||+|.. .+++.+++|++.......+++.+|+++++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3568999999999999999999996 4678999999987666667899999999999 6999999999997654
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 47999999999999998865442235689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
+.......... ....++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ....
T Consensus 160 ~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~ 228 (275)
T cd06608 160 SAQLDSTLGRR----NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALF 228 (275)
T ss_pred ceecccchhhh----cCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHH
Confidence 87654322211 12347889999998653 34678999999999999999999999643211 1111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... . .+.+. ........+.+++.+||..||++|||+.|+++
T Consensus 229 -~~~~~-~-----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -KIPRN-P-----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -Hhhcc-C-----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11000 0 01111 11223456778888999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=305.00 Aligned_cols=249 Identities=20% Similarity=0.336 Sum_probs=201.7
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||.|+||.||.++ ..++..+++|.+... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58889999999999999998 456889999988643 23456788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999876532 4589999999999999999999999 99999999999999999999999999998764433
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.. .....+++.|+|||+..+..++.++||||||+++|||++|+.||..... .+........ ...
T Consensus 156 ~~----~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~-~~~--- 219 (256)
T cd08221 156 SM----AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQG-NYT--- 219 (256)
T ss_pred cc----ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcC-CCC---
Confidence 21 1223478999999999888889999999999999999999999865322 1111111111 000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.........+.+++.+|++.+|.+||++.|+++.
T Consensus 220 ------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 ------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0012233456777779999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.83 Aligned_cols=201 Identities=23% Similarity=0.286 Sum_probs=165.1
Q ss_pred CCcEEeec--CCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 310 KNNIIGTG--RTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 310 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
..++||+| +|++||++.. .+|+.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 6889999984 678999999997542 23345778999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999865432 3489999999999999999999999 999999999999999999999999986544322111
Q ss_pred cc---cccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 464 HL---STFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 464 ~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
.. ........++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 00 001112236778999999875 46889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=312.13 Aligned_cols=244 Identities=25% Similarity=0.355 Sum_probs=196.6
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
|+..+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 55567899999999999985 467899999986432 334578899999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++.........
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 9999998864 2488999999999999999999999 9999999999999999999999999999766432211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||....... ......... .+
T Consensus 158 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~------~~ 219 (277)
T cd06642 158 R----NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNS------PP 219 (277)
T ss_pred h----hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCC------CC
Confidence 1 11237889999999998889999999999999999999999986432211 010110000 11
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 220 TL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CC----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11 1123456778888999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=309.25 Aligned_cols=256 Identities=23% Similarity=0.393 Sum_probs=201.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|++...||+|+||.||+|+.. +...|++|.+..... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999953 346799998865433 3467999999999999999999999999988999
Q ss_pred EEEeecCCCccccccCCCCCC-----CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHE-----VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
+||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998765421 12589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|++........ .......++..|+|||.+.+..++.++||||||+++|++++ |..||...... .... .
T Consensus 162 ~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~~~~---~ 230 (275)
T cd05046 162 SLSKDVYNSEY---YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLN---R 230 (275)
T ss_pred ccccccCcccc---cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----HHHH---H
Confidence 99875432211 11122235778999999888888999999999999999999 78888643221 1111 1
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.. ..... ..........+.+++.+||+.+|++||++.|+++.|.
T Consensus 231 ~~-~~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQ-AGKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HH-cCCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11 00000 0011123346777888999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=305.55 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=197.6
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-CeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-KERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e 381 (618)
+|++.+.||+|++|.||++.. .+++.|++|.+.... ...+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478899999999999999995 457899999986532 3345688999999999999999999987644 46789999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++++|.+++..... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999875432 4589999999999999999999999 9999999999999999999999999999866432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
... .....+++.|+|||+..+..++.++||||||+++|+|++|+.||...+. ......... ...
T Consensus 156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--------~~~~~~~~~-~~~--- 219 (257)
T cd08223 156 CDM----ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM--------NSLVYRIIE-GKL--- 219 (257)
T ss_pred CCc----cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHh-cCC---
Confidence 221 1123478899999999999999999999999999999999999864321 111111111 110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........+.+++.+|++.||++||++.|+++
T Consensus 220 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 ------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111223456778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=309.20 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=196.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
++|.+.+.||+|+||.||+|.. .+++.||+|.++... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677788999999999999984 568999999987543 23456788999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|.+++.... .+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999886543 489999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
. .....|+..|+|||++. ...++.++|||||||++|||++|+.||....... ... ...... .
T Consensus 162 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~----~~~----~~~~~~-~-- 226 (267)
T cd06645 162 K----RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR----ALF----LMTKSN-F-- 226 (267)
T ss_pred c----cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh----hHH----hhhccC-C--
Confidence 1 11234889999999874 4568899999999999999999999986533211 000 000000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+.... .......+.+++.+|++.+|++||+++++++
T Consensus 227 -~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 -QPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -CCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000000 0011235667788999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=305.74 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=197.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|++.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++|||++++++++... ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4688899999999999999975 67789999986543 346788999999999999999999998664 47999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 83 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 83 GNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 999999875432 4588999999999999999999999 999999999999999999999999999875432111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 156 -----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~-------- 214 (254)
T cd05083 156 -----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECVEKGY-------- 214 (254)
T ss_pred -----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhCCC--------
Confidence 1124567999999988889999999999999999998 9999865322 11111111110
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
...........+.+++.+|++.+|++||+++++++.|++
T Consensus 215 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 --RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 001112233566788889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.11 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=198.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|+..+.||+|++|.||+|... +++.||+|++.... ...+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999965 68999999986432 234567899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++++|..++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999988887765432 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc-------CHHHHHHHHh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-------SLVEWITLLN 533 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~-------~l~~~~~~~~ 533 (618)
.... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ....+.....
T Consensus 154 ~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GDDY----TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cccc----cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 2211 12236788999998765 5578999999999999999999999975432111000 0000000000
Q ss_pred cCCccchhccccccCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNG-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........+...... .......+.+++.+|++.||++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000000000 0112356778888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=304.73 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=189.6
Q ss_pred cEEeecCCeeEEEEEeCC---CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 312 NIIGTGRTGATYIAMLPG---GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
+.||+|+||.||+|...+ +..+++|.++... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998543 4679999887543 23356889999999999999999999999988999999999999
Q ss_pred ccccccCCCCC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 387 TLYDKLHPAEH-EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 387 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
+|.+++..... .....++..+..++.|++.|++|||+. +++||||||+||+++.++++||+|||.++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~- 156 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY- 156 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee-
Confidence 99999865432 223567888889999999999999999 9999999999999999999999999998754332211
Q ss_pred cccccCCCCcccccCCCCCCCC-------CCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTL-------VATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
.......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ .... .. ...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-----~~~~---~~-~~~ 226 (269)
T cd05087 157 -VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-----VLTY---TV-REQ 226 (269)
T ss_pred -ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-----HHHH---Hh-hcc
Confidence 111223467889999987542 35789999999999999996 999996543211 0000 00 001
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.....++.+.. .....+.+++.+|+ .+|++|||++||++.|+
T Consensus 227 ~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111111 12234566777998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.54 Aligned_cols=238 Identities=24% Similarity=0.363 Sum_probs=189.7
Q ss_pred cEEeecCCeeEEEEEeCCC-----------cEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 312 NIIGTGRTGATYIAMLPGG-----------CFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~-----------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+.||+|+||.||+|...+. ..|++|.+.........+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 4689999999999996543 358888876654446789999999999999999999999988 7789999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-------ceEEcccC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-------EPKLSDFG 453 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DfG 453 (618)
||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999987654 2589999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCC--CCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL--VATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWIT 530 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~ 530 (618)
++....... ...++..|+|||++.+. .++.++||||||+++|||++ |..||...... .+..
T Consensus 154 ~a~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--------~~~~ 217 (259)
T cd05037 154 IPITVLSRE--------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--------EKER 217 (259)
T ss_pred ccccccccc--------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--------hHHH
Confidence 998654311 12256789999998776 78999999999999999999 57777653211 1111
Q ss_pred HHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 531 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
....... .. ......+.+++.+|+..+|.+||++.|+++.|+
T Consensus 218 ~~~~~~~--------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 218 FYQDQHR--------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HHhcCCC--------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111000 00 001156778888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=322.86 Aligned_cols=198 Identities=23% Similarity=0.299 Sum_probs=168.0
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------ 373 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 373 (618)
..++|...+.||+|+||.||++.. ..++.||||++... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999994 46889999999653 23345678999999999999999999987543
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
...++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 67766632 378899999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
+++....... .....+|..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 172 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 172 LARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CccccCCCCc-----ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9986543221 122347899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=309.88 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=194.1
Q ss_pred CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
|++.+.||+|+||.||++... ++..+++|.+.... ...+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999954 57889999986533 3456788999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
++|..++.... .++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~- 159 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 159 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccc-
Confidence 99988876433 3589999999999999999999999 9999999999999999999999999998765332111
Q ss_pred cccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 466 STFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.....++..|+|||++. +..++.++|||||||++|||++|+.||...... +...........
T Consensus 160 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~-- 226 (282)
T cd06643 160 ---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPP-- 226 (282)
T ss_pred ---cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcCCC--
Confidence 12234789999999873 455788999999999999999999998753321 111111111000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+. ........+.+++.+||+.||.+||++.++++
T Consensus 227 ----~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 ----TLA--QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01112345677778999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.51 Aligned_cols=238 Identities=23% Similarity=0.352 Sum_probs=185.7
Q ss_pred cEEeecCCeeEEEEEeCC-------------CcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 312 NIIGTGRTGATYIAMLPG-------------GCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
+.||+|+||.||+|+..+ ...|++|.+.... .....+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998432 2368999886543 23456888999999999999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc-------eEEc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE-------PKLS 450 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~ 450 (618)
+||||+++|+|..++.... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999988876543 3589999999999999999999999 9999999999999987664 8999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHH-hCCCCCCCCCCCCccccCHHHH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELI-TGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~ell-tG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
|||++....... ...++..|+|||.+. +..++.++|||||||++|||+ +|+.||...... +.
T Consensus 155 d~g~~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~ 218 (262)
T cd05077 155 DPGIPITVLSRQ--------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--------EK 218 (262)
T ss_pred CCCCCccccCcc--------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--------HH
Confidence 999987553221 123678899999876 567899999999999999998 588887643211 11
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
........ .. .......+.+++.+||+.||.+||++.+|++.+
T Consensus 219 ~~~~~~~~--------~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ERFYEGQC--------ML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHHHhcCc--------cC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11100000 00 111234577888899999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.72 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=201.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
++|+..+.||+|++|.||+|.. .+++.+++|.+.... ...+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788899999999999999995 467899999987543 34567899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+........
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 9999999887642 3589999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccccccCCCCcccccCCCCCCCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTL---VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. ....++..|+|||.+.+. .++.++||||||+++|||++|+.||....... . ....... ..
T Consensus 157 ~~----~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------~-~~~~~~~-~~-- 221 (262)
T cd06613 157 KR----KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------A-LFLISKS-NF-- 221 (262)
T ss_pred cc----ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------H-HHHHHhc-cC--
Confidence 11 122378889999998776 88999999999999999999999997533211 0 0000000 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....+ .........+.+++.+|+..+|.+|||+.+++.
T Consensus 222 -~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 -PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 111234456788888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=344.96 Aligned_cols=262 Identities=19% Similarity=0.332 Sum_probs=199.7
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--Ce
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KE 375 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 375 (618)
....++|.+.+.||+|+||.||++.. .++..||+|.+.... .....+..|+.++++++||||++++++|... ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 34457899999999999999999995 457889999986532 3345688999999999999999999988653 46
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCC----CCceecCCCCCCeeeCC--------
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN----PRIIHRNISSKCILLDG-------- 443 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~-------- 443 (618)
.|+||||+++|+|.++|.........+++..++.|+.||+.||+|||+... .+|+||||||+|||++.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999987543323469999999999999999999998521 25999999999999964
Q ss_pred ---------CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCC
Q 007088 444 ---------DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPT 512 (618)
Q Consensus 444 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf 512 (618)
.+.+||+|||++......... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~-----~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMA-----HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccc-----cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 335899999999866432211 12348999999998754 45889999999999999999999999
Q ss_pred CCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHh
Q 007088 513 HLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ--LLRAI 586 (618)
Q Consensus 513 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i 586 (618)
..... ............ .+.. ......+.+|+..||+.+|.+||++.|++. .+..+
T Consensus 244 ~~~~~-------~~qli~~lk~~p--------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANN-------FSQLISELKRGP--------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCc-------HHHHHHHHhcCC--------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 75322 122222211111 1111 112345777888999999999999999984 44443
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=305.37 Aligned_cols=247 Identities=22% Similarity=0.326 Sum_probs=206.0
Q ss_pred CCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
|++.++||+|+||.||+|. ...|..+|||.+..+ .+.+++.+|+.++++++.|++|++||.|..+...|+|||||..|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 6667899999999999999 467999999998654 45678899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+..+.++.+. .++++.++..+++..++||+|||.. .-+|||||+.|||++.+|.+||+|||.|..+.+.-..
T Consensus 114 SiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-- 185 (502)
T KOG0574|consen 114 SISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-- 185 (502)
T ss_pred cHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHh--
Confidence 9999997665 5799999999999999999999999 8999999999999999999999999999876543222
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 546 (618)
.+...||+.|||||++..-.|..++||||+|++..||.-|++||.+..+-.....+ ... +..
T Consensus 186 --RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~--PPP 247 (502)
T KOG0574|consen 186 --RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTK--PPP 247 (502)
T ss_pred --hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCC--CCC
Confidence 23345999999999999999999999999999999999999999764432111100 000 111
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 547 LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....+.....++.+++++||-..|++|-|+.++++
T Consensus 248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11224455667888888999999999999988764
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=309.97 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=196.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+.|++.+.||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999964 58999999987543 34567889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|..++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 9999988775433 3489999999999999999999999 999999999999999999999999999875432211
Q ss_pred cccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
.. ....++..|+|||++. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 166 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~- 232 (292)
T cd06644 166 RR----DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEP- 232 (292)
T ss_pred cc----ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCC-
Confidence 11 1223788999999874 345688999999999999999999998653211 11111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.. ........++.+++.+||+.||++||++.|+++
T Consensus 233 -----~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 -----PTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -----ccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 001122345777888999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=308.33 Aligned_cols=253 Identities=21% Similarity=0.358 Sum_probs=198.1
Q ss_pred cCCCCcEEeecCCeeEEEEEeCC--CcEEEEEEeccC-----------ccCHHHHHHHHHHHhc-CCCCCccceeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPG--GCFIMIKRLEDS-----------QHSEKEFLSEINTLGS-VRHRNLVPLLGFCVA 372 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~-----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 372 (618)
+|++.+.||+|+||.||++.... ++.+|+|.+... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999654 788999987532 1223457788888865 799999999999999
Q ss_pred CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcc
Q 007088 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 373 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
.+..++||||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999998875432223568999999999999999999996 5 899999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
||.+........ .....++..|+|||...+..++.++||||||+++|||++|+.||..... ......
T Consensus 158 fg~~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~ 224 (269)
T cd08528 158 FGLAKQKQPESK-----LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATK 224 (269)
T ss_pred ccceeecccccc-----cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHH
Confidence 999987554321 1223478899999999988899999999999999999999999864321 111111
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
..... .. + ... ......+.+++.+|++.||++||++.|+.++++
T Consensus 225 ~~~~~-~~----~-~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 IVEAV-YE----P-LPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred Hhhcc-CC----c-CCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11110 00 0 000 112345677778999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.41 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=199.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCcc----CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQH----SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..+.||+|++|.||++... +++.||+|.+..... ..+.+..|++++++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999964 589999999975432 3456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+.+++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999875432 4589999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCccc-------------------------ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 461 VDTHLS-------------------------TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 461 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
...... .......|+..|+|||+..+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 211100 0111234788999999999888999999999999999999999999754
Q ss_pred CCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 007088 516 NAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT----MFEVYQ 581 (618)
Q Consensus 516 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 581 (618)
+... .+.... +..............+.+++.+|++.||++||+ ++|+++
T Consensus 236 ~~~~-------~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDE-------TFSNIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHH-------HHHHHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3211 111111 111111111113456778888999999999999 655554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.17 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=200.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 380 (618)
++|+..+.||.|++|.||++.. .+++.+|+|.+.... ....++.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999996 468999999987543 2456789999999999999999999998654 3679999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++.........+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999888754332335588999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||...............+... .. ...
T Consensus 158 ~~~~------~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~-~~~ 227 (287)
T cd06621 158 SLAG------TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MP-NPE 227 (287)
T ss_pred cccc------cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CC-chh
Confidence 2211 1236788999999988899999999999999999999999998653211111112222111 10 000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+..... ........+.+++.+|++.+|.+|||+.|+++
T Consensus 228 -~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 -LKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -hccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000000 00113456778888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.39 Aligned_cols=250 Identities=21% Similarity=0.317 Sum_probs=199.7
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeeEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA--KKERLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 380 (618)
+|++.+.||.|+||.||++.. .++..|++|++.... ...+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999984 578899999986533 234568889999999999999999998764 34578999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH-----HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
||+++++|.+++.........+++..++.++.|++.||+||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998764333456899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.......... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ .
T Consensus 158 ~~~~~~~~~~----~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~ 224 (265)
T cd08217 158 KILGHDSSFA----KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIK-E 224 (265)
T ss_pred ccccCCcccc----cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHh-c
Confidence 8765433211 123478899999999988899999999999999999999999975431 11111111 1
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... ..........+.+++.+|++.+|++||++.+|++
T Consensus 225 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 225 GKF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 110 1112233456778888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.73 Aligned_cols=259 Identities=19% Similarity=0.262 Sum_probs=193.5
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK----- 373 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 373 (618)
...++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3467899999999999999999994 578899999987532 2345677899999999999999999987543
Q ss_pred -CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 374 -KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 374 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 6799887753 2489999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|+++...... ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+..+...
T Consensus 163 g~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~ 231 (343)
T cd07878 163 GLARQADDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID----QLKRIMEV 231 (343)
T ss_pred ccceecCCCc-------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHH
Confidence 9998654321 12347899999998876 568899999999999999999999997543211 11111110
Q ss_pred HhcC----------Cccchhcc--ccccCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 532 LNTN----------SSLETAID--KSLLGN----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 532 ~~~~----------~~~~~~~d--~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ......+. +..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 00000000 000000 00011234678888999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=308.83 Aligned_cols=237 Identities=23% Similarity=0.335 Sum_probs=184.5
Q ss_pred EEeecCCeeEEEEEeCC-------------------------CcEEEEEEeccCcc-CHHHHHHHHHHHhcCCCCCccce
Q 007088 313 IIGTGRTGATYIAMLPG-------------------------GCFIMIKRLEDSQH-SEKEFLSEINTLGSVRHRNLVPL 366 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l 366 (618)
.||+|+||.||+|.... ...|++|++..... ....+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 14589998865432 34568889999999999999999
Q ss_pred eEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-
Q 007088 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF- 445 (618)
Q Consensus 367 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 445 (618)
++++.+....++||||+++|+|..++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999886533 3588999999999999999999999 999999999999997643
Q ss_pred ------ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHH-hCCCCCCCCCC
Q 007088 446 ------EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELI-TGERPTHLTNA 517 (618)
Q Consensus 446 ------~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~ell-tG~~Pf~~~~~ 517 (618)
.+|++|||.+....... ...++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.....
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~--------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSRE--------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred ccCccceeeecCCcccccccccc--------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 37999999886432211 1236788999998865 56899999999999999995 69999865432
Q ss_pred CCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 518 PESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
.+ ...... .... .. ......+.+++.+||+.+|++||++.++++.|
T Consensus 228 ~~-----~~~~~~---~~~~--------~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SE-----KERFYE---KKHR--------LP----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HH-----HHHHHH---hccC--------CC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 111111 0000 00 11123577888899999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.43 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=196.9
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc----------CHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH----------SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
+|.+.+.||+|++|.||+|.. .+++.||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477788999999999999985 4688999998864321 12457889999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG----AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 999999999999999996543 488999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc--cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 456 RLMNPVDTHL--STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 456 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
+......... ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... .. .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~-~~~~~ 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QA-IFKIG 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HH-HHHHh
Confidence 8765321111 00111223788999999998888999999999999999999999999753211 11 00000
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ...+.+ .......+.+++.+||+.||.+||++.|+++
T Consensus 226 ~------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E------NASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c------cCCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 001111 1123345667777999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.50 Aligned_cols=254 Identities=21% Similarity=0.339 Sum_probs=200.0
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
+|+..+.||+|++|.||++. ..+++.||+|.+.... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999998 4678999999986432 124568899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccCcccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARL 457 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~ 457 (618)
||||+++++|.+++.... ++++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999986543 488999999999999999999999 999999999999998776 599999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
................++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... . ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~-~~~~~~~~~~~- 227 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----H-LALIFKIASAT- 227 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----h-HHHHHHHhccC-
Confidence 65432211111122347889999999988889999999999999999999999996433211 1 11111100000
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
............+.+++.+|+..+|.+||++.|+++
T Consensus 228 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 --------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112234456778888999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=305.04 Aligned_cols=248 Identities=23% Similarity=0.303 Sum_probs=200.2
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|++.+.||+|+||.||++.. .+++.|++|++... ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 488899999999999999994 56899999998643 23345789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++..... ..+++.+++.++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998865432 3578999999999999999999999 99999999999999999999999999997654422
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....|+..|+|||+..+..++.++|||||||++++|++|+.||..... .+.+........
T Consensus 156 ~~~----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~----- 218 (256)
T cd08218 156 ELA----RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGSY----- 218 (256)
T ss_pred hhh----hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCCC-----
Confidence 211 122378889999999888899999999999999999999999864321 122211111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........+.+++.+|++.+|.+||++.||++
T Consensus 219 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 -----PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0011223446777888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=302.36 Aligned_cols=250 Identities=28% Similarity=0.464 Sum_probs=199.9
Q ss_pred CCCCcEEeecCCeeEEEEEeCC-----CcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 308 FSKNNIIGTGRTGATYIAMLPG-----GCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+++.+.||+|+||.||++...+ +..||+|.+..... ..+.+.+|++.+.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999643 48899999976543 4678999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999876442 2289999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
....... ...++..|+|||...+..++.++||||+|+++|||++ |+.||..... .............
T Consensus 156 ~~~~~~~---~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~- 223 (258)
T smart00219 156 DDYYKKK---GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRL- 223 (258)
T ss_pred ccccccc---cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCC-
Confidence 3222111 1226789999999988889999999999999999998 7888764221 1111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
.........+.+++.+|+..||++|||+.|+++.|
T Consensus 224 ---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 01112345677788899999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=311.63 Aligned_cols=200 Identities=23% Similarity=0.335 Sum_probs=161.1
Q ss_pred CcEEeecCCeeEEEEEeC---CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeeEEEEeecCC
Q 007088 311 NNIIGTGRTGATYIAMLP---GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA--KKERLLVYSYLEN 385 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~ 385 (618)
..+||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 468999999999999954 45789999987643 23467899999999999999999999854 4567899999875
Q ss_pred CccccccCCCC-----CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee----CCCCceEEcccCccc
Q 007088 386 GTLYDKLHPAE-----HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL----DGDFEPKLSDFGLAR 456 (618)
Q Consensus 386 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a~ 456 (618)
+|.+++.... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 7777664221 1224588999999999999999999999 99999999999999 566789999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
......... .......+|+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 161 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPL-ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccc-cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 765432211 11123347899999998876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.57 Aligned_cols=254 Identities=19% Similarity=0.188 Sum_probs=192.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.++||+|+||.||++... +++.||+|++.+.. .....+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999954 57889999986422 23345788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997533 3489999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...+. .+........
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~ 223 (332)
T cd05623 155 DGTVQ---SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNH 223 (332)
T ss_pred CCcce---ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCC
Confidence 22211 11234899999999875 34678999999999999999999999975332 1222222111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPT--PKERHTMFEVYQL 582 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~ 582 (618)
..... +. .........+.+++.+|+..+ +..|++++|+++.
T Consensus 224 ~~~~~-~p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 224 KERFQ-FP-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Ccccc-CC-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 10000 00 001112334555666777554 4447899998765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=318.94 Aligned_cols=253 Identities=19% Similarity=0.208 Sum_probs=193.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|.+.+.||+|+||.||+++. .+++.||+|++.... .....+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788999999999999999995 467899999986522 23345788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997533 3488999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+........
T Consensus 155 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~ 223 (331)
T cd05624 155 DGTVQS---SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNH 223 (331)
T ss_pred CCceee---ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcC
Confidence 322111 12348999999998765 4678899999999999999999999975332 1111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKE--RHTMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 581 (618)
..... +. .........+.+++.+|+..++++ |++++++++
T Consensus 224 ~~~~~-~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 224 EERFQ-FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCccc-CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 10000 00 011112345566666888765544 468888864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.49 Aligned_cols=252 Identities=19% Similarity=0.314 Sum_probs=196.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.+.||+|+||.||++... ++..||+|.++... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999964 78999999886532 2345788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++..... ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999988865421 235899999999999999999999632 89999999999999999999999999987654322
Q ss_pred CcccccccCCCCcccccCCCCCCCC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTL------VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
. ....++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ............
T Consensus 158 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~- 225 (286)
T cd06622 158 A------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAIVDG- 225 (286)
T ss_pred c------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHHhhc-
Confidence 1 122377899999987554 3488999999999999999999999653221 111111111000
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .+ .........+.+++.+|++.+|++||+++++++
T Consensus 226 ~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 D-----PP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C-----CC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0 00 111224456677888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.11 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=186.8
Q ss_pred EEeecCCeeEEEEEeCCC---cEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCc
Q 007088 313 IIGTGRTGATYIAMLPGG---CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT 387 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 387 (618)
.||+|+||.||++...++ ..+++|.+.... ...+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999984333 356677765432 345679999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccc
Q 007088 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467 (618)
Q Consensus 388 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 467 (618)
|.+++..........++..+..++.||++||+|||+. +++||||||+|||++.++.++|+|||++........ ..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~--~~ 156 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY--IE 156 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchh--hh
Confidence 9999976543334567788889999999999999999 999999999999999999999999999864322111 01
Q ss_pred cccCCCCcccccCCCCCCC-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 468 FVNGEFGDLGYVAPEYPRT-------LVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 468 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
......++..|+|||+... ..++.++||||||+++|||++ |..||..... .+........ ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~-~~~ 227 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLNHVIKD-QQV 227 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhh-ccc
Confidence 1122347889999998743 345789999999999999997 5667754322 1111111111 111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
...++.+... ....+.+++..|+ .+|++||+++||++.|.
T Consensus 228 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222211 2234556667899 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.78 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=197.0
Q ss_pred EEeecCCeeEEEEE-eCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcccc
Q 007088 313 IIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 390 (618)
+||+|.||+||.|+ ..+...+|||-+.... ...+-+..|+.+.++++|.|||+++|.+.++++.-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999 4567789999986533 344557889999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCcCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC-CCCceEEcccCcccccCCCCCcccc
Q 007088 391 KLHPAEHEVMHM--DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD-GDFEPKLSDFGLARLMNPVDTHLST 467 (618)
Q Consensus 391 ~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 467 (618)
++...- .++ .+.++-.+.+||++||.|||+. .|||||||-+|||++ -.|.+||+|||.++.+..-.....+
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 997654 345 7788889999999999999999 999999999999996 5789999999999987654433333
Q ss_pred cccCCCCcccccCCCCCCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 468 FVNGEFGDLGYVAPEYPRTL--VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 468 ~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
+ .||..|||||++..+ .|+.++|||||||++.||.||++||.....++.. ..+ -+ .-.
T Consensus 736 F----TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA------MFk----VG------myK 795 (1226)
T KOG4279|consen 736 F----TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA------MFK----VG------MYK 795 (1226)
T ss_pred c----ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh------hhh----hc------cee
Confidence 2 399999999998764 5889999999999999999999999865543210 000 00 000
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.....+.+...+...++.+|+.+||.+||+++++++
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 112234556667778888999999999999999975
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=301.39 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=200.1
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|++|.||++.. .+++.|++|.++.... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999995 4789999999876543 456789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987543 378899999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCCCCCCCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLV---ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...........++..|+|||++.+.. ++.++||||||+++||+++|+.||...... ......... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~~~-~~-- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHVGA-GH-- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHHhc-CC--
Confidence 32222122334788999999988766 889999999999999999999999753211 011100000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+.+.. .......+.+++.+|++.+|.+||++.|++.
T Consensus 224 ---~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 ---KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001100 1112345667778999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=309.13 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=198.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|++|.||++.. .++..||+|++.... ...+.+.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45688899999999999999996 468999999986543 3445788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999986543 3589999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
... ....++..|+|||.+. +..++.++||||||+++|||++|+.||...... +..........
T Consensus 158 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~ 225 (280)
T cd06611 158 QKR----DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEP 225 (280)
T ss_pred ccc----ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCC
Confidence 211 1223788999999864 345778999999999999999999999753221 11111111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+ .........+.+++.+||+.+|.+||++.++++
T Consensus 226 ------~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 ------PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred ------CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 000 001112345667777999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=311.26 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=193.4
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|++|.||+|+. .+|+.|++|+++... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999995 468999999986432 2235678899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++ +|.+++.... ..+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 974 7877775433 3489999999999999999999999 99999999999999999999999999998654322
Q ss_pred CcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH---------HHHHHHH
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL---------VEWITLL 532 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l---------~~~~~~~ 532 (618)
.. .....++..|+|||++.+. .++.++|||||||++|||++|..|+......+.....+ ..|....
T Consensus 154 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 RC----YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CC----cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence 11 1123468899999987664 46899999999999999999999975433211000000 0010000
Q ss_pred hcCCccch--hcccccc-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNSSLET--AIDKSLL-GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~~--~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....... ....... ..........+.+++.+||+.||.+|||++|+++
T Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 -KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred -hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 0000000 0001112345667788999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.96 Aligned_cols=250 Identities=20% Similarity=0.309 Sum_probs=192.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc------cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--Cee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 376 (618)
.+|+..+.||+|+||.||+|.. .++..|++|++.... ...+.+.+|+.++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999995 468999999885421 1234578899999999999999999998763 567
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++++||+++++|.+++.... .+++...+.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999986543 388999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
.......... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..........
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~--------~~~~~~~~~~ 225 (266)
T cd06651 155 RLQTICMSGT-GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM--------AAIFKIATQP 225 (266)
T ss_pred ccccccccCC-ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH--------HHHHHHhcCC
Confidence 6543211111 111233788999999999888999999999999999999999999753211 1111111100
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .+.+ .......+..++ +|+..+|++||+++|+++
T Consensus 226 ~-----~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 T-----NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C-----CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0 1111 111223344444 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.94 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=186.5
Q ss_pred EEeecCCeeEEEEEeCC---CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCc
Q 007088 313 IIGTGRTGATYIAMLPG---GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT 387 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 387 (618)
.||+|+||.||+|...+ ...+++|.+.... .....+.+|+..++.++|+||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 3578889876433 234568899999999999999999999999999999999999999
Q ss_pred cccccCCCCCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 388 LYDKLHPAEHE-VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 388 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
|.+++...... ....++.....++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99998765431 23356788899999999999999999 999999999999999999999999999875433221111
Q ss_pred ccccCCCCcccccCCCCCC-------CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 467 TFVNGEFGDLGYVAPEYPR-------TLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
.....++..|+|||+.. ...++.++|||||||++|||++ |..||......+ .+.. ..... .
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~----~~~~~-~ 227 (269)
T cd05042 159 --KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----VLKQ----VVREQ-D 227 (269)
T ss_pred --cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHH----Hhhcc-C
Confidence 11223567899999754 3456889999999999999999 788886432210 1111 11111 0
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
....++.+. ......+.+++..|+ .||++|||++||++.|.
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111111 122234455666888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.33 Aligned_cols=260 Identities=22% Similarity=0.274 Sum_probs=197.2
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc------CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH------SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
+|+..+.||+|++|.||+|.. .+++.|++|.+..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477888999999999999995 4689999999975432 234567899999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+ +|+|.+++.... ..+++..+..++.||++||+|||++ +++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997643 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc----
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT---- 534 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~---- 534 (618)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++|.+||......+. +.........
T Consensus 154 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~ 225 (298)
T cd07841 154 SPNRKM----THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ----LGKIFEALGTPTEE 225 (298)
T ss_pred CCCccc----cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH----HHHHHHHcCCCchh
Confidence 432211 11235788999998754 4678999999999999999999877764332110 1111100000
Q ss_pred ----CCccchhccccccCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 ----NSSLETAIDKSLLGN-----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ----~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
............... ........+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000 01223456788888999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=306.79 Aligned_cols=238 Identities=21% Similarity=0.350 Sum_probs=185.6
Q ss_pred cEEeecCCeeEEEEEeCC--------CcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 312 NIIGTGRTGATYIAMLPG--------GCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+.||+|+||.||+|.... ...|++|.+.... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998532 2358888876543 3345788999999999999999999999998999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc--------eEEcccCc
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE--------PKLSDFGL 454 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG~ 454 (618)
+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997654 2589999999999999999999999 9999999999999987765 69999998
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCC-CCCCCCCCCCccccCHHHHHHHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGE-RPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~-~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+....... ...++..|+|||++.+ ..++.++||||||+++|||++|. .|+..... .......
T Consensus 155 ~~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~~~ 218 (258)
T cd05078 155 SITVLPKE--------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQFY 218 (258)
T ss_pred ccccCCch--------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHHHH
Confidence 87543221 1236788999999876 45789999999999999999995 55443211 1111111
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
.... .+ +.....++.+++.+||+.||++|||++++++.|
T Consensus 219 ~~~~--------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 219 EDRH--------QL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred Hccc--------cC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1100 01 111224577888899999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=300.55 Aligned_cols=247 Identities=20% Similarity=0.317 Sum_probs=198.0
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ...+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999995 568899999986532 3356788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCcccccCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMNPV 461 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~~ 461 (618)
+++++|.+++..... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.+ +.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999976432 4589999999999999999999999 99999999999999855 45899999999876533
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .......... ..
T Consensus 156 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~-~~-- 219 (256)
T cd08220 156 SKA-----YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMSGT-FA-- 219 (256)
T ss_pred ccc-----cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHhcC-CC--
Confidence 211 1223788999999999888999999999999999999999998653321 1111111100 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.........+.+++.+||+.+|.+|||+.|+++
T Consensus 220 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 -------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 001123345677888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=312.06 Aligned_cols=251 Identities=20% Similarity=0.316 Sum_probs=196.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 380 (618)
...|++.++||+||.+.||++...+.+.||+|++... .....-|.+|+..|.+++ |.+||++++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3568999999999999999999888888898887543 344567999999999995 999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||-+. +|..+|.+... ....| .++.+..||+.|+.++|.+ ||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 440 E~Gd~-DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred ecccc-cHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 98754 99999987764 23334 7888999999999999999 999999999999984 46899999999998765
Q ss_pred CCCcccccccCCCCcccccCCCCCCCC-----------CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTL-----------VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
..+.. .....+||..||+||.+... +.++++||||+|||||+|+.|+.||.... ..|.
T Consensus 512 DTTsI--~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---------n~~a 580 (677)
T KOG0596|consen 512 DTTSI--VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---------NQIA 580 (677)
T ss_pred cccce--eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---------HHHH
Confidence 44332 23356799999999976532 36789999999999999999999997421 1222
Q ss_pred HHHhcCCccchhccccccCCCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFD-GELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+. ..+.++.-.-+++. ....+++++++.||..||++||++.|+++
T Consensus 581 Kl-------~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 KL-------HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HH-------HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 21 22223321111100 11123889999999999999999999975
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=308.73 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=197.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|+..+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999965 58999999986532 234568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++++|.++..... .+++..++.++.|++.||+|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999988887765432 389999999999999999999999 9999999999999999999999999998865433
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH-------Hh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL-------LN 533 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~-------~~ 533 (618)
... .....++..|+|||+..+ ..++.++||||||+++|||++|++||......+... .+..+... ..
T Consensus 154 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 154 GEV----YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY-HIIKCLGNLIPRHQEIF 228 (286)
T ss_pred ccc----cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH-HHHHHhCCCchhhHHHh
Confidence 221 112337889999998765 457889999999999999999999986433211000 00000000 00
Q ss_pred cCCc-cchhccccccCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSS-LETAIDKSLLGN-----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~-~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ......+..... ........+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000 000000000000 01122456788888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=319.35 Aligned_cols=239 Identities=21% Similarity=0.217 Sum_probs=182.6
Q ss_pred EeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC---CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 314 IGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV---RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 314 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
||+|+||.||+|+. .+++.||+|++.... .....+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999995 468999999986432 1223345566676655 699999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 g~L~~~l~~~~----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~- 152 (330)
T cd05586 81 GELFWHLQKEG----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT- 152 (330)
T ss_pred ChHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-
Confidence 99998886543 489999999999999999999999 9999999999999999999999999998754322211
Q ss_pred cccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||..... .+........ . .
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~-~------~ 214 (330)
T cd05586 153 ---TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFG-K------V 214 (330)
T ss_pred ---ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcC-C------C
Confidence 1233489999999988754 478999999999999999999999975332 1111111111 0 0
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHT----MFEVYQ 581 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 581 (618)
.+.....+ ..+.+++.+||+.||.+||+ +.|+++
T Consensus 215 ~~~~~~~~---~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 215 RFPKNVLS---DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCccCC---HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11111122 34556777999999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.63 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=202.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.+.||.|++|.||+|.. .++..+++|++.... ...+.+.+|++.++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999994 468899999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999865422 13589999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
...........++..|+|||++... .++.++|+|||||++|||++|+.||....... ...+... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~---~~------ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQ---ND------ 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhc---CC------
Confidence 2211111223478899999988766 78999999999999999999999997543211 1111111 10
Q ss_pred ccccccCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNG-FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+.+.... .......+.+++.+|++.||++||++.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 224 -PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00111100 1123456778888999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=300.07 Aligned_cols=246 Identities=23% Similarity=0.324 Sum_probs=196.9
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
+|+..+.||+|++|.||+|... ++..|++|.+.... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999965 78999999886432 2345788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999986543 488999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLV-ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
.... .....++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... .............
T Consensus 154 ~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~ 220 (258)
T cd06632 154 EFSF-----AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKEL 220 (258)
T ss_pred cccc-----ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhcccC
Confidence 3221 12234788999999887666 89999999999999999999999975331 1111111110000
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .........+.+++.+|++.+|.+||++.++++
T Consensus 221 ~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 P---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred C---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0 001112345667777999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=304.10 Aligned_cols=264 Identities=19% Similarity=0.217 Sum_probs=194.4
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++++|.+.+.||+|+||.||+|.. .++..|++|++.... .....+.+|+.++++++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467899999999999999999985 568899999986532 33346788999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+. +++.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9996 57776664432 3478888999999999999999999 999999999999999999999999999876433
Q ss_pred CCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH--------
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL-------- 531 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~-------- 531 (618)
.... .....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ..+.+....
T Consensus 156 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 156 PSQT----YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQLEKIWTVLGVPTEDT 228 (291)
T ss_pred CCCC----CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHHHHHHHHcCCCChhh
Confidence 2211 1122368899999988654 57889999999999999999999997543210 001000000
Q ss_pred ---HhcCCccchhccccccCCCC------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 532 ---LNTNSSLETAIDKSLLGNGF------DGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 532 ---~~~~~~~~~~~d~~l~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.................... ......+.+++.+|+..||++|||++|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000000000000 011345667788999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=303.33 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=196.7
Q ss_pred CCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 308 FSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
|.+.+.||+|+||.||+|... ++..||+|++.... ...+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999843 36899999987543 23456889999999999999999999886542
Q ss_pred eeEEEEeecCCCccccccCCCC--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAE--HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
..++++||+++|+|.+++.... .....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2378999999999988764322 1223588999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|.++........... ....++..|++||......++.++||||||+++|||++ |+.||...... .+..+
T Consensus 158 g~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-----~~~~~--- 227 (273)
T cd05074 158 GLSKKIYSGDYYRQG--CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-----EIYNY--- 227 (273)
T ss_pred cccccccCCcceecC--CCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-----HHHHH---
Confidence 999865432211111 11224578999999988889999999999999999999 88888643221 11111
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
........ ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 228 ~~~~~~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 228 LIKGNRLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHcCCcCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111100 0112335788888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.15 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=192.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHH-HhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINT-LGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|+||.||++.. .+|+.||+|+++... ....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688899999999999999995 469999999987643 234456667665 556689999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++ |+|.+++.........+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5887777543322356899999999999999999999853 7999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCCCCCCC----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
... ....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... ...... .....
T Consensus 158 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~~~-- 223 (283)
T cd06617 158 VAK-----TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQLK-QVVEE-- 223 (283)
T ss_pred ccc-----ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHHHH-HHHhc--
Confidence 111 11237889999998764 4568899999999999999999999864221 111111 11100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+.+... .....+.+++.+||..+|++||++.++++
T Consensus 224 ----~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 ----PSPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ----CCCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111111 12345777888999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=315.83 Aligned_cols=243 Identities=29% Similarity=0.401 Sum_probs=197.6
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.|+..+.||.|+||.||-|+ ..+...||||++..+. ..-.++..|+.+|.+++|||++.+.|+|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 35556779999999999999 5678999999997543 223578999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
||- |+-.|++...+ .++.+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.+||+|||.|....+.
T Consensus 107 YCl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 995 48888876655 5689999999999999999999999 9999999999999999999999999999876653
Q ss_pred CCcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
. ..+|||.|||||++. .+.|+-++||||+|++..||.-.++|+...+. +.........+
T Consensus 180 n--------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNe--- 241 (948)
T KOG0577|consen 180 N--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNE--- 241 (948)
T ss_pred h--------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcC---
Confidence 3 334999999999865 57899999999999999999999999765432 22222222222
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.|.+....++++...|++ .||+.-|.+|||.+++++
T Consensus 242 ----sPtLqs~eWS~~F~~Fvd---~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 ----SPTLQSNEWSDYFRNFVD---SCLQKIPQERPTSEELLK 277 (948)
T ss_pred ----CCCCCCchhHHHHHHHHH---HHHhhCcccCCcHHHHhh
Confidence 233444445555555544 999999999999988754
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=302.41 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=197.3
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
|+..+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++.+++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66788999999999999985 568999999986432 334578899999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 86 ~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 86 GGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence 99999988642 488999999999999999999999 9999999999999999999999999998765432211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
. ....++..|+|||+..+..++.++|||||||++|+|++|..||..... ............ +
T Consensus 158 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~------~ 219 (277)
T cd06641 158 R----NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKNNP------P 219 (277)
T ss_pred h----ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHhcCCC------C
Confidence 1 122378899999999888889999999999999999999999864321 111111111100 0
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+ .......+.+++.+|++.+|.+||++.++++.
T Consensus 220 ~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01 11233456777889999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=308.09 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=194.8
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|++|.||+|+. .+++.|++|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999985 468999999886432 2335788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 588888865433 4589999999999999999999999 99999999999999999999999999987654322
Q ss_pred CcccccccCCCCcccccCCCCCCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC-----
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLV-ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS----- 536 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~----- 536 (618)
... ....++..|+|||+..+.. ++.++||||||+++|||+||+.||......+ ...+.........
T Consensus 155 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 155 RTY----THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWP 226 (284)
T ss_pred ccc----ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhh
Confidence 211 1223678899999876544 5889999999999999999999997543211 1111111000000
Q ss_pred ----------ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 ----------SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ----------~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........... .........+.+++.+|++.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000011234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=304.83 Aligned_cols=249 Identities=27% Similarity=0.379 Sum_probs=199.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
++|.+.+.||+|+||.||++.. .++..|++|.+.... ...+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788899999999999999984 568899999986432 34566889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998643 378899999999999999999999 999999999999999999999999998876544322
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ....+++.|+|||.+.+..++.++||||||+++|++++|+.||.......... ......
T Consensus 171 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--------~~~~~~------- 231 (293)
T cd06647 171 KR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNG------- 231 (293)
T ss_pred cc----ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--------ehhcCC-------
Confidence 11 12237889999999988889999999999999999999999997543211100 000000
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.............+.+++.+||..+|++||++.+++..
T Consensus 232 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 -TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000111223456678889999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=303.26 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=201.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|+..+.||+|++|.||++... +++.|++|++.... ...+++.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999964 68999999987643 3456788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
+++++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999987653 358899999999999999999999 8 9999999999999999999999999998765332
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.... ..++..|+|||...+..++.++||||||+++|+|++|+.||...... .....+..........
T Consensus 155 ~~~~------~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~---- 221 (265)
T cd06605 155 LAKT------FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPP---- 221 (265)
T ss_pred Hhhc------ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCC----
Confidence 1111 33788999999999889999999999999999999999999754321 1112222222111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+.. ......+.+++.+|+..||++|||+.|++.
T Consensus 222 --~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 --PRLPS---GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --CCCCh---hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 01100 113445777888999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.68 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=194.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|+..+.||+|++|.||+|... +++.||+|.+.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999964 68999999986432 2234567899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 8998886543 3588999999999999999999999 99999999999999999999999999987543211
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH---------HHHHHHH
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL---------VEWITLL 532 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l---------~~~~~~~ 532 (618)
.. .....++..|+|||+..+ ..++.++||||+|+++|||++|+.||............. ..|....
T Consensus 158 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 KT----YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred cc----ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 11 111235788999998765 457899999999999999999999996543110000000 0000000
Q ss_pred hcCCccc---hhc-cccccCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNSSLE---TAI-DKSLLGNG-FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~---~~~-d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....... ... ...+.... .......+.+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 000 00000000 0001256678888999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=299.56 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=203.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.+.||+|++|.||+|+.. +++.|++|++.... ...+.+.+|+..+.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999965 58999999987654 3456799999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
+++++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999754 348999999999999999999999 8 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.... ....++..|+|||...+..++.++||||||+++|+|++|+.||...... ...+.........
T Consensus 154 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~----- 219 (264)
T cd06623 154 LDQC----NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAICDGP----- 219 (264)
T ss_pred CCcc----cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHhcCC-----
Confidence 3221 1123678999999999889999999999999999999999999765421 1111111111110
Q ss_pred ccccccCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 542 IDKSLLGNGFDG-ELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 542 ~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+.+ ... ....+.+++.+|++.+|++||++.|+++.
T Consensus 220 -~~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 -PPSL----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CCCC----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0011 111 34567778889999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=300.35 Aligned_cols=250 Identities=19% Similarity=0.228 Sum_probs=193.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc------cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--Cee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 376 (618)
.+|++.+.||+|+||.||++.. .++..|++|.+.... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999995 568999999885321 1234678899999999999999999998764 457
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999986443 378889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
......... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... .... ......
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~-~~~~~~ 225 (265)
T cd06652 155 RLQTICLSG-TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIF-KIATQP 225 (265)
T ss_pred ccccccccc-cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHH-HHhcCC
Confidence 654321111 1112234788999999998888999999999999999999999999643211 1111 111000
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ....+......+.+++.+|+ .+|++||+++|+++
T Consensus 226 ~---------~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 226 T---------NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred C---------CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 0 01112233445667777888 49999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.52 Aligned_cols=246 Identities=20% Similarity=0.322 Sum_probs=206.4
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
+-|+..+.||+|-|..|-+|+ .=+|..||||++.+.+ .....+.+|+.-|+-++|||||++|++.......|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 446667789999999999998 4589999999997654 345678899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee-CCCCceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL-DGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG~a~~~~~ 460 (618)
.-++|+|++||-+.. ..+.+....+++.||+.|+.|+|+. .+|||||||+||.+ ..-|-+||.|||++..+.+
T Consensus 98 LGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999998766 3589999999999999999999999 99999999999876 5678899999999987765
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVAT-PKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
... ....+|+..|-|||++.+..|+ +++||||+|||||.|++|++||+..++.+....
T Consensus 172 G~k-----L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------- 230 (864)
T KOG4717|consen 172 GKK-----LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------- 230 (864)
T ss_pred cch-----hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----------------
Confidence 432 3345699999999999998886 589999999999999999999997665443221
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
++|- +...++....++.+||..||..||++|.+.+||..
T Consensus 231 -ImDC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 231 -IMDC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -hhcc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1221 12234555667778888999999999999999865
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=306.87 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=193.9
Q ss_pred CCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 309 SKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
.....||+|+||.||++.. .++..||||.+.... ...+.+.+|+..+++++|+||+++++.+...+..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3346799999999999985 468899999986533 33456889999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||++..........
T Consensus 105 ~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~- 175 (292)
T cd06658 105 ALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR- 175 (292)
T ss_pred cHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC-
Confidence 999987532 388999999999999999999999 99999999999999999999999999987654322211
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 546 (618)
....++..|+|||+..+..++.++||||||+++|||++|+.||...... ....... ....+.+
T Consensus 176 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~------~~~~~~~ 238 (292)
T cd06658 176 ---KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------QAMRRIR------DNLPPRV 238 (292)
T ss_pred ---ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHH------hcCCCcc
Confidence 1234788999999998888999999999999999999999999753321 0011100 0011111
Q ss_pred cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 547 LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.. .......+.+++.+|+..||.+|||++|+++.
T Consensus 239 ~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 KD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 01122356667779999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.79 Aligned_cols=264 Identities=22% Similarity=0.269 Sum_probs=198.4
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|++.+.||+|++|.||+|.. .+|+.|++|++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999995 478999999987543 3346789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+ +++|.+++.... ..+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999886543 4589999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC--------HHHHHHHHh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS--------LVEWITLLN 533 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~--------l~~~~~~~~ 533 (618)
.. ......++..|+|||++.+. .++.++||||+|+++|||++|++||......+..... ...|....
T Consensus 154 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (286)
T cd07832 154 PR---LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT- 229 (286)
T ss_pred CC---ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc-
Confidence 11 11223478899999987654 4689999999999999999998877643321100000 00010000
Q ss_pred cCCccchhcccccc----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLL----GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........+.-. .....+....+.+++.+|++.||++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000000 0001123367788888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=300.68 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=195.5
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----c-------CHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----H-------SEKEFLSEINTLGSVRHRNLVPLLGFCVAKK 374 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 374 (618)
+|...+.||+|++|.||+|.. .+++.||+|.++... . ..+.+.+|+.++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999984 568999999885321 0 1245788999999999999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999987653 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV--ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
++......... ......++..|+|||...... ++.++||||||+++||+++|..||..... ........
T Consensus 155 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~ 225 (272)
T cd06629 155 SKKSDDIYDND--QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMFKLG 225 (272)
T ss_pred ccccccccccc--ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHHHhh
Confidence 97654321111 112234788999999877654 78999999999999999999999864321 11111111
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .....++... .......+.+++.+|+..+|++||++.++++
T Consensus 226 -~~-~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 226 -NK-RSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cc-ccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 0011111111 1122356777778999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=301.53 Aligned_cols=243 Identities=22% Similarity=0.288 Sum_probs=196.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..+.||+|++|.||++.. .+++.||+|.++... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688899999999999999995 468999999986532 23456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~----~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSG----RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 9999999999987653 489999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. ....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... .......... .
T Consensus 154 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~--- 214 (290)
T cd05580 154 RT-------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEG-K--- 214 (290)
T ss_pred CC-------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-C---
Confidence 31 122478999999999888889999999999999999999999975331 0111111110 0
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
..+ +......+.+++.+||..||.+|| +++|+++
T Consensus 215 ---~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 ---VRF----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---ccC----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 001 111234566777799999999999 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.90 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=196.7
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeeEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVR---HRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 380 (618)
.|+..+.||+|+||.||+|.. .+++.|++|.+... ....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999995 67899999998653 234567889999999996 999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988543 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..... ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... .+.......
T Consensus 154 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~~~~---- 217 (277)
T cd06917 154 NSSKR----STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMMLIPKS---- 217 (277)
T ss_pred Ccccc----ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhccccC----
Confidence 33211 12247889999998765 45689999999999999999999999753321 111100000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+.+... .....+.+++.+|++.||++||++.|+++
T Consensus 218 --~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 --KPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred --CCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11111111 13346777888999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.36 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=209.7
Q ss_pred CCCcEEeecCCeeEEEEEe-CCC----cEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 309 SKNNIIGTGRTGATYIAML-PGG----CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
...++||+|+||+||+|.+ +.| -+||+|++.... ...+++..|+.+|.+++|||+++++++|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3468899999999999994 444 478999986643 45788999999999999999999999998766 789999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++.|+|.++++..+ ..+-....+.|..|||+||.|||.+ +++||||-.+|||+.....+|+.|||+++.....
T Consensus 778 ~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999998766 4588899999999999999999999 9999999999999999999999999999998776
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
........ ..-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+ + .+
T Consensus 852 ~~ey~~~~--gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------I---------~d 911 (1177)
T KOG1025|consen 852 EKEYSAPG--GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------I---------PD 911 (1177)
T ss_pred cccccccc--cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------h---------hH
Confidence 54433321 113567999999999999999999999999999999 999988654321 1 11
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.+...-+-..+.-...++..++.+||..|+..||+++++...+.+.+..
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1111112233445667888899999999999999999999999988765
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=317.88 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=189.5
Q ss_pred CcEEeecCCeeEEEEEe-CCCcEEEE---EEec--cCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe--eEEEEee
Q 007088 311 NNIIGTGRTGATYIAML-PGGCFIMI---KRLE--DSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE--RLLVYSY 382 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~-~~~~~vav---K~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~ 382 (618)
..+||+|+|-+||+|.. .+|..||= |.-+ ++....++|..|+.+|+.|+||||+++|+++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 35799999999999995 45766662 2221 233444789999999999999999999999988765 6699999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccCcccccCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~ 461 (618)
+..|+|+.|+.+.+. ++...++.|++||++||.|||++ .|+|+|||||.+||||+. .|.+||+|+|+|......
T Consensus 125 ~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999987764 88889999999999999999997 678999999999999975 589999999999987654
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.... ..|||.|||||++. ..|++.+||||||+.++||+|+..||.....+. +..+.....-.
T Consensus 200 ~aks------vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A-------QIYKKV~SGiK---- 261 (632)
T KOG0584|consen 200 HAKS------VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA-------QIYKKVTSGIK---- 261 (632)
T ss_pred ccce------eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH-------HHHHHHHcCCC----
Confidence 4322 34999999999987 789999999999999999999999998654421 22222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
|.-.....+.+ +.++|.+|+.. ..+|||+.|+++
T Consensus 262 --P~sl~kV~dPe---vr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 262 --PAALSKVKDPE---VREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --HHHhhccCCHH---HHHHHHHHhcC-chhccCHHHHhh
Confidence 10011112234 44555599999 999999999975
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=316.64 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=204.6
Q ss_pred CcEEeecCCeeEEEEEeC--CC--cEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 311 NNIIGTGRTGATYIAMLP--GG--CFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++||+|.||.|++|.+. +| ..||||.++.+.. ...+|.+|+.+|.+|+|+|++++||+..+ ....||||.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 568999999999999964 34 5789999987653 56789999999999999999999999987 66789999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
.|+|.+.|++.. ...+.......++.|||.||.||.++ ++|||||..+|+++-....+||+|||+.+.++..+..
T Consensus 194 lGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 194 LGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999998833 25688888999999999999999999 9999999999999999999999999999988776554
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
+... ...--.+.|+|||.+...+++.++|||+|||++|||+| |..||-..... +. .+.+|
T Consensus 269 Yvm~-p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qI----------L~~iD 329 (1039)
T KOG0199|consen 269 YVMA-PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QI----------LKNID 329 (1039)
T ss_pred eEec-CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HH----------HHhcc
Confidence 4221 12224678999999999999999999999999999998 88898764321 11 12222
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
..-.-..+..+.+++.+++.+||..+|++|||+..|.+.+-
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 22222334557788999999999999999999999975443
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.74 Aligned_cols=257 Identities=18% Similarity=0.204 Sum_probs=198.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..+.||+|+||.||++.. ..++.|++|.+.... ...+.+.+|+++++.++||||+++++.+..+++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688899999999999999995 457899999986542 23456789999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 9999999999996543 489999999999999999999999 999999999999999999999999999874211
Q ss_pred CCCc-----------ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 461 VDTH-----------LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 461 ~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
.... .........++..|+|||++.+..++.++||||||+++||+++|+.||..... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~ 225 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELF 225 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 1000 00000112467899999999888899999999999999999999999964321 1111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
........ ..+.. .......+.+++.+|++.||++||++.++.+.|+.
T Consensus 226 ~~~~~~~~----~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 GQVISDDI----EWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHhccc----CCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111100 00000 01223456778889999999999998777666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=309.11 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=194.2
Q ss_pred CCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCc
Q 007088 310 KNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT 387 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 387 (618)
....||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.++..++||||+++++++...+..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345799999999999985 47899999998643 2345678899999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccc
Q 007088 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467 (618)
Q Consensus 388 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 467 (618)
|.+++.. ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 105 L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~-- 174 (297)
T cd06659 105 LTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-- 174 (297)
T ss_pred HHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccc--
Confidence 9987754 2388999999999999999999999 99999999999999999999999999987654322111
Q ss_pred cccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccccc
Q 007088 468 FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLL 547 (618)
Q Consensus 468 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 547 (618)
....++..|+|||++.+..++.++|||||||++|||++|+.||...... +.......... . ..
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~-~-----~~- 237 (297)
T cd06659 175 --KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRDSPP-P-----KL- 237 (297)
T ss_pred --cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCC-C-----Cc-
Confidence 1234789999999998888999999999999999999999999753321 11111111000 0 00
Q ss_pred CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 548 GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.........+.+++.+|++.+|++||++.|+++.
T Consensus 238 -~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 -KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011122356677779999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=299.15 Aligned_cols=248 Identities=21% Similarity=0.310 Sum_probs=198.4
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|+||.||++.. .+|..||+|.+... ....+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999995 45889999998653 23445788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccCcccccCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMNPV 461 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~ 461 (618)
+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999875433 3589999999999999999999999 999999999999999885 4699999999766532
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.... ....|++.|+|||+..+..++.++||||||+++|||++|+.||..... .++....... ....
T Consensus 156 ~~~~----~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~~- 221 (257)
T cd08225 156 MELA----YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQG-YFAP- 221 (257)
T ss_pred cccc----cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcc-cCCC-
Confidence 2211 122378899999999888899999999999999999999999864321 2222221111 1000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........+.+++.+|+..+|++|||+.|+++
T Consensus 222 --------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 --------ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01112345777788999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.23 Aligned_cols=266 Identities=23% Similarity=0.245 Sum_probs=198.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|+..+.||+|++|.||+|... +++.|++|+++... ...+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999964 58899999986532 334678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++++.+..+.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655433 3489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH-------HHHHHHHh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL-------VEWITLLN 533 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l-------~~~~~~~~ 533 (618)
.... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+...... ........
T Consensus 154 ~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PASP---LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred cccc---ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 3211 1123467889999998887 88999999999999999999999997543211000000 00000000
Q ss_pred cCCccch--hcc---cc-ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLET--AID---KS-LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~--~~d---~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....... ..+ .. +..........++.+++.+||..+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 000 00 000001112567888888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.34 Aligned_cols=270 Identities=22% Similarity=0.249 Sum_probs=196.4
Q ss_pred cCCCCcEEeecCCeeEEEEEeC---CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP---GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERL 377 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 377 (618)
+|++.++||+|++|.||+|... ++..||+|.+.... ...+.+.+|+.++.+++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999954 47999999997632 2345678899999999999999999999988 7899
Q ss_pred EEEeecCCCccccccCCCCCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC----CCceEEccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHE-VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG----DFEPKLSDF 452 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 452 (618)
+||||+++ +|.+.+...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 676666433221 23689999999999999999999999 9999999999999999 899999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-----cCHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK-----GSLV 526 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~-----~~l~ 526 (618)
|++......... ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ..+.
T Consensus 157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999876443221 111123347889999998765 457899999999999999999999998654332000 0011
Q ss_pred HHHHHHhcC-----------CccchhccccccCCCC----H-------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 527 EWITLLNTN-----------SSLETAIDKSLLGNGF----D-------GELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 527 ~~~~~~~~~-----------~~~~~~~d~~l~~~~~----~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+...... .......+........ . .....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111110000 0000000000000000 0 22346788888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=305.48 Aligned_cols=265 Identities=21% Similarity=0.219 Sum_probs=196.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 379 (618)
++|+..+.||+|+||.||+|... +++.+++|.++... .....+.+|++++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888999999999999999964 68899999996533 2234567899999999999999999999877 789999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 8988886543 2589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH--------HHHH
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV--------EWIT 530 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~--------~~~~ 530 (618)
...... ....++..|+|||.+.+. .++.++||||+|+++|||++|+.||......+....... .|..
T Consensus 158 ~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLKPY----TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred CCcccc----ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHH
Confidence 432111 123367889999987654 468999999999999999999999975432111100000 0100
Q ss_pred HHh---cC-CccchhccccccCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 531 LLN---TN-SSLETAIDKSLLGNGFDG-ELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 531 ~~~---~~-~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .. ..........+....... ....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 00 000000000011111111 2455677888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=302.12 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=203.2
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++.|+..+.||+|++|.||++... ++..|++|++.......+.+.+|++.+++++|+|++++++++...+..++|+||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4567888899999999999999965 688999999976554567789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999997654 3599999999999999999999998 99999999999999999999999999887654322
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....++..|+|||++.+..++.++||||||+++|+|++|+.||...... ......... ....
T Consensus 171 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~~-~~~~-- 235 (286)
T cd06614 171 SKR----NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITTK-GIPP-- 235 (286)
T ss_pred hhh----ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhc-CCCC--
Confidence 111 1123678999999998888999999999999999999999998643221 111111110 0000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .........+.+++.+|++.+|.+||++.++++
T Consensus 236 ---~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 236 ---L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 001113346777888999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.70 Aligned_cols=264 Identities=19% Similarity=0.196 Sum_probs=193.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCe-----
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKE----- 375 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 375 (618)
++|++.+.||+|+||.||+|.. .+++.||+|.++... .....+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688899999999999999995 468999999886532 23456888999999995 6999999999987665
Q ss_pred eEEEEeecCCCccccccCCCCCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccC
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHE-VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFG 453 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 453 (618)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 888887654322 34689999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+++......... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||......+. +.......
T Consensus 157 ~~~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~ 228 (295)
T cd07837 157 LGRAFSIPVKSY----THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ----LLHIFKLL 228 (295)
T ss_pred cceecCCCcccc----CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHh
Confidence 987654322111 11236788999998764 4578999999999999999999999975432111 00000000
Q ss_pred hcC-C-ccchhc-------cccccC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTN-S-SLETAI-------DKSLLG----NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~-~-~~~~~~-------d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... . ...... .+.... .........+.+++.+||..||.+||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0 000000 000000 000123355778888999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.11 Aligned_cols=245 Identities=27% Similarity=0.347 Sum_probs=193.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+.|+..+.||+|+||.||+|+. .+++.||+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999995 468999999986432 22356889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||++ |++.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 47777665332 3589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
.. ...++..|+|||++. ...++.++||||||+++|||++|+.||...... ..........
T Consensus 168 ~~--------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~~~~~- 230 (307)
T cd06607 168 AN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQND- 230 (307)
T ss_pred CC--------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHHhcCC-
Confidence 21 123678999999874 456889999999999999999999998653211 1111111000
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+.+. .......+.+++.+||+.||++||++.+++..
T Consensus 231 -----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 -----SPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -----CCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00110 12234567888889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=302.42 Aligned_cols=260 Identities=23% Similarity=0.301 Sum_probs=195.2
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
|++.+.||.|++|.||+|.. .+|..|++|++.... ...+.+.+|++++++++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999995 579999999986532 23456889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
+ ++|.+++..... ..+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689998865542 3589999999999999999999999 999999999999999999999999999976543221
Q ss_pred cccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC------
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS------ 536 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~------ 536 (618)
.. ....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+...........
T Consensus 155 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 155 TY----THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID----QLFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred cc----CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHHhhh
Confidence 11 112367889999987654 56889999999999999999999997543211 1111111000000
Q ss_pred -----ccchhccc---cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 -----SLETAIDK---SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 -----~~~~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.....+.. .............+.+++.+|++.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000 0000001112246778888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=297.15 Aligned_cols=248 Identities=21% Similarity=0.273 Sum_probs=201.8
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|++.++||+|++|.||++.. .+++.+++|.+.... ....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999984 478899999987532 3345678899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.........+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 999999999876433335689999999999999999999999 99999999999999999999999999998765431
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
. ....++..|+|||...+..++.++|+||+|+++|||++|+.||...+.. +...... ...
T Consensus 158 ~------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~-~~~----- 217 (256)
T cd08530 158 A------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------DLRYKVQ-RGK----- 217 (256)
T ss_pred c------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHh-cCC-----
Confidence 1 1233788999999999988999999999999999999999999753321 1111111 100
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........++.+++.+|++.+|++||++.|+++
T Consensus 218 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 ----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01112234466788888999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.23 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=196.2
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
|...+.||+|++|.||++.. .+++.|++|++.... ...+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44567999999999999995 578899999886433 3345688999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
++|.+++... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+..........
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 9999998652 388999999999999999999999 99999999999999999999999999887554322111
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
....|+..|+|||...+..++.++||||||+++|||++|+.||..... ........... .+.
T Consensus 173 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~~------~~~ 234 (285)
T cd06648 173 ----KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRDNL------PPK 234 (285)
T ss_pred ----ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHhcC------CCC
Confidence 123478899999999888899999999999999999999999865321 11111111110 000
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. ........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 LK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred Cc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 10 01112346778888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.82 Aligned_cols=266 Identities=20% Similarity=0.269 Sum_probs=197.2
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+|+..+.||.|++|.||+|+. .+|..||+|.++... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 578899999999999999996 468999999987543 33456788999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888765432 24589999999999999999999999 999999999999999999999999999976543211
Q ss_pred cccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH-------HHHHhcC
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW-------ITLLNTN 535 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~-------~~~~~~~ 535 (618)
. .....++..|++||.+.+ ..++.++||||||+++|+|++|+.||......+........+ .......
T Consensus 156 ~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 T----FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred c----cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 1 112236788999998765 456889999999999999999999997654322111100000 0000000
Q ss_pred Cccchhcccc---ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 536 SSLETAIDKS---LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~---l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......... ............+.+++.+|++.||.+||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000000 000001122356778888999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=302.43 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=193.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
.++|+..++||+|+||.||+|.. .+++.||+|.+.... .....+.+|++++++++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45789999999999999999995 468999999885432 22345678999999999999999999987654
Q ss_pred --eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 375 --ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 375 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
..++||||+.+ +|.+++.... ..+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999965 8887775443 3589999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|++..................++..|+|||.+.+. .++.++||||||+++|||++|+.||....... .......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-----~~~~~~~ 238 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-----QLTLISQ 238 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHH
Confidence 99987644322211112233467889999987654 46889999999999999999999987543211 0000001
Q ss_pred HhcC---------------------CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 532 LNTN---------------------SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 532 ~~~~---------------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ..........+... .....+.+++.+||..||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPY---VKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccc---cCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 00000000000000 01234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=325.21 Aligned_cols=270 Identities=18% Similarity=0.197 Sum_probs=186.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCC--CcEEEEE------------------EeccCccCHHHHHHHHHHHhcCCCCCc
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPG--GCFIMIK------------------RLEDSQHSEKEFLSEINTLGSVRHRNL 363 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~ni 363 (618)
..++|++.+.||+|+||.||++..+. +..++.| .+.........+.+|+.++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987432 2222222 222222334568899999999999999
Q ss_pred cceeEEEEeCCeeEEEEeecCCCccccccCCCCCC-CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHE-VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 364 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
+++++++...+..|+|+|++. ++|.+++...... ........+..++.||+.||+|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999985 4777766543211 12234567788999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~ 522 (618)
.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++........ .
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~-~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAF---DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP-G 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccccc---cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH-H
Confidence 99999999999998765432211 1123589999999999999999999999999999999998865433221110 0
Q ss_pred cCHHHHHHHHhcC-C-------ccchhcccc-c--cCCCCH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 523 GSLVEWITLLNTN-S-------SLETAIDKS-L--LGNGFD------GELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 523 ~~l~~~~~~~~~~-~-------~~~~~~d~~-l--~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+.+........ . ...+.++.. + ...... .....+.+++.+||+.||++|||+.|+++
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0111111100000 0 000000000 0 000000 01234667788999999999999999976
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.20 Aligned_cols=241 Identities=21% Similarity=0.245 Sum_probs=183.5
Q ss_pred EEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHH---hcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 313 IIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTL---GSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.||+|+||.||++.. .+++.||+|.+.... .....+.+|..++ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 568999999886532 1122344454433 33479999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQHG----VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 999999886543 489999999999999999999999 999999999999999999999999999875543211
Q ss_pred ccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
....|+..|+|||... +..++.++||||+||++|||++|+.||....... ... ....... ..
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~-~~~~~~~------~~ 215 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHE-IDRMTLT------VN 215 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----HHH-HHHHhhc------CC
Confidence 1224889999999876 4568899999999999999999999997543211 111 1110000 00
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQL 582 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 582 (618)
..+ +......+.+++.+||..||++|| +++|+++.
T Consensus 216 ~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VEL----PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCC----ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111 112334566777799999999999 58888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=295.65 Aligned_cols=246 Identities=22% Similarity=0.230 Sum_probs=198.8
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
+|++.+.||.|+||.||++... +++.|++|.+.... ...+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999964 68999999996532 345678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++++|.+++... .++++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998754 3589999999999999999999999 9999999999999999999999999998865443
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.. .....++..|+|||...+..++.++|+||||+++|+|++|+.||...... ...+....... ..
T Consensus 154 ~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~~-- 218 (258)
T cd05578 154 TL-----TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--AD-- 218 (258)
T ss_pred cc-----ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--cc--
Confidence 21 12234788999999998888999999999999999999999999764421 11111111110 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM--FEVY 580 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 580 (618)
...+......+.+++.+||+.||.+||++ +|++
T Consensus 219 ------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 ------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 01111223567788889999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.51 Aligned_cols=254 Identities=27% Similarity=0.406 Sum_probs=203.1
Q ss_pred HhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
..+-++....+||.|.||.||-|. .++|...|+|-++-. ....+.+.+|+.++..++|||+|+++|+-...+..++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345678889999999999999999 678999999987543 2344567899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
.||||++|+|.+.+...+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+
T Consensus 1312 FMEyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999976653 66777788899999999999999 9999999999999999999999999999988
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh-c
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLV---ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN-T 534 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~-~ 534 (618)
...............||+.|||||++.+.. ...+.||||+||++.||+||+.||...+. +|.-.+. .
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V~ 1455 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHVA 1455 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHHh
Confidence 765444445556777999999999987543 45799999999999999999999975443 1221111 0
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+. .|.+.. ..+.+-.+|++ +||+.||++|.++.|+++
T Consensus 1456 ~gh-----~Pq~P~-~ls~~g~dFle---~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 AGH-----KPQIPE-RLSSEGRDFLE---HCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ccC-----CCCCch-hhhHhHHHHHH---HHHhcCchhhhHHHHHHH
Confidence 000 011111 13344455555 999999999988887654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=307.49 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=196.0
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC------
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------ 373 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 373 (618)
..++|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999994 57899999998643 23345677899999999999999999998644
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 346999999964 88877743 278889999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC-------HH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS-------LV 526 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~-------l~ 526 (618)
+++....... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+........ ..
T Consensus 164 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 164 LARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred cceeCCCCCC-----CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9987643221 11233788999999999999999999999999999999999999754321100000 00
Q ss_pred HHH-------HHHhcC-C-----ccchhcccccc----CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 527 EWI-------TLLNTN-S-----SLETAIDKSLL----GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 527 ~~~-------~~~~~~-~-----~~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
++. ...... . ...+.....+. ..........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 000000 0 00000000000 0001123456778888999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=291.17 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=202.1
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 380 (618)
+|+..+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++.+++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999965 78999999987654 3456789999999999999999999999988 8899999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999987553 589999999999999999999998 999999999999999999999999999987655
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... .......++..|+|||...+..++.++||||||+++|+|++|+.||..... .............
T Consensus 154 ~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~--- 221 (260)
T cd06606 154 IETG--EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSGE--- 221 (260)
T ss_pred cccc--ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccCC---
Confidence 4321 011123478899999999888899999999999999999999999976431 1111111110000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...........+.+++.+|++.||++||++.|+++
T Consensus 222 ------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 ------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111223456778888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=297.50 Aligned_cols=260 Identities=20% Similarity=0.202 Sum_probs=191.5
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCC-CCCccceeEEEEeC--CeeEEEEe
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAK--KERLLVYS 381 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 381 (618)
|++.+.||+|+||.||+|.. .+++.||+|+++... .......+|+..+.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56778999999999999994 568999999987542 22334557888898885 99999999999987 88999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++ |+|.+.+.... ..+++..+..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 48887776533 3589999999999999999999999 9999999999999999 99999999999876432
Q ss_pred CCcccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-------cCHHHHHHHHh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK-------GSLVEWITLLN 533 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~-------~~l~~~~~~~~ 533 (618)
... ....++..|+|||+.. +..++.++|||||||++|||++|..||...+..+... .....|.....
T Consensus 153 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PPY-----TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCc-----CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 221 1123688999999754 4567889999999999999999999997543211100 00011110100
Q ss_pred cCCccchhccccccCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGN----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .......+..... ........+.+++.+||+.+|++||+++++++
T Consensus 228 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KS-RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cc-ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 0000000000000 01123567888888999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.59 Aligned_cols=258 Identities=15% Similarity=0.184 Sum_probs=183.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC----CcEEEEEEeccCccC---H---------HHHHHHHHHHhcCCCCCccceeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQHS---E---------KEFLSEINTLGSVRHRNLVPLLGF 369 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~---~---------~~~~~E~~~l~~l~h~niv~l~~~ 369 (618)
++|.+.++||+|+||.||+|...+ +..+++|........ + .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999999644 456666654322111 0 112233445667789999999997
Q ss_pred EEeCC----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC
Q 007088 370 CVAKK----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445 (618)
Q Consensus 370 ~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 445 (618)
+.... ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 66543 34678887744 555555432 2357888899999999999999999 999999999999999999
Q ss_pred ceEEcccCcccccCCCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc-
Q 007088 446 EPKLSDFGLARLMNPVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF- 521 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~- 521 (618)
.++|+|||+|+.......... .......||+.|+|||+..+..++.++|||||||++|||++|+.||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221111 1112234899999999999999999999999999999999999999865321111
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
.....++...... ..+.. ....+.+.+++..|++.+|++||+++++.+.+
T Consensus 244 ~~~~~~~~~~~~~---------~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHE---------GKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhh---------hhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0011111111111 11111 11235677778899999999999999999876
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.04 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=190.5
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|...+.||+|+||.||++.. .+++.||+|.+.... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 445567899999999999995 468999999986533 34556889999999996 99999999999999999999999
Q ss_pred cCCCcccccc---CCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 383 LENGTLYDKL---HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l---~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
++. ++.++. .... ...+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||+++...
T Consensus 85 ~~~-~l~~l~~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEVL--KSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 864 554432 2211 145899999999999999999999732 89999999999999999999999999997654
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTL---VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
..... ....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.........
T Consensus 160 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~ 227 (288)
T cd06616 160 DSIAK-----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGD 227 (288)
T ss_pred cCCcc-----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCC
Confidence 32211 112378899999998765 68999999999999999999999986432 1111111111100
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+.+...........+.+++.+|++.||++|||++||++.
T Consensus 228 ------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 ------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111112234567788889999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=290.34 Aligned_cols=248 Identities=26% Similarity=0.351 Sum_probs=200.9
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCcc-CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQH-SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
+|+..+.||+|++|.||++... +++.+++|++..... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999964 689999999976543 56778999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++.... ..+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987653 3589999999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....++..|+|||+..+..++.++||||||+++|+|++|+.||...... ........ ........
T Consensus 154 ----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~- 219 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--------KALFKIAT-NGPPGLRN- 219 (253)
T ss_pred ----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--------HHHHHHHh-cCCCCcCc-
Confidence 11223788999999998888999999999999999999999998753211 11111110 00000000
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......+.+++.+|++.||++|||+.|+++
T Consensus 220 ------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 ------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111356777888999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=301.59 Aligned_cols=248 Identities=26% Similarity=0.344 Sum_probs=194.4
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
|+..+.||+|+||.||+++. .++..||+|.+.... ...+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66688999999999999995 568999999986432 2235688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++ +|.+.+.... .++++.++..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 107 ~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (317)
T cd06635 107 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN 179 (317)
T ss_pred CCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence 975 7777765433 3589999999999999999999999 99999999999999999999999999987544321
Q ss_pred CcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...++..|+|||++. +..++.++|||||||++|||++|+.||...... ...........
T Consensus 180 --------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~-- 241 (317)
T cd06635 180 --------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES-- 241 (317)
T ss_pred --------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhccC--
Confidence 123788999999873 456889999999999999999999998653211 10111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
+.. ........+.+++.+|++.+|.+||++.++++.+-.+.
T Consensus 242 ----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 242 ----PTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ----CCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000 11123345677888999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=292.09 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=202.5
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|++|.||++... ++..|++|++.... ...+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999954 68999999997543 3456788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999876543335699999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.. .....+++.|+|||...+..++.++||||+|+++++|++|+.||..... .+........ ...
T Consensus 158 ~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~~--- 221 (258)
T cd08215 158 DL----AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKILKG-QYP--- 221 (258)
T ss_pred ce----ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHhcC-CCC---
Confidence 11 1223478899999999888899999999999999999999999865331 1111111111 000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ .......+.+++.+||..+|++||++.|+++
T Consensus 222 --~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 --PI----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01 1122346677888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=305.87 Aligned_cols=263 Identities=24% Similarity=0.322 Sum_probs=194.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----ee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK-----ER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 376 (618)
+++|++.++||+|+||.||+|.. .+|+.||+|.+... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999984 57899999998642 233456788999999999999999999876543 57
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++|+||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999975 887777542 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.......... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+... ....+... ...
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~-~~~ 228 (336)
T cd07849 155 IADPEHDHTG-FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGV-LGT 228 (336)
T ss_pred eccccccccC-CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHH-cCC
Confidence 7543222111 1123457899999998654 568899999999999999999999996532110 00000000 000
Q ss_pred Cc---cchhcc-------ccccC--C-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 536 SS---LETAID-------KSLLG--N-----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 536 ~~---~~~~~d-------~~l~~--~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.. .....+ ..... . ........+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 000000 00000 0 001123457788889999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=291.13 Aligned_cols=250 Identities=20% Similarity=0.225 Sum_probs=192.5
Q ss_pred HHHHHHhhccCCCCcEE--eecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 007088 298 LSDLMKATNSFSKNNII--GTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK 373 (618)
Q Consensus 298 ~~~l~~~~~~y~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 373 (618)
..+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+........ |+.....+ +||||+++++++...
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecC
Confidence 34555566778887777 9999999999994 5688999999865432221 22222222 799999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEccc
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDF 452 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df 452 (618)
+..++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999987543 589999999999999999999999 999999999999999998 9999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
|++........ ..++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+....
T Consensus 155 g~~~~~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~ 223 (267)
T PHA03390 155 GLCKIIGTPSC--------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQ 223 (267)
T ss_pred ccceecCCCcc--------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHHHhh
Confidence 99876543221 237889999999998899999999999999999999999997443211 1112222211
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-MFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 581 (618)
.... .........+.+++.+||+.||.+||+ ++|+++
T Consensus 224 ~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 QKKL------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccC------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1000 011123345677777999999999996 588863
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=297.64 Aligned_cols=262 Identities=24% Similarity=0.306 Sum_probs=195.8
Q ss_pred CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEEEEe
Q 007088 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLLVYS 381 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 381 (618)
|++.+.||+|++|.||+|+.. +++.+++|++.... .....+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999964 58999999997652 3345688999999999999999999999988 78999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8888886543 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC--cc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS--SL 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~--~~ 538 (618)
... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .+.+......... ..
T Consensus 154 ~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NSA---DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE-KIFELCGSPTDENWPGV 229 (287)
T ss_pred Ccc---cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCchhhcccc
Confidence 211 1112336788999997654 457899999999999999999999997544211100 0000000000000 00
Q ss_pred ch-----------hccccccCCCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ET-----------AIDKSLLGNGFDG-ELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~-----------~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .....+. +.... ....+.+++.+|++.+|.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLR-EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHH-HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0000000 00011 2567888999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.45 Aligned_cols=262 Identities=29% Similarity=0.298 Sum_probs=193.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 378 (618)
.++|++.+.||+|+||.||+|.. .+|+.||+|.++... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46789999999999999999995 468999999986432 2233567899999999999999999998765 46799
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+.+ +|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 8888776543 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc-CC
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT-NS 536 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~-~~ 536 (618)
....... ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+. +......... ..
T Consensus 159 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~----~~~~~~~~~~~~~ 230 (309)
T cd07845 159 GLPAKPM----TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ----LDLIIQLLGTPNE 230 (309)
T ss_pred CCccCCC----CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCCCCh
Confidence 5432111 11225778999998765 4578999999999999999999999975432111 0000000000 00
Q ss_pred cc----------chhccccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SL----------ETAIDKSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~----------~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .....+...... .......+.+++.+|++.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 000000000000 0112445677888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.48 Aligned_cols=264 Identities=21% Similarity=0.274 Sum_probs=197.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe----CCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA----KKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 376 (618)
.++|++.+.||+|++|.||+|.. .++..||+|++.... ...+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36789999999999999999994 568999999987532 334567889999999999999999998763 3467
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+. |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ----PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999996 58988886543 389999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc-
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT- 534 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~- 534 (618)
.................++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.... + ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~----~-~~~~~~~g~ 230 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ----L-KLILSVLGS 230 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH----H-HHHHHHhCC
Confidence 664432222222223457889999998765 4688999999999999999999999975432110 0 00000000
Q ss_pred ----------CCccchhcccc-ccCC-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 ----------NSSLETAIDKS-LLGN-----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ----------~~~~~~~~d~~-l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.....+..+.. .... ........+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000000 0000 01123456788888999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=293.92 Aligned_cols=241 Identities=21% Similarity=0.215 Sum_probs=192.6
Q ss_pred EeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 314 IGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 314 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
||.|++|.||+++.. +++.|++|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 58999999986532 3346789999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~---- 149 (262)
T cd05572 81 WTILRDRG----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---- 149 (262)
T ss_pred HHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc----
Confidence 99997643 388999999999999999999999 9999999999999999999999999999876543211
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ..+.......... ..
T Consensus 150 -~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~---------~~ 213 (262)
T cd05572 150 -WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDILKGNG---------KL 213 (262)
T ss_pred -ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHHhccCC---------CC
Confidence 1123788999999998888999999999999999999999999764321 1111111111000 00
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
..+......+.+++.+||+.+|++||+ ++|+++
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111112456788888999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.99 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=193.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|+..+.||+|++|.||+|.. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688899999999999999995 468999999986532 234568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~ 460 (618)
|++ ++|.+++..... ..+++..+..++.||+.||+|||++ +++||||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 488877754432 3467888899999999999999999 9999999999999985 55799999999976543
Q ss_pred CCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC-C--
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN-S-- 536 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~-~-- 536 (618)
.... .....+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||......+. +.......... .
T Consensus 156 ~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~----~~~~~~~~~~~~~~~ 227 (294)
T PLN00009 156 PVRT----FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE----LFKIFRILGTPNEET 227 (294)
T ss_pred Cccc----cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCCCChhh
Confidence 2111 112236789999998765 4578999999999999999999999975432111 11100000000 0
Q ss_pred -----ccchhcc--ccccCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 -----SLETAID--KSLLGN----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 -----~~~~~~d--~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+..... +..... ........+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 000000 00112345677888999999999999999986
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=296.66 Aligned_cols=242 Identities=23% Similarity=0.262 Sum_probs=188.9
Q ss_pred EeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 314 IGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 314 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
||+|+||.||++.. .+|+.|++|.+.... .....+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 568999999986432 2344567899999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----- 150 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----- 150 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc-----
Confidence 999875543 3589999999999999999999999 999999999999999999999999999876543111
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
.....++..|+|||+..+..++.++||||||+++|+|++|+.||....... .......... .. . .
T Consensus 151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~------~----~ 215 (277)
T cd05577 151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTL-EM------A----V 215 (277)
T ss_pred cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhccc-cc------c----c
Confidence 112336789999999988889999999999999999999999997543211 0001000000 00 0 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERH-----TMFEVY 580 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl 580 (618)
.........+.+++.+||+.||.+|| ++.+++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 01111234566777799999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=303.75 Aligned_cols=267 Identities=22% Similarity=0.261 Sum_probs=193.6
Q ss_pred EEeec--CCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 313 IIGTG--RTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 313 ~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
.||+| +||+||++.. .+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999995 5799999999865332 2356889999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
+|.+++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+...........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998876533 3488999999999999999999999 999999999999999999999999986543322111100
Q ss_pred ---ccccCCCCcccccCCCCCCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH----------
Q 007088 467 ---TFVNGEFGDLGYVAPEYPRTL--VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL---------- 531 (618)
Q Consensus 467 ---~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~---------- 531 (618)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||......+. .......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM----LLQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH----HHHHhcCCCCCCccccc
Confidence 000111245679999998763 478999999999999999999999975432111 0000000
Q ss_pred ------Hh----------------cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhh
Q 007088 532 ------LN----------------TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ--LLRAIA 587 (618)
Q Consensus 532 ------~~----------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 587 (618)
.. .........+..+...........+.+++.+||+.||++|||+.|+++ .++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 00 000000001111111112335567889999999999999999999974 444444
Q ss_pred h
Q 007088 588 E 588 (618)
Q Consensus 588 ~ 588 (618)
+
T Consensus 316 ~ 316 (328)
T cd08226 316 E 316 (328)
T ss_pred H
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=297.32 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=195.5
Q ss_pred CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCcc--CHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEeec
Q 007088 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQH--SEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
|++.+.||+|++|.||+|+.. +++.|++|++..... ......+|+..+.+++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999965 578999999865432 2334567999999999 999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
+|+|.+++..... ..+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 7799988876542 3589999999999999999999999 999999999999999999999999999986643222
Q ss_pred cccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc--------CHHHHHHHHhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG--------SLVEWITLLNT 534 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~--------~l~~~~~~~~~ 534 (618)
. ....++..|+|||++. ...++.++|+||||++++||++|+.||......+.... .-..|......
T Consensus 155 ~-----~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 Y-----TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred c-----CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 1 1233788999999774 45678999999999999999999999965432111000 00011111100
Q ss_pred CCccchhccccc---cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSL---LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......+.... ...........+.+++.+|++.||++||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000 00001112356888888999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=286.73 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=194.8
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|+..++||+|.||.|-+++ ...++.+|+|++++.. .....-..|-.+|+..+||.+..+.-.|...++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678889999999999999999 5679999999998753 2233456788999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||..||.|+-+|...+ .+++.....+-..|+.||.|||++ +||.||||.+|.|+|.+|++||+|||+++.--
T Consensus 247 MeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999997654 489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.... .....+||+.|.|||++....|+.+.|.|.+||++|||++|+.||...+....+.-++.+-++.
T Consensus 320 ~~g~----t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kF-------- 387 (516)
T KOG0690|consen 320 KYGD----TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKF-------- 387 (516)
T ss_pred cccc----eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccC--------
Confidence 2222 2334569999999999999999999999999999999999999998755432221111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH 574 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 574 (618)
....+.+.+.++. ..|..||.+|-
T Consensus 388 --------Pr~ls~eAktLLs---GLL~kdP~kRL 411 (516)
T KOG0690|consen 388 --------PRTLSPEAKTLLS---GLLKKDPKKRL 411 (516)
T ss_pred --------CccCCHHHHHHHH---HHhhcChHhhc
Confidence 1112344444444 88999999994
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=301.99 Aligned_cols=261 Identities=18% Similarity=0.189 Sum_probs=189.1
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCc
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT 387 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 387 (618)
.+.+|.|+++.||++.. +++.||+|++... ....+.+.+|++++++++|+||+++++++.+.+..+++|||+++|+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34445555555555544 7899999998654 2345678999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc---
Q 007088 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH--- 464 (618)
Q Consensus 388 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 464 (618)
|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.........
T Consensus 86 l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999876433 3488999999999999999999999 9999999999999999999999999988755322111
Q ss_pred ccccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH----------
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL---------- 532 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~---------- 532 (618)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM----LLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCccccccCch
Confidence 1111122346778999998865 3578999999999999999999999976432111 00000000
Q ss_pred -hcCCccch----hccccc----cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 -NTNSSLET----AIDKSL----LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 -~~~~~~~~----~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........ ..+... ..........++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000000 000000 00011123356778888999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=286.37 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=199.3
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|+..+.||+|++|.||+++.. +++.|++|.+..... ..+.+.+|++++.+++|+|++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999854 678999999976543 456789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998755 3489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....++..|+|||...+..++.++||||+|+++|+|++|+.||..... .......... ..
T Consensus 154 ~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~--~~---- 216 (254)
T cd06627 154 KDD----ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFRIVQD--DH---- 216 (254)
T ss_pred ccc----cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcc--CC----
Confidence 221 123378899999998888889999999999999999999999875321 1111111000 00
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+ .......+.+++.+||..+|++||++.|++.
T Consensus 217 -~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -PPL----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCC----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001 1112345667777999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=290.99 Aligned_cols=250 Identities=21% Similarity=0.265 Sum_probs=192.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC------ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC--Cee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS------QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 376 (618)
.+|++.+.||+|+||.||+|.. .++..|++|.+... ....+.+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999995 56899999987532 12235688999999999999999999998764 457
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++|+||+++++|.+++.... .+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999986543 378999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
.......... ......++..|+|||++.+..++.++|||||||++||+++|+.||...... .... ......
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~-~~~~~~ 225 (264)
T cd06653 155 RIQTICMSGT-GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIF-KIATQP 225 (264)
T ss_pred ccccccccCc-cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHH-HHHcCC
Confidence 6543211111 111234788999999998888999999999999999999999999753211 1111 110000
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. ...+......+.+++.+|+. +|..||++.+++.
T Consensus 226 -~~--------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 -TK--------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CC--------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00 01112233456666669998 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.64 Aligned_cols=248 Identities=21% Similarity=0.314 Sum_probs=195.9
Q ss_pred CCCCcEEeecCCeeEEEEEeCC-CcEEEEEEecc-CccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 308 FSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLED-SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
|.++..||.|+||.||+|..++ +-..|-|++.. +....++|.-|+++|..++||+||++++.|+..+..|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4556789999999999999554 45567777753 445567899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|-....+-.-+ ..+.+.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+..........
T Consensus 114 GAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred chHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99988876554 4699999999999999999999999 99999999999999999999999999886543322222
Q ss_pred cccccCCCCcccccCCCCC-----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 466 STFVNGEFGDLGYVAPEYP-----RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
....||+.|||||+. ...+|+.++||||||++|.||..+.+|-...+. +.-.+ .... .....
T Consensus 188 ----DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-------MRVll-KiaK-SePPT 254 (1187)
T KOG0579|consen 188 ----DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLL-KIAK-SEPPT 254 (1187)
T ss_pred ----ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-------HHHHH-HHhh-cCCCc
Confidence 233499999999974 467899999999999999999999999765432 11111 1111 11111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+. ++.....|.+++.+||..||..||++.++++
T Consensus 255 Llq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 111 2334455666777999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.02 Aligned_cols=263 Identities=22% Similarity=0.248 Sum_probs=197.3
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
|++.+.||+|++|.||++.. .+++.+++|++..... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999995 4789999999865432 3567889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++ +|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 8888876543 3589999999999999999999999 999999999999999999999999999987654331
Q ss_pred cccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH-------HHHHHhc-
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE-------WITLLNT- 534 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~-------~~~~~~~- 534 (618)
. .....++..|+|||...+. .++.++||||+|+++|+|++|+.||...+..+........ +......
T Consensus 154 ~----~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 P----YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred c----ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 1 1122367889999988766 7899999999999999999999999654321110000000 0000000
Q ss_pred -CCccchhccccc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 -NSSLETAIDKSL--LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 -~~~~~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
............ ..........++.+++.+||+.||.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000000 00011223567888899999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.51 Aligned_cols=259 Identities=23% Similarity=0.282 Sum_probs=193.8
Q ss_pred CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcC---CCCCccceeEEEEeCCe-----
Q 007088 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSV---RHRNLVPLLGFCVAKKE----- 375 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 375 (618)
|++.+.||+|+||.||+|+.. +++.||+|+++... .....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999965 48999999997432 2234566787777665 69999999999988776
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.+++|||+++ +|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 88888765432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
......... ....++..|+|||.+.+..++.++|||||||++|||++|++||......+ .+..........
T Consensus 155 ~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~ 225 (287)
T cd07838 155 RIYSFEMAL-----TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----QLDKIFDVIGLP 225 (287)
T ss_pred eeccCCccc-----ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----HHHHHHHHcCCC
Confidence 876433221 12236788999999998899999999999999999999999987543221 111111111000
Q ss_pred Ccc---------chhcccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 536 SSL---------ETAIDKSLL---GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 536 ~~~---------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... ......... ..........+.+++.+||+.||.+||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 000000000 0011223456778889999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=298.52 Aligned_cols=243 Identities=24% Similarity=0.378 Sum_probs=192.6
Q ss_pred CcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 311 NNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
..+||+|+||.||++.. .++..||+|.+.... .....+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999985 578999999886433 3455688999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+..........
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~--- 173 (292)
T cd06657 105 TDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--- 173 (292)
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc---
Confidence 9987532 378999999999999999999999 99999999999999999999999999887654322111
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
....++..|+|||+..+..++.++||||+|+++|||++|..||...... +........ ....+.
T Consensus 174 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--------~~~~~~~~~------~~~~~~- 237 (292)
T cd06657 174 -KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDN------LPPKLK- 237 (292)
T ss_pred -cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhh------CCcccC-
Confidence 1223788999999998888899999999999999999999998753221 111111100 000110
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........+.+++.+||+.||.+||++.++++
T Consensus 238 -~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01112335667777999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=292.54 Aligned_cols=247 Identities=24% Similarity=0.303 Sum_probs=201.3
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+.|+.-++||+||||.||-+. ..+|+.||+|.+.+. ...+.-..+|-.+|.+++.+.||.+--.|.+.+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 568888999999999999998 567999999988543 234455678999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
..|.||+|.-+|...+. ..+++..+.-++.+|+.||++||+. +||.||+||+|||+|+.|+++|+|+|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999987765 5699999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
... ..+++||.+|||||++....|+...|.||+||++|||+.|+.||....... -.+-+.....
T Consensus 340 g~~-----~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----k~eEvdrr~~------ 403 (591)
T KOG0986|consen 340 GKP-----IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----KREEVDRRTL------ 403 (591)
T ss_pred CCc-----cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----hHHHHHHHHh------
Confidence 443 344569999999999999999999999999999999999999997532210 0001111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 577 (618)
-|+.-..+.++++.+.+++ ..|+.||.+|--.+
T Consensus 404 -~~~~ey~~kFS~eakslc~---~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 -EDPEEYSDKFSEEAKSLCE---GLLTKDPEKRLGCR 436 (591)
T ss_pred -cchhhcccccCHHHHHHHH---HHHccCHHHhccCC
Confidence 0111122345666666666 78889999996544
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=304.48 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=202.7
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
....|.+...||+|.|+.|.+|+ ..++..||||.+.++.. ....+.+|+++|+.++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45678899999999999999999 45689999999987542 334588999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+.+|.+++++..... +.+..+..++.|+.+|++|+|++ .|+|||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999987764 66688999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
... .....+|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+...-.+.....
T Consensus 207 ~~~-----~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-------------- 267 (596)
T KOG0586|consen 207 YGL-----MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-------------- 267 (596)
T ss_pred ccc-----cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--------------
Confidence 432 2334569999999999998876 57999999999999999999999875433221111
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+...+.-. .....++-+++++++-.+|.+|++++++.+
T Consensus 268 ---l~gk~rIp--~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 ---LRGKYRIP--FYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ---eeeeeccc--ceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 01111100 111223445666999999999999999865
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=291.75 Aligned_cols=240 Identities=21% Similarity=0.238 Sum_probs=183.7
Q ss_pred EEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHH---HHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 313 IIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEIN---TLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.||+|+||.||++.. .+++.||+|.+.... .....+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999985 568999999986532 11222344433 3445579999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988644 3589999999999999999999999 999999999999999999999999999876543221
Q ss_pred ccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........ .. ....... ..
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~------~~ 215 (278)
T cd05606 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE-IDRMTLT------MA 215 (278)
T ss_pred -----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HH-HHHHhhc------cC
Confidence 123488999999998744 689999999999999999999999976432111 00 0000000 01
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
..+. ......+.+++.+|+..+|.+|| ++.|+++
T Consensus 216 ~~~~----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 216 VELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCC----CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1111 11234677777799999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.20 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=190.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC-CcEEEEEEeccCc--cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|++|.||+|...+ ++.||||+++... ....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999754 8999999997543 23455677887777774 9999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
|+++ ++.+++.... ..+++..+..++.|++.||+|||+ . +|+||||+|+||++++++.+||+|||++.....
T Consensus 95 ~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9854 6766654432 358999999999999999999997 5 899999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLV----ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
.... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .+.........
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~ 235 (296)
T cd06618 168 SKAK-----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEE 235 (296)
T ss_pred CCcc-----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCC
Confidence 2221 1123678999999987554 788999999999999999999999642211 11111111110
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.. .+.. .......+.+++.+||+.||++||++.++++.
T Consensus 236 -~~-----~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 -PP-----SLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CC-----CCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000 00123457778889999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.63 Aligned_cols=270 Identities=23% Similarity=0.323 Sum_probs=206.5
Q ss_pred CCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------eeEE
Q 007088 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ERLL 378 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 378 (618)
+...+.||+|+||.||+++ ...|+.||||.++.. ....+..-+|+++|++++|+|||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3345789999999999999 678999999999763 345567789999999999999999999865543 5689
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC--CCC--ceEEcccCc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD--GDF--EPKLSDFGL 454 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DfG~ 454 (618)
|||||.+|||+..+...++ ...+++.+.+.++.+++.||.|||++ +|+||||||.||++- .+| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999987653 46699999999999999999999999 999999999999983 333 479999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
|+.+++.. .+...+||..|.+||+... +.|+..+|.|||||++|+..||..||.....+..... ..|.....
T Consensus 171 Arel~d~s-----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~--~~~~~~tk 243 (732)
T KOG4250|consen 171 ARELDDNS-----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE--IMWHIITK 243 (732)
T ss_pred cccCCCCC-----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch--hhhhhhcc
Confidence 99887654 2344569999999999984 8899999999999999999999999987554322111 12222221
Q ss_pred cCCccchhcccccc------------CCCCHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHhhh
Q 007088 534 TNSSLETAIDKSLL------------GNGFDGELHQFLRVACNCVLPTPKERH--TMFEVYQLLRAIAE 588 (618)
Q Consensus 534 ~~~~~~~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~ 588 (618)
......-..++... ..........+-+.+..+|..+|++|- ...+....+..|..
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11111111111111 111234455666777788999999998 77777777777655
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.98 Aligned_cols=242 Identities=21% Similarity=0.214 Sum_probs=185.9
Q ss_pred cEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc----CHHHHHHHHHHH-hcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH----SEKEFLSEINTL-GSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.. .+++.||+|.+..... ....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999995 5689999999865421 122344555444 445899999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 150 (260)
T cd05611 82 GDCASLIKTLG----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---- 150 (260)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc----
Confidence 99999986543 488999999999999999999999 9999999999999999999999999998754321
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
....++..|+|||...+..++.++||||||+++|||++|..||...... .......... ..
T Consensus 151 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~------ 211 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSRR-IN------ 211 (260)
T ss_pred ----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcc-cC------
Confidence 1123778999999998888899999999999999999999999653221 1111111100 00
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
............+.+++.+||+.||++||++.++.+.|
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00001112345677888899999999999877665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.78 Aligned_cols=263 Identities=25% Similarity=0.297 Sum_probs=195.5
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK---- 374 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 374 (618)
...++|++.+.||+|+||.||+|+.. +++.||+|+++... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999964 68899999996532 33456788999999999999999999987654
Q ss_pred ------eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceE
Q 007088 375 ------ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448 (618)
Q Consensus 375 ------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 448 (618)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 6767665432 3589999999999999999999999 999999999999999999999
Q ss_pred EcccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH
Q 007088 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 449 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~ 527 (618)
|+|||.+.......... .....++..|+|||.+.+ ..++.++|||||||++|||++|++||......+ .+..
T Consensus 157 l~dfg~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~~~~ 229 (302)
T cd07864 157 LADFGLARLYNSEESRP---YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----QLEL 229 (302)
T ss_pred eCcccccccccCCcccc---cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHH
Confidence 99999998765432211 111235778999998754 457889999999999999999999997543211 1111
Q ss_pred HHHHHhcCCc---cchh--------ccc------cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 528 WITLLNTNSS---LETA--------IDK------SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 528 ~~~~~~~~~~---~~~~--------~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... ...... .... .+. .+. .........+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 230 ISR-LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHH-HhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 000000 0000 000 000 001112356778888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.78 Aligned_cols=245 Identities=27% Similarity=0.336 Sum_probs=191.5
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.|+..+.||+|++|.||+|+. .++..+++|.+.... ...+++.+|++++++++|+|++++++++...+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466678899999999999995 467899999886421 233567889999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+. |++.+.+.... .++++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 58877765433 3488999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
. ...++..|+|||.+. ...++.++|||||||++|||++|+.||...... ...........
T Consensus 169 ~--------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~- 231 (308)
T cd06634 169 N--------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNES- 231 (308)
T ss_pred c--------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhcCC-
Confidence 1 123788999999864 356788999999999999999999998653211 11111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 583 (618)
+... .......+.+++.+||+.+|++||++.++++.-
T Consensus 232 -----~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -----PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -----CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0111 112334567778899999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.06 Aligned_cols=249 Identities=19% Similarity=0.231 Sum_probs=192.8
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC------ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS------QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
+|.+.+.||+|+||.||+++.. .+..+++|.++.. .....++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999854 3445555655431 12334577899999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999988865333335699999999999999999999999 9999999999999975 569999999987654
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ....++..|+|||...+..++.++|+||||+++|+|++|..||.... ........... .
T Consensus 157 ~~~~~~----~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~-~-- 221 (260)
T cd08222 157 GSCDLA----TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEG-P-- 221 (260)
T ss_pred CCcccc----cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcC-C--
Confidence 322211 12237889999999888888999999999999999999999986422 11111111111 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ .........+.+++.+|++.+|++||++.|+++
T Consensus 222 ---~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00 112234457778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=291.82 Aligned_cols=247 Identities=23% Similarity=0.276 Sum_probs=193.0
Q ss_pred EeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 314 IGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 314 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
||+|+||.||++... +|+.|++|++.... ...+.+.+|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999975 48999999997543 2445688999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc---
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL--- 465 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~--- 465 (618)
.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99987543 489999999999999999999999 99999999999999999999999999987643321100
Q ss_pred -cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 -STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 -~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
........++..|+|||...+..++.++||||||+++||+++|+.||..... .+........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~~------ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILNG-KI------ 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-Cc------
Confidence 0011223467899999998888889999999999999999999999975432 1111111110 00
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
...........+.+++.+|++.+|++|||+.++.+.|+
T Consensus 219 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 --EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000002456677888999999999999966655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.46 Aligned_cols=254 Identities=23% Similarity=0.259 Sum_probs=197.0
Q ss_pred cCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 307 SFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
+|++.+.||+|++|.||++.. .+++.||+|.++... ...+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477789999999999999984 357889999986432 2345688999999999 599999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999886543 488999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV--ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
.......... ....++..|+|||...+.. .+.++||||||+++|||++|..||...... ............
T Consensus 154 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~ 226 (288)
T cd05583 154 EFLAEEEERA---YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILK 226 (288)
T ss_pred cccccccccc---ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHc
Confidence 6543322111 1223788999999987655 788999999999999999999999643221 111111111111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
.. .. ........+.+++.+||+.||++|||+.++.+.|+.
T Consensus 227 ~~-------~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 227 SK-------PP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cC-------CC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 10 00 111122456677779999999999999988777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=290.66 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=193.5
Q ss_pred cCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 307 SFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
+|++.+.||+|+||.||++.. .+|..||+|+++... ...+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 468999999986532 2345678899999999 599999999999998899
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 99999999999999987543 488999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL--VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
......... .....|+..|+|||...+. .++.++||||||+++|+|++|+.||...... ............
T Consensus 154 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~ 226 (290)
T cd05613 154 EFHEDEVER---AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILK 226 (290)
T ss_pred ecccccccc---cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhc
Confidence 654322111 1123478899999988653 4678999999999999999999999643221 112222222111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
... . ........+.+++.+|++.||++|| +++++++
T Consensus 227 ~~~-------~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 SEP-------P----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCC-------C----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 110 0 0111234566777799999999997 5666644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.85 Aligned_cols=268 Identities=23% Similarity=0.311 Sum_probs=195.1
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC---ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeC--Cee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS---QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK--KER 376 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 376 (618)
..++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999964 6889999988542 23345577899999999 999999999998654 367
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 4998888653 478999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcc-cccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH------
Q 007088 457 LMNPVDTHL-STFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW------ 528 (618)
Q Consensus 457 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~------ 528 (618)
......... ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+.... +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~-~~~~~~~~~~ 234 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK-IIEVIGPPSA 234 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH-HHHHhCCCCH
Confidence 664432210 011122347889999998754 5578899999999999999999999965432111000 0000
Q ss_pred --HHHHhcCCccchhccc----cc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 529 --ITLLNTNSSLETAIDK----SL--LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 529 --~~~~~~~~~~~~~~d~----~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
..... .......++. .. ...........+.+++.+|++.||++|||+.++++.
T Consensus 235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIK-SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHH-hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 0000000000 00 000011124567888889999999999999999873
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=279.16 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=197.9
Q ss_pred hhccCCCC-cEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeC----Cee
Q 007088 304 ATNSFSKN-NIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK----KER 376 (618)
Q Consensus 304 ~~~~y~~~-~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~ 376 (618)
.|++|++. ++||-|-.|.|-.+. ..+|+.+|+|++.++. ..++|+++.-.. .|||||.++++|.+. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 45666653 578999999999998 4578999999997765 345788776665 699999999998653 345
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEcccC
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSDFG 453 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 453 (618)
.+|||.|+||.|++.+++++. ..+.+.++-.|+.||+.|+.|||+. +|.||||||+|+|... +-.+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 799999999999999988775 6799999999999999999999999 9999999999999964 4569999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
+|+....... ....+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||+..... .....+......
T Consensus 210 FAK~t~~~~~-----L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-aispgMk~rI~~-- 281 (400)
T KOG0604|consen 210 FAKETQEPGD-----LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKRRIRT-- 281 (400)
T ss_pred cccccCCCcc-----ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-cCChhHHhHhhc--
Confidence 9997653221 22334699999999999999999999999999999999999999865432 111122111111
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+. .+ ...+.++...+...++|+.+|+.+|.+|.|+.|+++
T Consensus 282 --gq-y~-----FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 282 --GQ-YE-----FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --cC-cc-----CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 00 11 122234555666777888999999999999999975
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=296.73 Aligned_cols=266 Identities=21% Similarity=0.252 Sum_probs=192.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
.++|++.++||+|+||.||+|.. .+++.|++|++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999995 468999999885432 22345778999999999999999999875543
Q ss_pred --eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 375 --ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 375 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
..++||||+.+ ++.+.+.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46899999975 6776665432 3599999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCccc-------ccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC
Q 007088 453 GLARLMNPVDTHLS-------TFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS 524 (618)
Q Consensus 453 G~a~~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~ 524 (618)
|+++.......... .......+++.|+|||.+.+ ..++.++|||||||++|||++|++||.........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~--- 236 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL--- 236 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 99986543221111 11112236788999998764 45789999999999999999999999754321110
Q ss_pred HHHHHHHHhcC--------Cccch----hccccccC---CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 525 LVEWITLLNTN--------SSLET----AIDKSLLG---NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 525 l~~~~~~~~~~--------~~~~~----~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......... ..... ........ .........+.+++.+|++.||++|||+.|++.
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 237 -HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000000 00000 00000000 001112256778888999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.53 Aligned_cols=268 Identities=20% Similarity=0.263 Sum_probs=196.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Ce
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-----KE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 375 (618)
.++|.+.+.||+|+||.||+++. .+++.||+|.+... ......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45789999999999999999994 57899999998653 23345677899999999999999999988654 34
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999996 68888886543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHH----
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT---- 530 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~---- 530 (618)
+........ .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...... .+.....
T Consensus 156 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~ 230 (337)
T cd07858 156 RTTSEKGDF----MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK-LITELLGSPSE 230 (337)
T ss_pred cccCCCccc----ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHHhCCCCh
Confidence 866433211 112337889999998754 468899999999999999999999996532110000 0000000
Q ss_pred ---HHhcCCccchhc-------cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 007088 531 ---LLNTNSSLETAI-------DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL--LRAI 586 (618)
Q Consensus 531 ---~~~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 586 (618)
...........+ +.... .........+.+++.+||+.||++|||++|+++. ++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000 00000 0011234567788889999999999999999876 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=293.24 Aligned_cols=242 Identities=27% Similarity=0.357 Sum_probs=189.5
Q ss_pred CCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
|...+.||+|+||.||+|+. .++..|++|.+.... ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55677899999999999995 568999999986432 2234678899999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+. |++.+++.... .++++.++..++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 96 57777775433 3589999999999999999999999 9999999999999999999999999988643221
Q ss_pred CcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
....|+..|+|||++. ...++.++|||||||++|||++|..||...... ...........
T Consensus 175 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~-- 237 (313)
T cd06633 175 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNDS-- 237 (313)
T ss_pred -------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHhcCC--
Confidence 1223788999999874 456888999999999999999999998754321 11111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.... ......+.+++.+||+.+|.+||++.+++.
T Consensus 238 ----~~~~~---~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 ----PTLQS---NEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----CCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 112234667777999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.12 Aligned_cols=266 Identities=20% Similarity=0.261 Sum_probs=196.3
Q ss_pred HHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEe-CC
Q 007088 300 DLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVA-KK 374 (618)
Q Consensus 300 ~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 374 (618)
++..++++|++.+.||+|+||.||++.. .+++.||+|++... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3445788999999999999999999984 47899999988542 2334678899999999999999999999876 45
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++|+||+ +++|.+++... ++++.....++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 788999998 56888887542 378888899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc-------ccCHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESF-------KGSLV 526 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~-------~~~l~ 526 (618)
+....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .....
T Consensus 155 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 155 ARIQDPQM-------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccccCCCc-------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 87543211 12236788999998765 56899999999999999999999999654321000 00000
Q ss_pred HHHHHHhcCCccchhccc-cccCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 527 EWITLLNTNSSLETAIDK-SLLGNGF-----DGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~-~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
++........ ..+.+.. ....... ......+.+++.+|++.+|++||++.+++..
T Consensus 228 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111000000 0000000 0000000 1123567788889999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.24 Aligned_cols=264 Identities=21% Similarity=0.281 Sum_probs=192.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
.++|...+.||+|+||.||+|+. .+|+.||+|++.... .....+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999995 578999999986532 23456789999999999999999999987543
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++|+||+.. +|.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 6666542 2488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH-------H
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL-------V 526 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l-------~ 526 (618)
++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............+ .
T Consensus 164 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (342)
T cd07879 164 ARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236 (342)
T ss_pred CcCCCCCC-------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 87653211 12236788999998765 468899999999999999999999997543211000000 0
Q ss_pred HHHHHHhcCCccchhcc--ccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 007088 527 EWITLLNTNSSLETAID--KSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQL--LRAI 586 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d--~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 586 (618)
.+..... .......+. +...... .......+.+++.+||+.||++||+++|++.. ++..
T Consensus 237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 237 EFVQKLE-DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHhc-ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0000000 000000000 0000000 01123457788889999999999999999853 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.01 Aligned_cols=250 Identities=22% Similarity=0.267 Sum_probs=199.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 379 (618)
++|...+.||+|++|.||+++. .+++.|++|++... ....+.+.+|.+++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688899999999999999995 47899999998753 233466889999999998 99999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999997653 599999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCcc----------------cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 007088 460 PVDTHL----------------STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523 (618)
Q Consensus 460 ~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~ 523 (618)
...... ........++..|+|||...+..++.++||||||++++++++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence 432110 01111234678999999988888999999999999999999999999754311
Q ss_pred CHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM----FEVYQ 581 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 581 (618)
.......... ..........+.+++.+||+.+|.+||++ +|+++
T Consensus 229 ---~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 ---LTFQKILKLE-----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHHhcC-----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0011111000 01111224567788889999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=296.12 Aligned_cols=262 Identities=20% Similarity=0.266 Sum_probs=193.8
Q ss_pred HhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK---- 374 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 374 (618)
...++|++.+.||+|+||.||++. ..++..||+|++.... ...+.+.+|++++++++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 356789999999999999999998 4578999999986432 23356789999999999999999999987653
Q ss_pred --eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 375 --ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 375 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999998 6789888753 2489999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC-------
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS------- 524 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~------- 524 (618)
|++....... ....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||............
T Consensus 163 g~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 163 GLARQTDSEM-------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ccccccccCc-------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998654321 12236889999998765 45889999999999999999999999754321100000
Q ss_pred HHHHHHHHhcCCccchhcc--ccccC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 525 LVEWITLLNTNSSLETAID--KSLLG----NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 525 l~~~~~~~~~~~~~~~~~d--~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...+....... ....... +.... .........+.+++.+|++.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00011100000 0000000 00000 000112345778888999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=274.98 Aligned_cols=245 Identities=20% Similarity=0.324 Sum_probs=189.5
Q ss_pred CcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 311 NNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
...||+|..|.||+++. ..|..+|||.+.... ...+++...++++.+-+ +|.||+.+|||..+...++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 45799999999999995 568999999997654 44566788888876664 89999999999999999999999853
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
.++.++..-. .++++...-++...+.+||.||.++. +|+|||+||+|||+|+.|++|++|||++..+.+...+..
T Consensus 176 C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr 250 (391)
T KOG0983|consen 176 CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR 250 (391)
T ss_pred HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccccc
Confidence 4555554433 45888888899999999999999875 899999999999999999999999999988765544332
Q ss_pred ccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 467 TFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
..|-+.|||||.+. ..+|+.++||||||++++||.||+.||.....+ ...+ .....++ .
T Consensus 251 -----sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~l----tkvln~e------P 312 (391)
T KOG0983|consen 251 -----SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVL----TKVLNEE------P 312 (391)
T ss_pred -----ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHH----HHHHhcC------C
Confidence 23789999999875 347889999999999999999999999864321 1111 1111111 1
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+.+.. .....|.+++..||..|+.+||...++++
T Consensus 313 P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2222211 13345667777999999999999998875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=296.39 Aligned_cols=266 Identities=21% Similarity=0.275 Sum_probs=196.9
Q ss_pred CHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 007088 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372 (618)
Q Consensus 297 ~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 372 (618)
...++..++++|++.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999984 578999999987532 234567889999999999999999998864
Q ss_pred C------CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc
Q 007088 373 K------KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446 (618)
Q Consensus 373 ~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 446 (618)
. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888876 77998877542 389999999999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH
Q 007088 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525 (618)
Q Consensus 447 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l 525 (618)
+||+|||+++...... ....++..|+|||...+ ..++.++|||||||++|||++|+.||....... .+
T Consensus 159 ~kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~ 227 (345)
T cd07877 159 LKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QL 227 (345)
T ss_pred EEEecccccccccccc-------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH
Confidence 9999999987643211 12237889999998765 567889999999999999999999996533211 00
Q ss_pred HHHHHHHh----------cCCccchhcc--ccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 526 VEWITLLN----------TNSSLETAID--KSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 526 ~~~~~~~~----------~~~~~~~~~d--~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
........ ........+. +...... .......+.+++.+|++.||.+||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000 0000000000 0000000 00123456788889999999999999999764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.56 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=196.7
Q ss_pred CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
|+..+.||+|++|.||+|+.. +++.|++|.+... ....+.+.+|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999954 5899999999764 233467789999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
+ ++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 59999987653 3489999999999999999999999 999999999999999999999999999987644322
Q ss_pred cccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC--------HHHHHHHHhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS--------LVEWITLLNT 534 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~--------l~~~~~~~~~ 534 (618)
.. ....++..|+|||.+.+. .++.++||||||+++||+++|+.||......+..... -..|.... .
T Consensus 154 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 228 (282)
T cd07829 154 TY----THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVT-K 228 (282)
T ss_pred cc----CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhc-c
Confidence 11 122356789999988766 7899999999999999999999998754321110000 00000000 0
Q ss_pred CCccchhccccccC----CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLG----NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........ +.... .........+.+++.+||+.||++||++.+++.
T Consensus 229 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 00000 001112456888888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.52 Aligned_cols=263 Identities=22% Similarity=0.228 Sum_probs=193.3
Q ss_pred ccCCC-CcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccC---------------HHHHHHHHHHHhcCCCCCccceeE
Q 007088 306 NSFSK-NNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHS---------------EKEFLSEINTLGSVRHRNLVPLLG 368 (618)
Q Consensus 306 ~~y~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~l~~ 368 (618)
++|.. .+.||+|+||.||+|.. .+++.||+|.+...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45653 56799999999999995 46899999998653211 124778999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceE
Q 007088 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448 (618)
Q Consensus 369 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 448 (618)
++...+..++||||++ |+|.+++.... .+++.....++.|++.||+|||+. +++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI----RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 9999999999999997 58998886533 489999999999999999999999 999999999999999999999
Q ss_pred EcccCcccccCCCCCc----------ccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 449 LSDFGLARLMNPVDTH----------LSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 449 l~DfG~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
|+|||.+......... .........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999866521100 00111123367889999988764 468999999999999999999999976543
Q ss_pred CCccccCHHHHHHHHhcC--Cccchh------------ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 518 PESFKGSLVEWITLLNTN--SSLETA------------IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~--~~~~~~------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+. +.......... ...... ...... .........+.+++.+|++.+|++||+++|++.
T Consensus 240 ~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQ----LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHH----HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 211 11100000000 000000 000000 001112456778888999999999999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=295.11 Aligned_cols=266 Identities=19% Similarity=0.220 Sum_probs=190.6
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-C--CcEEEEEEeccCc---cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC----Ce
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-G--GCFIMIKRLEDSQ---HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK----KE 375 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 375 (618)
+|++.+.||+|+||.||++... . +..||+|++.... ...+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999953 3 7899999986432 2345678899999999 599999999875432 35
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++++||+. ++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899886 58988886543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC-------HHH
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS-------LVE 527 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~-------l~~ 527 (618)
+.................|+..|+|||+..+ ..++.++||||+||++|++++|+.||...+........ ..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 8665432221111223458899999998765 56899999999999999999999998754321100000 000
Q ss_pred HHHHHhcCCccchh---ccc--cc-cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 528 WITLLNTNSSLETA---IDK--SL-LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 528 ~~~~~~~~~~~~~~---~d~--~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+....... ..... ... .. ...........+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSP-KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhh-hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00000 000 00 00000112346778888999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=279.63 Aligned_cols=207 Identities=25% Similarity=0.330 Sum_probs=170.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC-----CcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe-CCee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG-----GCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA-KKER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 376 (618)
..|+....||+|.||.||+|...+ .+.+|+|.++... .......+|+.+++.++|||++.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 458889999999999999997322 3479999997653 122456789999999999999999999887 6678
Q ss_pred EEEEeecCCCccccccCCCCC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC----CceEEcc
Q 007088 377 LLVYSYLENGTLYDKLHPAEH-EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD----FEPKLSD 451 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 451 (618)
++++||.+. +|.+.++-.+. ....++...+..|+.||+.|+.|||+. =|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 89988865433 235688999999999999999999999 79999999999999877 8999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
||+++.+...-.... .....+-|..|+|||.+.+ ..|+.+.||||.|||+.||+|-++.|.....
T Consensus 180 lGlaR~~~~plkpl~-s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLA-SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred ccHHHHhhccccccc-cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 999998765432221 1233446899999998776 4689999999999999999999988876543
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.98 Aligned_cols=270 Identities=23% Similarity=0.296 Sum_probs=200.9
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----eeE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK-----ERL 377 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 377 (618)
+|++.+.||+|++|.||+|+.. ++..|++|++... ....+.+.+|++++++++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999964 5899999998753 234567899999999999999999999998775 789
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++ +|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999984 8988886543 589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH----
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL---- 532 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~---- 532 (618)
....... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.... +.......
T Consensus 153 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~ 230 (330)
T cd07834 153 VDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL-IVEVLGTPSEED 230 (330)
T ss_pred ecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH-HHHhcCCCChhH
Confidence 6543211 0111223478899999998877 789999999999999999999999976543211000 00000000
Q ss_pred ---hcCCccchhcccccc------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 007088 533 ---NTNSSLETAIDKSLL------GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL--LRAI 586 (618)
Q Consensus 533 ---~~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 586 (618)
.........+..... ..........+.+++.+||+.+|.+||+++++++. ++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000000 00011134567788889999999999999999863 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=319.35 Aligned_cols=257 Identities=24% Similarity=0.306 Sum_probs=188.2
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK----- 373 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 373 (618)
.+...+|+..+.||+||||.||+++. -||+.||||++.-. ......+.+|+..+.+|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45677899999999999999999994 48999999999754 34455688999999999999999987633210
Q ss_pred --------------------------------------------------------------------------------
Q 007088 374 -------------------------------------------------------------------------------- 373 (618)
Q Consensus 374 -------------------------------------------------------------------------------- 373 (618)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHH
Q 007088 374 ----------------------------------KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419 (618)
Q Consensus 374 ----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~ 419 (618)
...|+-||||+.-++.+++..+... -.....++++++|+.||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence 0136778888886777776654321 135678999999999999
Q ss_pred HHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC----C----------CCCcccccccCCCCcccccCCCCCC
Q 007088 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN----P----------VDTHLSTFVNGEFGDLGYVAPEYPR 485 (618)
Q Consensus 420 ~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~----~----------~~~~~~~~~~~~~gt~~y~aPE~~~ 485 (618)
|+|++ |||||||||.||++|++..+||+|||+|+... . ..........+.+||.-|+|||++.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 99999999999999999999999999998721 0 0011111233566999999999987
Q ss_pred CC---CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHH
Q 007088 486 TL---VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVA 562 (618)
Q Consensus 486 ~~---~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 562 (618)
+. .|+.|+|+||+|||++||+. ||...-+ -......+. .+.+... ...+.+....=.+++
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-------Ra~iL~~LR-~g~iP~~------~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-------RASILTNLR-KGSIPEP------ADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchHH-------HHHHHHhcc-cCCCCCC------cccccccchHHHHHH
Confidence 65 49999999999999999985 5654221 111111111 1111111 112233444456677
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 007088 563 CNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 563 ~~cl~~dP~~RPs~~evl~ 581 (618)
.++++.||.+|||+.|++.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 7999999999999999975
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.00 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=193.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe----
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE---- 375 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 375 (618)
..++|+..+.||+|++|.||+|.. .++..||+|++.... ...+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 466899999999999999999996 468899999986532 233567789999999999999999998866554
Q ss_pred --eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 376 --RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 376 --~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 5699988864 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH-------
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL------- 525 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l------- 525 (618)
++....... ....++..|+|||...+ ..++.++||||||+++||+++|+.||......+......
T Consensus 164 ~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred ccccccccc-------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 998654321 12236888999998754 467899999999999999999999997543211000000
Q ss_pred HHHHHHHhcCCccchhcccccc--CCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLL--GNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~--~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+...... ......+..... ... .......+.+++.+||..||++|||+.|+++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISS-ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccc-hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 000000000000 000 0112456788888999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=297.54 Aligned_cols=263 Identities=20% Similarity=0.281 Sum_probs=189.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeC----------
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK---------- 373 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 373 (618)
.+|...+.||.|+||.||+|.. .+++.||+|.+.... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788999999999999999995 568999999886543 3456788999999999999999999876554
Q ss_pred ----CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC-CCCceE
Q 007088 374 ----KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD-GDFEPK 448 (618)
Q Consensus 374 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 448 (618)
...++||||++ ++|.+++... .+++..++.++.||+.||.|||+. +|+||||||+||+++ .++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 4888877532 488999999999999999999999 999999999999997 455789
Q ss_pred EcccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH-
Q 007088 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV- 526 (618)
Q Consensus 449 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~- 526 (618)
++|||.++......... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.....+.
T Consensus 156 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred ECCcccceecCCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999997654322111 11112246889999997644 5678899999999999999999999975432111000000
Q ss_pred -------HHHHHHhcCCccchhcc-ccccCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 527 -------EWITLLNTNSSLETAID-KSLLGNG-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 527 -------~~~~~~~~~~~~~~~~d-~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+...... ...... ....... ......++.+++.+||..||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNV---IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhh---hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000000 000000 0000000 0112345677888999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=273.54 Aligned_cols=266 Identities=19% Similarity=0.293 Sum_probs=199.8
Q ss_pred CHHHHHHhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCC-CCCccceeEEEEeC
Q 007088 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAK 373 (618)
Q Consensus 297 ~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 373 (618)
+++|+.+-| .+.||+|+|+.|.-++ +.+|..||||++.+.. ..+.++.+|++++.+++ |+||++++++|+++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 456777766 4789999999999988 7899999999997654 55678999999999995 99999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc---eEEc
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE---PKLS 450 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~ 450 (618)
...|+|||-|.||+|..+|+++. .+++.++.++.++|+.||.|||.+ ||.|||+||+|||-.+... +||+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeee
Confidence 99999999999999999998765 499999999999999999999999 9999999999999975544 8999
Q ss_pred ccCcccccCCC--CC-cccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 007088 451 DFGLARLMNPV--DT-HLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522 (618)
Q Consensus 451 DfG~a~~~~~~--~~-~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~ 522 (618)
||.+..-+... -. -.+......+|+..|||||+.. ...|+.++|.||+|||+|-|+.|.+||...-..+-..
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 99877543221 11 1111223456889999999643 3468899999999999999999999997644321110
Q ss_pred c--C-----HHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 523 G--S-----LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 523 ~--~-----l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. . ........+ +...++.|+.+ .....+..+++...+..||.+|-++.+++.
T Consensus 302 drGe~Cr~CQ~~LFesIQ--EGkYeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQ--EGKYEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCCCccHHHHHHHHHHHh--ccCCcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 0 001111111 11122222221 222333445555788899999999998876
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.49 Aligned_cols=256 Identities=21% Similarity=0.222 Sum_probs=203.6
Q ss_pred HHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 007088 298 LSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372 (618)
Q Consensus 298 ~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 372 (618)
+.++.-..++|.+.++||+|+||.|..++. .+++.||+|++.+. .....-|..|-++|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 345555678899999999999999999995 56899999999873 2445678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 373 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
+++.|+|||||+||+|..++.... ++++..+..++..|+-||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999998765 489999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCC----C-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR----T-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~ 527 (618)
|.+-.+...+.... ...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||+.. .+++
T Consensus 220 GsClkm~~dG~V~s---~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slve 288 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRS---SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVE 288 (1317)
T ss_pred hhHHhcCCCCcEEe---ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHH
Confidence 99988875443322 2346999999999865 3 67899999999999999999999999864 3344
Q ss_pred HHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC---HHHH
Q 007088 528 WITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT---MFEV 579 (618)
Q Consensus 528 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ev 579 (618)
-............+.+. ...+++.+.+++ +.+ -+|+.|-. ++++
T Consensus 289 TY~KIm~hk~~l~FP~~----~~VSeeakdLI~---~ll-~~~e~RLgrngiedi 335 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPDE----TDVSEEAKDLIE---ALL-CDREVRLGRNGIEDI 335 (1317)
T ss_pred HHHHHhchhhhcCCCcc----cccCHHHHHHHH---HHh-cChhhhcccccHHHH
Confidence 33333333222222211 113445555444 433 57888877 5554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=286.26 Aligned_cols=264 Identities=20% Similarity=0.209 Sum_probs=205.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCC--C----CccceeEEEEeCCeeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH--R----NLVPLLGFCVAKKERL 377 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~~~~~~~~~~~ 377 (618)
+++|.+...+|+|.||.|-.+.. ..+..||+|+++.-....+.-.-|+++++++.+ | -+|.+.++|.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 78899999999999999999984 447999999998877777777889999999942 2 3788889999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC--------------
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-------------- 443 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------------- 443 (618)
+|+|.+ |-|+.+++..+.. .+++...+..|+.|++++++|||+. +++|-||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 999988 5599999987665 6799999999999999999999999 9999999999999932
Q ss_pred ------CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 444 ------DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 444 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
+..++|+|||.|+...+... . .+.|..|+|||++.+-.++.++||||+||||+|+.||...|+..++
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~hs---~----iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHHS---T----IVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCcc---e----eeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 23589999999987654332 2 2268999999999999999999999999999999999999988765
Q ss_pred CCccc---cCH---------HHHHHHHhcCCcc-----------chhccccc----cCCCCHHHHHHHHHHHhhccCCCC
Q 007088 518 PESFK---GSL---------VEWITLLNTNSSL-----------ETAIDKSL----LGNGFDGELHQFLRVACNCVLPTP 570 (618)
Q Consensus 518 ~~~~~---~~l---------~~~~~~~~~~~~~-----------~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP 570 (618)
.+... .++ ..........+.+ ..+.+... .....+.+..+|++|+.+||..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 43210 000 0000000000000 00011000 011245677889999999999999
Q ss_pred CCCCCHHHHHH
Q 007088 571 KERHTMFEVYQ 581 (618)
Q Consensus 571 ~~RPs~~evl~ 581 (618)
.+|+|+.|++.
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999975
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=310.62 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=207.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC--------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP--------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 373 (618)
.++..+.+.||+|.||.|++|... ....||||.++... ...+.+..|+++|+.+ +|+||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344455669999999999999832 14679999998644 3467799999999999 699999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCC---C-------CC--cCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 374 KERLLVYSYLENGTLYDKLHPAE---H-------EV--MHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
+..++|+||+..|+|.++++..+ . .. ..++....+.++.|||.|++||++. +++||||-++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999998766 0 01 2388899999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPES 520 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~ 520 (618)
.++..+||+|||+|+..............+. -...|||||.+....|+.|+|||||||+|||++| |..||.....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--- 527 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--- 527 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc---
Confidence 9999999999999997654433322211111 2456999999999999999999999999999999 8888864211
Q ss_pred cccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 521 FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 521 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
...+.+++ ....+.+.+..+..++.++++.||+.+|++||++.|+.+.++....
T Consensus 528 -~~~l~~~l-------------~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 -TEELLEFL-------------KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -HHHHHHHH-------------hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 01111111 1111222334456678889999999999999999999999998654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=275.91 Aligned_cols=235 Identities=24% Similarity=0.270 Sum_probs=189.5
Q ss_pred EeecCCeeEEEEEeC-CCcEEEEEEeccCcc----CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 314 IGTGRTGATYIAMLP-GGCFIMIKRLEDSQH----SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 314 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
||+|+||.||++... +++.+++|++..... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999964 589999999875432 345788999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTF 468 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 468 (618)
.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~---- 149 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR---- 149 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCc----
Confidence 99987553 489999999999999999999998 9999999999999999999999999999775443211
Q ss_pred ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 469 VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 469 ~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
.....++..|+|||...+...+.++|+||||+++|++++|+.||...+. .......... . .
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~-~--------~-- 210 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKD-P--------L-- 210 (250)
T ss_pred ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcC-C--------C--
Confidence 1223378899999999888889999999999999999999999965332 1111111110 0 0
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFE 578 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 578 (618)
.........+.+++.+|+..||++||++.+
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 011112356677888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=297.80 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=212.8
Q ss_pred HHHHHHhhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEe---
Q 007088 298 LSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVA--- 372 (618)
Q Consensus 298 ~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 372 (618)
++.+..-++.|++.+.||.|.+|.||+++ .++++.+|+|++......++++..|.++++.. .|||++.+++++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 44444567789999999999999999999 67899999999988888888899999999888 69999999999864
Q ss_pred --CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEc
Q 007088 373 --KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450 (618)
Q Consensus 373 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 450 (618)
+++.|||||||.+||..|+++... ...+.|..+..|++.++.|+.+||.. .++|||||-.|||++.++.+||+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 468999999999999999998765 36799999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l 525 (618)
|||.+..++.......+ ..||+.|||||++.- ..|+..+|+||+|++..||--|.+|+.+.-+...
T Consensus 166 DFGvSaQldsT~grRnT----~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra----- 236 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRRNT----FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA----- 236 (953)
T ss_pred eeeeeeeeecccccccC----cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----
Confidence 99999887654433333 349999999998753 3467899999999999999999999876432110
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+. +.. .+......+....++|.++|..||..|.++||++.++++
T Consensus 237 -----LF~----IpR--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 -----LFL----IPR--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -----hcc----CCC--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000 001 111222234566788888889999999999999988764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=312.51 Aligned_cols=144 Identities=23% Similarity=0.333 Sum_probs=130.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|.+.++||+|+||.||+|... +++.||+|+++... .....+..|+.++..++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999964 68999999997532 22356889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
||+++++|.+++.... .+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999986543 488899999999999999999999 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=273.81 Aligned_cols=222 Identities=23% Similarity=0.202 Sum_probs=175.1
Q ss_pred cCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCccccccCCC
Q 007088 317 GRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPA 395 (618)
Q Consensus 317 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~ 395 (618)
|.+|.||++.. .+++.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 88999999994 578999999997643 2334555555667999999999999999999999999999999988654
Q ss_pred CCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCc
Q 007088 396 EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475 (618)
Q Consensus 396 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt 475 (618)
. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++
T Consensus 80 ~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-------~~~~~~ 145 (237)
T cd05576 80 L----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-------DGEAVE 145 (237)
T ss_pred c----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-------ccCCcC
Confidence 3 489999999999999999999999 99999999999999999999999999886654321 112256
Q ss_pred ccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHH
Q 007088 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGEL 555 (618)
Q Consensus 476 ~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 555 (618)
..|+|||...+..++.++||||+|+++|||++|+.|+....... ... ....+ +....
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~------~~~~~----~~~~~ 202 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTH------TTLNI----PEWVS 202 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccc------cccCC----cccCC
Confidence 78999999988889999999999999999999998875321100 000 00001 11122
Q ss_pred HHHHHHHhhccCCCCCCCCCHHHH
Q 007088 556 HQFLRVACNCVLPTPKERHTMFEV 579 (618)
Q Consensus 556 ~~l~~li~~cl~~dP~~RPs~~ev 579 (618)
..+.+++.+|++.||++||++.+.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCcc
Confidence 456677779999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=268.37 Aligned_cols=268 Identities=21% Similarity=0.299 Sum_probs=194.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEecc---CccCHHHHHHHHHHHhcCCCCCccceeEEEEeC--------
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLED---SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-------- 373 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 373 (618)
+.|....+||+|.||.||+|+. ++|+.||+|+.-- ...-.....+|+++|..++|+|++.+++.|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3466678999999999999994 5578888886522 112234567899999999999999999887542
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
...|+||.+|+. +|..++.... ..++..++.+++.++..||.|+|+. .|+|||+||.|+||+.+|.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 247999999987 8999887654 4589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+++.+.............++-|..|++||.+.+ ..|+++.|||.-|||+.||.||.+-++...+..... .+.......
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~-~Is~LcGs~ 248 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH-LISQLCGSI 248 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH-HHHHHhccC
Confidence 998776554444333445567999999998765 579999999999999999999998887654321110 001100000
Q ss_pred hcCC-------ccchhcccc-ccCC---CCHHHHH------HHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNS-------SLETAIDKS-LLGN---GFDGELH------QFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~-------~~~~~~d~~-l~~~---~~~~~~~------~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+- .+.+.+... +... ...+..+ ..++|+..++..||.+|+++++++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 0000 001111000 1000 0111122 4566777999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.89 Aligned_cols=240 Identities=23% Similarity=0.245 Sum_probs=190.8
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++.|.....+|.|+|+.|-.+. ..+++..++|++.+.. .+..+|+.++.+. +||||+++.+.+.+..+.|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 36778888899999999999988 5678899999997652 2334677666665 79999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee-CCCCceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL-DGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG~a~~~~~ 460 (618)
++.+|-+.+.+..... .. .++..|+.+|+.|+.|||++ |++||||||+|||+ ++.++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999988887765442 23 67778999999999999999 99999999999999 6999999999999998765
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
. ..+.+-|..|.|||+.....|++++|+||||++||+|++|+.||...... .+..... .....
T Consensus 469 ~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i-~~~~~-- 531 (612)
T KOG0603|consen 469 S-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRI-QMPKF-- 531 (612)
T ss_pred h-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhh-cCCcc--
Confidence 4 12223578999999999999999999999999999999999999865432 1111111 00000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....+++.+++++ +||+.||.+||+|.++..
T Consensus 532 -------s~~vS~~AKdLl~---~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 -------SECVSDEAKDLLQ---QLLQVDPALRLGADEIGA 562 (612)
T ss_pred -------ccccCHHHHHHHH---HhccCChhhCcChhhhcc
Confidence 0223445555554 999999999999999964
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=278.15 Aligned_cols=239 Identities=21% Similarity=0.272 Sum_probs=189.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 379 (618)
.+|....+||+|+||.|.+|..+ +.+.+|||+++++. .+.+--..|-++|.-- +-|.++++..+|...+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999854 46889999998753 1222234565666554 578899999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+.||+|.-++++.+. +.++.+.-+|..||-||-+||++ ||+.||||.+|||+|.+|++||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999887654 88888999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..... ....+||+.|+|||++..++|+..+|.|||||+||||+.|++||+..++.+.+..+...
T Consensus 502 ~~~~T----TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh------------ 565 (683)
T KOG0696|consen 502 FDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH------------ 565 (683)
T ss_pred cCCcc----eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc------------
Confidence 33322 23456999999999999999999999999999999999999999986654322111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH 574 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 574 (618)
.. .++....++...+....+...|.+|-
T Consensus 566 -----nv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 -----NV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -----cC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 00 11122233445555588889999994
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-34 Score=269.93 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=188.2
Q ss_pred CcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 311 NNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
...||.|+||+|+|.. .+.|+..|||+++... ...++++.|.+...+- +.||||+++|.+..++..|+-||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 4569999999999998 5679999999997643 5567788888876555 799999999999999999999999964
Q ss_pred ccccccCCC-CCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 387 TLYDKLHPA-EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 387 sL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
||..+-..- ......+++...-+|....+.||.||.+.. .|||||+||+|||+|..|.+||+|||++..+..+-.
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-- 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-- 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence 665432210 011245888888889999999999998764 899999999999999999999999999977654221
Q ss_pred cccccCCCCcccccCCCCCC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 466 STFVNGEFGDLGYVAPEYPR--TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.....|-..|||||.+. +..|+.+|||||+|++|||+.||+.|+...+ .+-+.+..........-..+
T Consensus 224 ---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-------svfeql~~Vv~gdpp~l~~~ 293 (361)
T KOG1006|consen 224 ---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-------SVFEQLCQVVIGDPPILLFD 293 (361)
T ss_pred ---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-------HHHHHHHHHHcCCCCeecCc
Confidence 11234778999999875 3358899999999999999999999986432 22222333222221111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...-+....+.+++..|+..|-.+||...++.+
T Consensus 294 -----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 294 -----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -----ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111224456777777999999999999998865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=244.08 Aligned_cols=260 Identities=21% Similarity=0.265 Sum_probs=193.3
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|...++||+|.||+||+|+ .++++.||+|+.+-+. .......+|+-+++.++|.|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 56778899999999999999 5678999999986543 2345678999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
|.. +|..+..... ..++.+....++.|+++||.+.|++ ++.|||+||.|.+|+.+|+.|++|||+++-++-.-
T Consensus 83 cdq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 975 8888876554 3588999999999999999999999 99999999999999999999999999999876433
Q ss_pred CcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHh---cCCc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLN---TNSS 537 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~---~~~~ 537 (618)
.... ..+-|..|++|.++.+. -|+...|+||-|||+.|+.. |++.|...+- ...+....+..- ++.+
T Consensus 156 rcys----aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv----ddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 156 RCYS----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred Eeee----ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH----HHHHHHHHHHhCCCccccC
Confidence 2222 22358999999988765 58899999999999999987 6665654332 122222222211 1111
Q ss_pred --cchhccccccCCC-----CHHHHH----HHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 --LETAIDKSLLGNG-----FDGELH----QFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 --~~~~~d~~l~~~~-----~~~~~~----~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+....|-....-+ ++.... .=.+++.+.+.-+|.+|.++++.++
T Consensus 228 ps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 228 PSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111111111 111111 1234555888899999999988765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.10 Aligned_cols=265 Identities=18% Similarity=0.174 Sum_probs=168.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-C----CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEE------EEe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-G----GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGF------CVA 372 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~~ 372 (618)
..++|+..+.||+|+||.||+|+.. + +..||+|++......+. ...| .+....+.+++.++.. ...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-WMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-HHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4678999999999999999999964 4 68999998865332211 1111 1122222333322221 234
Q ss_pred CCeeEEEEeecCCCccccccCCCCCC----------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 007088 373 KKERLLVYSYLENGTLYDKLHPAEHE----------------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISS 436 (618)
Q Consensus 373 ~~~~~lV~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 436 (618)
..+.++||||+++++|.+++...... ........+..++.|++.||+|||++ +|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence 56789999999999999988654210 01112344668999999999999999 999999999
Q ss_pred CCeeeCC-CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC----------------------CCCCcc
Q 007088 437 KCILLDG-DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL----------------------VATPKG 493 (618)
Q Consensus 437 ~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~s 493 (618)
+|||++. ++.+||+|||+|+.+....... .....+++.|+|||.+... .++.++
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~---~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYI---PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccC---CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 9999985 5799999999998654322211 1223478999999954321 234567
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCC-----CccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCC
Q 007088 494 DVYSFGVVLLELITGERPTHLTNAP-----ESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLP 568 (618)
Q Consensus 494 DVwS~Gvil~elltG~~Pf~~~~~~-----~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~ 568 (618)
|||||||++|||+++..|+...... .........|......... .+ +... .+..+.......+|+.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~-~~~~--~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRAS-PD-LRRG--FEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccc-hh-hhhh--hhhccccchHHHHHHHHHccC
Confidence 9999999999999977664321000 0001112233222111100 00 0000 000011122345788899999
Q ss_pred CCCCCCCHHHHHH
Q 007088 569 TPKERHTMFEVYQ 581 (618)
Q Consensus 569 dP~~RPs~~evl~ 581 (618)
||++|||++|+++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999976
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=272.80 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=194.0
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccC--------HHHHHHHHHHHhcCCCCCccceeEEEEeC-Ce
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHS--------EKEFLSEINTLGSVRHRNLVPLLGFCVAK-KE 375 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~ 375 (618)
++|-..++||+|||+.||+|. +...+.||+|+-...... .+...+|..+.+.+.||.||++|+||.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 356677899999999999999 667899999987533221 23456899999999999999999999654 56
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC---CCCceEEccc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD---GDFEPKLSDF 452 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Df 452 (618)
+|-|+|||+|.+|.-||+..+. +++.++..|+.||+.||.||.+. +|+|||-||||.|||+- ..|.+||.||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7899999999999999987754 89999999999999999999986 67899999999999994 4578999999
Q ss_pred CcccccCCCCCccc---ccccCCCCcccccCCCCCCC----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH
Q 007088 453 GLARLMNPVDTHLS---TFVNGEFGDLGYVAPEYPRT----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525 (618)
Q Consensus 453 G~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l 525 (618)
|+++.++....... .......||++|++||.+-- .+.+.|+||||.|||+|..+.|+.||....... ++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----dI 693 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----DI 693 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----HH
Confidence 99999876443211 11223459999999997643 356889999999999999999999997643211 11
Q ss_pred HHHHHHHhcCCccchhcccccc-CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLL-GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+.-..+ ..-.-... ....+.+.+.|++ +||++.-++|....++..
T Consensus 694 LqeNTIl-------kAtEVqFP~KPvVsseAkaFIR---RCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQENTIL-------KATEVQFPPKPVVSSEAKAFIR---RCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhhhchh-------cceeccCCCCCccCHHHHHHHH---HHHHhhhhhhhhHHHHcc
Confidence 1111100 00000010 1123445555555 999999999998888753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-33 Score=279.99 Aligned_cols=263 Identities=20% Similarity=0.290 Sum_probs=203.4
Q ss_pred CcEEeecCCeeEEEEE-eCCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 311 NNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
.+.||+|.||+||-|+ .++|+.||||++.+. ...+.++++|+.+|++++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5789999999999999 568999999999663 34567899999999999999999999999999999999999965
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC---CceEEcccCcccccCCCCC
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD---FEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~~~~~ 463 (618)
+..+.+-..+. ..+++.....++.||+.||.|||.+ +|+|+||||+|||+... -++||+|||+|+.++...-
T Consensus 648 DMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 65555544333 4689999999999999999999999 99999999999999643 4699999999999875432
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
-+..+||+.|.|||++..+.|...-|+||.|||+|--++|..||..+.+ +.+..+. ..++-
T Consensus 723 -----RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQN-------AaFMy 783 (888)
T KOG4236|consen 723 -----RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQN-------AAFMY 783 (888)
T ss_pred -----hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhc-------ccccc
Confidence 2345699999999999999999999999999999999999999976432 1111111 00111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH-----------HHHHH----hhhhcCCCCCCcccCC
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVY-----------QLLRA----IAERYHFTTDDEIMLP 601 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-----------~~L~~----i~~~~~~~~~~~~~~~ 601 (618)
....+.+.....+++|...|+..-++|-+.++-+ ..|++ +-++|-+.+.|+.-|+
T Consensus 784 ---Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThesDD~~~~ 853 (888)
T KOG4236|consen 784 ---PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHESDDARWE 853 (888)
T ss_pred ---CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcchhhhhh
Confidence 1122344455667777788888888888876543 22333 3455666666655554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-33 Score=281.46 Aligned_cols=239 Identities=21% Similarity=0.224 Sum_probs=195.2
Q ss_pred CCCCcEEeecCCeeEEEEEeCCCc-EEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 308 FSKNNIIGTGRTGATYIAMLPGGC-FIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+.++..||-||||.|-++...... .+|+|.+++.. ...+.+..|-.+|..++.|.||++|..|.+....|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344567999999999999865543 48999887632 3456688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
|-||.|...+.+++. ++......++..+++|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+....
T Consensus 502 ClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 502 CLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999987764 88899999999999999999999 99999999999999999999999999999987654
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ..+||+.|.|||++.....+.++|.||+|+++|||++|.+||...++-..+..++.. +
T Consensus 575 KTw-----TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG--------------i 635 (732)
T KOG0614|consen 575 KTW-----TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG--------------I 635 (732)
T ss_pred cee-----eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh--------------h
Confidence 332 235999999999999999999999999999999999999999876543222111111 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHT 575 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 575 (618)
|. -..+....+...+++++.+..+|.+|--
T Consensus 636 d~---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 DK---IEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hh---hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 10 0112223445667777889999999965
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=276.89 Aligned_cols=216 Identities=23% Similarity=0.316 Sum_probs=178.8
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
-|..++.||-|+||.|.++. .++...||+|.+++.. .....+..|-+||.....+-||++|-.|.+++..|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 37778899999999999998 4557889999997643 223457789999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|++||++..+|.+.+- +.+..+..++.++..|+++.|.. |+|||||||+|||||.+|++||.|||++.-+...
T Consensus 710 YIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999877654 88888899999999999999999 9999999999999999999999999998644221
Q ss_pred C--------Cc-cc-----------------------------ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHH
Q 007088 462 D--------TH-LS-----------------------------TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLL 503 (618)
Q Consensus 462 ~--------~~-~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ 503 (618)
. .+ .. ......+||+.|+|||++....|+.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 00 00 0011224999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCccccCHHHHHH
Q 007088 504 ELITGERPTHLTNAPESFKGSLVEWIT 530 (618)
Q Consensus 504 elltG~~Pf~~~~~~~~~~~~l~~~~~ 530 (618)
||+.|+.||......+. ...+..|..
T Consensus 863 em~~g~~pf~~~tp~~t-q~kv~nw~~ 888 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET-QYKVINWRN 888 (1034)
T ss_pred HHhhCCCCccCCCCCcc-eeeeeehhh
Confidence 99999999987665432 334445543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=267.97 Aligned_cols=271 Identities=21% Similarity=0.266 Sum_probs=216.7
Q ss_pred cCHHHHHHhhccCCCCcEEeecCCeeEEEEEeCC------CcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCcccee
Q 007088 296 MRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLL 367 (618)
Q Consensus 296 ~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~ 367 (618)
.++.++.....+++....+.+|.||.||+|.+.+ .+.|.+|.++.. +.....+..|.-.+..+.|||+..+.
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence 3466777777788888999999999999997543 456777877653 33345688899999999999999999
Q ss_pred EEEEeC-CeeEEEEeecCCCccccccCCCCC----CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 368 GFCVAK-KERLLVYSYLENGTLYDKLHPAEH----EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 368 ~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
+++.+. ...+++|.++.-|+|..++...+. ....++..+...++.|++.|++|||++ +|||.||.++|.+||
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 998664 567899999999999999873221 235577788899999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~ 521 (618)
+..++||+|=.+++.+-+.+.+. .......+..||+||.+....|+.++|||||||++|||+| |+.|+...++.+..
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhc--LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHC--LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred hheeEEeccchhccccCcccccc--cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 99999999999999876655442 2233345778999999999999999999999999999998 99998765543211
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..+....+-..+.+++.++..++.-||..+|++||+.+|+..-|.+.-.+
T Consensus 509 ------------------~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 509 ------------------HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ------------------HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 11112222233456788999999999999999999999999999886443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=261.06 Aligned_cols=237 Identities=28% Similarity=0.353 Sum_probs=190.4
Q ss_pred CCeeEEEEEeC-CCcEEEEEEeccCccC--HHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCccccccCC
Q 007088 318 RTGATYIAMLP-GGCFIMIKRLEDSQHS--EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHP 394 (618)
Q Consensus 318 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 394 (618)
+||.||+|+.. +++.+++|++...... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 5899999999764322 57899999999999999999999999999999999999999999999875
Q ss_pred CCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCC
Q 007088 395 AEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474 (618)
Q Consensus 395 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~g 474 (618)
... +++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+........ .....+
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~ 148 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL-----LTTFVG 148 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccc-----cccccC
Confidence 432 88999999999999999999999 999999999999999999999999999987654321 122337
Q ss_pred cccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHH
Q 007088 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGE 554 (618)
Q Consensus 475 t~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 554 (618)
+..|++||...+..++.++||||||++++++++|..||..... ............... .......
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~~~~~~~~~~--------~~~~~~~ 213 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFKKIGKPKPPF--------PPPEWKI 213 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhccCCCC--------ccccccC
Confidence 8899999999888889999999999999999999999865321 111111111110000 0000003
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 555 LHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 555 ~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...+.+++.+|+..+|++||++.++++
T Consensus 214 ~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 214 SPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CHHHHHHHHHHccCCchhccCHHHHhh
Confidence 356778888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=282.12 Aligned_cols=262 Identities=20% Similarity=0.241 Sum_probs=179.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-----------------CCCcEEEEEEeccCcc-CHH--------------HHHHH
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-----------------PGGCFIMIKRLEDSQH-SEK--------------EFLSE 351 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~-~~~--------------~~~~E 351 (618)
..++|++.++||+|+||.||+|.. .+++.||||++..... ..+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999963 2356899999864321 112 23346
Q ss_pred HHHHhcCCCCCc-----cceeEEEEe--------CCeeEEEEeecCCCccccccCCCCC--------------------C
Q 007088 352 INTLGSVRHRNL-----VPLLGFCVA--------KKERLLVYSYLENGTLYDKLHPAEH--------------------E 398 (618)
Q Consensus 352 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~ 398 (618)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777753 3567999999999999998864321 0
Q ss_pred CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccc
Q 007088 399 VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478 (618)
Q Consensus 399 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y 478 (618)
...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........... ....+++.|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~---~~g~~tp~Y 376 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP---LYGMLDPRY 376 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc---cccCCCcce
Confidence 12357788999999999999999999 999999999999999999999999999976543211111 112247899
Q ss_pred cCCCCCCCCC--------------------C--CCccchHHHHHHHHHHHhCCC-CCCCCCC----CCccccCHHHHHHH
Q 007088 479 VAPEYPRTLV--------------------A--TPKGDVYSFGVVLLELITGER-PTHLTNA----PESFKGSLVEWITL 531 (618)
Q Consensus 479 ~aPE~~~~~~--------------------~--~~~sDVwS~Gvil~elltG~~-Pf~~~~~----~~~~~~~l~~~~~~ 531 (618)
+|||.+.... + ..+.||||+||++|||++|.. ||..... ......++..|...
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 9999865322 1 134799999999999999875 6643211 01112223333321
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTP---KERHTMFEVYQ 581 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 581 (618)
..... +- ...+.......+++.+++..+| .+|+|++|+++
T Consensus 457 ~~~~~------~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 457 KGQKY------DF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccCC------Cc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11110 10 1112223455666668888765 78999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=244.70 Aligned_cols=202 Identities=19% Similarity=0.284 Sum_probs=167.0
Q ss_pred ccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC--ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS--QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 381 (618)
+.......||+|++|.|-+-+ ..+|+..|+|+++.. .+..++...|+++..+. .+|.+|.++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 334446779999999998888 568999999999764 34556788899887665 79999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
.|.. ||..+-.+.-.....+++...-+|+..+.+||.|||++. .++|||+||+|||++.+|++|++|||++..+.++
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 9975 777665433333456899999999999999999999985 7999999999999999999999999999877653
Q ss_pred CCcccccccCCCCcccccCCCCCC----CCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPR----TLVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
-... -..|-..|||||.+. ...|+-++||||+|+++.||.+++.||...
T Consensus 203 iAkt-----~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IAKT-----MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hHHH-----HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 3221 122678899999865 347899999999999999999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=254.10 Aligned_cols=200 Identities=20% Similarity=0.273 Sum_probs=173.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 378 (618)
.++|....+||+|+|+.|..+.+ ++.+.||+|++++. ....+-++.|-.+..+. +||.+|-+..+|......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 35688899999999999999994 56789999999763 23334466677776666 79999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|.||++||+|.-+++.++. ++++.+..+...|.-||.|||++ ||+.||||.+|+|+|..|++||.|||+++.-
T Consensus 329 vieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999988877654 99999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
-...... ...+||+.|+|||++.+..|....|.|++||+++||+.|+.||+..
T Consensus 402 l~~gd~t----stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 402 LGPGDTT----STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred CCCCccc----ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 3322222 2345999999999999999999999999999999999999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=262.16 Aligned_cols=132 Identities=22% Similarity=0.373 Sum_probs=116.5
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-----C---CCccceeEEEEeC--
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-----H---RNLVPLLGFCVAK-- 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~~-- 373 (618)
.++|.+.++||-|-|++||++. ..+.+.||+|+.+..+...+.-..|+++|++++ | .+||+++++|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 3689999999999999999999 567899999999888777778889999999984 2 4699999999753
Q ss_pred --CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 374 --KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 374 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
.+.|||+|++ |.+|..+|..... ..++...++.|++||+.||.|||.+| ||||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4889999999 5689999877655 45889999999999999999999998 99999999999999
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=284.51 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=187.0
Q ss_pred CCCCcEEeecCCee-EEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 308 FSKNNIIGTGRTGA-TYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 308 y~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
|...+.+|.|+.|+ ||+|.. +|+.||||++-... ..-..+|+..|+.- +|||||++++.-.++...|+..|.|..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 55567789999874 799998 67799999985532 23456899999888 699999999999999999999999965
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---C--CceEEcccCcccccCC
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---D--FEPKLSDFGLARLMNP 460 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfG~a~~~~~ 460 (618)
+|.+++.....+.....-...+.+..|+++||++||+. +||||||||.||||+. + .+++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 99999987421111111134577889999999999998 9999999999999975 3 4699999999999876
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITG-ERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG-~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
....... ..+..||.+|+|||++....-+.++||||+||++|..++| .+||...-..+ ......+..+.
T Consensus 664 ~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~L~ 733 (903)
T KOG1027|consen 664 GKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYTLV 733 (903)
T ss_pred Ccchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------hhhhcCcccee
Confidence 5544433 4455699999999999988888899999999999999995 99997633211 11111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVY 580 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 580 (618)
.+ .. ..+. +..+||.+|+.+||..||++.+|+
T Consensus 734 ~L-----~~-~~d~---eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 HL-----EP-LPDC---EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred ee-----cc-CchH---HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 00 0111 556677799999999999999995
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-31 Score=247.09 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=192.0
Q ss_pred CcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-----eeEEEEe
Q 007088 311 NNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK-----ERLLVYS 381 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e 381 (618)
.+.||-|+||.||.++. ++|+.|+.|++.... ...+.+.+|+++|..++|.|++..++...-.. +.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 56799999999999995 579999999986532 45678899999999999999999998876543 5688999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
.|.. +|...+-... +++...++-++.||++||+|||+. +|.||||||.|.|++.+..+||+|||+++..+..
T Consensus 138 LmQS-DLHKIIVSPQ----~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQ----ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHh-hhhheeccCC----CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence 9865 8888876543 488889999999999999999999 9999999999999999999999999999976554
Q ss_pred CCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH--------HHHH
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW--------ITLL 532 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~--------~~~~ 532 (618)
+....+ ..+-|..|+|||++.+. .|+.+.||||.|||+.|++..+..|+..++.+.... +.+. .+..
T Consensus 210 ~~~hMT---qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~l-ItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 210 DRLNMT---HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQM-IIDLLGTPSQEAMKYA 285 (449)
T ss_pred hhhhhH---HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHH-HHHHhCCCcHHHHHHH
Confidence 332221 11257899999998864 689999999999999999999998886554322111 0000 0000
Q ss_pred hcCCccchhccccccC---------CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 533 NTNSSLETAIDKSLLG---------NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
-++....++....+. ......-.+-+.+.+.++..||++|.+..+.+..+.
T Consensus 286 -CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 286 -CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred -hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 001111111111110 001122334556666899999999999999876543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=239.62 Aligned_cols=258 Identities=20% Similarity=0.346 Sum_probs=196.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEE-EEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGF-CVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~e~ 382 (618)
+.|.+.+.+|+|.||.+-++.+ ...+.+++|.++......++|.+|...--.| .|.||+.-|++ |...+.+++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4688889999999999999995 4578999999999888899999998776666 59999988865 5667788899999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC--CCCceEEcccCcccccCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD--GDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~~~~ 460 (618)
+|.|+|.+-+...+ +.+....+++.|+++|+.|||++ ++||||||.+||||- +..++||+|||..+..+.
T Consensus 104 aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999887644 77888999999999999999999 999999999999993 445799999999987653
Q ss_pred CCCcccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.-.. ..-+..|.+||.... ....+.+|||.||+++|..+||..||+.... ......+|.....+.
T Consensus 176 tV~~-------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 176 TVKY-------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDKPYWEWEQWLKRK 245 (378)
T ss_pred eehh-------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCchHHHHHHHhccc
Confidence 2211 113567999996542 2457889999999999999999999984332 223445555443322
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.. .+. +.+........++.++-+.++|++|-...++.++-.....+
T Consensus 246 ~~-------~~P-~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 246 NP-------ALP-KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred Cc-------cCc-hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 11 111 11112223445555589999999997777777776665444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=260.84 Aligned_cols=195 Identities=24% Similarity=0.327 Sum_probs=168.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCH---------HHHHHHHHHHhcCC---CCCccceeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSE---------KEFLSEINTLGSVR---HRNLVPLLGFCVA 372 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~---h~niv~l~~~~~~ 372 (618)
.+|+..+.+|+|+||.|+.|+++ +...|+||.+.+.+.-. ..+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35889999999999999999954 56789999987654211 12567999999997 9999999999999
Q ss_pred CCeeEEEEeec-CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcc
Q 007088 373 KKERLLVYSYL-ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 373 ~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
++.+|++||-- ++-+|++++..... +++.++..|++|++.|+++||++ +|||||||-+||.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999965 46689999987654 99999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCC
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTH 513 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~ 513 (618)
||.|.+..... .....||..|.|||++.+.+| +..-|||++|++||.++....||+
T Consensus 714 fgsaa~~ksgp------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSGP------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCCC------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99997765432 223349999999999999887 567999999999999999999886
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=234.59 Aligned_cols=209 Identities=32% Similarity=0.483 Sum_probs=181.2
Q ss_pred EeecCCeeEEEEEeCC-CcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcccc
Q 007088 314 IGTGRTGATYIAMLPG-GCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390 (618)
Q Consensus 314 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 390 (618)
||+|++|.||++...+ ++.+++|++..... ..+.+.+|+..+++++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 89999999987554 35679999999999999999999999999899999999999999999
Q ss_pred ccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccCcccccCCCCCcccccc
Q 007088 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPVDTHLSTFV 469 (618)
Q Consensus 391 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~ 469 (618)
++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~ 150 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LL 150 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hh
Confidence 987542 3488999999999999999999999 9999999999999999 89999999999987654321 01
Q ss_pred cCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccC
Q 007088 470 NGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLG 548 (618)
Q Consensus 470 ~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 548 (618)
....+...|++||..... .++.++|+|++|++++++
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 112367889999998877 788999999999999999
Q ss_pred CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 549 NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
..+.+++.+|++.||.+||++.++++.
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246677789999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=231.46 Aligned_cols=195 Identities=19% Similarity=0.298 Sum_probs=164.6
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCC--eeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKK--ERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lV~ 380 (618)
.++|++.+++|+|.|+.||.|. ..+.+.++||+++.. ..+.+.+|+.+|..++ ||||+++++...++. ...+|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 4678889999999999999999 677899999999874 3567889999999997 999999999998765 456999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCcccccC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMN 459 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~ 459 (618)
||+.+-+...+. ..++...+..++.++++||.|+|++ ||.|||+||.|++||.. -.++|+|+|+|.+..
T Consensus 115 E~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999987766554 2367778899999999999999999 99999999999999954 469999999998876
Q ss_pred CCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
+... .+-++.+..|.-||.+-. +.|+..-|+|||||++..|+..+.||....
T Consensus 185 p~~e-----YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 185 PGKE-----YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred CCce-----eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 5432 223346778899998764 457889999999999999999999997543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=255.59 Aligned_cols=202 Identities=21% Similarity=0.177 Sum_probs=174.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC------CCCccceeEEEEeCCeeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR------HRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~ 377 (618)
-.+|.+....|+|-|++|.+|.. .-|..||||++...+...+.=+.|+++|++|+ --|+++++-.|...++.|
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 46788899999999999999994 45789999999988777777789999999995 358999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLAR 456 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~ 456 (618)
||+|-+.- +|.++|...+.+ ..+....+..++.|+.-||..|... +|+|.||||+|||+++. ..+||||||.|.
T Consensus 511 lVFE~Lsl-NLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 511 LVFEPLSL-NLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEehhhhc-hHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence 99998854 899999876543 4588889999999999999999998 99999999999999865 458999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
........... -+..|+|||++.|.+|+...|+||.||.||||.||+..|.+...
T Consensus 586 ~~~eneitPYL------VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 586 FASENEITPYL------VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ccccccccHHH------HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 77654433222 35689999999999999999999999999999999999986544
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=235.32 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=189.2
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
..+|.....+|.|.- .|..|. .-.++.||+|.+... ....++..+|...+..++|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777788899888 565555 345889999987542 344567789999999999999999999986443
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
+.|+|||||.. +|.+.+. ..++-..+..|+.|++.|++|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 57999999965 8888876 2367788899999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
|+..+.. ......+.|..|+|||++-+..+.+.+||||.||++.||++|+..|.+.+. +.+|.+....
T Consensus 165 ar~e~~~-----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-------idQ~~ki~~~ 232 (369)
T KOG0665|consen 165 ARTEDTD-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-------IDQWNKIIEQ 232 (369)
T ss_pred hcccCcc-----cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-------HHHHHHHHHH
Confidence 9865443 112233478899999999998899999999999999999999998875432 2222221111
Q ss_pred CCc---------------------------cchhc-cccccC--CCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSS---------------------------LETAI-DKSLLG--NGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~---------------------------~~~~~-d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+. ..+.+ |..... +...-......+++.+||..||++|.+++++++
T Consensus 233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 100 00111 111100 011123344556777999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=229.96 Aligned_cols=198 Identities=30% Similarity=0.423 Sum_probs=171.1
Q ss_pred CCCCcEEeecCCeeEEEEEeCC-CcEEEEEEeccCcc--CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 308 FSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
|...+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567899999999999999765 89999999976543 46788999999999999999999999999899999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... .+++.....++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999875432 178999999999999999999999 9999999999999999999999999999876543200
Q ss_pred ccccccCCCCcccccCCCCC-CCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 007088 465 LSTFVNGEFGDLGYVAPEYP-RTLVATPKGDVYSFGVVLLELITGERPTHL 514 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvil~elltG~~Pf~~ 514 (618)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 ---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11123367889999998 677788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=254.74 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=196.1
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|+....+|.|.||.|||++ ...++..|+|+++-.. ...+-+++|+-+++..+|||||.+++.+...+..|+.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3568888999999999999999 5678999999998644 3455678999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
|.+|+|++.-+... ++++.++....+..++|++|||++ +-+|||||-.||++++.|.+|++|||.+..+...-
T Consensus 94 cgggslQdiy~~Tg----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeecc----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh
Confidence 99999999877554 599999999999999999999999 99999999999999999999999999987765432
Q ss_pred CcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.... ...||+.|||||+.. .+.|..++|||+.|+...|+---++|..+.-+ ..+-.+.......
T Consensus 167 ~Krk----sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp---------mr~l~LmTkS~~q 233 (829)
T KOG0576|consen 167 AKRK----SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP---------MRALFLMTKSGFQ 233 (829)
T ss_pred hhhh----cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch---------HHHHHHhhccCCC
Confidence 2222 234999999999753 56788999999999999999887777543211 1111222211110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVY 580 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 580 (618)
.+.+.. .......|-++++.|+..+|++||+++.++
T Consensus 234 ---pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 234 ---PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ---CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 111111 112233455666699999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=236.48 Aligned_cols=205 Identities=24% Similarity=0.317 Sum_probs=166.8
Q ss_pred HHHhhccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 007088 301 LMKATNSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 301 l~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 375 (618)
+....+.|...++||+|.|++||++++. ....||+|.+.... ....+.+|+++|..+ .+.||+++.+++..+++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4445667899999999999999999943 46899999986643 334688999999999 49999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccCc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGL 454 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~ 454 (618)
..+|+||++..+..++.. .++...+..++..++.||+++|+. |||||||||+|++.+. .+.-.|.|||+
T Consensus 110 v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence 999999999988877764 377889999999999999999999 9999999999999985 45689999999
Q ss_pred ccccCCCC------C-------c---------------------------ccccccCCCCcccccCCCCCCC-CCCCCcc
Q 007088 455 ARLMNPVD------T-------H---------------------------LSTFVNGEFGDLGYVAPEYPRT-LVATPKG 493 (618)
Q Consensus 455 a~~~~~~~------~-------~---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~s 493 (618)
|....... . . .......+.||++|+|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211100 0 0 0000112459999999998764 4568899
Q ss_pred chHHHHHHHHHHHhCCCCCCCCC
Q 007088 494 DVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 494 DVwS~Gvil~elltG~~Pf~~~~ 516 (618)
||||.|||++-+++++.||....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred ceeeccceeehhhccccccccCc
Confidence 99999999999999999997544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-27 Score=270.69 Aligned_cols=198 Identities=17% Similarity=0.161 Sum_probs=138.8
Q ss_pred cCCC-CCccceeEEE-------EeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007088 357 SVRH-RNLVPLLGFC-------VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428 (618)
Q Consensus 357 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 428 (618)
.++| +||++++++| ...+..+.++||+ +++|.+++.... ..+++.+++.++.||++||+|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4456 6888888887 2234567888987 559999997543 4599999999999999999999999 9
Q ss_pred ceecCCCCCCeeeCC-------------------CCceEEcccCcccccCCCCCc------------ccccccCCCCccc
Q 007088 429 IIHRNISSKCILLDG-------------------DFEPKLSDFGLARLMNPVDTH------------LSTFVNGEFGDLG 477 (618)
Q Consensus 429 ivH~Dlkp~NIll~~-------------------~~~~kl~DfG~a~~~~~~~~~------------~~~~~~~~~gt~~ 477 (618)
|+||||||+|||++. ++.+|++|||+++........ .........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 445666666666542210000 0000011347889
Q ss_pred ccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHH
Q 007088 478 YVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQ 557 (618)
Q Consensus 478 y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 557 (618)
|+|||++.+..++.++|||||||++|||++|..|+.... ..+...... ...+. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~---------~~~~~-----~~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR---------VLPPQ-----ILLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh---------hcChh-----hhhcCHH
Confidence 999999999999999999999999999999988764311 011111100 00110 0112234
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHH
Q 007088 558 FLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 558 l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...++.+||+.||.+||++.|+++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 457777999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=210.04 Aligned_cols=169 Identities=22% Similarity=0.214 Sum_probs=127.1
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|||.+++...+ ..+++.+++.|+.|+++||+|||++ + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68888887543 3599999999999999999999998 6 999999999999999 99998764322
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+.......... +
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~----~-- 128 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEILLNGMPADDPR----D-- 128 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---cHHHHHHHHHhccCCcc----c--
Confidence 13789999999999999999999999999999999999999653221 11122221111111000 0
Q ss_pred ccCCCCHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 546 LLGNGFDGEL--HQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 546 l~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
........ ..+.+++.+||..||.+||++.|+++.+..+..
T Consensus 129 --~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 129 --RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred --cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 00011122 258888999999999999999999999877644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=210.22 Aligned_cols=279 Identities=18% Similarity=0.171 Sum_probs=219.8
Q ss_pred cCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecC
Q 007088 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.|.+.++||+|+||..+.|+ +-++++||||.-.. .....++..|....+.| ..+.|..++-|-..+.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL- 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL- 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence 68889999999999999999 67899999996543 33445678888888887 4789999998888888889999988
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-----ceEEcccCcccccC
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-----EPKLSDFGLARLMN 459 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~a~~~~ 459 (618)
|.+|+|++.-.+ ..++..++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+|+.+.
T Consensus 107 GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 779999887655 4699999999999999999999999 999999999999996443 48999999999987
Q ss_pred CCCCccccccc---CCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 460 PVDTHLSTFVN---GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 460 ~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
+..+......+ .-.||..||+--...+...+.+.|.=|+|-+++..+-|..||+....+. ..+.. .+.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-----nK~kY---eKIG 252 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-----NKEKY---EKIG 252 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc-----hHHHH---HHhc
Confidence 76655444333 2349999999999999999999999999999999999999998765421 11111 1111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCCCCC
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNT 604 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 604 (618)
.....-......+..+++...-++.+++ .+-.+-|..+-+...+.++..+.+.+.|-+++|-..+
T Consensus 253 e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 253 ETKRSTPIEVLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred cccccCCHHHHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 1111111111223355566666666555 7888889999999999999999999999999987554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-24 Score=219.42 Aligned_cols=278 Identities=19% Similarity=0.155 Sum_probs=205.9
Q ss_pred cCCCCcEEeecCCeeEEEEEeCCC--cEEEEEEeccCc-cCHHHHHHHHHHHhcCCC----CCccceeEEE-EeCCeeEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPGG--CFIMIKRLEDSQ-HSEKEFLSEINTLGSVRH----RNLVPLLGFC-VAKKERLL 378 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 378 (618)
+|.+.++||+|+||.||++..... ..+|+|...... .....+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 588999876542 222267788888888863 6899999998 47778899
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-----CceEEcccC
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-----FEPKLSDFG 453 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfG 453 (618)
||+.+ |.+|.++..... ...++..+..+|+.|++.+|++||+. |++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 679999875554 25699999999999999999999999 99999999999999765 469999999
Q ss_pred ccc--ccCCCCCc---cccc-ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH
Q 007088 454 LAR--LMNPVDTH---LSTF-VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 454 ~a~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~ 527 (618)
+++ ........ .... .....||..|.++....+...+++.|+||++.++.|++.|..||........ ..
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----~~ 247 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----KS 247 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----HH
Confidence 998 33222111 1111 1234499999999999999999999999999999999999999965443211 11
Q ss_pred HHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCCCCC
Q 007088 528 WITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNT 604 (618)
Q Consensus 528 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~ 604 (618)
-+.......... . .......+ +.++...+-..+..++|....+...+++.....+...++.++|+...
T Consensus 248 ~~~~~~~~~~~~----~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~ 315 (322)
T KOG1164|consen 248 KFEKDPRKLLTD----R--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKL 315 (322)
T ss_pred HHHHHhhhhccc----c--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccc
Confidence 111111000000 0 11112233 44444455558999999999999999999888777777777777553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=217.50 Aligned_cols=178 Identities=17% Similarity=0.148 Sum_probs=134.0
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEEeC--CCcEEEEEEeccC------ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAMLP--GGCFIMIKRLEDS------QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 373 (618)
....++|+..+.||+|+||.||+|... +++.||||++... ....+.+.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 345678999999999999999999853 5788899987532 1224568999999999999999863322 2
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCeeeCCCCceEEccc
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNI-SSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Df 452 (618)
+..++||||++|++|... .. .. ...++.|+++||+|||+. ||+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 467999999999999632 11 11 146788999999999999 9999999 999999999999999999
Q ss_pred CcccccCCCCCccc----ccccCCCCcccccCCCCCCCCC------CCCccchH
Q 007088 453 GLARLMNPVDTHLS----TFVNGEFGDLGYVAPEYPRTLV------ATPKGDVY 496 (618)
Q Consensus 453 G~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~------~~~~sDVw 496 (618)
|+|+.......... .......+++.|+|||++.-.+ .+..+|-|
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99997754332111 1112345788899999876432 23446666
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-23 Score=231.66 Aligned_cols=168 Identities=32% Similarity=0.574 Sum_probs=133.6
Q ss_pred cCCcchHHHHHHHHHhccCCCCccccCccCCCCCCCCCCcccceecCCCC-C--CcEEEEEecCCcceeeCCcCCCCCCC
Q 007088 31 LATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPD-E--NKVLNIRLSDMGLKGQFPRGIERCTS 107 (618)
Q Consensus 31 ~~~~~~~~~L~~~k~~~~~~~~~l~~~W~~~~~~~~~~c~w~gv~c~~~~-~--~~v~~l~l~~~~l~g~~p~~~~~l~~ 107 (618)
.+...|..||+.+|+++.++.. .+|+++ ++.+..|.|.||.|.... . ..|+.|+|++|+|+|.+|+++++|++
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~---~~W~g~-~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR---FGWNGD-PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc---CCCCCC-CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 3566899999999999977642 279743 222233489999995321 1 35899999999999999999999999
Q ss_pred CCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccc
Q 007088 108 LTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVA 187 (618)
Q Consensus 108 L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~ 187 (618)
|+.|+|++|+|+|.+|..++. +++|+.|+|++|+|+|.+|.++++|++|+.|+|++|+|+|.+|..++.+.
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~-l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~-------- 514 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGS-ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL-------- 514 (623)
T ss_pred CCEEECCCCcccCcCChHHhC-CCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcc--------
Confidence 999999999999999988875 99999999999999999999999999999999999999999998875431
Q ss_pred cccccCCCCCCCccccccccccCCCCCCCCCC-CCCCC
Q 007088 188 SNLLTGPVPSFANVNFTAEDFANNSGLCGKPL-NPCPG 224 (618)
Q Consensus 188 ~N~l~g~ip~~~~~~~~~~~~~~n~~~c~~~~-~~C~~ 224 (618)
.+...+++.+|+.+|+.|. ..|..
T Consensus 515 -------------~~~~~l~~~~N~~lc~~p~l~~C~~ 539 (623)
T PLN03150 515 -------------LHRASFNFTDNAGLCGIPGLRACGP 539 (623)
T ss_pred -------------ccCceEEecCCccccCCCCCCCCcc
Confidence 0223456788888998765 67853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.3e-24 Score=199.18 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=185.6
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
-+|.+...|..|+|+++++ .++.|+++-.+ ...++|..|.-.|+-+.||||..+++.|..+.+..++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 3688889999999998554 45567775432 3446799999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEc--ccCcccccCCCCCccc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS--DFGLARLMNPVDTHLS 466 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DfG~a~~~~~~~~~~~ 466 (618)
+..++.... ...+-.++.+++.++++|++|||+. .|-|..--|.+..+++|++.+++|+ |--++..
T Consensus 275 ynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq--------- 342 (448)
T KOG0195|consen 275 YNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------- 342 (448)
T ss_pred HHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee---------
Confidence 999997765 5678889999999999999999997 3335555788999999999988874 3222111
Q ss_pred ccccCCCCcccccCCCCCCCCCCC---CccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVAT---PKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
..++.-.+.|++||.++..+-+ .++|+|||.+++||+.|...||.+..+-+-.- ++.-
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-----------------kial 403 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-----------------KIAL 403 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-----------------hhhh
Confidence 1122246889999998776543 58999999999999999999998755422110 0011
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
..++...+......+.+++.-|+..||.+||.++.|+-.|+++
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1222222334455677777799999999999999999999876
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-23 Score=191.55 Aligned_cols=205 Identities=20% Similarity=0.247 Sum_probs=169.8
Q ss_pred hccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCC-CCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH-RNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|...++||+|+||.+|.|. ..+|..||||.-... ....++..|..+...+++ ..|..+..|..+..+-.+||+.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 4579999999999999999999 788999999986543 334467788888888875 6777788888888888999998
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC---CceEEcccCcccccC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD---FEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~~~ 459 (618)
+ |.+|++++.-.. ..++..+++.++.|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||+|+.+-
T Consensus 93 L-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred c-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 8 779999886554 4588999999999999999999999 99999999999999633 458999999999876
Q ss_pred CCCCcccccc---cCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 460 PVDTHLSTFV---NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 460 ~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
+..+...... ....||..|.+-....+...+.+.|+=|+|.+|..+--|..||+....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 5443332222 234589999998888788889999999999999999999999987543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-21 Score=199.08 Aligned_cols=263 Identities=26% Similarity=0.348 Sum_probs=195.5
Q ss_pred CCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc----CHHHHHHHHHHHhcCCCC-CccceeEEEEeCCeeEEEEee
Q 007088 308 FSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH----SEKEFLSEINTLGSVRHR-NLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 382 (618)
|...+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 7889999875432 366799999999999988 799999999777778999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccCcccccCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMNPV 461 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~ 461 (618)
+.++++.+++...... ..+.......+..|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999666544311 2588899999999999999999999 999999999999999988 7999999999865543
Q ss_pred CCccc--ccccCCCCcccccCCCCCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 462 DTHLS--TFVNGEFGDLGYVAPEYPRT---LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 462 ~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
..... .......|+..|+|||...+ ..++...|+||+|++++++++|..||...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcC
Confidence 32211 12234558999999999887 57889999999999999999999997654321 00111111111110
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.. .................+.+++..|+..+|..|.++.+....
T Consensus 232 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP--SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc--ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000000001223456677779999999999999888765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-23 Score=229.19 Aligned_cols=253 Identities=17% Similarity=0.182 Sum_probs=185.4
Q ss_pred CCCcEEeecCCeeEEEEEe-CCCcEEEEEEec----cCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 309 SKNNIIGTGRTGATYIAML-PGGCFIMIKRLE----DSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
...+.+|.|.+|.|+.... ...+..+.|.+. ... .....+..|+-+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998887773 233333444332 211 11122566777788889999988888777766666669
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++ +|+.++.... .+...++-.+++|+..|++|+|+. ||.|||+|++|++++.+|.+||+|||.+....-
T Consensus 401 E~~~~-Dlf~~~~~~~----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhccc----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 9999987652 378888999999999999999999 999999999999999999999999999976654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCCCCccc--cCHHHHHHHHhcCCc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATP-KGDVYSFGVVLLELITGERPTHLTNAPESFK--GSLVEWITLLNTNSS 537 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~--~~l~~~~~~~~~~~~ 537 (618)
..........+.+|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... .....|.....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~---- 548 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE---- 548 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc----
Confidence 4333334455677999999999999998876 6999999999999999999997654322110 00000000000
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
-........+.....++.+||+.||.+|.|+++|++
T Consensus 549 --------~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 --------GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --------ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000112334556677888999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=232.99 Aligned_cols=156 Identities=33% Similarity=0.655 Sum_probs=123.8
Q ss_pred CcchHHHHHHHHHhccCCCCccccCccCCCCCCCCCCcccceecCCCCCCcEEEEEecCCcceeeCCcCCCCCCCCCeEE
Q 007088 33 TLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLD 112 (618)
Q Consensus 33 ~~~~~~~L~~~k~~~~~~~~~l~~~W~~~~~~~~~~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~ 112 (618)
.+.|..||++||+++.+|.+.+. +|+.. .+||.|.||+|++ .++|+.|+|++|+++|.+|+.+..+++|+.|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~-~w~~~----~~~c~w~gv~c~~--~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~ 99 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLS-NWNSS----ADVCLWQGITCNN--SSRVVSIDLSGKNISGKISSAIFRLPYIQTIN 99 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCC-CCCCC----CCCCcCcceecCC--CCcEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence 55899999999999988877665 89643 4599999999975 46999999999999999999999999999999
Q ss_pred ccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccccccccccccccc
Q 007088 113 LSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 113 l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~ 192 (618)
|++|+++|.+|..++.++++|++|+|++|+++|.+|. +.+++|++|+|++|+++|.+|..++++++|+.|+|++|.++
T Consensus 100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 177 (968)
T PLN00113 100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177 (968)
T ss_pred CCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccc
Confidence 9999999999999885588888888888888776664 34566666666666666666666666666666666666666
Q ss_pred CCCCC
Q 007088 193 GPVPS 197 (618)
Q Consensus 193 g~ip~ 197 (618)
|.+|.
T Consensus 178 ~~~p~ 182 (968)
T PLN00113 178 GKIPN 182 (968)
T ss_pred ccCCh
Confidence 65554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=184.93 Aligned_cols=139 Identities=17% Similarity=0.139 Sum_probs=109.4
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc---C-------HHH-----------------HHHHHHHHhcCCCCCc
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH---S-------EKE-----------------FLSEINTLGSVRHRNL 363 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~-------~~~-----------------~~~E~~~l~~l~h~ni 363 (618)
.+.||+|++|.||+|...+|+.||+|+++.... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 467999999999999987999999999965421 1 112 2349999999988877
Q ss_pred cceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCCeeeC
Q 007088 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 364 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 442 (618)
.....+.. ...++||||++++++....... ..++......++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54443322 2348999999987776543222 3488999999999999999999 688 999999999999998
Q ss_pred CCCceEEcccCcccccC
Q 007088 443 GDFEPKLSDFGLARLMN 459 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~ 459 (618)
++.++|+|||+|....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=219.71 Aligned_cols=251 Identities=20% Similarity=0.223 Sum_probs=182.7
Q ss_pred cCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccC--ccCHHHHHHHHHH--HhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDS--QHSEKEFLSEINT--LGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+|...+.||++.|=.|.+|+.+.|. |+||++-+. ....+.|.++++- ...++|||++++.-+-......|||=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667788999999999999998887 889998543 2333444444333 4455899999998887777778899999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc--CC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM--NP 460 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~--~~ 460 (618)
+.+ +|.|.+..+. .+...+.+.|+.|++.||..+|.. ||+|||||.+|||++.-..+.|+||..-+.. ..
T Consensus 103 vkh-nLyDRlSTRP----FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP----FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccch----HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 977 9999998664 378888899999999999999999 9999999999999999999999999866542 11
Q ss_pred -CCCcccccccCCCCcccccCCCCCCCC----------C-CCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHH
Q 007088 461 -VDTHLSTFVNGEFGDLGYVAPEYPRTL----------V-ATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 461 -~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~ 527 (618)
.......+.........|+|||.+... . .+++-||||+||++.||++ |++||.. .+
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----------SQ 243 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----------SQ 243 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----------HH
Confidence 112222333444455689999965431 1 5688999999999999998 7888853 11
Q ss_pred HHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 528 WITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 528 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
............+.+-..+. -..+.+++..|++.||.+|-++++.++.-+
T Consensus 244 L~aYr~~~~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 244 LLAYRSGNADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHhHhccCccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 11111111111111111111 124667888999999999999999998743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=187.66 Aligned_cols=170 Identities=11% Similarity=0.099 Sum_probs=132.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHH----------HHHHHHHHhcCCCCCccceeEEEEeC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKE----------FLSEINTLGSVRHRNLVPLLGFCVAK 373 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~~~~~~~ 373 (618)
..++|...+.+|.|+||.||++.. ++..+|+|.+.......+. +.+|+..+.+++|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357899999999999999999766 5678999999754322222 57899999999999999999986643
Q ss_pred --------CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC
Q 007088 374 --------KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445 (618)
Q Consensus 374 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 445 (618)
+..++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 35789999999999987632 222 2456999999999999 999999999999999988
Q ss_pred ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHH
Q 007088 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELI 506 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ell 506 (618)
++|+|||............ .+.....+..++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~d----------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAKD----------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhHH----------------HHHHHhHhcccccccceeEeehHHH
Confidence 9999999887553211110 0233344667999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=179.48 Aligned_cols=140 Identities=16% Similarity=0.134 Sum_probs=111.8
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccC---------------------------HHHHHHHHHHHhcCCCCCc
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS---------------------------EKEFLSEINTLGSVRHRNL 363 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~ni 363 (618)
...||+|++|.||+|...+|+.||||+++..... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998754210 1123578999999999988
Q ss_pred cceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeC
Q 007088 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 364 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~ 442 (618)
.....+... ..++||||++++++....... ..++......++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 655554433 348999999987654332111 247788899999999999999999 8 999999999999999
Q ss_pred CCCceEEcccCcccccCC
Q 007088 443 GDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~ 460 (618)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=176.41 Aligned_cols=187 Identities=18% Similarity=0.138 Sum_probs=141.8
Q ss_pred CCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHH-----HHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEeec
Q 007088 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEK-----EFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
....|++|+||+||.+.. .+.+++.+.+.......+ .+.+|+++|+++. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 778888888876554333 5789999999995 5889999886 3469999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNI-SSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+|.+|.+.+.. ....++.|++.+|+++|+. ||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99888654321 1135778999999999999 9999999 7999999999999999999998654322
Q ss_pred Cc----cc-------ccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 463 TH----LS-------TFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 463 ~~----~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
.. .. ... ...++.|++|+...- ..--...+.++-|.-+|.++|++.+...+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~--~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHK--RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHH--HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 11 00 001 114677777774322 2222578999999999999999998776544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=192.22 Aligned_cols=219 Identities=26% Similarity=0.402 Sum_probs=163.7
Q ss_pred HhcCCCCCccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCc-eecC
Q 007088 355 LGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRI-IHRN 433 (618)
Q Consensus 355 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~D 433 (618)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..++|.-...+.++|+.||+|||.. +| .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence 457889999999999999999999999999999999998744 5699999999999999999999988 55 9999
Q ss_pred CCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC-------CCCCccchHHHHHHHHHHH
Q 007088 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-------VATPKGDVYSFGVVLLELI 506 (618)
Q Consensus 434 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDVwS~Gvil~ell 506 (618)
++++|.++|....+||+|||+............. .......-|.|||.+.+. ..+.+.||||||++++|++
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~--~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAH--HPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eccccceeeeeEEEEechhhhccccccccccccc--chhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999998876421000000 000124579999987753 1467899999999999999
Q ss_pred hCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 507 TGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 507 tG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
+.+.||......... ..+...+.. .....+.+.+.... +....+..++.+||..+|.+||++++|-..++.+
T Consensus 153 ~r~~~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred hccCccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999999875443222 112222211 01111222221111 2233688888999999999999999999988877
Q ss_pred hhh
Q 007088 587 AER 589 (618)
Q Consensus 587 ~~~ 589 (618)
...
T Consensus 225 ~~~ 227 (484)
T KOG1023|consen 225 NKG 227 (484)
T ss_pred ccc
Confidence 553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-19 Score=200.56 Aligned_cols=256 Identities=18% Similarity=0.180 Sum_probs=184.9
Q ss_pred HHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC---CCCccceeEEEEeCCee
Q 007088 300 DLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR---HRNLVPLLGFCVAKKER 376 (618)
Q Consensus 300 ~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 376 (618)
+.+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+..... +|+--.+++.||+ -+-|..+...+.-.+..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 334455678899999999999999999888999999998765433 2333334444554 24455555556667778
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC-------CCCceEE
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD-------GDFEPKL 449 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl 449 (618)
++|+||.+.|||.+++... ..++|...+.+..|+++-+++||.. +|||+||||+|.||. +..-++|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 9999999999999999844 4599999999999999999999999 999999999999994 2345899
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
+|||.+..+..-.. .+...+.++|-.+-.+|+..|..++.+.|.|.+..+++-|+.|+..-. .
T Consensus 843 IDfG~siDm~lfp~--~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-~-------------- 905 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPD--GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-K-------------- 905 (974)
T ss_pred EecccceeeeEcCC--CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh-c--------------
Confidence 99999976543111 133445668999999999999999999999999999999999986420 0
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
++.. ..++..+..-...+...+++. .+|..|-..=|...++...++++..+.
T Consensus 906 -----~g~~-~~~~~~~~Ry~~~~~W~~~F~---~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 906 -----NGSS-WMVKTNFPRYWKRDMWNKFFD---LLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred -----CCcc-eeccccchhhhhHHHHHHHHH---HHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 0000 000110000001122334555 455555555588888888888876654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.6e-19 Score=178.42 Aligned_cols=232 Identities=17% Similarity=0.186 Sum_probs=145.8
Q ss_pred CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCC----------CCccceeEEEEe
Q 007088 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRH----------RNLVPLLGFCVA 372 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~~ 372 (618)
+...+.||.|+++.||.++.. +++.+|+|++... ....+++.+|.-....+.+ -.++-.++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 344678999999999999964 5899999988432 2334566666655544322 223333333221
Q ss_pred C------------C-----eeEEEEeecCCCccccccCC---CCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 007088 373 K------------K-----ERLLVYSYLENGTLYDKLHP---AEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR 432 (618)
Q Consensus 373 ~------------~-----~~~lV~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 432 (618)
. . ..+++|+-+. ++|.+++.. .......+....++.+..|+++.+++||+. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1 1 2367788774 488777542 111112344556677889999999999999 99999
Q ss_pred CCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC--------CCCCCccchHHHHHHHHH
Q 007088 433 NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT--------LVATPKGDVYSFGVVLLE 504 (618)
Q Consensus 433 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwS~Gvil~e 504 (618)
||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|++|+++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999999999887765432111 114577999996532 357889999999999999
Q ss_pred HHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCC
Q 007088 505 LITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKER 573 (618)
Q Consensus 505 lltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 573 (618)
|.+|+.||........... .+. . ..+.++.+..||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~---------------------~f~-~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW---------------------DFS-R-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG---------------------GGT-T-SS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc---------------------cch-h-cCCcCHHHHHHHHHHccCCcccC
Confidence 9999999986433211100 111 1 12556677778889999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=194.63 Aligned_cols=184 Identities=26% Similarity=0.286 Sum_probs=156.0
Q ss_pred EeecCCeeEEEEE----eCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEeecCC
Q 007088 314 IGTGRTGATYIAM----LPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 314 lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+|+|.||.|+++. .+.|..+|+|..++.. ........|..++...+ ||.+|++...+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999876 3457889999886532 11114556778888886 99999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|.|...+..... +.+.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 82 g~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999998876643 67777788888999999999999 9999999999999999999999999999876432221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHL 514 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~ 514 (618)
+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 154 -------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 5899999999988 457899999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=165.45 Aligned_cols=136 Identities=17% Similarity=0.169 Sum_probs=105.7
Q ss_pred CCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccC-ccCHHHHHHHHHHHhcC-----CCCCccceeEEEEeCC---eeE-
Q 007088 308 FSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDS-QHSEKEFLSEINTLGSV-----RHRNLVPLLGFCVAKK---ERL- 377 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 377 (618)
++..+.||+|+||.||. .-.++.. +||++... ....+.+.+|+.+++++ +||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 3334444 68887643 33456799999999999 5799999999998873 333
Q ss_pred EEEee--cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecCCCCCCeeeCC----CCceEEc
Q 007088 378 LVYSY--LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGL-AWLHHNCNPRIIHRNISSKCILLDG----DFEPKLS 450 (618)
Q Consensus 378 lV~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~ 450 (618)
+|+|| +++|+|.+++.... +++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 56799999996532 4544 35678888777 999999 9999999999999974 3479999
Q ss_pred ccCcc
Q 007088 451 DFGLA 455 (618)
Q Consensus 451 DfG~a 455 (618)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=169.20 Aligned_cols=145 Identities=13% Similarity=0.108 Sum_probs=113.1
Q ss_pred HhhccCCCCcEEeecCCeeEEEEE--eCCCcEEEEEEeccCcc-------------------------CHHHHHHHHHHH
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAM--LPGGCFIMIKRLEDSQH-------------------------SEKEFLSEINTL 355 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~-------------------------~~~~~~~E~~~l 355 (618)
+-..-|.+.+.||+|++|.||+|. ..+|+.||+|+++.... ....+..|+..+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 333457889999999999999998 57899999999864321 012356899999
Q ss_pred hcCCCCC--ccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceec
Q 007088 356 GSVRHRN--LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR-IIHR 432 (618)
Q Consensus 356 ~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~ 432 (618)
.++.+.. +.+++++ ...++||||+++++|....... ..+.......++.|++.++++||+. + ++||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~ 173 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHG 173 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeC
Confidence 9997533 3444443 2358999999998887765322 2355666789999999999999999 9 9999
Q ss_pred CCCCCCeeeCCCCceEEcccCcccccC
Q 007088 433 NISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 433 Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
||||+||+++ ++.++|+|||.+....
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999 8899999999987544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-18 Score=170.82 Aligned_cols=200 Identities=18% Similarity=0.163 Sum_probs=139.5
Q ss_pred CCCCccceeEEEEeC---------------------------CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHH
Q 007088 359 RHRNLVPLLGFCVAK---------------------------KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIA 411 (618)
Q Consensus 359 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 411 (618)
+|||||++.++|.+. ...|+||..++. +|.+++..+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 599999999887642 235899998876 9999997654 5667778899
Q ss_pred HHHHHHHHHHHhCCCCCceecCCCCCCeee--CCCC--ceEEcccCcccccCCC--CCcccccccCCCCcccccCCCCCC
Q 007088 412 IGSARGLAWLHHNCNPRIIHRNISSKCILL--DGDF--EPKLSDFGLARLMNPV--DTHLSTFVNGEFGDLGYVAPEYPR 485 (618)
Q Consensus 412 ~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfG~a~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~~ 485 (618)
.|+++|+.|||++ ||.|||+|++|||+ |+|+ .+.|+|||.+---+.. ............|...-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 3443 4789999977432211 111111111233777889999876
Q ss_pred CCCC------CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHH
Q 007088 486 TLVA------TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFL 559 (618)
Q Consensus 486 ~~~~------~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 559 (618)
..+- -.|+|.|+.|.+.||+++...||+....... +...+.+ .. -+ ..++..+..+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L---~~r~Yqe-----~q-----LP----alp~~vpp~~r 487 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL---DTRTYQE-----SQ-----LP----ALPSRVPPVAR 487 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee---chhhhhh-----hh-----CC----CCcccCChHHH
Confidence 5431 3589999999999999999999986322100 0111100 00 01 11223344567
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 560 RVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 560 ~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
+++...|+.||.+|++..-....|+
T Consensus 488 qlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhHHH
Confidence 7888999999999999877666654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-17 Score=159.76 Aligned_cols=145 Identities=19% Similarity=0.182 Sum_probs=113.5
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc-----------------------CHHHHHHHHHHH
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH-----------------------SEKEFLSEINTL 355 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~E~~~l 355 (618)
.++......|...+.||+|+||.||++...+|+.||||++..... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445888899999999999999988899999998754321 112356788889
Q ss_pred hcCCCCC--ccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 007088 356 GSVRHRN--LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433 (618)
Q Consensus 356 ~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 433 (618)
.++.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++|||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 8887774 444443 2445899999999998765431 23467889999999999998 999999
Q ss_pred CCCCCeeeCCCCceEEcccCcccccCC
Q 007088 434 ISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 434 lkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
|||+||++++++.++|+|||.+.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=160.53 Aligned_cols=133 Identities=21% Similarity=0.286 Sum_probs=113.0
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCcc---------CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH---------SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+.||+|++|.||+|.. +|..|++|+...... ....+.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 667788997654221 123577899999999999998888887777888999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
++|++|.+++.... + .+..++.+++.+|.++|+. +++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999875321 2 7889999999999999999 999999999999999 78899999998864
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=182.19 Aligned_cols=141 Identities=18% Similarity=0.239 Sum_probs=114.0
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc--------cCHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ--------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 373 (618)
......|...+.||+|+||.||++.+.+...++.++..+.. ...+.+.+|++++.+++|++++....++.+.
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33445567789999999999999987555444333332211 1134588999999999999999888888877
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
+..++||||+++++|.+++. ....++.|++++|.|||+. +++||||||+||++ .++.++|+|||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 78899999999999988774 3467899999999999999 99999999999999 67799999999
Q ss_pred ccccc
Q 007088 454 LARLM 458 (618)
Q Consensus 454 ~a~~~ 458 (618)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 98753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-18 Score=186.90 Aligned_cols=210 Identities=20% Similarity=0.212 Sum_probs=139.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.+|+.++.|..|+||.||..+++ ..+.+|+|+=++.- +.+- ++.....|.+ |
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn--ilt~a~npfv---------------v----- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN--ILTFAGNPFV---------------V----- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc--cccccCCcce---------------e-----
Confidence 57888999999999999999864 46777875422211 1010 2222223332 2
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC--
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD-- 462 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 462 (618)
|+-...++..+. ++. +++.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 -gDc~tllk~~g~----lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP----LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhcccCCC----Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 344444443222 332 237899999999 99999999999999999999999999987532110
Q ss_pred --------Cccccc-ccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 463 --------THLSTF-VNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 463 --------~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
.....+ -...+||+.|+|||++..+.|+..+|+|++|+|+||.+.|..||..+..++.+...+...+...
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp- 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP- 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc-
Confidence 000111 1234799999999999999999999999999999999999999998765443322222111111
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH 574 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 574 (618)
+.......+..+++.+.|+.+|.+|-
T Consensus 279 ---------------E~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 279 ---------------EEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---------------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 01112223445555588999999994
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.5e-17 Score=156.38 Aligned_cols=129 Identities=22% Similarity=0.323 Sum_probs=106.6
Q ss_pred EEeecCCeeEEEEEeCCCcEEEEEEeccCc--c-------CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 313 IIGTGRTGATYIAMLPGGCFIMIKRLEDSQ--H-------SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 313 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.||+|++|.||+|.. ++..|++|...... . ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 56789999864321 1 1245778999999999888766666666777789999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+|++|.+.+.... ..++.+++.+|.+||+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988775321 07899999999999999 999999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-17 Score=172.24 Aligned_cols=126 Identities=26% Similarity=0.348 Sum_probs=106.6
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..|+.|++|...+|.+++...+. ....++...+.++.|++.|+.| + +.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 46899999999999999975442 2457888999999999999999 6 899999999999999999999999999
Q ss_pred ccccCCCCCc--ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh
Q 007088 455 ARLMNPVDTH--LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507 (618)
Q Consensus 455 a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt 507 (618)
.......... .........||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9876554311 1112234459999999999999999999999999999999997
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=138.73 Aligned_cols=136 Identities=18% Similarity=0.094 Sum_probs=115.6
Q ss_pred CCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCC--CCccceeEEEEeCCeeEEEEeecCCCc
Q 007088 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH--RNLVPLLGFCVAKKERLLVYSYLENGT 387 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gs 387 (618)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++++++++....+..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 35789999999999999755 7899999876544 5678999999999976 589999998888888999999999877
Q ss_pred cccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 388 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.+...
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 7654 45667788999999999999864447999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=4e-16 Score=148.19 Aligned_cols=136 Identities=18% Similarity=0.188 Sum_probs=99.4
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCH---HH----------------------HHHHHHHHhcCCCCC--c
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSE---KE----------------------FLSEINTLGSVRHRN--L 363 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~----------------------~~~E~~~l~~l~h~n--i 363 (618)
.+.||+|+||.||+|...+++.||||+++...... .. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999986532111 11 134555566654332 4
Q ss_pred cceeEEEEeCCeeEEEEeecCCCccccc-cCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeee
Q 007088 364 VPLLGFCVAKKERLLVYSYLENGTLYDK-LHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILL 441 (618)
Q Consensus 364 v~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll 441 (618)
.+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. . +|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 246899999998654322 11111 11 5678899999999999999 7 99999999999999
Q ss_pred CCCCceEEcccCcccccCC
Q 007088 442 DGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~ 460 (618)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5.3e-15 Score=145.46 Aligned_cols=135 Identities=19% Similarity=0.246 Sum_probs=105.4
Q ss_pred CcEEe-ecCCeeEEEEEeCCCcEEEEEEeccCc--------------cCHHHHHHHHHHHhcCCCCCc--cceeEEEEeC
Q 007088 311 NNIIG-TGRTGATYIAMLPGGCFIMIKRLEDSQ--------------HSEKEFLSEINTLGSVRHRNL--VPLLGFCVAK 373 (618)
Q Consensus 311 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 373 (618)
...|| .||.|+||.+... +..+++|++.... .....+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999885 6678888885311 123457889999999998875 6777765433
Q ss_pred C----eeEEEEeecCC-CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceE
Q 007088 374 K----ERLLVYSYLEN-GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448 (618)
Q Consensus 374 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 448 (618)
. ..++||||+++ .+|.+++... +++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6888887542 24433 357899999999999 999999999999999988999
Q ss_pred EcccCccccc
Q 007088 449 LSDFGLARLM 458 (618)
Q Consensus 449 l~DfG~a~~~ 458 (618)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-16 Score=173.46 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=186.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC--CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP--GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 379 (618)
..|...+.||+|.|+.|-..... ....+|+|.+.... ...+....|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 35666777999999999888753 34566777665432 23344555777777776 99999999999999999999
Q ss_pred EeecCCCcccccc-CCCCCCCcCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCCCCCCeeeCCCC-ceEEcccCccc
Q 007088 380 YSYLENGTLYDKL-HPAEHEVMHMDWPLRLRIAIGSARGLAWLH-HNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLAR 456 (618)
Q Consensus 380 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~ 456 (618)
++|..++++.+.+ +... ...+......++.|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999988 4332 13566677889999999999999 77 999999999999999999 99999999998
Q ss_pred ccCC-CCCcccccccCCCC-cccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 457 LMNP-VDTHLSTFVNGEFG-DLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 457 ~~~~-~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
.... .... ......+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|....
T Consensus 174 ~~~~~~g~~--~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---~~~~~~~~~- 247 (601)
T KOG0590|consen 174 AYRNKNGAE--RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---RYSSWKSNK- 247 (601)
T ss_pred cccccCCcc--eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---cceeecccc-
Confidence 7765 2222 22334557 9999999998874 456789999999999999999999986544321 111121110
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVY 580 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 580 (618)
... ....+........++..+++..+|..|.+.+++-
T Consensus 248 --~~~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 --GRF--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --ccc--------ccCccccCChhhhhcccccccCCchhcccccccc
Confidence 000 0001122223445566689999999999988874
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-14 Score=141.13 Aligned_cols=161 Identities=22% Similarity=0.314 Sum_probs=121.8
Q ss_pred HHHHHHhcCCCCCccceeEEEEeCC-----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhC
Q 007088 350 SEINTLGSVRHRNLVPLLGFCVAKK-----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424 (618)
Q Consensus 350 ~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~ 424 (618)
.-..-+-++.|.|||++..|+.+.. +..++.||+..|++.++|++.......+......+|+.||..||.|||+
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 3344556667999999999987643 4679999999999999998776666778888999999999999999999
Q ss_pred CCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHH
Q 007088 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLE 504 (618)
Q Consensus 425 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~e 504 (618)
|.|+|+|+++..+-|++..+|-+|+.----...................+-++|.+||+-.....+.++|||+||...+|
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 57889999999999999999888875321111000000000000111225689999999887788889999999999999
Q ss_pred HHhCCCC
Q 007088 505 LITGERP 511 (618)
Q Consensus 505 lltG~~P 511 (618)
|..+..-
T Consensus 275 mailEiq 281 (458)
T KOG1266|consen 275 MAILEIQ 281 (458)
T ss_pred HHHheec
Confidence 9887643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.7e-14 Score=161.11 Aligned_cols=93 Identities=41% Similarity=0.681 Sum_probs=89.0
Q ss_pred CCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccccccccc
Q 007088 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSV 186 (618)
Q Consensus 107 ~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l 186 (618)
.++.|+|++|.|+|.+|..+.. |++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..++++++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~-L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISK-LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhC-CCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 5889999999999999999976 999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCc
Q 007088 187 ASNLLTGPVPSFAN 200 (618)
Q Consensus 187 ~~N~l~g~ip~~~~ 200 (618)
++|+|+|.+|....
T Consensus 498 s~N~l~g~iP~~l~ 511 (623)
T PLN03150 498 NGNSLSGRVPAALG 511 (623)
T ss_pred cCCcccccCChHHh
Confidence 99999999998544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3e-13 Score=144.49 Aligned_cols=141 Identities=18% Similarity=0.150 Sum_probs=100.6
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccC-----------------------------------------HHHHH
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS-----------------------------------------EKEFL 349 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~~ 349 (618)
.+.||+|++|.||+|++.+|+.||||+.+..-.. +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4689999999999999999999999998643100 00244
Q ss_pred HHHHHHhcCC----CCCccceeEEEE-eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHH-HHHHHHh
Q 007088 350 SEINTLGSVR----HRNLVPLLGFCV-AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR-GLAWLHH 423 (618)
Q Consensus 350 ~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~ 423 (618)
+|...+.+++ |.+-+.+-.++. .....++||||++|++|.+....... .. .+..++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 5555555542 322233322332 23457999999999999887643211 12 23456666666 4788999
Q ss_pred CCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 424 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
. |++|+|+||.||+++.+++++++|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 8 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-14 Score=128.22 Aligned_cols=127 Identities=24% Similarity=0.395 Sum_probs=112.5
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
...++.|.|++|.++ .+|+.|..|.+|+.|+|++|++. .+|.++.+ |++|++|+++-|++. .+|..||.++.|+.|
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~iss-l~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISS-LPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhh-chhhhheecchhhhh-cCccccCCCchhhhh
Confidence 467899999999999 89999999999999999999999 89999987 999999999999999 899999999999999
Q ss_pred EccCcccCC-CCCccccccccccccccccccccCCCCCCCcc-ccccccccCC
Q 007088 161 KLNNNRFTG-KIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANN 211 (618)
Q Consensus 161 ~l~~N~l~g-~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n 211 (618)
||+.|+++- .+|..|..+..|+.|+|++|.|.-..|....+ ++.-+.+..|
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccC
Confidence 999999975 47999999999999999999998777765543 3444444444
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-12 Score=140.38 Aligned_cols=144 Identities=15% Similarity=0.180 Sum_probs=95.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC-CcEEEEEEeccCcc---------------------------C--------HH---
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQH---------------------------S--------EK--- 346 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------------------------~--------~~--- 346 (618)
.+|+. +.||+|++|.||+|++.+ |+.||||+.+..-. . .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45776 789999999999999877 99999999964310 0 01
Q ss_pred ---HHHHHHHHHhcCC----CCCccceeEEEEe-CCeeEEEEeecCCCccccc--cCCCCCCCcCCCHHHHHHHHHHHHH
Q 007088 347 ---EFLSEINTLGSVR----HRNLVPLLGFCVA-KKERLLVYSYLENGTLYDK--LHPAEHEVMHMDWPLRLRIAIGSAR 416 (618)
Q Consensus 347 ---~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~l~~~~~~~i~~~i~~ 416 (618)
++.+|+..+.+++ +.+.+.+-.++.+ ....++||||++|+.+.+. +...+.....+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 2344554444442 3444444444433 4567899999999999774 2222111112222223333333
Q ss_pred HHHHHHhCCCCCceecCCCCCCeeeCCCC----ceEEcccCcccccCC
Q 007088 417 GLAWLHHNCNPRIIHRNISSKCILLDGDF----EPKLSDFGLARLMNP 460 (618)
Q Consensus 417 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~a~~~~~ 460 (618)
++.. |++|+|+||.||+++.++ +++++|||++..++.
T Consensus 276 ----if~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3446 999999999999999888 999999999976643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=121.31 Aligned_cols=131 Identities=16% Similarity=0.113 Sum_probs=97.8
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCcc-ceeEEEEeCCeeEEEEeecCCCccc
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLV-PLLGFCVAKKERLLVYSYLENGTLY 389 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gsL~ 389 (618)
.+.++.|.++.||++... +..|++|...........+.+|+.++..+.+.+++ +++.+. ....++||||++|.++.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 456889999999999875 67899999866543334567899999988655544 455443 33458999999998876
Q ss_pred cccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC--NPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 390 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+. . . ....++.+++++|+.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~----~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE----D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 53 0 0 11345678999999999982 12359999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.3e-13 Score=139.56 Aligned_cols=249 Identities=20% Similarity=0.193 Sum_probs=178.8
Q ss_pred cCCCCcEEee--cCCeeEEEEEe---CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeE
Q 007088 307 SFSKNNIIGT--GRTGATYIAML---PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 307 ~y~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 377 (618)
.|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.. ......=.+|+....++ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999985 46788999884321 12222234666666667 4999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDF 452 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 452 (618)
+-+|++. .+|.++.+... ..++....+.+..+..+ |+.++|+. +++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999985 58888876544 23666777788888888 99999999 99999999999999999 88999999
Q ss_pred CcccccCCCCCcccccccCC-CCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGE-FGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|+...+.............. .|...|++||...+ .++.++|+|++|.++.+..+|..+...... ..|...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQL 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--------CCcccc
Confidence 99988876543222221122 47788999998754 568999999999999999998877654311 111110
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
- ... +..++.......+...+..+++.+|..|++.+.+..
T Consensus 339 r----~~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 R----QGY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c----ccc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 000 111111122233344777899999999999887754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.2e-13 Score=122.02 Aligned_cols=130 Identities=26% Similarity=0.415 Sum_probs=108.4
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCc-cccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLS-GSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~-g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~ 159 (618)
..++..|++.-|+|. .+|..||.++.|+.|||++|+++ ..+|..++. ++.|+.|+|+.|.|. .+|..+++|++|+.
T Consensus 78 l~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~-m~tlralyl~dndfe-~lp~dvg~lt~lqi 154 (264)
T KOG0617|consen 78 LPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFY-MTTLRALYLGDNDFE-ILPPDVGKLTNLQI 154 (264)
T ss_pred chhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhH-HHHHHHHHhcCCCcc-cCChhhhhhcceeE
Confidence 346777788778877 78888999999999999998886 468888886 888999999999998 89999999999999
Q ss_pred EEccCcccCCCCCccccccccccccccccccccCCCCCCCccc----cccccccCCCCC
Q 007088 160 LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN----FTAEDFANNSGL 214 (618)
Q Consensus 160 l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~----~~~~~~~~n~~~ 214 (618)
|.+..|.+- ++|.+++.++.|+.|++.+|+|+-..|....+. -......+|||.
T Consensus 155 l~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 155 LSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred EeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 999999998 799999999999999999999998888765532 223355666654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.3e-11 Score=113.47 Aligned_cols=137 Identities=16% Similarity=0.132 Sum_probs=100.4
Q ss_pred CcEEeecCCeeEEEEEeCC-------CcEEEEEEeccCc-----------------------cCHHHHH----HHHHHHh
Q 007088 311 NNIIGTGRTGATYIAMLPG-------GCFIMIKRLEDSQ-----------------------HSEKEFL----SEINTLG 356 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----------------------~~~~~~~----~E~~~l~ 356 (618)
...||.|--+.||.|...+ +..+|||+++.+. ...+.+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998543 5799999884210 0012233 8999999
Q ss_pred cCCC--CCccceeEEEEeCCeeEEEEeecCCCcccc-ccCCCCCCCcCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceec
Q 007088 357 SVRH--RNLVPLLGFCVAKKERLLVYSYLENGTLYD-KLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNCNPRIIHR 432 (618)
Q Consensus 357 ~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~ 432 (618)
++.. -++.+++++ ...++||||+.++.+.. .+.. ..++..+...+..+++.+|.+| |+. +|+|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9853 466677765 45689999997654322 2221 1244556677889999999999 787 99999
Q ss_pred CCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 433 NISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 433 Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||++.||+++ ++.++|+|||.+.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 46899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.3e-10 Score=113.21 Aligned_cols=142 Identities=20% Similarity=0.261 Sum_probs=112.5
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc--CHHHHHHHHHHHhcCCC--CCccceeEEEEeCC---eeEEEEeec
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH--SEKEFLSEINTLGSVRH--RNLVPLLGFCVAKK---ERLLVYSYL 383 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lV~e~~ 383 (618)
.+.|+.|.++.||++...+|..+++|....... ....+.+|.++++.+++ .++.+++.+..... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 356899999999999987778999999865432 45578899999999975 34677787776542 568999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC-------------------------------------- 425 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 425 (618)
+|.++.+.+.. ..++......++.+++++|.+||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99988876642 23677888889999999999998631
Q ss_pred ---------------CCCceecCCCCCCeeeCC--CCceEEcccCcccc
Q 007088 426 ---------------NPRIIHRNISSKCILLDG--DFEPKLSDFGLARL 457 (618)
Q Consensus 426 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~ 457 (618)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 66689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.5e-13 Score=133.15 Aligned_cols=122 Identities=19% Similarity=0.314 Sum_probs=96.9
Q ss_pred EEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCc-CCCCCcEEEccC
Q 007088 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLA-NCTFLNVLKLNN 164 (618)
Q Consensus 86 ~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~-~l~~L~~l~l~~ 164 (618)
.||...|-| +++|++++.|.+|..|||..|++. .+| ++.+ ++.|+.|+++.|++. .+|.+.+ +|++|.+|||.+
T Consensus 187 ~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~g-cs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRd 261 (565)
T KOG0472|consen 187 HLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FLP-EFPG-CSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRD 261 (565)
T ss_pred hcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cCC-CCCc-cHHHHHHHhcccHHH-hhHHHHhcccccceeeeccc
Confidence 344433333 467777777777777777777777 677 4554 677777777777777 7777766 899999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCCC
Q 007088 165 NRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSG 213 (618)
Q Consensus 165 N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~ 213 (618)
|++. ++|.++..+.+|.+||+|+|.+++..++..++.+..+.+.|||.
T Consensus 262 Nklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNPl 309 (565)
T KOG0472|consen 262 NKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNPL 309 (565)
T ss_pred cccc-cCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCch
Confidence 9999 89999999999999999999999999998888888888999963
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-11 Score=130.40 Aligned_cols=248 Identities=19% Similarity=0.184 Sum_probs=173.9
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe--CCCcEEEEEEeccCccC---HHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML--PGGCFIMIKRLEDSQHS---EKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
..+.+|..+..||.|.|+.|+.... .++..|++|.+.+.-.. ...-..|+.+...+ .|.++++....+...++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788899999999999999873 56889999988654311 11123566555555 588899888877777788
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCcc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLA 455 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a 455 (618)
|+--||++++++...+... ..++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+
T Consensus 342 ~ip~e~~~~~s~~l~~~~~----~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTS----QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhHHH----HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 8999999999887665222 3477788899999999999999999 99999999999999886 78899999998
Q ss_pred cccCCCCCcccccccCCCCcccc-cCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGY-VAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
..+.-...... ..+..| .+|+......+..+.|+||||..+.|.+++...-.... +|.....
T Consensus 415 t~~~~~~~~~~------~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~~i~~- 477 (524)
T KOG0601|consen 415 TRLAFSSGVFH------HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSLTIRS- 477 (524)
T ss_pred cccceeccccc------ccccccccchhhccccccccccccccccccccccccCcccCcccc----------cceeeec-
Confidence 75332111110 023334 35666667788899999999999999999875432211 1111100
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
...... ......+..+...+...++..||.+.+.....+-
T Consensus 478 ----------~~~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 478 ----------GDTPNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----------ccccCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000000 1112455666668888999999999887655443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.9e-12 Score=133.55 Aligned_cols=109 Identities=29% Similarity=0.446 Sum_probs=80.3
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
...++.||||+|+|. ..|..+.+-+++-.|+||+|++. +||..++-+|+-|-+||||+|+|. .+|+.+..|..|++|
T Consensus 102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 345777888888887 67777777788888888888887 788877777888888888888887 778777777777777
Q ss_pred EccCcccC-------------------------CCCCcccccccccccccccccccc
Q 007088 161 KLNNNRFT-------------------------GKIPPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 161 ~l~~N~l~-------------------------g~~p~~l~~~~~L~~l~l~~N~l~ 192 (618)
+||+|.+. ..+|.++..+.+|..+++|.|+|.
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp 235 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP 235 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence 77777543 245566666666666666666664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.9e-10 Score=121.19 Aligned_cols=165 Identities=16% Similarity=0.187 Sum_probs=124.4
Q ss_pred eCCCcEEEEEEeccCcc-CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHH
Q 007088 327 LPGGCFIMIKRLEDSQH-SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWP 405 (618)
Q Consensus 327 ~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~ 405 (618)
..++.+|.|..++.... ......+-++.|+.+|||||+++++.+...+..|+|+|-+. .|..++.. +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 55778888888765443 23446778889999999999999999999999999999884 45555543 2345
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCC
Q 007088 406 LRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485 (618)
Q Consensus 406 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 485 (618)
.....+.||+.||.|||+.| +++|++|.-+-|+++..|+.||++|.++............ ..--..|..|+.+.
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~----~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS----LYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc----chhhhcccChhhcC
Confidence 56677899999999999776 8999999999999999999999999888655432210000 01123466666543
Q ss_pred CCCCCCccchHHHHHHHHHHHhC
Q 007088 486 TLVATPKGDVYSFGVVLLELITG 508 (618)
Q Consensus 486 ~~~~~~~sDVwS~Gvil~elltG 508 (618)
... ...|.|-||++++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 221 456999999999999999
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.16 E-value=3.6e-12 Score=126.83 Aligned_cols=127 Identities=27% Similarity=0.359 Sum_probs=77.8
Q ss_pred cEEEEEecCCcce-----------------------eeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEee
Q 007088 83 KVLNIRLSDMGLK-----------------------GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLS 139 (618)
Q Consensus 83 ~v~~l~l~~~~l~-----------------------g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~ 139 (618)
-|+.++++.|++. +.+|..+..+++|+.|+|++|-+. .+|.+.+. +..|+.||+|
T Consensus 389 ~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~-lv~Lq~LnlS 466 (565)
T KOG0472|consen 389 IVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS-LVRLQTLNLS 466 (565)
T ss_pred ceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhh-hhhhheeccc
Confidence 3888888888654 345566677777777777777777 77777776 7777777777
Q ss_pred CCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcc-ccccccccccccccccccCCCCCCCcc-ccccccccCCCC
Q 007088 140 SNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNSG 213 (618)
Q Consensus 140 ~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~-l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~ 213 (618)
+|+|. .+|..+-.+..|+.+-.++|++. .+|++ +.++.+|.+|||.+|.+.-.+|..... ++..+.+.|||.
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 77776 55554444444444444444443 33333 556666666666666665544443332 455556666653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.5e-10 Score=102.79 Aligned_cols=130 Identities=24% Similarity=0.354 Sum_probs=100.3
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEE-EeccCc--------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIK-RLEDSQ--------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
..+++|+-+.+|.+.+.+.. +++| +.++.. -......+|+.++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764444 5555 444321 1124467899999998766666666666777888899999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
++|-.|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888654 245677788888899999 999999999999998774 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.7e-10 Score=101.97 Aligned_cols=143 Identities=20% Similarity=0.236 Sum_probs=105.2
Q ss_pred CCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc--------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ--------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
....+-+|+-+.|+++...+...++-+++.+.. -..++..+|++.+.+++--.|.-..-++.+...-.++||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 467899999999999998554444444554321 234567899999999976666655666777777789999
Q ss_pred ecCC-CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC---ceEEcccCcccc
Q 007088 382 YLEN-GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF---EPKLSDFGLARL 457 (618)
Q Consensus 382 ~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~ 457 (618)
|++| -++.+++...... .........++.+|-+.+.-||.. +|+|+||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9976 3677776543321 122223367888999999999999 999999999999996554 358999999853
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.4e-12 Score=136.04 Aligned_cols=129 Identities=26% Similarity=0.368 Sum_probs=112.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..+..|.|.+|.|+...=+-|.+..+|+.|+|++|+|. ++|+....++..|+.|+||+|+|+ .||..+.++..|++|.
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 36778899999999888888999999999999999999 899988888999999999999999 8999999999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCC-CCCCCc-cccccccccCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP-VPSFAN-VNFTAEDFANNSGL 214 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~-ip~~~~-~~~~~~~~~~n~~~ 214 (618)
..+|++. .+| ++.++++|+.+||+.|+|+-. +|.... .++..++++||.++
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9999998 678 889999999999999999753 443322 46788899999863
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-10 Score=115.49 Aligned_cols=88 Identities=20% Similarity=0.227 Sum_probs=61.2
Q ss_pred CCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--ccccccc
Q 007088 130 LQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAED 207 (618)
Q Consensus 130 l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~ 207 (618)
|++|+.|+|++|++++.-+.+|..+..|+.|+|..|+|.-.--..|.++++|++|+|.+|+++-.-|.+++ ..+..+.
T Consensus 273 L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~ 352 (498)
T KOG4237|consen 273 LPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLN 352 (498)
T ss_pred cccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeee
Confidence 45566666666666655556666666666666666666533334566778888888888988888886544 2567788
Q ss_pred ccCCCCCCCC
Q 007088 208 FANNSGLCGK 217 (618)
Q Consensus 208 ~~~n~~~c~~ 217 (618)
+.+||+.|.+
T Consensus 353 l~~Np~~CnC 362 (498)
T KOG4237|consen 353 LLSNPFNCNC 362 (498)
T ss_pred hccCcccCcc
Confidence 8899999875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-11 Score=127.28 Aligned_cols=115 Identities=34% Similarity=0.513 Sum_probs=97.4
Q ss_pred CcEEEEEecCCccee-eCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCC-cCCCCCcE
Q 007088 82 NKVLNIRLSDMGLKG-QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNV 159 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g-~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~-~~l~~L~~ 159 (618)
.+++++.+..|+|.. .||+.|.+|..|+.||||+|+|. ..|.++-. -+++.+|+||+|++. +||.++ .+|+.|-.
T Consensus 78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~-AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEY-AKNSIVLNLSYNNIE-TIPNSLFINLTDLLF 154 (1255)
T ss_pred hhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhh-hcCcEEEEcccCccc-cCCchHHHhhHhHhh
Confidence 456677777787753 58999999999999999999999 89998864 889999999999999 899874 58999999
Q ss_pred EEccCcccCCCCCccccccccccccccccccccC----CCCCCCc
Q 007088 160 LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG----PVPSFAN 200 (618)
Q Consensus 160 l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g----~ip~~~~ 200 (618)
||||+|++. .+|+.+..+..|++|.|++|.|.- .+|+...
T Consensus 155 LDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmts 198 (1255)
T KOG0444|consen 155 LDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTS 198 (1255)
T ss_pred hccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchh
Confidence 999999998 789999999999999999998853 5675443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.6e-11 Score=130.61 Aligned_cols=209 Identities=21% Similarity=0.229 Sum_probs=143.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCcc----CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQH----SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
..+.+.+.+-+.+|.++.++.+. ...|...+.|....... ..+....+-.++-.-++|-+++..--+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45567777788899999998877 22343334443332211 11122223222222344555554444445567789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|++|+.+++|...++.... .+..-.......+..+++|||.. .+.|+|++|.|++...+++.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999887652 44444555666788899999998 7999999999999999999999999844332
Q ss_pred CCC---------------------CCc---cc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCC
Q 007088 459 NPV---------------------DTH---LS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511 (618)
Q Consensus 459 ~~~---------------------~~~---~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~P 511 (618)
.-. ... .. .......||+.|.+||...+......+|.|+.|++++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 110 000 00 001123489999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 007088 512 THLTNAPE 519 (618)
Q Consensus 512 f~~~~~~~ 519 (618)
|.......
T Consensus 1035 ~na~tpq~ 1042 (1205)
T KOG0606|consen 1035 FNAETPQQ 1042 (1205)
T ss_pred CCCcchhh
Confidence 98765543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.8e-11 Score=123.36 Aligned_cols=134 Identities=22% Similarity=0.276 Sum_probs=101.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCC---CcCCCCCc
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG---LANCTFLN 158 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~---~~~l~~L~ 158 (618)
.++..|+|++|+|+.--+.+|.-|+.|+.|+|+.|+++ .|-+..+..+++|+.|||++|.+++.|-.. +..|++|+
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr 395 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR 395 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh
Confidence 46777777777777666666777777788888888777 666666666888999999999999888643 66788999
Q ss_pred EEEccCcccCCCCC-ccccccccccccccccccccCCCCCCC-ccccccccccCCCCCCCC
Q 007088 159 VLKLNNNRFTGKIP-PQLGLLNRIKTFSVASNLLTGPVPSFA-NVNFTAEDFANNSGLCGK 217 (618)
Q Consensus 159 ~l~l~~N~l~g~~p-~~l~~~~~L~~l~l~~N~l~g~ip~~~-~~~~~~~~~~~n~~~c~~ 217 (618)
.|+|.+|++. .|| .+|..+.+|+.|+|.+|.+...-|..+ ..++..+-+..-+.+|.+
T Consensus 396 kL~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 396 KLRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDC 455 (873)
T ss_pred heeecCceee-ecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEec
Confidence 9999999998 565 468889999999999999887777533 345555555555566665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.1e-09 Score=99.70 Aligned_cols=125 Identities=18% Similarity=0.193 Sum_probs=83.7
Q ss_pred eEEEEEeCCCcEEEEEEeccCc--------------c-------------CHHHHHHHHHHHhcCCCC--CccceeEEEE
Q 007088 321 ATYIAMLPGGCFIMIKRLEDSQ--------------H-------------SEKEFLSEINTLGSVRHR--NLVPLLGFCV 371 (618)
Q Consensus 321 ~Vy~~~~~~~~~vavK~~~~~~--------------~-------------~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 371 (618)
.||.|...+|..+|+|+.+... . ......+|.+.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999999999999984310 0 013467899999999765 566776552
Q ss_pred eCCeeEEEEeecC--CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceecCCCCCCeeeCCCCceE
Q 007088 372 AKKERLLVYSYLE--NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW-LHHNCNPRIIHRNISSKCILLDGDFEPK 448 (618)
Q Consensus 372 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k 448 (618)
...+||||++ |..+..+. ... ++......++.+++..+.. +|.. ||+|+||.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-DVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-HCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHH-hcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3579999998 54444332 221 1123456677888886666 4677 99999999999999988 999
Q ss_pred EcccCcccccC
Q 007088 449 LSDFGLARLMN 459 (618)
Q Consensus 449 l~DfG~a~~~~ 459 (618)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.4e-11 Score=126.02 Aligned_cols=123 Identities=28% Similarity=0.409 Sum_probs=109.1
Q ss_pred EEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccC
Q 007088 85 LNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164 (618)
Q Consensus 85 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~ 164 (618)
..+.|..|.+. .||..+++|..|++|||+.|+++ .+|..++. |+ |+.|-+++|+++ .+|..++.+..|..||.+.
T Consensus 101 e~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~-lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~ 175 (722)
T KOG0532|consen 101 ESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCD-LP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSK 175 (722)
T ss_pred HHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhc-Cc-ceeEEEecCccc-cCCcccccchhHHHhhhhh
Confidence 34455555565 78999999999999999999999 89999986 77 999999999999 8999999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCCC
Q 007088 165 NRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSG 213 (618)
Q Consensus 165 N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~ 213 (618)
|++. .+|+.++.+.+|+.|++..|++.-..+....+.+-.+||+.|.-
T Consensus 176 nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNki 223 (722)
T KOG0532|consen 176 NEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKI 223 (722)
T ss_pred hhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCce
Confidence 9998 89999999999999999999999888877777788888988864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.8e-11 Score=123.40 Aligned_cols=130 Identities=22% Similarity=0.162 Sum_probs=98.4
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.++..|+|+.|+++..-..++.+|++|+.||||+|.+..--++.+. ..++|+.|+||+|+++--=|.++..|..|++|+
T Consensus 269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Ws-ftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln 347 (873)
T KOG4194|consen 269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWS-FTQKLKELDLSSNRITRLDEGSFRVLSQLEELN 347 (873)
T ss_pred cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhh-hcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence 4677888888888877777888899999999999998855556554 378899999999999844445678888888888
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc----c-ccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN----V-NFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~----~-~~~~~~~~~n~ 212 (618)
|++|+++-.--..|..+++|+.|||.+|.+++.|-.... + .+..++|.||.
T Consensus 348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 888888855556677888888999999998888764221 1 34455666664
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=1e-08 Score=102.13 Aligned_cols=140 Identities=15% Similarity=0.059 Sum_probs=101.1
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCc------------cCHHHHHHHHHHHhcCCCCC--ccceeEEEEe-----
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ------------HSEKEFLSEINTLGSVRHRN--LVPLLGFCVA----- 372 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 372 (618)
+.+-.-....|++... +|+.|.||+..... .....+.+|...+.++...+ .++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444455777666 66789999774322 11124778999988885443 3445666543
Q ss_pred CCeeEEEEeecCCC-ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-------C
Q 007088 373 KKERLLVYSYLENG-TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-------D 444 (618)
Q Consensus 373 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~ 444 (618)
....++|+|++++- +|.+++..... .+.+...+..++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23568999999875 78888753211 2355677789999999999999999 9999999999999975 4
Q ss_pred CceEEcccCcccc
Q 007088 445 FEPKLSDFGLARL 457 (618)
Q Consensus 445 ~~~kl~DfG~a~~ 457 (618)
+.+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998854
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=7.2e-09 Score=116.92 Aligned_cols=116 Identities=26% Similarity=0.428 Sum_probs=87.9
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
+.+.|+|++++|+ .+|..+. ++|+.|+|++|+|+ .+|..++ ++|+.|+|++|+|+ .||..+. ++|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 3568999999988 5787664 57999999999999 7888664 57889999999998 6787654 46888888
Q ss_pred cCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 212 (618)
++|++. .+|..+. ++|+.|++++|+|+. +|.....++..+++++|.
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~~sL~~L~Ls~N~ 294 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLPEELRYLSVYDNS 294 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccCCCCcEEECCCCc
Confidence 888887 6777664 578888888888884 554322256667777774
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.4e-08 Score=103.43 Aligned_cols=169 Identities=22% Similarity=0.317 Sum_probs=128.0
Q ss_pred CeeEEEEE-eCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeeEEEEeecCC-Cccccc
Q 007088 319 TGATYIAM-LPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVA----KKERLLVYSYLEN-GTLYDK 391 (618)
Q Consensus 319 ~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~ 391 (618)
..+.|++. ..||..|++||++..+ ........-++.++++.|+|+|++.+++.. +...++||+|+|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789998 5689999999995433 122233456788999999999999998863 3467899999985 567665
Q ss_pred cCCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 392 LHPAEH-----------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 392 l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
-..... .....++...|.++.|+..||.++|+. |+.-+-|.+.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 432211 124477899999999999999999999 999999999999999999999998887765543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~P 511 (618)
... |-+.+ -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT------------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC------------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 221 11111 2367888999999999999654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.4e-10 Score=102.28 Aligned_cols=104 Identities=27% Similarity=0.401 Sum_probs=33.0
Q ss_pred cEEEEEecCCcceeeCCcCCC-CCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCC-cCCCCCcEE
Q 007088 83 KVLNIRLSDMGLKGQFPRGIE-RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVL 160 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~-~~l~~L~~l 160 (618)
+++.|+|.+|+++ .|. .++ .|++|+.|||++|.++ .|+. +.. |++|+.|+|++|+++ .++..+ ..+++|+.|
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~-L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLEG-LPG-LPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-cccC-ccC-hhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 4567777777776 343 455 4677777777777777 5653 433 777777777777777 455444 357777777
Q ss_pred EccCcccCCCC-Ccccccccccccccccccccc
Q 007088 161 KLNNNRFTGKI-PPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 161 ~l~~N~l~g~~-p~~l~~~~~L~~l~l~~N~l~ 192 (618)
+|++|++...- =..+..+++|+.|+|.+|.++
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 77777776311 123556666777776666654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.4e-09 Score=82.53 Aligned_cols=61 Identities=41% Similarity=0.581 Sum_probs=40.8
Q ss_pred CCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCccc
Q 007088 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRF 167 (618)
Q Consensus 106 ~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l 167 (618)
++|++|+|++|+++ .||+..+.++++|++|+|++|+++..-|..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 35667777777777 66666655677777777777777644445567777777777777764
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.2e-07 Score=95.89 Aligned_cols=265 Identities=15% Similarity=0.133 Sum_probs=156.3
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEE----E--EeCC-eeEEEEee
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGF----C--VAKK-ERLLVYSY 382 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~----~--~~~~-~~~lV~e~ 382 (618)
...||+|+.+.+|-.--- .-.+-|+++......+. +.++.|... .||-+-.-+.+ . -+.. ..-+.|+.
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a--qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA--QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchh--hchhheeecCCCchHHH--HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 567999999999965321 11245777654322211 223333333 45544331111 1 1112 24577887
Q ss_pred cCCCc-cccccCCC--CCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 383 LENGT-LYDKLHPA--EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gs-L~~~l~~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
+++.. ...+.... +..-....|...++.++.++.+.+.||.. |.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~- 167 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN- 167 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec-
Confidence 76531 22222211 11224578999999999999999999999 9999999999999999999999985433322
Q ss_pred CCCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCccccCHHHHHHHHh
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITG-ERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG-~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
..+... ...+|...|.+||... +..-+...|-|.+||++++++.| ++||...........-...-..
T Consensus 168 ~ng~~~----~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia--- 240 (637)
T COG4248 168 ANGTLH----LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA--- 240 (637)
T ss_pred cCCceE----ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh---
Confidence 222222 2344889999999644 44557789999999999999986 9999764322111111110000
Q ss_pred cCCccchhcccc--cc----CCCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHHhhhhcC
Q 007088 534 TNSSLETAIDKS--LL----GNGFDGELHQFLRVACNCVLP--TPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 534 ~~~~~~~~~d~~--l~----~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
.+.....-+.. +. .-..+--...+..+..+|+.. ++.-|||++-.+..|.++.++..
T Consensus 241 -~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 241 -HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred -cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00000000000 00 000111223344444478754 47799999999999998877643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.6e-08 Score=95.06 Aligned_cols=144 Identities=19% Similarity=0.189 Sum_probs=102.8
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc-----------------------cCHHHHHHHHHHH
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ-----------------------HSEKEFLSEINTL 355 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~E~~~l 355 (618)
..+.+-..-+.+..+||-|--+.||.|..+.|.++|||.=+... ......++|.++|
T Consensus 84 ~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L 163 (304)
T COG0478 84 HALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEAL 163 (304)
T ss_pred HHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHH
Confidence 33333333345678999999999999999999999999642110 1123457899999
Q ss_pred hcCCCC--CccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 007088 356 GSVRHR--NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433 (618)
Q Consensus 356 ~~l~h~--niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D 433 (618)
.++... .+.+.+++ +...+||||++|-.|...- ++....-.++..|+.-+.-+-.. ||||+|
T Consensus 164 ~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGD 227 (304)
T COG0478 164 QRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGD 227 (304)
T ss_pred HHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccC
Confidence 999654 67777765 4568999999986554432 12223344555555555555566 999999
Q ss_pred CCCCCeeeCCCCceEEcccCccccc
Q 007088 434 ISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 434 lkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
+++-||+++++|.+.++||--+...
T Consensus 228 lSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 228 LSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CchheEEEecCCCEEEEeCcccccC
Confidence 9999999999999999999766543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=4.9e-09 Score=118.26 Aligned_cols=99 Identities=26% Similarity=0.486 Sum_probs=73.0
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .||..+. .+|+.|+|++|++. .||..+. ++|+.|+
T Consensus 199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 46788999999999 6787664 58889999999888 6887653 35777778877777 6776654 4677777
Q ss_pred ccCcccCCCCCccccccccccccccccccccC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g 193 (618)
|++|+|+ .+|..+. .+|+.|+|++|+|++
T Consensus 269 Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~ 297 (754)
T PRK15370 269 LFHNKIS-CLPENLP--EELRYLSVYDNSIRT 297 (754)
T ss_pred CcCCccC-ccccccC--CCCcEEECCCCcccc
Confidence 7777777 4666553 467777777777765
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.3e-09 Score=119.05 Aligned_cols=114 Identities=25% Similarity=0.275 Sum_probs=68.2
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
.++.|+|++|+|++ +|... .+|+.|++++|+|+ .||.. +++|+.|+|++|+|+ .+|... ++|+.|+|
T Consensus 343 ~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdL 409 (788)
T PRK15387 343 GLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLT-SLPVLP---SELKELMV 409 (788)
T ss_pred ccceEecCCCccCC-CCCCC---cccceehhhccccc-cCccc----ccccceEEecCCccc-CCCCcc---cCCCEEEc
Confidence 45566666666663 44322 34445555555555 35531 345777788888877 466543 46777888
Q ss_pred cCcccCCCCCccccccccccccccccccccCCCCCCC-cc-ccccccccCCCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-NV-NFTAEDFANNSGL 214 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-~~-~~~~~~~~~n~~~ 214 (618)
++|+|++ +|.. ..+|+.|++++|+|+ .+|... .+ .+..+++++|+..
T Consensus 410 S~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 410 SGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred cCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 8888873 6653 245677788888877 466422 11 4556677777643
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.7e-08 Score=113.35 Aligned_cols=37 Identities=27% Similarity=0.463 Sum_probs=26.6
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPS 124 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~ 124 (618)
+++.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.
T Consensus 223 ~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~ 259 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPV 259 (788)
T ss_pred CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccC
Confidence 5677888888777 46642 467888888888887 5664
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.6e-09 Score=97.76 Aligned_cols=107 Identities=23% Similarity=0.376 Sum_probs=37.5
Q ss_pred CCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccc-ccccc
Q 007088 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQL-GLLNR 180 (618)
Q Consensus 102 ~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l-~~~~~ 180 (618)
+.+..++++|+|.+|.++ .|. .++..+.+|+.|||++|.++ .|+ .+..|++|+.|++++|+++ .+++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 567778999999999999 675 46645899999999999999 675 5888999999999999999 565555 46899
Q ss_pred ccccccccccccCCCC--CCCc-cccccccccCCCC
Q 007088 181 IKTFSVASNLLTGPVP--SFAN-VNFTAEDFANNSG 213 (618)
Q Consensus 181 L~~l~l~~N~l~g~ip--~~~~-~~~~~~~~~~n~~ 213 (618)
|+.|++++|++...-- .... .++..+++.+||-
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 9999999999975311 1111 1466778888863
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.2e-09 Score=78.30 Aligned_cols=60 Identities=35% Similarity=0.515 Sum_probs=54.3
Q ss_pred CCCCEEEeeCCCCcccCC-CCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccc
Q 007088 131 QYVTSLDLSSNSLSGEIP-SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLL 191 (618)
Q Consensus 131 ~~L~~L~l~~N~l~g~ip-~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l 191 (618)
++|++|+|++|+++ .|| ..+.++++|++|++++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 47899999999999 566 5789999999999999999976677899999999999999986
|
... |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.3e-09 Score=111.64 Aligned_cols=106 Identities=24% Similarity=0.419 Sum_probs=86.8
Q ss_pred EEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEcc
Q 007088 84 VLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163 (618)
Q Consensus 84 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~ 163 (618)
+..|-+++|+++ .+|..|+.+..|..||.+.|.+. ++|+.+++ |.+|+.|++..|++. .+|.+++.| .|..||+|
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~-l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfS 219 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGY-LTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFS 219 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhh-HHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecc
Confidence 556777788877 78888888888888888888888 78888876 888888888888888 788888855 47888888
Q ss_pred CcccCCCCCccccccccccccccccccccCCC
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTGPV 195 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~i 195 (618)
.|+++ .||-.|.+|+.|++|.|.+|.|..+.
T Consensus 220 cNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred cCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence 88888 78888888888888888888887654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.4e-09 Score=116.14 Aligned_cols=103 Identities=28% Similarity=0.444 Sum_probs=91.0
Q ss_pred CcEEEEEecCCcceeeCCc-CCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPR-GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~-~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
.++..|+|++|+|. .+|+ .+.+|..|++|+||+|+|. .||..+.. +..|++|...+|++. ..| ++.+++.|+.+
T Consensus 383 ~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~-~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~l 457 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVAN-LGRLHTLRAHSNQLL-SFP-ELAQLPQLKVL 457 (1081)
T ss_pred cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHh-hhhhHHHhhcCCcee-ech-hhhhcCcceEE
Confidence 57999999999998 5665 4889999999999999999 99998876 999999999999999 789 89999999999
Q ss_pred EccCcccCCC-CCcccccccccccccccccc
Q 007088 161 KLNNNRFTGK-IPPQLGLLNRIKTFSVASNL 190 (618)
Q Consensus 161 ~l~~N~l~g~-~p~~l~~~~~L~~l~l~~N~ 190 (618)
|+|.|+|+-. +|..+- -++|++|||++|.
T Consensus 458 DlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 458 DLSCNNLSEVTLPEALP-SPNLKYLDLSGNT 487 (1081)
T ss_pred ecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence 9999999843 444432 3899999999997
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.65 E-value=8.6e-09 Score=110.54 Aligned_cols=154 Identities=19% Similarity=0.220 Sum_probs=100.3
Q ss_pred HHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccC-----CCCcccccCCCCCC
Q 007088 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNG-----EFGDLGYVAPEYPR 485 (618)
Q Consensus 411 ~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~-----~~gt~~y~aPE~~~ 485 (618)
+.+++.|+.|+|... ++||++|.|++|.++..+..||+.|+.+..........-..+.. ......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 334558999999875 89999999999999999999999999886654421111000000 11356899999999
Q ss_pred CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhh
Q 007088 486 TLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACN 564 (618)
Q Consensus 486 ~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~ 564 (618)
+...+.++|+||+|+++|.+.. |+.-+........+ . ...... +... .....+.+.++.+-+.+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~-~~~~~~--------~~~~-~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----S-FSRNLL--------NAGA-FGYSNNLPSELRESLKK 247 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh-----h-hhhccc--------cccc-ccccccCcHHHHHHHHH
Confidence 9888999999999999999994 55444433221111 0 000000 0000 00112334455555668
Q ss_pred ccCCCCCCCCCHHHHHH
Q 007088 565 CVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 565 cl~~dP~~RPs~~evl~ 581 (618)
++..++.-||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999998777643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.5e-08 Score=115.28 Aligned_cols=125 Identities=18% Similarity=0.278 Sum_probs=70.1
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|+++.+. .+|..+..+++|+.|+|++|..-+.+|. +. .+++|+.|+|++|..-..+|.++++|++|+.|+
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls-~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LS-MATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cc-cCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 34555666666555 4555566666666666665544445553 33 266666666666554456666666666666666
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANN 211 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n 211 (618)
|++|..-+.+|..+ ++++|+.|++++|...+.+|.... ++..+++.+|
T Consensus 688 L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~-nL~~L~L~~n 735 (1153)
T PLN03210 688 MSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDIST-NISWLDLDET 735 (1153)
T ss_pred CCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccC-CcCeeecCCC
Confidence 66654444556544 556666666666655555554332 3444444444
|
syringae 6; Provisional |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.7e-07 Score=85.59 Aligned_cols=137 Identities=13% Similarity=0.100 Sum_probs=103.3
Q ss_pred EeecCCeeEEEEEeCCCcEEEEEEecc----C---ccCHHHHHHHHHHHhcCCCC--CccceeEEEE-eC----CeeEEE
Q 007088 314 IGTGRTGATYIAMLPGGCFIMIKRLED----S---QHSEKEFLSEINTLGSVRHR--NLVPLLGFCV-AK----KERLLV 379 (618)
Q Consensus 314 lG~G~~g~Vy~~~~~~~~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~lV 379 (618)
-|+||.+.|++....+. .+-+|+-.. + ......|.+|+..+.++... .+.++. ++. .. ...+||
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 46789999999887554 688887652 1 23567899999999998532 345555 332 11 235799
Q ss_pred EeecCC-CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc--eEEcccCccc
Q 007088 380 YSYLEN-GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE--PKLSDFGLAR 456 (618)
Q Consensus 380 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~ 456 (618)
+|-+++ -+|.+++..... .+.+...+..+..+++..++-||+. |+.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998763 478888755432 3467788889999999999999999 9999999999999986666 9999998765
Q ss_pred c
Q 007088 457 L 457 (618)
Q Consensus 457 ~ 457 (618)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.2e-06 Score=83.85 Aligned_cols=155 Identities=17% Similarity=0.261 Sum_probs=108.8
Q ss_pred ccccCHHHHHHhhccCCCCcEEe---ecCCeeEEEEEeCCCcEEEEEEeccCcc--------------------CHHH--
Q 007088 293 VEKMRLSDLMKATNSFSKNNIIG---TGRTGATYIAMLPGGCFIMIKRLEDSQH--------------------SEKE-- 347 (618)
Q Consensus 293 ~~~~~~~~l~~~~~~y~~~~~lG---~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------------~~~~-- 347 (618)
....+++.+....++..+....| +|.-+.||+|...++..+|+|+++.+.. ..++
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 45667778888777777766655 5566689999988899999999864211 1111
Q ss_pred ---HHHHHHHHhcCC--CCCccceeEEEEeCCeeEEEEeecCCC-ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHH
Q 007088 348 ---FLSEINTLGSVR--HRNLVPLLGFCVAKKERLLVYSYLENG-TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421 (618)
Q Consensus 348 ---~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L 421 (618)
..+|+.-|.++. +-.+.+.+++. +-.+||||+... .-.-.|.+ .++...+...+..++++.+.-|
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHH
Confidence 356777777774 44555666654 336999999643 11222222 2233336777888888888888
Q ss_pred HhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 422 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
-..+ ++||+||+.-|||+. ++.+.++|||-|....
T Consensus 183 ~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 183 YKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 8733 999999999999999 7799999999887654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-07 Score=112.06 Aligned_cols=128 Identities=22% Similarity=0.301 Sum_probs=103.0
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|++.++.+. .+|..+ .+.+|+.|+|++|++. .+|.++.. +++|+.|+|++|+..+.+|. ++.+++|+.|+
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~-l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~ 663 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHS-LTGLRNIDLRGSKNLKEIPD-LSMATNLETLK 663 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccccc-CCCCCEEECCCCCCcCcCCc-cccCCcccEEE
Confidence 35677777777765 777776 5789999999999998 78888765 99999999998876668884 88999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNSGL 214 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~~ 214 (618)
|++|.....+|..++++++|+.|++++|..-+.+|.... .++..+.+++|..+
T Consensus 664 L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L 717 (1153)
T PLN03210 664 LSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRL 717 (1153)
T ss_pred ecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCc
Confidence 999887788999999999999999999877777776432 25666777777544
|
syringae 6; Provisional |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.2e-08 Score=67.84 Aligned_cols=41 Identities=34% Similarity=0.614 Sum_probs=28.0
Q ss_pred cchHHHHHHHHHhccC-CCCccccCccCCCCCCCCCCcccceecC
Q 007088 34 LNDIECLKSVKNSLED-PFNYLTTSWNFNNNTEGFICQFTGVDCW 77 (618)
Q Consensus 34 ~~~~~~L~~~k~~~~~-~~~~l~~~W~~~~~~~~~~c~w~gv~c~ 77 (618)
..|++||++||+++.+ |.+.+. +|+.++ ..+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~-~W~~~~--~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLS-SWNPSS--DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCT-T--TT----S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccc-cCCCcC--CCCCeeeccEEeC
Confidence 4689999999999985 545554 998653 3579999999994
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.7e-07 Score=87.88 Aligned_cols=107 Identities=24% Similarity=0.232 Sum_probs=84.6
Q ss_pred HHHHHHHHHHHhcCCC--CCccceeEEEEeCC----eeEEEEeecCCC-ccccccCCCCCCCcCCCHHHHHHHHHHHHHH
Q 007088 345 EKEFLSEINTLGSVRH--RNLVPLLGFCVAKK----ERLLVYSYLENG-TLYDKLHPAEHEVMHMDWPLRLRIAIGSARG 417 (618)
Q Consensus 345 ~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~ 417 (618)
.....+|...+.++.. -.+++.+++..... ..++|+|++++. +|.+++..... .+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 3457788888887753 34566677766532 458999999874 78888865332 5566778999999999
Q ss_pred HHHHHhCCCCCceecCCCCCCeeeCCCC---ceEEcccCccccc
Q 007088 418 LAWLHHNCNPRIIHRNISSKCILLDGDF---EPKLSDFGLARLM 458 (618)
Q Consensus 418 L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~ 458 (618)
++-||.. ||+|+|+++.|||++.+. .+.++||+.++..
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.2e-07 Score=100.16 Aligned_cols=139 Identities=19% Similarity=0.216 Sum_probs=93.0
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCccC-----------------------------------------HHHHHH
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS-----------------------------------------EKEFLS 350 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~~~ 350 (618)
+-|+.++-|.||+|++.+|+.||||+.+..-.. +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999998542100 012445
Q ss_pred HHHHHhcCC-----CCCccceeEEEE-eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHH-HHHHHh
Q 007088 351 EINTLGSVR-----HRNLVPLLGFCV-AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARG-LAWLHH 423 (618)
Q Consensus 351 E~~~l~~l~-----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-L~~LH~ 423 (618)
|...+.+++ .+++ ++=.++. -.....++|||++|-.+.+...-... ..+ +..++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~---g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA---GID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence 555555542 2332 2223332 24567899999999888887422221 133 23333333332 223333
Q ss_pred CCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 424 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
. |++|.|..|.||+++.+|++.+.|||+...+++
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 4 899999999999999999999999999987654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=1e-08 Score=105.87 Aligned_cols=131 Identities=21% Similarity=0.226 Sum_probs=94.8
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCC---CCeEEccCCcCcc----ccCchhhhcC-CCCCEEEeeCCCCccc----CC
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTS---LTGLDLSSNNLSG----SIPSDISSRL-QYVTSLDLSSNSLSGE----IP 148 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~---L~~L~l~~n~l~g----~ip~~~~~~l-~~L~~L~l~~N~l~g~----ip 148 (618)
..+++.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+...+.. + ++|+.|+|++|++++. ++
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~-~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD-LPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh-CCCCceEEEcCCCcCCchHHHHHH
Confidence 468999999999998777777666666 9999999999983 33334443 5 8899999999999953 33
Q ss_pred CCCcCCCCCcEEEccCcccCCC----CCccccccccccccccccccccCCCCCC----Cc--cccccccccCCC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGK----IPPQLGLLNRIKTFSVASNLLTGPVPSF----AN--VNFTAEDFANNS 212 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~g~ip~~----~~--~~~~~~~~~~n~ 212 (618)
..+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.-+.. .. .++..+++++|+
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~ 232 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNN 232 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCc
Confidence 4566778899999999999853 3445556678999999999987543211 00 135566676663
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.8e-08 Score=102.59 Aligned_cols=111 Identities=25% Similarity=0.426 Sum_probs=73.2
Q ss_pred CcEEEEEecCCccee----eCCcCCCCC-CCCCeEEccCCcCccccC----chhhhcCCCCCEEEeeCCCCccc----CC
Q 007088 82 NKVLNIRLSDMGLKG----QFPRGIERC-TSLTGLDLSSNNLSGSIP----SDISSRLQYVTSLDLSSNSLSGE----IP 148 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g----~~p~~~~~l-~~L~~L~l~~n~l~g~ip----~~~~~~l~~L~~L~l~~N~l~g~----ip 148 (618)
.+++.|+|++|++++ .+...+..+ .+|+.|+|++|.+++..+ ..+. .+++|++|+|++|.+++. ++
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~~~~~l~ 186 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR-ANRDLKELNLANNGIGDAGIRALA 186 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH-hCCCcCEEECcCCCCchHHHHHHH
Confidence 347888888887763 344455666 778888888888875332 2232 356788888888887742 33
Q ss_pred CCCcCCCCCcEEEccCcccCCC----CCccccccccccccccccccccC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGK----IPPQLGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~g 193 (618)
..+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++
T Consensus 187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 3445556788888888877643 23345566778888888887775
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3e-08 Score=95.71 Aligned_cols=102 Identities=24% Similarity=0.304 Sum_probs=54.2
Q ss_pred EEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEcc
Q 007088 84 VLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163 (618)
Q Consensus 84 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~ 163 (618)
++.||||+|.++ .|..+..-++.++.|+||.|++. .+-. +.. |++|+.||||+|.|+ .+-.+=..|-+.++|.|+
T Consensus 286 LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~-L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAE-LPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhh-cccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 445666666655 55555555566666666666665 3433 332 566666666666665 344333344445555555
Q ss_pred CcccCCCCCcccccccccccccccccccc
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~ 192 (618)
+|.+.. + +.++.+-+|..||+.+|++.
T Consensus 361 ~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 361 QNKIET-L-SGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred hhhHhh-h-hhhHhhhhheeccccccchh
Confidence 555431 1 22444555555666666553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.5e-06 Score=83.21 Aligned_cols=132 Identities=14% Similarity=0.084 Sum_probs=86.8
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC--ccceeEEEEeCCeeEEEEeecCCCc-c
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN--LVPLLGFCVAKKERLLVYSYLENGT-L 388 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs-L 388 (618)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 24467788876533 4456789999998886433 5677888877777889999999863 2
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHH---------------------------------------HHHHhC-CCCC
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGL---------------------------------------AWLHHN-CNPR 428 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L---------------------------------------~~LH~~-~~~~ 428 (618)
...+.. +......++.++++.+ .+|... ..+.
T Consensus 83 ~~~~~~--------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 83 SRIISD--------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhcC--------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 211110 0111111222222222 222211 1235
Q ss_pred ceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 429 IIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 429 ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++|+|+.|.||++++++ +.++||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.7e-08 Score=93.78 Aligned_cols=119 Identities=24% Similarity=0.304 Sum_probs=94.9
Q ss_pred ccceecCCCC---CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccC
Q 007088 71 FTGVDCWHPD---ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEI 147 (618)
Q Consensus 71 w~gv~c~~~~---~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~i 147 (618)
..-++|.+-. ..+++.|+||.|++. .+-. +..|.+|+.||||+|.|+ .+-. +-.+|-+.++|.|+.|.+. .+
T Consensus 293 ~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~G-wh~KLGNIKtL~La~N~iE-~L 367 (490)
T KOG1259|consen 293 GNLITQIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVG-WHLKLGNIKTLKLAQNKIE-TL 367 (490)
T ss_pred ccchhhhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhh-hHhhhcCEeeeehhhhhHh-hh
Confidence 3345564322 368999999999998 4433 889999999999999999 5544 3345889999999999987 33
Q ss_pred CCCCcCCCCCcEEEccCcccCCCCC--ccccccccccccccccccccCCCC
Q 007088 148 PSGLANCTFLNVLKLNNNRFTGKIP--PQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 148 p~~~~~l~~L~~l~l~~N~l~g~~p--~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
+.++.|-+|..||+++|++. .+- ..+|+++-|+.+.|-+|.+++.+-
T Consensus 368 -SGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 368 -SGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred -hhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCccccch
Confidence 56889999999999999997 332 458999999999999999998764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.3e-07 Score=100.88 Aligned_cols=103 Identities=32% Similarity=0.552 Sum_probs=69.9
Q ss_pred cEEEEEecCCcceeeCCcCCCCCC-CCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCT-SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~-~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.++.|++.+|+++ .||+.++.++ +|+.|++++|++. .+|..+.. +++|+.|++++|+++ .+|...+.++.|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~-l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRN-LPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhc-cccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 4666777777666 6666666664 7777777777777 66655554 777777777777777 6666666667777777
Q ss_pred ccCcccCCCCCcccccccccccccccccc
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNL 190 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~ 190 (618)
+++|+++ .+|..+..+..|+.|.+++|.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 7777776 566665555667777777774
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.9e-08 Score=85.16 Aligned_cols=102 Identities=24% Similarity=0.363 Sum_probs=55.6
Q ss_pred EEEecCCcceeeCCcC---CCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 86 NIRLSDMGLKGQFPRG---IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 86 ~l~l~~~~l~g~~p~~---~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
.++|+++.|- .|+.. +....+|+..+|++|.|- .+|+.+....+.+++|+|++|.++ .+|.+++.++.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 4455544432 33332 233344444566666665 556555554445566666666666 56666666666666666
Q ss_pred cCcccCCCCCccccccccccccccccccc
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLL 191 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l 191 (618)
+.|.|. ..|.-+..|.+|..|+..+|..
T Consensus 108 ~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 108 RFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred ccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 666665 4455555555666666555554
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.4e-08 Score=87.16 Aligned_cols=112 Identities=24% Similarity=0.341 Sum_probs=92.1
Q ss_pred CCcEEEEEecCCcceeeCCcCCCC-CCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIER-CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~-l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~ 159 (618)
..+++.++|++|++. .+|+.|.. .+.++.|+|++|.++ .+|.++.. ++.|+.|++++|.|. ..|.-+..|.+|..
T Consensus 52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aa-m~aLr~lNl~~N~l~-~~p~vi~~L~~l~~ 127 (177)
T KOG4579|consen 52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAA-MPALRSLNLRFNPLN-AEPRVIAPLIKLDM 127 (177)
T ss_pred CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhh-hHHhhhcccccCccc-cchHHHHHHHhHHH
Confidence 457899999999999 66766654 468999999999999 89999876 999999999999999 78988999999999
Q ss_pred EEccCcccCCCCCccccccccccccccccccccCCCCC
Q 007088 160 LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 160 l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
||..+|.+. .||-.+-.-+..-..++.+|.+.|.-|.
T Consensus 128 Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 128 LDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred hcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 999999987 7876644333444556677777776664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.8e-06 Score=80.63 Aligned_cols=137 Identities=15% Similarity=0.193 Sum_probs=91.1
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCH-H---------HHHHHHHHHhcCCC---CCccceeEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSE-K---------EFLSEINTLGSVRH---RNLVPLLGFC 370 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~---------~~~~E~~~l~~l~h---~niv~l~~~~ 370 (618)
..++|...+.+-......|.+... +|..+++|..+...... + ...+++..+.+++. ...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346788778887777777777666 56788899876532211 1 12344444444432 2333333332
Q ss_pred Ee-----CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC
Q 007088 371 VA-----KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445 (618)
Q Consensus 371 ~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 445 (618)
.. ....+++|||++|..|.+... ++. .++..+..++.-||+. |++|+|..|.|++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-
Confidence 22 234568999999988876542 222 2556677889999999 99999999999999866
Q ss_pred ceEEcccCcccc
Q 007088 446 EPKLSDFGLARL 457 (618)
Q Consensus 446 ~~kl~DfG~a~~ 457 (618)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.1e-07 Score=99.26 Aligned_cols=124 Identities=28% Similarity=0.433 Sum_probs=100.7
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
+++.|++++|++. .+|..+++++.|+.|++++|+++ .+|...+. +++|+.|++++|+++ .||..+..+..|++|++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~-~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~ 216 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSN-LSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhh-hhhhhheeccCCccc-cCchhhhhhhhhhhhhh
Confidence 7999999999998 88888999999999999999999 89987654 899999999999999 89998878888999999
Q ss_pred cCcccCCCCCccccccccccccccccccccCCC--CCCCccccccccccCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPV--PSFANVNFTAEDFANNS 212 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~i--p~~~~~~~~~~~~~~n~ 212 (618)
++|++. .+|..+.++.++..+.+++|++.-.+ ..... .+..+++++|.
T Consensus 217 ~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~-~l~~L~~s~n~ 266 (394)
T COG4886 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLS-NLETLDLSNNQ 266 (394)
T ss_pred cCCcce-ecchhhhhcccccccccCCceeeeccchhcccc-ccceecccccc
Confidence 999644 56777888888888888888876521 11111 35556666664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=8.2e-06 Score=79.86 Aligned_cols=144 Identities=17% Similarity=0.129 Sum_probs=84.7
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCC--CccceeEEEEeC---CeeEEEEeecCC
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHR--NLVPLLGFCVAK---KERLLVYSYLEN 385 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~e~~~~ 385 (618)
++.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+.... ...+++|+++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 3579999999999999877 58899987665 4556788899888888533 356777654333 346899999999
Q ss_pred Ccccccc-------------------CCCCCCCcCCCHHH---------HHHH------------HHHHHH-HHHHHHhC
Q 007088 386 GTLYDKL-------------------HPAEHEVMHMDWPL---------RLRI------------AIGSAR-GLAWLHHN 424 (618)
Q Consensus 386 gsL~~~l-------------------~~~~~~~~~l~~~~---------~~~i------------~~~i~~-~L~~LH~~ 424 (618)
.++.... +..........+.. .... ...+.. .+..+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 8777600 01100001111100 0000 111222 23333321
Q ss_pred ----CCCCceecCCCCCCeeeC-CCCceEEcccCccc
Q 007088 425 ----CNPRIIHRNISSKCILLD-GDFEPKLSDFGLAR 456 (618)
Q Consensus 425 ----~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~ 456 (618)
....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 233699999999999999 66666899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.5e-08 Score=106.57 Aligned_cols=128 Identities=25% Similarity=0.401 Sum_probs=92.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC-CCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS-GLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~l 160 (618)
+.+...+.+.|.|+ .+..++.-++.|+.|||++|+|. ..- .+- .|++|++|||++|.|. .+|. +...+. |+.|
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr-~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L 237 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLR-RLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLL 237 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHH-hcccccccccccchhc-cccccchhhhh-heee
Confidence 35666777888887 67777888889999999999998 443 454 4889999999999998 6774 233444 8889
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCC---CCCCccccccccccCCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPV---PSFANVNFTAEDFANNSGLCGK 217 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~i---p~~~~~~~~~~~~~~n~~~c~~ 217 (618)
.|+||-++. + ..+.+|.+|+.|||+.|-|++-- |-+.-..+..+.+.|||.-|.+
T Consensus 238 ~lrnN~l~t-L-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 238 NLRNNALTT-L-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred eecccHHHh-h-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 999998872 3 23678888999999999887642 2111114566778888876654
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.20 E-value=9.1e-07 Score=61.72 Aligned_cols=36 Identities=36% Similarity=0.607 Sum_probs=18.8
Q ss_pred CCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccC
Q 007088 132 YVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFT 168 (618)
Q Consensus 132 ~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~ 168 (618)
+|++|+|++|+++ .||+++++|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 45555555555555555555555
|
... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=2.7e-07 Score=98.06 Aligned_cols=184 Identities=17% Similarity=0.086 Sum_probs=132.6
Q ss_pred CCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC-ccceeEEEEeCCeeEEEEeecCCC-c
Q 007088 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN-LVPLLGFCVAKKERLLVYSYLENG-T 387 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~~~g-s 387 (618)
..+-.++|+++.+||.+-...+....+.+... ....-++++|.+++||| .++.++-+..++..+++++++.++ +
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs 321 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS 321 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence 34457889999999987433333335544332 34567889999999999 666677676677888999999876 3
Q ss_pred cccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccc
Q 007088 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467 (618)
Q Consensus 388 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 467 (618)
-........ ..+...+...+.+.-.++++|+|+. .=+|+| ||+..+ +..+..||+....+.....
T Consensus 322 ~~~~~~~se---~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~---- 386 (829)
T KOG0576|consen 322 SALEMTVSE---IALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMK---- 386 (829)
T ss_pred ccccCChhh---Hhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccc----
Confidence 222222111 2344555566777778899999987 568998 777665 5799999999887765431
Q ss_pred cccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 007088 468 FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTH 513 (618)
Q Consensus 468 ~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~ 513 (618)
.+...+++.++|||......+..+.|+|+.|+--.++--|.+|-.
T Consensus 387 -~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 387 -PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 123348999999999999999999999999987777777777654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.7e-05 Score=78.59 Aligned_cols=140 Identities=14% Similarity=0.050 Sum_probs=85.4
Q ss_pred EeecCC-eeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEeecCCCccccc
Q 007088 314 IGTGRT-GATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391 (618)
Q Consensus 314 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~ 391 (618)
|-.|.+ ..||+...++ ..+++|+..... ..++.+|++++..+. +--+.+++++....+..++|||+++|.++.+.
T Consensus 6 ~~~g~~~~~v~~~~~~~-~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-PGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCC-CcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 445555 7899997654 688889876543 345678888888773 44566778877766678999999999777643
Q ss_pred cC-------------------CCCCCCcCCCH--HHHHHHHH--------------------HHHHHHHHHHhC----CC
Q 007088 392 LH-------------------PAEHEVMHMDW--PLRLRIAI--------------------GSARGLAWLHHN----CN 426 (618)
Q Consensus 392 l~-------------------~~~~~~~~l~~--~~~~~i~~--------------------~i~~~L~~LH~~----~~ 426 (618)
.. .......++.. ........ .+...+..|-.. ..
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 11100011110 00000000 011111222111 13
Q ss_pred CCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 427 PRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 427 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
+.++|+|+.|.||+++++....|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999998778899998775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.2e-05 Score=86.55 Aligned_cols=140 Identities=17% Similarity=0.150 Sum_probs=90.2
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccC--------------------------------HH------HHHHHH
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS--------------------------------EK------EFLSEI 352 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------------~~------~~~~E~ 352 (618)
.+.||.-+.|.||+|++++|+.||||+-+..-.. .+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3679999999999999999999999997643110 01 244454
Q ss_pred HHHhcC----CCCC------ccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHH
Q 007088 353 NTLGSV----RHRN------LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422 (618)
Q Consensus 353 ~~l~~l----~h~n------iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 422 (618)
+-..++ .|-+ |.+++-.+ .....|+||||+|..+.+.-.-.. ..++.. .++..+.++. ++
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~---~i~~~l~~~~--~~ 315 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK---RGISPH---DILNKLVEAY--LE 315 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH---cCCCHH---HHHHHHHHHH--HH
Confidence 443333 3444 33333222 246789999999988777532221 124444 3333333332 22
Q ss_pred hCCCCCceecCCCCCCeeeC----CCCceEEcccCcccccCC
Q 007088 423 HNCNPRIIHRNISSKCILLD----GDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 423 ~~~~~~ivH~Dlkp~NIll~----~~~~~kl~DfG~a~~~~~ 460 (618)
.....|++|+|=.|.||++. .++.+.+-|||+......
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22223899999999999998 367899999999887654
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.08 E-value=3e-06 Score=59.12 Aligned_cols=40 Identities=38% Similarity=0.699 Sum_probs=31.9
Q ss_pred CCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC
Q 007088 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148 (618)
Q Consensus 106 ~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip 148 (618)
++|++|+|++|+++ .||+++.. |++|+.|+|++|+++ .+|
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~-l~~L~~L~l~~N~i~-~i~ 40 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSN-LPNLETLNLSNNPIS-DIS 40 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTT-CTTSSEEEETSSCCS-BEG
T ss_pred CcceEEEccCCCCc-ccCchHhC-CCCCCEEEecCCCCC-CCc
Confidence 47899999999999 78887765 999999999999988 443
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 618 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-60 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-59 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 6e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 7e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-06 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-118
Identities = 126/306 (41%), Positives = 180/306 (58%), Gaps = 7/306 (2%)
Query: 298 LSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRL--EDSQHSEKEFLSEINTL 355
L +L A+++FS NI+G G G Y L G + +KRL E +Q E +F +E+ +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 356 GSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSA 415
HRNL+ L GFC+ ERLLVY Y+ NG++ L +DWP R RIA+GSA
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGLA+LH +C+P+IIHR++ + ILLD +FE + DFGLA+LM+ DTH++T V G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI-- 199
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535
G++APEY T ++ K DV+ +GV+LLELITG+R L L++W+ L
Sbjct: 200 -GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR--AIAERYHFT 593
LE +D L GN D E+ Q ++VA C +P ER M EV ++L +AER+
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEW 318
Query: 594 TDDEIM 599
+E+
Sbjct: 319 QKEEMF 324
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-103
Identities = 117/317 (36%), Positives = 166/317 (52%), Gaps = 12/317 (3%)
Query: 271 GNKWAKRIKGTKGIKVSAFEKSVEKMR--LSDLMKATNSFSKNNIIGTGRTGATYIAMLP 328
G+K++K S++ E R L DL +ATN+F +IG G G Y +L
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 329 GGCFIMIKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT 387
G + +KR +S +EF +EI TL RH +LV L+GFC + E +L+Y Y+ENG
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447
L L+ ++ M M W RL I IG+ARGL +LH IIHR++ S ILLD +F P
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 448 KLSDFGLARLMNPVD-THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELI 506
K++DFG+++ +D THLST V G GY+ PEY T K DVYSFGVVL E++
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTL---GYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 507 TGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCV 566
+ E +L EW + N LE +D +L L +F A C+
Sbjct: 236 CARSAIVQSLPRE--MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 567 LPTPKERHTMFEVYQLL 583
+ ++R +M +V L
Sbjct: 294 ALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 7e-91
Identities = 96/304 (31%), Positives = 147/304 (48%), Gaps = 29/304 (9%)
Query: 298 LSDLMKATNSFSK------NNIIGTGRTGATYIAMLPGGCFIMIKRLE-----DSQHSEK 346
+L TN+F + N +G G G Y + + +K+L ++ ++
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQ 75
Query: 347 EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPL 406
+F EI + +H NLV LLGF + LVY Y+ NG+L D+L + W +
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS-CLDGTPPLSWHM 134
Query: 407 RLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD--TH 464
R +IA G+A G+ +LH N IHR+I S ILLD F K+SDFGLAR T
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARAS-EKFAQTV 190
Query: 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS 524
+++ + G Y+APE R + TPK D+YSFGVVLLE+ITG P+
Sbjct: 191 MTSRIVGTT---AYMAPEALRGEI-TPKSDIYSFGVVLLEIITGLPAVDEHREPQ----L 242
Query: 525 LVEWI-TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583
L++ + + ++E IDK + + + VA C+ +R + +V QLL
Sbjct: 243 LLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 584 RAIA 587
+ +
Sbjct: 302 QEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 6e-66
Identities = 61/316 (19%), Positives = 112/316 (35%), Gaps = 32/316 (10%)
Query: 298 LSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGS 357
+L + + GR G + A ++ +K + E+ +L
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74
Query: 358 VRHRNLVPLLGFCV----AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIG 413
++H N++ +G + L+ ++ E G+L D L + W IA
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAET 129
Query: 414 SARGLAWLHHN-------CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466
ARGLA+LH + P I HR+I SK +LL + ++DFGLA +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 467 TFVNGEFGDLGYVAPEYPRTLV-----ATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521
T +G+ G Y+APE + A + D+Y+ G+VL EL + + +
Sbjct: 190 T--HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA--DGPVDEY 245
Query: 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGF------DGELHQFLRVACNCVLPTPKERHT 575
E I + ++ + + C + R +
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 576 MFEVYQLLRAIAERYH 591
V + + + +
Sbjct: 306 AGCVGERITQMQRLTN 321
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-45
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 36/304 (11%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
++G G G A + IK++E S+ K F+ E+ L V H N+V L G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGAC- 70
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
LV Y E G+LY+ LH AE + + + + ++G+A+LH +IH
Sbjct: 71 -LNPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 432 RNISSKCILLDGDFE-PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT 490
R++ +LL K+ DFG A + T G ++APE +
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-------NNKGSAAWMAPEVFEGSNYS 181
Query: 491 PKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL---L 547
K DV+S+G++L E+IT +P F + + A+ L
Sbjct: 182 EKCDVFSWGIILWEVITRRKP---------FDE-------IGGPAFRIMWAVHNGTRPPL 225
Query: 548 GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDP 607
+ + C P +R +M E+ +++ + + D+ + P P
Sbjct: 226 IKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFP-GADEPLQYPCQHSLP 281
Query: 608 NFPD 611
D
Sbjct: 282 PGED 285
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-45
Identities = 64/326 (19%), Positives = 115/326 (35%), Gaps = 45/326 (13%)
Query: 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSE--INTLG 356
S+ ++ +IG GR GA Y L + +K S + + F++E I +
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF--SFANRQNFINEKNIYRVP 62
Query: 357 SVRHRNLVPLLGFCV-----AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIA 411
+ H N+ + + E LLV Y NG+L L DW R+A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLA 117
Query: 412 IGSARGLAWLH------HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465
RGLA+LH + P I HR+++S+ +L+ D +SDFGL+ +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 466 STFV----NGEFGDLGYVAPEYPRTLV-------ATPKGDVYSFGVVLLELITGERPTHL 514
E G + Y+APE V A + D+Y+ G++ E+
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 515 TNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGN----------GFDGELHQFLRVACN 564
+ ++ + + T + + + E + +
Sbjct: 238 GESVPEYQ---MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 565 CVLPTPKERHTMFEVYQLLRAIAERY 590
C + R T + + + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIW 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-45
Identities = 71/203 (34%), Positives = 102/203 (50%), Gaps = 10/203 (4%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRNLVPLLG 368
IG G G + A G + +K L + EFL E+ + +RH N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
+V YL G+LY LH + +D RL +A A+G+ +L HN NP
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYL-HNRNPP 159
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV 488
I+HRN+ S +L+D + K+ DFGL+RL T LS+ G ++APE R
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSS--KSAAGTPEWMAPEVLRDEP 215
Query: 489 ATPKGDVYSFGVVLLELITGERP 511
+ K DVYSFGV+L EL T ++P
Sbjct: 216 SNEKSDVYSFGVILWELATLQQP 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-44
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
+ +G + G I++K L + S ++F E L H N++P+LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 369 FCVAKKERLL--VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
C + + ++ G+LY+ LH + V+ D ++ A+ ARG+A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV--DQSQAVKFALDMARGMAFLH-TLE 131
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE---Y 483
P I ++S+ +++D D ++S + S G +VAPE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKF---------SFQSPGRMYAPAWVAPEALQK 182
Query: 484 PRTLVATPKGDVYSFGVVLLELITGERP 511
D++SF V+L EL+T E P
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-43
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 29/216 (13%)
Query: 312 NIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSE--------KEFLSEINTLGSVRHRN 362
IG G G + L + IK L +EF E+ + ++ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
+V L G +V ++ G LY +L H + W ++LR+ + A G+ ++
Sbjct: 85 IVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYMQ 139
Query: 423 HNCNPRIIHRNISSKCILLD-----GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
N NP I+HR++ S I L K++DFGL++ + G G+
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-------GLLGNFQ 191
Query: 478 YVAPE--YPRTLVATPKGDVYSFGVVLLELITGERP 511
++APE T K D YSF ++L ++TGE P
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 65/301 (21%), Positives = 110/301 (36%), Gaps = 36/301 (11%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC- 370
IG GR G ++ G + +K ++ + +EI +RH N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 371 ---VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH----- 422
+ + L+ Y ENG+LYD L +D L++A S GL LH
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
P I HR++ SK IL+ + ++D GLA + N G Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 483 ------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536
+ D+YSFG++L E+ + + + + L+ ++
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ------LPYHDLVPSDP 270
Query: 537 SLETAIDKSLLGNG-----FDGELHQFLRVACN----CVLPTPKERHTMFEVYQLLRAIA 587
S E + + + LR C P R T V + L ++
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330
Query: 588 E 588
E
Sbjct: 331 E 331
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 314 IGTGRTGATYIAMLPGGCFI-MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
IG+G G Y G + M+ + + F +E+ L RH N++ +G+
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-- 89
Query: 373 KKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
+L +V + E +LY LH +E + + IA +ARG+ +LH IIH
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
R++ S I L D K+ DFGLA + S G + ++APE R + P
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKS--RWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 492 ---KGDVYSFGVVLLELITGERP-THLTNA 517
+ DVY+FG+VL EL+TG+ P +++ N
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNR 231
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-41
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRL-----EDSQHSEKEFLSEINTLGSVRHRNLVPL 366
IIG G G Y A G + +K ED + + E ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
G C+ + LV + G L L + + + A+ ARG+ +LH
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 427 PRIIHRNISSKCILLDGDFEP--------KLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
IIHR++ S IL+ E K++DFGLAR + T G +
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH------RTTKMSAAGAYAW 180
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+APE R + + DV+S+GV+L EL+TGE P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-40
Identities = 53/216 (24%), Positives = 88/216 (40%), Gaps = 21/216 (9%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
+G GR G + G + +K +E+ +RH N++ + +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 372 AKK----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH----- 422
+ + L+ Y E G+LYD L + +D LRI + A GLA LH
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
P I HR++ SK IL+ + + ++D GLA + + L N G Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 483 ------YPRTLVATPKGDVYSFGVVLLELITGERPT 512
+ + D+++FG+VL E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN 223
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 312 NIIGTGRTGATYIAMLPGGCFI-MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC 370
+IG GR G Y G I +I D++ K F E+ RH N+V +G C
Sbjct: 39 ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRII 430
++ ++ S + TLY + A+ +D +IA +G+ +LH I+
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 431 HRNISSKCILLDGDFEPKLSDFGLARLMNPVD-THLSTFVNGEFGDLGYVAPEYPRTLVA 489
H+++ SK + D + + ++DFGL + + + + G L ++APE R L
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 490 ---------TPKGDVYSFGVVLLELITGERP 511
+ DV++ G + EL E P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 61/306 (19%), Positives = 114/306 (37%), Gaps = 42/306 (13%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
IG GR G + G + +K + +EI +RH N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106
Query: 372 ----AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH----- 422
+ LV Y E+G+L+D L+ + V +++A+ +A GLA LH
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTV---TVEGMIKLALSTASGLAHLHMEIVG 161
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
P I HR++ SK IL+ + ++D GLA + + N G Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 483 ------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536
+ + + D+Y+ G+V E+ E ++ + + L+ ++
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI---GGIHEDYQ---LPYYDLVPSDP 275
Query: 537 SLET------------AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584
S+E I + + +R C R T + + L
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332
Query: 585 AIAERY 590
++++
Sbjct: 333 QLSQQE 338
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 4e-39
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIM-IKRLED-SQHSEKEFLSEINTLGSVRHRNLVPLLGF 369
++G G G +M +K L + +++ FL E+ + + H N++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 370 CVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRI 429
K + Y++ GTL + + W R+ A A G+A+LH I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF----------GDLGYV 479
IHR+++S L+ + ++DFGLARLM T + + G+ ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELITGERP 511
APE K DV+SFG+VL E+I
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 9/166 (5%)
Query: 36 DIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDC-WHPDENKVLNIRLSDMGL 94
D + L +K L +P +SW T+ + GV C +V N+ LS + L
Sbjct: 7 DKQALLQIKKDLGNP--TTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 95 KGQF--PRGIERCTSLTGLDLSS-NNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL 151
+ P + L L + NNL G IP I+ +L + L ++ ++SG IP L
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA-KLTQLHYLYITHTNVSGAIPDFL 121
Query: 152 ANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
+ L L + N +G +PP + L + + N ++G +P
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 41/184 (22%), Positives = 57/184 (30%), Gaps = 49/184 (26%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ S L G P I +L G+ N +SG+IP S + TS+ +S N L+G+
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN------ 200
IP AN L + L+ N G G + +A N L +
Sbjct: 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 201 ------------------------------------------VNFTAEDFANNSGLCGKP 218
F +ANN LCG P
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308
Query: 219 LNPC 222
L C
Sbjct: 309 LPAC 312
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-33
Identities = 39/167 (23%), Positives = 67/167 (40%), Gaps = 26/167 (15%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
K + + + +G + R ++ +++S G + + LD+S N
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN-NGSMMFLDMSYNM 643
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP------ 196
LSG IP + + +L +L L +N +G IP ++G L + ++SN L G +P
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703
Query: 197 ---SFANV----------------NFTAEDFANNSGLCGKPLNPCPG 224
+ ++ F F NN GLCG PL C
Sbjct: 704 TMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 45/133 (33%), Positives = 65/133 (48%), Gaps = 4/133 (3%)
Query: 69 CQFTGV---DCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSD 125
F+G + +N + + L + G G+ P + C+ L L LS N LSG+IPS
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSS 437
Query: 126 ISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFS 185
+ S L + L L N L GEIP L L L L+ N TG+IP L + S
Sbjct: 438 LGS-LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496
Query: 186 VASNLLTGPVPSF 198
+++N LTG +P +
Sbjct: 497 LSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-28
Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 6/130 (4%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ +S G P SL L L+ N +G IP +S +T LDLS N G
Sbjct: 252 LNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVP-SFANVNFT 204
+P +C+ L L L++N F+G++P L + +K ++ N +G +P S N++ +
Sbjct: 310 VPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSAS 369
Query: 205 AE--DFANNS 212
D ++N+
Sbjct: 370 LLTLDLSSNN 379
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-28
Identities = 42/111 (37%), Positives = 64/111 (57%), Gaps = 1/111 (0%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ LS L G P + + L L L N L G IP ++ ++ + +L L N L+GE
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY-VKTLETLILDFNDLTGE 481
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
IPSGL+NCT LN + L+NNR TG+IP +G L + +++N +G +P+
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-27
Identities = 41/112 (36%), Positives = 60/112 (53%), Gaps = 4/112 (3%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
++ +S L G F R I CT L L++SSN G IP LQY L L+ N +G
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQY---LSLAENKFTG 283
Query: 146 EIPSGLA-NCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
EIP L+ C L L L+ N F G +PP G + +++ +++SN +G +P
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-27
Identities = 37/104 (35%), Positives = 59/104 (56%), Gaps = 1/104 (0%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
L+G+ P+ + +L L L N+L+G IPS +S + + LS+N L+GEIP +
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS-NCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
L +LKL+NN F+G IP +LG + + +NL G +P+
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-27
Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 4/117 (3%)
Query: 87 IRLSDMGLKGQFPRGIERC--TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS 144
+ LS G + + +L L L +N +G IP +S+ + SL LS N LS
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN-CSELVSLHLSFNYLS 431
Query: 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP-SFAN 200
G IPS L + + L LKL N G+IP +L + ++T + N LTG +P +N
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 17/174 (9%)
Query: 30 SLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRL 89
S + +I L S K+ L D N L W+ N N C F GV C ++KV +I L
Sbjct: 7 SQSLYREIHQLISFKDVLPDK-NLLP-DWSSNKN----PCTFDGVTC---RDDKVTSIDL 57
Query: 90 SDMGLK---GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
S L + T L L LS+++++GS+ +TSLDLS NSLSG
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG--FKCSASLTSLDLSRNSLSGP 115
Query: 147 IPSG--LANCTFLNVLKLNNNRFTGKIPPQLGL-LNRIKTFSVASNLLTGPVPS 197
+ + L +C+ L L +++N GL LN ++ +++N ++G
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 5/105 (4%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
L G+ P G+ CT+L + LS+N L+G IP I L+ + L LS+NS SG IP+ L +
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR-LENLAILKLSNNSFSGNIPAELGD 536
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
C L L LN N F G IP + + +A+N + G +
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 35/129 (27%), Positives = 56/129 (43%), Gaps = 7/129 (5%)
Query: 87 IRLSDMGLKGQFPRGIER---CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSL 143
+ LS + G G C L L +S N +SG + SR + LD+SSN+
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNF 212
Query: 144 SGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNF 203
S IP L +C+ L L ++ N+ +G + +K +++SN GP+P +
Sbjct: 213 STGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL 271
Query: 204 TAEDFANNS 212
A N
Sbjct: 272 QYLSLAENK 280
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 39/118 (33%), Positives = 60/118 (50%), Gaps = 6/118 (5%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ +S + G + RC +L LD+SSNN S IP + LD+S N LSG+
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGD 238
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFT 204
++ CT L +L +++N+F G IPP L ++ S+A N TG +P F +
Sbjct: 239 FSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACD 294
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 41/112 (36%), Positives = 58/112 (51%), Gaps = 3/112 (2%)
Query: 89 LSDMGLKGQFPRG-IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEI 147
LS G+ P + + L LDLS N SG +P +++ + +LDLSSN+ SG I
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384
Query: 148 PSGLANC--TFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
L L L L NN FTGKIPP L + + + ++ N L+G +PS
Sbjct: 385 LPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 7/117 (5%)
Query: 89 LSDMGLKGQFPRGIE--RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
LS L G C+ L L++SSN L +L + LDLS+NS+SG
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 147 IPSGLA---NCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
G C L L ++ N+ +G + + ++ V+SN + +P +
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-21
Identities = 32/130 (24%), Positives = 54/130 (41%), Gaps = 9/130 (6%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
I LS+ L G+ P+ I R +L L LS+N+ SG+IP+++ + + LDL++N +G
Sbjct: 495 ISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD-CRSLIWLDLNTNLFNGT 553
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNL--LTGPVPS--FANVN 202
IP+ + + + N GK + K A NL G
Sbjct: 554 IPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLST 609
Query: 203 FTAEDFANNS 212
+ +
Sbjct: 610 RNPCNITSRV 619
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-20
Identities = 29/130 (22%), Positives = 52/130 (40%), Gaps = 9/130 (6%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
++LS+ G P + C SL LDL++N +G+IP+ + S +++N ++G+
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK-----QSGKIAANFIAGK 573
Query: 147 IPSGLANCTFLNVLKL--NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF--ANVN 202
+ N N F G QL L+ ++ S + G N +
Sbjct: 574 RYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633
Query: 203 FTAEDFANNS 212
D + N
Sbjct: 634 MMFLDMSYNM 643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-10
Identities = 21/71 (29%), Positives = 35/71 (49%), Gaps = 4/71 (5%)
Query: 133 VTSLDLSSNSLS---GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASN 189
VTS+DLSS L+ + S L + T L L L+N+ G + + + ++ N
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRN 110
Query: 190 LLTGPVPSFAN 200
L+GPV + +
Sbjct: 111 SLSGPVTTLTS 121
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 63/287 (21%), Positives = 108/287 (37%), Gaps = 46/287 (16%)
Query: 310 KNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNLVP 365
+ IG G Y + + L+D + ++ E F E L ++H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 366 LLGFCV---AKKERLLVYS-YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
K+ +++ + + +GTL L M + +GL +L
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 145
Query: 422 HHNCNPRIIHRNISSKC--ILLDG-DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
H P IIHR++ KC I + G K+ D GLA L + + G +
Sbjct: 146 H-TRTPPIIHRDL--KCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVI----GTPEF 196
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERP-THLTNAPESFKGSLVEWITLLNTNSS 537
+APE DVY+FG+ +LE+ T E P + NA + ++ T+
Sbjct: 197 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---------RVTSGV 246
Query: 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584
+ DK E+ + + C+ ER++ + LL
Sbjct: 247 KPASFDK-----VAIPEVKEIIE---GCIRQNKDERYS---IKDLLN 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-25
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLV 364
+ + +G G+ G Y + + +K L++ +EFL E + ++H NLV
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
LLG C + ++ ++ G L D L E + + L +A + + +L
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
IHRN++++ L+ + K++DFGL+RLM DT+ + G + + APE
Sbjct: 338 ---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH--AGAKFPIKWTAPESL 391
Query: 485 RTLVATPKGDVYSFGVVLLELIT-GERP 511
+ K DV++FGV+L E+ T G P
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
S +G G G ++ G + IK L+ S + FL E + +RH LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L ++ +V Y+ G+L D L ++ P + +A A G+A++
Sbjct: 244 LYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM- 299
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+HR++ + IL+ + K++DFGLARL+ D + +F + + APE
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKF-PIKWTAPEAAL 354
Query: 486 TLVATPKGDVYSFGVVLLELIT-GERP 511
T K DV+SFG++L EL T G P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
+G G+ G ++A + +K ++ S + FL+E N + +++H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
K+ ++ ++ G+L D L E P + + A G+A++ IH
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP 491
R++ + IL+ K++DFGLAR++ D + +F + + APE T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKF-PIKWTAPEAINFGSFTI 364
Query: 492 KGDVYSFGVVLLELIT-GERP 511
K DV+SFG++L+E++T G P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 50/215 (23%), Positives = 83/215 (38%), Gaps = 22/215 (10%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGG-CFIMIKRLED--SQHSEKEFLSEINTLGSVRHRN 362
IG G G + L + +K + + +FL E L H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
+V L+G C K+ +V ++ G L + L++ +A G+ +L
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL---RVKTLLQMVGDAAAGMEYLE 230
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV--- 479
IHR+++++ L+ K+SDFG++R S G L V
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS-------GGLRQVPVK 280
Query: 480 --APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
APE + + DV+SFG++L E + G P
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 2e-23
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
S +G G G ++ G + IK L+ S + FL E + +RH LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L ++ +V Y+ G+L D L ++ P + +A A G+A++
Sbjct: 327 LYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERM- 382
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+HR++ + IL+ + K++DFGLARL+ D + +F + + APE
Sbjct: 383 --NYVHRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKF-PIKWTAPEAAL 437
Query: 486 TLVATPKGDVYSFGVVLLELIT-GERP 511
T K DV+SFG++L EL T G P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 7e-23
Identities = 44/191 (23%), Positives = 79/191 (41%), Gaps = 18/191 (9%)
Query: 335 IKRLE-DSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV----AKKERLLVYSYLENGTLY 389
+KR+ Q +E E + H N++ L+ +C+ AK E L+ + + GTL+
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449
+++ + + + L + +G RGL +H HR++ ILL + +P L
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVL 175
Query: 450 SDFGLARLMNPVDTHLSTFVNGE-----FGDLGYVAPE----YPRTLVATPKGDVYSFGV 500
D G + + + Y APE ++ + DV+S G
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVI-DERTDVWSLGC 234
Query: 501 VLLELITGERP 511
VL ++ GE P
Sbjct: 235 VLYAMMFGEGP 245
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
+ +G G+ G ++ G + +K L+ S FL+E N + ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L ++ ++ Y+ENG+L D L + + L +A A G+A++
Sbjct: 73 LYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV---APE 482
IHR++ + IL+ K++DFGLARL+ D + +F + APE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFP----IKWTAPE 180
Query: 483 YPRTLVATPKGDVYSFGVVLLELIT-GERP 511
T K DV+SFG++L E++T G P
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 46/197 (23%), Positives = 83/197 (42%), Gaps = 43/197 (21%)
Query: 335 IKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH 393
+K L + ++ + F + + + H++LV G CV E +LV +++ G+L L
Sbjct: 45 LKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK 104
Query: 394 PAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEP----- 447
++ + + +L +A A + +L + IH N+ +K ILL + +
Sbjct: 105 KNKNCINILW---KLEVAKQLAAAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNP 157
Query: 448 ---KLSDFGLARLMNPVDTHLSTFVNGEFGDLGY------VAPE---YPRTLVATPKGDV 495
KLSD G++ + P D V PE P+ L D
Sbjct: 158 PFIKLSDPGISITVLPKD--------------ILQERIPWVPPECIENPKNL--NLATDK 201
Query: 496 YSFGVVLLELIT-GERP 511
+SFG L E+ + G++P
Sbjct: 202 WSFGTTLWEICSGGDKP 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-22
Identities = 51/208 (24%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
+ + IG+G+ G ++ + IK + + SE++F+ E + + H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHN 424
L G C+ + LV ++E+G L D L L + + G+A+L
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC 124
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
IHR+++++ L+ + K+SDFG+ R + D ++ +F + + +PE
Sbjct: 125 V----IHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKF-PVKWASPEVF 177
Query: 485 RTLVATPKGDVYSFGVVLLELIT-GERP 511
+ K DV+SFGV++ E+ + G+ P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
+ +GTG+ G G + IK +++ SE EF+ E + ++ H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHN 424
L G C ++ ++ Y+ NG L + L H L + + +L
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---LLEMCKDVCEAMEYLESKQ 140
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV---AP 481
+HR+++++ L++ K+SDFGL+R + D ++ V +F V P
Sbjct: 141 F----LHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSVGSKFP----VRWSPP 190
Query: 482 EYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
E + K D+++FGV++ E+ + G+ P
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 57/282 (20%), Positives = 102/282 (36%), Gaps = 31/282 (10%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKE---FLSEINTLGSVRHRN 362
F IG G+ Y A L G + +K+++ K + EI+ L + H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
++ + E +V + G L + + + + + + L +H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
R++HR+I + + KL D GL R + T + V G Y++PE
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPE 206
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN--TNSSLET 540
K D++S G +L E+ + P F G + +L
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSP---------FYGDKMNLYSLCKKIEQCDYP- 256
Query: 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582
L + + EL Q + C+ P P++R + VY +
Sbjct: 257 ----PLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDV 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 25/225 (11%)
Query: 302 MKAT-NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE---FLSEINTLG 356
M + + IGTG G G ++ K L+ +E E +SE+N L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 357 SVRHRNLVPLLGFCVAKKERLL--VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGS 414
++H N+V + + L V Y E G L + E ++D LR+
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 415 ARGLAWLH--HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE 472
L H + ++HR++ + LDG KL DFGLAR++N + TFV
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--- 177
Query: 473 FGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERP 511
G Y++PE Y K D++S G +L EL P
Sbjct: 178 -GTPYYMSPEQMNRMSY------NEKSDIWSLGCLLYELCALMPP 215
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 11/209 (5%)
Query: 335 IKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLENGTLYDK 391
+K+L +++F EI L ++ +V G + LV YL +G L D
Sbjct: 57 VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 116
Query: 392 LHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451
L + L L + +G+ +L R +HR+++++ IL++ + K++D
Sbjct: 117 LQRHRARLDASR--L-LLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD 170
Query: 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GER 510
FGLA+L+ + G+ + + APE + + + DV+SFGVVL EL T ++
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQS-PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 511 PTHLTNAPESFKGSLVEWITLLNTNSSLE 539
+ G + L LE
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLE 258
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 306 NSFSKNNIIGTGRTGATY--IAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV 358
F K ++G+G G Y + + G + IK L + S + KE L E + SV
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGL 418
+ ++ LLG C+ L+ + G L D + + ++ L + A+G+
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGM 130
Query: 419 AWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+L R++HR+++++ +L+ K++DFGLA+L+ + G+ + +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKV-PIKW 185
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+A E + T + DV+S+GV + EL+T G +P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 13/203 (6%)
Query: 313 IIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNLVPLLG 368
IG G G + G +IK + S+ S KE E+ L +++H N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
+V Y E G L+ +++ + + L + L +H +
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVHDR---K 145
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV 488
I+HR+I S+ I L D +L DFG+AR++N + G Y++PE
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI----GTPYYLSPEICENKP 201
Query: 489 ATPKGDVYSFGVVLLELITGERP 511
K D+++ G VL EL T +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 313 IIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
+G+G+ G + G + +K +++ SE EF E T+ + H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR 432
+ +V Y+ NG L + L + L + G+A+L + + IHR
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ---LLEMCYDVCEGMAFLESH---QFIHR 128
Query: 433 NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV---APEYPRTLVA 489
+++++ L+D D K+SDFG+ R + D + V +F V APE
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFP----VKWSAPEVFHYFKY 182
Query: 490 TPKGDVYSFGVVLLELIT-GERP 511
+ K DV++FG+++ E+ + G+ P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMP 205
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIM-IKRLEDSQHSEKEFLSEINTLGSVRHRNLV 364
+ + +G G+ G Y + + +K L++ +EFL E + ++H NLV
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HH 423
LLG C + ++ ++ G L D L E + + L +A + + +L
Sbjct: 73 QLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY 483
N IHR+++++ L+ + K++DFGL+RLM DT+ + +F + + APE
Sbjct: 131 NF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH-AGAKF-PIKWTAPES 183
Query: 484 PRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ K DV++FGV+L E+ T G P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 54/214 (25%), Positives = 102/214 (47%), Gaps = 17/214 (7%)
Query: 306 NSFSKNNIIGTGRTGATY--IAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV 358
F K ++G+G G Y + + G + IK L + S + KE L E + SV
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGL 418
+ ++ LLG C+ L+ + G L D + + ++ L + A+G+
Sbjct: 75 DNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGM 130
Query: 419 AWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+L R++HR+++++ +L+ K++DFGLA+L+ + G+ + +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKV-PIKW 185
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+A E + T + DV+S+GV + EL+T G +P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 11/193 (5%)
Query: 335 IKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLENGTLYDK 391
+K+L ++ ++F EI L S++H N+V G C + R L+ YL G+L D
Sbjct: 44 VKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 103
Query: 392 LHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451
L + + H+ L+ +G+ +L R IHR+++++ IL++ + K+ D
Sbjct: 104 LQKHKERIDHIK---LLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157
Query: 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GER 510
FGL +++ GE + + APE + DV+SFGVVL EL T E+
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGES-PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 216
Query: 511 PTHLTNAPESFKG 523
G
Sbjct: 217 SKSPPAEFMRMIG 229
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 42/195 (21%), Positives = 88/195 (45%), Gaps = 12/195 (6%)
Query: 335 IKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLENGTLYD 390
+K L E + + EI L ++ H N+V G C L+ +L +G+L +
Sbjct: 55 VKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 114
Query: 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
L ++++ +L+ A+ +G+ +L + +HR+++++ +L++ + + K+
Sbjct: 115 YLPKNKNKINLKQ---QLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIG 168
Query: 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GE 509
DFGL + + + + + + + + APE DV+SFGV L EL+T +
Sbjct: 169 DFGLTKAIETDKEYYTVKDDRDS-PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCD 227
Query: 510 RPTHLTNAPESFKGS 524
+ G
Sbjct: 228 SDSSPMALFLKMIGP 242
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 54/208 (25%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
IG G G + G + +K +++ + + FL+E + + +RH NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQ 250
Query: 366 LLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
LLG V +K L +V Y+ G+L D L + L+ ++ + +L N
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+HR+++++ +L+ D K+SDFGL + + G+ + + APE
Sbjct: 309 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKL-PVKWTAPEAL 358
Query: 485 RTLVATPKGDVYSFGVVLLELIT-GERP 511
R + K DV+SFG++L E+ + G P
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 17/214 (7%)
Query: 306 NSFSKNNIIGTGRTGATY--IAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV 358
K ++G+G G + + + G + IK +ED + S + + +GS+
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGL 418
H ++V LLG C LV YL G+L D + + L L + A+G+
Sbjct: 73 DHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQL--L-LNWGVQIAKGM 128
Query: 419 AWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+L + ++HRN++++ +LL + +++DFG+A L+ P D L + + +
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-SEAKT-PIKW 183
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+A E T + DV+S+GV + EL+T G P
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 335 IKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLENGTLYDK 391
+K+L ++ ++F EI L S++H N+V G C + R L+ YL G+L D
Sbjct: 75 VKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY 134
Query: 392 LHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451
L + + H+ L+ +G+ +L R IHR+++++ IL++ + K+ D
Sbjct: 135 LQKHKERIDHIK---LLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188
Query: 452 FGLARLMNPVDTHLSTFVNGEFGDL--GYVAPEYPRTLVATPKGDVYSFGVVLLELIT-G 508
FGL ++ + + E G+ + APE + DV+SFGVVL EL T
Sbjct: 189 FGLTKV---LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245
Query: 509 ERPTHLTNAPESFKG 523
E+ G
Sbjct: 246 EKSKSPPAEFMRMIG 260
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 24/110 (21%), Positives = 44/110 (40%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
+S + F +SL L ++ N+ + DI + L+ +T LDLS L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
+ + + L VL +++N F LN ++ + N +
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 22/112 (19%), Positives = 35/112 (31%), Gaps = 2/112 (1%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ LS G+ L LD +NL + L+ + LD+S
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPS 197
+ L VLK+ N F P L + ++ L P+
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-17
Identities = 24/114 (21%), Positives = 39/114 (34%), Gaps = 3/114 (2%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
LS L+ L LDLS + S L ++++L L+ N +
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQS-LSHLSTLILTGNPIQSLAL 93
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG--PVPSFAN 200
+ + L L +G L +K +VA NL+ F+N
Sbjct: 94 GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-16
Identities = 23/113 (20%), Positives = 40/113 (35%), Gaps = 5/113 (4%)
Query: 83 KVLNIRLSDMGLKGQFPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141
+VL ++ + F I +LT LDLS L P+ +S L + L++S N
Sbjct: 448 EVLK--MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS-LSSLQVLNMSHN 504
Query: 142 SLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLG-LLNRIKTFSVASNLLTG 193
+ L VL + N +L + + ++ N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-13
Identities = 19/100 (19%), Positives = 33/100 (33%), Gaps = 6/100 (6%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
+E ++T N IP ++ + LDLS N L + L VL
Sbjct: 4 VEVVPNIT-YQCMELNFY-KIPDNLPFSTKN---LDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP-SFAN 200
L+ L+ + T + N + +F+
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 21/145 (14%), Positives = 43/145 (29%), Gaps = 5/145 (3%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ + L I +L L+++ N + + S L + LDLSSN +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 147 IPSGLANCTFLNV----LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN 202
+ L + + L L+ N P + + ++ +N + V
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQG 223
Query: 203 FTAEDFANNSGLCGKPLNPCPGVPK 227
+ + K
Sbjct: 224 LAGLEVHRLVLGEFRNEGNLEKFDK 248
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 35/167 (20%), Positives = 57/167 (34%), Gaps = 18/167 (10%)
Query: 35 NDIECLKSVKNSLEDPFNYLT--TSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDM 92
+ L + + D FN LT +S++ + T + F+ ++ L +
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY-------NFGWQHLELVNC 314
Query: 93 GLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS--GEIPSG 150
GQFP SL L +SN + L++ LDLS N LS G
Sbjct: 315 KF-GQFPTLK--LKSLKRLTFTSNKGGNAFSEVDLPSLEF---LDLSRNGLSFKGCCSQS 368
Query: 151 LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
T L L L+ N + L +++ + L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 18/139 (12%), Positives = 36/139 (25%), Gaps = 25/139 (17%)
Query: 84 VLNIRLSDMGLK-GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
+ RL+ + T+++ L S + + Q+ L+L +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH---LELVNCK 315
Query: 143 LS-------------------GEIPSGLANCTFLNVLKLNNNR--FTGKIPPQLGLLNRI 181
G + L L L+ N F G +
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 182 KTFSVASNLLTGPVPSFAN 200
K ++ N + +F
Sbjct: 376 KYLDLSFNGVITMSSNFLG 394
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 18/95 (18%), Positives = 30/95 (31%), Gaps = 4/95 (4%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
+VLN +S + SL LD S N++ S ++ + L+L+ N
Sbjct: 497 QVLN--MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 143 LSGEIPSG--LANCTFLNVLKLNNNRFTGKIPPQL 175
+ L L + R P
Sbjct: 555 FACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 16/144 (11%), Positives = 35/144 (24%), Gaps = 12/144 (8%)
Query: 89 LSDMGLKGQFPRG-IERCTSLTGLDLSSNNLSGS--IPSDISSRLQYVTSLDLSSNSLS- 144
L + + I+ L L + S L+ + +L + L+
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 145 -----GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA 199
+I T ++ L + + + + P+
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ-FPTLK 323
Query: 200 NVNFTAEDFANNSGLCGKPLNPCP 223
+ F +N G P
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLP 347
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 18/106 (16%), Positives = 34/106 (32%), Gaps = 5/106 (4%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166
++ L+ + D+ + L V+S L S ++ + L+L N +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCK 315
Query: 167 FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212
F P L +K + SN + D + N
Sbjct: 316 FGQ-FPTL--KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 46/213 (21%), Positives = 78/213 (36%), Gaps = 20/213 (9%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHR 361
+ + +G G G + G +K RLE + E + +
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE------LVACAGLSSP 110
Query: 362 NLVPLLGFCVAKKERLLVY-SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
+VPL G V + + ++ LE G+L + + L + GL +
Sbjct: 111 RIVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEY 165
Query: 421 LHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMNPVDTHLSTFVNGEF-GDLGY 478
LH RI+H ++ + +LL D L DFG A + P S G +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+APE K D++S ++L ++ G P
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 8e-20
Identities = 49/237 (20%), Positives = 91/237 (38%), Gaps = 22/237 (9%)
Query: 289 FEKSVEKMRLSDLMKATNSFSKNNIIGTGRT--GATYIAM-LPGGCFIMIKR--LEDSQH 343
+++ +S + + +IG G +A P G ++ ++R LE +
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN 67
Query: 344 SEKEFLS-EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHM 402
FL E++ H N+VP +A E +V S++ G+ D + + M+
Sbjct: 68 EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE 127
Query: 403 DWPLRLRIAI---GSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459
IA G + L ++HH +HR++ + IL+ D + LS M
Sbjct: 128 LA-----IAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179
Query: 460 PVDTHLSTFVNGEFGDLG---YVAPEYPRTLVA--TPKGDVYSFGVVLLELITGERP 511
+ + +++PE + + K D+YS G+ EL G P
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 9e-20
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
IG G G + G + +K +++ + + FL+E + + +RH NLV LLG V
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 372 AKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNCNPRI 429
+K L +V Y+ G+L D L + L+ ++ + +L +N
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---- 138
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV---APEYPRT 486
+HR+++++ +L+ D K+SDFGL + + + G+ V APE R
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQ-DTGKLP----VKWTAPEALRE 188
Query: 487 LVATPKGDVYSFGVVLLELIT-GERP 511
+ K DV+SFG++L E+ + G P
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 27/260 (10%), Positives = 58/260 (22%), Gaps = 45/260 (17%)
Query: 287 SAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAM--LPGGCF---IMIKRLEDS 341
+ + ++ E S L + + G ++ F + E+S
Sbjct: 43 TVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102
Query: 342 QHSEKEFLSEINTLGSVRHRNLVPLLGFC--------------------------VAKKE 375
+ + + + A
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 376 RLLVYSYL--ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRN 433
LL+ + L+ L + R A L ++H +
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGH 219
Query: 434 ISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY--PRTLVATP 491
+ + + D L D V T + Y E+ T T
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW---KVGTRGPASS----VPVTYAPREFLNASTATFTH 272
Query: 492 KGDVYSFGVVLLELITGERP 511
+ + G+ + + P
Sbjct: 273 ALNAWQLGLSIYRVWCLFLP 292
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 306 NSFSKNNIIGTGRTGATYIAML--PGGCFIM--IKRL----EDSQHSEKEFLSEINTLGS 357
+G G G P G + +K L + +F+ E+N + S
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 358 VRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARG 417
+ HRNL+ L G + +V G+L D+L + + R A+ A G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLL---GTLSRYAVQVAEG 133
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
+ +L R IHR+++++ +LL K+ DFGL R + D H + +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV-PFA 189
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ APE +T + D + FGV L E+ T G+ P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 43/235 (18%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNL 363
+ F + ++G G G A + IK++ ++ LSE+ L S+ H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 364 VPLLGFCVAKKERLLVYS-------------YLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
V + ++ + + Y ENGTLYD +H + R+
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL---NQQRDEYWRL 121
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN--------- 459
L+++H IIHR++ K I +D K+ DFGLA+ ++
Sbjct: 122 FRQILEALSYIHSQ---GIIHRDL--KPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 460 -----PVDTHLSTFVNGEFGDLGYVAPE-YPRTLVATPKGDVYSFGVVLLELITG 508
+L++ + G YVA E T K D+YS G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAI----GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 306 NSFSKNNIIGTGRTGATYIAML--PGGCFIM--IKRL--EDSQHSEKEFLSEINTLGSVR 359
+ S + ++G G G L P I IK L ++ ++FL E + +G
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 360 HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
H N++ L G K ++V Y+ENG+L L + + + + G A G+
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF---TVIQLVGMLRGIASGMK 161
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
+L +HR+++++ IL++ + K+SDFGL R++ T G+ + +
Sbjct: 162 YLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI-PIRWT 217
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+PE T DV+S+G+VL E+++ GERP
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 41/181 (22%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 335 IKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
IK L + +E + E + + + +V L+G C + +LV G L+ L
Sbjct: 42 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL 100
Query: 393 HPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSD 451
+ + + G+ +L N +HR+++++ +LL K+SD
Sbjct: 101 VGKRE---EIPVSNVAELLHQVSMGMKYLEEKNF----VHRDLAARNVLLVNRHYAKISD 153
Query: 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GER 510
FGL++ + D++ + G++ L + APE + + DV+S+GV + E ++ G++
Sbjct: 154 FGLSKALGADDSYYTARSAGKW-PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
Query: 511 P 511
P
Sbjct: 213 P 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 19/214 (8%)
Query: 306 NSFSKNNIIGTGRTGATY--IAMLPGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVR 359
IG G+ G + I M P + IK ++ S ++FL E T+
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 360 HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
H ++V L+G + ++ G L L ++ + + A + LA
Sbjct: 75 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALA 130
Query: 420 WL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+L +HR+I+++ +L+ + KL DFGL+R M D+ G+ + +
Sbjct: 131 YLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKL-PIKW 183
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+APE T DV+ FGV + E++ G +P
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 82/299 (27%), Positives = 121/299 (40%), Gaps = 46/299 (15%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKR--LEDSQHSEKEFLSEINTLGSVRHRN 362
+ + +IG+G T A P + IKR LE Q S E L EI + H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 363 LVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR-LRIAI---GSARG 417
+V K+ L LV L G++ D + + H L IA G
Sbjct: 75 IVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL-ARLMNPVDTHLS----TFVNGE 472
L +LH N IHR++ + ILL D +++DFG+ A L D + TFV
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 473 FGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525
++APE Y K D++SFG+ +EL TG P + P
Sbjct: 191 C----WMAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP-YHKYPP-----MK 234
Query: 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584
V +TL N SLET + + + + + + C+ P++R T +LLR
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL---CLQKDPEKRPT---AAELLR 287
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 49/210 (23%), Positives = 87/210 (41%), Gaps = 19/210 (9%)
Query: 310 KNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVPLL 367
++G G G Y L I IK + + EI ++H+N+V L
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 368 GFCVAKKERLLVY-SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
G + + ++ + G+L L ++ + + GL +LH N
Sbjct: 86 GSFS-ENGFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 141
Query: 427 PRIIHRNISSKC--ILLD-GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE- 482
+I+HR+I K +L++ K+SDFG ++ + ++ TF G L Y+APE
Sbjct: 142 -QIVHRDI--KGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT----GTLQYMAPEI 194
Query: 483 -YPRTLVATPKGDVYSFGVVLLELITGERP 511
D++S G ++E+ TG+ P
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 4e-19
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 313 IIGTGRTGATY--IAMLPGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVRHRNLVPL 366
IG G+ G + I M P + IK ++ S ++FL E T+ H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH-HNC 425
+G + ++ G L L + + + A + LA+L
Sbjct: 457 IGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQLSTALAYLESKRF 512
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+HR+I+++ +L+ + KL DFGL+R M D+ G+ + ++APE
Sbjct: 513 ----VHRDIAARNVLVSSNDCVKLGDFGLSRYME--DSTYYKASKGKL-PIKWMAPESIN 565
Query: 486 TLVATPKGDVYSFGVVLLELIT-GERP 511
T DV+ FGV + E++ G +P
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 53/197 (26%), Positives = 81/197 (41%), Gaps = 18/197 (9%)
Query: 335 IKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER--LLVYSYLENGTLYD 390
+K L + + EI+ L ++ H +++ G C LV Y+ G+L D
Sbjct: 65 VKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRD 124
Query: 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
L H + L A G+A+LH IHR+++++ +LLD D K+
Sbjct: 125 YLP--RHSIGLAQ---LLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIG 176
Query: 451 DFGLARLMNPVDTHLSTFVNGEFGDL--GYVAPEYPRTLVATPKGDVYSFGVVLLELIT- 507
DFGLA+ V + E GD + APE + DV+SFGV L EL+T
Sbjct: 177 DFGLAKA---VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
Query: 508 GERPTHLTNAPESFKGS 524
+ G
Sbjct: 234 CDSSQSPPTKFLELIGI 250
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 46/207 (22%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 313 IIGTGRTGATYIAMLPGGCFIM---IKRL---EDSQHSEKEFLSEINTLGSVRHRNLVPL 366
+G+G G + +K L + + E L+E N + + + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNC 425
+G C + +LV E G L L ++ H+ + + + G+ +L N
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQ--QNR--HVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+HR+++++ +LL K+SDFGL++ + + + +G++ + + APE
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW-PVKWYAPECIN 193
Query: 486 TLVATPKGDVYSFGVVLLELIT-GERP 511
+ K DV+SFGV++ E + G++P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 6e-19
Identities = 53/199 (26%), Positives = 80/199 (40%), Gaps = 21/199 (10%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLL------GFCVAKKERLLVYSYLENGT 387
++ ++ E+ + EI + + H N+V LL Y E G
Sbjct: 46 QCRQELSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGD 104
Query: 388 LYDKLHPAEHE-VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446
L L+ E+ + L I SA L +LH N RIIHR++ + I+L +
Sbjct: 105 LRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLHEN---RIIHRDLKPENIVLQPGPQ 159
Query: 447 P---KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLL 503
K+ D G A+ ++ + FV G L Y+APE T D +SFG +
Sbjct: 160 RLIHKIIDLGYAKELDQ-GELCTEFV----GTLQYLAPELLEQKKYTVTVDYWSFGTLAF 214
Query: 504 ELITGERPTHLTNAPESFK 522
E ITG RP P +
Sbjct: 215 ECITGFRPFLPNWQPVQWH 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 6e-19
Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 13/181 (7%)
Query: 335 IKRL--EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
IK L + +E + E + + + +V L+G C + +LV G L+ L
Sbjct: 368 IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL 426
Query: 393 HPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSD 451
+ + + G+ +L N +HRN++++ +LL K+SD
Sbjct: 427 VGKRE---EIPVSNVAELLHQVSMGMKYLEEKNF----VHRNLAARNVLLVNRHYAKISD 479
Query: 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GER 510
FGL++ + D++ + G++ L + APE + + DV+S+GV + E ++ G++
Sbjct: 480 FGLSKALGADDSYYTARSAGKW-PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 511 P 511
P
Sbjct: 539 P 539
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 335 IKRLEDSQHSEKEFLS----EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390
IK + ++E L E++ + H+N+V ++ LV Y+E TL +
Sbjct: 41 IKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSE 100
Query: 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
+ + + G+ H RI+HR+I + IL+D + K+
Sbjct: 101 YIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIF 153
Query: 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGER 510
DFG+A+ ++ +T L T N G + Y +PE + D+YS G+VL E++ GE
Sbjct: 154 DFGIAKALS--ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
Query: 511 P 511
P
Sbjct: 211 P 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 55/281 (19%), Positives = 94/281 (33%), Gaps = 57/281 (20%)
Query: 335 IKRLE-DSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKER-------LLVYSYLEN 385
+KRL + + + + E+ + + H N+V KE L+ + L
Sbjct: 58 LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 386 GTLYDKLHPA-------EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438
G L + L V L+I + R + +H P IIHR++ +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTV--------LKIFYQTCRAVQHMHR-QKPPIIHRDLKVEN 168
Query: 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNG--------EFGDLGYVAPE---YPRTL 487
+LL KL DFG A ++ + + Y PE
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 488 VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLL 547
K D+++ G +L L + P F+ I +N S+ +
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHP---------FEDGAKLRI--VNGKYSIPPHDTQY-- 275
Query: 548 GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588
H +R + P+ER ++ EV L+ IA
Sbjct: 276 -----TVFHSLIR---AMLQVNPEERLSIAEVVHQLQEIAA 308
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-19
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVP 365
+++ IG G +G Y AM + G + I+++ Q ++ ++EI + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 366 LLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAI---GSARGLAWL 421
L + L +V YL G+L D + + IA + L +L
Sbjct: 82 YLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ--------IAAVCRECLQALEFL 132
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
H N ++IHR+I S ILL D KL+DFG + P + ST V G ++AP
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAP 185
Query: 482 EYPRTLVATPKGDVYSFGVVLLELITGERP 511
E PK D++S G++ +E+I GE P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 17/215 (7%)
Query: 306 NSFSKNNIIGTGRTGATYIAML--PGGCFIM---IKRL--EDSQHSEKEFLSEINTLGSV 358
+ ++ +IG G G Y ML G + IK L ++ +FL E +G
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGL 418
H N++ L G K +++ Y+ENG L L + E + + G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF---SVLQLVGMLRGIAAGM 160
Query: 419 AWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
+L + N +HR+++++ IL++ + K+SDFGL+R++ T G+ +
Sbjct: 161 KYLANMNY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI-PIR 215
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+ APE T DV+SFG+V+ E++T GERP
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 8/134 (5%)
Query: 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437
+V Y++ TL D +H M + + + + L + H N IIHR++
Sbjct: 93 IVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPA 145
Query: 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYS 497
I++ K+ DFG+AR + + T G Y++PE R + DVYS
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 498 FGVVLLELITGERP 511
G VL E++TGE P
Sbjct: 205 LGCVLYEVLTGEPP 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 312 NIIGTGRTGATYIAML--PGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVRHRNLVP 365
IIG+G +G L PG + IK L+ ++ ++FLSE + +G H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HHN 424
L G + ++V Y+ENG+L L + + M + + G G+ +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGMRYLSDLG 171
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+HR+++++ +L+D + K+SDFGL+R++ T G+ + + APE
Sbjct: 172 Y----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI-PIRWTAPEAI 226
Query: 485 RTLVATPKGDVYSFGVVLLELIT-GERP 511
+ DV+SFGVV+ E++ GERP
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 48/191 (25%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC-----VAKKERLLVYSYLENGTL 388
+K SQ +EFLSE + H N++ LLG C + +++ +++ G L
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 389 YDKLHPAEHEVMHMDWPLR--LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446
+ L + E PL+ L+ + A G+ +L + +HR+++++ +L D
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMT 185
Query: 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV-----APEYPRTLVATPKGDVYSFGVV 501
++DFGL++ + D + G + + A E V T K DV++FGV
Sbjct: 186 VCVADFGLSKKIYSGDYY-------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 502 LLELIT-GERP 511
+ E+ T G P
Sbjct: 239 MWEIATRGMTP 249
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 311 NNIIGTGRTG----ATYIAMLPGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVRHRN 362
+ +G G G ++ IK + + S EFL+E + + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRL------RIAIGSAR 416
+V LLG + L++ + G L L + + ++A A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
G+A+L+ N + +HR+++++ ++ DF K+ DFG+ R + D + G
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-------RKGGK 199
Query: 477 GYV-----APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
G + +PE + V T DV+SFGVVL E+ T E+P
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 71/299 (23%), Positives = 126/299 (42%), Gaps = 18/299 (6%)
Query: 223 PGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMRGVYVKKKEDDPEGNKWAKRIKGTK 282
P G A+ AAG+ G+ C + + + N + +
Sbjct: 6 PMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVH 65
Query: 283 GIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATY--IAMLPGGCFIM--IKRL 338
+ + V+ ++ + ++ N +IG G G Y + G I +K L
Sbjct: 66 IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 125
Query: 339 ED--SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE-RLLVYSYLENGTLYDKLHPA 395
+FL+E + H N++ LLG C+ + L+V Y+++G L + +
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
Query: 396 EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455
H D + + A+G+ +L + +HR+++++ +LD F K++DFGLA
Sbjct: 186 THNPTVKD---LIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 239
Query: 456 RLMNPVDTHLSTFVNGEFGDL--GYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
R M + + N L ++A E +T T K DV+SFGV+L EL+T G P
Sbjct: 240 RDMYDKEFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 47/226 (20%), Positives = 92/226 (40%), Gaps = 43/226 (19%)
Query: 306 NSFSKNNIIGTGRTGATYIAML--PGGCFIM--IKRL--EDSQHSEKEFLSEINTLGSVR 359
N I+G G G Y + G I +K + + ++++F+SE + ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 360 HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
H ++V L+G ++ ++ G L L ++ + + + ++ + +A
Sbjct: 72 HPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMA 127
Query: 420 WL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+L NC +HR+I+ + IL+ KL DFGL+R + D Y
Sbjct: 128 YLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIE---------------DEDY 168
Query: 479 V------------APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
+PE T DV+ F V + E+++ G++P
Sbjct: 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 16/207 (7%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVP 365
IG G TG +A G + +K ++ Q + +E+ + +H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 366 LLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
+ E L ++ +L+ G L D + + + LA+LH
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHAQ 160
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+IHR+I S ILL D KLSDFG ++ + V G ++APE
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVI 213
Query: 485 RTLVATPKGDVYSFGVVLLELITGERP 511
+ + D++S G++++E++ GE P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 20/211 (9%)
Query: 312 NIIGTGRTGATY--IAMLPGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVRHRNLVP 365
+IG G G Y + I IK L + FL E + + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 366 LLGFCVAKKERLL-VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL-HH 423
L+G + + + Y+ +G L + + D + + ARG+ +L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEYLAEQ 143
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL--GYVAP 481
+HR+++++ +LD F K++DFGLAR + D + L + A
Sbjct: 144 KF----VHRDLAARNCMLDESFTVKVADFGLARDIL--DREYYSVQQHRHARLPVKWTAL 197
Query: 482 EYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
E +T T K DV+SFGV+L EL+T G P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 40/193 (20%), Positives = 76/193 (39%), Gaps = 29/193 (15%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS------------- 381
IKR++ ++ ++ E+ L + H N+V G S
Sbjct: 41 IKRVK---YNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFI 97
Query: 382 ---YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438
+ + GTL + E +D L L + +G+ ++H ++I+R++
Sbjct: 98 QMEFCDKGTLEQWIEKRRGE--KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSN 152
Query: 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSF 498
I L + K+ DFGL + D + G L Y++PE + + D+Y+
Sbjct: 153 IFLVDTKQVKIGDFGLVTSLKN-DGKRTRSK----GTLRYMSPEQISSQDYGKEVDLYAL 207
Query: 499 GVVLLELITGERP 511
G++L EL+
Sbjct: 208 GLILAELLHVCDT 220
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 42/223 (18%), Positives = 80/223 (35%), Gaps = 39/223 (17%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLV------ 364
+G G G + A C IK RL + + + ++ + E+ L + H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 365 ---PLLGFCVAKKERLLVY---SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGL 418
++ +Y L D ++ + + + L I + A +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQIAEAV 131
Query: 419 AWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG- 477
+LH ++HR++ I D K+ DFGL M+ + +
Sbjct: 132 EFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 478 -------YVAPE------YPRTLVATPKGDVYSFGVVLLELIT 507
Y++PE Y + K D++S G++L EL+
Sbjct: 189 GQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY 225
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 29/181 (16%), Positives = 52/181 (28%), Gaps = 15/181 (8%)
Query: 32 ATLNDIECLKSVKNSLEDP-------FNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKV 84
+ D LK + ++L +WNFN + + Q GV +V
Sbjct: 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQ-PGVSLN--SNGRV 83
Query: 85 LNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL---DLSSN 141
+ L G G+ P I + T L L L S+ + + S
Sbjct: 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143
Query: 142 SLSGEIPSGLANCTFLNV--LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA 199
F ++ +N++ I + + SN +T +
Sbjct: 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVM 203
Query: 200 N 200
Sbjct: 204 R 204
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 15/141 (10%), Positives = 41/141 (29%), Gaps = 14/141 (9%)
Query: 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISS 128
F N + LT +++ + +P+ +
Sbjct: 216 SPFVAE----NICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL-K 270
Query: 129 RLQYVTSLDLSSNSL--------SGEIPSGLANCTFLNVLKLNNNRF-TGKIPPQLGLLN 179
L + ++++ N + + + ++ + N T + L +
Sbjct: 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK 330
Query: 180 RIKTFSVASNLLTGPVPSFAN 200
++ N L G +P+F +
Sbjct: 331 KLGMLECLYNQLEGKLPAFGS 351
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 22/118 (18%), Positives = 45/118 (38%), Gaps = 5/118 (4%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNL-SGSIPSDISSRLQYVTSLDLSSNSLSGEI 147
+ Q + + + NNL + + + + +++ + L+ N L G++
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ-KMKKLGMLECLYNQLEGKL 346
Query: 148 PSGLANCTFLNVLKLNNNRFTGKIPPQL-GLLNRIKTFSVASNLLTGPVPSFANVNFT 204
P+ + L L L N+ T IP G +++ S A N L F + +
Sbjct: 347 PA-FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-17
Identities = 25/108 (23%), Positives = 40/108 (37%), Gaps = 9/108 (8%)
Query: 98 FPRGIERCTSLTGLDLSSNNLSGSIPSDIS-SRLQYVTSLDLSSNSLSGEIPSGLANCTF 156
+ LT +DL N L+ + D + L Y+ +DLS NS S P+ N +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 157 LNVLKLNN------NRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
L + N NR + P + L + + SN +
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-16
Identities = 18/124 (14%), Positives = 40/124 (32%), Gaps = 11/124 (8%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
I D + +++ ++LS+N +S S+ ++S++L N L+
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST-GSPLSSINLMGNMLTE 471
Query: 146 -------EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLN--RIKTFSVASNLLTGPVP 196
+ N L + L N+ T + + ++ N +
Sbjct: 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPT 530
Query: 197 SFAN 200
N
Sbjct: 531 QPLN 534
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 17/117 (14%), Positives = 37/117 (31%), Gaps = 13/117 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISS------RLQYVTSLDLSSNSLSGEIPSGLANC 154
+ + ++ +D S N + + + V+S++LS+N +S +
Sbjct: 397 DAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTG 456
Query: 155 TFLNVLKLNNNRFTG-------KIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFT 204
+ L+ + L N T + + + N LT F
Sbjct: 457 SPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP 513
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 17/142 (11%), Positives = 43/142 (30%), Gaps = 28/142 (19%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS--------------- 127
K I + + + R T L + ++ +
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242
Query: 128 ---SRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFT--------GKIPPQLG 176
L+ +T +++ + ++P+ L + ++ + NR +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 177 LLNRIKTFSVASN-LLTGPVPS 197
+ +I+ + N L T PV +
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVET 324
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 21/133 (15%), Positives = 42/133 (31%), Gaps = 9/133 (6%)
Query: 85 LNIRLSDMGLKGQFPRGIER--CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
+ M + F R + L ++S+ SI L+ T + SN+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD-TQIGQLSNN 194
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-V 201
++ + + T L + N+ F + + + A T + N
Sbjct: 195 ITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN---ENSEYAQQYKTED-LKWDNLK 249
Query: 202 NFTAEDFANNSGL 214
+ T + N L
Sbjct: 250 DLTDVEVYNCPNL 262
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
++P GI C SLT L + SN++ + I+ + LD+ N
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISV---LDIKDNPNIS 601
Query: 146 EIPSGLANCTFLNVLKLNNNR 166
S + + L ++
Sbjct: 602 IDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 16/102 (15%), Positives = 29/102 (28%), Gaps = 22/102 (21%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF 156
+FP ++L G + + D N E P G+ C
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQ-------------------RDAQGNRTLREWPEGITLCPS 567
Query: 157 LNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
L L++ +N + + I + N S+
Sbjct: 568 LTQLQIGSNDIRK-VNE--KITPNISVLDIKDNPNISIDLSY 606
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 312 NIIGTGRTGATY--IAMLPGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVRHRNLVP 365
+IG G G Y + G I +K L +FL+E + H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 366 LLGFCVAKKE-RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
LLG C+ + L+V Y+++G L + + H D + + A+G+ +L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLASK 147
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV---AP 481
+ +HR+++++ +LD F K++DFGLAR M + + V+ + G V A
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYS---VHNKTGAKLPVKWMAL 201
Query: 482 EYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
E +T T K DV+SFGV+L EL+T G P
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 41/164 (25%), Positives = 62/164 (37%), Gaps = 10/164 (6%)
Query: 348 FLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
E T G ++ ++VP+ F + + + L L + P
Sbjct: 81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRA 136
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467
+ I L H HR++ + IL+ D L DFG+A D L T
Sbjct: 137 VAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKL-T 190
Query: 468 FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+ G L Y+APE AT + D+Y+ VL E +TG P
Sbjct: 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 32/234 (13%), Positives = 66/234 (28%), Gaps = 40/234 (17%)
Query: 305 TNSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRLEDSQHSEKEFL-SEINTLGS 357
+ ++++G G Y A ++K + + E + L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 358 VRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMH-MDWPLRLRIAIGSAR 416
+ + + +LV GTL + ++ ++ M L + A+
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEP-----------KLSDFGLARLMN--PVDT 463
+ +H IIH +I +L F L D G + M P T
Sbjct: 184 MIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 464 HLSTFVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ G+ E + + D + + ++ G
Sbjct: 241 IFTAKC----ETSGFQCVEMLSNKPW------NYQIDYFGVAATVYCMLFGTYM 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKR--LEDSQHSEKEFLSEINTLGSVRHRNLV 364
F+K IG G G + + + IK LE+++ ++ EI L +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 365 PLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR-LRIAI---GSARGLA 419
G K +L ++ YL G+ D L P PL +IA +GL
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPG---------PLDETQIATILREILKGLD 133
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
+LH + IHR+I + +LL E KL+DFG+A + +TFV G ++
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWM 186
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELITGERP 511
APE + K D++S G+ +EL GE P
Sbjct: 187 APEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-18
Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 314 IGTGRTG----ATYIAMLPGGCFIM--IKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPL 366
+G G G A + P ++ +K L + + + K+F E L +++H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKL---HPAEHEVMHMDWPLR---------LRIAIGS 414
G C ++V+ Y+++G L L P ++ L IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 415 ARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
A G+ +L + +HR+++++ L+ + K+ DFG++R + D +
Sbjct: 143 ASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-------RV 191
Query: 474 GDLGYV-----APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
G + PE T + DV+SFGV+L E+ T G++P
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 53/239 (22%), Positives = 84/239 (35%), Gaps = 40/239 (16%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE--FLSEINTLGSVRHRNLV 364
+ ++I+G G T + G IK + + E L + H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 365 PLLGF--CVAKKERLLVYSYLENGTLYDKLHP-------AEHEVMHMDWPLRLRIAIGSA 415
L + ++L+ + G+LY L E E + + +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV--------V 122
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILL----DGDFEPKLSDFGLARLMNPVDTHLSTFVNG 471
G+ L N I+HRNI I+ DG KL+DFG AR + D +
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY-- 176
Query: 472 EFGDLGYVAPE-YPRTLVA-------TPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
G Y+ P+ Y R ++ D++S GV TG P P K
Sbjct: 177 --GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 24/150 (16%), Positives = 43/150 (28%), Gaps = 11/150 (7%)
Query: 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISS 436
L T + L + RL++ + R LA LHH ++H +
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRP 239
Query: 437 KCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-----YPRTLVATP 491
I+LD L+ F + + F A + T
Sbjct: 240 VDIVLDQRGGVFLTGFEHLV---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296
Query: 492 KGDVYSFGVVLLELITGERPTHLTNAPESF 521
D ++ G+ + + + P A
Sbjct: 297 AFDTWTLGLAIYWIWCADLPNTDDAALGGS 326
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 32/167 (19%), Positives = 66/167 (39%), Gaps = 14/167 (8%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
E+ + +++ + G E ++Y Y+EN ++ + + +++
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 411 AIGSAR----GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466
+ +++H+ N I HR++ IL+D + KLSDFG + M D +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIK 208
Query: 467 TFVNGEFGDLGYVAPE--YPRTLVATPKGDVYSFGVVLLELITGERP 511
G ++ PE + K D++S G+ L + P
Sbjct: 209 GSR----GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 335 IKRL-EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL- 392
+K L E S+ + ++F E L ++H+++V G C + L+V+ Y+ +G L L
Sbjct: 76 VKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLR 135
Query: 393 --HPAEHEVMHMDWPLR--------LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442
P + + L +A A G+ +L +HR+++++ L+
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192
Query: 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV-----APEYPRTLVATPKGDVYS 497
K+ DFG++R + D + G + PE T + DV+S
Sbjct: 193 QGLVVKIGDFGMSRDIYSTDYY-------RVGGRTMLPIRWMPPESILYRKFTTESDVWS 245
Query: 498 FGVVLLELIT-GERP 511
FGVVL E+ T G++P
Sbjct: 246 FGVVLWEIFTYGKQP 260
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 48/253 (18%), Positives = 89/253 (35%), Gaps = 40/253 (15%)
Query: 287 SAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEK 346
S + E + + +S IG+G + + + IK + + +
Sbjct: 9 SGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ 68
Query: 347 E---FLSEINTLGSVRHRNL--VPLLGFCVAKKERLLVYSYLE--NGTLYDKLHPAEHEV 399
+ +EI L ++ + + L + + + +Y +E N L L +
Sbjct: 69 TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLK----KK 121
Query: 400 MHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARL 457
+D R + +H + I+H ++ K L+ D KL DFG+A
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDL--KPANFLIV-DGMLKLIDFGIANQ 175
Query: 458 MNP--VDTHLSTFVNGEFGDLGYVAPE-----------YPRTLVATPKGDVYSFGVVLLE 504
M P + V G + Y+ PE +PK DV+S G +L
Sbjct: 176 MQPDTTSVVKDSQV----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 505 LITGERP-THLTN 516
+ G+ P + N
Sbjct: 232 MTYGKTPFQQIIN 244
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 31/197 (15%), Positives = 61/197 (30%), Gaps = 32/197 (16%)
Query: 344 SEKEFLSEINTLGSVRHRNLVPLLGFC--VAKKERLLVYSYLENGTLYDKL-----HPAE 396
F+ + + + + ++ + + R +Y L H +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY-PRMQSNLQTFGEVLLSHSST 199
Query: 397 HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
H+ + RL++ + R LA LHH ++H + I+LD L+ F
Sbjct: 200 HK--SLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 457 LMNPVDTHLSTFVNGEFGDLGYVAPEY-----------PRTLVATPKGDVYSFGVVLLEL 505
D G+ PE R + T D ++ G+V+ +
Sbjct: 255 R----DGARVVSS----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 506 ITGERPTHLTNAPESFK 522
+ P A +
Sbjct: 307 WCADLPITKDAALGGSE 323
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 62/316 (19%), Positives = 101/316 (31%), Gaps = 50/316 (15%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE--FLSEINTLGSVRHRNLV 364
+ ++I+G G T + G IK + + E L + H+N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 365 PLLGF--CVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GL 418
L + ++L+ + G+LY L + L + R G+
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-----GLPESEFLIVLRDVVGGM 125
Query: 419 AWLHHNCNPRIIHRNISSKCILL----DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
L N I+HRNI I+ DG KL+DFG AR + D + G
Sbjct: 126 NHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLY----G 177
Query: 475 DLGYVAPE-YPRTLVA-------TPKGDVYSFGVVLLELITGERPTHLTNAPESFK---- 522
Y+ P+ Y R ++ D++S GV TG P P K
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 523 ----GSLVEWITLLNTNSSLETAIDKSL-----LGNGFDGELHQFLRVACNCVLPTPKER 573
G I+ + + + L G L L N + ++
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA---NILEADQEKC 294
Query: 574 HTMFEVYQLLRAIAER 589
+ + I R
Sbjct: 295 WGFDQFFAETSDILHR 310
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 52/209 (24%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPL 366
F +G G G+ Y A+ G + IK++ + +E + EI+ + ++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 367 LGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAI---GSARGLAWLH 422
G K L +V Y G++ D + ++ + D IA + +GL +LH
Sbjct: 90 YG-SYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDE-----IATILQSTLKGLEYLH 142
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
R IHR+I + ILL+ + KL+DFG+A + +T + F ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF----WMAPE 195
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ + D++S G+ +E+ G+ P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 37/196 (18%), Positives = 69/196 (35%), Gaps = 22/196 (11%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDK 391
++ K+ + +E+ ++H +++ L + LV NG +
Sbjct: 43 MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRY 101
Query: 392 LHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451
L G+ +LH + I+HR+++ +LL + K++D
Sbjct: 102 LKNRVK---PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD 155
Query: 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVLLELI 506
FGLA + T G Y++PE +AT DV+S G + L+
Sbjct: 156 FGLATQLKMPHEKHYTLC----GTPNYISPE-----IATRSAHGLESDVWSLGCMFYTLL 206
Query: 507 TGERPTHLTNAPESFK 522
G P +
Sbjct: 207 IGRPPFDTDTVKNTLN 222
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 50/234 (21%), Positives = 89/234 (38%), Gaps = 52/234 (22%)
Query: 312 NIIGTGRTG----ATYIAMLPGGCFIM--IKRLED--SQHSEKEFLSEINTLGSVRHRNL 363
+G R G PG IK L+D +EF E ++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKL--------HPAEHEVMHMDWPLR----LRIA 411
V LLG + +++SY +G L++ L + + + L + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 412 IGSARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVN 470
A G+ +L H+ +H++++++ +L+ K+SD GL R + D
Sbjct: 135 AQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFREVYAADY------- 183
Query: 471 GEFGDLGYV------------APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
Y APE + D++S+GVVL E+ + G +P
Sbjct: 184 -------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 40/192 (20%), Positives = 80/192 (41%), Gaps = 24/192 (12%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC------VAKKERLLVYSYLENGT 387
M+K + +EFL E + H ++ L+G +++ ++++G
Sbjct: 58 MLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117
Query: 388 LYDKL--HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF 445
L+ L ++ +R + A G+ +L IHR+++++ +L D
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV-----APEYPRTLVATPKGDVYSFGV 500
++DFGL+R + D + G + A E + T DV++FGV
Sbjct: 175 TVCVADFGLSRKIYSGDYY-------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227
Query: 501 VLLELIT-GERP 511
+ E++T G+ P
Sbjct: 228 TMWEIMTRGQTP 239
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 24/191 (12%)
Query: 335 IKRLED--SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+K L + S+ E +FL E + H+N+V +G + R ++ + G L L
Sbjct: 65 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 124
Query: 393 H---PAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP-- 447
P + + L +A A G +L N IHR+I+++ LL
Sbjct: 125 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 181
Query: 448 -KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV-----APEYPRTLVATPKGDVYSFGVV 501
K+ DFG+AR + + G + PE + T K D +SFGV+
Sbjct: 182 AKIGDFGMARDIYRASYY-------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 502 LLELIT-GERP 511
L E+ + G P
Sbjct: 235 LWEIFSLGYMP 245
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 5e-17
Identities = 47/232 (20%), Positives = 85/232 (36%), Gaps = 40/232 (17%)
Query: 308 FSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNL- 363
+S IG+G + + + IK + + + + +EI L ++ +
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 364 -VPLLGFCVAKKERLLVYSYLE--NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
+ L + + + +Y +E N L L + +D R +
Sbjct: 118 IIRLYDYEITDQY---IYMVMECGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 170
Query: 421 LHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMNPVDT--HLSTFVNGEFGDL 476
+H + I+H ++ K L+ D KL DFG+A M P T + V G +
Sbjct: 171 IHQH---GIVHSDL--KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV----GAV 220
Query: 477 GYVAPE-----------YPRTLVATPKGDVYSFGVVLLELITGERP-THLTN 516
Y+ PE +PK DV+S G +L + G+ P + N
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 53/232 (22%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV-RHRNLVP 365
++IG G G A + M IKR+++ S+ ++F E+ L + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKL--------HPAEHEVMHMDWPLR----LRIAIG 413
LLG C + L Y +G L D L PA L L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 414 SARGLAWL-HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE 472
ARG+ +L IHR+++++ IL+ ++ K++DFGL+R
Sbjct: 151 VARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR---------------- 190
Query: 473 FGDLGYV------------APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
G YV A E V T DV+S+GV+L E+++ G P
Sbjct: 191 -GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 28/219 (12%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLG 368
+G G+ G Y+A + +K L +Q E + E+ +RH N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
+ L+ Y GT+Y +L D A L++ H R
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---R 129
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV 488
+IHR+I + +LL E K++DFG + + + G L Y+ PE +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC----GTLDYLPPE-----M 178
Query: 489 ATPKG-----DVYSFGVVLLELITGERPTHLTNAPESFK 522
+ D++S GV+ E + G+ P E++K
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 217
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 9e-17
Identities = 47/219 (21%), Positives = 71/219 (32%), Gaps = 36/219 (16%)
Query: 307 SFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSV-RHR 361
SF + + +G G G + G +KR K+ L+E+ + V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 362 NLVPLLGFCVAKKERLLVYSYLE--NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
V L + L Y E +L E + + LA
Sbjct: 118 CCVRLEQ-AWEEGGIL--YLQTELCGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALA 171
Query: 420 WLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
LH ++H ++ K I L KL DFGL + GD
Sbjct: 172 HLHSQ---GLVHLDV--KPANIFLGPRGRCKLGDFGLLVELGTAGAG-EVQE----GDPR 221
Query: 478 YVAPE-----YPRTLVATPKGDVYSFGVVLLELITGERP 511
Y+APE Y DV+S G+ +LE+
Sbjct: 222 YMAPELLQGSY------GTAADVFSLGLTILEVACNMEL 254
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 57/303 (18%), Positives = 98/303 (32%), Gaps = 38/303 (12%)
Query: 260 VY-VKKKEDDPEGNKWA-KRIKGTKGIKVSAFEKSV-EKMRLSDLMKATNSFSKNNIIGT 316
V+ K K D +A KRI+ + A EK + E L+ L N + T
Sbjct: 22 VFEAKNKVD---DCNYAIKRIR--LPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET 76
Query: 317 GRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376
S +I + +N V L K
Sbjct: 77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136
Query: 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISS 436
+ L D ++ + + + L I I A + +LH ++HR++
Sbjct: 137 YIQMQLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKP 192
Query: 437 KCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG--------YVAPEYPRTLV 488
I D K+ DFGL M+ + + Y++PE
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 489 ATPKGDVYSFGVVLLELITG-----ERPTHLTNA-----PESFKG------SLVEWITLL 532
+ K D++S G++L EL+ ER +T+ P F +V+ +L
Sbjct: 253 YSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQD--ML 310
Query: 533 NTN 535
+ +
Sbjct: 311 SPS 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 24/191 (12%)
Query: 335 IKRLED--SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+K L + S+ E +FL E + H+N+V +G + R ++ + G L L
Sbjct: 106 VKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 165
Query: 393 H---PAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP-- 447
P + + L +A A G +L N IHR+I+++ LL
Sbjct: 166 RETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222
Query: 448 -KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV-----APEYPRTLVATPKGDVYSFGVV 501
K+ DFG+AR + + G + PE + T K D +SFGV+
Sbjct: 223 AKIGDFGMARDIYRAGYY-------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275
Query: 502 LLELIT-GERP 511
L E+ + G P
Sbjct: 276 LWEIFSLGYMP 286
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 50/218 (22%), Positives = 83/218 (38%), Gaps = 26/218 (11%)
Query: 314 IGTGRTGATYIA-MLPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLG 368
+G G+ G Y+A + +K L SQ E + EI +RH N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPA----EHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
+ +K L+ + G LY +L E L A L + H
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--------ADALHYCHER 133
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
++IHR+I + +L+ E K++DFG + T G L Y+ PE
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTM----CGTLDYLPPEMI 184
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
K D++ GV+ E + G P + E+ +
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR 222
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 42/244 (17%)
Query: 291 KSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFL 349
+S++++ LS L F ++G G G Y + G IK ++ + E+E
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK 68
Query: 350 SEINTLGSV-RHRNLVPLLG-----FCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHM 402
EIN L HRN+ G ++L LV + G++ D + + +
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 403 DWPLRLRIAI---GSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459
+W IA RGL+ LH + ++IHR+I + +LL + E KL DFG++ ++
Sbjct: 129 EW-----IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180
Query: 460 PVDTHLSTFV------------NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
+TF+ E D Y K D++S G+ +E+
Sbjct: 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATY-----------DFKSDLWSLGITAIEMAE 229
Query: 508 GERP 511
G P
Sbjct: 230 GAPP 233
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 45/205 (21%)
Query: 335 IKRL-EDSQHSEK-EFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391
+K L +D+ + + +SE+ + + +H+N++ LLG C ++ Y G L +
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 392 L--------HPAEHEVMHMDWPLR----LRIAIGSARGLAWLHHNCNPRIIHRNISSKCI 439
L + + + + ARG+ +L + IHR+++++ +
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188
Query: 440 LLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV------------APEYPRTL 487
L+ + K++DFGLAR +N +D Y APE
Sbjct: 189 LVTENNVMKIADFGLARDINNIDY--------------YKKTTNGRLPVKWMAPEALFDR 234
Query: 488 VATPKGDVYSFGVVLLELIT-GERP 511
V T + DV+SFGV++ E+ T G P
Sbjct: 235 VYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 45/205 (21%)
Query: 335 IKRL-EDSQHSEK-EFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391
+K L D+ + + +SE+ + + +H+N++ LLG C ++ Y G L +
Sbjct: 106 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 165
Query: 392 L--------HPAEHEVMHMDWPLRLR----IAIGSARGLAWLHHNCNPRIIHRNISSKCI 439
L + + + + L + A ARG+ +L + IHR+++++ +
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222
Query: 440 LLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV------------APEYPRTL 487
L+ D K++DFGLAR ++ +D Y APE
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDY--------------YKKTTNGRLPVKWMAPEALFDR 268
Query: 488 VATPKGDVYSFGVVLLELIT-GERP 511
+ T + DV+SFGV+L E+ T G P
Sbjct: 269 IYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 17/214 (7%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEF---LSEINTLGSVRHRNLVPLLGF 369
IG G +A + G + IK ++ +Q + E+ + + H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 370 CVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRI 429
+K L+ Y G ++D L H M I SA + + H I
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL--VAHGRMKEKEARSKFRQIVSA--VQYCHQKR---I 135
Query: 430 IHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-YPRTLV 488
+HR++ ++ +LLD D K++DFG + L F G Y APE +
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFC----GAPPYAAPELFQGKKY 190
Query: 489 ATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
P+ DV+S GV+L L++G P N E +
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-16
Identities = 37/196 (18%), Positives = 68/196 (34%), Gaps = 29/196 (14%)
Query: 335 IKRLEDSQHSE--KEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-----LVYSYLENGT 387
+K L S +E ++E L V H ++V + F +V Y+ +
Sbjct: 111 LKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS 170
Query: 388 LYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447
L + + + + L++LH +++ ++ + I+L + +
Sbjct: 171 L------KRSKGQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QL 220
Query: 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT 507
KL D G + G G+ APE RT T D+Y+ G L L
Sbjct: 221 KLIDLGAVSRI----NSFGYLY----GTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTL 271
Query: 508 GERP---THLTNAPES 520
++ PE
Sbjct: 272 DLPTRNGRYVDGLPED 287
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 45/204 (22%)
Query: 335 IKRL-EDSQHSEK-EFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391
+K L + EK +SE+ + + +H N+V LLG C L++ Y G L +
Sbjct: 81 VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF 140
Query: 392 L------HPAEHEVMHMDWPLRLR----IAIGSARGLAWL-HHNCNPRIIHRNISSKCIL 440
L + + R + A+G+A+L NC IHR+++++ +L
Sbjct: 141 LRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVL 196
Query: 441 LDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV------------APEYPRTLV 488
L K+ DFGLAR + Y+ APE V
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSN--------------YIVKGNARLPVKWMAPESIFDCV 242
Query: 489 ATPKGDVYSFGVVLLELIT-GERP 511
T + DV+S+G++L E+ + G P
Sbjct: 243 YTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 47/232 (20%), Positives = 85/232 (36%), Gaps = 40/232 (17%)
Query: 308 FSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNL- 363
+S IG+G + + + IK + + + + +EI L ++ +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 364 -VPLLGFCVAKKERLLVYSYLE--NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
+ L + + + +Y +E N L L + +D R +
Sbjct: 71 IIRLYDYEITDQY---IYMVMECGNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 123
Query: 421 LHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMNPVDT--HLSTFVNGEFGDL 476
+H + I+H ++ K L+ D KL DFG+A M P T + V G +
Sbjct: 124 IHQH---GIVHSDL--KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV----GTV 173
Query: 477 GYVAPE-----------YPRTLVATPKGDVYSFGVVLLELITGERP-THLTN 516
Y+ PE +PK DV+S G +L + G+ P + N
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 31/200 (15%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDK 391
I+ K L H ++ EI+ S+ H+++V G + + +V +L +
Sbjct: 73 IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLEL 131
Query: 392 L----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447
E E R G +LH N R+IHR++ + L+ D E
Sbjct: 132 HKRRKALTEPEA-------R-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 180
Query: 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVL 502
K+ DFGLA + G Y+APE V + KG DV+S G ++
Sbjct: 181 KIGDFGLATKVEYDGERKKVLC----GTPNYIAPE-----VLSKKGHSFEVDVWSIGCIM 231
Query: 503 LELITGERPTHLTNAPESFK 522
L+ G+ P + E++
Sbjct: 232 YTLLVGKPPFETSCLKETYL 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 8e-16
Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 31/200 (15%)
Query: 333 IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDK 391
I+ K L H ++ EI+ S+ H+++V G + + +V +L +
Sbjct: 47 IVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLEL 105
Query: 392 L----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447
E E R G +LH N R+IHR++ + L+ D E
Sbjct: 106 HKRRKALTEPEA-------R-YYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 154
Query: 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVL 502
K+ DFGLA + G Y+APE V + KG DV+S G ++
Sbjct: 155 KIGDFGLATKVEYDGERKKVLC----GTPNYIAPE-----VLSKKGHSFEVDVWSIGCIM 205
Query: 503 LELITGERPTHLTNAPESFK 522
L+ G+ P + E++
Sbjct: 206 YTLLVGKPPFETSCLKETYL 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 46/216 (21%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVP 365
+ +G G G Y A G K +E S+ ++++ EI L + H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 366 LLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR-LRIAI---GSARGLAW 420
LLG +L ++ + G + + + L +I + L +
Sbjct: 81 LLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDR-------GLTEPQIQVVCRQMLEALNF 132
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
LH RIIHR++ + +L+ + + +L+DFG++ +F+ + ++A
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY----WMA 185
Query: 481 PE-----YPRTLVATPKGDVYSFGVVLLELITGERP 511
PE + K D++S G+ L+E+ E P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 22/105 (20%), Positives = 40/105 (38%), Gaps = 9/105 (8%)
Query: 96 GQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS-SRLQYVTSLDLSSNSLSGEIPSGLANC 154
+ LT +DL N L+ S+ D + L Y++++D+S N S P+ N
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNS 775
Query: 155 TFLNVLKL------NNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
+ L + NR + P + + + SN +
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK 820
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 8e-15
Identities = 25/202 (12%), Positives = 57/202 (28%), Gaps = 8/202 (3%)
Query: 13 HTLTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFT 72
H+ TV + + ++ K D L S + + +
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS-DLLQDAINRNPEMK 415
Query: 73 GVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY 132
+ K I + + I+R T L + +++ + +
Sbjct: 416 PIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW----- 469
Query: 133 VTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ +N L ++L N ++P L L +++ ++A N
Sbjct: 470 -EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
Query: 193 GPVPSFANVNFTAEDFANNSGL 214
A+ A+D +
Sbjct: 529 SAAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 32/205 (15%), Positives = 63/205 (30%), Gaps = 43/205 (20%)
Query: 32 ATLNDIECLKSVKNSLEDPFNYLT----------TSWNFNNNTEGFICQFTGVDCWHPDE 81
+ D + LK++ +L+ +WNFN + GVD +
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELD-MWGDQPGVDL--DNN 322
Query: 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSG--------------------- 120
+V + L+ G KG+ P I + T L L +++ +
Sbjct: 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382
Query: 121 ---SIPSDISSRLQYVTSLDLSSNSLS-----GEIPSGLANCTFLNVLKLNNNRFTGKIP 172
Q + DL ++++ I + NR T I
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-IS 441
Query: 173 PQLGLLNRIKTFSVASNLLTGPVPS 197
+ L +++ A++ T +
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIA 466
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 18/124 (14%), Positives = 39/124 (31%), Gaps = 5/124 (4%)
Query: 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141
N+ ++ + + + + NNL S ++ + LD N
Sbjct: 525 NRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583
Query: 142 SLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLG-LLNRIKTFSVASNLLTGPVPSFAN 200
+ + + L LKL+ N+ IP ++++ + N L F
Sbjct: 584 KVR-HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNA 640
Query: 201 VNFT 204
+
Sbjct: 641 KSVY 644
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 9e-13
Identities = 19/116 (16%), Positives = 36/116 (31%), Gaps = 13/116 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQY-----VTSLDLSSNSLSGEIPSGLANCT 155
+ + +D S N + S +IS + +++ LS N + A +
Sbjct: 639 NAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGS 697
Query: 156 FLNVLKLNNNRFT-------GKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFT 204
++ + L+NN T + T + N LT F
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLP 753
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 16/115 (13%), Positives = 40/115 (34%), Gaps = 11/115 (9%)
Query: 88 RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS--- 144
++ G + + + + LS N + P+++ + ++++ LS+N ++
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSIP 713
Query: 145 ----GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGL--LNRIKTFSVASNLLTG 193
N L + L N+ T + L + V+ N +
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 20/103 (19%), Positives = 37/103 (35%), Gaps = 8/103 (7%)
Query: 97 QFPRGI-ERCTSLTGLDLSSNNLSGSIPSDIS-SRLQYVTSLDLSSNSLSGEIPSGLA-- 152
+ P + GL S N L IP+ + + + S+D S N + E +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 153 ---NCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ + L+ N + I T +++NL+T
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 18/83 (21%), Positives = 34/83 (40%), Gaps = 6/83 (7%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSL-S 144
+ Q+P GI C SL L + SN++ + ++ +L LD++ N S
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYI---LDIADNPNIS 841
Query: 145 GEIPSGLANCTF-LNVLKLNNNR 166
++ S + VL + +
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 13/87 (14%), Positives = 26/87 (29%)
Query: 135 SLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP 194
+ + + + L N + L L G++P +G L +K S ++ T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 195 VPSFANVNFTAEDFANNSGLCGKPLNP 221
F + T +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKK 389
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 52/212 (24%)
Query: 335 IKRL-EDSQHSEK-EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL 392
+K L E++ SE + LSE N L V H +++ L G C LL+ Y + G+L L
Sbjct: 58 VKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL 117
Query: 393 ---HPAEHEVMHMDWPLR-----------------LRIAIGSARGLAWLHHNCNPRIIHR 432
+ + A ++G+ +L +++HR
Sbjct: 118 RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174
Query: 433 NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV------------A 480
+++++ IL+ + K+SDFGL+R + D+ YV A
Sbjct: 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDS--------------YVKRSQGRIPVKWMA 220
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
E + T + DV+SFGV+L E++T G P
Sbjct: 221 IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 45/205 (21%)
Query: 335 IKRLED--SQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391
+K L+D ++ + +SE+ + + +H+N++ LLG C ++ Y G L +
Sbjct: 118 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 177
Query: 392 L--------HPAEHEVMHMDWPLR----LRIAIGSARGLAWLHHNCNPRIIHRNISSKCI 439
L + + + + ARG+ +L + IHR+++++ +
Sbjct: 178 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234
Query: 440 LLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV------------APEYPRTL 487
L+ + K++DFGLAR +N +D Y APE
Sbjct: 235 LVTENNVMKIADFGLARDINNIDY--------------YKKTTNGRLPVKWMAPEALFDR 280
Query: 488 VATPKGDVYSFGVVLLELIT-GERP 511
V T + DV+SFGV++ E+ T G P
Sbjct: 281 VYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 27/121 (22%), Positives = 48/121 (39%), Gaps = 7/121 (5%)
Query: 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSS 140
++V + S + L Q P + T++T L+L+ N L ++ + R +TSLD+
Sbjct: 5 SHEVAD--CSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFT-RYSQLTSLDVGF 58
Query: 141 NSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP-SFA 199
N++S P L VL L +N + + + SN + F
Sbjct: 59 NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118
Query: 200 N 200
Sbjct: 119 K 119
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 5/123 (4%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISS-RLQYVTSLDLSSNSLSG 145
+ LS GL + +L L LS+N + ++ + L+LSSN +
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGL---LNRIKTFSVASNLLTGPVP-SFANV 201
P L L LNN + + +L L I+ S++++ L+ +F +
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 202 NFT 204
+T
Sbjct: 246 KWT 248
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-15
Identities = 19/118 (16%), Positives = 33/118 (27%), Gaps = 4/118 (3%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
+LN L+ + L LDL N + + L+ + + LS N
Sbjct: 384 HILN--LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTG--KIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
+ A L L L P L + +++N +
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 23/99 (23%), Positives = 40/99 (40%), Gaps = 6/99 (6%)
Query: 104 RCT-SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
+CT S D S L+ +P D+ + + T L+L+ N L + + L L +
Sbjct: 1 KCTVSHEVADCSHLKLT-QVPDDLPTNI---TVLNLTHNQLRRLPAANFTRYSQLTSLDV 56
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP-SFAN 200
N + P L +K ++ N L+ +FA
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-14
Identities = 24/132 (18%), Positives = 45/132 (34%), Gaps = 4/132 (3%)
Query: 87 IRLSDMGLKGQFPRGI---ERCTSLTGLDLSSNNLSGSIPSDISS-RLQYVTSLDLSSNS 142
+ L+++ L + TS+ L LS++ LS + + + +T LDLS N+
Sbjct: 200 LFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNN 259
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN 202
L+ A L L N L L ++ ++ + + +
Sbjct: 260 LNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319
Query: 203 FTAEDFANNSGL 214
F L
Sbjct: 320 IDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-13
Identities = 19/107 (17%), Positives = 39/107 (36%), Gaps = 1/107 (0%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ + + P ++ L L+L N LS + + +T L L SNS+
Sbjct: 54 LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKI 112
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
+ L L L++N + L ++ +++N +
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 24/125 (19%), Positives = 40/125 (32%), Gaps = 7/125 (5%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLS-------GSIPSDISSRLQYVTSLDLS 139
+ LS+ + +E L LDL NNL+ P L ++ L+L
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544
Query: 140 SNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA 199
SN + L ++ L N +K+ ++ NL+T
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 200 NVNFT 204
F
Sbjct: 605 GPAFR 609
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 28/117 (23%), Positives = 40/117 (34%), Gaps = 11/117 (9%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSG--SIPSDISSRLQYVTSLDLSSNSLS 144
I LS SL L L L S PS L+ +T LDLS+N+++
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP-LRNLTILDLSNNNIA 493
Query: 145 GEIPSGLANCTFLNVLKLNNNRFT--------GKIPPQLGLLNRIKTFSVASNLLTG 193
L L +L L +N G L L+ + ++ SN
Sbjct: 494 NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 20/110 (18%), Positives = 33/110 (30%), Gaps = 2/110 (1%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ L G + L +DL NNL+ S ++ + SL+L N ++
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN-QVSLKSLNLQKNLITSV 599
Query: 147 IPSGLA-NCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPV 195
L L + N F +N I L+
Sbjct: 600 EKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 22/121 (18%), Positives = 45/121 (37%), Gaps = 7/121 (5%)
Query: 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141
+S L + L L++ N++ G I S++ + L + L LS++
Sbjct: 305 RSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNS 363
Query: 142 SLS-----GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
S E LA+ + L++L L N+ + L ++ + N + +
Sbjct: 364 FTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 197 S 197
Sbjct: 423 G 423
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 16/127 (12%), Positives = 42/127 (33%), Gaps = 13/127 (10%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS--------IPSDISSRLQYVTSLDL 138
L ++ F + ++ L+L + S I L+ + L++
Sbjct: 277 FFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336
Query: 139 SSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLN----RIKTFSVASNLLTGP 194
N + G + L L L+N+ + + ++ + ++ N ++
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396
Query: 195 VP-SFAN 200
+F+
Sbjct: 397 ESDAFSW 403
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 21/112 (18%), Positives = 38/112 (33%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ +S K F TSL L ++ N+ + S++ + +T LDLS L
Sbjct: 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQI 488
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
L +L +++N L + T + N +
Sbjct: 489 SWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 23/111 (20%), Positives = 39/111 (35%), Gaps = 4/111 (3%)
Query: 83 KVLNIRLSDMGLKGQFPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141
L ++ K + T+LT LDLS L I + L + L++S N
Sbjct: 451 NTLK--MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE-QISWGVFDTLHRLQLLNMSHN 507
Query: 142 SLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+L S L+ L + NR + F++ +N +
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 16/97 (16%), Positives = 26/97 (26%), Gaps = 1/97 (1%)
Query: 98 FPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFL 157
L LD + L L+ + LD+S + + T L
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 158 NVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTG 193
N LK+ N F + ++ L
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 23/117 (19%), Positives = 34/117 (29%), Gaps = 5/117 (4%)
Query: 85 LNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS 144
+ + D L + P I +S +DLS N L + S S + LDLS +
Sbjct: 14 ITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIE 69
Query: 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN 200
L+ L L N P L ++ L
Sbjct: 70 TIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 2/96 (2%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
+ L LDLS + L ++++L L+ N + P + T L L
Sbjct: 54 NFSELQWLDLSRCEIETIEDKAWHG-LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSF 198
+ +G L +K +VA N + +P++
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 16/125 (12%), Positives = 28/125 (22%), Gaps = 10/125 (8%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG---------EI 147
+ L L L N S +I L + L I
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 148 PSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAED 207
GL + T +L + L + S+A + + + +
Sbjct: 255 MEGLCDVTIDE-FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLS 313
Query: 208 FANNS 212
Sbjct: 314 IIRCQ 318
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 19/122 (15%), Positives = 40/122 (32%), Gaps = 5/122 (4%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ + L I + +L L+++ N + S L + +DLS N +
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 147 IP---SGLANCTFLNV-LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVN 202
L +N+ L ++ N I Q ++ ++ N + + N
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
Query: 203 FT 204
Sbjct: 228 LA 229
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 22/100 (22%), Positives = 33/100 (33%), Gaps = 8/100 (8%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN--CTFLNVLKL 162
L L L+ N S S L Y LDLS N+LS ++ L L L
Sbjct: 327 LPFLKSLTLTMNKGSISFKKVALPSLSY---LDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTG--PVPSFAN 200
+ N + L ++ + L +F +
Sbjct: 384 SFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 25/123 (20%), Positives = 39/123 (31%), Gaps = 11/123 (8%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDIS---SRLQYVTSLDLSSNSLSGEIPSGLAN 153
+ P T+L +DLS N + +D+ Q SLD+S N + I
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQ 202
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGL-LNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212
L+ L L N + I L + + N + +
Sbjct: 203 GIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD------ERNLEIFEPSIME 256
Query: 213 GLC 215
GLC
Sbjct: 257 GLC 259
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 18/122 (14%), Positives = 43/122 (35%), Gaps = 9/122 (7%)
Query: 84 VLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSL 143
+ RL+ +++ + L+ ++ + Q SL + L
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQ---SLSIIRCQL 319
Query: 144 SGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFANVN 202
+ P+ + FL L L N+ + I + L + ++ N L+ S++++
Sbjct: 320 K-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLG 374
Query: 203 FT 204
Sbjct: 375 TN 376
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 55/197 (27%), Positives = 84/197 (42%), Gaps = 27/197 (13%)
Query: 335 IKRLED--SQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTL--- 388
+K L+ + +SE+ L + H N+V LLG C L++ Y G L
Sbjct: 58 VKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 389 ---------YDKLHPAEHEVMHMDWPLR--LRIAIGSARGLAWLHHNCNPRIIHRNISSK 437
K PA E + L L + A+G+A+L IHR+++++
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174
Query: 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL--GYVAPEYPRTLVATPKGDV 495
ILL K+ DFGLAR + +V L ++APE V T + DV
Sbjct: 175 NILLTHGRITKICDFGLARDIKNDS----NYVVKGNARLPVKWMAPESIFNCVYTFESDV 230
Query: 496 YSFGVVLLELIT-GERP 511
+S+G+ L EL + G P
Sbjct: 231 WSYGIFLWELFSLGSSP 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 42/236 (17%), Positives = 82/236 (34%), Gaps = 50/236 (21%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSV-RHRN 362
F + IG+G G+ + + GC IKR + + L E+ + +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 363 LVPLLGFCVAKKERLLVYS-YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
+V A+ + +L+ + Y G+L D + + + + + RGL ++
Sbjct: 73 VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 422 HHNCNPRIIHRNISSKC--ILLDGDFEP-------------------KLSDFGLARLMNP 460
H ++H +I K I + P K+ D G ++
Sbjct: 132 HSM---SLVHMDI--KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 461 VDTHLSTFVNGEFGDLGYVAPE-----YPRTLVATPKGDVYSFGVVLLELITGERP 511
E GD ++A E Y PK D+++ + ++ E
Sbjct: 187 PQV--------EEGDSRFLANEVLQENYTHL----PKADIFALALTVVCAAGAEPL 230
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 335 IKRLED--SQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKE-RLLVYSYLENGTLYD 390
+K L++ + + +SE+ L + H N+V LLG C +++ + + G L
Sbjct: 62 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 391 KLHPAEHEVMHMDWPLR------------LRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438
L +E + + + A+G+ +L + IHR+++++
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARN 178
Query: 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL--GYVAPEYPRTLVATPKGDVY 496
ILL K+ DFGLAR + +V L ++APE V T + DV+
Sbjct: 179 ILLSEKNVVKICDFGLARDIYKDP----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 497 SFGVVLLELIT-GERP 511
SFGV+L E+ + G P
Sbjct: 235 SFGVLLWEIFSLGASP 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 52/227 (22%), Positives = 89/227 (39%), Gaps = 38/227 (16%)
Query: 312 NIIGTGRTGATYIAM--LPGGCFIM--IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLL 367
+G+G G + + + I++ S S + L E+ L + H N++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 368 GFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
F K+ LV + G L+D++ E + I G+ +LH
Sbjct: 103 DFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV--------IIKQVLSGVTYLHK 154
Query: 424 NCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
+ I+HR++ + +LL + D K+ DFGL+ + + + G Y+A
Sbjct: 155 H---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-QKKMKERL----GTAYYIA 206
Query: 481 PE-----YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
PE Y K DV+S GV+L L+ G P E +
Sbjct: 207 PEVLRKKY------DEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 37/176 (21%)
Query: 351 EINTLGSVRHRNLVPLLGFCV---AKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPL 406
EI L + H N+V L V ++ L +V+ + G + M+ P
Sbjct: 86 EIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV-------------MEVPT 130
Query: 407 RLRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458
++ AR G+ +LH+ +IIHR+I +L+ D K++DFG++
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 459 NPVDTHLSTFVNGEFGDLGYVAPE---YPRTLVATPKGDVYSFGVVLLELITGERP 511
D LS V G ++APE R + + DV++ GV L + G+ P
Sbjct: 188 KGSDALLSNTV----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 55/243 (22%), Positives = 95/243 (39%), Gaps = 43/243 (17%)
Query: 301 LMKATNSFSKN----NIIGTGRTGATYIA-MLPGG----CFIMIKRLEDSQHSEKEFLSE 351
+ +T FS ++G G G + G ++ KR + ++ L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 352 INTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLR 407
+ L + H N++ L F K LV G L+D++ +E +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 130
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTH 464
I G+ ++H N +I+HR++ + +LL D ++ DFGL+
Sbjct: 131 --IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKK 184
Query: 465 LSTFVNGEFGDLGYVAPE-----YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519
+ + G Y+APE Y K DV+S GV+L L++G P + N +
Sbjct: 185 MKDKI----GTAYYIAPEVLHGTY------DEKCDVWSTGVILYILLSGCPPFNGANEYD 234
Query: 520 SFK 522
K
Sbjct: 235 ILK 237
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 49/216 (22%), Positives = 86/216 (39%), Gaps = 23/216 (10%)
Query: 307 SFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTL-GSVRHRNLVP 365
SF +++G G G + + +KR+ S + E+ L S H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIR 82
Query: 366 LLGFCVAKKERLLVYSYLE--NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
K+R Y +E TL + + + + H+ + + + GLA LH
Sbjct: 83 YFCTE---KDRQFQYIAIELCAATLQEYV--EQKDFAHLG-LEPITLLQQTTSGLAHLHS 136
Query: 424 NCNPRIIHRNISSKCILL-----DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
I+HR++ IL+ G + +SDFGL + + H + +G G G+
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV-GRHSFSRRSGVPGTEGW 192
Query: 479 VAPEY---PRTLVATPKGDVYSFGVVLLELITGERP 511
+APE T D++S G V +I+
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 50/245 (20%), Positives = 82/245 (33%), Gaps = 50/245 (20%)
Query: 314 IGTGRTGATYIAM-LPGGC-----FIMIKRLEDSQHSEKE-FLSEINTLGSVRHRNLVPL 366
IG G G +A+ + ++ + E +E+ + + H N+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR---------- 416
++ LV G L DKL+ + ++ I
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 417 --------------------------GLAWLHHNCNPRIIHRNISSKCILL--DGDFEPK 448
L +LH+ I HR+I + L + FE K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA--TPKGDVYSFGVVLLELI 506
L DFGL++ ++ + + G +VAPE T PK D +S GV+L L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 507 TGERP 511
G P
Sbjct: 271 MGAVP 275
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 49/224 (21%), Positives = 81/224 (36%), Gaps = 36/224 (16%)
Query: 313 IIGTGRTGATYIA-MLPGGCFIMIKRLEDSQHSEKE-FLSEINTLGSVRHRNLVPLLGFC 370
IG G G IA K++ + + F EI + S+ H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 371 VAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
+ LV G L++++ E + + ++ + +A+ H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL-- 125
Query: 427 PRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE- 482
+ HR++ + L D KL DFGLA P + T V G YV+P+
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMMRTKV----GTPYYVSPQV 179
Query: 483 ----YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
Y P+ D +S GV++ L+ G P E
Sbjct: 180 LEGLY------GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 23/252 (9%)
Query: 308 FSKNNIIGTGRTGATYIAML-PGGCFIMIK--RLEDSQHSEKEFLSEINTLGSVRHRNLV 364
F K + +G G G + P G + K LE + + E+ L +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPA----EHEVMHMDWPLRLRIAIGSARGLAW 420
G + E + +++ G+L L A E + ++I +GL +
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--------VSIAVIKGLTY 146
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
L I+HR++ IL++ E KL DFG++ + +D+ ++FV G Y++
Sbjct: 147 LREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV----GTRSYMS 198
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540
PE + + + D++S G+ L+E+ G P +A E +
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258
Query: 541 AIDKSLLGNGFD 552
+ L G D
Sbjct: 259 TPGRPLNKFGMD 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 32/221 (14%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
IG+G G + + +K +E ++ EI S+RH N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR--------GLAWLHHN 424
++ Y G LY+++ D AR G+++ H
Sbjct: 88 PTHLAIIMEYASGGELYERI--CNAGRFSED----------EARFFFQQLLSGVSYCHSM 135
Query: 425 CNPRIIHRNISSKCILLDGDFEP--KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
+I HR++ + LLDG P K+ DFG ++ + + V G Y+APE
Sbjct: 136 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV----GTPAYIAPE 187
Query: 483 -YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
R DV+S GV L ++ G P P ++
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 50/245 (20%), Positives = 87/245 (35%), Gaps = 38/245 (15%)
Query: 297 RLSDLMKATNSFSK----NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEI 352
R++++ S I+G G +G G + +KR+ L EI
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALMEI 59
Query: 353 NTLG-SVRHRNLVPLLGFCVAKKERLLVYSYLE--NGTLYDKL---HPAEHEVMHMDWPL 406
L S H N++ +Y LE N L D + + ++ +
Sbjct: 60 KLLTESDDHPNVIRYYCSE---TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYN 116
Query: 407 RLRIAIGSARGLAWLHHNCNPRIIHR-----NI--------SSKCILLDGDFEPKLSDFG 453
+ + A G+A LH +IIHR NI ++ + +SDFG
Sbjct: 117 PISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELI 506
L + ++ + T +N G G+ APE T D++S G V ++
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 507 TGERP 511
+ +
Sbjct: 234 SKGKH 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 32/202 (15%)
Query: 335 IKRLEDSQHSE--KEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDK 391
+K L++ S + +SE+ + + H N+V LLG C L++ Y G L +
Sbjct: 80 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 139
Query: 392 L---------------HPAEHEVMHMDWPLRLR----IAIGSARGLAWLHHNCNPRIIHR 432
L + E L A A+G+ +L +HR
Sbjct: 140 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196
Query: 433 NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL--GYVAPEYPRTLVAT 490
+++++ +L+ K+ DFGLAR + +V L ++APE + T
Sbjct: 197 DLAARNVLVTHGKVVKICDFGLARDIMSDS----NYVVRGNARLPVKWMAPESLFEGIYT 252
Query: 491 PKGDVYSFGVVLLELIT-GERP 511
K DV+S+G++L E+ + G P
Sbjct: 253 IKSDVWSYGILLWEIFSLGVNP 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 54/213 (25%)
Query: 335 IKRLED--SQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTL---- 388
+K L++ S + +F E + + N+V LLG C K L++ Y+ G L
Sbjct: 82 VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
Query: 389 ------------YDKLHPAEHEVMHMDWPLR----LRIAIGSARGLAWLH-HNCNPRIIH 431
+ L PL L IA A G+A+L +H
Sbjct: 142 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VH 197
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV------------ 479
R+++++ L+ + K++DFGL+R + D Y
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADY--------------YKADGNDAIPIRWM 243
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511
PE T + DV+++GVVL E+ + G +P
Sbjct: 244 PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 46/163 (28%), Positives = 67/163 (41%), Gaps = 14/163 (8%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGT-LYDKLHPAEHEVMHMDWPLRLR 409
EI L V H N++ +L + LV +G L+ + H +D PL
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI--DRHP--RLDEPLASY 134
Query: 410 IAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFV 469
I + +L IIHR+I + I++ DF KL DFG A + TF
Sbjct: 135 IFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC 190
Query: 470 NGEFGDLGYVAPE-YPRTLVATPKGDVYSFGVVLLELITGERP 511
G + Y APE P+ +++S GV L L+ E P
Sbjct: 191 ----GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 34/189 (17%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL-- 392
++ + +E +EI+ L S+ H N++ L KK LV + E G L++++
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 393 --HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEP 447
E + + I G+ +LH + I+HR+I + ILL +
Sbjct: 140 RHKFDECDAAN--------IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188
Query: 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-----YPRTLVATPKGDVYSFGVVL 502
K+ DFGL+ + D L + G Y+APE Y K DV+S GV++
Sbjct: 189 KIVDFGLSSFFSK-DYKLRDRL----GTAYYIAPEVLKKKY------NEKCDVWSCGVIM 237
Query: 503 LELITGERP 511
L+ G P
Sbjct: 238 YILLCGYPP 246
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 34/223 (15%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLS----EINTLGSVRHRNLVPLLG 368
+G G G I G + +K L + + + EI L RH +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR--------GLAW 420
+ +V Y+ G L+D + +H R+ AR + +
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI--CKHG----------RVEEMEARRLFQQILSAVDY 126
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
H + ++HR++ + +LLD K++DFGL+ +M+ L T G Y A
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC----GSPNYAA 178
Query: 481 PE-YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
PE L A P+ D++S GV+L L+ G P + P FK
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFK 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 52/264 (19%), Positives = 96/264 (36%), Gaps = 34/264 (12%)
Query: 263 KKKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNI---IGTGRT 319
+ + D +G + + F+ + +K + +I +GTG
Sbjct: 111 RGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAF 170
Query: 320 GATYIAM-----LPGGC-FIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373
G + F+M D ++ EI T+ +RH LV L
Sbjct: 171 GVVHRVTERATGNNFAAKFVMTPHESD----KETVRKEIQTMSVLRHPTLVNLHDAFEDD 226
Query: 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GLAWLHHNCNPRI 429
E +++Y ++ G L++K+ +++ + A+ R GL +H N
Sbjct: 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDE-------AVEYMRQVCKGLCHMHEN---NY 276
Query: 430 IHRNISSKCILLDGDFEP--KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL 487
+H ++ + I+ KL DFGL ++P V G + APE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-----KQSVKVTTGTAEFAAPEVAEGK 331
Query: 488 VATPKGDVYSFGVVLLELITGERP 511
D++S GV+ L++G P
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 54/275 (19%), Positives = 102/275 (37%), Gaps = 46/275 (16%)
Query: 257 MRGVY--------VKKKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSF 308
MRG + V+ K D P+ N + K + + +++ + + +
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIW----KKYVPQPVEVKQGSV---YDYY 53
Query: 309 SKNNIIGTGRTGATYIAM-----LPGGC-FIMIKRLEDSQHSEKEFLSEINTLGSVRHRN 362
+G+G G + + FI D + +EI+ + + H
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD----KYTVKNEISIMNQLHHPK 109
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GL 418
L+ L K E +L+ +L G L+D++ ++++ + I R GL
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE-------VINYMRQACEGL 162
Query: 419 AWLHHNCNPRIIHRNISSKCILL--DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
+H + I+H +I + I+ K+ DFGLA +NP V
Sbjct: 163 KHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-----DEIVKVTTATA 214
Query: 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+ APE D+++ GV+ L++G P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 25/126 (19%), Positives = 43/126 (34%), Gaps = 3/126 (2%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
S L R +LT LDL+ + I D + +L L++N L
Sbjct: 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLTANPLIFMAE 98
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN-VNFTAE 206
+ L+ L L + L +++ + SN ++ +P
Sbjct: 99 TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVL 158
Query: 207 DFANNS 212
DF NN+
Sbjct: 159 DFQNNA 164
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 23/118 (19%), Positives = 36/118 (30%), Gaps = 4/118 (3%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ LS + C L LDL+ L L + L+LS + L
Sbjct: 381 LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDIS 440
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKI---PPQLGLLNRIKTFSVASNLLTG-PVPSFAN 200
L L L N F L L R++ ++ L+ +F +
Sbjct: 441 SEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 26/114 (22%), Positives = 45/114 (39%), Gaps = 3/114 (2%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSI--PSDISSRLQYVTSLDLSSNSLS 144
+ LS L + + +L L+L N+ ++ L + L LS LS
Sbjct: 430 LNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLS 489
Query: 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
+ +N + L++NR T L L I ++ASN ++ +PS
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 17/103 (16%), Positives = 33/103 (32%), Gaps = 2/103 (1%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ L L L++N L + S + + L +S L N L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLI-FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN 200
L L +N + P+ ++K +N + ++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 4/113 (3%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
K L LS + SLT L + N + + L+ + LDLS +
Sbjct: 304 KKLV--LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 143 L--SGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
+ S L N + L L L+ N +++ +A L
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 20/120 (16%), Positives = 40/120 (33%), Gaps = 2/120 (1%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
+ L++ D+ + + L L+LS N S+ ++ + LDL+
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTR 411
Query: 143 LSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV 201
L + N L VL L+++ L ++ ++ N N
Sbjct: 412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNS 471
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 20/117 (17%), Positives = 37/117 (31%), Gaps = 4/117 (3%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ +L L +S + + + + SL L SN +S L
Sbjct: 98 ETALSGPKALKHLFFIQTGISSIDFIPLHN-QKTLESLYLGSNHISSIKLPKGFPTEKLK 156
Query: 159 VLKLNNNRFTGKIPPQLGLLN--RIKTFSVASNLLTG-PVPSFANVNFTAEDFANNS 212
VL NN + L + ++ N + G +F + F + +F
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 23/114 (20%), Positives = 42/114 (36%), Gaps = 3/114 (2%)
Query: 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSS 140
E V +I L + L LDL++ +LS +PS + L + L LS+
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG-LSTLKKLVLSA 310
Query: 141 NSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTG 193
N +N L L + N ++ L L ++ ++ + +
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 24/110 (21%), Positives = 45/110 (40%), Gaps = 3/110 (2%)
Query: 87 IRLSDMGLKGQFPRG-IERCTSLTGLDLSSNNLSGSIPSDIS-SRLQYVTSLDLSSNSLS 144
+ + + + G +E +L LDLS +++ S ++ L ++ SL+LS N
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389
Query: 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPP-QLGLLNRIKTFSVASNLLTG 193
C L +L L R K L+ +K +++ +LL
Sbjct: 390 SLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 17/134 (12%), Positives = 40/134 (29%), Gaps = 10/134 (7%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISS--RLQYVTSLDLSSNSLS 144
+ L + L LD +N + D+SS + ++ L+L+ N ++
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLS-LNLNGNDIA 192
Query: 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGL--LNRIKTFSVASNLLTGPVPS----F 198
I G + L + I L + + + P+
Sbjct: 193 -GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 199 ANVNFTAEDFANNS 212
++ + + +
Sbjct: 252 CEMSVESINLQKHY 265
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 21/81 (25%), Positives = 33/81 (40%), Gaps = 2/81 (2%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
LS L + +DLS N L+ S + S L+ + L+L+SN +S +P
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGIY-LNLASNHISIILP 540
Query: 149 SGLANCTFLNVLKLNNNRFTG 169
S L + + L N
Sbjct: 541 SLLPILSQQRTINLRQNPLDC 561
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 57/261 (21%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 263 KKKEDDPEGNKWAKRIKGTKGIKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGAT 322
E P +K + + F+ + + + + + SK I+G GR G
Sbjct: 47 DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQV 105
Query: 323 YIAM--LPGGCF----IMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376
+ G I + ++D ++E +EI+ + + H NL+ L +K +
Sbjct: 106 HKCEETATGLKLAAKIIKTRGMKD----KEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161
Query: 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GLAWLHHNCNPRIIHR 432
+LV Y++ G L+D++ + + +D I + G+ +H I+H
Sbjct: 162 VLVMEYVDGGELFDRIIDESYNLTELD-------TILFMKQICEGIRHMHQM---YILHL 211
Query: 433 NISSKCILLDGDFEP--KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT 490
++ + IL K+ DFGLAR P L FG ++APE +
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVN----FGTPEFLAPEVVNYDFVS 266
Query: 491 PKGDVYSFGVVLLELITGERP 511
D++S GV+ L++G P
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSP 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 47/216 (21%), Positives = 86/216 (39%), Gaps = 38/216 (17%)
Query: 312 NIIGTGRTGATYIAM--LPGGCFIM--IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLL 367
++G G G + + + I + L E+ L + H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 368 GFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
+V G L+D++ +EH+ + ++ G+ ++H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHK 139
Query: 424 NCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
+ I+HR++ + ILL + D + K+ DFGL+ +T + + G Y+A
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI----GTAYYIA 191
Query: 481 PE-----YPRTLVATPKGDVYSFGVVLLELITGERP 511
PE Y K DV+S GV+L L++G P
Sbjct: 192 PEVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLS----EINTLGSVRHRNLVPLLG 368
+G G G + G + +K L + + + EI L RH +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR--------GLAW 420
+ +V Y+ G L+D + ++ R+ +R G+ +
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI--CKNG----------RLDEKESRRLFQQILSGVDY 131
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
H + ++HR++ + +LLD K++DFGL+ +M+ L T G Y A
Sbjct: 132 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTSC----GSPNYAA 183
Query: 481 PE-YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
PE L A P+ D++S GV+L L+ G P + P FK
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK 226
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 51/224 (22%), Positives = 85/224 (37%), Gaps = 33/224 (14%)
Query: 314 IGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKE--FLSEINTLGSVRHRNLVPLLGFC 370
+G+G G ++ G +IK + + +EI L S+ H N++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GLAWLHHNCN 426
+V E G L +++ A+ L + LA+ H
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKA----LSEGYVAELMKQMMNALAYFHSQ-- 143
Query: 427 PRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE- 482
++H+++ + IL K+ DFGLA L D H + G Y+APE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-DEHSTNAA----GTALYMAPEV 197
Query: 483 ----YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
T K D++S GVV+ L+TG P T+ E +
Sbjct: 198 FKRDV------TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 64/217 (29%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLS----EINTLGSVRHRN 362
FS IG G GA Y A + + IK++ S E E+ L +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 363 LVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR-LRIAI---GSARG 417
+ G C ++ LV Y G+ D L + PL+ + IA G+ +G
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCL-GSASDLLEVHKK-------PLQEVEIAAVTHGALQG 166
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
LA+LH + +IHR++ + ILL KL DFG A +M P + +FV G
Sbjct: 167 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN----SFV----GTPY 215
Query: 478 YVAPE---YPRTLVATPKGDVYSFGVVLLELITGERP 511
++APE K DV+S G+ +EL + P
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 45/218 (20%), Positives = 80/218 (36%), Gaps = 25/218 (11%)
Query: 313 IIGTGRTGATYIAM--LPGGCF----IMIKRLEDSQHSEKE-FLSEINTLGSVRHRNLVP 365
+IG G + G F + + + S E E + ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----GLAWL 421
LL + +V+ +++ L ++ + + +A R L +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEI--VKRA--DAGFVYSEAVASHYMRQILEALRYC 146
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEP---KLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
H N IIHR++ C+LL KL FG+A + V G +
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV----GTPHF 199
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516
+APE + DV+ GV+L L++G P + T
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 49/172 (28%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
EI + H N+V G + L Y G L+D++ M
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEP------- 105
Query: 411 AIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM--NP 460
A+ G+ +LH I HR+I + +LLD K+SDFGLA + N
Sbjct: 106 ---DAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
Query: 461 VDTHLSTFVNGEFGDLGYVAPE-YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ L+ G L YVAPE R DV+S G+VL ++ GE P
Sbjct: 160 RERLLNKMC----GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 32/215 (14%)
Query: 313 IIGTGRTGATYIAM--LPGGCF----IMIKRLEDSQHSE--KEFLSEINTLGSVRHRNLV 364
+G+G+ G + I ++ S+ +E E++ L V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAW 420
L + + +L+ + G L+D L +E E ++ + G+ +
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNY 130
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEP----KLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
LH +I H ++ + I+L P KL DFGLA + FG
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED-----GVEFKNIFGTP 182
Query: 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+VAPE + D++S GV+ L++G P
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 53/218 (24%), Positives = 84/218 (38%), Gaps = 40/218 (18%)
Query: 314 IGTGRTGATYIAM--LPGGCF----IMIKRLEDSQHSE--KEFLSEINTLGSVRHRNLVP 365
+G+G+ G + I +RL S+ +E E+N L +RH N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
L K + +L+ + G L+D L E E L+ + G+ +L
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHYL 124
Query: 422 HHNCNPRIIHR-----NISSKCILLDGDFEP---KLSDFGLARLMNPVDTHLSTFVNGEF 473
H RI H NI +LLD + KL DFG+A +
Sbjct: 125 HSK---RIAHFDLKPENI----MLLDKNVPNPRIKLIDFGIAHKIEA-GNEFKNIF---- 172
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
G +VAPE + D++S GV+ L++G P
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 5/96 (5%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF 156
F +L L+L N + + + + +LDLSSN L+ + +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQVV--FAKLKTLDLSSNKLA-FMGPEFQSAAG 215
Query: 157 LNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ + L NN+ I L ++ F + N
Sbjct: 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 15/87 (17%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
+ + LDL N + +++++ + L+L N + ++ L L L++N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSN 201
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ + P+ + S+ +N L
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
++ ++L + + V LDLS N LS + LA T L +L L++N
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L+ ++T + +N +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 28/119 (23%), Positives = 38/119 (31%), Gaps = 12/119 (10%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
L LDLSSN L+ + + S VT + L +N L I L L L
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQS-AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 165 NRFTGKIPPQL-GLLNRIKTFSVASN-LLTGPVPSFANV-------NFTAEDFANNSGL 214
N F R++T + + LTG V + ED
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 30/114 (26%), Positives = 48/114 (42%), Gaps = 9/114 (7%)
Query: 88 RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEI 147
+++D LK + ++ LDLS N LS I + + + L+LSSN L E
Sbjct: 16 KVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 148 PSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN 200
L + + L L LNNN +L + I+T A+N ++
Sbjct: 74 LD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 11/93 (11%), Positives = 33/93 (35%), Gaps = 7/93 (7%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
+ S+ L ++NN+S + + ++ L++N ++ + + L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 162 LNNNRFTGKIPPQ--LGLLNRIKTFSVASNLLT 192
L N + + ++ ++ N +
Sbjct: 151 LKLNEID-TVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 11/77 (14%), Positives = 28/77 (36%), Gaps = 1/77 (1%)
Query: 124 SDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKT 183
+I ++ +SL + S + + L L+ N + L +++
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 184 FSVASNLLTGPVPSFAN 200
+++SN+L +
Sbjct: 63 LNLSSNVLYE-TLDLES 78
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 10/86 (11%), Positives = 24/86 (27%), Gaps = 3/86 (3%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS-GEIPSGLANCT 155
+ +T + L +N L I + Q + DL N G + +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF-SQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 156 FLNVLKLNNNRFTGKIPPQLGLLNRI 181
+ + + + + +
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTL 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 18/96 (18%), Positives = 26/96 (27%), Gaps = 1/96 (1%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF 156
I L LDL + P + L L S +P + T
Sbjct: 220 ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG-RAPLKRLILKDCSNLLTLPLDIHRLTQ 278
Query: 157 LNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L L ++P + L V +L
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 21/102 (20%), Positives = 40/102 (39%), Gaps = 4/102 (3%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
L + L QFP R + L + + + L +P + + + +L L+ N L +P
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM-QQFAGLETLTLARNPLR-ALP 143
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNL 190
+ +A+ L L + ++P L + NL
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 20/104 (19%), Positives = 39/104 (37%), Gaps = 11/104 (10%)
Query: 98 FPRGIERCTSLTGLDLSSNNLSGSIPSDISS--------RLQYVTSLDLSSNSLSGEIPS 149
P I L L + + +P ++S L + SL L + +P+
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 150 GLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVAS-NLLT 192
+AN L LK+ N+ + + P + L +++ + L
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 12/99 (12%), Positives = 32/99 (32%), Gaps = 5/99 (5%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSG--SIPSDIS-SRLQYVTSLDLSSNSLSGEIPSGLAN 153
R + + + + + + +L+L S L + P
Sbjct: 44 NRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ L + ++ ++P + ++T ++A N L
Sbjct: 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 3e-04
Identities = 11/114 (9%), Positives = 28/114 (24%), Gaps = 21/114 (18%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDIS----------------SRLQYVTSLDLSSNS 142
+ L + +S R + + + +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT 64
Query: 143 LSG--EIPSGLANCTFLN--VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L + T L+L + + P Q L+ ++ ++ + L
Sbjct: 65 GRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 49/172 (28%), Positives = 69/172 (40%), Gaps = 30/172 (17%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
EI + H N+V G + L Y G L+D++ M
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEP------- 105
Query: 411 AIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM--NP 460
A+ G+ +LH I HR+I + +LLD K+SDFGLA + N
Sbjct: 106 ---DAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
Query: 461 VDTHLSTFVNGEFGDLGYVAPE-YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ L+ G L YVAPE R DV+S G+VL ++ GE P
Sbjct: 160 RERLLNKMC----GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 27/101 (26%), Positives = 39/101 (38%), Gaps = 5/101 (4%)
Query: 94 LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153
G L GLDLS N+L + + + SL+LS L ++P GL
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP- 273
Query: 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP 194
L+VL L+ NR P L ++ S+ N
Sbjct: 274 -AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 25/177 (14%), Positives = 53/177 (29%), Gaps = 8/177 (4%)
Query: 23 FCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDEN 82
G L TL ++E + L + N N + +
Sbjct: 91 VLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPG 150
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIP---SDISSRLQYVTSLDLS 139
+ + ++ + +L+ LDLS N G + + + L L
Sbjct: 151 -LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 140 SN---SLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGL-LNRIKTFSVASNLLT 192
+ + SG + A L L L++N +++ + +++ L
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 19/99 (19%), Positives = 33/99 (33%), Gaps = 8/99 (8%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANC----TFLNVLK 161
L L ++ + + + +++LDLS N GE A C L VL
Sbjct: 149 PGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 162 LNNNRFT---GKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
L N G +++ ++ N L +
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 27/150 (18%), Positives = 47/150 (31%), Gaps = 12/150 (8%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY--VTSLDLSSNSLS 144
++ D I + SL L + + + I L + L L + ++
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 145 GEIPSGLANCTFLNV--LKLNNNRFTG--KIPPQLG--LLNRIKTFSVASNLLTG-PVPS 197
G P L T ++ L L N + +L L +K S+A
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 198 FAN-VNFTAEDFANNSGLCGKPLNP--CPG 224
+ D ++N L + L CP
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPL 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 50/235 (21%), Positives = 84/235 (35%), Gaps = 50/235 (21%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIK-----RLEDSQHSEKEFLSEINTLGSVRHRNLVPLL 367
+G G G + C +K +L + E EI L +RH+N++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 368 G-FCVAKKERL-LVYSYLENGT--LYDKLHPAEHEVMHMDWPLRLRIAIGSAR------- 416
+K+++ +V Y G + D + R + A
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSV-------------PEKRFPVCQAHGYFCQLI 119
Query: 417 -GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV--DTHLSTFVNGEF 473
GL +LH I+H++I +LL K+S G+A ++P D T
Sbjct: 120 DGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---- 172
Query: 474 GDLGYVAPEYPRTLVATPKG------DVYSFGVVLLELITGERPTHLTNAPESFK 522
G + PE + D++S GV L + TG P N + F+
Sbjct: 173 GSPAFQPPE----IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 40/218 (18%)
Query: 314 IGTGRTGATYIAM--LPGGCF----IMIKRLEDSQHSE--KEFLSEINTLGSVRHRNLVP 365
+G+G+ G + I ++ S+ +E E++ L V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
L + + +L+ + G L+D L +E E ++ + G+ +L
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNYL 131
Query: 422 HHNCNPRIIHR-----NISSKCILLDGDFEP---KLSDFGLARLMNPVDTHLSTFVNGEF 473
H +I H NI +LLD + KL DFGLA + F
Sbjct: 132 HTK---KIAHFDLKPENI----MLLDKNIPIPHIKLIDFGLAHEIED-----GVEFKNIF 179
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
G +VAPE + D++S GV+ L++G P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 50/238 (21%), Positives = 88/238 (36%), Gaps = 59/238 (24%)
Query: 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKR-LEDSQHSEKEFLSEINTLGSVRH 360
K + F + G G G + G + IK+ ++D + +E L + L + H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHH 78
Query: 361 RNLVPLLGFCVAKKER-------LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIG 413
N+V L + ER +V Y+ + TL H + ++
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TL--------HRCCRNYYRRQVAPPPI 129
Query: 414 S--------ARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPVDTH 464
R + LH + HR+I +L++ D KL DFG A+ ++P + +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 465 LSTFVNGEFGDLGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
++ Y+ APE Y T D++S G + E++ GE
Sbjct: 189 VA-----------YICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 35/223 (15%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLS----EINTLGSVRHRNLVPLLG 368
+G G G +A + +K + + + EI+ L +RH +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR--------GLAW 420
+ ++V Y G L+D + E + R+ R + +
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYI--VEKK----------RMTEDEGRRFFQQIICAIEY 123
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
H + +I+HR++ + +LLD + K++DFGL+ +M L T G Y A
Sbjct: 124 CHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSC----GSPNYAA 175
Query: 481 PE-YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
PE L A P+ DV+S G+VL ++ G P P FK
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 38/215 (17%)
Query: 313 IIGTGRTGATYIA-MLPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNLVPLLG 368
++G G G +K + + K+ L E+ L + H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 369 FCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
+V G L+D++ +EH+ + ++ G+ ++H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVFS---GITYMHKH 140
Query: 425 CNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
I+HR++ + ILL + D + K+ DFGL+ +T + + G Y+AP
Sbjct: 141 ---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRI----GTAYYIAP 192
Query: 482 E-----YPRTLVATPKGDVYSFGVVLLELITGERP 511
E Y K DV+S GV+L L++G P
Sbjct: 193 EVLRGTY------DEKCDVWSAGVILYILLSGTPP 221
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 40/185 (21%), Positives = 71/185 (38%), Gaps = 27/185 (14%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL- 392
+EI L + H ++ + F A+ +V +E G L+DK+
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV 231
Query: 393 ---HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP-- 447
E + + + +LH N IIHR++ + +LL E
Sbjct: 232 GNKRLKEATCKLYFYQM--------LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 280
Query: 448 -KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE---YPRTLVATPKGDVYSFGVVLL 503
K++DFG ++++ + + T G Y+APE T D +S GV+L
Sbjct: 281 IKITDFGHSKILGE-TSLMRTLC----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335
Query: 504 ELITG 508
++G
Sbjct: 336 ICLSG 340
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 40/201 (19%), Positives = 76/201 (37%), Gaps = 26/201 (12%)
Query: 313 IIGTGRTGATYIAM--LPGGCFIM--IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
+G G + L G + I + S ++ E ++H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 369 FCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
+ L++ + G L++ + + +E + H ++ + + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE---AVLHCHQM 129
Query: 425 CNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
++HRN+ + +LL KL+DFGLA + F G GY++P
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA----GTPGYLSP 182
Query: 482 EYPRTLVATPKGDVYSFGVVL 502
E R D+++ GV+L
Sbjct: 183 EVLRKDPYGKPVDLWACGVIL 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 46/194 (23%), Positives = 79/194 (40%), Gaps = 34/194 (17%)
Query: 332 FIMIKRLEDSQHSE--KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLY 389
FI +R + S+ ++ E++ L ++H N++ L K + +L+ + G L+
Sbjct: 43 FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 102
Query: 390 DKL----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR-----NISSKCIL 440
D L E E L+ + G+ +LH +I H NI +L
Sbjct: 103 DFLAEKESLTEEEATEF-----LKQILN---GVYYLHSL---QIAHFDLKPENI----ML 147
Query: 441 LDGDFEP---KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYS 497
LD + K+ DFGLA ++ G +VAPE + D++S
Sbjct: 148 LDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIF----GTPEFVAPEIVNYEPLGLEADMWS 202
Query: 498 FGVVLLELITGERP 511
GV+ L++G P
Sbjct: 203 IGVITYILLSGASP 216
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 58/270 (21%), Positives = 94/270 (34%), Gaps = 72/270 (26%)
Query: 312 NIIGTGRTGATYIAMLPG------GCFIMIKRLED--SQHSEKEFLSEINTLGSV-RHRN 362
+G G G A G + +K L++ + + +SE+ L + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 363 LVPLLGFCVAKKERLLV-YSYLENGTLYDKLHPAEHEVM-------------------HM 402
+V LLG C L+V + + G L L +E + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 403 DWPLRLRIAIGS----------ARGLAWLHHNCNPRIIHRNI------------------ 434
D RL S + L+ + P ++++
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 435 ---SSKCI---------LLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
S KCI LL K+ DFGLAR + ++ + L ++APE
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDARL-PLKWMAPE 265
Query: 483 YPRTLVATPKGDVYSFGVVLLELIT-GERP 511
V T + DV+SFGV+L E+ + G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 42/187 (22%), Positives = 73/187 (39%), Gaps = 29/187 (15%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHR--NLVPLLGFCVAKKERLLVYSYLEN-GTLYDK 391
I + + + + E+ L V ++ LL + +L+ E L+D
Sbjct: 81 ISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 139
Query: 392 LHPAEHEVMHMDWPLRLRIAIGSARGLAW-----LHHNCNPRIIHRNISSKCILLDGD-F 445
+ E + + AR W + H N ++HR+I + IL+D +
Sbjct: 140 I--TERGALQEE----------LARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 187
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY-PRTLVATPKGDVYSFGVVLLE 504
E KL DFG L+ DT + F G Y PE+ V+S G++L +
Sbjct: 188 ELKLIDFGSGALLK--DTVYTDFD----GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 241
Query: 505 LITGERP 511
++ G+ P
Sbjct: 242 MVCGDIP 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 30/173 (17%)
Query: 351 EINTLGSVR----HRNLVPLLGFCVAKKERLLVYSYLENGT-LYDKLHPAEHEVMHMDWP 405
E+ L V H ++ LL + ++ +LV L+D + E +
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI--TEKGPLGEG-- 139
Query: 406 LRLRIAIGSARGLAW-----LHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMN 459
+R + H + ++HR+I + IL+D KL DFG L++
Sbjct: 140 --------PSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 460 PVDTHLSTFVNGEFGDLGYVAPEY-PRTLVATPKGDVYSFGVVLLELITGERP 511
D + F G Y PE+ R V+S G++L +++ G+ P
Sbjct: 192 --DEPYTDFD----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 41/206 (19%), Positives = 83/206 (40%), Gaps = 24/206 (11%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
+G G G + + M K ++ + EI+ L RHRN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 373 KKERLLVYSYLENGTLYDKL-----HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNP 427
+E ++++ ++ +++++ E E++ + L +LH +
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLHSH--- 121
Query: 428 RIIHRNISSKCILL--DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
I H +I + I+ K+ +FG AR + P + F Y APE +
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLL----FTAPEYYAPEVHQ 176
Query: 486 TLVATPKGDVYSFGVVLLELITGERP 511
V + D++S G ++ L++G P
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 27/184 (14%)
Query: 339 EDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL----H 393
E+ Q + L E++ L V H N++ L LV+ ++ G L+D L
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120
Query: 394 PAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453
+E E + +R + + LH I+HR++ + ILLD D KL+DFG
Sbjct: 121 LSEKETRKI-----MRALLE---VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169
Query: 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELIT 507
+ ++P L G Y+APE + D++S GV++ L+
Sbjct: 170 FSCQLDP-GEKLREVC----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
Query: 508 GERP 511
G P
Sbjct: 225 GSPP 228
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 21/107 (19%), Positives = 33/107 (30%), Gaps = 2/107 (1%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ LS G+ L LD +NL + L+ + LD+S
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
+ L VLK+ N F P L + ++ L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 23/102 (22%), Positives = 44/102 (43%), Gaps = 2/102 (1%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
+S + F +SL L ++ N+ + DI + L+ +T LDLS L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASN 189
+ + + L VL + +N+ +P L ++ + +N
Sbjct: 488 TAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/104 (18%), Positives = 32/104 (30%), Gaps = 4/104 (3%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
++ + P + S LDLS N L + S + LDLS +
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ + L+ L L N L+ ++ L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 1/89 (1%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
L LDLS + +I L ++++L L+ N + + + L L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+G L +K +VA NL+
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 20/86 (23%), Positives = 34/86 (39%), Gaps = 4/86 (4%)
Query: 83 KVLNIRLSDMGLKGQFPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141
+VL ++ + F I +LT LDLS L + + L + L+++SN
Sbjct: 448 EVLK--MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASN 504
Query: 142 SLSGEIPSGLANCTFLNVLKLNNNRF 167
L T L + L+ N +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 33/188 (17%), Positives = 61/188 (32%), Gaps = 20/188 (10%)
Query: 22 LFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLT--TSWNFNNNTEGFICQFTG------ 73
G L++ + L + + D FN LT +S++ + T + F+
Sbjct: 250 ALEGLCNLTI-EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308
Query: 74 VDCWHPDENKVLNIRLSDM------GLKGQFPRGIERCTSLTGLDLSSNNLSG-SIPSDI 126
++ + + ++L + KG SL LDLS N LS S
Sbjct: 309 LELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 127 SSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQ--LGLLNRIKTF 184
+ LDLS N + + S L L ++ ++ L +
Sbjct: 369 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYL 426
Query: 185 SVASNLLT 192
++
Sbjct: 427 DISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 21/116 (18%), Positives = 43/116 (37%), Gaps = 3/116 (2%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
+ L++ + + KG + TSL LDLS N + ++ S+ L+ + LD ++
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG-LEQLEHLDFQHSN 407
Query: 143 LSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
L + L L +++ L+ ++ +A N
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 22/115 (19%), Positives = 41/115 (35%), Gaps = 5/115 (4%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ + L I +L L+++ N + + S L + LDLSSN +
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164
Query: 147 IPSGLANCTFLNV----LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
+ L + + L L+ N I P R+ ++ +N + V
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 19/125 (15%), Positives = 35/125 (28%), Gaps = 9/125 (7%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDL------SSNSLSGEIPSG 150
G + L L L +N S ++ L + L + +L S
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 151 LANCTFLNVLKLNNNR---FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAED 207
L L + + + I L + +FS+ S + N + +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 208 FANNS 212
N
Sbjct: 311 LVNCK 315
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 48/218 (22%), Positives = 84/218 (38%), Gaps = 42/218 (19%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEINTL-GSVRHRNLVPLLGF 369
+G+G G + G I +K R ++ K L +++ + S +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG- 91
Query: 370 CVAKKERLLVYSYLENGTLY----------DKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
+++ N ++ +KL + L ++ + + L
Sbjct: 92 -----------TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI-LG-KMTVAIVKALY 138
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL-ARLMNPVDTHLSTFVNGEFGDLGY 478
+L +IHR++ ILLD + KL DFG+ RL++ G Y
Sbjct: 139 YLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSA----GCAAY 190
Query: 479 VAPE-----YPRTLVATPKGDVYSFGVVLLELITGERP 511
+APE P + DV+S G+ L+EL TG+ P
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 18/110 (16%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
L L+ + L P + +T L+++ N L S+P +S + LD N
Sbjct: 62 SELQ--LNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS----LEYLDACDNR 111
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
LS +P A+ L+ ++NN+ T +P LL + + +N LT
Sbjct: 112 LS-TLPELPASLKHLD---VDNNQLT-MLPELPALL---EYINADNNQLT 153
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 26/117 (22%), Positives = 43/117 (36%), Gaps = 12/117 (10%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFL----N 158
E TSL L + +N L+ +P S L+ +LD+S+N L +P+
Sbjct: 157 ELPTSLEVLSVRNNQLT-FLPELPES-LE---ALDVSTNLLE-SLPAVPVRNHHSEETEI 210
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASN-LLTGPVPSFANVNFTAEDFANNSGL 214
+ NR T IP + L+ T + N L + S + +
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQ---YVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
SL LD+S+N L S+P+ N ++ IP + + + L
Sbjct: 180 ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIIL 237
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+N + +I L + +
Sbjct: 238 EDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 19/96 (19%), Positives = 30/96 (31%), Gaps = 9/96 (9%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLT----GLDLSSNNLSGSIPSDISSRLQYVTSLDL 138
+ L+ +S L+ P R N ++ IP +I L ++ L
Sbjct: 183 EALD--VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL-SLDPTCTIIL 237
Query: 139 SSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQ 174
N LS I L+ T F+ Q
Sbjct: 238 EDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 10/87 (11%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
+ N + + + L L+ +LS +P L + VL++ N
Sbjct: 37 EKQALPGENRNEAVSLLKE---CLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQN 90
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLT 192
+P L + N L+
Sbjct: 91 ALI-SLPELPASL---EYLDACDNRLS 113
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 17/85 (20%), Positives = 27/85 (31%), Gaps = 7/85 (8%)
Query: 110 GLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF--LNVLKLNNNRF 167
+ N +S +D S L + E S L C + L+LN
Sbjct: 14 SQNSFYNTIS-GTYADYFSAWDKWEKQALPGENR-NEAVSLLKECLINQFSELQLNRLNL 71
Query: 168 TGKIPPQLGLLNRIKTFSVASNLLT 192
+ +P L +I + N L
Sbjct: 72 S-SLPDNLP--PQITVLEITQNALI 93
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 9e-11
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ + LT L++ +N +S DI+ L + L++ SN +S S L N + LN
Sbjct: 238 PLANLSQLTWLEIGTNQIS-----DINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
L LNNN+ + +G L + T ++ N +T + A+
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLAS 331
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 28/100 (28%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
GIE T+L L+L+ N ++ P S L +T+L + +N ++ S L N T L L
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISP---LSNLVKLTNLYIGTNKIT--DISALQNLTNLREL 115
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
LN + + I P L L ++ + ++ +N + +N
Sbjct: 116 YLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSN 153
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 3e-10
Identities = 25/92 (27%), Positives = 45/92 (48%), Gaps = 5/92 (5%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
++ T L L++ SN +S S +++ L + SL L++N L E + T L L
Sbjct: 260 AVKDLTKLKMLNVGSNQISD--ISVLNN-LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L+ N T I P L L+++ + A+ ++
Sbjct: 317 FLSQNHITD-IRP-LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 22/102 (21%), Positives = 42/102 (41%), Gaps = 8/102 (7%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ T L L ++ + + P + L + SL L+ N + P LA+ T L+
Sbjct: 148 LSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQIEDISP--LASLTSLH 202
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
N+ T P + + R+ + + +N +T + AN
Sbjct: 203 YFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSPLAN 241
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 3/87 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
++ ++L + + V LDLS N LS + LA T L +L L++N
Sbjct: 10 NRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L+ ++T + +N +
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 18/107 (16%), Positives = 42/107 (39%), Gaps = 3/107 (2%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
NI L++ + + + LDL N + +++++ + L+L N +
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
++ L L L++N+ + P+ + S+ +N L
Sbjct: 183 DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 25/117 (21%), Positives = 37/117 (31%), Gaps = 7/117 (5%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
L LDLSSN L+ + + S VT + L +N L I L L L
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQS-AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 165 NRFTGKIPPQL-GLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGLCGKPLN 220
N F R++T + + + T + C + L
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGAYCCEDLP 300
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 31/119 (26%), Positives = 49/119 (41%), Gaps = 11/119 (9%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
K+ ++D LK + ++ LDLS N LS I + + + L+LSSN
Sbjct: 13 KIEK--VTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNV 69
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN 200
L E L + + L L LNNN +L + I+T A+N ++
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 11/93 (11%), Positives = 33/93 (35%), Gaps = 7/93 (7%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
+ S+ L ++NN+S + + ++ L++N ++ + + L
Sbjct: 95 LLVGPSIETLHAANNNIS-RVSCSRGQGKK---NIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 162 LNNNRFTGKIPPQ--LGLLNRIKTFSVASNLLT 192
L N + + ++ ++ N +
Sbjct: 151 LKLNEID-TVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 11/77 (14%), Positives = 28/77 (36%), Gaps = 1/77 (1%)
Query: 124 SDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKT 183
+I ++ +SL + S + + L L+ N + L +++
Sbjct: 3 HEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLEL 62
Query: 184 FSVASNLLTGPVPSFAN 200
+++SN+L +
Sbjct: 63 LNLSSNVLYE-TLDLES 78
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 15/96 (15%), Positives = 25/96 (26%), Gaps = 2/96 (2%)
Query: 98 FPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFL 157
+ + +L DL N D S+ Q V ++ ++ CT
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVP 286
Query: 158 NVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
+ P L +K A G
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 17/89 (19%), Positives = 38/89 (42%), Gaps = 9/89 (10%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
L++ + L+ ++P + + + T+L + N+L+ +P+ L L+++
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCLPAHI---TTLVIPDNNLT-SLPALPPE---LRTLEVS 89
Query: 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
N+ T +P L + FS L
Sbjct: 90 GNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 24/110 (21%), Positives = 44/110 (40%), Gaps = 11/110 (10%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
+ L L +S N L+ S+P S + L +S N L+ +P + L+ +
Sbjct: 218 ALPSGLKELIVSGNRLT-SLPVLPSE----LKELMVSGNRLT-SLPMLPSGLLSLS---V 268
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212
N+ T ++P L L+ T ++ N L+ A T+ +
Sbjct: 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGP 316
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 22/122 (18%), Positives = 37/122 (30%), Gaps = 23/122 (18%)
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPS------------DISSRL 130
+ L +S L P L+ +L +
Sbjct: 84 RTLE--VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLP 140
Query: 131 QYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNL 190
+ L +S N L+ +P+ + L L NN+ T +P L + SV+ N
Sbjct: 141 PGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLPMLPSGL---QELSVSDNQ 192
Query: 191 LT 192
L
Sbjct: 193 LA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 26/107 (24%), Positives = 43/107 (40%), Gaps = 17/107 (15%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
+ + L P + L L +S N L+ S+P+ S + L +N L+
Sbjct: 165 KLWAYNNQLT-SLPMLP---SGLQELSVSDNQLA-SLPTLPSE----LYKLWAYNNRLT- 214
Query: 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+P+ + L L ++ NR T +P L K V+ N LT
Sbjct: 215 SLPALPSG---LKELIVSGNRLTS-LPVLPSEL---KELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 18/106 (16%), Positives = 30/106 (28%), Gaps = 7/106 (6%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
+ +S L P + L L + N L+ +P + L T+++L N LS
Sbjct: 245 ELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESL-IHLSSETTVNLEGNPLS- 297
Query: 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLL 191
E R + A L+
Sbjct: 298 ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLV 343
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 47/225 (20%)
Query: 313 IIGTGRTGATYIAM--LPGGCF----IMIKRL----EDSQHSEKEFLSEINTLGSVR-HR 361
+IG G + + G F + + E + + E + L V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAIGSARG 417
+++ L+ + LV+ + G L+D L +E E + +R +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MRSLLE---A 212
Query: 418 LAWLHHNCNPRIIHR-----NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE 472
+++LH N I+HR NI LLD + + +LSDFG + + P L
Sbjct: 213 VSFLHAN---NIVHRDLKPENI-----LLDDNMQIRLSDFGFSCHLEP-GEKLRELC--- 260
Query: 473 FGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERP 511
G GY+APE + D+++ GV+L L+ G P
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 49/217 (22%), Positives = 87/217 (40%), Gaps = 31/217 (14%)
Query: 301 LMKATNSFSKN----NIIGTGRTGATYIAM--LPGGCFIM--IKRLEDSQHSEKEFLSEI 352
+M A+ FS N +G G + G F I + S ++ E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 353 NTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRL 408
++H N+V L + LV+ + G L++ + +E + H +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----I 134
Query: 409 RIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP---KLSDFGLARLMNPVDTHL 465
+ + +A+ H N I+HRN+ + +LL + KL+DFGLA +N
Sbjct: 135 QQILE---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAW 187
Query: 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVL 502
F G GY++PE + + D+++ GV+L
Sbjct: 188 HGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 1e-10
Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 31/222 (13%)
Query: 305 TNSFSKN----NIIGTGRTGATYIAM--LPGGCFIM--IKRLEDSQHSEKEFLSEINTLG 356
+ FS N +G G + G F I + S ++ E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 357 SVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL----HPAEHEVMHMDWPLRLRIAI 412
++H N+V L + LV+ + G L++ + +E + H ++ +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQIL 115
Query: 413 GSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP---KLSDFGLARLMNPVDTHLSTFV 469
+A+ H N I+HRN+ + +LL + KL+DFGLA +N F
Sbjct: 116 E---SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-SEAWHGFA 168
Query: 470 NGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
G GY++PE + + D+++ GV+L L+ G P
Sbjct: 169 ----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 9/130 (6%)
Query: 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141
++V ++ +G+K G+E +LT ++ S+N L+ P L + + +++N
Sbjct: 46 DQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNN 100
Query: 142 SLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV 201
++ P LAN T L L L NN+ T I P L L + ++SN ++
Sbjct: 101 QIADITP--LANLTNLTGLTLFNNQITD-IDP-LKNLTNLNRLELSSNTISDISALSGLT 156
Query: 202 NFTAEDFANN 211
+ F N
Sbjct: 157 SLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 24/100 (24%), Positives = 42/100 (42%), Gaps = 8/100 (8%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
+ + T+L L ++N +S P L + L L+ N L LA+ T L L
Sbjct: 194 VLAKLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 248
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
L NN+ + P L L ++ + +N ++ + A
Sbjct: 249 DLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAG 285
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 18/108 (16%), Positives = 35/108 (32%), Gaps = 9/108 (8%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
D + F L N++ ++ + L VT+L +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS---QTDLDQVTTLQADRLGIK--SI 61
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
G+ L + +NN+ T P L L ++ + +N + P
Sbjct: 62 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP 107
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 7/96 (7%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
+ T+LT LDL++N +S P +S L +T L L +N +S P LA T L L
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSG-LTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
+LN N+ P + L + ++ N ++ P
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 16/96 (16%), Positives = 31/96 (32%), Gaps = 5/96 (5%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ T++ L N +S P + L +T L L+ + + + AN + N
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTPL---ANLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP 194
+K P + + NL +
Sbjct: 403 TVKNVTGALI--APATISDGGSYTEPDITWNLPSYT 436
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 53/197 (26%), Positives = 82/197 (41%), Gaps = 53/197 (26%)
Query: 343 HSEKE-F----LSEINTLGSVRHRNLVPLLGFCVAKKERL--------LVYSYLEN---G 386
+EKE F L EI L ++H N+V L+ C K LV+ + E+ G
Sbjct: 53 ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG 112
Query: 387 TLYDKLHP-AEHEV---MHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC--IL 440
L + L E+ M M L GL ++H N +I+HR++ K +L
Sbjct: 113 LLSNVLVKFTLSEIKRVMQM-----L------LNGLYYIHRN---KILHRDM--KAANVL 156
Query: 441 LDGDFEPKLSDFGLARLMN-PVDTHLSTFVNGEFGDLGYVAPE-------YPRTLVATPK 492
+ D KL+DFGLAR + ++ + + N L Y PE Y P
Sbjct: 157 ITRDGVLKLADFGLARAFSLAKNSQPNRYTN-RVVTLWYRPPELLLGERDY------GPP 209
Query: 493 GDVYSFGVVLLELITGE 509
D++ G ++ E+ T
Sbjct: 210 IDLWGAGCIMAEMWTRS 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 41/186 (22%), Positives = 74/186 (39%), Gaps = 31/186 (16%)
Query: 335 IKRLEDSQH--SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDK 391
IK + +E+ LS ++ + +V + + ++L + + G L
Sbjct: 227 IKMKQGETLALNERIMLSLVS---TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL--H 280
Query: 392 LHPAEHEVMHMDWPLRLRIAIGS-ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450
H ++H V +R GL +H+ +++R++ ILLD ++S
Sbjct: 281 YHLSQHGVFSEA---DMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 334
Query: 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVLLEL 505
D GLA + H V G GY+APE ++ D +S G +L +L
Sbjct: 335 DLGLACDFSKKKPH--ASV----GTHGYMAPE----VLQKGVAYDSSADWFSLGCMLFKL 384
Query: 506 ITGERP 511
+ G P
Sbjct: 385 LRGHSP 390
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 50/172 (29%), Positives = 74/172 (43%), Gaps = 36/172 (20%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
EI L +RH NLV LL C KK LV+ ++++ T+ D L E +D+ + +
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKY 129
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-PVD--THL 465
G+ + H + IIHR+I K IL+ KL DFG AR + P +
Sbjct: 130 LFQIINGIGFCHSH---NIIHRDI--KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184
Query: 466 -STFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
+T Y APE Y DV++ G ++ E+ GE
Sbjct: 185 VAT--------RWYRAPELLVGDVKY------GKAVDVWAIGCLVTEMFMGE 222
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 42/218 (19%), Positives = 83/218 (38%), Gaps = 40/218 (18%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEIN-TLGSVRHRNLVPLLGF 369
+G G G +P G + +K R + +K L +++ ++ +V V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG- 73
Query: 370 CVAKKERLLVYSYLENGTLY----------DKLHPAEHEVMH-MDWPLRLRIAIGSARGL 418
+ G ++ DK + + + + +IA+ + L
Sbjct: 74 -----------ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 419 AWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH-LSTFVNGEFGDLG 477
LH + +IHR++ +L++ + K+ DFG++ + VD G
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDA----GCKP 174
Query: 478 YVAPE----YPRTLVATPKGDVYSFGVVLLELITGERP 511
Y+APE + K D++S G+ ++EL P
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 35/203 (17%)
Query: 313 IIGTGRTGATYIAM--LPGGCFIM--IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
+G G T Y + + +K+ D +K +EI L + H N++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEH--EVMHMDWPLRLRIAIGSAR----GLAWLH 422
E LV + G L+D++ + E R A + + +A+LH
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSE----------RDAADAVKQILEAVAYLH 165
Query: 423 HNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
N I+HR++ + +L D K++DFGL++++ + T G GY
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTVC----GTPGYC 217
Query: 480 APEYPRTLVATPKGDVYSFGVVL 502
APE R P+ D++S G++
Sbjct: 218 APEILRGCAYGPEVDMWSVGIIT 240
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 55/221 (24%), Positives = 86/221 (38%), Gaps = 45/221 (20%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEFLSEINT-LGSVRHRNLVPLLGF 369
IG G G+ + P G + +K R + +K+ L +++ + S +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG- 88
Query: 370 CVAKKERLLVYSYLENGTLY----------DKLHPAEHEVMHMDWPLRL--RIAIGSARG 417
+ G + DK + + V+ P + +I + + +
Sbjct: 89 -----------ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L L N IIHR+I ILLD KL DFG++ + VD+ T D G
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTR------DAG 187
Query: 478 ---YVAPE----YPRTLVATPKGDVYSFGVVLLELITGERP 511
Y+APE + DV+S G+ L EL TG P
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 47/224 (20%), Positives = 81/224 (36%), Gaps = 48/224 (21%)
Query: 301 LMKATNSFSKN----NIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTL 355
L + + F+ IG G + +K ++ S+ E EI L
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIEIL 69
Query: 356 G-SVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEH-------EVMHMDWPLR 407
+H N++ L K +V ++ G L DK+ + V+
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT----- 124
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEP-KLSDFGLARLMNPVDT 463
I + +LH ++HR++ IL G+ E ++ DFG A+ + +
Sbjct: 125 ----ITKT--VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVL 502
L T +VAPE V +G D++S GV+L
Sbjct: 176 LLMTPC----YTANFVAPE-----VLERQGYDAACDIWSLGVLL 210
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 47/172 (27%), Positives = 72/172 (41%), Gaps = 36/172 (20%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
EI L ++H NLV LL K+ LV+ Y ++ T+ +L + + L I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSI 107
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-PVD--THL 465
+ + + + H + IHR++ K IL+ KL DFG ARL+ P D
Sbjct: 108 TWQTLQAVNFCHKH---NCIHRDV--KPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162
Query: 466 -STFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
+T Y +PE Y P DV++ G V EL++G
Sbjct: 163 VAT--------RWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 46/187 (24%), Positives = 77/187 (41%), Gaps = 39/187 (20%)
Query: 341 SQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEH-- 397
S+ E EI L H N+V L + LV L G L++++ +H
Sbjct: 45 SKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS 104
Query: 398 -----EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKL 449
+M + SA ++ +H ++HR++ + +L + + E K+
Sbjct: 105 ETEASYIMRK---------LVSA--VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKI 150
Query: 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVLLE 504
DFG ARL P + L T L Y APE + G D++S GV+L
Sbjct: 151 IDFGFARLKPPDNQPLKTPC----FTLHYAAPE-----LLNQNGYDESCDLWSLGVILYT 201
Query: 505 LITGERP 511
+++G+ P
Sbjct: 202 MLSGQVP 208
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 32/186 (17%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLH 393
IK+ + + L+E L V R +V L + K+ L LV + + G L
Sbjct: 222 IKKRKGEAMA----LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK---- 272
Query: 394 PAEHEVMHMDWPLRLRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGDF 445
H+ + A GL LH RI++R++ + ILLD
Sbjct: 273 ------FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHG 323
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLEL 505
++SD GLA + T + V G +GY+APE + T D ++ G +L E+
Sbjct: 324 HIRISDLGLAVHVPEGQT-IKGRV----GTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 378
Query: 506 ITGERP 511
I G+ P
Sbjct: 379 IAGQSP 384
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 48/237 (20%), Positives = 79/237 (33%), Gaps = 60/237 (25%)
Query: 304 ATNSFSKN---------NIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-FLSEI 352
+T+SFS +++G G + L +K +E + E+
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 353 NTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEH-------EVMHMDW 404
L + HRN++ L+ F + LV+ + G++ +H H V+
Sbjct: 62 EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD-- 119
Query: 405 PLRLRIAIGSARGLAWLHHNCNPRIIHR-----NI--SSKCILLDGDFEPKLSDFGLARL 457
+ SA L +LH+ I HR NI + K+ DF L
Sbjct: 120 -------VASA--LDFLHNK---GIAHRDLKPENILCEHP----NQVSPVKICDFDLGSG 163
Query: 458 MNPVDTH-------LSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVL 502
+ L T G Y+APE D++S GV+L
Sbjct: 164 IKLNGDCSPISTPELLTPC----GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 38/216 (17%)
Query: 314 IGTGRTGATYIAM--LPGGCFIM--IKRLEDSQHSEKEFLSEINTLGSVRHR-NLVPLLG 368
+G G+ + G + +K+ Q E L EI L + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 369 FCVAKKERLLVYSYLENGTLYDKL------HPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
E +L+ Y G ++ +E++V+ + ++ + G+ +LH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYYLH 148
Query: 423 HNCNPRIIHR-----NI--SSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
N I+H NI SS + K+ DFG++R + L + G
Sbjct: 149 QN---NIVHLDLKPQNILLSSI----YPLGDIKIVDFGMSRKIGH-ACELREIM----GT 196
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511
Y+APE T D+++ G++ L+T P
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 9e-10
Identities = 57/228 (25%), Positives = 99/228 (43%), Gaps = 55/228 (24%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIK--RLEDSQHSEKE-----FLSEINTLGSV 358
+ K +G G G Y A G + +K RL+ +E E + EI+ L +
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLD----AEDEGIPSTAIREISLLKEL 76
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLEN--GTLYDKLHPA--EHEV---MHMDWPLRLRIA 411
H N+V L+ +++ LV+ ++E + D+ + ++ ++
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ--------- 127
Query: 412 IGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-PVDTHLSTF 468
RG+A H + RI+HR++ K +L++ D KL+DFGLAR PV ++
Sbjct: 128 --LLRGVAHCHQH---RILHRDL--KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 469 VNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
V L Y AP+ Y + D++S G + E+ITG+
Sbjct: 181 VT-----LWYRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 23/99 (23%), Positives = 42/99 (42%), Gaps = 12/99 (12%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
++ + L +D+ +N+L +P S + + +N L E+P L N FL +
Sbjct: 149 LQNSSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAGNNQLE-ELPE-LQNLPFLTAIY 201
Query: 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
+NN K+P L ++ +N+L P N
Sbjct: 202 ADNNSLK-KLPDLPLSL---ESIVAGNNILEEL-PELQN 235
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 23/91 (25%), Positives = 38/91 (41%), Gaps = 11/91 (12%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
++ LT + +N+L +P S + S+ +N L E+P L N FL +
Sbjct: 191 LQNLPFLTAIYADNNSLK-KLPDLPLS----LESIVAGNNILE-ELPE-LQNLPFLTTIY 243
Query: 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+NN +P L + +V N LT
Sbjct: 244 ADNNLLK-TLPDLPPSL---EALNVRDNYLT 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 26/115 (22%), Positives = 47/115 (40%), Gaps = 16/115 (13%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
++ S L + P + SL + + LS P + L +S+N L
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL--------LEYLGVSNNQLE- 144
Query: 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
++P L N +FL ++ ++NN K+P L + + +N L +P N
Sbjct: 145 KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSL---EFIAAGNNQLEE-LPELQN 193
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 18/113 (15%), Positives = 34/113 (30%), Gaps = 17/113 (15%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISS------------RLQYVTSLDLSSNSLS 144
+ P E S T + + + P + L+L++ LS
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
+P + L L + N T ++P L + + L+ P
Sbjct: 85 -SLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 19/78 (24%), Positives = 39/78 (50%), Gaps = 7/78 (8%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
++ LT + +N L ++P S + +L++ N L+ ++P + TFL+V +
Sbjct: 233 LQNLPFLTTIYADNNLLK-TLPDLPPS----LEALNVRDNYLT-DLPELPQSLTFLDVSE 286
Query: 162 LNNNRFTGKIPPQLGLLN 179
+ + ++PP L LN
Sbjct: 287 NIFSGLS-ELPPNLYYLN 303
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 19/87 (21%), Positives = 35/87 (40%), Gaps = 9/87 (10%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
L L +S+N L +P ++ +D+ +NSL ++P + L + NN
Sbjct: 131 PLLEYLGVSNNQLE-KLPE--LQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNN 183
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ P+L L + +N L
Sbjct: 184 QLE--ELPELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 23/119 (19%), Positives = 39/119 (32%), Gaps = 21/119 (17%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPS------------DISSRLQYV 133
+ + D L P + T L + + LS P+ + +
Sbjct: 261 ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 319
Query: 134 TSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L++S+N L E+P+ L L + N ++P L K V N L
Sbjct: 320 EELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNL---KQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 18/124 (14%), Positives = 37/124 (29%), Gaps = 27/124 (21%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV----- 159
L L S N+L+ +P + + L + N L E P + L +
Sbjct: 336 PPRLERLIASFNHLA-EVPELPQN----LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLA 389
Query: 160 -----------LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP-SFANVNFTAED 207
L + N + P + ++ + S + P + + +D
Sbjct: 390 EVPELPQNLKQLHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDD 445
Query: 208 FANN 211
+
Sbjct: 446 VFEH 449
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 17/100 (17%), Positives = 33/100 (33%), Gaps = 19/100 (19%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN------------ 153
T L S+NL+ +P + ++ T + + P G
Sbjct: 11 TFLQEPLRHSSNLT-EMPVEA-ENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 154 -CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ L+LNN + +P +++ + N LT
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT 104
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 15/102 (14%), Positives = 30/102 (29%), Gaps = 20/102 (19%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISS---------------RLQYVTSLDLSSNSLSGEIPSG 150
+L L + N L P S Q + L + +N L E P
Sbjct: 357 QNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDI 414
Query: 151 LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ + L++N+ R ++++ +
Sbjct: 415 PES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 11/66 (16%), Positives = 19/66 (28%), Gaps = 5/66 (7%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
E +L L + +N L P S V L ++S + L
Sbjct: 393 ELPQNLKQLHVETNPLR-EFPDIPES----VEDLRMNSERVVDPYEFAHETTDKLEDDVF 447
Query: 163 NNNRFT 168
++
Sbjct: 448 EHHHHH 453
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 1e-09
Identities = 97/671 (14%), Positives = 181/671 (26%), Gaps = 222/671 (33%)
Query: 1 MALMNKDATIFAHTLTVVVVILFCGNVR------LSLATLNDI--------------ECL 40
KD I + V C +V+ LS ++ I L
Sbjct: 14 HQYQYKD--ILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL 71
Query: 41 KS---------VKNSLEDPFNYLTTSWNFNNN-----TEGFICQ----FTGVDCWHPD-- 80
S V+ L + +L + T +I Q + +
Sbjct: 72 LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 81 --ENKVLNIR-----------------------------LSDMGLKGQFPRGI-----ER 104
L +R ++ + I +
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKN 191
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK-LN 163
C S + L I + +SR + +++ L +S+ E+ L + + N L L
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 164 N-------NRFTG--KIPPQLGLLNRIK--TFSVASNLLTGPVPSFANVNFTAEDFANNS 212
N N F KI L L R K T +++ T ++ T ++
Sbjct: 252 NVQNAKAWNAFNLSCKI---L-LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE---VK 304
Query: 213 GLCGKPLN-PCPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMRGVYVKKKEDDPEG 271
L K L+ +P++ + I + D
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTN------------PRRLSII---------AESIRDGL-- 341
Query: 272 NKWAKRIKGTKGIKVS-AFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGG 330
W K K++ E S+ + ++ K + ++ P
Sbjct: 342 ATW-DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL----------------SVFPPS 384
Query: 331 CFIMIKRLE----DSQHSEKE-FLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS-YLE 384
I L D S+ +++++ V + K+ + + S YLE
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP----------KESTISIPSIYLE 434
Query: 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR----------GLAWL---------HHNC 425
K+ +H R + +L HH
Sbjct: 435 L-----KVKLENEYALH-------RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLK 482
Query: 426 NPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMNPVDTHLSTFVNGEFGDL----GYVA 480
N R + + LD F E K+ A N + L+T L Y+
Sbjct: 483 NIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW--NASGSILNT-----LQQLKFYKPYIC 535
Query: 481 ---PEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537
P+Y R + + F L E +L + + L+ I L+ + +
Sbjct: 536 DNDPKYERLV-----NAILDF------LPKIE--ENLICSKYT---DLLR-IALMAEDEA 578
Query: 538 L----ETAIDK 544
+ + +
Sbjct: 579 IFEEAHKQVQR 589
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 53/234 (22%), Positives = 92/234 (39%), Gaps = 62/234 (26%)
Query: 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEF-LSEINTLGSVRHRNL 363
+++ +IG G G + A L + IK++ +K F E+ + V+H N+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNV 94
Query: 364 VPLLGFCVAKKERL------LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGS--- 414
V L F + ++ LV Y+ T+ + L+ + +
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TV--------YRASRHYAKLKQTMPMLLIKL 145
Query: 415 -----ARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMNPVDTHLSTF 468
R LA++H I HR+I + +LLD KL DFG A+++ + ++S
Sbjct: 146 YMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS-- 200
Query: 469 VNGEFGDLGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
Y+ APE Y T D++S G V+ EL+ G+
Sbjct: 201 ---------YICSRYYRAPELIFGATNY------TTNIDIWSTGCVMAELMQGQ 239
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 48/180 (26%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN--GTLYDKLHPA--EHEV---MHMD 403
EI L ++H+N+V L + K+ LV+ + + +D + V +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ- 109
Query: 404 WPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-P 460
+GL + H ++HR++ K +L++ + E KL++FGLAR P
Sbjct: 110 ----------LLKGLGFCHSR---NVLHRDL--KPQNLLINRNGELKLANFGLARAFGIP 154
Query: 461 VD--THLSTFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGERP 511
V + E L Y P+ Y + D++S G + EL RP
Sbjct: 155 VRCYSA-------EVVTLWYRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRP 201
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 32/211 (15%)
Query: 313 IIGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVPLLGFC 370
++G+G ++ G +K ++ + +EI L ++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 371 VAKKERLLVYSYLENGTLYDKLHPAEH-------EVMHMDWPLRLRIAIGSARGLAWLHH 423
+ LV + G L+D++ V+ + SA + +LH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ---------VLSA--VKYLHE 124
Query: 424 NCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
N I+HR++ + +L + + + ++DFGL+++ +ST G GYVA
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTAC----GTPGYVA 175
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERP 511
PE + D +S GV+ L+ G P
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 49/223 (21%)
Query: 308 FSKNNIIGTGRTGATYIAMLPGGCFIMIK--RLEDSQHSEKE-----FLSEINTLGSVRH 360
+ IG G G Y A G +K RLE E E + EI+ L ++H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE----KEDEGIPSTTIREISILKELKH 59
Query: 361 RNLVPLLGFCVAKKERLLVYSYLEN--GTLYDKLHPA--EHEVMHMDWPLRLRIAIGSAR 416
N+V L KK +LV+ +L+ L D L
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL--------LN 111
Query: 417 GLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-PVDTHLSTFVNGEF 473
G+A+ H R++HR++ K +L++ + E K++DFGLAR PV + V
Sbjct: 112 GIAYCHDR---RVLHRDL--KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--- 163
Query: 474 GDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
L Y AP+ Y + D++S G + E++ G
Sbjct: 164 --LWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 45/189 (23%), Positives = 73/189 (38%), Gaps = 35/189 (18%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLH 393
+K+ + Q + + E L V R +V L + K L LV + + G + + H
Sbjct: 223 LKKRKGYQGA----MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI--RYH 275
Query: 394 PAEHEVMHMDWPLRLRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGDF 445
++ A GL LH II+R++ + +LLD D
Sbjct: 276 ------IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDG 326
Query: 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG---DVYSFGVVL 502
++SD GLA + T + G G++APE L+ D ++ GV L
Sbjct: 327 NVRISDLGLAVELKAGQTKTKGYA----GTPGFMAPE---LLLGEEYDFSVDYFALGVTL 379
Query: 503 LELITGERP 511
E+I P
Sbjct: 380 YEMIAARGP 388
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 20/102 (19%), Positives = 37/102 (36%), Gaps = 10/102 (9%)
Query: 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF 156
P + + L+LSS + + + I L+ LD+S+N+L L
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEV---LDVSNNNLD-SFSLFLPR--- 452
Query: 157 LNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
L L ++ N+ +P L + ++ N L
Sbjct: 453 LQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGI 492
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 6/89 (6%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
C + D S + + SIPS +++ ++ LDLS N ++ L C L VL L +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGLTAAMKS---LDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
+R I L ++ ++ N L+
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLS 87
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 28/191 (14%), Positives = 61/191 (31%), Gaps = 15/191 (7%)
Query: 28 RLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNI 87
R + L E +K S+N +I + + V+ N + +
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
Query: 88 RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEI 147
S+ + + + ++ L + L S + S L+ V + + ++ + +
Sbjct: 270 NPSESDVVSELGK--VETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVF-LV 325
Query: 148 PSG-LANCTFLNVLKLNNNRFTGKIPPQ---LGLLNRIKTFSVASNLLTGPVPSFANVNF 203
P + L L L+ N + G ++T ++ N L ++
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-------SMQK 378
Query: 204 TAEDFANNSGL 214
T E L
Sbjct: 379 TGEILLTLKNL 389
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 22/92 (23%), Positives = 36/92 (39%), Gaps = 2/92 (2%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ C +L L L S+ ++ +I D L + LDLS N LS S + L
Sbjct: 43 HGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK 101
Query: 159 VLKLNNNRFTG-KIPPQLGLLNRIKTFSVASN 189
L L N + + L ++T + +
Sbjct: 102 YLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV 133
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 23/130 (17%), Positives = 45/130 (34%), Gaps = 5/130 (3%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ LSD L +SL L+L N + + L + +L + + E
Sbjct: 79 LDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSE 138
Query: 147 IPSG-LANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPSFANV--N 202
I A T LN L++ Q L + I ++ + + FA++ +
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 203 FTAEDFANNS 212
+ + +
Sbjct: 198 VRYLELRDTN 207
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 7/90 (7%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
SL L LS N+L S+ L+ +TSLD+S N+ +P + L L
Sbjct: 360 WPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNL 417
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
++ + + ++ V++N L
Sbjct: 418 SSTGIR-VVKT--CIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 13/88 (14%), Positives = 32/88 (36%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
T+L L + + I + L + L++ + SL L + ++ L L+ +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLTG 193
+ +L+ ++ + L
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 13/92 (14%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
+LT LD+S N +P + + L+LSS + + + + L VL ++NN
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQW-PEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNN 441
Query: 166 RFTGKIPPQLGLL-------NRIKTFSVASNL 190
L L N++KT AS
Sbjct: 442 NLD-SFSLFLPRLQELYISRNKLKTLPDASLF 472
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 13/62 (20%), Positives = 21/62 (33%), Gaps = 3/62 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
L L +S N L + + L + +S N L T L + L+ N
Sbjct: 451 PRLQELYISRNKLKTLPDASLFPVLLV---MKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 166 RF 167
+
Sbjct: 508 PW 509
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 57/226 (25%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 302 MKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEF----LSEINT 354
M +++ F + +G G Y + G ++ +K +L+ SE+ + EI+
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLD----SEEGTPSTAIREISL 56
Query: 355 LGSVRHRNLVPLLGFCVAKKERLLVYSYLENG-TLYDKLHPAEHEVMHMDWPLRLRIAIG 413
+ ++H N+V L + + LV+ +++N Y + ++ L
Sbjct: 57 MKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 414 SARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-PVDTHLSTFVN 470
+GLA+ H N +I+HR++ K +L++ + KL DFGLAR PV+T S V
Sbjct: 117 LLQGLAFCHEN---KILHRDL--KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 471 GEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
L Y AP+ Y + D++S G +L E+ITG+
Sbjct: 172 -----LWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 27/179 (15%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKL- 392
+EI L + H ++ + F A+ +V +E G L+DK+
Sbjct: 48 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV 106
Query: 393 ---HPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP-- 447
E + + +LH N IIHR++ + +LL E
Sbjct: 107 GNKRLKEATCKLY-----FYQMLL---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCL 155
Query: 448 -KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE---YPRTLVATPKGDVYSFGVVL 502
K++DFG ++++ + + T G Y+APE T D +S GV+L
Sbjct: 156 IKITDFGHSKILGE-TSLMRTLC----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 36/175 (20%), Positives = 63/175 (36%), Gaps = 38/175 (21%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN--GTLYDKLHP-AEHEVMHMDWPLR 407
E++ L ++HRN++ L L++ Y EN DK + + + L
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL- 141
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP-----KLSDFGLARLMN-PV 461
G+ + H R +HR++ + +LL K+ DFGLAR P+
Sbjct: 142 -------INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
Query: 462 DTHLSTFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
+ L Y PE Y + D++S + E++
Sbjct: 192 RQFTHEIIT-----LWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 19/102 (18%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDL 476
L +L + RIIHR++ ILLD ++DF +A ++ +T ++T G
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMA----GTK 178
Query: 477 GYVAPEYPRTLVATPKGDVY-------SFGVVLLELITGERP 511
Y+APE + ++ KG Y S GV EL+ G RP
Sbjct: 179 PYMAPE----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 41/183 (22%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERL--LVYSYLENGTLYDKLHPAEHEVMHMDWPLRL 408
EI L ++H N++ L ++ +R L++ Y E +D H + +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPV 123
Query: 409 RIAIGSA--------RGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEP----KLSDFGL 454
++ G G+ +LH N ++HR++ K IL+ G+ K++D G
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN---WVLHRDL--KPANILVMGEGPERGRVKIADMGF 178
Query: 455 ARLMN-PVDTHLSTFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELI 506
ARL N P+ ++ Y APE Y T D+++ G + EL+
Sbjct: 179 ARLFNSPLKPL--ADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELL 230
Query: 507 TGE 509
T E
Sbjct: 231 TSE 233
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 64/237 (27%)
Query: 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEF-LSEINTLGSVRHRN 362
S++ +IG G G Y A L G + IK++ +K F E+ + + H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCN 108
Query: 363 LVPLLGFCVAKKERL------LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGS-- 414
+V L F + E+ LV Y+ T+ + V + + +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TV--------YRVARHYSRAKQTLPVIYVK 159
Query: 415 ------ARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP-KLSDFGLARLMNPVDTHLST 467
R LA++H I HR+I + +LLD D KL DFG A+ + + ++S
Sbjct: 160 LYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS- 215
Query: 468 FVNGEFGDLGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGERP 511
Y+ APE Y T DV+S G VL EL+ G +P
Sbjct: 216 ----------YICSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLG-QP 255
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 22/70 (31%), Positives = 33/70 (47%), Gaps = 3/70 (4%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
R + L L L N + I + S L + L L +N LS +P+GL + L V+ L+
Sbjct: 215 RYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH 272
Query: 164 NNRFTGKIPP 173
N T K+
Sbjct: 273 TNNIT-KVGV 281
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 26/100 (26%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
+L L L N + +I + R + L L N + I +G L+ L L L+N
Sbjct: 193 ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDN 250
Query: 165 NRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFANVNF 203
N+ + ++P L L ++ + +N +T V F V F
Sbjct: 251 NKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF 289
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 24/102 (23%), Positives = 41/102 (40%), Gaps = 10/102 (9%)
Query: 103 ERCT-SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVL 160
C L + S L ++P +IS LDL +N +S E+ L L
Sbjct: 29 FGCHCHLRVVQCSDLGLK-AVPKEISPDTTL---LDLQNNDIS-ELRKDDFKGLQHLYAL 83
Query: 161 KLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTG-PVPSFAN 200
L NN+ + KI + L +++ ++ N L P ++
Sbjct: 84 VLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSS 124
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 18/88 (20%), Positives = 37/88 (42%), Gaps = 5/88 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSL-SGEIPSGLANCTFLNVLKLNN 164
+SL L + N + +P + S L+ + +++ N L + G + LN L+++
Sbjct: 123 SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 165 NRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ T IP L + + N +
Sbjct: 182 AKLT-GIPK--DLPETLNELHLDHNKIQ 206
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 15/77 (19%), Positives = 33/77 (42%), Gaps = 11/77 (14%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-------LANCTFL 157
+L L L +N LS +P+ + L+ + + L +N+++ ++ +
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPD-LKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296
Query: 158 NVLKLNNNRFT-GKIPP 173
N + L NN ++ P
Sbjct: 297 NGISLFNNPVPYWEVQP 313
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 14/88 (15%), Positives = 32/88 (36%), Gaps = 10/88 (11%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSD------ISSRLQYVTSLDLSS 140
+ L + L + P G+ L + L +NN++ + + + Y + L +
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303
Query: 141 NSLS-GEIPSGLANCTF-LNVLKLNNNR 166
N + E+ C ++ N +
Sbjct: 304 NPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 14/102 (13%), Positives = 42/102 (41%), Gaps = 7/102 (6%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
GIE ++ L +++ + + + + S L + L + ++ + L+ T L
Sbjct: 61 GIEYAHNIKDLTINNIHAT-----NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN 200
+L ++++ I ++ L ++ + ++ N +
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKT 157
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 24/108 (22%), Positives = 41/108 (37%), Gaps = 4/108 (3%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
+R+ + + TSLT LD+S + SI + I++ L V S+DLS N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT-LPKVNSIDLSYNGAIT 150
Query: 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
+I L L L + + + ++ S + G
Sbjct: 151 DI-MPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 28/88 (31%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
SLT L L N ++ + + L + L LS NS+S + +G LAN L L LNN
Sbjct: 192 PSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNN 249
Query: 165 NRFTGKIPPQLGLLNRIKTFSVASNLLT 192
N+ K+P L I+ + +N ++
Sbjct: 250 NKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 18/66 (27%), Positives = 38/66 (57%), Gaps = 2/66 (3%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
+ +L L LS N++S ++ + + ++ L L++N L ++P GLA+ ++ V+ L
Sbjct: 213 KGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270
Query: 163 NNNRFT 168
+NN +
Sbjct: 271 HNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 29/125 (23%), Positives = 51/125 (40%), Gaps = 22/125 (17%)
Query: 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISS 128
C V C SD+GL+ + P+ + LDL +N ++ I
Sbjct: 31 CHLRVVQC-------------SDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFK 73
Query: 129 RLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVA 187
L+ + +L L +N +S +I G A L L L+ N+ ++P + ++ V
Sbjct: 74 NLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVH 129
Query: 188 SNLLT 192
N +T
Sbjct: 130 ENEIT 134
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 18/89 (20%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSL-SGEIPSG-LANCTFLNVLKLN 163
+L L + N ++ + + + L + ++L +N L S I +G L+ +++
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ T IP GL + + N +T
Sbjct: 180 DTNIT-TIPQ--GLPPSLTELHLDGNKIT 205
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 11/77 (14%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-------LANCTFL 157
L L L++N L +P ++ +Y+ + L +N++S I S
Sbjct: 239 TPHLRELHLNNNKLV-KVPGGLAD-HKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 158 NVLKLNNNRFT-GKIPP 173
+ + L +N +I P
Sbjct: 296 SGVSLFSNPVQYWEIQP 312
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 18/86 (20%), Positives = 37/86 (43%), Gaps = 10/86 (11%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSD------ISSRLQYVTSLDLSSNS 142
L++ L + P G+ + + L +NN+S +I S+ +++ + + L SN
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNP 304
Query: 143 LS-GEIPSGLANC-TFLNVLKLNNNR 166
+ EI C ++L N +
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 55/228 (24%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG-GCFIMIK--RLEDSQHSEKEF----LSEINTLGSV 358
++ K + +G G Y + +K RLE E+ + E++ L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAIREVSLLKDL 57
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLEN---GTLYDKLHP-AEHEV---MHMDWPLRLRIA 411
+H N+V L +K LV+ YL+ L D + H V +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------- 108
Query: 412 IGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-PVDTHLSTF 468
RGLA+ H +++HR++ K +L++ E KL+DFGLAR + P T+ +
Sbjct: 109 --LLRGLAYCHRQ---KVLHRDL--KPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161
Query: 469 VNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
V L Y P+ Y + + D++ G + E+ TG
Sbjct: 162 VT-----LWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 18/103 (17%), Positives = 32/103 (31%), Gaps = 6/103 (5%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLK 161
L L+L S +I + L + LDL S+ + + L L+
Sbjct: 45 PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELR 103
Query: 162 LNNNRFTGKIPPQLGL--LNRIKTFSVASNLLT--GPVPSFAN 200
L + + L + ++ N + PSF
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 19/106 (17%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
L Q P+ + + L LS N + ++ + L+ + L+L S I
Sbjct: 11 YRFCNLT-QVPQVL---NTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 149 SG-LANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
N L +L L +++ + P L + + L+
Sbjct: 66 KEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLS 110
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 8/149 (5%)
Query: 45 NSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIER 104
SL + + + F+N + F G+ + V ++ LS + R E
Sbjct: 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLA-----RSSVRHLDLSHGFVFSLNSRVFET 288
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLN 163
L L+L+ N ++ I + L + L+LS N L E+ S + + L
Sbjct: 289 LKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQ 346
Query: 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
N L +++T + N LT
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 34/133 (25%), Positives = 47/133 (35%), Gaps = 8/133 (6%)
Query: 87 IRLSDMGLKG-QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145
I LS+ L+ + R L L L+ N S S + L L N L
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 146 EIPSGLANCTF-----LNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPSFA 199
+ L F L VL LN+N +PP L ++ S+ SN LT +
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDL 524
Query: 200 NVNFTAEDFANNS 212
N D + N
Sbjct: 525 PANLEILDISRNQ 537
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 14/83 (16%), Positives = 29/83 (34%), Gaps = 6/83 (7%)
Query: 111 LDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGK 170
NL+ +P +++ L LS N + S L +L+L +
Sbjct: 9 AFYRFCNLT-QVPQVLNT----TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 171 IPPQ-LGLLNRIKTFSVASNLLT 192
I + L ++ + S+ +
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIY 86
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 28/143 (19%), Positives = 46/143 (32%), Gaps = 14/143 (9%)
Query: 83 KVLNI---RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLS 139
L + LSD LK + R +LT LDLS N + +L + S+D S
Sbjct: 100 FELRLYFCGLSDAVLKDGYFRN---LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156
Query: 140 SNSLSGEIPSGLANCTF--LNVLKLNNNRFTGKIPPQLGLLN------RIKTFSVASNLL 191
SN + L L+ L N ++ G ++ V+ N
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216
Query: 192 TGPVPSFANVNFTAEDFANNSGL 214
T + + + +
Sbjct: 217 TVDITGNFSNAISKSQAFSLILA 239
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 25/107 (23%), Positives = 43/107 (40%), Gaps = 5/107 (4%)
Query: 88 RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEI 147
+S +LT L ++ NL+ ++P L Y+ L+LS N +S I
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TI 263
Query: 148 PSG-LANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
L L ++L + + P LN ++ +V+ N LT
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 30/136 (22%), Positives = 50/136 (36%), Gaps = 17/136 (12%)
Query: 69 CQFTGVDCWH----------PDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNL 118
Q V C P E ++L+ L +K L L+L+ N +
Sbjct: 11 AQDRAVLCHRKRFVAVPEGIPTETRLLD--LGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 119 SGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQL-G 176
S ++ + L + +L L SN L IP G + L L ++ N+ + +
Sbjct: 69 S-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125
Query: 177 LLNRIKTFSVASNLLT 192
L +K+ V N L
Sbjct: 126 DLYNLKSLEVGDNDLV 141
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
SL L L NL+ SIP++ S L + L L +++ I L VL++++
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISH 209
Query: 165 NRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ + P + + S+ LT
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 23/98 (23%), Positives = 43/98 (43%), Gaps = 6/98 (6%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNN 164
+L L L SN L IP + + L +T LD+S N + + + + L L++ +
Sbjct: 80 FNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGD 137
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASNLLTG-PVPSFAN 200
N I + LN ++ ++ LT P + ++
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH 174
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 19/92 (20%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLK 161
+R L L++S ++ + L +TSL ++ +L+ +P + + +L L
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLN-LTSLSITHCNLT-AVPYLAVRHLVYLRFLN 254
Query: 162 LNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
L+ N + I L L R++ + L
Sbjct: 255 LSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 9/94 (9%)
Query: 103 ERCT---SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159
RC + ++P I + + LDL N + A+ L
Sbjct: 5 PRCECSAQDRAVLCHRKRFV-AVPEGIPTETRL---LDLGKNRIKTLNQDEFASFPHLEE 60
Query: 160 LKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
L+LN N + + P L ++T + SN L
Sbjct: 61 LELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK 93
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 9e-09
Identities = 42/220 (19%), Positives = 88/220 (40%), Gaps = 55/220 (25%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCV 371
+G G+ + A+ + +++K L+ + +K+ EI L ++R N++ L +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLA--DI 99
Query: 372 ----AKKERLLVYSYLENG---TLYDKLHPAE-----HEVMHMDWPLRLRIAIGSARGLA 419
+ LV+ ++ N LY L + +E++ + L
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL---------------KALD 144
Query: 420 WLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+ H I+HR++ +++D + + +L D+GLA +P + N +
Sbjct: 145 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-----NVRVASRYF 196
Query: 479 VAPE-------YPRTLVATPKGDVYSFGVVLLELITGERP 511
PE Y +L D++S G +L +I + P
Sbjct: 197 KGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 22/175 (12%), Positives = 42/175 (24%), Gaps = 44/175 (25%)
Query: 347 EFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH--PAEHEVMHMDW 404
E LS L + + +L + L+V ++ G+L + P+
Sbjct: 77 ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA----- 131
Query: 405 PLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464
+R A H + + + D + L+
Sbjct: 132 ---IRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174
Query: 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519
+ A P+ D+ G L L+ P
Sbjct: 175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 20/150 (13%), Positives = 56/150 (37%), Gaps = 8/150 (5%)
Query: 45 NSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIER 104
++ Y ++ + + + + G + + K++ + ++ ++
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQD-VYFGFEDITLNNQKIVT--FKNSTMRKLPAALLDS 67
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLN 163
+ L+L+ + I + + + L + N++ +P N L VL L
Sbjct: 68 FRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLE 125
Query: 164 NNRFTGKIPPQL-GLLNRIKTFSVASNLLT 192
N + +P + ++ T S+++N L
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 17/87 (19%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
+ L L +S+N L ++ + + LDLS N L + L L L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASN 189
++N + + +K +++ N
Sbjct: 326 DHNSIV-TLKL--STHHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 6/89 (6%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLN 163
LT L L NNL+ + +DLS N L +I L L ++
Sbjct: 225 NVELTILKLQHNNLT-DTAW--LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYIS 280
Query: 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
NNR + + +K ++ N L
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 27/122 (22%), Positives = 40/122 (32%), Gaps = 24/122 (19%)
Query: 97 QFPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG----- 150
PRGI LT L +S+NNL I D + +L LSSN L+ +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSL 188
Query: 151 ------------LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
LA + L ++N + + + + N LT
Sbjct: 189 FHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAWL 244
Query: 199 AN 200
N
Sbjct: 245 LN 246
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 43/188 (22%), Positives = 73/188 (38%), Gaps = 35/188 (18%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLH 393
I + + E + + + H V L F E+L SY +NG L +
Sbjct: 68 IIKENKVPYV----TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR 122
Query: 394 PAEHEVMHMDWPLRLRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGDF 445
R L +LH IIHR++ + ILL+ D
Sbjct: 123 KIG------------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDM 167
Query: 446 EPKLSDFGLARLMNPVDTHL--STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLL 503
+++DFG A++++P ++FV G YV+PE A D+++ G ++
Sbjct: 168 HIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTEKSACKSSDLWALGCIIY 223
Query: 504 ELITGERP 511
+L+ G P
Sbjct: 224 QLVAGLPP 231
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 46/179 (25%), Positives = 70/179 (39%), Gaps = 50/179 (27%)
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN---GTLYDKLHP-AEHEV---MHMD 403
EI L + H N++ LL K LV+ ++E + D + M M
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM- 120
Query: 404 WPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN-P 460
+ +GL +LH + I+HR++ K +LLD + KL+DFGLA+ P
Sbjct: 121 ----------TLQGLEYLHQH---WILHRDL--KPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 461 VD--THL-STFVNGEFGDLGYVAPE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
TH T Y APE Y D+++ G +L EL+
Sbjct: 166 NRAYTHQVVT--------RWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 56/253 (22%), Positives = 87/253 (34%), Gaps = 56/253 (22%)
Query: 285 KVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTG-----------RTGATYIAMLPGGCFI 333
F V++MRL F +IG G + AM +
Sbjct: 58 WAKPFTSKVKQMRLH-----REDFEILKVIGRGAFGEVAVVKLKNADKVF-AMKILNKWE 111
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKL 392
M+KR ++ F E + L + + + L + L LV Y G L L
Sbjct: 112 MLKR-AETAC----FREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 393 HPAEHEVMHMDWPLRLRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGD 444
E R+ AR + +H +HR+I IL+D +
Sbjct: 166 SKFED-----------RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN 211
Query: 445 FEPKLSDFGLA-RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSF 498
+L+DFG +LM S V G Y++PE + + D +S
Sbjct: 212 GHIRLADFGSCLKLMEDGTVQSSVAV----GTPDYISPEILQAMEGGKGRYGPECDWWSL 267
Query: 499 GVVLLELITGERP 511
GV + E++ GE P
Sbjct: 268 GVCMYEMLYGETP 280
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 31/166 (18%), Positives = 58/166 (34%), Gaps = 15/166 (9%)
Query: 29 LSLATLNDIE-CLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVD-CWHPDENKVLN 86
S L ++E K ++ L + + VD + + +
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQ-YFSTLKAVDPMRAAYLDDLRS 427
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
L + + + L L+ +L+ + +L VT LDLS N L
Sbjct: 428 KFLLENSVLKMEYADVRV------LHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-A 477
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+P LA L VL+ ++N + + L R++ + +N L
Sbjct: 478 LPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQ 521
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 17/89 (19%), Positives = 36/89 (40%), Gaps = 5/89 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
+ L+L+ + I + + + L + N++ +P N L VL L
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLER 132
Query: 165 NRFTGKIPPQL-GLLNRIKTFSVASNLLT 192
N + +P + ++ T S+++N L
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE 160
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 6/89 (6%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLN 163
LT L L NNL+ + +DLS N L +I L L ++
Sbjct: 231 NVELTILKLQHNNLT-DTAW--LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYIS 286
Query: 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
NNR + + +K ++ N L
Sbjct: 287 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 17/87 (19%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
+ L L +S+N L ++ + + LDLS N L + L L L
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYGQP-IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 331
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASN 189
++N + + +K +++ N
Sbjct: 332 DHNSIV-TLKL--STHHTLKNLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 27/122 (22%), Positives = 40/122 (32%), Gaps = 24/122 (19%)
Query: 97 QFPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG----- 150
PRGI LT L +S+NNL I D + +L LSSN L+ +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSL 194
Query: 151 ------------LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
LA + L ++N + + + + N LT
Sbjct: 195 FHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLT-DTAWL 250
Query: 199 AN 200
N
Sbjct: 251 LN 252
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 26/117 (22%), Positives = 37/117 (31%), Gaps = 15/117 (12%)
Query: 69 CQFTGVDCWH----------PDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNL 118
C T + C P L L L+ ++ T LT L LSSN L
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLE--LESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 119 S-GSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQ 174
S S + LDLS N + + S L L ++ ++
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 119
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 21/92 (22%), Positives = 41/92 (44%), Gaps = 4/92 (4%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLK 161
+SL L ++ N+ + DI + L+ +T LDLS L ++ + + L VL
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 162 LNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
+++N F + LN ++ + N +
Sbjct: 206 MSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 6e-08
Identities = 19/96 (19%), Positives = 30/96 (31%), Gaps = 3/96 (3%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFL 157
L LD +NL + L+ + LD+S +G + L
Sbjct: 94 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSL 152
Query: 158 NVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
VLK+ N F P L + ++ L
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 9/102 (8%)
Query: 103 ERCT-SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVL 160
RC+ S T + +S L+ S+P+ I S L+L SN L +P G T L L
Sbjct: 3 SRCSCSGTEIRCNSKGLT-SVPTGIPSSATR---LELESNKLQ-SLPHGVFDKLTQLTKL 57
Query: 161 KLNNNRFTGKIPPQLGL--LNRIKTFSVASNLLTGPVPSFAN 200
L++N + K +K ++ N + +F
Sbjct: 58 SLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG 99
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 9/104 (8%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLK 161
+L LDLSSN+L ++ + S LQ + L L +N + + + L L
Sbjct: 85 VPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLY 142
Query: 162 LNNNRFTGKIPPQ----LGLLNRIKTFSVASNLLTG-PVPSFAN 200
L+ N+ + + P + L ++ ++SN L P+
Sbjct: 143 LSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 8/82 (9%)
Query: 98 FPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG----LA 152
+ +L L L +N++ + + + + L LS N +S P
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN 160
Query: 153 NCTFLNVLKLNNNRFTGKIPPQ 174
L +L L++N+ K+P
Sbjct: 161 KLPKLMLLDLSSNKLK-KLPLT 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 27/108 (25%), Positives = 41/108 (37%), Gaps = 21/108 (19%)
Query: 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS- 127
C + C S L P+ + + LDLS NNLS + ++ +
Sbjct: 18 CASNILSC-------------SKQQLP-NVPQSLP--SYTALLDLSHNNLS-RLRAEWTP 60
Query: 128 SRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQ 174
+RL + SL LS N L+ I S L L L++N +
Sbjct: 61 TRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEF 106
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 24/94 (25%), Positives = 45/94 (47%), Gaps = 11/94 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
GI+ ++T L L+ N L +DI + L+ + L L N + ++ S L + L
Sbjct: 60 GIQYLPNVTKLFLNGNKL-----TDIKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLK 112
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L +N + I L L ++++ + +N +T
Sbjct: 113 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 23/118 (19%), Positives = 47/118 (39%), Gaps = 15/118 (12%)
Query: 79 PDEN--KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVT 134
PD+ + + L + S+ + +++++ + L VT
Sbjct: 16 PDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-----KSVQGIQYLPNVT 68
Query: 135 SLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L+ N L+ +I L N L L L+ N+ + L L ++K+ S+ N ++
Sbjct: 69 KLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 15/67 (22%), Positives = 28/67 (41%), Gaps = 7/67 (10%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ T L L LS N++S D+ + L+ + L+L S + + +N N
Sbjct: 170 PLAGLTKLQNLYLSKNHIS-----DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 224
Query: 159 VLKLNNN 165
+K +
Sbjct: 225 TVKNTDG 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 14/176 (7%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
L+E L + RH L L + +RL V Y G L+ L E + + R
Sbjct: 196 LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRAR 251
Query: 408 LRIA-IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466
A I SA L +LH N +++R++ + ++LD D K++DFGL + +
Sbjct: 252 FYGAEIVSA--LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
TF G Y+APE D + GVV+ E++ G P + + + F+
Sbjct: 308 TFC----GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 359
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 57/255 (22%), Positives = 81/255 (31%), Gaps = 63/255 (24%)
Query: 285 KVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTG-----------RTGATYIAMLPGGCFI 333
+ + +R+ + +IG G T Y AM F
Sbjct: 53 RYKDTINKIRDLRMK-----AEDYEVVKVIGRGAFGEVQLVRHKSTRKVY-AMKLLSKFE 106
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKL 392
MIKR DS F E + + +V L + L +V Y+ G L
Sbjct: 107 MIKR-SDSAF----FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLV--- 157
Query: 393 HPAEHEVMHMDWPLRLRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGD 444
M + AR L +H IHR++ +LLD
Sbjct: 158 -------NLMS---NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKS 204
Query: 445 FEPKLSDFGLARLMNPVDTHLS-TFVNGEFGDLGYVAPEYPRTLVATPKGDVY------- 496
KL+DFG MN T V G Y++PE L + Y
Sbjct: 205 GHLKLADFGTCMKMNKEGMVRCDTAV----GTPDYISPE---VLKSQGGDGYYGRECDWW 257
Query: 497 SFGVVLLELITGERP 511
S GV L E++ G+ P
Sbjct: 258 SVGVFLYEMLVGDTP 272
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 23/124 (18%), Positives = 44/124 (35%), Gaps = 10/124 (8%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
+ T L LD + ++ + S+ + L L++ L+ E+ +++ T L L
Sbjct: 293 VTHNTQLYLLDCQAAGIT-ELD---LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLS 345
Query: 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFANVNFTAEDFANNSGLCGKPLN 220
N +G + + A P + N + T + G P+N
Sbjct: 346 CVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403
Query: 221 PCPG 224
PG
Sbjct: 404 IEPG 407
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 31/123 (25%), Positives = 51/123 (41%), Gaps = 11/123 (8%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
GIE+ T LT L +SNN++ ++ S+ +T L SN L+ + + T L L
Sbjct: 59 GIEKLTGLTKLICTSNNIT-TLD---LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGLCGKPLN 220
+ N+ T K+ + + + A N LT + N T D N + +
Sbjct: 112 NCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EIDVSHNTQLTELDCHLNKKITKLDVT 167
Query: 221 PCP 223
P
Sbjct: 168 PQT 170
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 10/91 (10%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
+ + L L+ +NN++ + ++ +T LD SSN L+ EI + T L
Sbjct: 187 VSQNKLLNRLNCDTNNIT-KLD---LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ N T ++ + L+++ T L
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 7/98 (7%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKL-N 163
+L L+L N L+ +IP+ L + L L +N + IPS L L L
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGE 169
Query: 164 NNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPSFAN 200
R + I L+ ++ ++A L +P+
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPNLTP 205
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 26/94 (27%), Positives = 40/94 (42%), Gaps = 7/94 (7%)
Query: 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141
N+ + L+ + P GI T+ L+L N + I + L+++ L LS N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN 98
Query: 142 SLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQ 174
+ I G LN L+L +NR T IP
Sbjct: 99 HIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNG 130
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 20/86 (23%), Positives = 34/86 (39%), Gaps = 5/86 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
L LDLS N+LS +I L ++ L + + + I N L + L +
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAH 264
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASN 189
N T +P L+ ++ + N
Sbjct: 265 NNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 22/91 (24%), Positives = 35/91 (38%), Gaps = 4/91 (4%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
R SL LDL I L + L+L+ +L EIP+ L L+ L L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL 214
Query: 163 NNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
+ N + I P L ++ + + +
Sbjct: 215 SGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 45/195 (23%), Positives = 65/195 (33%), Gaps = 41/195 (21%)
Query: 334 MIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKL 392
M+KR + F E + L + R + L F + L LV Y G L L
Sbjct: 99 MLKR-GEVSC----FREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL 152
Query: 393 HPAEHEVMHMDWPLRLRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGD 444
RI AR + +H +HR+I ILLD
Sbjct: 153 SKFGE-----------RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC 198
Query: 445 FEPKLSDFGLA-RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVY------- 496
+L+DFG +L V G Y++PE + + P Y
Sbjct: 199 GHIRLADFGSCLKLRADGTVRSLVAV----GTPDYLSPEILQAVGGGPGTGSYGPECDWW 254
Query: 497 SFGVVLLELITGERP 511
+ GV E+ G+ P
Sbjct: 255 ALGVFAYEMFYGQTP 269
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 20/89 (22%), Positives = 30/89 (33%), Gaps = 4/89 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
L LDLS N S+ L + +L L L E+ G L L L +
Sbjct: 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQD 138
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
N +P L + + N ++
Sbjct: 139 NALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 5/89 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
+L L L N L ++P D L +T L L N +S +P L+ L L+
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQ 186
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
NR + P L R+ T + +N L+
Sbjct: 187 NRVA-HVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 20/87 (22%), Positives = 34/87 (39%), Gaps = 5/87 (5%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLN 163
+LT L L N +S S+P L + L L N ++ + + L L L
Sbjct: 152 LGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLF 209
Query: 164 NNRFTGKIPPQ-LGLLNRIKTFSVASN 189
N + +P + L L ++ + N
Sbjct: 210 ANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 22/100 (22%), Positives = 38/100 (38%), Gaps = 9/100 (9%)
Query: 75 DCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVT 134
C++ + GL+ P GI + + L N +S +P+ + +T
Sbjct: 7 VCYNEPKVTT---SCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLT 59
Query: 135 SLDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPP 173
L L SN L+ I + L L L++N + P
Sbjct: 60 ILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 26/158 (16%), Positives = 42/158 (26%), Gaps = 18/158 (11%)
Query: 69 CQFTGVDCWH---------PDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLS 119
C + P ++ LS + R L L +
Sbjct: 10 VIGYNAICINRGLHQVPELPAHVNYVD--LSLNSIAELNETSFSRLQDLQFLKVEQQTPG 67
Query: 120 GSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQ--LG 176
I ++ L + L L N ++ +G L VL L G +
Sbjct: 68 LVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFK 126
Query: 177 LLNRIKTFSVASNLLT--GPVPSFAN-VNFTAEDFANN 211
L ++ + N + P F N F D N
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 35/200 (17%), Positives = 64/200 (32%), Gaps = 15/200 (7%)
Query: 4 MNKDATIFAHTLTVVVVILFCGNVRLSLATL--NDIECLKSVKNSLEDPFNYLTTSWNFN 61
+ + L N ++ L N + + + + + N
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 62 NNTEGFICQFTGVD------CWHPDENKVLNIRLSDMGLKGQFPRGI-ERCTSLTGLDLS 114
+ G T + + V LS + + + T L L L+
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLA 307
Query: 115 SNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNNNRFTGKIPP 173
N ++ I + L ++ L+LS N L I S + N L VL L+ N +
Sbjct: 308 QNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGD 364
Query: 174 QL-GLLNRIKTFSVASNLLT 192
Q L +K ++ +N L
Sbjct: 365 QSFLGLPNLKELALDTNQLK 384
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 7/98 (7%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKL-N 163
SL L+L N L+ IPS L + L L +N + IPS L L L
Sbjct: 123 ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGE 180
Query: 164 NNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPSFAN 200
+ I L +K ++ + +P+
Sbjct: 181 LKKLE-YISEGAFEGLFNLKYLNLGMCNIKD-MPNLTP 216
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 16/88 (18%), Positives = 29/88 (32%), Gaps = 5/88 (5%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKL 162
L L++S N+ I L + L + ++ +S I L L L
Sbjct: 216 PLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNL 273
Query: 163 NNNRFTGKIPPQ-LGLLNRIKTFSVASN 189
+N + +P L + + N
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 9/92 (9%)
Query: 104 RCTS-LTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLK 161
C++ + + + LS +P I S +Y L+L N++ I + + L VL+
Sbjct: 51 SCSNQFSKVVCTRRGLS-EVPQGIPSNTRY---LNLMENNIQ-MIQADTFRHLHHLEVLQ 105
Query: 162 LNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
L N +I L + T + N LT
Sbjct: 106 LGRNSIR-QIEVGAFNGLASLNTLELFDNWLT 136
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 4/91 (4%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
R SL LDL I L + L+L ++ ++P+ L L L++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225
Query: 163 NNNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
+ N F +I P L+ +K V ++ ++
Sbjct: 226 SGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 24/94 (25%), Positives = 44/94 (46%), Gaps = 11/94 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
G++ +L GL+L N + +D++ L +T L+LS N L S +A +
Sbjct: 58 GVQYLNNLIGLELKDNQI-----TDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIK 110
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L + + T + P L L+ ++ + N +T
Sbjct: 111 TLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT 142
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 21/94 (22%), Positives = 45/94 (47%), Gaps = 11/94 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ ++L L L N ++ +IS + L + L + + +S ++ + LAN + L
Sbjct: 124 PLAGLSNLQVLYLDLNQIT-----NISPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLT 176
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
LK ++N+ + I P L L + + +N ++
Sbjct: 177 TLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 25/129 (19%), Positives = 46/129 (35%), Gaps = 15/129 (11%)
Query: 68 ICQFTGVDCWHPDEN--KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSD 125
I Q T ++ PD + I + +T L + +
Sbjct: 3 ITQPTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-----TT 55
Query: 126 IS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKT 183
I L + L+L N ++ ++ + L N T + L+L+ N + + L IKT
Sbjct: 56 IEGVQYLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGNPLK-NVSA-IAGLQSIKT 111
Query: 184 FSVASNLLT 192
+ S +T
Sbjct: 112 LDLTSTQIT 120
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 21/80 (26%), Positives = 33/80 (41%), Gaps = 9/80 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ + LT L N + SDIS + L + + L +N +S S LAN + L
Sbjct: 168 PLANLSKLTTLKADDNKI-----SDISPLASLPNLIEVHLKNNQISDV--SPLANTSNLF 220
Query: 159 VLKLNNNRFTGKIPPQLGLL 178
++ L N T + L
Sbjct: 221 IVTLTNQTITNQPVFYNNNL 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 46/199 (23%), Positives = 78/199 (39%), Gaps = 51/199 (25%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFC----VAKKERLLVYSYLENGTLY 389
+K L DS + E++ ++V +L K+ L++ +E G L+
Sbjct: 59 LKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114
Query: 390 DKLHPAEH---------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCIL 440
++ E+M IG+A + +LH + I HR++ + +L
Sbjct: 115 SRIQERGDQAFTEREAAEIMRD---------IGTA--IQFLHSH---NIAHRDVKPENLL 160
Query: 441 L---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG---- 493
+ D KL+DFG A+ L T YVAPE V P+
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQ--NALQTPC----YTPYYVAPE-----VLGPEKYDKS 209
Query: 494 -DVYSFGVVLLELITGERP 511
D++S GV++ L+ G P
Sbjct: 210 CDMWSLGVIMYILLCGFPP 228
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-07
Identities = 57/238 (23%), Positives = 90/238 (37%), Gaps = 58/238 (24%)
Query: 303 KATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIK--RLEDSQHSEKEF----LSEINTL 355
AT+ + IG G G Y A G F+ +K R+ + + E+ L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 356 ---GSVRHRNLVPLLGFCVAKKERL-----LVYSYLEN--GTLYDKLHP---AEHEVMHM 402
+ H N+V L+ C + LV+ +++ T DK P + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125
Query: 403 DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSDFGLARLMN- 459
RGL +LH N I+HR++ K IL+ KL+DFGLAR+ +
Sbjct: 126 MRQF--------LRGLDFLHAN---CIVHRDL--KPENILVTSGGTVKLADFGLARIYSY 172
Query: 460 PVD-THL-STFVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGE 509
+ T + T L Y APE Y D++S G + E+ +
Sbjct: 173 QMALTPVVVT--------LWYRAPEVLLQSTY------ATPVDMWSVGCIFAEMFRRK 216
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 24/94 (25%), Positives = 45/94 (47%), Gaps = 11/94 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
GI+ ++T L L+ N L +DI + L+ + L L N + ++ S L + L
Sbjct: 63 GIQYLPNVTKLFLNGNKL-----TDIKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLK 115
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L +N + I L L ++++ + +N +T
Sbjct: 116 SLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 23/118 (19%), Positives = 47/118 (39%), Gaps = 15/118 (12%)
Query: 79 PDEN--KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVT 134
D+ + + L + S+ + +++++ + L VT
Sbjct: 19 SDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-----KSVQGIQYLPNVT 71
Query: 135 SLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L+ N L+ +I LAN L L L+ N+ + L L ++K+ S+ N ++
Sbjct: 72 KLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 26/113 (23%), Positives = 42/113 (37%), Gaps = 9/113 (7%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ R T L L L N +S DI + L + +L LS N +S ++ LA L+
Sbjct: 151 VLSRLTKLDTLSLEDNQIS-----DIVPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLD 203
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANN 211
VL+L + K L T L P + ++ + +
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWH 256
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
SL LD+S N++S S + + SL++SSN L+ I L + VL L++N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSN 431
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN 200
+ IP Q+ L ++ +VASN L P F
Sbjct: 432 KIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDR 466
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 5/63 (7%)
Query: 111 LDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGK 170
+D S N L +P D+S + L++S N +S S + + + L +L +++NR
Sbjct: 5 VDRSKNGLI-HVPKDLSQKTTI---LNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 171 IPP 173
+
Sbjct: 60 LDI 62
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 23/114 (20%), Positives = 42/114 (36%), Gaps = 6/114 (5%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
+ L L +S N + + + Q + LDLS N L N L+ L+
Sbjct: 43 SLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHLD---LS 98
Query: 164 NNRFTG-KIPPQLGLLNRIKTFSVASNLLT-GPVPSFANVNFTAEDFANNSGLC 215
N F I + G ++++K +++ L V A++N +
Sbjct: 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 30/174 (17%), Positives = 68/174 (39%), Gaps = 22/174 (12%)
Query: 26 NVRLSLATLNDIE--CLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCW-HPDEN 82
L +++ + ++ + + F+ + + T + + C
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-----RMVHMLCPSKISPF 326
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIP--SDISSRLQYVTSLDLSS 140
L+ S+ L T L L L N L + ++++++++ + LD+S
Sbjct: 327 LHLD--FSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQ 383
Query: 141 NSLSGEIPSGL-ANCTFLNVLKLNNNRFT----GKIPPQLGLL----NRIKTFS 185
NS+S + G + L L +++N T +PP++ +L N+IK+
Sbjct: 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIP 437
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 12/95 (12%), Positives = 36/95 (37%), Gaps = 5/95 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
+++ + + + + S++ LD S+N L+ + + T L L L N
Sbjct: 300 SNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358
Query: 166 RFTGKIPPQLGL---LNRIKTFSVASNLLTGPVPS 197
+ ++ + + ++ ++ N ++
Sbjct: 359 QLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 7/104 (6%)
Query: 89 LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148
S GL P+ + T L++S N +S SDI S L + L +S N +
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILS-LSKLRILIISHNRIQYLDI 62
Query: 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
S L L L++N+ KI +K ++ N
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD 103
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 4e-07
Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 64/247 (25%)
Query: 296 MRLSDLMKATNSFSKNNIIGTGRTGATYIA--MLPGGCFIMIK--RLEDSQHSEKE---- 347
M L +A + IG G G + A + GG F+ +K R++ + +E
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ----TGEEGMPL 56
Query: 348 -FLSEINTL---GSVRHRNLVPLLGFCVAKKERL-----LVYSYLEN--GTLYDKLHP-- 394
+ E+ L + H N+V L C + LV+ +++ T DK+
Sbjct: 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 116
Query: 395 -AEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC--ILLDGDFEPKLSD 451
+ M + L RGL +LH + R++HR++ K IL+ + KL+D
Sbjct: 117 VPTETIKDMMFQL--------LRGLDFLHSH---RVVHRDL--KPQNILVTSSGQIKLAD 163
Query: 452 FGLARLMN-PVD-THL-STFVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVL 502
FGLAR+ + + T + T L Y APE Y D++S G +
Sbjct: 164 FGLARIYSFQMALTSVVVT--------LWYRAPEVLLQSSY------ATPVDLWSVGCIF 209
Query: 503 LELITGE 509
E+ +
Sbjct: 210 AEMFRRK 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 46/203 (22%), Positives = 77/203 (37%), Gaps = 58/203 (28%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFC----VAKKERLLVYSYLENGTLY 389
+K L+D + +E + + ++V ++ +K L+V L+ G L+
Sbjct: 92 LKMLQDCPKARRE----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147
Query: 390 DKLHPAEH---------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR-----NI- 434
++ E+M IG A + +LH I HR N+
Sbjct: 148 SRIQDRGDQAFTEREASEIMKS---------IGEA--IQYLHSI---NIAHRDVKPENLL 193
Query: 435 -SSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG 493
+SK + KL+DFG A+ L+T YVAPE V P+
Sbjct: 194 YTSK----RPNAILKLTDFGFAKETTS-HNSLTTPC----YTPYYVAPE-----VLGPEK 239
Query: 494 -----DVYSFGVVLLELITGERP 511
D++S GV++ L+ G P
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPP 262
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 50/218 (22%), Positives = 84/218 (38%), Gaps = 31/218 (14%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLED---SQHSEKEFLSEINTLGSVRH 360
+ IG+G G A + IK+L +Q K E+ + V H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 361 RNLVPLLG-FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMD-WPLRLR-IAIGSARG 417
+N++ LL F K Y+ + + + +V+ M+ R+ + G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYI----VMELMDANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
+ LH + IIHR++ I++ D K+ DFGLAR + + T
Sbjct: 140 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMT---------P 185
Query: 478 YV------APEYPRTLVATPKGDVYSFGVVLLELITGE 509
YV APE + D++S G ++ E+I G
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 31/211 (14%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIKRLED---SQHSEKEFLSEINTLGSVRHRNLVPLL 367
IG+G G A + IK+L +Q K E+ + V H+N++ LL
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 368 G-FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMD-WPLRLRIAIGSA-RGLAWLHHN 424
F K YL + + + +V+ M+ R+ + G+ LH
Sbjct: 128 NVFTPQKTLEEFQDVYL----VMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 181
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV----- 479
+ IIHR++ I++ D K+ DFGLAR + + T YV
Sbjct: 182 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMT---------PYVVTRYY 229
Query: 480 -APEYPRTLVATPKGDVYSFGVVLLELITGE 509
APE + D++S G ++ E++ +
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 34/108 (31%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
R + ++H I HR+I + +L++ D KL DFG A+ + P + ++
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVA-------- 200
Query: 475 DLGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
Y+ APE Y TP D++S G V ELI G+
Sbjct: 201 ---YICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGELILGK 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 29/107 (27%), Positives = 48/107 (44%), Gaps = 22/107 (20%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
R + LH N +IHR++ +L++ + + K+ DFGLAR+++ S + G
Sbjct: 123 RAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 476 LGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
+ +V APE Y + DV+S G +L EL
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 28/107 (26%), Positives = 48/107 (44%), Gaps = 35/107 (32%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
+GL ++H + ++HR++ + ++ D E K+ DFGLAR + T
Sbjct: 137 KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT------------ 181
Query: 476 LGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
GYV APE Y D++S G ++ E++TG+
Sbjct: 182 -GYVVTRWYRAPEVILSWMHY------NQTVDIWSVGCIMAEMLTGK 221
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 12/68 (17%), Positives = 25/68 (36%), Gaps = 4/68 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLA-NCTFLNVLKLNN 164
+ L+ L L+ N + S+ S L + L +L+ + + + L L + +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAH 133
Query: 165 NRFTGKIP 172
N
Sbjct: 134 NLIQ-SFK 140
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 22/121 (18%), Positives = 45/121 (37%), Gaps = 10/121 (8%)
Query: 99 PRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSL-SGEIPSGLANCTF 156
G +SL L NL+ S+ + L+ + L+++ N + S ++P +N T
Sbjct: 92 ALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 157 LNVLKLNNNRFTGKIPPQL-----GLLNRIKTFSVASNLLTG-PVPSFANVNFTAEDFAN 210
L L L++N+ I + + ++ N + +F +
Sbjct: 151 LEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDT 209
Query: 211 N 211
N
Sbjct: 210 N 210
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 24/74 (32%), Positives = 32/74 (43%), Gaps = 7/74 (9%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRL----QYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
T+L LDLSSN + SI L SLDLS N ++ I G L L
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELA 206
Query: 162 LNNNRFTGKIPPQL 175
L+ N+ +P +
Sbjct: 207 LDTNQLK-SVPDGI 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 35/107 (32%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
+GL ++H IIHR++ + ++ D E K+ DFGLAR + T
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT------------ 183
Query: 476 LGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
GYV APE Y T D++S G ++ E+ITG+
Sbjct: 184 -GYVVTRWYRAPEVILNWMRY------TQTVDIWSVGCIMAEMITGK 223
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 19/73 (26%), Positives = 35/73 (47%), Gaps = 4/73 (5%)
Query: 96 GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCT 155
+ R S+ L+LSSN L+GS+ + +++ LDL +N + IP + +
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKV---LDLHNNRIM-SIPKDVTHLQ 473
Query: 156 FLNVLKLNNNRFT 168
L L + +N+
Sbjct: 474 ALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 6/66 (9%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKL 162
+ L L LS N + S+ + Q + LD+S N L I +A+ L+ L
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLD---L 128
Query: 163 NNNRFT 168
+ N F
Sbjct: 129 SFNDFD 134
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 22/103 (21%), Positives = 40/103 (38%), Gaps = 10/103 (9%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG--LANCTFLNVL 160
L LD+S N L +I + L++ LDLS N +P N T L L
Sbjct: 97 LFNQDLEYLDVSHNRLQ-NISCCPMASLRH---LDLSFNDFD-VLPVCKEFGNLTKLTFL 151
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNF 203
L+ +F ++ L + + + +L++ + +
Sbjct: 152 GLSAAKFR-QLD--LLPVAHLHLSCILLDLVSYHIKGGETESL 191
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 24/100 (24%), Positives = 43/100 (43%), Gaps = 18/100 (18%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
+ +D S+ NL+ +P D+ R + L LS NS+S ++ + L VL+L+
Sbjct: 29 SNELESMVDYSNRNLT-HVPKDLPPRTKA---LSLSQNSISELRMPDISFLSELRVLRLS 84
Query: 164 NNRFTGKIP-------PQLGLL----NRIKT--FSVASNL 190
+NR + L L NR++ ++L
Sbjct: 85 HNRIR-SLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASL 123
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 27/109 (24%), Positives = 45/109 (41%), Gaps = 20/109 (18%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIP--SDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF 156
+G L L L N L + + ++ + + +LD+S NSL S + T
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSL----NSHAYDRTC 424
Query: 157 -----LNVLKLNNNRFTG----KIPPQLGLL----NRIKTFSVASNLLT 192
+ VL L++N TG +PP++ +L NRI + L
Sbjct: 425 AWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQ 473
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 24/216 (11%), Positives = 54/216 (25%), Gaps = 34/216 (15%)
Query: 10 IFAHTLTVVVVILFCGNVRLSLATLNDIECLKSVKNSLEDPFNYLT--------TSWNFN 61
+ H ++ V + L L++I+ L + LT T +
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260
Query: 62 NNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGI------------------- 102
+ + F + + N+ +++ + +F
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320
Query: 103 -----ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFL 157
+ LS ++ I T L+ + N + + G + L
Sbjct: 321 KEALYSVFAEMNIKMLSISDTP-FIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 158 NVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193
L L N + + + L
Sbjct: 380 QTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS 414
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 8e-04
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 4/96 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
+SL LD+S N+L+ + + + L+LSSN L+G + L + VL L+NN
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNN 460
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN 200
R IP + L ++ +VASN L P F
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDR 495
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 31/98 (31%), Positives = 42/98 (42%), Gaps = 9/98 (9%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFL 157
P + +LT LD+S N L+ S+P L + L L N L +P GL L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKL 150
Query: 158 NVLKLNNNRFTGKIPPQLGL---LNRIKTFSVASNLLT 192
L L NN T ++P GL L + T + N L
Sbjct: 151 EKLSLANNNLT-ELPA--GLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 21/70 (30%), Positives = 31/70 (44%), Gaps = 5/70 (7%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
T LT L+L L+ + + L + +LDLS N L +P L VL ++
Sbjct: 53 PYTRLTQLNLDRAELT-KLQ--VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108
Query: 164 NNRFTGKIPP 173
NR T +P
Sbjct: 109 FNRLT-SLPL 117
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 5/77 (6%)
Query: 99 PRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTF 156
P G L L L N L ++P + + + L L++N+L+ E+P+GL
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLEN 173
Query: 157 LNVLKLNNNRFTGKIPP 173
L+ L L N IP
Sbjct: 174 LDTLLLQENSLYT-IPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 21/87 (24%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165
S ++ NL+ ++P D+ L LS N L + L T L L L+
Sbjct: 10 ASHLEVNCDKRNLT-ALPPDLPKDTTI---LHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 166 RFTGKIPPQLGLLNRIKTFSVASNLLT 192
T K+ L + T ++ N L
Sbjct: 66 ELT-KLQVDGTLPV-LGTLDLSHNQLQ 90
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 50/183 (27%), Positives = 83/183 (45%), Gaps = 15/183 (8%)
Query: 342 QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVM 400
E + L V H +V L + + +L L+ +L G L+ +L EVM
Sbjct: 67 VRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS---KEVM 122
Query: 401 HMDWPLRLRIA-IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459
+ ++ +A + A L LH II+R++ + ILLD + KL+DFGL++
Sbjct: 123 FTEEDVKFYLAELALA--LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177
Query: 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519
+ +F G + Y+APE T D +SFGV++ E++TG P + E
Sbjct: 178 DHEKKAYSFC----GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 520 SFK 522
+
Sbjct: 234 TMT 236
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 32/107 (29%), Positives = 46/107 (42%), Gaps = 35/107 (32%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL ++H + IIHR++ + ++ D E K+ DFGLAR T
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT------------ 187
Query: 476 LGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
GYV APE Y D++S G ++ EL+TG
Sbjct: 188 -GYVATRWYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTGR 227
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 4e-06
Identities = 10/78 (12%), Positives = 24/78 (30%), Gaps = 3/78 (3%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFL 157
+ +LT L + + + L + +L + + L + L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRL 82
Query: 158 NVLKLNNNRFTGKIPPQL 175
+ L L+ N + +
Sbjct: 83 SRLNLSFNALE-SLSWKT 99
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 8/91 (8%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKL 162
C SS +L+ SIPS ++ ++ LDLS+N ++ I + L C L L L
Sbjct: 29 SCDRNGICKGSSGSLN-SIPSGLTEAVKS---LDLSNNRIT-YISNSDLQRCVNLQALVL 83
Query: 163 NNNRFTGKIPPQL-GLLNRIKTFSVASNLLT 192
+N I L ++ ++ N L+
Sbjct: 84 TSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS 113
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 3/89 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
+SLT L+L N + + S L + L + + +I A TFL L+++
Sbjct: 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA 183
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
+ P+ L + + +
Sbjct: 184 SDLQ-SYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 4/98 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNN 164
SL LDLS N LS ++ S L +T L+L N + L ++ T L +L++ N
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASNLLTG-PVPSFAN 200
KI + L ++ + ++ L S +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS 196
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 3/74 (4%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLK 161
T L L++ +++L S +Q V+ L L + + + L+
Sbjct: 171 AGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 162 LNNNRFTGKIPPQL 175
L + +L
Sbjct: 229 LRDTDLDTFHFSEL 242
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 11/91 (12%), Positives = 32/91 (35%), Gaps = 4/91 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
T L L + + + I + L ++ L++ ++ L L + ++ L L+
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHM 207
Query: 165 NRFTGKIPPQL-GLLNRIKTFSVASNLLTGP 194
+ + + + ++ + L
Sbjct: 208 KQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 20/91 (21%), Positives = 33/91 (36%), Gaps = 9/91 (9%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY----VTSLDLSSN 141
+ L++ K + +L L+L SN L + LQ + L L +
Sbjct: 37 DCGLTEARCKD-ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 95
Query: 142 SLSGE----IPSGLANCTFLNVLKLNNNRFT 168
L+G + S L L L L++N
Sbjct: 96 CLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 126
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 25/97 (25%), Positives = 35/97 (36%), Gaps = 10/97 (10%)
Query: 82 NKVLNIRLSDMGLKG--QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYV----TS 135
+ L I + KG R + SL L L+ N L + L S
Sbjct: 258 LRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES 317
Query: 136 LDLSSNSLSGE----IPSGLANCTFLNVLKLNNNRFT 168
L + S S + S LA FL L+++NNR
Sbjct: 318 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 8/76 (10%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYV----TSLDLSSNSLSGE----IPSGLA 152
+ + L L +S+N L + ++ L L L+ +S + + L
Sbjct: 336 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL 395
Query: 153 NCTFLNVLKLNNNRFT 168
L L L+NN
Sbjct: 396 ANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 14/91 (15%), Positives = 34/91 (37%), Gaps = 9/91 (9%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY----VTSLDLSSN 141
LS + + L +S+N+++ + + L+ + +L L S
Sbjct: 151 YCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESC 209
Query: 142 SLSGE----IPSGLANCTFLNVLKLNNNRFT 168
++ + + +A+ L L L +N+
Sbjct: 210 GVTSDNCRDLCGIVASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 15/66 (22%), Positives = 24/66 (36%), Gaps = 4/66 (6%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE----IPSGLANCTFLNVLK 161
+ LD+ LS + +++ LQ + L L+ I S L L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 162 LNNNRF 167
L +N
Sbjct: 63 LRSNEL 68
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 20/90 (22%), Positives = 28/90 (31%), Gaps = 9/90 (10%)
Query: 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYV----TSLDLSSN 141
N L+ G + +L L LS N L + + L L L
Sbjct: 94 NCCLTGAGCG-VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC 152
Query: 142 SLSGE----IPSGLANCTFLNVLKLNNNRF 167
SLS + S L L ++NN
Sbjct: 153 SLSAASCEPLASVLRAKPDFKELTVSNNDI 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 15/97 (15%), Positives = 32/97 (32%), Gaps = 12/97 (12%)
Query: 83 KVLNIR---LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY----VTS 135
+ L + ++ + + SL L L SN L +++ L + + +
Sbjct: 202 EALKLESCGVTSDNCRD-LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 136 LDLSSNSLSGE----IPSGLANCTFLNVLKLNNNRFT 168
L + ++ + + L L L L N
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 15/66 (22%), Positives = 30/66 (45%), Gaps = 4/66 (6%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
+ +L L L N + I ++ + + L +S N ++ + SG+ L VL
Sbjct: 65 SLSGMENLRILSLGRNLIK-KI-ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVL 120
Query: 161 KLNNNR 166
++NN+
Sbjct: 121 YMSNNK 126
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 19/94 (20%), Positives = 40/94 (42%), Gaps = 10/94 (10%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ + L LS+NN+ IS S ++ + L L N + +I + A L
Sbjct: 43 TLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L ++ N+ + + L ++ +++N +T
Sbjct: 97 ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 36/178 (20%), Positives = 56/178 (31%), Gaps = 37/178 (20%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
G ++H IIHR++ LL+ D K+ DFGLAR +N E +
Sbjct: 140 LGENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 476 LGYVAPEYPRTL---VAT----------------PKGDVYSFGVVLLELITGERPTHLTN 516
G + L V T D++S G + EL+ +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 517 APES--FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKE 572
F GS S + D++ Q + ++ TP E
Sbjct: 257 TNRFPLFPGS-----------SCFPLSPDRNSKKVHEKSNRDQLNIIF--NIIGTPTE 301
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 25/99 (25%), Positives = 43/99 (43%), Gaps = 15/99 (15%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLD------GDFEPKLSDFGLARLMNPVDTHLSTFVN 470
GL ++H C IIH +I + +L++ + K++D G A D H + +
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSIQ 197
Query: 471 GEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE 509
Y +PE D++S ++ ELITG+
Sbjct: 198 TRE----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 3/89 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNN 164
S L L +L +IPS S L ++ + +S + ++ S N + + +++ N
Sbjct: 31 PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 165 NRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
R I P L L +K + + L
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 20/90 (22%), Positives = 36/90 (40%), Gaps = 4/90 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVT-SLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
L+++ N SIP + L T +L L +N + + N T L+ + LN
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188
Query: 165 NRFTGKIPPQL--GLLNRIKTFSVASNLLT 192
N++ I G+ + V+ +T
Sbjct: 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 5/91 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP--SGLANCTFLNVLKLN 163
+ +T +++ + I D L + L + + L P + + + +L++
Sbjct: 80 SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEIT 138
Query: 164 NNRFTGKIPPQL--GLLNRIKTFSVASNLLT 192
+N + IP GL N T + +N T
Sbjct: 139 DNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 14/97 (14%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNN 164
+++ + +S + + S L VT +++ + I L L L + N
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 165 NRFTGKIPPQ--LGLLNRIKTFSVASNLLTGPVPSFA 199
P + + + N +P A
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 18/74 (24%), Positives = 24/74 (32%), Gaps = 9/74 (12%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDIS-SRLQYVTSLDLSSNSLSGEIP----SGLANCTFLNV 159
L L + + L P L+++ N IP GL N
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN--ETLT 160
Query: 160 LKLNNNRFTGKIPP 173
LKL NN FT +
Sbjct: 161 LKLYNNGFT-SVQG 173
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 8/92 (8%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
++ T L L ++ N L ++ S+ L L L +N L L + L +L
Sbjct: 80 PLKDLTKLEELSVNRNRLK-NLNGIPSACLSR---LFLDNNELRD--TDSLIHLKNLEIL 133
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+ NN+ I LG L++++ + N +T
Sbjct: 134 SIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 17/94 (18%), Positives = 40/94 (42%), Gaps = 11/94 (11%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ +L ++ +D+ L V + + ++++ + +G+ T L
Sbjct: 14 PDPGLANAVKQNLGKQSV-----TDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLK 66
Query: 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
L L++N+ + + P L L +++ SV N L
Sbjct: 67 ELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 18/87 (20%), Positives = 32/87 (36%), Gaps = 12/87 (13%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ +L L + +N L I L + LDL N ++ GL +N
Sbjct: 123 SLIHLKNLEILSIRNNKLK-----SIVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVN 175
Query: 159 VLKLNNNRFTGKIP---PQLGLLNRIK 182
+ L + + P+L + N +K
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVK 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 35/107 (32%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
GL +LH I++R++ ILLD D K++DFG+ + M +TF G
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFC----GT 181
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
Y+APE D +SFGV+L E++ G+ P H + E F
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 26/107 (24%), Positives = 41/107 (38%), Gaps = 33/107 (30%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
GL LH ++HR++ ILL + + + DF LAR D + +
Sbjct: 145 LGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTA-DANKT--------- 191
Query: 476 LGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
YV APE + T D++S G V+ E+ +
Sbjct: 192 -HYVTHRWYRAPELVMQFKGF------TKLVDMWSAGCVMAEMFNRK 231
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 21/114 (18%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
L +LH II+R++ +LLD + KL+D+G+ + + P DT STF G
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC----GT 173
Query: 476 LGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523
Y+APE Y ++ D ++ GV++ E++ G P + + ++
Sbjct: 174 PNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 14/69 (20%), Positives = 34/69 (49%), Gaps = 4/69 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNN 164
+ + + L+SN L ++ + L+ + +L L SN ++ + + + + +L L +
Sbjct: 81 SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138
Query: 165 NRFTGKIPP 173
N+ T + P
Sbjct: 139 NQIT-TVAP 146
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 9e-05
Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 4/70 (5%)
Query: 98 FPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCT 155
+ + SL L L SN ++ + +D L V L L N ++ + G
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153
Query: 156 FLNVLKLNNN 165
L+ L L N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 22/106 (20%), Positives = 42/106 (39%), Gaps = 19/106 (17%)
Query: 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISS 128
C+ T VDC S+ L + P I L L++N + + I
Sbjct: 11 CEGTTVDC-------------SNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFK 54
Query: 129 RLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPP 173
+L + ++ S+N ++ +I G + +N + L +NR +
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQH 98
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 46/190 (24%), Positives = 76/190 (40%), Gaps = 43/190 (22%)
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLR 407
++E L + RH L L + +RL V Y G L+ H+
Sbjct: 53 VTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELF----------FHLSRERV 101
Query: 408 LRIAIGSAR--------GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-M 458
AR L +LH +++R+I + ++LD D K++DFGL + +
Sbjct: 102 FTEE--RARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156
Query: 459 NPVDTHLSTFVNGEFGDLGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPT 512
+ T + TF G Y+APE Y R + D + GVV+ E++ G P
Sbjct: 157 SDGAT-MKTFC----GTPEYLAPEVLEDNDYGRAV------DWWGLGVVMYEMMCGRLPF 205
Query: 513 HLTNAPESFK 522
+ + F+
Sbjct: 206 YNQDHERLFE 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 16/101 (15%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
L LH II+R+I + ILLD + L+DFGL++ + F G
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC----GT 223
Query: 476 LGYVAPEYPRTLVATPKG-----DVYSFGVVLLELITGERP 511
+ Y+AP+ + G D +S GV++ EL+TG P
Sbjct: 224 IEYMAPD---IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 17/69 (24%), Positives = 29/69 (42%), Gaps = 4/69 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNN 164
+L L ++ N L ++P + +L + L L N L +P + + T L L L
Sbjct: 85 KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGY 142
Query: 165 NRFTGKIPP 173
N +P
Sbjct: 143 NELQ-SLPK 150
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNN 164
TSL L L +N L +P +L + +L L +N L +P G + L +L+L
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQE 214
Query: 165 N 165
N
Sbjct: 215 N 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 2e-05
Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 29/195 (14%)
Query: 335 IKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL-LVYSYLENGTLYDKLH 393
++ +D+ H+ +E N L V+H +V L+ + +L L+ YL G L+ +L
Sbjct: 59 VRNAKDTAHT----KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE 113
Query: 394 PAEHEVMHMDWPLRLRIA-IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452
E + M+ +A I A L LH II+R++ + I+L+ KL+DF
Sbjct: 114 ---REGIFMEDTACFYLAEISMA--LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDF 165
Query: 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKG-----DVYSFGVVLLELIT 507
GL + T TF G + Y+APE + G D +S G ++ +++T
Sbjct: 166 GLCKESIHDGTVTHTFC----GTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLT 216
Query: 508 GERPTHLTNAPESFK 522
G P N ++
Sbjct: 217 GAPPFTGENRKKTID 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 29/107 (27%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
RGL ++H + N ++HR++ +LL+ + K+ DFGLAR+ +P H
Sbjct: 139 RGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------ 189
Query: 476 LGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGE 509
YV APE Y T D++S G +L E+++
Sbjct: 190 -EYVATRWYRAPEIMLNSKGY------TKSIDIWSVGCILAEMLSNR 229
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 21/114 (18%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
L +LH II+R++ +LLD + KL+D+G+ + + P DT STF G
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFC----GT 216
Query: 476 LGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523
Y+APE Y ++ D ++ GV++ E++ G P + + ++
Sbjct: 217 PNYIAPEILRGEDYGFSV------DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
GL +L II+R++ ++LD + K++DFG+ + + T TF G
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFC----GT 505
Query: 476 LGYVAPEYPRTLVATPKG---DVYSFGVVLLELITGERPTHLTNAPESFK 522
Y+APE + P G D ++FGV+L E++ G+ P + E F+
Sbjct: 506 PDYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 98 FPRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF 156
P+ + E SL L L++N ++ + D L + L L N L +
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 157 LNVLKLNNN 165
+ + L N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 20/85 (23%), Positives = 36/85 (42%), Gaps = 3/85 (3%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNN 164
SL L L N ++ +P + L + L L++N ++ + + LN+L L +
Sbjct: 80 RSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYD 137
Query: 165 NRFTGKIPPQLGLLNRIKTFSVASN 189
N+ L I+T +A N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 39/189 (20%), Positives = 61/189 (32%), Gaps = 51/189 (26%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
G+ ++H I+HR++ L++ D K+ DFGLAR ++ + S D
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 476 L-----------------GYV------APE-------YPRTLVATPKGDVYSFGVVLLEL 505
G+V APE Y T DV+S G + EL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY------TEAIDVWSIGCIFAEL 277
Query: 506 ITGERPTHLTNAPES--FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVAC 563
+ + +A F GS + + G Q +
Sbjct: 278 LNMIKENVAYHADRGPLFPGS--------SCFPLSPDQKAGNDFKFHTRGNRDQLNVIF- 328
Query: 564 NCVLPTPKE 572
+L TP E
Sbjct: 329 -NILGTPSE 336
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 3e-05
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 21/113 (18%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
L +LH II+R++ +LLD + KL+DFG+ + + T +TF G
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TATFC----GT 187
Query: 476 LGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
Y+APE Y + D ++ GV+L E++ G P N + F+
Sbjct: 188 PDYIAPEILQEMLYGPAV------DWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 16/70 (22%), Positives = 27/70 (38%), Gaps = 7/70 (10%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
+ L L + L+ I+ +L + L+LS N +SG + C L
Sbjct: 37 LTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91
Query: 159 VLKLNNNRFT 168
L L+ N+
Sbjct: 92 HLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 9e-04
Identities = 13/90 (14%), Positives = 35/90 (38%), Gaps = 2/90 (2%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162
+ + L L ++ + ++ + + L + L+ I + L L L+L
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLEL 71
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
++NR +G + + +++ N +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
GL +L II+R++ ++LD + K++DFG+ + + T TF G
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKTFC----GT 184
Query: 476 LGYVAPEYPRTLVATPKG---DVYSFGVVLLELITGERPTHLTNAPESFK 522
Y+APE + P G D ++FGV+L E++ G+ P + E F+
Sbjct: 185 PDYIAPE---IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 15/69 (21%), Positives = 25/69 (36%), Gaps = 7/69 (10%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDIS--SRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159
+L L L + L +S +L + L+LS N + G + L
Sbjct: 45 TAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99
Query: 160 LKLNNNRFT 168
L L+ N+
Sbjct: 100 LNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 8e-05
Identities = 17/67 (25%), Positives = 27/67 (40%), Gaps = 4/67 (5%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS--GEIPSGLANCTFLN 158
+ + L L+LS N + ++ +L +T L+LS N L + L L
Sbjct: 66 NLPKLPKLKKLELSENRIF-GGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLK 123
Query: 159 VLKLNNN 165
L L N
Sbjct: 124 SLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 2/86 (2%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166
++ L L + + +++ + L L + L + S L L L+L+ NR
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENR 82
Query: 167 FTGKIPPQLGLLNRIKTFSVASNLLT 192
G + L + +++ N L
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)
Query: 100 RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS--GEIPSGLANCTFL 157
G L L +++N + I + L +T L L++NSL G++ LA+ L
Sbjct: 58 DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSL 115
Query: 158 NVLKLNNNRFT 168
L + N T
Sbjct: 116 TYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 18/92 (19%), Positives = 31/92 (33%), Gaps = 4/92 (4%)
Query: 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160
LDL + I ++ + L ++D S N + ++ G L L
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VI-ENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192
+NNNR L + + +N L
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 14/118 (11%), Positives = 40/118 (33%), Gaps = 7/118 (5%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+ + + P + + L L I S + +++S N +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 147 IPSG-LANCTFLNVLKLNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPSFANVN 202
I + +N L+ +++ I P+ L ++ +++ + +P ++
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIH 126
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 16/90 (17%), Positives = 27/90 (30%), Gaps = 5/90 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTF-LNVLKLN 163
+L L +S+ + +P LD+ N I +F +L LN
Sbjct: 104 PNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162
Query: 164 NNRFTGKIPPQ-LGLLNRIKTFSVASNLLT 192
N +I + +N L
Sbjct: 163 KNGIQ-EIHNSAFNGTQLDELNLSDNNNLE 191
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 21/82 (25%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFL 157
T L L+LS NN +P+D+ LD+S + +PS L N L
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKL 228
Query: 158 NVLKLNNNRFTGKIPPQLGLLN 179
N + K+P L+
Sbjct: 229 RARSTYNLK---KLPTLEKLVA 247
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 28/116 (24%), Positives = 46/116 (39%), Gaps = 16/116 (13%)
Query: 69 CQFTGVDCWH----------PDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNL 118
VDC P + + L L GL T LT L+L N L
Sbjct: 14 EGKKEVDCQGKSLDSVPSGIPADTEKL--DLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71
Query: 119 SGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKLNNNRFTGKIPP 173
++ + + L + +L L++N L+ +P G+ + T L+ L L N+ +P
Sbjct: 72 Q-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPS 124
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 23/75 (30%), Positives = 34/75 (45%), Gaps = 10/75 (13%)
Query: 99 PRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG----LAN 153
G+ + T L L L++N L+ S+P + L + L L N L +PSG L
Sbjct: 75 SAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTK 132
Query: 154 CTFLNVLKLNNNRFT 168
L L+LN N+
Sbjct: 133 ---LKELRLNTNQLQ 144
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 22/69 (31%), Positives = 35/69 (50%), Gaps = 4/69 (5%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANC-TFLNVLKLNN 164
T+LT L L+ N L S+P+ + +L + L L N L +P G+ + T L L L +
Sbjct: 85 TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAH 142
Query: 165 NRFTGKIPP 173
N+ +P
Sbjct: 143 NQLQ-SLPK 150
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 9e-05
Identities = 12/79 (15%), Positives = 30/79 (37%), Gaps = 6/79 (7%)
Query: 103 ERCTSLTGLDLSSNNLSGSIPSDI--SSRLQYVTSLDLSSNSLSGE----IPSGLANCTF 156
+R +L L + + S L + ++D+S+ L+ E + +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 157 LNVLKLNNNRFTGKIPPQL 175
L + + N + ++ +L
Sbjct: 309 LKFINMKYNYLSDEMKKEL 327
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 18/109 (16%), Positives = 31/109 (28%), Gaps = 21/109 (19%)
Query: 81 ENKVL-NIRLSD--MGLKG--QFPRGIERCTSLTGLDLSSNN------------LSGSIP 123
+ L +RLSD G + + T L L L +N L
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151
Query: 124 SDISSRLQYVTSLDLSSNSLSGE----IPSGLANCTFLNVLKLNNNRFT 168
+ + + S+ N L + L+ +K+ N
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 14/72 (19%), Positives = 32/72 (44%), Gaps = 8/72 (11%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRL---QYVTSLDLSSNSLSGE----IPSGLANCTFLNV 159
S+ G L + ++ + + L V + LS N++ E + +A+ L +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 160 LKLNNNRFTGKI 171
+ ++ FTG++
Sbjct: 65 AEFSDI-FTGRV 75
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 16/99 (16%), Positives = 36/99 (36%), Gaps = 15/99 (15%)
Query: 85 LNIRLSDMGLKG--QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRL---QYVTSLDLS 139
+++L + + + S+ + LS N + +S + + + + S
Sbjct: 9 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 68
Query: 140 SNS---LSGEIPSG-------LANCTFLNVLKLNNNRFT 168
+ EIP L C L+ ++L++N F
Sbjct: 69 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 14/79 (17%), Positives = 28/79 (35%), Gaps = 8/79 (10%)
Query: 100 RGIERCTSLTGLDLSSNNLSGS-IPSDISSRLQY---VTSLDLSSNSLSGE----IPSGL 151
+ + L + + N + I + L Y + LDL N+ + + L
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240
Query: 152 ANCTFLNVLKLNNNRFTGK 170
+ L L LN+ + +
Sbjct: 241 KSWPNLRELGLNDCLLSAR 259
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 20/98 (20%), Positives = 36/98 (36%), Gaps = 12/98 (12%)
Query: 83 KVLNIRLSDMGLKG--QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYV-----TS 135
KVL+++ + G ++ +L L L+ LS + + + +
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278
Query: 136 LDLSSNSLSGEIPSGLA-----NCTFLNVLKLNNNRFT 168
L L N + + L L L+LN NRF+
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 27/120 (22%), Positives = 48/120 (40%), Gaps = 34/120 (28%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
+ + +LH ++HR++ ILL+ + K++DFGL+R + + +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 476 L-----------GYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGERP 511
YV APE Y T D++S G +L E++ G +P
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKY------TKGIDMWSLGCILGEILCG-KP 229
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 22/76 (28%), Positives = 31/76 (40%), Gaps = 9/76 (11%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQ----YVTSLDLSSNSLSGE----IPSGLA- 152
+T LDLS NNL ++ VTSL+LS NSL + + LA
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 153 NCTFLNVLKLNNNRFT 168
+ L L+ N +
Sbjct: 78 IPANVTSLNLSGNFLS 93
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 9/72 (12%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQ----YVTSLDLSSNSLSGE----IPSGLANC-TF 156
S+T L+LS N+L ++ L VTSL+LS N LS + + LA
Sbjct: 51 ASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFT 110
Query: 157 LNVLKLNNNRFT 168
+ VL L N F+
Sbjct: 111 ITVLDLGWNDFS 122
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 9e-04
Identities = 17/72 (23%), Positives = 30/72 (41%), Gaps = 8/72 (11%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQ----YVTSLDLSSNSLSGE----IPSGLANCTF 156
S+T LDLS+N L ++++ +V SL+L N L G + +
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254
Query: 157 LNVLKLNNNRFT 168
L + L+ +
Sbjct: 255 LQTVYLDYDIVK 266
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 26/110 (23%), Positives = 49/110 (44%), Gaps = 31/110 (28%)
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLD-GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFG 474
RGL ++H + N ++HR++ + ++ D K+ DFGLAR+M+P +H
Sbjct: 131 RGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS----- 182
Query: 475 DLGYV------APE-------YPRTLVATPKGDVYSFGVVLLELITGERP 511
+ +P Y T D+++ G + E++TG +
Sbjct: 183 --EGLVTKWYRSPRLLLSPNNY------TKAIDMWAAGCIFAEMLTG-KT 223
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 25/68 (36%), Positives = 38/68 (55%), Gaps = 3/68 (4%)
Query: 99 PRGI-ERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFL 157
P G+ + T LT LDL +N L+ +PS + RL ++ L + N L+ E+P G+ T L
Sbjct: 80 PVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHL 137
Query: 158 NVLKLNNN 165
L L+ N
Sbjct: 138 THLALDQN 145
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 13/88 (14%), Positives = 31/88 (35%), Gaps = 8/88 (9%)
Query: 88 RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQ---YVTSLDLSSNSLS 144
R+S ++ + L++ +S S + ++ + L++ SN L+
Sbjct: 53 RVSKERIR-SLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111
Query: 145 GE----IPSGLANCTFLNVLKLNNNRFT 168
E + + K +N R +
Sbjct: 112 PELLARLLRSTLVTQSIVEFKADNQRQS 139
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 21/102 (20%)
Query: 417 GLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL-MNPVDTHLSTFVNGEFGD 475
L +LH I++R++ + ILLD L+DFGL + + T STF G
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TSTFC----GT 202
Query: 476 LGYVAPE------YPRTLVATPKGDVYSFGVVLLELITGERP 511
Y+APE Y RT+ D + G VL E++ G P
Sbjct: 203 PEYLAPEVLHKQPYDRTV------DWWCLGAVLYEMLYGLPP 238
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 5/68 (7%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE----IPSGLA-NCTFLNVL 160
+L ++L+S L + + L L NSL E + L + + L
Sbjct: 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTL 160
Query: 161 KLNNNRFT 168
+L+NN T
Sbjct: 161 RLSNNPLT 168
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 20/68 (29%), Positives = 33/68 (48%), Gaps = 3/68 (4%)
Query: 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFL 157
P+ + LT +DLS+N +S ++ + S + + +L LS N L IP L
Sbjct: 47 PKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSL 104
Query: 158 NVLKLNNN 165
+L L+ N
Sbjct: 105 RLLSLHGN 112
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 13/68 (19%), Positives = 29/68 (42%), Gaps = 7/68 (10%)
Query: 106 TSLTGLDLSSNNLSGSIPSDISSRLQY---VTSLDLSSNSLSGE----IPSGLANCTFLN 158
T + + + + ++ L+ + SL++ SN +SG + L + T L
Sbjct: 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLI 124
Query: 159 VLKLNNNR 166
L+++N
Sbjct: 125 ELRIDNQS 132
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 618 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.88 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.77 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.71 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.68 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.64 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.63 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.62 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.61 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.6 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.6 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.59 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.59 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.59 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.59 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.58 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.58 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.58 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.57 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.57 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.55 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.55 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.55 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.55 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.54 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.54 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.54 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.54 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.54 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.53 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.53 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.52 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.52 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.52 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.52 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.51 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.51 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.5 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.5 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.5 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.49 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.49 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.49 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.49 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.48 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.48 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.48 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.48 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.47 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.47 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.47 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.47 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.47 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.46 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.46 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.46 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.46 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.46 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.46 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.44 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.44 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.44 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.43 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.42 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.42 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.41 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.41 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.4 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.39 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.39 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.38 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.38 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.37 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.37 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.37 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.36 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.34 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.31 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.31 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.28 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.27 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.27 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.26 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.25 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.25 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.24 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.22 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.2 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.2 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.19 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.18 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.1 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.09 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.07 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.04 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.02 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.01 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.88 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.79 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.74 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.39 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.26 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.1 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.1 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.05 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.95 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.87 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.85 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.77 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.71 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.47 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.21 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.21 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.16 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.12 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.11 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.06 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.02 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.68 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.54 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.37 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.29 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.59 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.52 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.4 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 95.4 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.89 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.26 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.0 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.56 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 93.52 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.9 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.72 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.32 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.66 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 84.8 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.57 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-55 Score=442.65 Aligned_cols=262 Identities=22% Similarity=0.365 Sum_probs=211.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|.+.+.||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999853 47899999997643 345779999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCC---------CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 379 VYSYLENGTLYDKLHPAE---------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
|||||++|+|.++|+... .....++|.+++.|+.||++||+|||++ +|+||||||+|||+++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999996542 2235699999999999999999999999 9999999999999999999999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~ 528 (618)
+|||+|+.......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..... .+.
T Consensus 170 ~DFGla~~~~~~~~~~~--~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~ 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRV--GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEV 239 (299)
T ss_dssp CCCSCHHHHTGGGCEEE--TTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHH
T ss_pred CCcccceecCCCCceee--cCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 99999987654332211 122348999999999999999999999999999999999 9999976432 111
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
......... ...+...+.++.+|+.+||+.||++|||++||++.|+++.+.-
T Consensus 240 ~~~i~~~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 240 IECITQGRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHcCCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111111111 0111223456778888999999999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-54 Score=443.28 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=205.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|...++||+|+||.||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++++|.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677889999999999999864 47899999997643 445779999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCC-----------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 379 VYSYLENGTLYDKLHPAEH-----------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
||||+++|+|.++++.... ...+++|.+++.|+.||++||+|||++ +|+||||||+|||+++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999876432 124699999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+|+......... ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 198 Ki~DFGla~~~~~~~~~~--~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~ 267 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYR--VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------T 267 (329)
T ss_dssp EECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------H
T ss_pred EEcccccceeccCCCcce--ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999998765432221 1123458999999999999999999999999999999999 9999975432 1
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
+........... ..+.....++.+|+.+||+.||++|||++||++.|+.+.+.
T Consensus 268 ~~~~~i~~g~~~----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 268 EAIDCITQGREL----------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHHTCCC----------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCCCC----------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 111111111110 11122345677888899999999999999999999999774
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=440.05 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=208.3
Q ss_pred cCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
+++..++||+|+||.||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556789999999999999862 4689999999753 3456789999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc
Q 007088 379 VYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 446 (618)
|||||++|+|.++|..... ....++|.++++|+.|||+||+|||++ +|+||||||+|||++++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 9999999999999965321 124699999999999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCH
Q 007088 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSL 525 (618)
Q Consensus 447 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l 525 (618)
+||+|||+|+........ .......||+.|||||++.++.|+.++|||||||++|||+| |+.||.....
T Consensus 184 ~Ki~DFGlar~~~~~~~~--~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-------- 253 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYY--KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------- 253 (308)
T ss_dssp EEECCSCCBCGGGGGGCB--CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--------
T ss_pred EEECCcccceeccCCCce--eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--------
Confidence 999999999876433221 11233458999999999999999999999999999999998 8999975432
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
.+.......... ...+...+..+.+|+.+||+.||++|||++||++.|+.+
T Consensus 254 ~~~~~~i~~~~~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 QDVVEMIRNRQV----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHcCCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112222211111 111233445678888899999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=432.41 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=202.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|...++||+|+||+||+|++.+ .||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788999999999999998754 58999987533 334679999999999999999999998854 568999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
|++|+|.++++... ..++|.++..|+.||++||+|||++ +|+||||||+|||+++++++||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 99999999997554 3599999999999999999999999 99999999999999999999999999998765422
Q ss_pred CcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.. .......||+.|||||++. ...|+.++|||||||++|||+||+.||...... ...........
T Consensus 187 ~~--~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--------~~~~~~~~~~~-- 254 (307)
T 3omv_A 187 GS--QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--------DQIIFMVGRGY-- 254 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--------HHHHHHHHTTC--
T ss_pred cc--eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcCC--
Confidence 21 1122345999999999875 346899999999999999999999999754321 11111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
..+.+ .......+..+.+++.+||+.||++|||+.||++.|+.+...+
T Consensus 255 --~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 255 --ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp --CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred --CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 01111 1112233456778888999999999999999999999887654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=430.36 Aligned_cols=274 Identities=21% Similarity=0.287 Sum_probs=207.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----eeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK----ERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e 381 (618)
++|...++||+|+||.||+|++ +|+.||||+++........+..|+..+.+++|||||++++++.+++ ..|+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4677789999999999999998 6899999999765433333455666677899999999999998764 5799999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC-----NPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
|+++|+|.++++.. .++|..+.+++.|+++||+|||+++ .++|+||||||+|||++.++++||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999653 4899999999999999999999762 4589999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-------c
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL------VATPKGDVYSFGVVLLELITGERPTHLTNAPESFK-------G 523 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~-------~ 523 (618)
.................||+.|||||++.+. .++.++|||||||++|||+||++||......+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 7755433322223345699999999998654 46789999999999999999998876443221111 1
Q ss_pred CHHHHHHHHhcCCccchhccccccCC-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGN-GFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
............ . .++.+... ...+....+.+|+.+||+.||++||||.||++.|+++.++-
T Consensus 237 ~~~~~~~~~~~~-~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 237 SVEEMRKVVCEQ-K----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTS-C----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHHhcc-c----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 122222211111 1 11111111 12346678889999999999999999999999999998753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=438.11 Aligned_cols=249 Identities=21% Similarity=0.306 Sum_probs=199.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999995 579999999997543 234678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
||+||+|.+++...+. ..+++.+++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999965443 4589999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||...+. .+..........
T Consensus 179 ~~~----~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~---- 242 (350)
T 4b9d_A 179 VEL----ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGSF---- 242 (350)
T ss_dssp HHH----HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCC----
T ss_pred ccc----ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCC----
Confidence 211 1223499999999999999999999999999999999999999975432 122222211110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+ ......++.+|+.+||+.||++|||++|+++
T Consensus 243 --~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 --PPV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001 1112345667777999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=429.50 Aligned_cols=260 Identities=17% Similarity=0.176 Sum_probs=207.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.+.|+..++||+|+||.||+|+. .+|+.||||+++..... .+|+.++++++|||||++++++.+++..|+||||+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 35688889999999999999995 56899999999764322 46999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccCcccccCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMNPVD 462 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~ 462 (618)
+||+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+....
T Consensus 133 ~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999997543 499999999999999999999999 999999999999999987 69999999999875433
Q ss_pred Cccc-ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 463 THLS-TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 463 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+ .+..... ......
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~---~~~~~~-- 276 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----LCLKIAS---EPPPIR-- 276 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----CHHHHHH---SCCGGG--
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHHc---CCCCch--
Confidence 2211 11223469999999999999999999999999999999999999997654332 1111111 111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
.+ +......+.+++.+||+.||++|||+.|+++.|....++..
T Consensus 277 ---~~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 277 ---EI----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp ---GS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---hc----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 01 11223456667779999999999999999999998877654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=429.44 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=204.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+.|+..++||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688899999999999999995 579999999996533 34456889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998643 489999999999999999999999 999999999999999999999999999998754433
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ...+||+.|||||++.+..|+.++||||+||++|||++|+.||..... .+......... .
T Consensus 226 ~~----~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~------~ 287 (346)
T 4fih_A 226 RR----KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNL------P 287 (346)
T ss_dssp CB----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSS------C
T ss_pred cc----cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCC------C
Confidence 22 234599999999999999999999999999999999999999975332 11111111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+ ........++.+++.+||+.||++|||++|+++
T Consensus 288 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 288 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001 111122345667777999999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=425.05 Aligned_cols=248 Identities=21% Similarity=0.271 Sum_probs=205.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5799999999999999999995 57899999999653 345677999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||++||+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 9999999999997543 499999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+. .+.........
T Consensus 185 ~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~---- 250 (311)
T 4aw0_A 185 ESKQ--ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLE---- 250 (311)
T ss_dssp TTTC--CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC----
T ss_pred CCCc--ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC----
Confidence 3221 122345699999999999999999999999999999999999999975432 11111111111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+. +..+ .++.+++.+||+.||++|||++|++.
T Consensus 251 ---~~~p-~~~s---~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 ---YDFP-EKFF---PKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCCC-TTCC---HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCCC-cccC---HHHHHHHHHHccCCHhHCcChHHHcC
Confidence 0011 1122 34566777999999999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=415.68 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=192.8
Q ss_pred CCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeeEEEE
Q 007088 309 SKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA----KKERLLVY 380 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 380 (618)
...++||+|+||.||+|.. .++..||+|++.... ...+.|.+|++++++++|||||++++++.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4556899999999999995 568999999996543 334678999999999999999999999875 34579999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeCC-CCceEEcccCcccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLDG-DFEPKLSDFGLARL 457 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~ 457 (618)
|||++|+|.+++.... .+++..+..|+.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999997543 599999999999999999999998 6 999999999999984 78999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
..... ....+||+.|||||++.+ +|+.++|||||||++|||+||+.||..... .............
T Consensus 182 ~~~~~------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 182 KRASF------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVK 247 (290)
T ss_dssp CCTTS------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCC
T ss_pred CCCCc------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcCCC
Confidence 44321 123459999999998865 699999999999999999999999975332 1122222211111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...++ ...+ .++.+++.+||+.||++|||++|+++
T Consensus 248 -~~~~~-----~~~~---~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 -PASFD-----KVAI---PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CGGGG-----GCCC---HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCC-----ccCC---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 1112 34667777999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=412.06 Aligned_cols=244 Identities=21% Similarity=0.337 Sum_probs=189.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|+. .+|+.||+|++++.. ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999994 579999999996532 34567999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+ +|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHSC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 679999987543 499999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
... ....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||...+. ............
T Consensus 165 ~~~-----~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~-- 229 (275)
T 3hyh_A 165 GNF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVY-- 229 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC--
T ss_pred CCc-----cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 322 123459999999999998876 5799999999999999999999975321 222222211110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ ....+ .++.+++.+||+.||++|||++|+++
T Consensus 230 -----~~-p~~~s---~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -----TL-PKFLS---PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----CC-CTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----CC-CCCCC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01 01122 34566777999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=429.41 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=214.1
Q ss_pred HHHHHHhhccCCCCcEEeecCCeeEEEEEeCC------CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCC-CCccceeE
Q 007088 298 LSDLMKATNSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRH-RNLVPLLG 368 (618)
Q Consensus 298 ~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h-~niv~l~~ 368 (618)
.++.+...++|++.+.||+|+||.||+|.+.+ ++.||||+++... ...++|.+|+++|.+++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34444556789999999999999999998532 4689999997643 335679999999999965 89999999
Q ss_pred EEEeC-CeeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 007088 369 FCVAK-KERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNIS 435 (618)
Q Consensus 369 ~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 435 (618)
+|.+. +..++|||||++|+|.++|+.... ....+++.+++.++.|||+||+|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99765 568999999999999999965322 124589999999999999999999999 99999999
Q ss_pred CCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCC
Q 007088 436 SKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHL 514 (618)
Q Consensus 436 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~ 514 (618)
|+|||+++++.+||+|||+|+.......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~--~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVR--KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEE--ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCcee--eccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987654332211 123348999999999999999999999999999999998 9999976
Q ss_pred CCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 515 TNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 515 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
....+ .+...+ ..... ...+.....++.+++.+||+.||++|||++||++.|+++.+.
T Consensus 291 ~~~~~----~~~~~i---~~g~~----------~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDE----EFCRRL---KEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSH----HHHHHH---HHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH----HHHHHH---HcCCC----------CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 43221 111111 11111 111122334677788899999999999999999999998765
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=426.30 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=204.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+.|+..++||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.+|++++|||||+++++|.+.+..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999995 569999999996533 34556889999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
+||+|.+++... .+++.++..|+.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999998643 389999999999999999999999 999999999999999999999999999988755433
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ...+||+.|||||++.+..|+.++|||||||++|||++|+.||..... .+......... .
T Consensus 303 ~~----~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~------~ 364 (423)
T 4fie_A 303 RR----KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRDNL------P 364 (423)
T ss_dssp CB----CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC------C
T ss_pred cc----cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCC------C
Confidence 22 234599999999999999999999999999999999999999975332 11111111111 0
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+. ........+.+|+.+||+.||++|||++|+++
T Consensus 365 ~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 365 PRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 11112245666777999999999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=418.99 Aligned_cols=241 Identities=22% Similarity=0.266 Sum_probs=190.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|++.+.||+|+||.||+|+. .+++.||||+++... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999985 247899999996532 233468899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||++||+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999997543 499999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
...... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||...+. .+..........
T Consensus 177 ~~~~~~----~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~- 243 (304)
T 3ubd_A 177 IDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILKAKL- 243 (304)
T ss_dssp ----CC----CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-
T ss_pred cCCCcc----ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHcCCC-
Confidence 433222 2234599999999999999999999999999999999999999975432 111211111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
.. .... ..++.+++.+||+.||++|||+
T Consensus 244 ------~~-p~~~---s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ------GM-PQFL---SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ------CC-CTTS---CHHHHHHHHHHTCSSGGGSTTC
T ss_pred ------CC-CCcC---CHHHHHHHHHHcccCHHHCCCC
Confidence 00 1112 2356667779999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=399.87 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=188.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC--------
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK-------- 374 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 374 (618)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999995 578999999986533 33467899999999999999999999987654
Q ss_pred ----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEc
Q 007088 375 ----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450 (618)
Q Consensus 375 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 450 (618)
..|+||||+++|+|.+++..... ....++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 36899999999999999976543 23466778899999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCCCCccc--------ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 007088 451 DFGLARLMNPVDTHLS--------TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~ 522 (618)
|||+|+.......... ....+.+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~------ 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM------ 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH------
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc------
Confidence 9999988754322111 11223469999999999999999999999999999999996 775311
Q ss_pred cCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 523 GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 523 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......... ...... ........+.+++.+||+.||++|||+.|+++
T Consensus 232 -~~~~~~~~~~-~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -ERVRTLTDVR-NLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHHHHH-TTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHh-cCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011111111 111000 01223345567888999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=398.45 Aligned_cols=291 Identities=41% Similarity=0.709 Sum_probs=251.8
Q ss_pred ccccCHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEE
Q 007088 293 VEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFC 370 (618)
Q Consensus 293 ~~~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~ 370 (618)
...+++.++..+.++|+..+.||+|+||.||+|...+++.||+|++.... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 45789999999999999999999999999999998889999999997643 2234689999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEc
Q 007088 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450 (618)
Q Consensus 371 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 450 (618)
.+.+..++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+.++|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999998776555679999999999999999999999877789999999999999999999999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT 530 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~ 530 (618)
|||+++.......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...............|..
T Consensus 177 Dfg~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVT---TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp CCSSCEECCSSSSCEE---CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred cCccccccCccccccc---ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 9999987654333221 2334899999999998888999999999999999999999999643222233446677777
Q ss_pred HHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 531 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
............+..+......+....+.+++.+||+.||.+|||++||++.|++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 77777777777777777777888999999999999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=402.37 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=198.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeC------Ce
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAK------KE 375 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 375 (618)
++|++.+.||+|+||.||+|+. .+|+.||||+++.... ..+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 5799999999976432 345688999999999999999999997643 56
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.|+||||++ |+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 68999997654 599999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
+.+..............+||+.|+|||++.+. .++.++||||+||++|||++|++||...+..+ .+.........
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~----~l~~I~~~~g~ 281 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH----QLQLIMMVLGT 281 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhcCC
Confidence 87654332222333456799999999998765 56999999999999999999999997643211 11111110000
Q ss_pred CC-c---------cchhccccccCC--C-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NS-S---------LETAIDKSLLGN--G-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~-~---------~~~~~d~~l~~~--~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. . ....+. .+... . ......++.+|+.+||..||++|||++|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQ-SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCGGGTC-----CHHHHHH-SSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHhhhhhhhhhhhhhh-cCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0 000000 00000 0 0011245667788999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=393.55 Aligned_cols=204 Identities=23% Similarity=0.318 Sum_probs=173.4
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
....++|++.++||+|+||+||+|+. ..++.||+|++.... ...++.+|+++++++ +||||+++++++.+.++.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34567899999999999999999984 247899999986643 456788999999998 699999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCcc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLA 455 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a 455 (618)
|+||||+++|+|.+++. .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|
T Consensus 96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 99999999999999983 389999999999999999999999 99999999999999876 79999999999
Q ss_pred cccCCCCCcc------------------------cccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCC
Q 007088 456 RLMNPVDTHL------------------------STFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGER 510 (618)
Q Consensus 456 ~~~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~ 510 (618)
+......... .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 8654432111 0112234699999999998775 58999999999999999999999
Q ss_pred CCCCCC
Q 007088 511 PTHLTN 516 (618)
Q Consensus 511 Pf~~~~ 516 (618)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 997543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=387.23 Aligned_cols=288 Identities=36% Similarity=0.580 Sum_probs=243.6
Q ss_pred ccCHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 007088 295 KMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 373 (618)
.+++.++..++++|+..+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 455566677889999999999999999999998889999999987643 3456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
+..++||||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999987655445699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......|.....
T Consensus 185 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~ 260 (321)
T 2qkw_B 185 ISKKGTELDQTH--LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESH 260 (321)
T ss_dssp TCEECSSSSCCC--CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS--CCCHHHHTHHHH
T ss_pred cccccccccccc--cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH--HHHHHHHhhhcc
Confidence 998654322111 1122347999999999988899999999999999999999999998655432 234556665555
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
........+++.+......+....+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 56666667777766666778889999999999999999999999999999998653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=409.06 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=204.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999995 579999999986643 3456788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC--CceEEcccCcccccCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD--FEPKLSDFGLARLMNP 460 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~ 460 (618)
|+||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999986543 3589999999999999999999999 99999999999999854 8999999999998765
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .+...........
T Consensus 310 ~~~~-----~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~~~-- 374 (573)
T 3uto_A 310 KQSV-----KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWN-- 374 (573)
T ss_dssp TSEE-----EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCC--
T ss_pred CCce-----eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCCCC--
Confidence 3322 223599999999999999999999999999999999999999975432 1111111111100
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.... .......+.+|+.+||+.||.+|||++|+++
T Consensus 375 -~~~~~----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 -MDDSA----FSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -CCSGG----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCccc----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 1112234566777999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=403.28 Aligned_cols=248 Identities=21% Similarity=0.250 Sum_probs=196.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHH---HHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFL---SEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|++.+.||+|+||.||+|+. .+|+.||||++.+.. .....+. .++.+++.++|||||+++++|.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46799999999999999999995 569999999996432 2233333 446777888999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
|+||||++||+|.+++.... .+++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999997543 499999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
....... ...+||+.|||||++. +..|+.++||||+||++|||++|+.||...... ...+........
T Consensus 341 ~~~~~~~------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~ 409 (689)
T 3v5w_A 341 DFSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTM 409 (689)
T ss_dssp ECSSCCC------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHC
T ss_pred ecCCCCC------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCC
Confidence 7654322 2346999999999986 457999999999999999999999999754322 111111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
. ..+ ....+ .++.+|+.+||+.||.+|++ ++||++
T Consensus 410 ~-------~~~-p~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 A-------VEL-PDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C-------CCC-CTTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C-------CCC-CccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 0 001 11123 34566677999999999998 677643
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=360.05 Aligned_cols=283 Identities=34% Similarity=0.573 Sum_probs=229.8
Q ss_pred ccccCHHHHHHhhccCCCC------cEEeecCCeeEEEEEeCCCcEEEEEEeccC-----ccCHHHHHHHHHHHhcCCCC
Q 007088 293 VEKMRLSDLMKATNSFSKN------NIIGTGRTGATYIAMLPGGCFIMIKRLEDS-----QHSEKEFLSEINTLGSVRHR 361 (618)
Q Consensus 293 ~~~~~~~~l~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~ 361 (618)
...|++.++..++++|... +.||+|+||.||+|.. +++.||+|++... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4578999999999999887 9999999999999987 6789999998643 23356789999999999999
Q ss_pred CccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 362 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
||+++++++.+.+..++||||+++|+|.+++..... ..++++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999865432 24699999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~ 521 (618)
+.++.+||+|||+++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~- 242 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTV--MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL- 242 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCE--ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-
T ss_pred cCCCcEEEeecccccccccccccc--cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-
Confidence 999999999999998765432211 1123458999999998865 579999999999999999999999986544321
Q ss_pred ccCHHHHHHHHhc-CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 522 KGSLVEWITLLNT-NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 522 ~~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
+..+...... ...+...+++.+ ..........+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 243 ---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 ---LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp ---TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred ---HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222222222 222333444433 23456677889999999999999999999999999999854
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.47 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=214.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|+..+.||+|+||.||+|...++..||+|++.......+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 56888999999999999999988899999999988777788899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 161 (269)
T 4hcu_A 90 GCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 161 (269)
T ss_dssp CBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH--
T ss_pred CcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc--
Confidence 99999996544 3589999999999999999999999 999999999999999999999999999987654221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .+..........
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~------- 225 (269)
T 4hcu_A 162 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR------- 225 (269)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC-------
T ss_pred -ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCcc-------
Confidence 11223346788999999988899999999999999999999 9999975322 111111111100
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..........+.+++.+||+.||++|||++|+++.|+++.++
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 001111234577778899999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=361.79 Aligned_cols=262 Identities=23% Similarity=0.365 Sum_probs=211.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
++|...+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5688899999999999999996 46899999988653 345677999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999997643 3589999999999999999999999 999999999999999999999999999987654322
Q ss_pred ccc----------ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc-CHHHHHHHH
Q 007088 464 HLS----------TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-SLVEWITLL 532 (618)
Q Consensus 464 ~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~-~l~~~~~~~ 532 (618)
... .......||+.|+|||++.+..++.++||||||+++|||++|..|+........... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY 243 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc
Confidence 111 001134589999999999999999999999999999999999999876443222111 122211111
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
. .......+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 244 -------------~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 244 -------------C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------------C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0112235677888999999999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=363.53 Aligned_cols=262 Identities=28% Similarity=0.397 Sum_probs=203.5
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
...++|++.+.||+|+||.||+|.. +++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456899999999999999999987 688899999976442 335688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
|||+++|+|.+++..... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 113 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999976432 13489999999999999999999999 8 99999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+..........
T Consensus 189 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~ 256 (309)
T 3p86_A 189 KASTFLS----SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFKCK 256 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHSCC
T ss_pred ccccccc----cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC
Confidence 5432211 1223489999999999999999999999999999999999999975332 111111110100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
. ..........+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 257 ~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 R---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp C---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred C---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 0 0111122345777888999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.51 Aligned_cols=264 Identities=25% Similarity=0.362 Sum_probs=204.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhc--CCCCCccceeEEEEeC----CeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGS--VRHRNLVPLLGFCVAK----KERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~l 378 (618)
.++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46899999999999999999988 6899999999764 34455666666655 7999999999997653 45789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCeeeCCCCceEEc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH--------HNCNPRIIHRNISSKCILLDGDFEPKLS 450 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 450 (618)
||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||+
T Consensus 84 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred ehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 99999999999999543 4899999999999999999999 77 99999999999999999999999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCCC------CCCCccchHHHHHHHHHHHhC----------CCCCCC
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL------VATPKGDVYSFGVVLLELITG----------ERPTHL 514 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvil~elltG----------~~Pf~~ 514 (618)
|||+++.................||+.|+|||++.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999987654433322222334689999999998776 455799999999999999999 788765
Q ss_pred CCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 515 TNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 515 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
...... ................. +... .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ~~~~~~---~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDP---SFEDMRKVVCVDQQRPN-IPNR---WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSC---CHHHHHHHHTTSCCCCC-CCGG---GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCc---chhhhhHHHhccCCCCC-CChh---hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 433221 12222221111111110 0000 01234667888999999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=359.45 Aligned_cols=258 Identities=22% Similarity=0.387 Sum_probs=213.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|++.+.||+|+||.||+|...++..||+|+++......+++.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 46788899999999999999999889899999998877778889999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999986543 3589999999999999999999999 9999999999999999999999999999876543321
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .............
T Consensus 161 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~----- 224 (268)
T 3sxs_A 161 S---SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVSQGHRL----- 224 (268)
T ss_dssp E---CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCCC-----
T ss_pred c---ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHHcCCCC-----
Confidence 1 123346778999999988889999999999999999999 9999975332 1111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.. .......+.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 225 --~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 225 --YR---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --CC---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --CC---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 00 111224577788899999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=362.16 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=204.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999994 67899999998653 34567789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999998653 389999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 171 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------~~~~~~~~~~~~---- 234 (297)
T 3fxz_A 171 SKR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTP---- 234 (297)
T ss_dssp CCB----CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSC----
T ss_pred ccc----CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCC----
Confidence 322 2335899999999999999999999999999999999999999753321 111111110000
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ..........+.+++.+||+.||++|||++|+++
T Consensus 235 --~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 235 --E--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --C--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --C--CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 0011223345677888999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=366.66 Aligned_cols=274 Identities=22% Similarity=0.286 Sum_probs=212.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----eeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK----ERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~ 380 (618)
.++|++.++||+|+||.||+|+.. ++.||||++............|+.++++++||||+++++++.... ..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 467889999999999999999875 789999999876655666778999999999999999999998754 369999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-------CCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC-------NPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||
T Consensus 102 e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999653 3899999999999999999999862 3379999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc------
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK------ 522 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~------ 522 (618)
+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 177 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 177 LALKFEAGKSAG--DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp TCEEECTTSCCC--CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred cccccccccCcc--ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 998765433221 1223458999999999876 356678999999999999999999998654322111
Q ss_pred --cCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 523 --GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 523 --~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
.....+........ ....+.... ........+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 255 ~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKK-KRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTSC-CCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhccc-CCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01112221111111 000001000 01245667889999999999999999999999999997754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=369.05 Aligned_cols=261 Identities=24% Similarity=0.382 Sum_probs=209.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.++|.+.+.||+|+||.||+|... .+..||||+++... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357888999999999999999963 45679999997642 345679999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999996543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 202 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~- 271 (325)
T 3kul_A 202 EDDPDAAYT-TTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEGY- 271 (325)
T ss_dssp C----CCEE-CC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTC-
T ss_pred ccCccceee-ccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCC-
Confidence 543222111 122336788999999988899999999999999999999 9999975332 11111111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
...........+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 01111223356777888999999999999999999999997754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.03 Aligned_cols=263 Identities=22% Similarity=0.359 Sum_probs=211.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe--------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML--------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 373 (618)
.++|.+.+.||+|+||.||+|.. .++..||+|+++... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 36788899999999999999984 245689999997643 3346789999999999 899999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999875432 123589999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPES 520 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~ 520 (618)
+.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-- 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCT--TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred CCCCCEEEccccCCcccCcccceec--ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence 9999999999999987654322111 122346889999999988999999999999999999999 99999754321
Q ss_pred cccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 521 FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 521 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
.+.... .... ....+......+.+++.+||+.||.+||++.|+++.|+++....
T Consensus 313 ---~~~~~~---~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 313 ---ELFKLL---KEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ---GHHHHH---HTTC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---HHHHHH---hcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111 1110 01111223346777888999999999999999999999987643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.94 Aligned_cols=283 Identities=15% Similarity=0.125 Sum_probs=223.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+++++++ +||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 35788999999999999999995 678999999986543 234588999999999 999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc-----eEEcccCcccc
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE-----PKLSDFGLARL 457 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~a~~ 457 (618)
+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 899999987542 3599999999999999999999999 9999999999999998887 99999999987
Q ss_pred cCCCCCcccc---cccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 458 MNPVDTHLST---FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 458 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
.......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~ 234 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD-----TLKERYQKIGD 234 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS-----SHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccc-----cHHHHHHHHHh
Confidence 6443221111 112345899999999999999999999999999999999999999865432 11111111100
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCCCCCCCC
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTGDP 607 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~~ 607 (618)
.. ........... .+ .+.+++.+|++.||.+||++++|.+.|+++.++.+...+..++|......+
T Consensus 235 ~~---~~~~~~~~~~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~~~ 300 (330)
T 2izr_A 235 TK---RATPIEVLCEN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPT 300 (330)
T ss_dssp HH---HHSCHHHHTTT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTSCCCC
T ss_pred hh---ccCCHHHHhcc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCCCcCC
Confidence 00 00000000011 12 677888899999999999999999999999999988888888887554443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=360.23 Aligned_cols=259 Identities=20% Similarity=0.319 Sum_probs=211.8
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
..++|++.+.||+|+||.||++...++..||+|+++......+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34678889999999999999999989999999999887777888999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999997643 3599999999999999999999999 999999999999999999999999999987654221
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ............
T Consensus 176 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~----- 239 (283)
T 3gen_A 176 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGLR----- 239 (283)
T ss_dssp ---HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHHTTCC-----
T ss_pred ---ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHhcccC-----
Confidence 11223346788999999988889999999999999999998 9999975332 111111111100
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..........+.+++.+||+.||.+|||++|+++.|+++.++
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 240 -----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 001111234577788899999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=370.51 Aligned_cols=286 Identities=14% Similarity=0.181 Sum_probs=217.7
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCC------CcEEEEEEeccCccC------------HHHHHHHHHHHhcCCCCCccc
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRLEDSQHS------------EKEFLSEINTLGSVRHRNLVP 365 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~ 365 (618)
..++|.+.+.||+|+||.||+|...+ ++.||||++...... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999654 478999998654311 122445666778889999999
Q ss_pred eeEEEEeC----CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 366 LLGFCVAK----KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 366 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998775 4579999999 999999997643 4599999999999999999999999 99999999999999
Q ss_pred C--CCCceEEcccCcccccCCCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 442 D--GDFEPKLSDFGLARLMNPVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 442 ~--~~~~~kl~DfG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
+ .++.+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 889999999999987654322111 11123448999999999999999999999999999999999999997532
Q ss_pred CCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCC
Q 007088 517 APESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDD 596 (618)
Q Consensus 517 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~ 596 (618)
... ....+..... ...+...+++.+..... +..+.+++..||+.||.+||+++++++.|+++.++.+...+.
T Consensus 266 ~~~----~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~ 337 (364)
T 3op5_A 266 KDP----KYVRDSKIRY-RENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDG 337 (364)
T ss_dssp TCH----HHHHHHHHHH-HHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCH----HHHHHHHHHh-hhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCC
Confidence 211 1111111111 11223333333322222 345667777999999999999999999999999999999988
Q ss_pred cccCCCCC
Q 007088 597 EIMLPSNT 604 (618)
Q Consensus 597 ~~~~~~~~ 604 (618)
.++|....
T Consensus 338 ~~dw~~~~ 345 (364)
T 3op5_A 338 KLDLSVVE 345 (364)
T ss_dssp CCCC----
T ss_pred ccceEecc
Confidence 88886443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=354.13 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=211.3
Q ss_pred cccCHHHHHHhhcc----------CCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCC
Q 007088 294 EKMRLSDLMKATNS----------FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHR 361 (618)
Q Consensus 294 ~~~~~~~l~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~ 361 (618)
..++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45788888888864 677789999999999999965 7999999999654 34567789999999999999
Q ss_pred CccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 362 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 9999999999999999999999999999998643 489999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~ 521 (618)
+.++.+||+|||++.......... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---- 246 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPKR----KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---- 246 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCCB----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred CCCCcEEEeeeeeeeecccCcccc----ccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence 999999999999998765432221 233589999999999999999999999999999999999999975321
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........... .+.+. ........+.+++.+||+.||++|||++|+++
T Consensus 247 ----~~~~~~~~~~~------~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 247 ----VQAMKRLRDSP------PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp ----HHHHHHHHHSS------CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHHHHHHhcCC------CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111111 00000 01112345677777999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.25 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=200.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ...+++.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357999999999999999999854 57889999997542 345679999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+........
T Consensus 198 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~-- 266 (373)
T 2qol_A 198 EDDPEAAYT-TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEG-- 266 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTT--
T ss_pred ccCCcccee-ccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC--
Confidence 543221111 112235778999999998899999999999999999998 9999975332 1111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
............+.+++.+||+.||++||++.|+++.|+++.+..
T Consensus 267 --------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 --------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp --------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred --------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111112233456778888999999999999999999999997654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=383.80 Aligned_cols=260 Identities=24% Similarity=0.371 Sum_probs=213.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
..++|...+.||+|+||.||+|...++..||||+++......+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45678889999999999999999988999999999887777889999999999999999999999986 56789999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999975432 3588999999999999999999999 999999999999999999999999999987653211
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 340 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~----- 403 (454)
T 1qcf_A 340 ---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERGYR----- 403 (454)
T ss_dssp ---HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHTCC-----
T ss_pred ---eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC-----
Confidence 11122336788999999988899999999999999999999 9999975332 111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
...+......+.+++.+||+.||++|||+++|++.|+++....
T Consensus 404 -----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 404 -----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1111223456778888999999999999999999999886543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=376.97 Aligned_cols=260 Identities=21% Similarity=0.309 Sum_probs=209.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|...+.||+|+||.||+|... +++.||||+++... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888999999999999999975 78999999997542 223468899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999997543 3589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 267 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~~~--- 333 (377)
T 3cbl_A 267 VYA--ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKGGR--- 333 (377)
T ss_dssp EEE--CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTTCC---
T ss_pred cee--ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC---
Confidence 111 11111225678999999988889999999999999999998 9999975332 111111111111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
...+......+.+++.+||+.||++|||++++++.|+++.+++
T Consensus 334 -------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 334 -------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 0111223346777888999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=365.19 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=202.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999996 689999999997543 33456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999986543 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVAT-PKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
... .....||+.|+|||++.+..+. .++||||+||++|||++|+.||..... .+..........
T Consensus 167 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~-- 231 (328)
T 3fe3_A 167 GGK-----LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRGKY-- 231 (328)
T ss_dssp SCG-----GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC--
T ss_pred CCc-----cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC--
Confidence 322 2234589999999999887765 799999999999999999999975321 222222211110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .+......+.+++.+||+.||.+|||++|+++
T Consensus 232 -----~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 -----R----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----C----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----C----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 01112345667777999999999999999975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=353.97 Aligned_cols=278 Identities=15% Similarity=0.117 Sum_probs=221.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+.++.++ +|+|++++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 35789999999999999999994 679999999986543 334578899999999 799999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc-----eEEcccCcccc
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE-----PKLSDFGLARL 457 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~a~~ 457 (618)
+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 899999997543 3589999999999999999999999 9999999999999987776 99999999987
Q ss_pred cCCCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 458 MNPVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 458 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~- 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQ- 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHHHH-
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-HHHHHHHhhcc-
Confidence 654322111 1123345899999999999999999999999999999999999999865432110 01111110000
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCC
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLP 601 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 601 (618)
...... +. ......+.+++.+||+.||++||++++|++.|+++.++.....++.++|.
T Consensus 239 ~~~~~~-----~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 239 STPLRE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp HSCHHH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred CccHHH-----HH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 000000 00 11234677788899999999999999999999999999998888888885
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=361.78 Aligned_cols=247 Identities=20% Similarity=0.246 Sum_probs=202.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|+..+.||+|+||.||+|+. .+|+.||+|++++. ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 36789999999999999999995 46899999999753 34566788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999986543 489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ............
T Consensus 157 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~-- 222 (337)
T 1o6l_A 157 SDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEI-- 222 (337)
T ss_dssp CTTCC----BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC--
T ss_pred cCCCc----ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 32221 1233489999999999999999999999999999999999999975321 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
.+ +......+.+++.+||+.||++|| +++|+++
T Consensus 223 -----~~----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -----RF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----CC----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 01 111223566777799999999999 8999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.89 Aligned_cols=280 Identities=25% Similarity=0.366 Sum_probs=208.3
Q ss_pred CHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcC--CCCCccceeEEEEeC-
Q 007088 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV--RHRNLVPLLGFCVAK- 373 (618)
Q Consensus 297 ~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~- 373 (618)
....-....++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++... +||||+++++++...
T Consensus 28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 33344445678999999999999999999975 8999999986543 33445566665554 899999999999887
Q ss_pred ---CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeeeCCCC
Q 007088 374 ---KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC-----NPRIIHRNISSKCILLDGDF 445 (618)
Q Consensus 374 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~ 445 (618)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 6789999999999999999543 4899999999999999999999762 34899999999999999999
Q ss_pred ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCc------cchHHHHHHHHHHHhC----------C
Q 007088 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPK------GDVYSFGVVLLELITG----------E 509 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------sDVwS~Gvil~elltG----------~ 509 (618)
.+||+|||+++.................||+.|+|||++.+...+.+ +|||||||++|||++| +
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999998765443332222234468999999999887766665 9999999999999999 5
Q ss_pred CCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 510 RPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 510 ~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.||........ .......... ............ ........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 260 ~p~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 260 LPYHDLVPSDP---SYEDMREIVC-IKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CTTTTTSCSSC---CHHHHHHHHT-TSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccHhhhcCCCC---chhhhHHHHh-hhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 55544322211 1112111111 111111111000 0125677888999999999999999999999999999876
Q ss_pred cC
Q 007088 590 YH 591 (618)
Q Consensus 590 ~~ 591 (618)
..
T Consensus 333 ~~ 334 (337)
T 3mdy_A 333 QD 334 (337)
T ss_dssp TT
T ss_pred cc
Confidence 43
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=364.07 Aligned_cols=251 Identities=19% Similarity=0.266 Sum_probs=205.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 46799999999999999999995 46899999999876666677899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC--CCceEEcccCcccccCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG--DFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~ 461 (618)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999997643 3589999999999999999999999 9999999999999987 789999999999877543
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+...........
T Consensus 158 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~--- 221 (321)
T 1tki_A 158 DNF-----RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYT--- 221 (321)
T ss_dssp CEE-----EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCC---
T ss_pred Ccc-----ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCC---
Confidence 321 122389999999999988899999999999999999999999975332 1111111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+... .......+.+++.+||..||++|||+.|+++
T Consensus 222 ~~~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000 0112345677888999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=357.27 Aligned_cols=270 Identities=23% Similarity=0.338 Sum_probs=205.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--Cee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 376 (618)
.++|++.+.||+|+||.||+|++ .+++.||+|++.... ...+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788899999999999999984 368999999997643 3346789999999999999999999998654 458
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 99999999999999997653 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-------CccccCHHHHH
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAP-------ESFKGSLVEWI 529 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~-------~~~~~~l~~~~ 529 (618)
......... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFF-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp --------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred cccCCccee-eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence 765432211 1112234678899999998889999999999999999999999998642110 00000000000
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
... +...............+.+++.+||+.||++|||++|+++.|+++.++.
T Consensus 242 ~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 242 IEL---------LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHH---------HHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHH---------HhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000 0111111112233456778888999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=352.03 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=213.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|+..+.||+|+||.||++...++..||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 57888999999999999999988899999999988777778899999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 158 (267)
T 3t9t_A 88 GCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--- 158 (267)
T ss_dssp CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH---
T ss_pred CcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc---
Confidence 99999997543 3589999999999999999999999 99999999999999999999999999998764321
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..........
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~------- 223 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFR------- 223 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC-------
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCc-------
Confidence 111223346789999999988889999999999999999999 8999875321 111211111100
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..........+.+++.+||+.||++||++.|+++.|+++.++
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 ---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000111234567778899999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=357.67 Aligned_cols=263 Identities=21% Similarity=0.305 Sum_probs=205.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35788999999999999999995 568999999985432 2346788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... ++++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 99999999999986543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ........... ..
T Consensus 163 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~-~~ 230 (294)
T 4eqm_A 163 ETSLTQ---TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQDS-VP 230 (294)
T ss_dssp ---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSSC-CC
T ss_pred cccccc---cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhcc-CC
Confidence 432211 1223489999999999999999999999999999999999999975332 11111111110 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhhhhcC
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-TMFEVYQLLRAIAERYH 591 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~~ 591 (618)
.. .... .......+.+++.+|++.||.+|| +++++.+.|+.+..+..
T Consensus 231 ~~-~~~~----~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 231 NV-TTDV----RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CH-HHHS----CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred Cc-chhc----ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 00 0001 112234677788899999999998 99999999998765443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=364.21 Aligned_cols=280 Identities=19% Similarity=0.306 Sum_probs=197.0
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEeCC-C---cEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAMLPG-G---CFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
...++|++.+.||+|+||.||+|.... + ..||+|+++.. ....+.+.+|++++++++||||+++++++...+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999543 3 28999999753 2345678999999999999999999999988765
Q ss_pred e------EEEEeecCCCccccccCCCCC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 376 R------LLVYSYLENGTLYDKLHPAEH--EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 376 ~------~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
. ++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 999999999999999864321 223589999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++.......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... ...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~ 249 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQ--GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----EIY 249 (323)
T ss_dssp EECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHH
T ss_pred EEeeccccccccccccccc--cccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-----HHH
Confidence 9999999987654322111 112336788999999988899999999999999999999 99999764322 111
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCCCCCC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPSNTG 605 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~~~ 605 (618)
.. ...... ..........+.+++.+||+.||++|||+.|+++.|+++...........-++...++
T Consensus 250 ~~---~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~~~ 315 (323)
T 3qup_A 250 NY---LIGGNR----------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYINIE 315 (323)
T ss_dssp HH---HHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------------
T ss_pred HH---HhcCCC----------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCCCC
Confidence 11 111110 0111223346778888999999999999999999999998876665555555554443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=368.34 Aligned_cols=267 Identities=22% Similarity=0.342 Sum_probs=214.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe--------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML--------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 373 (618)
.++|.+.+.||+|+||.||+|.. ..+..||+|+++... ...+++.+|+++++++ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 46788899999999999999984 234689999997643 3346789999999999 999999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999875432 124599999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPES 520 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~ 520 (618)
+.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKK--TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCC--CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred cCCCcEEEcccCccccccccccccc--ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999987654322111 122347889999999999999999999999999999999 9999875321
Q ss_pred cccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 007088 521 FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTT 594 (618)
Q Consensus 521 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (618)
.+.......... ..........+.+++.+||+.||++|||++|+++.|+++........
T Consensus 300 -----~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 300 -----EELFKLLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp -----HHHHHHHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred -----HHHHHHHHcCCC----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 122222211111 01111223467778889999999999999999999999987665444
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=353.29 Aligned_cols=274 Identities=20% Similarity=0.277 Sum_probs=214.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC--eeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK--ERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 380 (618)
++|.+.++||+|+||.||+|... +++.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888999999999999999964 58999999997533 44677889999999999999999999998765 679999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee----CCCCceEEcccCccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL----DGDFEPKLSDFGLAR 456 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a~ 456 (618)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999976542 23489999999999999999999999 99999999999999 788889999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCC--------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPR--------TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||............+...
T Consensus 165 ~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 165 ELEDDEQF-----VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp ECCTTCCB-----CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ecCCCCce-----eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 76543322 2234899999999875 5788999999999999999999999997654432222222222
Q ss_pred HHHHhcCCccchh---------ccccc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 529 ITLLNTNSSLETA---------IDKSL--LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 529 ~~~~~~~~~~~~~---------~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..... ....... ....+ ...........+.+++.+||+.||++|||++|+++...+.+..
T Consensus 240 ~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 240 ITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred hcCCC-cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 21111 1000000 00011 1123456777888999999999999999999999998876543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=359.40 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=201.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.++||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46799999999999999999999889999999997543 224678899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 8888776543 3589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc--c
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS--L 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~--~ 538 (618)
.... ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+ .+............ .
T Consensus 173 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 173 VRSY----THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----QLPKIFSILGTPNPREW 244 (311)
T ss_dssp CC-------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----HHHHHHHHHCCCCTTTS
T ss_pred cccc----cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHCCCChHHh
Confidence 2221 22348999999998876 568999999999999999999999997654322 11221111111000 0
Q ss_pred chh------ccccc--cCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETA------IDKSL--LGNG-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~------~d~~l--~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .+... .... ......++.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00000 0000 0112346678888999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=358.61 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=211.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 56788999999999999999985 345899999997543 3346788999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCC--------------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 007088 377 LLVYSYLENGTLYDKLHPAEH--------------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISS 436 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 436 (618)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999875432 123489999999999999999999999 999999999
Q ss_pred CCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCC
Q 007088 437 KCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLT 515 (618)
Q Consensus 437 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~ 515 (618)
+||+++.++.+||+|||+++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVK--RSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEEC--SSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred heEEEcCCCCEEEcccccccccccccccee--ccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999987654332211 122346789999999988889999999999999999999 99999754
Q ss_pred CCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 516 NAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 516 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
... .+...... .. ...........+.+++.+||+.||++||++.|+++.|+++.++
T Consensus 257 ~~~-----~~~~~~~~---~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPE-----RLFNLLKT---GH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGG-----GHHHHHHT---TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHH-----HHHHHhhc---CC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 321 11111111 10 0011122334677788899999999999999999999998765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.54 Aligned_cols=272 Identities=22% Similarity=0.313 Sum_probs=213.9
Q ss_pred cCHHHHHHhhccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccce
Q 007088 296 MRLSDLMKATNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPL 366 (618)
Q Consensus 296 ~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l 366 (618)
+...+.....++|.+.+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455566778999999999999999999973 346899999997643 2345689999999999 79999999
Q ss_pred eEEEEeCCe-eEEEEeecCCCccccccCCCCCC-----------------------------------------------
Q 007088 367 LGFCVAKKE-RLLVYSYLENGTLYDKLHPAEHE----------------------------------------------- 398 (618)
Q Consensus 367 ~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~~----------------------------------------------- 398 (618)
++++.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999998765421
Q ss_pred ---------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 399 ---------------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 399 ---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999999 999999999999999999999999999987643322
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.. ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+ .+..... ....
T Consensus 249 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~---~~~~----- 314 (359)
T 3vhe_A 249 YV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLK---EGTR----- 314 (359)
T ss_dssp CE--EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHHHHH---HTCC-----
T ss_pred ch--hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----HHHHHHH---cCCC-----
Confidence 11 1122347889999999988899999999999999999998 999997643321 1111111 1100
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..........+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 315 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 315 -----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 001111234577788899999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.77 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=202.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 46789999999999999999995 468999999996532 1357899999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC----ceEEccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF----EPKLSDF 452 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 452 (618)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999997643 499999999999999999999999 999999999999998877 7999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
|+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... .+.....
T Consensus 164 G~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i 230 (361)
T 2yab_A 164 GLAHEIEDGVE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANI 230 (361)
T ss_dssp SSCEECCTTCC-----CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHH
T ss_pred CCceEcCCCCc-----cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence 99987654322 1234589999999999999999999999999999999999999975332 1111111
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... ..++... ......+.+++.+||..||++|||+.|+++
T Consensus 231 ~~~~~---~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 TAVSY---DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HTTCC---CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhcCC---CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11100 0000000 111245667777999999999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=360.50 Aligned_cols=257 Identities=23% Similarity=0.388 Sum_probs=202.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCc----EEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGC----FIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|+..++||+|+||.||+|+. .+++ +||+|.+... ....+++.+|+.++++++||||+++++++.+.+ .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5688899999999999999995 3444 4688888543 345678999999999999999999999998755 789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999987644 3589999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... .+...... ..
T Consensus 168 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~---~~- 236 (327)
T 3poz_A 168 GAEEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEK---GE- 236 (327)
T ss_dssp TTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHT---TC-
T ss_pred cCCccccc--ccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----HHHHHHHc---CC-
Confidence 54332221 122346889999999999999999999999999999999 99999754321 12221111 10
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
...........+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 237 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 0111122344677888899999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.73 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=200.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999954 78999999986433 234568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999997653 499999999999999999999999 9999999999999999999999999999865422
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... .....+.. .....
T Consensus 159 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~~---~~~~~-- 228 (323)
T 3tki_A 159 NR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKE---KKTYL-- 228 (323)
T ss_dssp TE--ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHHT---TCTTS--
T ss_pred Cc--ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHhc---ccccC--
Confidence 21 111223458999999999877665 779999999999999999999997644321 11111111 10000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 --------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 --------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001122345667888999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=378.40 Aligned_cols=259 Identities=25% Similarity=0.345 Sum_probs=207.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|+..+.||+|+||.||+|...++..||||+++......++|.+|++++++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 45688899999999999999999888899999998766677889999999999999999999999876 67899999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999975322 3589999999999999999999999 9999999999999999999999999999876532211
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 337 ---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~------ 399 (452)
T 1fmk_A 337 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYR------ 399 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCC------
T ss_pred ---cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC------
Confidence 1122336789999999988899999999999999999999 9999975322 111111111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
...+......+.+++.+||+.||++|||++++++.|+++....
T Consensus 400 ----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 ----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1111223456778888999999999999999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=383.70 Aligned_cols=259 Identities=23% Similarity=0.377 Sum_probs=214.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCC-CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.++|+..+.||+|+||.||+|.... +..||||+++......++|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 4568889999999999999999754 889999999887777889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 299 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999975432 4589999999999999999999999 999999999999999999999999999987653221
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
. ......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .+.+.+. .
T Consensus 374 ~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----~~~~~~~---~-------- 434 (495)
T 1opk_A 374 T---AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLE---K-------- 434 (495)
T ss_dssp E---CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHH---T--------
T ss_pred e---ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---c--------
Confidence 1 1123336789999999988889999999999999999999 99999764321 1112111 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
......+......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 435 --~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 435 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred --CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111111222345677888899999999999999999999987544
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=351.50 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=194.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---------------------------CHHHHHHHHHHHh
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---------------------------SEKEFLSEINTLG 356 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~ 356 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 35789999999999999999995 5689999999865321 1246889999999
Q ss_pred cCCCCCccceeEEEEe--CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 007088 357 SVRHRNLVPLLGFCVA--KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNI 434 (618)
Q Consensus 357 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 434 (618)
+++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 5678999999999999987643 3589999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCC---CCCccchHHHHHHHHHHHhCCCC
Q 007088 435 SSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV---ATPKGDVYSFGVVLLELITGERP 511 (618)
Q Consensus 435 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvil~elltG~~P 511 (618)
||+||+++.++.+||+|||+++........ .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.|
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDAL----LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSCE----ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CHHHEEECCCCCEEEecCCCcccccccccc----ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999876543322 12345899999999987665 37789999999999999999999
Q ss_pred CCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 512 THLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 512 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
|.... ............. ...........+.+++.+||+.||++|||+.|+++
T Consensus 240 f~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDER--------IMCLHSKIKSQAL---------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSS--------HHHHHHHHHHCCC---------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCcc--------HHHHHHHHhcccC---------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 97532 1122111111100 00000112345677777999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=363.62 Aligned_cols=268 Identities=23% Similarity=0.353 Sum_probs=212.2
Q ss_pred HHHhhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 007088 301 LMKATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372 (618)
Q Consensus 301 l~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 372 (618)
+....++|++.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3345678999999999999999999963 35899999997643 335678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCccccccCCCCCC--------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 007088 373 KKERLLVYSYLENGTLYDKLHPAEHE--------------------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR 432 (618)
Q Consensus 373 ~~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 432 (618)
.+..++||||+++|+|.+++...... ...+++.+++.++.||+.||+|||++ +|+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 99999999999999999998654211 14699999999999999999999999 99999
Q ss_pred CCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCC
Q 007088 433 NISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERP 511 (618)
Q Consensus 433 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~P 511 (618)
||||+||+++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB--C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc--cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 99999999999999999999999876432211 11122347889999999988889999999999999999999 9999
Q ss_pred CCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 512 THLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 512 f~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
|..... .+........ ... .........+.+++.+||+.||++||++.|+++.|+++.+++.
T Consensus 277 ~~~~~~--------~~~~~~~~~~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 277 YYGMAH--------EEVIYYVRDG-NIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTTSCH--------HHHHHHHHTT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCCCh--------HHHHHHHhCC-CcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 975321 1111111111 110 0111223467778889999999999999999999999987664
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=349.83 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=193.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|+..+.||+|+||.||+|... ++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999974 8899999986532 2346789999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC--------CCceEEcc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG--------DFEPKLSD 451 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D 451 (618)
|||+++++|.+++... .+++..++.++.|++.||+|||++...+|+||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998643 4899999999999999999999991112999999999999986 67899999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
||+++........ ...||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .....
T Consensus 160 fg~~~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~ 225 (271)
T 3dtc_A 160 FGLAREWHRTTKM------SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL--------AVAYG 225 (271)
T ss_dssp CCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH--------HHHHH
T ss_pred CCccccccccccc------CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHh
Confidence 9999865543221 234899999999998888999999999999999999999999753311 11111
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
..... ............+.+++.+||+.||++|||+.|+++.|+++
T Consensus 226 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 226 VAMNK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHTSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhcCC---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11110 00111122334677788899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=350.81 Aligned_cols=259 Identities=25% Similarity=0.374 Sum_probs=212.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|++.+.||+|+||.||+|...++..||+|+++......+.+.+|++++++++||||+++++++. .+..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence 4678889999999999999999988889999999877777888999999999999999999999986 456899999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 91 ~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999975432 3589999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..........
T Consensus 166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~~~~------ 228 (279)
T 1qpc_A 166 ---AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYR------ 228 (279)
T ss_dssp ---CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCC------
T ss_pred ---cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHhcccC------
Confidence 1122336788999999988889999999999999999999 9999875322 111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
..........+.+++.+|++.||++|||++++++.|+++....
T Consensus 229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 0011122346777888999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=354.79 Aligned_cols=263 Identities=22% Similarity=0.365 Sum_probs=216.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
..++|++.+.||+|+||.||+|... ++..||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4567888999999999999999965 488999999988776778899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999975433 4589999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...... ........ .
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----~~~~~~~~---~------ 228 (288)
T 3kfa_A 166 YTA---HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEK---D------ 228 (288)
T ss_dssp SEE---ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----GHHHHHHT---T------
T ss_pred ccc---ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHhc---c------
Confidence 221 122336788999999988899999999999999999999 99998754321 11111111 1
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
............+.+++.+||+.||.+|||+.|+++.|+.+.++...
T Consensus 229 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 229 ----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 01111122335677788899999999999999999999998776443
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=372.60 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=207.8
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-eeEEEEee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK-ERLLVYSY 382 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 382 (618)
..++|+..+.||+|+||.||+|... ++.||||+++... ..+.|.+|+.++++++||||+++++++...+ ..++||||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 3467888999999999999999985 7799999998654 4567999999999999999999999987765 78999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 999999999976432 3479999999999999999999999 99999999999999999999999999998643221
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
. ...++..|+|||.+.+..++.++|||||||++|||++ |+.||...... .....+. ...
T Consensus 344 ~-------~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i~---~~~----- 403 (450)
T 1k9a_A 344 D-------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPRVE---KGY----- 403 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----THHHHHH---TTC-----
T ss_pred c-------CCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHH---cCC-----
Confidence 1 1236789999999999999999999999999999998 99999764432 1111111 110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
....+......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 404 -----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 -----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1111222345677888899999999999999999999998653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=363.97 Aligned_cols=250 Identities=18% Similarity=0.234 Sum_probs=196.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc----CHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH----SEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 378 (618)
.++|++.++||+|+||.||+|+. .+++.||+|++++... ..+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999995 4688999999976432 224578899999887 89999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 999999999999987543 499999999999999999999999 9999999999999999999999999999863
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH-HHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI-TLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~-~~~~~~~~ 537 (618)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......... .......
T Consensus 204 ~~~~~~----~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~- 278 (396)
T 4dc2_A 204 LRPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ- 278 (396)
T ss_dssp CCTTCC----BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-
T ss_pred ccCCCc----cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-
Confidence 322221 2234599999999999999999999999999999999999999975433221111111111 1111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
+ ..+......+.+++.+||+.||++||++
T Consensus 279 --------~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 --------I--RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --------C--CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --------c--CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0 0111123456677779999999999996
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=356.20 Aligned_cols=245 Identities=22% Similarity=0.329 Sum_probs=200.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35789999999999999999995 67899999998643 23345789999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+ +|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 679998886543 499999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......+.....
T Consensus 160 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------------- 220 (336)
T 3h4j_B 160 DGNF-----LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-------------- 220 (336)
T ss_dssp TSBT-----TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--------------
T ss_pred CCcc-----cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--------------
Confidence 4322 223458999999999988776 68999999999999999999999764432211110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ...+......+.+++.+||+.||.+|||++|+++
T Consensus 221 ----~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 221 ----NSCV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----CSSC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----HcCC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000 0011112345667777999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.55 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=196.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCC----CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.++|++.+.||+|+||.||+|.... +..||+|+++... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4678889999999999999998632 5679999987533 33567899999999999999999999984 567899
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... ....
T Consensus 167 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----~~~~~i~---~~~~ 235 (281)
T 1mp8_A 167 EDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIE---NGER 235 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHH---TTCC
T ss_pred Ccccccc---cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----HHHHHHH---cCCC
Confidence 5432211 112236789999999988889999999999999999997 99999764321 1111111 1110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..........+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 236 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 ----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 001122334677788899999999999999999999998764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=370.82 Aligned_cols=252 Identities=18% Similarity=0.221 Sum_probs=202.2
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
..++|++.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456899999999999999999984 578999999997543 2345688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC---CCCceEEcccCccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD---GDFEPKLSDFGLAR 456 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~ 456 (618)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 89 ~E~~~gg~L~~~i~~~~----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp ECCCBCCBHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999887653 499999999999999999999999 999999999999998 56789999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||..... .+.........
T Consensus 162 ~~~~~~~~----~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~ 229 (444)
T 3soa_A 162 EVEGEQQA----WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGA 229 (444)
T ss_dssp CCCTTCCB----CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTC
T ss_pred EecCCCce----eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCC
Confidence 76543322 1234589999999999999999999999999999999999999975332 11111111110
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. . ............+.+++.+||+.||++|||+.|+++
T Consensus 230 ~--~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 Y--D-----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp C--C-----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C--C-----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0 0 001111122345667777999999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=370.60 Aligned_cols=264 Identities=20% Similarity=0.298 Sum_probs=208.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|.+.+.||+|+||.||+|... ++..||||+++.. .....++.+|+.++++++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888999999999999999943 4678999999753 23445688999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC---ceEEc
Q 007088 377 LLVYSYLENGTLYDKLHPAEH---EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF---EPKLS 450 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 450 (618)
++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999875432 224589999999999999999999999 999999999999999555 59999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
|||+++.......... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+..
T Consensus 227 DFG~a~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~ 296 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL 296 (367)
T ss_dssp CCHHHHHHHHHSSCTT--CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred CCcccccccccccccc--CCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence 9999975432211111 111237889999999988899999999999999999998 9999975432 1112
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
........ ..........+.+++.+||+.||++|||+.||++.|+.+.+...
T Consensus 297 ~~i~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 297 EFVTSGGR----------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHHcCCC----------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 22111111 01111223457788889999999999999999999999877543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=357.93 Aligned_cols=249 Identities=20% Similarity=0.287 Sum_probs=202.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|.+.+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35688999999999999999996 468999999986532 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC----ceEEccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF----EPKLSDF 452 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 452 (618)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||+++.++ .+||+||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999999997543 489999999999999999999999 999999999999999887 7999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
|+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.....
T Consensus 163 g~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~ 229 (326)
T 2y0a_A 163 GLAHKIDFGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANV 229 (326)
T ss_dssp TTCEECCTTSCC-----CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHH
T ss_pred CCCeECCCCCcc-----ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHH
Confidence 999876543221 233489999999999999999999999999999999999999975321 1111111
Q ss_pred hcC-CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTN-SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... ..... .. .......+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~----~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 230 SAVNYEFED----EY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHTCCCCCH----HH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhcCCCcCc----cc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 00000 00 0112245667788999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.09 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=203.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 380 (618)
++|.+.+.||+|+||.||+|+.. ++.||+|+++... ...+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888999999999999999984 8899999997643 3345689999999999999999999999887 7789999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999976543 4689999999999999999999998 7 999999999999999999999999887643
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCC---ccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATP---KGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
... ...||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ..........
T Consensus 164 ~~~---------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~ 226 (271)
T 3kmu_A 164 QSP---------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEIGMKVALE 226 (271)
T ss_dssp SCT---------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHHHHHHHHS
T ss_pred ccc---------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHHHHHHHhc
Confidence 221 223789999999987765554 79999999999999999999975322 1111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
.. .+ .........+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 227 ~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GL-----RP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC-----CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 10 01 1112223457777889999999999999999999999865
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=348.14 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=207.2
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-C---CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee-EEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-G---GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER-LLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 379 (618)
.|...++||+|+||.||+|... + +..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999842 2 3479999997543 3346789999999999999999999999876655 999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997643 4589999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..............+|+.|+|||.+.+..++.++||||||+++|||++|..|+...... ..+........ .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~~~~---~-- 246 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLAQGR---R-- 246 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHHTTC---C--
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhhcCC---C--
Confidence 43322222223345789999999999999999999999999999999966665433221 11222111110 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFT 593 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (618)
..........+.+++.+||+.||.+|||++|+++.|+++.++....
T Consensus 247 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 247 --------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred --------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 0011112345777888999999999999999999999998876533
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=351.73 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=198.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999996533 2346788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 9988886543 3589999999999999999999999 99999999999999999999999999998765322
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC--ccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS--SLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~--~~~ 539 (618)
... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+........... ...
T Consensus 155 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 155 RKY----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA----DQLMRIFRILGTPNSKNWP 226 (288)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCCCCTTTST
T ss_pred ccc----ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHHCCCChhhch
Confidence 211 22347999999998865 45899999999999999999999999754321 11111111110000 000
Q ss_pred -----hhcccccc-------CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 -----TAIDKSLL-------GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 -----~~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...++... ..........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00010000 0001112345677888999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=359.25 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=202.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC------ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS------QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 35799999999999999999995 56899999998532 224678999999999999999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc---eEEcccCc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE---PKLSDFGL 454 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~ 454 (618)
+||||+++|+|.+++.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999888765433334589999999999999999999999 9999999999999986654 99999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........
T Consensus 180 a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---------~~~~~i~~ 246 (351)
T 3c0i_A 180 AIQLGESGLV----AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---------RLFEGIIK 246 (351)
T ss_dssp CEECCTTSCB----CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---------HHHHHHHH
T ss_pred eeEecCCCee----ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---------HHHHHHHc
Confidence 9876543221 1234589999999999999999999999999999999999999975211 11111111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ..+... ......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~---~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYK---MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCC---CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC---CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1000 000000 012345677788999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=361.54 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=202.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
..++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456899999999999999999995 4689999999975432 345688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC---ceEEcccCccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF---EPKLSDFGLAR 456 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~ 456 (618)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp ECCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 99999999999987653 489999999999999999999999 999999999999998654 59999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 180 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~ 246 (362)
T 2bdw_A 180 EVNDSEA-----WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGA 246 (362)
T ss_dssp CCTTCCS-----CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred EecCCcc-----cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCC
Confidence 7654322 1234589999999999999999999999999999999999999975321 11111111110
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. ............+.+++.+||+.||++||++.|+++
T Consensus 247 ~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 247 YD-------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CC-------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CC-------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000011122345677888999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=351.70 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=200.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|++.+.||+|+||.||+|... ++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCC
Confidence 56888999999999999999974 788999999654 34567899999999999999999999876 347999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc-eEEcccCcccccCCCCCc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE-PKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~a~~~~~~~~~ 464 (618)
|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999976542 235789999999999999999999932128999999999999998886 7999999997654321
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............. +
T Consensus 161 -----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~------~ 223 (307)
T 2eva_A 161 -----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVHNGTR------P 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHHTTCC------C
T ss_pred -----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHhcCCC------C
Confidence 1223899999999999999999999999999999999999999754321 1111111111100 0
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
.. .......+.+++.+||+.||++|||++|+++.|+.+.+.+..
T Consensus 224 ~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 PL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp CC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred Cc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 01 111234567788899999999999999999999999877654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=354.86 Aligned_cols=264 Identities=24% Similarity=0.341 Sum_probs=211.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 375 (618)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 46788899999999999999984 357899999997643 2346789999999999 99999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCC--------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 376 RLLVYSYLENGTLYDKLHPAEH--------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999875432 123589999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPES 520 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~ 520 (618)
+.++.+||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSE--ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred cCCCCEEEccccccccccccccce--eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-
Confidence 999999999999998765433211 1122336789999999988899999999999999999999 999997643211
Q ss_pred cccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 521 FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 521 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
........ . ............+.+++.+||+.||.+|||+.|+++.|+++.++.
T Consensus 256 ---~~~~~~~~---~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 256 ---KFYKMIKE---G----------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp ---HHHHHHHH---T----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ---HHHHHhcc---C----------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 11111111 0 000111122346777888999999999999999999999987754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=348.95 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=205.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCC----CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVA-KKERL 377 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 377 (618)
..+|...+.||+|+||.||+|...+ ...||+|.+.... ...+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467888999999999999998532 2468999987533 334678999999999999999999999654 55789
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccc
Confidence 9999999999999996543 4589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
................+|+.|+|||.+.+..++.++||||||+++|||++ |.+||...... ....... ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~-----~~~~~~~---~~~ 249 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLL---QGR 249 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT-----THHHHHH---TTC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHHh---cCC
Confidence 65433222222334457889999999988899999999999999999999 55555443221 1111111 110
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
. ... .......+.+++.+||+.||++|||++|+++.|+++...+..
T Consensus 250 ~-------~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 250 R-------LLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp C-------CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred C-------CCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 000 111234577788899999999999999999999999887653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=347.33 Aligned_cols=280 Identities=18% Similarity=0.202 Sum_probs=215.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEE-EeCCeeEEEEe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC-VAKKERLLVYS 381 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 381 (618)
..++|++.+.||+|+||.||+|+. .+++.||+|++..... .+.+.+|++++++++|++++..+.++ ...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999995 6789999998755332 23578899999999988877777665 56677899999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---CCCCceEEcccCccccc
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLM 458 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~ 458 (618)
|+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 889999987433 3599999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 459 NPVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 459 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
........ .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..+..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcccccc
Confidence 54332111 1122345899999999999999999999999999999999999999865443221 1111111111100
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCCC
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPS 602 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 602 (618)
... . + .. .....+.+++.+||+.||++|||++|+++.|+++.++.+.+.+..++|..
T Consensus 238 -~~~-~----~-~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 238 -PIE-V----L-CK---GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp -CHH-H----H-TT---TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred -hhh-h----h-hc---cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 000 0 0 00 11346777888999999999999999999999999999998888888754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=362.08 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=197.4
Q ss_pred cCCCCcEEeecCCeeEEEEEeC--C--CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeeEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP--G--GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVA-KKERLLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 379 (618)
.|...+.||+|+||.||+|... + +..||+|.++... ...+++.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999853 3 2468999987533 345679999999999999999999999755 4578999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999997543 3588999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
..............+|+.|+|||.+.+..++.++|||||||++|||++ |.+||...... ....... .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~~~~~~---~~~~~ 315 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLL---QGRRL 315 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CHHHHHH---TTCCC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HHHHHHH---cCCCC
Confidence 432222112223347789999999988899999999999999999999 67777654322 1222111 11000
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFT 593 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 593 (618)
..+......+.+++.+||+.||++|||++|+++.|+++...+...
T Consensus 316 ----------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 316 ----------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 001122346777888999999999999999999999998877643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.18 Aligned_cols=278 Identities=22% Similarity=0.320 Sum_probs=216.5
Q ss_pred cCHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhc--CCCCCccceeEEEEeC
Q 007088 296 MRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGS--VRHRNLVPLLGFCVAK 373 (618)
Q Consensus 296 ~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~ 373 (618)
.++.--....++|.+.+.||+|+||.||+|+. +++.||+|++... ..+.+.+|.+++.. ++||||+++++++...
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 34444455678899999999999999999998 5899999999653 35667888888877 7899999999999887
Q ss_pred C----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCeee
Q 007088 374 K----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH--------HNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 374 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll 441 (618)
+ ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||++
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll 180 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV 180 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred CCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence 6 789999999999999999643 4899999999999999999999 77 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC------CCCCccchHHHHHHHHHHHhC-------
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL------VATPKGDVYSFGVVLLELITG------- 508 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvil~elltG------- 508 (618)
+.++.+||+|||++..................||+.|+|||++.+. .++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 9999999999999987654433222222344589999999998765 234689999999999999999
Q ss_pred ---CCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 007088 509 ---ERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRA 585 (618)
Q Consensus 509 ---~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 585 (618)
+.||....... .....+........ ....+.... ...+....+.+++.+||+.||++|||+.|+++.|++
T Consensus 261 ~~~~~p~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 261 EDYQLPYYDLVPSD---PSVEEMRKVVCEQK-LRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCCTTTTTSCSS---CCHHHHHHHHTTSC-CCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccCccccCcCc---ccHHHHHHHHHHHH-hCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 67776543221 12233332222111 110011110 123566788899999999999999999999999999
Q ss_pred hhhhcC
Q 007088 586 IAERYH 591 (618)
Q Consensus 586 i~~~~~ 591 (618)
+.++..
T Consensus 334 i~~~~~ 339 (342)
T 1b6c_B 334 LSQQEG 339 (342)
T ss_dssp HHHTTC
T ss_pred HHHHhc
Confidence 988654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.55 Aligned_cols=279 Identities=18% Similarity=0.197 Sum_probs=218.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEE-EeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC-VAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ..+++.+|+.++++++|++++..+.++ ...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 46799999999999999999995 679999999986543 234688999999999988877766665 556678999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---CCCCceEEcccCcccccC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~ 459 (618)
+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9 889999986433 3599999999999999999999999 99999999999999 488899999999998765
Q ss_pred CCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 460 PVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 460 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..+...........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-hhhhhhcccccCCc
Confidence 4332111 1112345899999999999999999999999999999999999999865432211 11111111111000
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCCC
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLPS 602 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~ 602 (618)
. . .+. ......+.+++.+||+.||++|||++|+++.|+++.++.....++.++|..
T Consensus 239 -~-~----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 239 -I-E----VLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp -H-H----HHT----TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred -h-H----HHH----hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 0 0 000 112245777888999999999999999999999999999998888888865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=349.30 Aligned_cols=262 Identities=23% Similarity=0.273 Sum_probs=198.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5788999999999999999996 468999999996533 234678899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9986 5655554332 3599999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCcccccccCCCCcccccCCCCCCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC--Ccc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLV-ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN--SSL 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~--~~~ 538 (618)
.... ....||+.|+|||++.+.. ++.++|||||||++|||++|..||...... ...+.......... ...
T Consensus 155 ~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~---~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 155 VRCY----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CSCC----CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTC
T ss_pred cccc----cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCChhhh
Confidence 2221 2334899999999987765 799999999999999999998887543321 11111111111100 000
Q ss_pred ---chhcc---------ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ---ETAID---------KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ---~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....+ ..............+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 00000011123345667778999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.27 Aligned_cols=278 Identities=22% Similarity=0.308 Sum_probs=204.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHH--HhcCCCCCccceeEEEEe-----CCeeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINT--LGSVRHRNLVPLLGFCVA-----KKERL 377 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~~ 377 (618)
.++|++.+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 46788999999999999999987 68999999997543 3344444444 556899999999986643 22568
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecCCCCCCeeeCCCCceEEcc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC------NPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
+||||+++|+|.+++.... .++..+..++.||+.||+|||+.+ .++|+||||||+|||++.++.+||+|
T Consensus 89 lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 9999999999999996543 588999999999999999999873 33899999999999999999999999
Q ss_pred cCcccccCCCCCcc----cccccCCCCcccccCCCCCCC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007088 452 FGLARLMNPVDTHL----STFVNGEFGDLGYVAPEYPRT-------LVATPKGDVYSFGVVLLELITGERPTHLTNAPES 520 (618)
Q Consensus 452 fG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~ 520 (618)
||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998765432111 111223458999999999876 4567899999999999999999888765443322
Q ss_pred cccCHHH---------HHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 521 FKGSLVE---------WITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 521 ~~~~l~~---------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
....... ..............+.... .........+.+++.+||+.||++|||++|+++.|+++.+.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 2221111 0111111111111111111 1123466678999999999999999999999999999998775
Q ss_pred C
Q 007088 592 F 592 (618)
Q Consensus 592 ~ 592 (618)
.
T Consensus 322 ~ 322 (336)
T 3g2f_A 322 R 322 (336)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=363.97 Aligned_cols=247 Identities=19% Similarity=0.262 Sum_probs=197.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 378 (618)
.++|++.+.||+|+||.||+|+. .+++.||+|+++.. ....+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 46899999999999999999995 46899999999753 23456688999999988 79999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999987543 499999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+..........
T Consensus 175 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~- 241 (353)
T 3txo_A 175 ICNGVT----TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEV- 241 (353)
T ss_dssp CC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-
T ss_pred ccCCcc----ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCC-
Confidence 332221 1234589999999999888899999999999999999999999975432 111111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM------FEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 581 (618)
..+......+.+++.+||+.||.+||++ +|+++
T Consensus 242 ----------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ----------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0011122356677779999999999998 66653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=360.99 Aligned_cols=253 Identities=20% Similarity=0.253 Sum_probs=195.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.++|++.+.||+|+||.||+++.. +++.||+|++.......+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 467999999999999999999964 7899999999876666678999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc--eEEcccCcccccCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE--PKLSDFGLARLMNPV 461 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~ 461 (618)
++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 9999999986543 499999999999999999999999 9999999999999987765 999999999754322
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPK-GDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. .....||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... ..............
T Consensus 172 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~~~--- 239 (361)
T 3uc3_A 172 SQ-----PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQRILSVKY--- 239 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHHHHTTCC---
T ss_pred CC-----CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhcCCC---
Confidence 11 122348999999999887777655 899999999999999999998654322 22222222211110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
...........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 ------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 000000122456677779999999999999999763
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=358.92 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=201.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCc----EEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGC----FIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|++.+.||+|+||.||+|.. .+++ +||+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 4688899999999999999995 3444 48888875432 23346778999999999999999999986 456889
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999987653 3588999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....+|..|+|||++.+..++.++||||||+++|||++ |+.||...... .+..... ....
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~---~~~~ 235 (325)
T 3kex_A 166 PPDDKQLL--YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-----EVPDLLE---KGER 235 (325)
T ss_dssp CCCTTCCC-------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-----HHHHHHH---TTCB
T ss_pred Cccccccc--ccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-----HHHHHHH---cCCC
Confidence 54332211 122347889999999998899999999999999999999 99999764321 1111111 1100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
. .........+.+++.+||+.||.+||+++|+++.|+.+...
T Consensus 236 ~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 236 L----------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp C----------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred C----------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00111223466788899999999999999999999998653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=359.46 Aligned_cols=265 Identities=20% Similarity=0.307 Sum_probs=207.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
..++|.+.+.||+|+||.||+|.. .++..||+|+++... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457899999999999999999995 246789999997532 3446789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCCC-------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHE-------------------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNIS 435 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 435 (618)
..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+. +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 999999999999999999765321 13489999999999999999999999 99999999
Q ss_pred CCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCC
Q 007088 436 SKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHL 514 (618)
Q Consensus 436 p~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~ 514 (618)
|+||+++.++.+||+|||++.......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccce--eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999998664332211 1122336789999999988889999999999999999998 9999976
Q ss_pred CCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 515 TNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 515 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
..... ....... .. ............+.+++.+||+.||.+|||+.|+++.|+.+.+..
T Consensus 278 ~~~~~----~~~~~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 278 IPVDA----NFYKLIQ---NG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCCSH----HHHHHHH---TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCcHH----HHHHHHh---cC----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 44321 1111111 11 001111122346777888999999999999999999999986654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=355.18 Aligned_cols=249 Identities=18% Similarity=0.231 Sum_probs=196.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 379 (618)
++|+..+.||+|+||.||+|+. .+++.||+|+++... ...+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5688899999999999999996 468999999997543 2345578899999988 899999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999986543 489999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc-CHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-SLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~-~l~~~~~~~~~~~~~ 538 (618)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ............. .
T Consensus 162 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-~ 236 (345)
T 3a8x_A 162 RPGDT----TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-I 236 (345)
T ss_dssp CTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-C
T ss_pred CCCCc----ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-C
Confidence 32221 2234589999999999999999999999999999999999999975432211111 1111111111110 0
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
.+ +......+.+++.+||+.||++||++
T Consensus 237 ------~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ------RI----PRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ------CC----CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ------CC----CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 01 11123456677779999999999996
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=359.84 Aligned_cols=281 Identities=17% Similarity=0.184 Sum_probs=217.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC---------CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccc----------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP---------GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP---------- 365 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 365 (618)
.++|.+.+.||+|+||.||+|... +++.||+|++... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 367999999999999999999965 3789999998754 36789999999999999887
Q ss_pred -----eeEEEEe-CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCe
Q 007088 366 -----LLGFCVA-KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCI 439 (618)
Q Consensus 366 -----l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 439 (618)
+++++.. .+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 6778776 67889999999 9999999976522 4599999999999999999999999 999999999999
Q ss_pred eeCCCC--ceEEcccCcccccCCCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 007088 440 LLDGDF--EPKLSDFGLARLMNPVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHL 514 (618)
Q Consensus 440 ll~~~~--~~kl~DfG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~ 514 (618)
+++.++ .+||+|||+++.......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 899999999987654322111 111233589999999999999999999999999999999999999976
Q ss_pred CCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 007088 515 TNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTT 594 (618)
Q Consensus 515 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (618)
..... ..+........... ....+...... .....+.+++.+||+.||++|||++|+++.|+++.++.....
T Consensus 271 ~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~ 342 (352)
T 2jii_A 271 CLPNT---EDIMKQKQKFVDKP--GPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP 342 (352)
T ss_dssp GTTCH---HHHHHHHHHHHHSC--CCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred CCcCH---HHHHHHHHhccCCh--hhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence 43211 11222221111111 11111110001 123456777779999999999999999999999999999999
Q ss_pred CCcccCCCC
Q 007088 595 DDEIMLPSN 603 (618)
Q Consensus 595 ~~~~~~~~~ 603 (618)
++.++|+..
T Consensus 343 ~~~~dw~~~ 351 (352)
T 2jii_A 343 YDPIGLPMV 351 (352)
T ss_dssp TSCCCCCC-
T ss_pred CccccCcCC
Confidence 999988754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=346.79 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=200.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc--C------HHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH--S------EKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
.++|+..+.||+|+||.||+|.. .+++.||+|++..... . .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36788899999999999999996 5789999999864321 1 167899999999999999999999986654
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeCCCCc-----eE
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLDGDFE-----PK 448 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~k 448 (618)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999998886544 4599999999999999999999999 8 999999999999988776 99
Q ss_pred EcccCcccccCCCCCcccccccCCCCcccccCCCCC--CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH
Q 007088 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP--RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 449 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~ 526 (618)
|+|||+++..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||....... .
T Consensus 170 l~Dfg~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~ 236 (287)
T 4f0f_A 170 VADFGLSQQSVHS-------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------I 236 (287)
T ss_dssp ECCCTTCBCCSSC-------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH------H
T ss_pred eCCCCcccccccc-------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH------H
Confidence 9999999754331 1223489999999998 45567899999999999999999999997543221 1
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
........... ...........+.+++.+||+.||++|||++|+++.|+++
T Consensus 237 ~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 KFINMIREEGL---------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHSCC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHhccCC---------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111111111 1111122335677788899999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=361.05 Aligned_cols=273 Identities=19% Similarity=0.231 Sum_probs=203.4
Q ss_pred hccCCCCcEEeec--CCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTG--RTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.++|++.++||+| +||.||+|+.. +++.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999964 78999999997543 234567889999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999876532 3489999999999999999999999 9999999999999999999999999988654
Q ss_pred CCCCCc---ccccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 459 NPVDTH---LSTFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 459 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.....+........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 321111 1111122358999999999887 67899999999999999999999999765443222111111000000
Q ss_pred cCC------------------ccchhcc---cc------ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 534 TNS------------------SLETAID---KS------LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 534 ~~~------------------~~~~~~d---~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
... .....+. +. ............+.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0000000 00 0000111223567788889999999999999999853
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=355.37 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=200.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||++.. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5789999999999999999995 46899999999653 244577899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV----HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999997643 499999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT---LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 168 ~~~-----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~~~~~~- 236 (384)
T 4fr4_A 168 ETQ-----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHTFETTV- 236 (384)
T ss_dssp TCC-----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHHHHHCC-
T ss_pred CCc-----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhhcc-
Confidence 322 223459999999999864 45899999999999999999999999754332 1122221111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-MFEVY 580 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl 580 (618)
...+......+.+++.+||+.||.+||+ ++++.
T Consensus 237 ----------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 237 ----------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred ----------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 0011122345677777999999999998 66664
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=355.64 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=210.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe--------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML--------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAK 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 373 (618)
.++|.+.+.||+|+||.||+|.. .++..||+|+++... ...+.+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 46899999999999999999985 346789999997643 3346788999999999 899999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCCC------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHE------------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL 441 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 441 (618)
+..++||||+++|+|.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999765421 23489999999999999999999999 99999999999999
Q ss_pred CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 007088 442 DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPES 520 (618)
Q Consensus 442 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~ 520 (618)
+.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKK--TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEEC--CSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred cCCCCEEEccccccccccccccccc--cCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 9999999999999987654332111 122346789999999988889999999999999999999 9999975321
Q ss_pred cccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 521 FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 521 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
.+.......... ..........+.+++.+||+.||.+|||+.|+++.|+++.....
T Consensus 266 -----~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 -----EELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp -----HHHHHHHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -----HHHHHHHhcCCC----------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111111111110 01111223467778889999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=356.88 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=188.7
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
..++|++.+.||+|+||.||+|+.. +++.||+|+++... ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3567999999999999999999965 57899999997643 345688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEcccCcccccC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a~~~~ 459 (618)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999997653 489999999999999999999999 9999999999999975 8899999999998764
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 203 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~-- 268 (349)
T 2w4o_A 203 HQVL-----MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEY-- 268 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCC--
T ss_pred cccc-----cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCC--
Confidence 3221 12234899999999999999999999999999999999999999754321 111111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ............+.+++.+||+.||++|||+.|+++
T Consensus 269 ~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 Y-----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp C-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000111223346677888999999999999999976
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=346.20 Aligned_cols=261 Identities=19% Similarity=0.305 Sum_probs=208.8
Q ss_pred ccCCCCc-EEeecCCeeEEEEEeC---CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNN-IIGTGRTGATYIAMLP---GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|.+.+ .||+|+||.||+|... ++..||+|+++... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555565 8999999999999853 67889999997643 3456789999999999999999999999 55678999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999997543 4589999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... +..........
T Consensus 162 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~~- 231 (287)
T 1u59_A 162 ADDSYYT-ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR- 231 (287)
T ss_dssp TCSCEEC-CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCC-
T ss_pred cCcceee-ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCCc-
Confidence 4332211 1122346889999999988889999999999999999998 99999754321 11111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
...+......+.+++.+||+.||++||++.|+++.|+++..+...
T Consensus 232 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 232 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ---------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 011122335677788899999999999999999999999876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=351.06 Aligned_cols=269 Identities=18% Similarity=0.282 Sum_probs=202.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|.+.+.||+|+||.||+|.. .+|+.||+|+++.. ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999995 57899999999752 23346688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999865332235689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ............. .
T Consensus 188 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-~- 255 (310)
T 2wqm_A 188 SKTTAA----HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCD-Y- 255 (310)
T ss_dssp ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHHHTTC-S-
T ss_pred CCCccc----cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHhhccc-C-
Confidence 432211 123488999999999999999999999999999999999999975321 1122222221111 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCC
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTD 595 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~ 595 (618)
+..... .....+.+++.+||+.||++|||++|+++.|+++.+....+.+
T Consensus 256 ----~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 256 ----PPLPSD---HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp ----CCCCTT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred ----CCCccc---ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 001111 1234567777799999999999999999999999887665543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.70 Aligned_cols=251 Identities=19% Similarity=0.280 Sum_probs=203.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46799999999999999999995 468999999997543 3445789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC--CCceEEcccCcccccCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG--DFEPKLSDFGLARLMNP 460 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~ 460 (618)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999987643 3589999999999999999999999 9999999999999974 57799999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
..... ...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 204 ~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~~~~~--- 267 (387)
T 1kob_A 204 DEIVK-----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDW--- 267 (387)
T ss_dssp TSCEE-----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCC---
T ss_pred Cccee-----eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC---
Confidence 33211 22489999999999999999999999999999999999999975321 111111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.............+.+++.+||+.||++|||+.|+++
T Consensus 268 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 268 ----EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ----CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0001111222345677788999999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=356.63 Aligned_cols=268 Identities=23% Similarity=0.320 Sum_probs=208.3
Q ss_pred CCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--CeeEE
Q 007088 308 FSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KERLL 378 (618)
Q Consensus 308 y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 378 (618)
|++.+.||+|+||.||++.+ .+++.||+|+++... ...+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48899999999999999864 368899999997643 3356689999999999999999999999884 57899
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999654 389999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCc----cccCHHHHHHHHhc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPES----FKGSLVEWITLLNT 534 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~----~~~~l~~~~~~~~~ 534 (618)
....... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ .........
T Consensus 185 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 258 (318)
T 3lxp_A 185 PEGHEYY-RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL----- 258 (318)
T ss_dssp CTTCSEE-EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH-----
T ss_pred ccccccc-ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH-----
Confidence 5533221 112233478889999999888899999999999999999999999864211000 000000000
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
...+.+...............+.+++.+||+.||++|||++|+++.|+++.+++.
T Consensus 259 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 259 --RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp --HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 0011111111111222334567788889999999999999999999999988765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.44 Aligned_cols=244 Identities=21% Similarity=0.287 Sum_probs=201.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||+++. .+|+.||+|+++... ...+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 35788999999999999999995 478999999997532 3456788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999997543 489999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ............
T Consensus 158 ~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~-- 220 (318)
T 1fot_A 158 DVT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAEL-- 220 (318)
T ss_dssp SCB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCC--
T ss_pred Ccc-------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC--
Confidence 321 123589999999999999999999999999999999999999975321 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
.+ +......+.+++.+||+.||++|| +++|+++
T Consensus 221 -----~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -----RF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CC----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 00 111223566777799999999999 8888864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=354.33 Aligned_cols=253 Identities=21% Similarity=0.304 Sum_probs=197.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC-------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------- 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 374 (618)
.++|++.+.||+|+||.||+|+.. +|+.||||+++.. ....+.+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999965 7899999999643 334577999999999999999999999986543
Q ss_pred --------------------------------------------------eeEEEEeecCCCccccccCCCCCCCcCCCH
Q 007088 375 --------------------------------------------------ERLLVYSYLENGTLYDKLHPAEHEVMHMDW 404 (618)
Q Consensus 375 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~ 404 (618)
..++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 27899999999999999976543 244677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc--------ccccCCCCcc
Q 007088 405 PLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS--------TFVNGEFGDL 476 (618)
Q Consensus 405 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~--------~~~~~~~gt~ 476 (618)
..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999999 999999999999999999999999999987765322111 1122345899
Q ss_pred cccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHH
Q 007088 477 GYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELH 556 (618)
Q Consensus 477 ~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 556 (618)
.|+|||++.+..++.++|||||||++|||++|..|+.. ......... ..... ........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~-~~~~~---------~~~~~~~~ 300 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVR-NLKFP---------LLFTQKYP 300 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHH-TTCCC---------HHHHHHCH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhh-ccCCC---------cccccCCh
Confidence 99999999999999999999999999999998766421 011111111 10000 00123345
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 557 QFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 557 ~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+.+++.+||+.||++|||++|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 6678888999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=344.36 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=195.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.++||+|+||.||+|+..+ .||+|+++... ...+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 4678999999999999999998644 59999997543 2346689999999999999999999965 5566899999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 100 WCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred ecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999997554 4589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
... .......||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ .+...... .. .
T Consensus 174 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~---~~-~ 243 (289)
T 3og7_A 174 SGS--HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIEMVGR---GS-L 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH----HHHHHHHH---TS-C
T ss_pred ccc--ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH----HHHHHhcc---cc-c
Confidence 211 1112334899999999886 5678889999999999999999999997543211 11111111 10 0
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
. +.+ ..........+.+++.+||+.||.+|||+.|+++.|+++.+
T Consensus 244 ~----~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 S----PDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp C----CCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred C----cch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 000 01112234567788889999999999999999999999865
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=381.22 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=211.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
..++|++.++||+|+||.||+|...++..||||+++......++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456788899999999999999999888899999998776677889999999999999999999999876 6789999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 344 ~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 344 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp TTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred cCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 99999999975322 3589999999999999999999999 99999999999999999999999999998765321
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
........++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+..........
T Consensus 418 --~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~----- 482 (535)
T 2h8h_A 418 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYR----- 482 (535)
T ss_dssp --HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTTCC-----
T ss_pred --eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC-----
Confidence 111122346789999999988899999999999999999999 9999975322 111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..........+.+++.+||+.||++|||+++|++.|+++...
T Consensus 483 -----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 483 -----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 011122334677888899999999999999999999987544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.95 Aligned_cols=275 Identities=20% Similarity=0.276 Sum_probs=214.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC--eeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK--ERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 379 (618)
.++|.+.++||+|+||.||+|... +++.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 357888999999999999999964 58999999997533 44677889999999999999999999998765 67999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee----CCCCceEEcccCcc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL----DGDFEPKLSDFGLA 455 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~a 455 (618)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 999999999999976543 23489999999999999999999999 99999999999999 78888999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT--------LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~ 527 (618)
+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||............+..
T Consensus 164 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 164 RELEDDEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp EECCCGGG-----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred eEccCCCc-----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 87654322 123458999999998754 56788999999999999999999999764433222222222
Q ss_pred HHHHHhcCCccchh---c------cccc--cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 528 WITLLNTNSSLETA---I------DKSL--LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 528 ~~~~~~~~~~~~~~---~------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
...... ....... . ...+ ...........+.+++.+||+.||++||+++|+++.++++.++
T Consensus 239 ~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111100 0000000 0 0011 1122356777888999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.70 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=206.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcE--EEEEEeccC--ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCF--IMIKRLEDS--QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 379 (618)
++|+..+.||+|+||.||+|+. .++.. |++|+++.. ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788899999999999999995 45654 499988653 23455689999999999 899999999999999999999
Q ss_pred EeecCCCccccccCCCC------------CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 380 YSYLENGTLYDKLHPAE------------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997654 2234699999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++........ ....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 182 kL~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~ 248 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------A 248 (327)
T ss_dssp EECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------H
T ss_pred EEcccCcCccccccccc-----cCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------H
Confidence 99999999753321111 11236789999999988889999999999999999998 9999975331 1
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
+......... ...........+.+++.+||+.||.+|||++|+++.|+++.++...
T Consensus 249 ~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 249 ELYEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp HHHHHGGGTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHHHHhhcCC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 1222211110 0011112234677788899999999999999999999999886543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=359.59 Aligned_cols=211 Identities=21% Similarity=0.266 Sum_probs=184.7
Q ss_pred ccccCHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-----CCCccce
Q 007088 293 VEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-----HRNLVPL 366 (618)
Q Consensus 293 ~~~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l 366 (618)
...+++.+.....++|.+.++||+|+||.||+|.. .+++.||||+++......+.+..|++++++++ ||||+++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34556666666788999999999999999999996 57899999999876666677888999999986 9999999
Q ss_pred eEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---
Q 007088 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG--- 443 (618)
Q Consensus 367 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--- 443 (618)
++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTC
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccc
Confidence 99999999999999999 8899999976543 3589999999999999999999999 9999999999999975
Q ss_pred ----------------------CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHH
Q 007088 444 ----------------------DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVV 501 (618)
Q Consensus 444 ----------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvi 501 (618)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 248 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCV 248 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC-------cCccCcccccCcHHHcCCCCCCccchHHHHHH
Confidence 7889999999998654322 12348999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 007088 502 LLELITGERPTHLTN 516 (618)
Q Consensus 502 l~elltG~~Pf~~~~ 516 (618)
+|||++|+.||....
T Consensus 249 l~ell~g~~pf~~~~ 263 (360)
T 3llt_A 249 LAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHSSCSCCCSS
T ss_pred HHHHHHCCCCCCCCc
Confidence 999999999997643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.00 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=200.5
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
...++|.+.+.||+|+||.||+|+. .+++.||+|+++.. ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3457899999999999999999996 46899999999753 24456788899999876 899999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 99999999999999987543 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
........ ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.........
T Consensus 167 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~ 234 (345)
T 1xjd_A 167 ENMLGDAK----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDN 234 (345)
T ss_dssp CCCCTTCC----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC
T ss_pred hcccCCCc----ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC
Confidence 64332221 1234589999999999999999999999999999999999999975332 11111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMF-EVY 580 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 580 (618)
... +......+.+++.+||+.||++||++. |++
T Consensus 235 -------~~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 -------PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -------CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -------CCC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 001 111224566777799999999999997 553
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=353.46 Aligned_cols=257 Identities=23% Similarity=0.385 Sum_probs=199.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCc----EEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGC----FIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|++.+.||+|+||.||+|.. .+++ +|++|.+... ....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 5788899999999999999995 3444 4678877543 356778999999999999999999999998765 789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|+||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999987644 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+...... ..
T Consensus 168 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~~~---~~- 236 (327)
T 3lzb_A 168 GAEEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEK---GE- 236 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHHT---TC-
T ss_pred cCcccccc--ccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHc---CC-
Confidence 54322211 122346789999999999999999999999999999999 99999764321 12221111 10
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
...........+.+++.+||+.||.+||++.|+++.|+++.+.
T Consensus 237 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 237 ---------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0111122334577788899999999999999999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.54 Aligned_cols=268 Identities=22% Similarity=0.340 Sum_probs=212.5
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEE
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFC 370 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~ 370 (618)
++.....++|++.+.||+|+||.||+|+.. +++.||+|++.... .....+.+|++++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344556788999999999999999999853 37889999997543 3345688999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCccccccCCCCC------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC
Q 007088 371 VAKKERLLVYSYLENGTLYDKLHPAEH------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD 444 (618)
Q Consensus 371 ~~~~~~~lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 444 (618)
.+.+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 999999999999999999999865321 113578999999999999999999999 99999999999999999
Q ss_pred CceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 007088 445 FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKG 523 (618)
Q Consensus 445 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~ 523 (618)
+.+||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------ 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYR--KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------ 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEE--GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------
T ss_pred CeEEECcCccccccccccccc--cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------
Confidence 999999999998654322111 1122346889999999988889999999999999999999 8899865321
Q ss_pred CHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.+......... .. .........+.+++.+||+.||.+|||+.|+++.|+++.+.
T Consensus 247 --~~~~~~~~~~~-~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 247 --EQVLRFVMEGG-LL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp --HHHHHHHHTTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred --HHHHHHHHcCC-cC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11111111111 00 01122334577788899999999999999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=358.18 Aligned_cols=263 Identities=22% Similarity=0.239 Sum_probs=200.7
Q ss_pred HHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC------ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 007088 301 LMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS------QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373 (618)
Q Consensus 301 l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 373 (618)
+....++|.+.+.||+|+||.||+|.. .++..||+|++... ....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 455677899999999999999999995 56889999998643 23456789999999999999999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCC------------------------------------CCcCCCHHHHHHHHHHHHHH
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEH------------------------------------EVMHMDWPLRLRIAIGSARG 417 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------~~~~l~~~~~~~i~~~i~~~ 417 (618)
+..++||||+++|+|.+++..... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998852110 01224677888999999999
Q ss_pred HHHHHhCCCCCceecCCCCCCeeeCCCC--ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC--CCCCCcc
Q 007088 418 LAWLHHNCNPRIIHRNISSKCILLDGDF--EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT--LVATPKG 493 (618)
Q Consensus 418 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~s 493 (618)
|+|||+. +|+||||||+||+++.++ .+||+|||+++.................||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 89999999998654322222222234458999999998865 6789999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCC
Q 007088 494 DVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKER 573 (618)
Q Consensus 494 DVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 573 (618)
||||||+++|||++|+.||...... +............ ...........+.+++.+||+.||.+|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999999754321 1111111111000 000011123456778889999999999
Q ss_pred CCHHHHHH
Q 007088 574 HTMFEVYQ 581 (618)
Q Consensus 574 Ps~~evl~ 581 (618)
|++.|+++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=368.51 Aligned_cols=258 Identities=19% Similarity=0.219 Sum_probs=204.0
Q ss_pred HHHHHHhhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEe
Q 007088 298 LSDLMKATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372 (618)
Q Consensus 298 ~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 372 (618)
+.++....++|++.++||+|+||.||+|+.. +++.||+|++++.. ...+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455567789999999999999999999964 68999999996522 233457899999999999999999999999
Q ss_pred CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 373 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
.+..|+||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999998643 389999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV----ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
|+++........ .....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.. ..
T Consensus 213 G~a~~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~ 281 (410)
T 3v8s_A 213 GTCMKMNKEGMV---RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GT 281 (410)
T ss_dssp TTCEECCTTSEE---ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HH
T ss_pred ceeEeeccCCcc---cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hH
Confidence 999876543321 122345999999999987655 789999999999999999999999754321 11
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKE--RHTMFEVYQ 581 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 581 (618)
......... .+...........+.+++.+||..+|.+ ||+++||++
T Consensus 282 ~~~i~~~~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 282 YSKIMNHKN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHTHHH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHhccc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111110000 0000000112235566677999999988 999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=352.70 Aligned_cols=247 Identities=21% Similarity=0.225 Sum_probs=191.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
.++|++.+.||+|+||.||+++. .+++.||+|+++... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36799999999999999999996 578999999997642 234557889999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 999999999999999986543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
+........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 169 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~ 236 (327)
T 3a62_A 169 KESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKC 236 (327)
T ss_dssp --------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHT
T ss_pred cccccCCcc----ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhC
Confidence 764332211 1234589999999999999999999999999999999999999975332 1111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
. ..+ +......+.+++.+||+.||++|| ++.|+++
T Consensus 237 ~-------~~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 K-------LNL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp C-------CCC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred C-------CCC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0 000 111234566777799999999999 6777754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.08 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=206.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeC--Cee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK--KER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 376 (618)
++|++.+.||+|+||.||+|++ .+++.||+|+++... ...+.+.+|++++++++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 468999999997532 4557899999999999999999999999876 568
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999995443 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC-------CCccccCHHHHH
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA-------PESFKGSLVEWI 529 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~-------~~~~~~~l~~~~ 529 (618)
......... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+..... ............
T Consensus 175 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 175 AIETDKEYY-TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp ECCTTCCEE-ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred cccCCCcce-eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 775543221 122234578889999999888899999999999999999999998643110 000000111111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
...... ............+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 254 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 NTLKEG----------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcc----------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111 111112223456778888999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=378.16 Aligned_cols=262 Identities=19% Similarity=0.312 Sum_probs=205.5
Q ss_pred CCCCc-EEeecCCeeEEEEEeC---CCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 308 FSKNN-IIGTGRTGATYIAMLP---GGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 308 y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
+.+.+ .||+|+||.||+|... ++..||||+++.. ....+++.+|++++++++||||+++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 33334 7999999999999853 5678999999764 3456789999999999999999999999976 56899999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 416 ~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 416 MAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp CCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 999999999997543 4599999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .+.. .......
T Consensus 490 ~~~~~~-~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~~~~---~i~~~~~--- 557 (613)
T 2ozo_A 490 DSYYTA-RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-----EVMA---FIEQGKR--- 557 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-----HHHH---HHHTTCC---
T ss_pred Cceeee-ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHH---HHHcCCC---
Confidence 221111 112235688999999988899999999999999999998 99999764331 1111 1111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCC
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTD 595 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~ 595 (618)
...+......+.+++.+||+.||++||++.++++.|+.+........+
T Consensus 558 -------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~ 605 (613)
T 2ozo_A 558 -------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 605 (613)
T ss_dssp -------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred -------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence 111222345677888899999999999999999999998877654443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.18 Aligned_cols=270 Identities=21% Similarity=0.302 Sum_probs=208.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVA--KKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 377 (618)
++|++.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999983 468999999997653 344668999999999999999999999874 45688
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999997543 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC-------ccccCHHHHHH
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE-------SFKGSLVEWIT 530 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~-------~~~~~l~~~~~ 530 (618)
........ .......+|..|+|||++.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 177 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYY-VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEE-ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred cccCCccc-eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 65433221 11223447888999999988889999999999999999999999986422100 00000011111
Q ss_pred HHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 007088 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHF 592 (618)
Q Consensus 531 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~ 592 (618)
.+...............+.+++.+||+.||++|||++|+++.|+.+......
T Consensus 256 ----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 256 ----------LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp ----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred ----------HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 1111111112223345677888899999999999999999999998765543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=355.63 Aligned_cols=247 Identities=18% Similarity=0.229 Sum_probs=200.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC----ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS----QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 378 (618)
.++|+..+.||+|+||.||+|+.. +++.||+|+++.. ....+.+..|..++..+ +||||+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999965 4889999999753 24456788999999988 89999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999987543 489999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+..........
T Consensus 172 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~- 238 (353)
T 2i0e_A 172 IWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNV- 238 (353)
T ss_dssp CCTTCC----BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-
T ss_pred ccCCcc----cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCC-
Confidence 332221 2234589999999999999999999999999999999999999975332 111111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
. .+......+.+++.+||+.||.+||+ ++|+++
T Consensus 239 ------~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ------A----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ------C----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ------C----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 01112345667777999999999996 456543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.40 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=179.6
Q ss_pred CcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 311 NNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
.+.||+|+||.||+|.. .+++.||+|++... ....+.+|+.++++++ ||||+++++++.+.+..++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 47899999999999996 46899999999653 4567889999999997 99999999999999999999999999999
Q ss_pred ccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC---ceEEcccCcccccCCCCCcc
Q 007088 389 YDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF---EPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 389 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~a~~~~~~~~~~ 465 (618)
.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.........
T Consensus 94 ~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 94 FERIKKKK----HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99997643 499999999999999999999999 999999999999997665 89999999998765433221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+...........
T Consensus 167 ----~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~------- 234 (325)
T 3kn6_A 167 ----KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFS------- 234 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCC-------
T ss_pred ----cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCC-------
Confidence 223479999999999999999999999999999999999999976443211 11222222222111100
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 000000112356777888999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=355.33 Aligned_cols=244 Identities=18% Similarity=0.224 Sum_probs=201.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|+..+.||+|+||.||+++. .+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 35789999999999999999996 468999999996532 3456788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999997543 489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 193 ~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~-- 255 (350)
T 1rdq_E 193 GRT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKV-- 255 (350)
T ss_dssp SCB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC--
T ss_pred CCc-------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 321 123489999999999999999999999999999999999999975321 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
.+ +......+.+++.+||+.||.+||+ ++|+++
T Consensus 256 -----~~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -----RF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----CC----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----CC----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01 1112345667777999999999998 777754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=356.03 Aligned_cols=252 Identities=18% Similarity=0.244 Sum_probs=191.5
Q ss_pred ccCCCC-cEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHh-cCCCCCccceeEEEEe----CCeeEE
Q 007088 306 NSFSKN-NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLG-SVRHRNLVPLLGFCVA----KKERLL 378 (618)
Q Consensus 306 ~~y~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~l 378 (618)
++|.+. +.||+|+||.||++.. .+++.||||+++.. ..+.+|++++. ..+||||+++++++.. .+..|+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 456655 6899999999999995 46899999999643 35678888874 4589999999999876 567899
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEcccCcc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSDFGLA 455 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a 455 (618)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999976542 4599999999999999999999999 9999999999999997 789999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
+....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ......... .
T Consensus 212 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~i~~~--~ 283 (400)
T 1nxk_A 212 KETTSHNS-----LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKTRIRMG--Q 283 (400)
T ss_dssp EECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-SHHHHHHHT--C
T ss_pred cccCCCCc-----cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-HHHHHHHcC--c
Confidence 87543221 123348999999999999999999999999999999999999998654332211 121211110 0
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.. ............+.+++.+||+.||++|||+.|+++.
T Consensus 284 ~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 YE--------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC--------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc--------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000111223456777789999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=339.99 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=182.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46789999999999999999995 578999999996532 3346789999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999987543 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.... ... .
T Consensus 164 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------~~~----~ 227 (278)
T 3cok_A 164 MPHEKH----YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK--------VVL----A 227 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCS----S
T ss_pred CCCCcc----eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH--------Hhh----c
Confidence 322211 123489999999999998999999999999999999999999976443211100 000 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+... +......+.+++.+||+.||++|||++|+++
T Consensus 228 ---~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 ---DYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---CCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---ccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0001 1112345667788999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=368.92 Aligned_cols=262 Identities=18% Similarity=0.187 Sum_probs=205.7
Q ss_pred CHHHHHHhhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEE
Q 007088 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCV 371 (618)
Q Consensus 297 ~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 371 (618)
.+.++....++|++.++||+|+||.||+|+.. +++.||+|++++.. ...+.+.+|..++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34566667889999999999999999999965 57899999996522 22334889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcc
Q 007088 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 372 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
+.+..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999997643 3599999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~ 526 (618)
||+++......... ....+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+
T Consensus 219 FGla~~~~~~~~~~---~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------- 288 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQ---SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------- 288 (437)
T ss_dssp CTTCEECCTTSCEE---CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-------
T ss_pred hhhhhhcccCCCcc---cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH-------
Confidence 99998765433221 12345999999999886 5678999999999999999999999997643211
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKE--RHTMFEVYQ 581 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 581 (618)
......... .....+. ........+.+++.+||..+|++ ||+++|+++
T Consensus 289 -~~~~i~~~~--~~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 289 -TYGKIMNHK--ERFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp -HHHHHHTHH--HHCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred -HHHhhhhcc--ccccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 111111000 0000000 00112234566667999888888 999999865
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=351.54 Aligned_cols=273 Identities=23% Similarity=0.315 Sum_probs=213.9
Q ss_pred CHHHHHHhhccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCcccee
Q 007088 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLL 367 (618)
Q Consensus 297 ~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~ 367 (618)
...+.....++|.+.+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3444445568899999999999999999983 356899999997643 2345788999999999 799999999
Q ss_pred EEEEeCC-eeEEEEeecCCCccccccCCCCCC------------CcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 007088 368 GFCVAKK-ERLLVYSYLENGTLYDKLHPAEHE------------VMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNI 434 (618)
Q Consensus 368 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 434 (618)
+++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9988765 489999999999999999765431 12388999999999999999999999 9999999
Q ss_pred CCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCC
Q 007088 435 SSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTH 513 (618)
Q Consensus 435 kp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~ 513 (618)
||+||+++.++.+||+|||+++.......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVR--KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEE--ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceEEECCCCCEEECCCccccccccCcccee--ccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999987654322111 122336889999999988899999999999999999998 999997
Q ss_pred CCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 514 LTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 514 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
.....+ .+.. ....... ..........+.+++.+||+.||.+|||+.|+++.|+++.+...
T Consensus 253 ~~~~~~----~~~~---~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDE----EFCR---RLKEGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSH----HHHH---HHHHTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhH----HHHH---HhccCcc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 543211 1111 1111100 00111123457778889999999999999999999999987543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.07 Aligned_cols=265 Identities=21% Similarity=0.309 Sum_probs=187.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46799999999999999999995 568999999986532 344678899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCC--CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 382 YLENGTLYDKLHPAEH--EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|++ |+|.+++..... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 599888764321 124589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC-Cc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN-SS 537 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~-~~ 537 (618)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.......... ..
T Consensus 160 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 160 IPVNT----FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDIMGTPNES 231 (317)
T ss_dssp SCCCC----CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCTT
T ss_pred CCccc----CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChh
Confidence 32221 123348999999999876 468999999999999999999999997643211 111111110000 00
Q ss_pred cchh------ccccc------------cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETA------IDKSL------------LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~------~d~~l------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ..+.+ ...........+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000 00000 00000012245777888999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.29 Aligned_cols=261 Identities=24% Similarity=0.372 Sum_probs=202.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC-----CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG-----GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
++|+..+.||+|+||.||+|.... +..||+|+++... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456778999999999999998532 3469999997543 334568899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999987543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..........
T Consensus 198 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~ 268 (333)
T 1mqb_A 198 EDDPEATY-TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC
T ss_pred cccccccc-ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCCCc
Confidence 54322111 1112336788999999988899999999999999999999 9999965321 111111111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
..........+.+++.+||+.||++||++.|+++.|+++.+...
T Consensus 269 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 269 ----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 01111233467778889999999999999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=347.04 Aligned_cols=259 Identities=20% Similarity=0.302 Sum_probs=204.8
Q ss_pred hccCCCCc-EEeecCCeeEEEEEe---CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 305 TNSFSKNN-IIGTGRTGATYIAML---PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 305 ~~~y~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
.++|.+.+ .||+|+||.||+|.. .+++.||+|+++... ...+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 45677777 999999999999963 347899999997543 2356789999999999999999999999 566789
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhCc----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999997643 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+.........
T Consensus 167 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~ 237 (291)
T 1xbb_A 167 LRADENYYKA-QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGE 237 (291)
T ss_dssp CCTTCSEEEC-----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTC
T ss_pred eccCCCcccc-cccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC
Confidence 6543322111 122336788999999988888999999999999999999 9999975332 11111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
. ..........+.+++.+||+.||++||++.|+++.|+++....
T Consensus 238 ~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 238 R----------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp C----------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred C----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 0 0111223346777888999999999999999999999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=345.84 Aligned_cols=269 Identities=21% Similarity=0.342 Sum_probs=201.0
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEE
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCV 371 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 371 (618)
.++....++|.+.+.||+|+||.||+|... ++..||+|+++... ...+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 333445678999999999999999999843 35689999997543 23456889999999999999999999998
Q ss_pred eCCe-----eEEEEeecCCCccccccCCCC--CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC
Q 007088 372 AKKE-----RLLVYSYLENGTLYDKLHPAE--HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD 444 (618)
Q Consensus 372 ~~~~-----~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 444 (618)
+.+. .++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 7653 499999999999999884321 2235699999999999999999999999 99999999999999999
Q ss_pred CceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 007088 445 FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKG 523 (618)
Q Consensus 445 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~ 523 (618)
+.+||+|||+++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 256 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQ--GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----- 256 (313)
T ss_dssp SCEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----
T ss_pred CcEEEeecCcceecccccccCc--ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-----
Confidence 9999999999987644321111 112336789999999998899999999999999999999 88898754321
Q ss_pred CHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
...... ..... ..........+.+++.+||+.||.+|||+.++++.|+++.++.
T Consensus 257 ~~~~~~---~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 257 EMYDYL---LHGHR----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp GHHHHH---HTTCC----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHH---HcCCC----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111 11100 0111122346778888999999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=343.95 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=200.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CC-------cEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GG-------CFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
++|.+.+.||+|+||.||+|... ++ ..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 57888999999999999999843 23 579999996543 4567799999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc--------eE
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE--------PK 448 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~k 448 (618)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999997643 3489999999999999999999999 9999999999999998887 99
Q ss_pred EcccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH
Q 007088 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 449 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~ 527 (618)
|+|||++....... . ..+|+.|+|||++.+ ..++.++||||||+++|||++|..|+..... ...
T Consensus 162 l~Dfg~~~~~~~~~----~----~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~~~ 226 (289)
T 4fvq_A 162 LSDPGISITVLPKD----I----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------SQR 226 (289)
T ss_dssp ECCCCSCTTTSCHH----H----HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHH
T ss_pred eccCcccccccCcc----c----cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-------hHH
Confidence 99999997653321 1 126889999999877 6789999999999999999996655543221 111
Q ss_pred HHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 528 WITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 528 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
............. .....+.+++.+||+.||++|||++|+++.|+++....
T Consensus 227 ~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 227 KLQFYEDRHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HHHHHHTTCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred HHHHhhccCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1111111111110 11234667888999999999999999999999986543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=343.96 Aligned_cols=253 Identities=24% Similarity=0.382 Sum_probs=199.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeC-CeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-KERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 383 (618)
.++|++.+.||+|+||.||++.. +|+.||+|+++... ..+.+.+|++++++++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 46788999999999999999987 48899999997653 456789999999999999999999997654 4789999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 98 AKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp TTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence 99999999865432 3488999999999999999999999 999999999999999999999999999976543211
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .... .....
T Consensus 173 -------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~---~~~~~------- 230 (278)
T 1byg_A 173 -------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVP---RVEKG------- 230 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHH---HHTTT-------
T ss_pred -------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH---HHhcC-------
Confidence 1236789999999988889999999999999999998 99999754321 1111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
............+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 ---YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 00111122334677788899999999999999999999998754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.71 Aligned_cols=265 Identities=20% Similarity=0.268 Sum_probs=203.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLVPLLGFCVA----KKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 378 (618)
.++|++.+.||+|+||.||++.. .+++.||+|++... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999995 67899999988653 3445678999999999999999999999873 347789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999876433335699999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCccc-----ccccCCCCcccccCCCCCCCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHH
Q 007088 459 NPVDTHLS-----TFVNGEFGDLGYVAPEYPRTLV---ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT 530 (618)
Q Consensus 459 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~---~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~ 530 (618)
........ .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALAVQ 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHHHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHHhh
Confidence 42111100 0011123689999999987554 689999999999999999999998531110 001111110
Q ss_pred HHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 531 LLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 531 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
. .............+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus 262 ~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 N-------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C-------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred c-------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 00001111223467778889999999999999999999998854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=358.88 Aligned_cols=247 Identities=22% Similarity=0.310 Sum_probs=194.2
Q ss_pred CCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCCC
Q 007088 309 SKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENG 386 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 386 (618)
...+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999995 568999999997643 44567899999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee--CCCCceEEcccCcccccCCCCCc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL--DGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++........
T Consensus 172 ~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245 (373)
T ss_dssp EEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence 9999886543 3589999999999999999999999 99999999999999 67789999999999876543221
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........... . ..
T Consensus 246 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~--~-~~ 309 (373)
T 2x4f_A 246 -----KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRWD--L-ED 309 (373)
T ss_dssp -----CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCC--S-CS
T ss_pred -----ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCC--C-Ch
Confidence 223489999999999988999999999999999999999999975432 1111111111100 0 00
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ........+.+++.+||+.||.+|||+.|+++
T Consensus 310 ~----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 310 E----EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp G----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 01112345677777999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=343.20 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=202.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCC----CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.++|...+.||+|+||.||+|...+ +..||+|.++... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999998532 3469999997642 345678999999999999999999999865 45789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999996543 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........ ...
T Consensus 164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~~~~~~~---~~~ 232 (281)
T 3cc6_A 164 EDEDYYK---ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DVIGVLEK---GDR 232 (281)
T ss_dssp ------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GHHHHHHH---TCC
T ss_pred ccccccc---cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HHHHHHhc---CCC
Confidence 5432211 112336789999999988889999999999999999998 99999754321 12221111 100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
. .........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 233 ~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 233 L----------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 0 00111234577788899999999999999999999998653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=337.11 Aligned_cols=246 Identities=23% Similarity=0.332 Sum_probs=199.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46799999999999999999985 457899999986432 3456789999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999986543 489999999999999999999999 99999999999999999999999999986544
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...........
T Consensus 161 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~--- 223 (279)
T 3fdn_A 161 SSRR------TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVE--- 223 (279)
T ss_dssp -------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTC---
T ss_pred cccc------cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH--------HHHHHHHHhCC---
Confidence 3221 123489999999999999999999999999999999999999975321 11111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
. ..+......+.+++.+||+.||++|||++|+++.
T Consensus 224 ----~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 ----F----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----C----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----C----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0111123456677779999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=360.26 Aligned_cols=248 Identities=23% Similarity=0.273 Sum_probs=190.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHH-HhcCCCCCccceeEEEEeCCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINT-LGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.++|++.+.||+|+||.||+|+.. +++.||+|++++.. .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999964 58899999997643 233456677776 567899999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 999999999999987543 489999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+..........
T Consensus 190 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~- 256 (373)
T 2r5t_A 190 IEHNST----TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPL- 256 (373)
T ss_dssp BCCCCC----CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSCC-
T ss_pred ccCCCc----cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhccc-
Confidence 322211 1234589999999999999999999999999999999999999975322 111111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+. ... ...+.+++.+||+.||.+||++.+.++.
T Consensus 257 ------~~~-~~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 257 ------QLK-PNI---TNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp ------CCC-SSS---CHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred ------CCC-CCC---CHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 001 112 2356667779999999999998644433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=347.37 Aligned_cols=263 Identities=22% Similarity=0.261 Sum_probs=197.3
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc------cCHHHHHHHHHHHhcCC---CCCccceeEEEEeC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ------HSEKEFLSEINTLGSVR---HRNLVPLLGFCVAK 373 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 373 (618)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999994 678999999986322 22356778888777764 99999999999876
Q ss_pred C-----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceE
Q 007088 374 K-----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448 (618)
Q Consensus 374 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 448 (618)
. ..++||||+. |+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 4789999997 599999876543 3489999999999999999999999 999999999999999999999
Q ss_pred EcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 449 l~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
|+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+...
T Consensus 161 l~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i 231 (308)
T 3g33_A 161 LADFGLARIYSYQMAL-----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKI 231 (308)
T ss_dssp ECSCSCTTTSTTCCCS-----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHH
T ss_pred EeeCccccccCCCccc-----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence 9999999876543222 12348999999999988999999999999999999999999997643211 11111
Q ss_pred HHHHhcC---Cccchh--ccccccCC--C-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 529 ITLLNTN---SSLETA--IDKSLLGN--G-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 529 ~~~~~~~---~~~~~~--~d~~l~~~--~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....... .+.... ........ . ..+....+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111100 000000 00000000 0 0112346677888999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=338.47 Aligned_cols=251 Identities=21% Similarity=0.268 Sum_probs=196.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|.+.+.||+|+||.||++.. .++..||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5788899999999999999995 568999999986543 4567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---CCCCceEEcccCcccccC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~ 459 (618)
+++|+|.+++.........+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998865432235699999999999999999999999 99999999999999 456789999999998665
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..... ....||+.|+|||.+. ..++.++||||||+++|||++|+.||..... ..............
T Consensus 179 ~~~~~-----~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 179 SDEHS-----TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--------EEVQQKATYKEPNY 244 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC
T ss_pred CcccC-----cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--------HHHHhhhccCCccc
Confidence 43221 2234899999999875 4688999999999999999999999975321 11111111111000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ..... ....+.+++.+||+.||++|||+.|+++
T Consensus 245 ~-----~~~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 A-----VECRP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp C-----C--CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c-----cccCc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00001 2245667788999999999999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=343.82 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=196.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccC---HHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHS---EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|+||.||+|... +|+.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999964 5899999998654432 4567899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 999999998876543 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc-------CHHHHHHHHh
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-------SLVEWITLLN 533 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~-------~l~~~~~~~~ 533 (618)
.... ....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ....+.....
T Consensus 156 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SDYY----DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp --------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccc----CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 2221 22348999999998865 6789999999999999999999999976432111000 0000000111
Q ss_pred cCCccchhccccccCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNG-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..........+...... .......+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000000000000 0122345778888999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.47 Aligned_cols=261 Identities=22% Similarity=0.298 Sum_probs=195.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe----
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE---- 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 375 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45789999999999999999995 678999999997643 223568899999999999999999999877653
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 399999999999999987543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
+......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 164 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~ 234 (311)
T 3ork_A 164 RAIADSGNSV-TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRE 234 (311)
T ss_dssp -------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHC
T ss_pred cccccccccc-ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcC
Confidence 8765432211 112234489999999999998999999999999999999999999975332 1111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHHHhhh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVY-QLLRAIAE 588 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~i~~ 588 (618)
.... +..... .....+.+++.+||+.||++||++.+++ ..+..+..
T Consensus 235 ~~~~----~~~~~~---~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 235 DPIP----PSARHE---GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp CCCC----HHHHST---TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred CCCC----cccccC---CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 1100 000001 1234567778899999999999665554 55555533
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.40 Aligned_cols=245 Identities=20% Similarity=0.342 Sum_probs=201.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999964 79999999996532 34567899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999997643 499999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
... ....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... ...........
T Consensus 169 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~--- 232 (476)
T 2y94_A 169 GEF-----LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDGI--- 232 (476)
T ss_dssp TCC-----BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTTC---
T ss_pred ccc-----ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCC---
Confidence 321 223458999999999988765 6899999999999999999999975432 11111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ..+......+.+++.+||+.||.+|||++|+++
T Consensus 233 ------~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 ------F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ------C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ------c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 0 001111235667777999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.78 Aligned_cols=252 Identities=24% Similarity=0.357 Sum_probs=202.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467999999999999999999964 78999999986432 345678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999997543 489999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....... .....|.. .....
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~---~~~~~-- 228 (276)
T 2yex_A 159 NRE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKE---KKTYL-- 228 (276)
T ss_dssp TEE--CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHHHT---TCTTS--
T ss_pred cch--hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHhhh---ccccc--
Confidence 211 11223458999999999887665 779999999999999999999997644321 11112211 00000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.........+.+++.+||+.||++|||++|+++
T Consensus 229 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 --------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001122345667888999999999999999865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.40 Aligned_cols=243 Identities=21% Similarity=0.245 Sum_probs=190.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccC---HHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHS---EKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|+..++||+|+||+||+|... +++.||||++...... ...+..|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 7999999998654322 33445566555555 8999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 669988886543 3599999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.... ....||+.|+|||++.+ .++.++|||||||++|||++|..|+.... .|... . .....
T Consensus 210 ~~~~-----~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~-~-~~~~~- 270 (311)
T 3p1a_A 210 AGAG-----EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQL-R-QGYLP- 270 (311)
T ss_dssp ----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHH-T-TTCCC-
T ss_pred CCCC-----cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHH-h-ccCCC-
Confidence 3221 12348999999998876 78999999999999999999987765311 11111 1 11100
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+.+. ......+.+++.+||+.||++|||++|+++
T Consensus 271 ---~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 ---PEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0111 112346777888999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.75 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=194.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCC--CCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRH--RNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++.+++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 356889999999999999999988899999999975432 34668899999999976 9999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|| +.+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 45789999997643 489999999999999999999999 999999999999997 5789999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRT-----------LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 159 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~ 230 (343)
T 3dbq_A 159 PDTTSV--VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKL 230 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHH
T ss_pred cccccc--cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHHH
Confidence 432211 1123458999999998754 6788999999999999999999999975321 11111
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
. ... ++.............+.+++.+||+.||.+|||+.|+++.
T Consensus 231 ~-~~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 231 H-AII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp H-HHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H-HHh---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 111 1111111111122456778889999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=340.96 Aligned_cols=250 Identities=20% Similarity=0.271 Sum_probs=201.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999995 4689999999965432 3456889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc---eEEcccCcccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE---PKLSDFGLARL 457 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~ 457 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||.+..
T Consensus 85 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999988886543 489999999999999999999999 9999999999999986655 99999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............
T Consensus 158 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~ 224 (284)
T 3kk8_A 158 VNDSEAW-----HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAY 224 (284)
T ss_dssp CCSSCBC-----CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC
T ss_pred cccCccc-----cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHHhccc
Confidence 6543221 223489999999999999999999999999999999999999975322 111111111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ............+.+++.+||+.||++|||+.|+++
T Consensus 225 ~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 D-------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp C-------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c-------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 000011122345677778999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.48 Aligned_cols=260 Identities=20% Similarity=0.234 Sum_probs=198.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc----CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH----SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999996 4789999999975432 236788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999987543 489999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 186 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~ 254 (309)
T 2h34_A 186 DEKLT---QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQAIPRP 254 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSCCCCG
T ss_pred ccccc---cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccCCCCc
Confidence 43211 11233489999999999999999999999999999999999999975321 11111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhhhhc
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-TMFEVYQLLRAIAERY 590 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 590 (618)
... .......+.+++.+||+.||++|| +++++++.|+++.+..
T Consensus 255 ~~~--------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 255 STV--------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp GGT--------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccc--------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 000 111223566777799999999999 9999999999876544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=362.18 Aligned_cols=247 Identities=20% Similarity=0.234 Sum_probs=192.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++.. ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999995 56899999999753 23345678899999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999986543 48999999999999999999998 8 9999999999999999999999999999864
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............
T Consensus 300 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~- 366 (446)
T 4ejn_A 300 IKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEI- 366 (446)
T ss_dssp CC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-
T ss_pred cCCCcc----cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCC-
Confidence 332221 2234589999999999999999999999999999999999999975332 111111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
. .+......+.+++.+||+.||.+|| +++|+++
T Consensus 367 ------~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ------R----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ------C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ------C----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 0111224566777799999999999 9999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=355.16 Aligned_cols=264 Identities=22% Similarity=0.309 Sum_probs=209.0
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeCC------CcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
..++|...+.||+|+||.||+|.... ...||+|.+.... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999999532 2489999997643 3356789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCC----------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH----------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD 444 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 444 (618)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 99999999999999999864321 123589999999999999999999999 99999999999999999
Q ss_pred CceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcccc
Q 007088 445 FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKG 523 (618)
Q Consensus 445 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~ 523 (618)
+.+||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 274 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYI--VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---- 274 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSE--ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH----
T ss_pred CeEEECcccccccccccccee--ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH----
Confidence 999999999998654322211 1122336789999999988889999999999999999999 999997543211
Q ss_pred CHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.......... ...........+.+++.+||+.||.+|||+.|+++.|+++.++
T Consensus 275 ~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 KFYKLVKDGY-------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHHTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCC-------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111111100 0001111234677788899999999999999999999998765
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=340.43 Aligned_cols=250 Identities=21% Similarity=0.275 Sum_probs=202.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|++.+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457899999999999999999964 68999999996532 2467899999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC----ceEEccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF----EPKLSDF 452 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 452 (618)
++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999997543 489999999999999999999999 999999999999999888 7999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
|++......... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.....
T Consensus 164 g~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i 230 (321)
T 2a2a_A 164 GLAHEIEDGVEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANI 230 (321)
T ss_dssp TTCEECCTTCCC-----CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHH
T ss_pred ccceecCccccc-----cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHH
Confidence 999876543221 233489999999999999999999999999999999999999975321 1111111
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... ..++... ......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~---~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 231 TSVSY---DFDEEFF----SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HTTCC---CCCHHHH----TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred Hhccc---ccChhhh----cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11100 0000000 012245677788999999999999999976
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.19 Aligned_cols=242 Identities=22% Similarity=0.298 Sum_probs=199.4
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---------CHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---------SEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 373 (618)
..++|++.+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 456899999999999999999994 6789999999975431 233577899999999999999999999999
Q ss_pred CeeEEEEeecCCC-ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 374 KERLLVYSYLENG-TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 374 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
+..++||||+.+| +|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 9999987654 499999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|+++......... ...||+.|+|||++.+..+ +.++|||||||++|||++|+.||......
T Consensus 175 g~a~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------- 236 (335)
T 3dls_A 175 GSAAYLERGKLFY-----TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------- 236 (335)
T ss_dssp TTCEECCTTCCBC-----EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------
T ss_pred ccceECCCCCcee-----ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------
Confidence 9998765433221 2348999999999888776 78999999999999999999999642110
Q ss_pred HhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 532 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
....... .......+.+++.+||+.||++|||++|+++.
T Consensus 237 ----------~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----------VEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------HhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 01122356777779999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=366.27 Aligned_cols=250 Identities=21% Similarity=0.258 Sum_probs=203.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|...+.||+|+||.||+|+. .+|+.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 46788999999999999999996 469999999996532 3456788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999876544345699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ...+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..............
T Consensus 341 ~~~~~~----~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~----~~~~~~~~i~~~~~-- 410 (543)
T 3c4z_A 341 AGQTKT----KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRVLEQAV-- 410 (543)
T ss_dssp TTCCCB----CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----CHHHHHHHHHHCCC--
T ss_pred CCCccc----ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch----hHHHHHHHHhhccc--
Confidence 433221 22359999999999999999999999999999999999999998653221 11222221111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
..+......+.+++.+||+.||++||++
T Consensus 411 ---------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 ---------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0111223456667779999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=346.69 Aligned_cols=262 Identities=19% Similarity=0.236 Sum_probs=205.5
Q ss_pred ccCHHHHHHhhccCCCC-cEEeecCCeeEEEEEeC-CCcEEEEEEeccC---ccCHHHHHHHHHHHhcC-CCCCccceeE
Q 007088 295 KMRLSDLMKATNSFSKN-NIIGTGRTGATYIAMLP-GGCFIMIKRLEDS---QHSEKEFLSEINTLGSV-RHRNLVPLLG 368 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~ 368 (618)
...+.......++|.+. +.||+|+||.||+|... +++.||+|+++.. ......+.+|+.++.++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34445555666778877 88999999999999954 6899999999753 24467899999999999 4699999999
Q ss_pred EEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CC
Q 007088 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DF 445 (618)
Q Consensus 369 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 445 (618)
++.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 99999999999999999999999865433 4599999999999999999999999 9999999999999987 78
Q ss_pred ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH
Q 007088 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l 525 (618)
.+||+|||+++........ ....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 172 ~~kL~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------- 239 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACEL-----REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------- 239 (327)
T ss_dssp CEEECCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred cEEEeeCccccccCCcccc-----ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------
Confidence 9999999999876543221 2234899999999999999999999999999999999999999753321
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+......... ..............+.+++.+||+.||++|||++|+++
T Consensus 240 -~~~~~i~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 240 -ETYLNISQVN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -HHHHHHHHTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -HHHHHHHhcc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1111111100 00011111223345777888999999999999999865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=350.05 Aligned_cols=268 Identities=16% Similarity=0.185 Sum_probs=198.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCcc------------CHHHHHHHHHHHhcCCCCCccceeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQH------------SEKEFLSEINTLGSVRHRNLVPLLG 368 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~~ 368 (618)
.++|.+.+.||+|+||.||+|... ++..||+|++..... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999965 578999999865431 1234667888999999999999999
Q ss_pred EEEe----CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC
Q 007088 369 FCVA----KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD 444 (618)
Q Consensus 369 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 444 (618)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9988 67889999999 999999997654 599999999999999999999999 99999999999999887
Q ss_pred C--ceEEcccCcccccCCCCCc---ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCC
Q 007088 445 F--EPKLSDFGLARLMNPVDTH---LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519 (618)
Q Consensus 445 ~--~~kl~DfG~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~ 519 (618)
+ .+||+|||+++........ .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432211 1111233458999999999999899999999999999999999999996422111
Q ss_pred ccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 520 SFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 520 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
. ............ ....+....... .....+.+++.+||+.||++||++++|++.|+++..
T Consensus 268 ~---~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 V---AVQTAKTNLLDE--LPQSVLKWAPSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp H---HHHHHHHHHHHT--TTHHHHHHSCTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred H---HHHHHHHhhccc--ccHHHHhhcccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0 111111111100 011111111100 123467777779999999999999999999988643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.71 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=203.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEe----------
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA---------- 372 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 372 (618)
..++|+..+.||+|+||.||+|... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 3457899999999999999999965 78999999997643 356789999999999999999999864
Q ss_pred ------CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc
Q 007088 373 ------KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446 (618)
Q Consensus 373 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 446 (618)
....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 3457899999999999999965432 4589999999999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH
Q 007088 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 447 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~ 526 (618)
+||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+... .
T Consensus 161 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~ 225 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------S 225 (284)
T ss_dssp EEECCCTTCEESSCCSCC-----CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------H
T ss_pred EEECcchhheeccccccc-----cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------H
Confidence 999999999876543221 1234899999999998889999999999999999999999886421 1
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
....... ... + .... ...+.+++.+||+.||.+|||+.|+++.|+.+.+...
T Consensus 226 ~~~~~~~-~~~--------~-~~~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 226 KFFTDLR-DGI--------I-SDIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHH-TTC--------C-CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHHhh-ccc--------c-cccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111111 111 1 1112 2346677779999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=350.04 Aligned_cols=257 Identities=13% Similarity=0.107 Sum_probs=205.5
Q ss_pred hhccCCCCcEEeecCCeeEEEEE------eCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC---CCCccceeEEEEeCC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM------LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR---HRNLVPLLGFCVAKK 374 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 374 (618)
..++|.+.++||+|+||.||+|. ..+++.||+|+++.. ...++..|++++.+++ |+||+++++++...+
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 35679999999999999999994 456899999999764 4567888888888886 999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCC-CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC----------
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH-EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---------- 443 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---------- 443 (618)
..++||||+++|+|.+++..... ....+++..++.|+.||+.||+|||++ +|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999964221 124599999999999999999999999 9999999999999998
Q ss_pred -CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 007088 444 -DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522 (618)
Q Consensus 444 -~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~ 522 (618)
++.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999976542211 112234569999999999999999999999999999999999999986432210
Q ss_pred cCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHHhhhhc
Q 007088 523 GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKER-HTMFEVYQLLRAIAERY 590 (618)
Q Consensus 523 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~~~~ 590 (618)
..+...+......+ .+.+++..|++.+|.+| |+++++.+.|+++.++.
T Consensus 293 -----------------~~~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -----------------CKPEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----------------EEECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------------eeechhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00111111111233 44556669999999999 68999999999887764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=361.53 Aligned_cols=262 Identities=19% Similarity=0.182 Sum_probs=204.2
Q ss_pred cCHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEE
Q 007088 296 MRLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFC 370 (618)
Q Consensus 296 ~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~ 370 (618)
+++.+.....++|++.+.||+|+||.||+++. .+|+.||+|++++.. ...+.+.+|..++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 34556666788999999999999999999996 478999999996532 2233478999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEc
Q 007088 371 VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450 (618)
Q Consensus 371 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 450 (618)
.+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997543 3589999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCC-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-------TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~ 523 (618)
|||+++......... ....+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..
T Consensus 205 DFGla~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----- 276 (412)
T 2vd5_A 205 DFGSCLKLRADGTVR---SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA----- 276 (412)
T ss_dssp CCTTCEECCTTSCEE---CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred echhheeccCCCccc---cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----
Confidence 999998765433211 12345999999999886 457899999999999999999999999764321
Q ss_pred CHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHH
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKER---HTMFEVYQ 581 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 581 (618)
+......... .....+.. .... ...+.+++.+||. +|.+| |+++|+++
T Consensus 277 ---~~~~~i~~~~--~~~~~p~~-~~~~---s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 277 ---ETYGKIVHYK--EHLSLPLV-DEGV---PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---HHHHHHHTHH--HHCCCC-----CC---CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---HHHHHHHhcc--cCcCCCcc-ccCC---CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111111000 00000000 0112 2356667779999 99998 58888854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=347.07 Aligned_cols=270 Identities=22% Similarity=0.323 Sum_probs=208.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-----CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC--ee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-----PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK--ER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 376 (618)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688899999999999999983 468999999997643 34567899999999999999999999987654 67
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 99999999999999997653 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCC-------CccccCHHHHH
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAP-------ESFKGSLVEWI 529 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~-------~~~~~~l~~~~ 529 (618)
......... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...........
T Consensus 194 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYY-KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp ECCSSCSEE-ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred hcccccccc-ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 765433211 1112234678899999998888999999999999999999999987632100 00000000000
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
.. .+...............+.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus 273 ~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 273 IE---------LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HH---------HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HH---------HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 00 11110011112223456777888999999999999999999999998753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=356.59 Aligned_cols=250 Identities=20% Similarity=0.263 Sum_probs=194.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCC--CCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVR--HRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||++...+++.||||++.... ...+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4699999999999999999998889999999996543 33467899999999996 599999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
| +.+++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++....
T Consensus 136 E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 56789999987643 489999999999999999999999 999999999999996 57899999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT-----------LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .....
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~ 277 (390)
T 2zmd_A 207 DTTSV--VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKL 277 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHH
T ss_pred CCccc--cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHH
Confidence 32211 1223458999999998754 4688999999999999999999999975321 11111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
..... ..............+.+++.+||+.||++|||+.|+++.
T Consensus 278 ~~~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 278 HAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhC---------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111 111111111113456778889999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.28 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=197.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.+.|+..+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688899999999999999995 678999999996543 2235688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 58888775432 3589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCcccccccCCCCcccccCCCCC---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYP---RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
... ...||+.|+|||++ .+..++.++|||||||++|||++|+.||..... ...........
T Consensus 206 ~~~--------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~~~~ 269 (348)
T 1u5q_A 206 PAN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE 269 (348)
T ss_dssp SBC--------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC
T ss_pred CCC--------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcC
Confidence 321 23489999999987 356789999999999999999999999975321 11111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+....... ...+.+++.+||+.||++|||++|+++.
T Consensus 270 ------~~~~~~~~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 ------SPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ------CCCCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ------CCCCCCCCC---CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111111122 2346677779999999999999999763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=331.56 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=200.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|... ++..||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467999999999999999999964 5789999998654 34567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---CCCCceEEcccCcccccC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~ 459 (618)
+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999886543 489999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC-cc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS-SL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~-~~ 538 (618)
..... ....||+.|+|||.+.+. ++.++||||||+++|||++|+.||..... .+......... ..
T Consensus 161 ~~~~~-----~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 226 (277)
T 3f3z_A 161 PGKMM-----RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREGTFTF 226 (277)
T ss_dssp TTSCB-----CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCC
T ss_pred Cccch-----hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCC
Confidence 43321 223489999999988664 89999999999999999999999975332 11111111110 00
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... .......+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~--------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKD--------WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHH--------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred Cchh--------hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0012346777888999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=366.80 Aligned_cols=252 Identities=25% Similarity=0.304 Sum_probs=204.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|+..+.||+|+||.||+|.. .+|+.||+|++... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46789999999999999999996 47899999999653 24456788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999876543 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .............
T Consensus 338 ~~~~-----~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~~--- 405 (576)
T 2acx_A 338 EGQT-----IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVP--- 405 (576)
T ss_dssp TTCC-----EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHCC---
T ss_pred cCcc-----ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhccc---
Confidence 4322 123459999999999999999999999999999999999999998643221 1111111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
.. ........+.+++.+||+.||.+|| +++|+++
T Consensus 406 ----~~----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 ----EE----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----cc----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00 1111224566777799999999999 7788764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=349.55 Aligned_cols=252 Identities=19% Similarity=0.258 Sum_probs=198.2
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEe
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 381 (618)
..++|++.+.||+|+||.||++.. .+++.||+|++...... ..+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356799999999999999999996 46899999999765432 34688888887 79999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC----CceEEcccCcccc
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD----FEPKLSDFGLARL 457 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~ 457 (618)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||+++.
T Consensus 97 ~~~gg~L~~~i~~~~----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILRQK----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHTCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999987553 489999999999999999999999 99999999999998433 3599999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..........
T Consensus 170 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 170 LRAENGL----LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKF 240 (342)
T ss_dssp CBCTTCC----BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCC
T ss_pred CcCCCCc----eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCc
Confidence 6543221 1234589999999999888889999999999999999999999975322 122222222211110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+....+......+.+++.+||+.||++||++.|+++
T Consensus 241 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 -------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111111223345667777999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.25 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=191.0
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---------cCHHHHHHHHHHHhcCCCCCccceeEEEEeC
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK 373 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 373 (618)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|++++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 467899999999999999999995 568999999986532 11224789999999999999999999975 4
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC---ceEEc
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF---EPKLS 450 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 450 (618)
+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 56799999999999999987654 499999999999999999999999 999999999999997544 59999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT---LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~ 527 (618)
|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..
T Consensus 285 DFG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~ 355 (419)
T 3i6u_A 285 DFGHSKILGETSL-----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKD 355 (419)
T ss_dssp CSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHHH
T ss_pred ecccceecCCCcc-----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHHH
Confidence 9999987654221 123348999999999853 567889999999999999999999997543321 2222
Q ss_pred HHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 528 WITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 528 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...... ... .+.. .......+.+++.+||+.||++|||++|+++
T Consensus 356 ~i~~~~--~~~----~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGK--YNF----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTC--CCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCC--CCC----Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111100 000 0000 0112346777888999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=330.81 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=204.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|++.+.||+|+||.||++... +++.||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56889999999999999999965 68999999986532 24678999999999999999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC----ceEEcccC
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF----EPKLSDFG 453 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 453 (618)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999998653 3489999999999999999999999 999999999999998877 89999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
.+......... ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .+......
T Consensus 158 ~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~ 224 (283)
T 3bhy_A 158 IAHKIEAGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNIS 224 (283)
T ss_dssp TCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH
T ss_pred cceeccCCCcc-----cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhH
Confidence 99876543221 223489999999999989999999999999999999999999975321 11111111
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhhhh
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ--LLRAIAER 589 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~~~ 589 (618)
..... .+.... ......+.+++.+||+.||++|||+.|+++ .++++..+
T Consensus 225 ~~~~~---~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 225 AVNYD---FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp TTCCC---CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred hcccC---Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 11000 000000 112345677888999999999999999997 56666544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=356.16 Aligned_cols=258 Identities=21% Similarity=0.245 Sum_probs=193.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC------C
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------K 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 374 (618)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999984 56899999999753 23456788999999999999999999999655 3
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
+.|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999976 56666642 388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH--
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL-- 532 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~-- 532 (618)
++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+ .+.......
T Consensus 211 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~----~~~~i~~~lg~ 281 (464)
T 3ttj_A 211 ARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID----QWNKVIEQLGT 281 (464)
T ss_dssp C-----CCC-----C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCS
T ss_pred eeecCCCcc-----cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCC
Confidence 987654221 123458999999999999999999999999999999999999997643211 111111000
Q ss_pred ----------------hcC-Cc-----cchhccccccCCCC---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 ----------------NTN-SS-----LETAIDKSLLGNGF---DGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ----------------~~~-~~-----~~~~~d~~l~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .. ....+...+..... ......+.+++.+||+.||++|||++|+++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00 00000111100000 112456888999999999999999999976
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=346.33 Aligned_cols=262 Identities=19% Similarity=0.275 Sum_probs=195.1
Q ss_pred ccCCCC-cEEeecCCeeEEEEE-eCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKN-NIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~-~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 381 (618)
+.|.+. +.||+|+||.||+|. ..+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467764 789999999999999 4578999999996543 4567899999999885 79999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc---eEEcccCccccc
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE---PKLSDFGLARLM 458 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a~~~ 458 (618)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999997543 489999999999999999999999 9999999999999998776 999999999765
Q ss_pred CCCCCc---ccccccCCCCcccccCCCCCCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccC------
Q 007088 459 NPVDTH---LSTFVNGEFGDLGYVAPEYPRT-----LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGS------ 524 (618)
Q Consensus 459 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~------ 524 (618)
...... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 432111 0111123458999999998764 56889999999999999999999999865432211100
Q ss_pred -HHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 525 -LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 525 -l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
............. ...... .......+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~i~~~~~--~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKY--EFPDKD-----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCC--CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCc--ccCchh-----cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0011111111100 000000 0012345777888999999999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.16 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=200.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeeEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA--KKERLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 378 (618)
.++|++.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46789999999999999999996 478999999997543 334568899999999999999999998854 567899
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCCeeeCCCCceEEcccC
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR-----IIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
||||+++|+|.+++.........+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976443335599999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
.++.......... ...|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........
T Consensus 162 ~~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~ 229 (279)
T 2w5a_A 162 LARILNHDTSFAK----TFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIR 229 (279)
T ss_dssp HHHHC---CHHHH----HHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred hheeecccccccc----ccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHh
Confidence 9987654322111 12378999999999888899999999999999999999999975421 11111111
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
.. ... .+ .......+.+++.+||+.||++||++.|+++.+.
T Consensus 230 ~~-~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 230 EG-KFR-----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HT-CCC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred hc-ccc-----cC----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11 000 01 1122345677778999999999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=346.93 Aligned_cols=264 Identities=20% Similarity=0.234 Sum_probs=190.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCC-CCCccceeEEEEe--------C
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVR-HRNLVPLLGFCVA--------K 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--------~ 373 (618)
..+|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++.++. ||||+++++++.. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35788999999999999999995 578999999885543 34567889999999996 9999999999943 3
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeCCCCceEEcc
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
...++||||+. |+|.+++..... ...+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 35789999996 699888864221 13599999999999999999999998 8 99999999999999999999999
Q ss_pred cCcccccCCCCCccc--------ccccCCCCcccccCCCCC---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCc
Q 007088 452 FGLARLMNPVDTHLS--------TFVNGEFGDLGYVAPEYP---RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPES 520 (618)
Q Consensus 452 fG~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~ 520 (618)
||+++.......... .......||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 999987654322110 011123489999999988 567789999999999999999999999975332110
Q ss_pred cccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 007088 521 FKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTT 594 (618)
Q Consensus 521 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (618)
... .............+.+++.+||+.||.+|||+.|+++.|+.+.+......
T Consensus 262 --------~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 262 --------VNG-------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred --------hcC-------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 000 00000001112246677889999999999999999999999988765444
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=339.09 Aligned_cols=246 Identities=19% Similarity=0.328 Sum_probs=196.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC---ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS---QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 378 (618)
..++|++.+.||+|+||.||+|... +++.||+|+++.. .....++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999964 7899999999753 23456788999999999 99999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC--------------
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-------------- 444 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------- 444 (618)
||||+++|+|.+++.........+++..++.++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976433234589999999999999999999999 99999999999999844
Q ss_pred -----CceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 007088 445 -----FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAP 518 (618)
Q Consensus 445 -----~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~ 518 (618)
..+||+|||.+........ ..||+.|+|||.+.+. .++.++||||||+++|||++|.+|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~~--------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQV--------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSCC--------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred ccCCceEEEEcccccccccCCccc--------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 4799999999987654321 2389999999998765 56689999999999999999988764321
Q ss_pred CccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 519 ESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 519 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+..... ... +.+. ......+.+++.+||+.||++|||+.|+++
T Consensus 236 --------~~~~~~~--~~~-----~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 --------QWHEIRQ--GRL-----PRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --------HHHHHHT--TCC-----CCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHHHHc--CCC-----CCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111111 110 1111 112345677777999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.83 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=202.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
+.|+..+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 4688899999999999999985 56899999999654 34567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998643 489999999999999999999999 99999999999999999999999999998765432
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 174 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~------ 235 (303)
T 3a7i_A 174 IKR----NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKNN------ 235 (303)
T ss_dssp CCB----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC------
T ss_pred ccc----CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHhhcCC------
Confidence 211 223489999999999999999999999999999999999999975321 11111111110
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+.+. ......+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 PPTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCc----cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01111 1123456777789999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=374.91 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=198.9
Q ss_pred cEEeecCCeeEEEEEe---CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAML---PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
+.||+|+||.||+|.+ ..++.||||+++... ...+++.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 356899999997643 345789999999999999999999999964 568899999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..++.|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 454 g~L~~~l~~~~----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999996543 489999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
. ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+.........
T Consensus 527 ~-~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~~-------- 589 (635)
T 4fl3_A 527 K-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGE-------- 589 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTC--------
T ss_pred c-cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC--------
Confidence 1 1122336788999999998899999999999999999998 9999975432 11111111111
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
....+......+.+++.+||+.||++||++++|++.|+++..+
T Consensus 590 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 590 --RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1111222345677888899999999999999999999988654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=332.56 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=201.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57889999999999999999964 6789999998643 234567899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999987543 489999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
... ....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 167 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~---- 228 (284)
T 2vgo_A 167 LRR------RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVNVD---- 228 (284)
T ss_dssp SCB------CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTC----
T ss_pred ccc------ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhccc----
Confidence 221 123489999999999999999999999999999999999999975321 11111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+ .......+.+++.+||+.||.+||+++|+++
T Consensus 229 ---~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 ---LKF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ---CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 001 1112345667777999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=349.18 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=204.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|.+.+.||+|+||.||+|+. .++..||+|++... .....++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46799999999999999999983 34678999999653 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCCC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEc
Q 007088 377 LLVYSYLENGTLYDKLHPAEH---EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLS 450 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 450 (618)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976532 124589999999999999999999999 9999999999999984 4469999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
|||++........... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..
T Consensus 186 Dfg~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~ 255 (327)
T 2yfx_A 186 DFGMARDIYRASYYRK--GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL 255 (327)
T ss_dssp CCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred cccccccccccccccc--CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHH
Confidence 9999976533221111 112237889999999988889999999999999999998 9999875321 1111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
......... .........+.+++.+||+.||.+||++.|+++.|+.+....
T Consensus 256 ~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 256 EFVTSGGRM----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHHhcCCCC----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 111111110 011122346777888999999999999999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.85 Aligned_cols=263 Identities=18% Similarity=0.227 Sum_probs=192.7
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
...++|++.++||+|+||.||+|.. .+++.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999994 578999999997543 223567899999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee-----CCCCceEEcccC
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL-----DGDFEPKLSDFG 453 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfG 453 (618)
||||+++ +|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 111 v~e~~~~-~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCSE-EHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCCC-CHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999985 9999987554 489999999999999999999999 99999999999999 455569999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+++......... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.......
T Consensus 183 ~a~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~ 254 (329)
T 3gbz_A 183 LARAFGIPIRQF----THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI----DQLFKIFEVL 254 (329)
T ss_dssp HHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHH
T ss_pred CccccCCccccc----CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH----HHHHHHHHHh
Confidence 998765332221 223479999999998764 4899999999999999999999999754321 1111111111
Q ss_pred hcCC--ccchh--------ccccccCCCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNS--SLETA--------IDKSLLGNGFD-----GELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~--~~~~~--------~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ..... ..+........ .....+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 00000 00000000000 02246678888999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=349.04 Aligned_cols=264 Identities=20% Similarity=0.246 Sum_probs=195.3
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc------CHHHHHHHHHHHhcCCCCCccceeEEEEeCCe
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH------SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE 375 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 375 (618)
...++|++.+.||+|+||.||+|.. .+|+.||+|++..... ..+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 3457899999999999999999995 4689999999975321 12467899999999999999999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999986 8888887643 3588899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
+........ .....||+.|+|||++.+. .++.++|||||||++|||++|.+||...... ..+.........
T Consensus 160 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~----~~~~~i~~~~~~ 231 (346)
T 1ua2_A 160 KSFGSPNRA----YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL----DQLTRIFETLGT 231 (346)
T ss_dssp STTTSCCCC----CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCC
T ss_pred eeccCCccc----CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHcCC
Confidence 876543222 1233489999999988654 5889999999999999999999998754321 111111111110
Q ss_pred C--Cccc------hhccccccCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 N--SSLE------TAIDKSLLGNGF-----DGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~--~~~~------~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .... +.+...-..... ......+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0000 000000000000 122356778888999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.10 Aligned_cols=204 Identities=22% Similarity=0.331 Sum_probs=163.1
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCC--ee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKK--ER 376 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 376 (618)
..++|++.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999995 578999999986532 33456789999999997 999999999997654 68
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
|+||||++ |+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999997 5899888643 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc-----------------ccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 457 LMNPVDTH-----------------LSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 457 ~~~~~~~~-----------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
........ .........||+.|+|||++.+ ..++.++||||+||++|||++|++||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 65431110 0111233469999999998876 678999999999999999999999997643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.48 Aligned_cols=249 Identities=20% Similarity=0.301 Sum_probs=199.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|.+.+.||+|+||.||+++. .+|+.||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 45789999999999999999996 478999999997643 3445688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---CCCCceEEcccCcccccC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~ 459 (618)
+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999886543 489999999999999999999999 99999999999999 788999999999997654
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
..... ...||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ............
T Consensus 161 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~-- 224 (304)
T 2jam_A 161 NGIMS------TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGYY-- 224 (304)
T ss_dssp CBTTH------HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCCC--
T ss_pred CCccc------cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 32111 12378999999999999999999999999999999999999975321 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.............+.+++.+||+.||++|||+.|+++
T Consensus 225 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 -----EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -----CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -----CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000111122346777888999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=357.28 Aligned_cols=278 Identities=19% Similarity=0.201 Sum_probs=214.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCC-CCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH-RNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|.+.++||+|+||.||+|.. .+++.||||++..... ..++.+|+++++.++| +++..+..++...+..++||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46799999999999999999995 6789999998865432 2357899999999987 5566666667778888999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---CCCCceEEcccCcccccC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~ 459 (618)
+ +++|.+++.... ..+++..++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 ~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 889999997433 3599999999999999999999999 99999999999999 688999999999998765
Q ss_pred CCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 460 PVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 460 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
....... .......||..|+|||++.+..++.++|||||||++|||++|+.||......... ..+......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~-~ 235 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVA-T 235 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-HHHHHHHHHHHH-S
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-HHHHHHhhcccc-c
Confidence 4332211 1112345899999999999999999999999999999999999999865432111 111111111000 0
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCC
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLP 601 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 601 (618)
.... +.. ....++.+++.+||+.||++||++.+|++.|+++.++.....+..++|.
T Consensus 236 ~~~~-----l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 236 SIEA-----LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp CHHH-----HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred cHHH-----Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 0000 000 1134677888899999999999999999999999888777666555543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=346.18 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=197.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.++|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999964 589999999865432 2455789999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988765443 489999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH-------HHHHHHH
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL-------VEWITLL 532 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l-------~~~~~~~ 532 (618)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...... ..+....
T Consensus 177 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 177 PGEV----YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred Cccc----cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 3221 1223489999999988765 78999999999999999999999997643211100000 0000001
Q ss_pred hcCCccchhccccccCCCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGF-----DGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...........+.+..... ......+.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111111111111111 122456778888999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=335.52 Aligned_cols=248 Identities=21% Similarity=0.255 Sum_probs=202.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467888999999999999999964 57899999986542 3346688999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999886543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .+..........
T Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-- 232 (294)
T 2rku_A 167 YDGERK----KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNEY-- 232 (294)
T ss_dssp STTCCB----CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCC--
T ss_pred cCcccc----ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhhccC--
Confidence 332221 223489999999999998899999999999999999999999975321 111111111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+ .......+.+++.+||+.||++|||++|+++.
T Consensus 233 -----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -----SI----PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CC----ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 11122356677779999999999999999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=346.16 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=200.9
Q ss_pred ccCHHHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEe
Q 007088 295 KMRLSDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVA 372 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 372 (618)
.+++.++....++|++.+.||+|+||.||+|.. .+++.||+|++.......+.+.+|+.+++++ +||||+++++++..
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 344455556788999999999999999999996 5789999999987666677899999999998 79999999999987
Q ss_pred ------CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc
Q 007088 373 ------KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE 446 (618)
Q Consensus 373 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 446 (618)
.+..++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence 4578999999999999999875432 4689999999999999999999999 9999999999999999999
Q ss_pred eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007088 447 PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521 (618)
Q Consensus 447 ~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~ 521 (618)
+||+|||++.......... ....||+.|+|||++. +..++.++|||||||++|||++|+.||......
T Consensus 168 ~kl~Dfg~~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--- 240 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVGRR----NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--- 240 (326)
T ss_dssp EEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH---
T ss_pred EEEeeCcCceecCcCcccc----ccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---
Confidence 9999999998764322111 1234899999999886 567899999999999999999999999653211
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......... .+....... ...+.+++.+||+.||.+||++.|+++
T Consensus 241 -----~~~~~~~~~~------~~~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 241 -----RALFLIPRNP------APRLKSKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -----HHHHHHHHSC------CCCCSCSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HHHHHhhcCc------cccCCcccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111111110 011111112 245667777999999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=349.95 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=200.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
.++|++.+.||+|+||.||+++. .+++.||||+++... ...+.+.+|++++.++ +||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999996 478999999986532 3345677899999999 6999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 9999999999999999997543 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
++......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus 206 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~ 278 (355)
T 1vzo_A 206 SKEFVADETER---AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRI 278 (355)
T ss_dssp EEECCGGGGGG---GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHH
T ss_pred CeecccCCCCc---ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----hHHHHHHHH
Confidence 98764322211 122348999999999875 357899999999999999999999997544321 222222222
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQL 582 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 582 (618)
.... + .........+.+++.+||+.||.+|| +++|+++.
T Consensus 279 ~~~~-------~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 LKSE-------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHCC-------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred hccC-------C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 1111 0 01112234566777899999999999 89988764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=348.90 Aligned_cols=258 Identities=19% Similarity=0.257 Sum_probs=201.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccC------------------HHHHHHHHHHHhcCCCCCccce
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHS------------------EKEFLSEINTLGSVRHRNLVPL 366 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~E~~~l~~l~h~niv~l 366 (618)
.++|.+.+.||+|+||.||+|.. +++.||+|++...... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 9999999999643211 1789999999999999999999
Q ss_pred eEEEEeCCeeEEEEeecCCCccccc------cCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCe
Q 007088 367 LGFCVAKKERLLVYSYLENGTLYDK------LHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCI 439 (618)
Q Consensus 367 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NI 439 (618)
++++.+.+..++||||+++|+|.++ +.... ...+++..++.++.|++.||+|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY--TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS--CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc--ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 54422 2569999999999999999999999 8 999999999999
Q ss_pred eeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCC-ccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 440 LLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATP-KGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 440 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
+++.++.+||+|||.+...... ......||..|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred EEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999875432 11234489999999998877 5666 99999999999999999999976433
Q ss_pred CCccccCHHHHHHHHhcCCc-cch----hcccccc---CCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 518 PESFKGSLVEWITLLNTNSS-LET----AIDKSLL---GNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~~-~~~----~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .+.......... ... ...+... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 258 ~-------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 258 L-------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp S-------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 111111111100 000 0000000 0000123356777888999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.40 Aligned_cols=247 Identities=21% Similarity=0.261 Sum_probs=201.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|.+.+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467889999999999999999964 57899999986542 3356788999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK----ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999886543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+..........
T Consensus 193 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~-- 258 (335)
T 2owb_A 193 YDGERK----KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNEY-- 258 (335)
T ss_dssp STTCCB----CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCC--
T ss_pred cCcccc----cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhcCCC--
Confidence 332221 223489999999999888899999999999999999999999975321 111111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ .......+.+++.+||+.||++|||++|+++
T Consensus 259 -----~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -----SI----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -----CC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0112235667777999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.20 Aligned_cols=245 Identities=22% Similarity=0.309 Sum_probs=194.5
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeeEE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA----KKERLL 378 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 378 (618)
.|.+.+.||+|+||.||+|.. .++..||+|.+.... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 467778999999999999995 568899999987543 334568899999999999999999999876 345799
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeC-CCCceEEcccCcc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLD-GDFEPKLSDFGLA 455 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a 455 (618)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 999999999999996543 489999999999999999999999 7 99999999999998 7899999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
........ ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ...........
T Consensus 180 ~~~~~~~~------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~ 245 (290)
T 1t4h_A 180 TLKRASFA------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSG 245 (290)
T ss_dssp GGCCTTSB------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTT
T ss_pred cccccccc------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHHHhcc
Confidence 76543221 12348999999998764 589999999999999999999999975332 12222222111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. ....+ ......+.+++.+||+.||.+|||++|+++
T Consensus 246 ~~-~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VK-PASFD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC-CGGGG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC-ccccC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 10011 111235777888999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.22 Aligned_cols=261 Identities=19% Similarity=0.249 Sum_probs=192.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCH--HHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSE--KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|.+.+.||+|+||.||+|... +++.||+|++....... ..+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999964 78999999996543221 2355799999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 58988886543 3589999999999999999999999 99999999999999999999999999998654322
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC--Cccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN--SSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~--~~~~ 539 (618)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+.......... ....
T Consensus 155 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 155 KT----YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWP 226 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTST
T ss_pred cc----cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhch
Confidence 21 122347999999998876 568999999999999999999999997643211 111111111000 0000
Q ss_pred hhcc---------ccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAID---------KSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d---------~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... +...... .......+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 0000000 0112345677888999999999999999976
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.15 Aligned_cols=264 Identities=21% Similarity=0.242 Sum_probs=202.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC--------CCCccceeEEEE----
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR--------HRNLVPLLGFCV---- 371 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---- 371 (618)
.++|++.++||+|+||.||+|+. .+++.||+|+++......+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 46799999999999999999984 56899999999876666678899999999985 788999999987
Q ss_pred eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC------
Q 007088 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF------ 445 (618)
Q Consensus 372 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------ 445 (618)
.....++||||+ +++|.+.+..... ..+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 4566666544322 45899999999999999999999864 799999999999999775
Q ss_pred -------------------------------------------ceEEcccCcccccCCCCCcccccccCCCCcccccCCC
Q 007088 446 -------------------------------------------EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482 (618)
Q Consensus 446 -------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 482 (618)
.+||+|||+++...... ....||+.|+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-------~~~~gt~~y~aPE 263 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-------TEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-------CSCCSCGGGCCHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-------ccCCCCCcccCCh
Confidence 79999999998764321 2234899999999
Q ss_pred CCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc--CHHHHHHHHhcCC---------ccchhcccc-----c
Q 007088 483 YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG--SLVEWITLLNTNS---------SLETAIDKS-----L 546 (618)
Q Consensus 483 ~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~--~l~~~~~~~~~~~---------~~~~~~d~~-----l 546 (618)
++.+..++.++|||||||++|||++|+.||......+.... .+..... ..... ......... +
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccCCccccccc
Confidence 99998999999999999999999999999986554322110 0111111 00000 000000000 0
Q ss_pred --------------cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 547 --------------LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 547 --------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...........+.+++.+||+.||++|||++|+++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01224566778999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=356.70 Aligned_cols=196 Identities=23% Similarity=0.302 Sum_probs=154.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Ce
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-----KE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 375 (618)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999995 478999999996532 3346788999999999999999999999543 46
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.|+||||+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 899999985 69999886543 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc-----------------------cccccCCCCcccccCCCCC-CCCCCCCccchHHHHHHHHHHHhC
Q 007088 456 RLMNPVDTHL-----------------------STFVNGEFGDLGYVAPEYP-RTLVATPKGDVYSFGVVLLELITG 508 (618)
Q Consensus 456 ~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvil~elltG 508 (618)
+......... .....+.+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 8765322110 0122345689999999975 566799999999999999999993
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.84 Aligned_cols=269 Identities=19% Similarity=0.211 Sum_probs=199.5
Q ss_pred cCHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc------------CHHHHHHHHHHHhcCCCCCc
Q 007088 296 MRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH------------SEKEFLSEINTLGSVRHRNL 363 (618)
Q Consensus 296 ~~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~ni 363 (618)
..+.++....++|.+.+.||+|+||.||+|...+|+.||||++..... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 346788889999999999999999999999988899999999864221 12678999999999999999
Q ss_pred cceeEEEEeC-----CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 007088 364 VPLLGFCVAK-----KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438 (618)
Q Consensus 364 v~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 438 (618)
+++++++... ...++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence 9999998543 35799999998 58888876543 4589999999999999999999999 99999999999
Q ss_pred eeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 439 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
|+++.++.+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADANK-----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp EEECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEcCCCCEEEEecCccccccccccc-----ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999754432221 12348899999998876 6789999999999999999999999976432
Q ss_pred CCccccCHHHHHHHHhcCCcc-----------chhcccccc---CCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 007088 518 PESFKGSLVEWITLLNTNSSL-----------ETAIDKSLL---GNG----FDGELHQFLRVACNCVLPTPKERHTMFEV 579 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~~~-----------~~~~d~~l~---~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ev 579 (618)
.+ .+....... ..... .+.+..... ... .......+.+++.+||+.||++|||+.|+
T Consensus 240 ~~----~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 314 (362)
T 3pg1_A 240 YN----QLNKIVEVV-GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314 (362)
T ss_dssp HH----HHHHHHHHH-CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HH----HHHHHHHHc-CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 11 111111100 00000 000000000 000 11123457788889999999999999999
Q ss_pred HH
Q 007088 580 YQ 581 (618)
Q Consensus 580 l~ 581 (618)
++
T Consensus 315 l~ 316 (362)
T 3pg1_A 315 LR 316 (362)
T ss_dssp HT
T ss_pred Hc
Confidence 75
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=342.45 Aligned_cols=265 Identities=21% Similarity=0.258 Sum_probs=200.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------- 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 373 (618)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46799999999999999999996 578999999986432 3345788999999999999999999999873
Q ss_pred -CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 374 -KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 374 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
+..++||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 468999999985 7777765543 3489999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|+++.................||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ........
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~ 243 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQ 243 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHH
Confidence 9998765433332333344568999999998876 45799999999999999999999999764321 11111111
Q ss_pred HhcCCc---cchhcccc----c---c--CCCCHHH------HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 532 LNTNSS---LETAIDKS----L---L--GNGFDGE------LHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 532 ~~~~~~---~~~~~d~~----l---~--~~~~~~~------~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...... ....-... + . .....+. ...+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 111000 00000000 0 0 0001111 234778888999999999999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=343.43 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=202.9
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCcc---------CHHHHHHHHHHHhcC-CCCCcccee
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQH---------SEKEFLSEINTLGSV-RHRNLVPLL 367 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l-~h~niv~l~ 367 (618)
.......++|++.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556678999999999999999999974 799999999865321 134678999999999 799999999
Q ss_pred EEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 368 GFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 368 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
+++...+..++||||+++++|.+++... ..+++..+..++.||+.||.|||+. ||+||||||+||+++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999998654 3489999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcc
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR------TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESF 521 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~ 521 (618)
||+|||++........ .....||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 240 kl~DfG~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---- 310 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK-----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ---- 310 (365)
T ss_dssp EECCCTTCEECCTTCC-----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----
T ss_pred EEEecCcccccCCCcc-----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----
Confidence 9999999987654322 12345899999999875 33588999999999999999999999975321
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.............. ..+.. ......+.+++.+||+.||++|||+.|+++
T Consensus 311 ----~~~~~~i~~~~~~~--~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ----ILMLRMIMEGQYQF--SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----HHHHHHHHHTCCCC--CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----HHHHHHHHhCCCCC--CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111110000 00000 012245777888999999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.49 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=200.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
..++|++.+.||+|+||.||+|.. .+++.||+|++... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 346799999999999999999996 47899999998642 34567899999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC---CCCceEEcccCccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD---GDFEPKLSDFGLAR 456 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~ 456 (618)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999886543 489999999999999999999999 999999999999995 55679999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+.........
T Consensus 173 ~~~~~~~-----~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~ 238 (486)
T 3mwu_A 173 CFQQNTK-----MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGK 238 (486)
T ss_dssp TBCCC---------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred ECCCCCc-----cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence 7654322 223458999999999875 589999999999999999999999975432 11111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.... ...+......+.+++.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 239 YAFD-------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCSC-------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCC-------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00011223456677779999999999999999873
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.09 Aligned_cols=246 Identities=20% Similarity=0.320 Sum_probs=194.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|.+.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999965 7899999998643 23456789999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 99999999999986543 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
..... ....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ............
T Consensus 163 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~- 228 (276)
T 2h6d_A 163 DGEFL-----RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV--------PTLFKKIRGGVF- 228 (276)
T ss_dssp C------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-
T ss_pred CCcce-----ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHHHHhhcCcc-
Confidence 43211 12348899999999987765 6899999999999999999999975321 111111111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ .......+.+++.+||+.||++|||+.|+++
T Consensus 229 ------~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ------YI----PEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ------CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cC----chhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00 1112245677778999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=338.94 Aligned_cols=257 Identities=17% Similarity=0.223 Sum_probs=197.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEe--CCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVA--KKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~ 380 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 36799999999999999999984 67899999999753 4577899999999997 9999999999988 56789999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccCcccccC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMN 459 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~ 459 (618)
||+++++|.+++. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999874 388999999999999999999999 999999999999999776 89999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH------
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL------ 532 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~------ 532 (618)
..... ....||..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+.......
T Consensus 183 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 183 PGQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAKVLGTEDLY 254 (330)
T ss_dssp TTCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH---HHHHHHHHHHCHHHHH
T ss_pred CCCcc-----ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH---HHHHHHHHhcCCchhh
Confidence 43321 22348899999999876 678999999999999999999999996533211 0111110000
Q ss_pred ---hcCC-c----cchh--------ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 ---NTNS-S----LETA--------IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ---~~~~-~----~~~~--------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... . ..+. ................+.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0 0000 0000011111113456778888999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=350.57 Aligned_cols=274 Identities=21% Similarity=0.258 Sum_probs=198.1
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeC-------
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------- 373 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 373 (618)
....++|++.+.||+|+||.||+|.. .+|+.||+|++...... ..+|++++++++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 44567899999999999999999995 67899999998654322 23799999999999999999998543
Q ss_pred -------------------------------CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHH
Q 007088 374 -------------------------------KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422 (618)
Q Consensus 374 -------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH 422 (618)
...++||||+++ +|.+.+.........+++..+..++.||++||+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347899999984 877776542222346999999999999999999999
Q ss_pred hCCCCCceecCCCCCCeeeC-CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHH
Q 007088 423 HNCNPRIIHRNISSKCILLD-GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGV 500 (618)
Q Consensus 423 ~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gv 500 (618)
+. +|+||||||+||+++ .++.+||+|||+++........ ....+|+.|+|||.+.+. .++.++||||+||
T Consensus 159 ~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 159 SL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-----VAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp TT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC-----CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC-----cCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 99 999999999999998 6889999999999876543322 123478999999988764 4899999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc---------CCccchhccccccCC-----CCHHHHHHHHHHHhhcc
Q 007088 501 VLLELITGERPTHLTNAPESFKGSLVEWITLLNT---------NSSLETAIDKSLLGN-----GFDGELHQFLRVACNCV 566 (618)
Q Consensus 501 il~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~---------~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl 566 (618)
++|||++|+.||......+ .+......... .....+..-+.+... ........+.+++.+||
T Consensus 231 il~ell~g~~pf~~~~~~~----~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSID----QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 9999999999997643211 11111111100 000000000011101 01112345778888999
Q ss_pred CCCCCCCCCHHHHHH--HHHHhhhhcC
Q 007088 567 LPTPKERHTMFEVYQ--LLRAIAERYH 591 (618)
Q Consensus 567 ~~dP~~RPs~~evl~--~L~~i~~~~~ 591 (618)
+.||++|||+.|+++ .++++...+.
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~~~~~ 333 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLRNSYE 333 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHHHC--
T ss_pred cCChhhCCCHHHHhcCHHHHHHHhhcc
Confidence 999999999999984 4555554433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=357.36 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=201.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457999999999999999999964 7899999998643 34567899999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---CCCCceEEcccCccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLAR 456 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~ 456 (618)
|||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCS----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999887553 489999999999999999999999 99999999999999 567899999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
......... ...||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... .+.........
T Consensus 178 ~~~~~~~~~-----~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~ 243 (484)
T 3nyv_A 178 HFEASKKMK-----DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVEKGK 243 (484)
T ss_dssp HBCCCCSHH-----HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC
T ss_pred Ecccccccc-----cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCC
Confidence 765433221 2248999999998866 689999999999999999999999975432 11111111111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ...+......+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 244 YTFE-------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCC-------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0000 0001122345667777999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=357.10 Aligned_cols=250 Identities=25% Similarity=0.322 Sum_probs=198.6
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--------------cCHHHHHHHHHHHhcCCCCCccceeE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--------------HSEKEFLSEINTLGSVRHRNLVPLLG 368 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~ 368 (618)
..++|.+.++||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999995 468899999996532 23567899999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC---
Q 007088 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF--- 445 (618)
Q Consensus 369 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 445 (618)
++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence 9999999999999999999999886543 499999999999999999999999 999999999999998776
Q ss_pred ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH
Q 007088 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l 525 (618)
.+||+|||+++....... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||.....
T Consensus 187 ~~kl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------- 252 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK-----LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-------- 252 (504)
T ss_dssp SEEECCCTTCEECCTTSC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred cEEEEECCCCEEcCCCCc-----cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------
Confidence 699999999987654322 12345899999999987 4689999999999999999999999975432
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+............ +... +......+.+++.+||+.||.+|||++|+++
T Consensus 253 ~~~~~~i~~~~~~~---~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 253 QDIIKKVEKGKYYF---DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHHHHHCCCCC---CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcCCCCC---Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11222211111000 0000 0112245677778999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=337.54 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=194.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 374 (618)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999995 468999999986532 12235789999999999999999999987655
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc---eEEcc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE---PKLSD 451 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 451 (618)
.++||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 899999999999999987543 489999999999999999999999 9999999999999987654 99999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCC---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP---RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
||+++........ ....||+.|+|||++ ....++.++|||||||++|||++|+.||....... .+...
T Consensus 161 fg~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~ 231 (322)
T 2ycf_A 161 FGHSKILGETSLM-----RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQ 231 (322)
T ss_dssp CTTCEECCCCHHH-----HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHH
T ss_pred Cccceeccccccc-----ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHH
Confidence 9999876542211 112379999999986 35678999999999999999999999997644321 22222
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... .... .+... ......+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~--~~~~----~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSG--KYNF----IPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHT--CCCC----CHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhC--cccc----Cchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1110 0000 00000 112346778888999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=357.00 Aligned_cols=199 Identities=22% Similarity=0.253 Sum_probs=173.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC------CCCCccceeEEEEeCCeeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV------RHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~ 377 (618)
..+|++.+.||+|+||.||+|.. .+++.||||+++......+++.+|+.++..+ +|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 45799999999999999999985 4689999999987665566788888888776 5779999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc--eEEcccCcc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE--PKLSDFGLA 455 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a 455 (618)
+||||+. ++|.+++..... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999996 599998876543 3589999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 250 ~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQRV-------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCCC-------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCcc-------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 7654321 12348999999999999999999999999999999999999997643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=334.13 Aligned_cols=251 Identities=20% Similarity=0.282 Sum_probs=195.1
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
+|.....||+|+||.||+|.. .+++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355567999999999999995 568899999987643 345678999999999999999999999999999999999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccCcccccCCCCC
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~ 463 (618)
+++|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||.+........
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999875432 23577899999999999999999999 9999999999999987 89999999999987654222
Q ss_pred cccccccCCCCcccccCCCCCCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLV--ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.. ....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...... ...........
T Consensus 179 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~------ 242 (295)
T 2clq_A 179 CT----ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVGMFK------ 242 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHHHHC------
T ss_pred cc----cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhcccc------
Confidence 11 2234899999999986543 789999999999999999999999643211 00111100000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+.+ .......+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 243 VHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCC----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00111 1122345677778999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=355.36 Aligned_cols=249 Identities=14% Similarity=0.144 Sum_probs=191.3
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHH---HHHhcCCCCCcccee-------E
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEI---NTLGSVRHRNLVPLL-------G 368 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~---~~l~~l~h~niv~l~-------~ 368 (618)
..++|.+.+.||+|+||.||+|+. .+|+.||||++... ....+.+.+|+ +.+++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 356788999999999999999994 67999999999642 23457789999 556666899999998 7
Q ss_pred EEEeCCe-----------------eEEEEeecCCCccccccCCCCC---CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007088 369 FCVAKKE-----------------RLLVYSYLENGTLYDKLHPAEH---EVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428 (618)
Q Consensus 369 ~~~~~~~-----------------~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 428 (618)
++.+.+. .++||||+ +|+|.+++..... ....+++..++.|+.||+.||+|||++ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 7766532 78999999 6799999875321 112345688899999999999999999 9
Q ss_pred ceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC-----------CCCCccchHH
Q 007088 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-----------VATPKGDVYS 497 (618)
Q Consensus 429 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDVwS 497 (618)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwS 298 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTCE-------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCCc-------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHH
Confidence 999999999999999999999999999864321 123347 999999998877 8999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 007088 498 FGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577 (618)
Q Consensus 498 ~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 577 (618)
|||++|||++|+.||........... .. ... ... ...+.+++.+||+.||++|||+.
T Consensus 299 lG~il~elltg~~Pf~~~~~~~~~~~-----------------~~-~~~--~~~---~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 299 LGLVIYWIWCADLPITKDAALGGSEW-----------------IF-RSC--KNI---PQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp HHHHHHHHHHSSCCC------CCSGG-----------------GG-SSC--CCC---CHHHHHHHHHHTCSSGGGCCCHH
T ss_pred HHHHHHHHHHCCCCCcccccccchhh-----------------hh-hhc--cCC---CHHHHHHHHHHcCCCchhCCCHH
Confidence 99999999999999975443221110 00 000 111 24566777799999999999999
Q ss_pred HHHH--HHHHhh
Q 007088 578 EVYQ--LLRAIA 587 (618)
Q Consensus 578 evl~--~L~~i~ 587 (618)
|+++ .++++.
T Consensus 356 e~l~hp~f~~~~ 367 (377)
T 3byv_A 356 QAMETPEYEQLR 367 (377)
T ss_dssp HHHTSHHHHHHH
T ss_pred HHhhChHHHHHH
Confidence 9985 444443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=343.44 Aligned_cols=199 Identities=22% Similarity=0.364 Sum_probs=174.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 457999999999999999999964 68999999997642 334678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999997543 4899999999999999999999831 7999999999999999999999999999754321
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLT 515 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~ 515 (618)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 186 ~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 M------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp C----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred c------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 12234899999999999999999999999999999999999999754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=336.34 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=184.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc--CH-HHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH--SE-KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.... .. +.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46789999999999999999995 5789999999976432 22 23445555688889999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++ +|.+++.........+++..++.++.|++.||+|||+++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 887777543222356999999999999999999999843 899999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCC----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYP----RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
.... ....||+.|+|||++ .+..++.++||||||+++|||++|+.||..... .......... ..
T Consensus 163 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~ 230 (290)
T 3fme_A 163 DVAK-----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVE-EP 230 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHH-SC
T ss_pred cccc-----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhc-cC
Confidence 3221 122489999999985 566789999999999999999999999975322 1111111111 11
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. +.... ......+.+++.+||+.||++|||+.|+++
T Consensus 231 ~------~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 S------PQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C------CCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C------CCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0 01111 112345677788999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=344.89 Aligned_cols=270 Identities=20% Similarity=0.239 Sum_probs=191.3
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe--
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE-- 375 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 375 (618)
.+.....++|++.+.||+|+||.||+|.. .+++.||||++.........+.+|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45667788999999999999999999996 468999999987665555567788888999999999999999976443
Q ss_pred -----eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceecCCCCCCeeeCC-CCce
Q 007088 376 -----RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH--HNCNPRIIHRNISSKCILLDG-DFEP 447 (618)
Q Consensus 376 -----~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~ 447 (618)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999987 554433321112245899999999999999999999 88 9999999999999996 8999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++........ ....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.
T Consensus 172 kl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~ 242 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEPN-----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----QLH 242 (360)
T ss_dssp EECCCTTCBCCCTTSCC-----CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred EEeeCCCceecCCCCCc-----ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH----HHH
Confidence 99999999876543322 123489999999988654 48999999999999999999999997643211 111
Q ss_pred HHHHHHhc-----------CCccchhcc------ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 527 EWITLLNT-----------NSSLETAID------KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 527 ~~~~~~~~-----------~~~~~~~~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
........ ........+ ..............+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111100 000000000 00001111123567888888999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.52 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=196.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC--CC--cEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP--GG--CFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|++.+.||+|+||.||+|... ++ ..||+|+++... ...+.+.+|++++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999842 33 368999987532 34567899999999999999999999998765 8
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999987543 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.......... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+........
T Consensus 170 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~ 240 (291)
T 1u46_A 170 ALPQNDDHYV-MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKE 240 (291)
T ss_dssp ECCC-CCEEE-C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTS
T ss_pred cccccccchh-hhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHcc
Confidence 7654332211 1122347788999999988888999999999999999999 9999975432 1222222111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
... ..........+.+++.+||+.||++|||+.++++.|+++..
T Consensus 241 ~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GER---------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCC---------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 110 00111233567778889999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=327.87 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=195.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcCCCCCccceeEEEE--eCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSVRHRNLVPLLGFCV--AKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 376 (618)
.++|.+.+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999995 568999999997532 34567999999999999999999999985 34578
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||++++ |.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 6666654332 4589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLV--ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
......... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ..+.......
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~ 227 (305)
T 2wtk_C 158 ALHPFAADD--TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGK 227 (305)
T ss_dssp ECCTTCSSC--EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHH
T ss_pred ccCcccccc--ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhc
Confidence 765322211 122344899999999987644 3779999999999999999999997532 1122222111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
... .+ .......+.+++.+||+.||.+|||++|+++.
T Consensus 228 ~~~-------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 228 GSY-------AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCC-------CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCC-------CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 01 11123456677889999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.20 Aligned_cols=249 Identities=20% Similarity=0.308 Sum_probs=195.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.++|++.+.||+|+||.||+|+.. ++..||+|++.... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999964 78999999997532 34567899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC---CceEEcccCcccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD---FEPKLSDFGLARL 457 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a~~ 457 (618)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.. +.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999886543 489999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
...... .....||+.|+|||++. ..++.++||||+||++|+|++|+.||..... .+..........
T Consensus 189 ~~~~~~-----~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~ 254 (494)
T 3lij_A 189 FENQKK-----MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGKY 254 (494)
T ss_dssp CBTTBC-----BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCC
T ss_pred CCCCcc-----ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC
Confidence 654322 22345899999999886 4689999999999999999999999975432 111111111110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ...+. .......+.+++.+||+.||.+|||+.|+++
T Consensus 255 ~--~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 T--FDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp C--CCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 00000 0112345667777999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=336.97 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=197.8
Q ss_pred hhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 3567999999999999999999964 58999999997643 346788999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.......
T Consensus 106 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999986322 3589999999999999999999999 99999999999999999999999999998764432
Q ss_pred CcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 542 (618)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............ .
T Consensus 180 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~-~--- 243 (314)
T 3com_A 180 AK----RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFMIPTNPP-P--- 243 (314)
T ss_dssp SC----BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCC-C---
T ss_pred cc----cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCCC-c---
Confidence 21 1223489999999999998999999999999999999999999975321 111111111110 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 543 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .........+.+++.+||+.||.+|||+.|+++
T Consensus 244 --~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 --TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00 001112346777888999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=373.38 Aligned_cols=243 Identities=19% Similarity=0.231 Sum_probs=198.7
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 377 (618)
..++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456899999999999999999995 46889999999753 23456678899999988 7999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 9999999999999997643 499999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+.........
T Consensus 492 ~~~~~~~----~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~- 558 (674)
T 3pfq_A 492 NIWDGVT----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHN- 558 (674)
T ss_dssp CCCTTCC----BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSSC-
T ss_pred cccCCcc----cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCC-
Confidence 4332222 2234599999999999999999999999999999999999999976432 12222221111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 576 (618)
+ ..+.....++.+|+.+||+.||++||++
T Consensus 559 --------~--~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 559 --------V--AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp --------C--CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred --------C--CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 0 0111223456677779999999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.01 Aligned_cols=252 Identities=10% Similarity=-0.005 Sum_probs=179.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHH---HHHhcCCCCCcccee-------EE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEI---NTLGSVRHRNLVPLL-------GF 369 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 369 (618)
..+|...+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+ ..++. +||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 44688899999999999999995 478999999997743 2345577784 55556 799987754 55
Q ss_pred EEeC-----------------CeeEEEEeecCCCccccccCCCCCCCcCCCHHHH------HHHHHHHHHHHHHHHhCCC
Q 007088 370 CVAK-----------------KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLR------LRIAIGSARGLAWLHHNCN 426 (618)
Q Consensus 370 ~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~ 426 (618)
+... ...++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||++
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-- 213 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence 5443 23799999998 89999997642 23455555 78889999999999999
Q ss_pred CCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHH
Q 007088 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLE 504 (618)
Q Consensus 427 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~e 504 (618)
+|+||||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++||
T Consensus 214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred -CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 999999999999999999999999999987643211 1226799999999987 779999999999999999
Q ss_pred HHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 505 LITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 505 lltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
|++|+.||........... ........................+.+++.+||+.||++|||+.|+++
T Consensus 286 lltg~~Pf~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSW----------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCC----------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred HHhCCCCCCCcCcccccch----------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999999986533211000 000000000111111111123456777778999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=342.94 Aligned_cols=256 Identities=22% Similarity=0.278 Sum_probs=191.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46789999999999999999995 578999999996532 23456889999999999999999999997753
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 78999988642 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
++...... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+ .+........
T Consensus 175 a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g 243 (367)
T 1cm8_A 175 ARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTG 243 (367)
T ss_dssp CEECCSSC-------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHC
T ss_pred cccccccc-------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcC
Confidence 98754321 23348999999998776 679999999999999999999999997643211 1111111000
Q ss_pred cCC----------ccchh-------ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNS----------SLETA-------IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~----------~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... ..... ....+ ..........+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 000 00000 00000 0011122345777788999999999999999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=335.06 Aligned_cols=259 Identities=19% Similarity=0.232 Sum_probs=202.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe--CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCC------CccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML--PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHR------NLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~~ 376 (618)
.++|++.+.||+|+||.||+|.. .+++.||+|+++......+.+.+|++++++++|+ +++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35789999999999999999985 4689999999987665667788999999888655 499999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-------------
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG------------- 443 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------------- 443 (618)
++||||+ +++|.+++..... .++++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 7899999876543 4589999999999999999999999 9999999999999987
Q ss_pred ------CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 444 ------DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 444 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred ccccccCCCceEeeCcccccCcccc-------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 6689999999998654321 123489999999999999999999999999999999999999976432
Q ss_pred CCccccCHHHHHHHHhcCCc--------cchh---------------------cccc-ccCCCCHHHHHHHHHHHhhccC
Q 007088 518 PESFKGSLVEWITLLNTNSS--------LETA---------------------IDKS-LLGNGFDGELHQFLRVACNCVL 567 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~~--------~~~~---------------------~d~~-l~~~~~~~~~~~l~~li~~cl~ 567 (618)
.+ .. ........... .... ..+. -...........+.+++.+||+
T Consensus 240 ~~----~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 240 KE----HL-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp HH----HH-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred HH----HH-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 11 01 11110000000 0000 0000 0011123456788899999999
Q ss_pred CCCCCCCCHHHHHH
Q 007088 568 PTPKERHTMFEVYQ 581 (618)
Q Consensus 568 ~dP~~RPs~~evl~ 581 (618)
.||.+|||+.|+++
T Consensus 315 ~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 315 YDPAKRITLREALK 328 (339)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred cCcccccCHHHHhc
Confidence 99999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=337.09 Aligned_cols=266 Identities=23% Similarity=0.344 Sum_probs=198.4
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
...++|++.+.||+|+||.||+|...+ .||+|+++... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345789999999999999999999754 48999986432 2335577899999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++...
T Consensus 108 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred eecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999997654 3589999999999999999999999 999999999999998 6799999999987653
Q ss_pred CCCCc-ccccccCCCCcccccCCCCCCC---------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 460 PVDTH-LSTFVNGEFGDLGYVAPEYPRT---------LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 460 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
..... .........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ....
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~ 252 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------EAII 252 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------HHHH
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 22111 1111223348999999998764 4578899999999999999999999975321 1111
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTT 594 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (618)
...... . .+...... ....+.+++.+||+.||++|||+.|+++.|+++.++.....
T Consensus 253 ~~~~~~-~-----~~~~~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~ 308 (319)
T 2y4i_B 253 WQMGTG-M-----KPNLSQIG---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308 (319)
T ss_dssp HHHHTT-C-----CCCCCCSS---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--------
T ss_pred HHhccC-C-----CCCCCcCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCC
Confidence 111111 0 11111111 12346777889999999999999999999999987755433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=334.12 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=200.8
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----------cCHHHHHHHHHHHhcCC-CCCccceeEEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----------HSEKEFLSEINTLGSVR-HRNLVPLLGFCV 371 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 371 (618)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++ ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 356899999999999999999996 468999999996532 12356789999999995 999999999999
Q ss_pred eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcc
Q 007088 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 372 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
..+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999998754 3489999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR------TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL 525 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l 525 (618)
||++......... ....|++.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 168 fg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 234 (298)
T 1phk_A 168 FGFSCQLDPGEKL-----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------- 234 (298)
T ss_dssp CTTCEECCTTCCB-----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------
T ss_pred ccchhhcCCCccc-----ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------
Confidence 9999876543221 2234899999999874 45688999999999999999999999975321
Q ss_pred HHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 VEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
............ .............+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 235 MLMLRMIMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHHHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhcCCc-------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111111110 0000111223456778888999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.16 Aligned_cols=255 Identities=22% Similarity=0.271 Sum_probs=190.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46799999999999999999995 468999999997532 33456889999999999999999999997665
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999975 7888774 2388999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ..+......
T Consensus 174 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~i~~~ 241 (371)
T 2xrw_A 174 ARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-------DQWNKVIEQ 241 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHC-
T ss_pred ccccccccc-----cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHH
Confidence 986643221 12234899999999999999999999999999999999999999764321 111111000
Q ss_pred ---------------------C-Cc-----cchhccccccCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 ---------------------N-SS-----LETAIDKSLLGNG---FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ---------------------~-~~-----~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .. ............. .......+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00 0000000000000 1123567888999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.65 Aligned_cols=251 Identities=19% Similarity=0.268 Sum_probs=196.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467899999999999999999965 5899999998654 34567899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999886533 3489999999999999999999999 99999999999999999999999999875432111
Q ss_pred CcccccccCCCCcccccCCCCC-----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYP-----RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
. ......||+.|+|||++ .+..++.++||||||+++|||++|+.||..... ............
T Consensus 172 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 239 (302)
T 2j7t_A 172 Q----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSDP 239 (302)
T ss_dssp H----C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCC
T ss_pred c----ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHHHHHhccCC
Confidence 0 11123489999999987 467789999999999999999999999975332 111111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. . .........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PT-L-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CC-C-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cc-c-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 0 001122345777888999999999999999865
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=350.18 Aligned_cols=261 Identities=23% Similarity=0.247 Sum_probs=190.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe------eEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE------RLL 378 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l 378 (618)
..+|+..+.||+|+||.||+|+...+..||+|++...... ..+|++++++++||||+++++++...+. .++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 3568999999999999999999877777898888553321 2369999999999999999999966443 789
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC-CCCceEEcccCcccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD-GDFEPKLSDFGLARL 457 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~ 457 (618)
||||++++ +.+.+.........+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999874 4333321111124589999999999999999999999 999999999999999 799999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC-
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN- 535 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~- 535 (618)
....... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+ .+..........
T Consensus 192 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 192 LIAGEPN-----VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID----QLVEIIKVLGTPS 262 (394)
T ss_dssp CCTTCCC-----CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCC
T ss_pred ccCCCCC-----cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCC
Confidence 6443322 123489999999988664 58999999999999999999999997643211 111111111000
Q ss_pred --------CccchhccccccCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 536 --------SSLETAIDKSLLGNG-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 536 --------~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......-+...... .......+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000000000 0112346778888999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=333.30 Aligned_cols=264 Identities=28% Similarity=0.395 Sum_probs=184.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
..++|.+.+.||+|+||.||+|.. .+++.||+|++... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 357899999999999999999994 57899999998653 234567889999999999999999999999999999999
Q ss_pred eecCCCccccccCCC----CCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 381 SYLENGTLYDKLHPA----EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 381 e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
||+++|+|.+++... ......+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988631 11124589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 457 LMNPVDTH-LSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 457 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
........ .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .. ......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~---~~~~~~ 242 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VL---MLTLQN 242 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HH---HHHHTS
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HH---HHHhcc
Confidence 66432211 1111123348999999998865 568999999999999999999999997643211 11 111111
Q ss_pred CC-ccc-hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NS-SLE-TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~-~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. ... ...+.... ......+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEML----KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCC----CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhh----hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 10 000 00111111 112345677788999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=350.08 Aligned_cols=260 Identities=25% Similarity=0.268 Sum_probs=191.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC------eeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l 378 (618)
.+|+..+.||+|+||.||+|+. .+|+.||||++..... ...+|++++++++||||+++++++.... ..++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4688899999999999999996 4689999999865432 2347999999999999999999986432 3579
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-CceEEcccCcccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARL 457 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~ 457 (618)
||||+++ +|.+.+.........+++..++.++.||++||+|||+. +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 66665543222224699999999999999999999999 99999999999999965 5689999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc--
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT-- 534 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~-- 534 (618)
....... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+.......
T Consensus 207 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~----~~l~~i~~~lg~p~ 277 (420)
T 1j1b_A 207 LVRGEPN-----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPT 277 (420)
T ss_dssp CCTTCCC-----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCSCC
T ss_pred cccCCCc-----eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCC
Confidence 6543221 123489999999988764 7899999999999999999999999764321 112222211100
Q ss_pred -------CCccchhccccccCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 -------NSSLETAIDKSLLGNG-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 -------~~~~~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.....+...+.+.... .......+.+|+.+||+.||.+|||+.|+++
T Consensus 278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000111111111110 0112356778888999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.41 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=193.7
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEe----------
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA---------- 372 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 372 (618)
..++|++.+.||+|+||.||+|+. .+++.||+|++.......+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356799999999999999999995 578999999997665566788999999999999999999999865
Q ss_pred ---CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 373 ---KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 373 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 356789999999999999997543 3578899999999999999999999 9999999999999999999999
Q ss_pred cccCcccccCCCCCc----------ccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCC
Q 007088 450 SDFGLARLMNPVDTH----------LSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAP 518 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~----------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~ 518 (618)
+|||++......... .........||+.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 999999876432110 01112234589999999998764 68999999999999999998 543210
Q ss_pred CccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 519 ESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 519 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
............ ...+...........+.+++.+||+.||.+|||+.|+++
T Consensus 233 -----~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -----ERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -----HHHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hHHHHHHhcccc-------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111111 011111122233455677888999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.66 Aligned_cols=264 Identities=19% Similarity=0.225 Sum_probs=200.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-----------CCCccceeEEEEeC
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-----------HRNLVPLLGFCVAK 373 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 373 (618)
++|.+.+.||+|+||.||+|.. .+++.||+|++.......+.+.+|++++++++ |+||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 5789999999999999999995 67899999999876666677889999998886 89999999999865
Q ss_pred C----eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC------C
Q 007088 374 K----ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD------G 443 (618)
Q Consensus 374 ~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~------~ 443 (618)
+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ +|+||||||+|||++ .
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 4 789999999 8899999876443 35899999999999999999999953 899999999999994 4
Q ss_pred CCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-
Q 007088 444 DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK- 522 (618)
Q Consensus 444 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~- 522 (618)
.+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 174 ~~~~kl~Dfg~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp EEEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cceEEEcccccccccCCCC-------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4589999999998764321 12348999999999999899999999999999999999999998644221110
Q ss_pred -cCHHHHHHHHhcC-----------------Cccchhccc----------cccCCCCHHHHHHHHHHHhhccCCCCCCCC
Q 007088 523 -GSLVEWITLLNTN-----------------SSLETAIDK----------SLLGNGFDGELHQFLRVACNCVLPTPKERH 574 (618)
Q Consensus 523 -~~l~~~~~~~~~~-----------------~~~~~~~d~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 574 (618)
..+.......... ......+.. .-...........+.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 0111111110000 000000000 001123456778899999999999999999
Q ss_pred CHHHHHH
Q 007088 575 TMFEVYQ 581 (618)
Q Consensus 575 s~~evl~ 581 (618)
|++|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=347.15 Aligned_cols=201 Identities=22% Similarity=0.293 Sum_probs=166.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Ce
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-----KE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 375 (618)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999995 568999999997532 3346789999999999999999999999776 56
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.|+||||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999986 59999987543 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcc------------------cccccCCCCcccccCCCCC-CCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 007088 456 RLMNPVDTHL------------------STFVNGEFGDLGYVAPEYP-RTLVATPKGDVYSFGVVLLELITGERPTH 513 (618)
Q Consensus 456 ~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDVwS~Gvil~elltG~~Pf~ 513 (618)
+......... ........||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 8765432110 0112345689999999975 56679999999999999999998655553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=367.23 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=205.0
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEeC----CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAMLP----GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
...++|++.+.||+|+||.||+|... .+..||+|+++... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34567889999999999999999863 25689999987533 33467899999999999999999999984 4668
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence 99999999999999997543 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.......... ....+|+.|+|||.+.+..++.++|||||||++|||++ |..||..... .+........
T Consensus 540 ~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~~~ 608 (656)
T 2j0j_A 540 YMEDSTYYKA---SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENG 608 (656)
T ss_dssp SCCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHHT
T ss_pred ecCCCcceec---cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHcC
Confidence 7654322111 12236789999999988899999999999999999997 9999975432 1111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
... ..+......+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 609 ~~~----------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ERL----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC----------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 100 01122334677788899999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=338.27 Aligned_cols=263 Identities=22% Similarity=0.286 Sum_probs=198.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Ce
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-----KE 375 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 375 (618)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 356899999999999999999995 478899999997533 3346788999999999999999999999765 36
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcce
Confidence 799999997 4999988543 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
+......... .......||+.|+|||++. +..++.++|||||||++|||++|+.||......+. +....... .
T Consensus 176 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~-~ 249 (364)
T 3qyz_A 176 RVADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGIL-G 249 (364)
T ss_dssp EECCGGGCBC-CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH----HHHHHHHH-C
T ss_pred EecCCCCCcc-ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH----HHHHHHHh-C
Confidence 8765432211 1123345899999999754 45589999999999999999999999976543221 11111110 0
Q ss_pred CCccc-----------hhccccc-cCCC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLE-----------TAIDKSL-LGNG-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~-----------~~~d~~l-~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... ....... .... .......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0000000 0000 0112345778888999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.88 Aligned_cols=257 Identities=19% Similarity=0.251 Sum_probs=196.2
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCC--CCCccceeEEEEeC
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVR--HRNLVPLLGFCVAK 373 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 373 (618)
..+....++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|++++.+++ |+||+++++++.+.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 33344567899999999999999999998889999999996543 33467899999999997 59999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
+..++||| +.+++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||++++ +.+||+|||
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CEEEEEEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecc
Confidence 99999999 56789999987543 489999999999999999999999 9999999999999965 799999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-----------LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~ 522 (618)
+++......... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 244 (313)
T 3cek_A 172 IANQMQPDTTSV--VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----- 244 (313)
T ss_dssp SSCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----
T ss_pred ccccccCccccc--cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----
Confidence 998765432211 1123348999999998765 4688899999999999999999999975321
Q ss_pred cCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 523 GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 523 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.. ........ ..............+.+++.+||+.||++||++.|+++.
T Consensus 245 -~~-~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 -QI-SKLHAIID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -HH-HHHHHHHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HH-HHHHHHHh---------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 11111111 111111111113456777789999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=339.80 Aligned_cols=203 Identities=23% Similarity=0.255 Sum_probs=173.1
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CC-----CccceeEEEEeCCe
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HR-----NLVPLLGFCVAKKE 375 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 375 (618)
...++|++.+.||+|+||.||+|.. .+++.||||+++.......++..|+.++..++ |+ +|+++++++...+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3467899999999999999999995 46889999999876555667888998888875 44 49999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC--CCCceEEcccC
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD--GDFEPKLSDFG 453 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG 453 (618)
.++||||++ |+|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999996 499999876543 3589999999999999999999952 12899999999999994 57889999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 207 SSCQLGQRI-------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp TCEETTCCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cceeccccc-------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998764321 12348999999999999999999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=338.81 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=197.1
Q ss_pred hhccCCCCcEEeecCCeeEEEEEe--CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcC---CCCCccceeEEEE----
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAML--PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSV---RHRNLVPLLGFCV---- 371 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 371 (618)
+.++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 557899999999999999999996 468999999986432 1223466777776665 8999999999987
Q ss_pred -eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEc
Q 007088 372 -AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450 (618)
Q Consensus 372 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 450 (618)
.....++||||++ |+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 599999875443 3489999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT 530 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~ 530 (618)
|||+++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||......+ .+.....
T Consensus 163 Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~ 233 (326)
T 1blx_A 163 DFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILD 233 (326)
T ss_dssp SCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHH
T ss_pred cCcccccccCCC-----CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHH
Confidence 999998654321 1223458999999999999899999999999999999999999997643211 1111111
Q ss_pred HHhcC---Cccc------hhccc---cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 531 LLNTN---SSLE------TAIDK---SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 531 ~~~~~---~~~~------~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... .+.. ..... .............+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11000 0000 00000 0000011122345667777999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=339.78 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=180.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC------C
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------K 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 374 (618)
.++|+..+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 46899999999999999999994 578999999996532 3346788999999999999999999999754 4
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
..++|+||+ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 579999999 67999988652 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+ .+........
T Consensus 179 a~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g 247 (367)
T 2fst_X 179 ARHTADE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILRLVG 247 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHC
T ss_pred ccccccc-------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhC
Confidence 9865432 122348999999998876 678999999999999999999999997643211 1111111100
Q ss_pred cCC----------ccchhccc--cccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNS----------SLETAIDK--SLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~----------~~~~~~d~--~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .....+.. ...... .......+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 00000000 000000 0111345677888999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=336.20 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=172.3
Q ss_pred hccCCCCc-EEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeeEE
Q 007088 305 TNSFSKNN-IIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA----KKERLL 378 (618)
Q Consensus 305 ~~~y~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 378 (618)
.++|.+.+ .||+|+||.||+|... +++.||+|++.......+ .....++.++||||+++++++.. ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 56788854 6999999999999965 689999999976432222 22333566799999999999976 445799
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEcccCcc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSDFGLA 455 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~a 455 (618)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999976543 4699999999999999999999999 9999999999999976 455999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
+....... ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||........... ..... ...
T Consensus 179 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~---~~~ 248 (336)
T 3fhr_A 179 KETTQNAL------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-MKRRI---RLG 248 (336)
T ss_dssp EEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred eecccccc------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-HHHhh---hcc
Confidence 86543221 123479999999999888899999999999999999999999976443211100 00000 000
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...............+.+++.+||+.||.+|||++|+++
T Consensus 249 -------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 -------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011111223345677788999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.47 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=200.0
Q ss_pred HhhccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 303 KATNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 303 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
...++|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999964 7899999998653 2456789999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC---CceEEcccCcc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD---FEPKLSDFGLA 455 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~a 455 (618)
||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.+ +.+||+|||++
T Consensus 99 v~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999998886543 489999999999999999999999 99999999999999754 46999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
.......... ...+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||..... ..........
T Consensus 172 ~~~~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~ 237 (287)
T 2wei_A 172 TCFQQNTKMK-----DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETG 237 (287)
T ss_dssp GTBCCCSSCS-----CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC
T ss_pred eeecCCCccc-----cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence 8765432211 1237889999998875 489999999999999999999999975321 1111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... +. .........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~---~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 238 KYAF---DL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCC---CS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC---Cc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1000 00 000112345677788999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=341.28 Aligned_cols=205 Identities=22% Similarity=0.318 Sum_probs=156.1
Q ss_pred ccCCC-CcEEeecCCeeEEEEEeC---CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeeEEE
Q 007088 306 NSFSK-NNIIGTGRTGATYIAMLP---GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA--KKERLLV 379 (618)
Q Consensus 306 ~~y~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 379 (618)
+.|++ .++||+|+||.||+|+.. +++.||+|++..... ...+.+|+.++++++||||+++++++.. ....++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 34555 558999999999999964 578999999976543 3468899999999999999999999965 5688999
Q ss_pred EeecCCCccccccCCCC-----CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee----CCCCceEEc
Q 007088 380 YSYLENGTLYDKLHPAE-----HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL----DGDFEPKLS 450 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 450 (618)
|||+++ +|.+++.... .....+++..++.++.||+.||+|||+. +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999975 8877765321 1123599999999999999999999999 99999999999999 778899999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 175 Dfg~a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 175 DMGFARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ECCCceecCCCCcc-cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 99999876542211 111223458999999998877 458999999999999999999999997644
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=333.79 Aligned_cols=264 Identities=20% Similarity=0.252 Sum_probs=195.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Cee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-----KER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 376 (618)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467899999999999999999964 68999999996533 3345688999999999999999999998764 578
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 5999888642 489999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccc------ccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHH
Q 007088 457 LMNPVDTHLS------TFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 457 ~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~ 529 (618)
.......... .......||+.|+|||++. +..++.++|||||||++|||++|+.||......+ .+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~ 236 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH----QLLLIF 236 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHH
Confidence 7654221111 0112345899999999765 4678999999999999999999999997643210 011111
Q ss_pred HHHhcCC---ccc--------hhccc--cccCC----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 530 TLLNTNS---SLE--------TAIDK--SLLGN----GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 530 ~~~~~~~---~~~--------~~~d~--~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....... ... +.+.. ..... ........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 000 00000 00000 00112345677888999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=335.89 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=193.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCee----
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER---- 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 376 (618)
.++|...+.||+|+||.||+|.. .+|+.||+|++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46788999999999999999995 5689999999976432 346788999999999999999999999877654
Q ss_pred --EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 377 --LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 377 --~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
++||||+. ++|.+++. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999997 58888774 2389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+........
T Consensus 191 a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~ 259 (371)
T 4exu_A 191 ARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTG 259 (371)
T ss_dssp C---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHC
T ss_pred ccccccCc-------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhC
Confidence 98654321 22347999999998876 788999999999999999999999997643211 1111111000
Q ss_pred cCCc----------cchhccc--cccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNSS----------LETAIDK--SLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~~----------~~~~~d~--~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ....... ...... .......+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 0000000 000000 0112356778888999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=343.93 Aligned_cols=255 Identities=20% Similarity=0.223 Sum_probs=187.2
Q ss_pred cCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 307 SFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 34456889999999998877778999999998653 245678999999876 89999999999999999999999996
Q ss_pred CccccccCCCCCCCcC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC-------------CceEE
Q 007088 386 GTLYDKLHPAEHEVMH---MDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD-------------FEPKL 449 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl 449 (618)
|+|.+++......... .++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 6999999765432111 13345678999999999999999 99999999999999654 48999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCC-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-------LVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~ 521 (618)
+|||+++.................||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--- 246 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--- 246 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH---
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh---
Confidence 9999999876543222222233458999999998865 678999999999999999999 99999653221
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...... ..... +.............+.+++.+||+.||.+|||+.|+++
T Consensus 247 ---~~~i~~---~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ---ESNIIR---GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HHHHHH---TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHhc---CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 011111 11000 01111123445677888999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.53 Aligned_cols=259 Identities=17% Similarity=0.181 Sum_probs=199.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-C-CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC------ccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-G-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN------LVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~ 376 (618)
.++|++.+.||+|+||.||+|... + ++.||+|+++......+.+.+|+.++++++|++ ++.+++++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 367999999999999999999953 3 479999999876666677889999999987655 89999999999999
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeee---------------
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILL--------------- 441 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--------------- 441 (618)
++||||+ ++++.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 5577776654432 4589999999999999999999999 99999999999999
Q ss_pred ----CCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCC
Q 007088 442 ----DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517 (618)
Q Consensus 442 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~ 517 (618)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccCCCcEEEeecCccccccccc-------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 567899999999998654322 123489999999999999999999999999999999999999976432
Q ss_pred CCccccCHHHHHHHHhcCC---------ccchhcccc---------------------ccCCCCHHHHHHHHHHHhhccC
Q 007088 518 PESFKGSLVEWITLLNTNS---------SLETAIDKS---------------------LLGNGFDGELHQFLRVACNCVL 567 (618)
Q Consensus 518 ~~~~~~~l~~~~~~~~~~~---------~~~~~~d~~---------------------l~~~~~~~~~~~l~~li~~cl~ 567 (618)
.+ .+ .......... ......... ........+...+.+++.+||+
T Consensus 245 ~~----~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 245 RE----HL-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp HH----HH-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred HH----HH-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 11 01 1111100000 000000000 0001123445678899999999
Q ss_pred CCCCCCCCHHHHHH
Q 007088 568 PTPKERHTMFEVYQ 581 (618)
Q Consensus 568 ~dP~~RPs~~evl~ 581 (618)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.05 Aligned_cols=263 Identities=20% Similarity=0.272 Sum_probs=188.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEE-----------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCV----------- 371 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 371 (618)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ...+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357889999999999999999965 58999999986543 34567899999999999999999999874
Q ss_pred ---eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC-CCCce
Q 007088 372 ---AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD-GDFEP 447 (618)
Q Consensus 372 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~ 447 (618)
+.+..++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence 3457899999998 5999998642 489999999999999999999999 999999999999997 56799
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++......... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .+.
T Consensus 161 kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~ 235 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE----QMQ 235 (320)
T ss_dssp EECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH
T ss_pred EEccCccccccCCCcccc-cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH----HHH
Confidence 999999998764322111 11122336889999997754 678999999999999999999999997643211 011
Q ss_pred HHHHHHhcC---------CccchhccccccCC-C-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 527 EWITLLNTN---------SSLETAIDKSLLGN-G-----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 527 ~~~~~~~~~---------~~~~~~~d~~l~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
......... ......+....... . .......+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111000000 00000000000000 0 0112346777888999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.98 Aligned_cols=255 Identities=21% Similarity=0.275 Sum_probs=176.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHH-HHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEIN-TLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|...+.||+|+||.||+|.. .+|+.||+|+++... ....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 6788899999999999999996 478999999997643 23345566666 6777899999999999999999999999
Q ss_pred ecCCCccccccCCCC-CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAE-HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
|+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 7777765211 01245899999999999999999999852 799999999999999999999999999987643
Q ss_pred CCCcccccccCCCCcccccCCCCC----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYP----RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
.... ....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... +...
T Consensus 179 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~------ 240 (327)
T 3aln_A 179 SIAK-----TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLT------ 240 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C------
T ss_pred cccc-----ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHH------
Confidence 3211 122489999999998 46678999999999999999999999997532210 0000
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......+.+...........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000000111111111123346777888999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=326.15 Aligned_cols=256 Identities=19% Similarity=0.269 Sum_probs=193.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-----
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE----- 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 375 (618)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 35788899999999999999995 5689999999975432 24568899999999999999999999987654
Q ss_pred -eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 376 -RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 376 -~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
.++||||++ |+|.+++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 589888742 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+ .+........
T Consensus 173 ~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~ 241 (353)
T 3coi_A 173 ARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD----QLTQILKVTG 241 (353)
T ss_dssp TTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH----HHHHHHHHHC
T ss_pred ccCCCCCc-------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhC
Confidence 98654321 12347999999998876 678999999999999999999999997643211 1111111000
Q ss_pred cCC-----cc-----chh---ccccc---cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TNS-----SL-----ETA---IDKSL---LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~~-----~~-----~~~---~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .. ... +.... ...........+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 00 000 00000 00111223456777888999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=329.48 Aligned_cols=244 Identities=19% Similarity=0.264 Sum_probs=187.6
Q ss_pred HHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc-------CHHHHHHHHHHHhcC----CCCCcccee
Q 007088 300 DLMKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH-------SEKEFLSEINTLGSV----RHRNLVPLL 367 (618)
Q Consensus 300 ~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~ 367 (618)
+.....++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3444567899999999999999999985 5789999999965432 223356788888888 899999999
Q ss_pred EEEEeCCeeEEEEee-cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC-CCC
Q 007088 368 GFCVAKKERLLVYSY-LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD-GDF 445 (618)
Q Consensus 368 ~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~ 445 (618)
+++...+..++|||| +++++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 78999999997543 489999999999999999999999 999999999999999 889
Q ss_pred ceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCCCCccccC
Q 007088 446 EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT-PKGDVYSFGVVLLELITGERPTHLTNAPESFKGS 524 (618)
Q Consensus 446 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~ 524 (618)
.+||+|||+++....... ....|+..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEPY------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSCB------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred eEEEEEcchhhhcccCcc------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------
Confidence 999999999987654321 223489999999988766654 58999999999999999999996421
Q ss_pred HHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 525 LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 525 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
+... .... + .......+.+++.+||+.||++|||++|+++
T Consensus 244 --~~~~---~~~~--------~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 --EILE---AELH--------F----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HHHH---TCCC--------C----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --HHhh---hccC--------C----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1000 0000 0 1112345677788999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=330.24 Aligned_cols=242 Identities=20% Similarity=0.287 Sum_probs=195.5
Q ss_pred HHhhccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc-------CHHHHHHHHHHHhcCC--CCCccceeEEEE
Q 007088 302 MKATNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH-------SEKEFLSEINTLGSVR--HRNLVPLLGFCV 371 (618)
Q Consensus 302 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~~~~~ 371 (618)
....++|++.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33457899999999999999999984 5789999999965421 2245678999999996 599999999999
Q ss_pred eCCeeEEEEeecCC-CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC-CCCceEE
Q 007088 372 AKKERLLVYSYLEN-GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD-GDFEPKL 449 (618)
Q Consensus 372 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 449 (618)
..+..++||||+.+ ++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++ +++.+||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 99999999999976 8999998754 3489999999999999999999999 999999999999999 7889999
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEW 528 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~ 528 (618)
+|||+++....... ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ..
T Consensus 192 ~Dfg~~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------~~ 255 (320)
T 3a99_A 192 IDFGSGALLKDTVY------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI 255 (320)
T ss_dssp CCCTTCEECCSSCB------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH
T ss_pred eeCccccccccccc------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------hh
Confidence 99999987654221 12348999999998876665 678999999999999999999996421 10
Q ss_pred HHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 529 ITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 529 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ..... .... ....+.+++.+||+.||++|||++|+++
T Consensus 256 ~---~~~~~---------~~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 I---RGQVF---------FRQR---VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp H---HCCCC---------CSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h---ccccc---------cccc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 0111 2245667777999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=334.41 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=186.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
..+|...+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 346888899999999997766667899999999965432 2356899999999 7999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-----CCceEEcccCccccc
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-----DFEPKLSDFGLARLM 458 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~a~~~ 458 (618)
+ |+|.+++..... ...+..++.++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++..
T Consensus 101 ~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 599999876542 244455678999999999999999 9999999999999943 346889999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCC---CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPR---TLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |..||..... ........
T Consensus 174 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~~~~~~ 243 (432)
T 3p23_A 174 AVGRHSF-SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQANILLG 243 (432)
T ss_dssp -------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHHHHHTT
T ss_pred cCCCcce-eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHHHHHhc
Confidence 5432111 1122345899999999987 4567889999999999999999 9999854321 11111111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... ... .........+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 244 ACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1110 000 011233455678888999999999999999983
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=322.94 Aligned_cols=250 Identities=20% Similarity=0.287 Sum_probs=176.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccC--H-HHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHS--E-KEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.++|+..+.||+|+||.||+|... +|+.||+|++...... . +.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888999999999999999964 7899999999764322 2 23444555688889999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
||+ ++.+..+..... ..+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 445544443222 358999999999999999999998 6 89999999999999999999999999997654
Q ss_pred CCCCcccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
..... ....||+.|+|||++. ...++.++||||||+++|||++|+.||..... ..........
T Consensus 177 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~ 244 (318)
T 2dyl_A 177 DDKAK-----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKVLQ 244 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHH
T ss_pred CCccc-----cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHHhc
Confidence 42221 1234899999999984 56788999999999999999999999975321 1111111111
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... +.+.. .......+.+++.+||+.||.+||+++|+++
T Consensus 245 ~~~------~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 245 EEP------PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SCC------CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCC------CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 00000 0112245667777999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=348.06 Aligned_cols=268 Identities=23% Similarity=0.280 Sum_probs=201.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEe------CCe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVA------KKE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 375 (618)
.++|++.+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999995 568999999987542 335678999999999999999999999765 567
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCc---eEEccc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFE---PKLSDF 452 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 452 (618)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence 8999999999999999976442 23588999999999999999999999 9999999999999997665 999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
|.+......... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..|....
T Consensus 169 G~a~~~~~~~~~-----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-------~~~~~~i 236 (676)
T 3qa8_A 169 GYAKELDQGELC-----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-------VQWHGKV 236 (676)
T ss_dssp CCCCBTTSCCCC-----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-------HHSSTTC
T ss_pred cccccccccccc-----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-------hhhhhhh
Confidence 999876543221 2234899999999999999999999999999999999999999753211 1110000
Q ss_pred hcCCc----cchhc------ccc--ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH-----HHHHHHHhhh
Q 007088 533 NTNSS----LETAI------DKS--LLGNGFDGELHQFLRVACNCVLPTPKERHTMFE-----VYQLLRAIAE 588 (618)
Q Consensus 533 ~~~~~----~~~~~------d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~i~~ 588 (618)
..... ..+.. ... ............+.+++.+||+.||++|||+.| ..+.++++.+
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000 00000 000 011123345677888888999999999999988 5666766654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=308.92 Aligned_cols=231 Identities=13% Similarity=0.080 Sum_probs=182.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCcc----CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQH----SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+..+.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57999999999999999999964 589999999976532 2367899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++++|.+++... ....++.+++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999532 35567889999999999999999 99999999999999999999998443
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
|++| ++.++|||||||++|||++|+.||......+........ . ...
T Consensus 175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~----~--~~~--- 221 (286)
T 3uqc_A 175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD----T--AGQ--- 221 (286)
T ss_dssp -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC----T--TSC---
T ss_pred -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH----h--ccC---
Confidence 3333 578999999999999999999999865432211000000 0 000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.....-. .......+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 222 ~~~~~~~---~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 222 PIEPADI---DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp BCCHHHH---CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCChhhc---ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0000000 01123456777889999999999 999999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=348.27 Aligned_cols=239 Identities=20% Similarity=0.285 Sum_probs=192.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC--CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCe-----
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP--GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKE----- 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 375 (618)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999964 68999999986533 334568899999999999999999999987665
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987753 489999999999999999999999 99999999999999986 8999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
+..... ....||+.|+|||++.+. ++.++|||||||++|||++|..||.........
T Consensus 229 ~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------------- 285 (681)
T 2pzi_A 229 SRINSF--------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------------- 285 (681)
T ss_dssp EETTCC--------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC--------------
T ss_pred hhcccC--------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc--------------
Confidence 876543 123489999999988665 488999999999999999999887642111000
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-TMFEVYQLLRAIA 587 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 587 (618)
...........+.+++.+||+.||++|| +++++...|..+.
T Consensus 286 -----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 -----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000112234677888899999999999 5667777777654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.72 Aligned_cols=242 Identities=15% Similarity=0.146 Sum_probs=178.9
Q ss_pred hhccCCCCcEEeecCCeeEEEEE-eCCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCC-CCc---------cceeE
Q 007088 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRH-RNL---------VPLLG 368 (618)
Q Consensus 304 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h-~ni---------v~l~~ 368 (618)
.+..|...+.||+|+||.||+|. ..+|+.||||++.... ...+.+.+|+.+++.++| +|. +...+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34567778999999999999999 5579999999997332 235678999999999987 321 11111
Q ss_pred E------------EEe-----CCeeEEEEeecCCCccccccCCC---CCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007088 369 F------------CVA-----KKERLLVYSYLENGTLYDKLHPA---EHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428 (618)
Q Consensus 369 ~------------~~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 428 (618)
. +.. ....+++|+++ +++|.+++... ......+++..++.++.||++||+|||++ +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 1 111 12356777765 57999888411 11124588899999999999999999999 9
Q ss_pred ceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCC----------CCCCCCCccchHHH
Q 007088 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP----------RTLVATPKGDVYSF 498 (618)
Q Consensus 429 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDVwS~ 498 (618)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 999999999999999999999999999865432 223347 999999998 66678899999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 007088 499 GVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFE 578 (618)
Q Consensus 499 Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 578 (618)
||++|||++|+.||......+... ..+... ... ...+.+++.+||+.||++||++.|
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~-----------------~~~~~~---~~~---~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSE-----------------WIFRSC---KNI---PQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSG-----------------GGGSSC---CCC---CHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHCCCCCCCcchhhhHH-----------------HHHhhc---ccC---CHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999999997643221111 011100 011 245777778999999999999777
Q ss_pred HH
Q 007088 579 VY 580 (618)
Q Consensus 579 vl 580 (618)
++
T Consensus 361 ~l 362 (413)
T 3dzo_A 361 AM 362 (413)
T ss_dssp HT
T ss_pred HH
Confidence 64
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.35 Aligned_cols=227 Identities=19% Similarity=0.255 Sum_probs=176.7
Q ss_pred hccCCCC-cEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHH-hcCCCCCccceeEEEEe----CCeeE
Q 007088 305 TNSFSKN-NIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTL-GSVRHRNLVPLLGFCVA----KKERL 377 (618)
Q Consensus 305 ~~~y~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 377 (618)
.++|.+. +.||+|+||.||++.. .+++.||+|+++.. ..+.+|++++ +..+||||+++++++.. ....+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 3456666 7799999999999995 57899999999653 3567888887 55699999999999987 66789
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEcccCc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSDFGL 454 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~ 454 (618)
+||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999976543 4599999999999999999999999 9999999999999998 78899999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
+.... +..++.++|||||||++|||++|+.||...........
T Consensus 167 a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----------- 209 (299)
T 3m2w_A 167 AKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------- 209 (299)
T ss_dssp CEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC-----------
T ss_pred ccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH-----------
Confidence 86432 13457899999999999999999999975432211000
Q ss_pred CCccchhccccccCCCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGF----DGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....+... ..... ......+.+++.+||+.||.+|||+.|+++
T Consensus 210 ---~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 ---MKTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---SCCSSCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHHhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000 00001 112346777888999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=317.83 Aligned_cols=237 Identities=14% Similarity=0.087 Sum_probs=182.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---------cCHHHHHHHHHHHhcCC---------CCCccce
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---------HSEKEFLSEINTLGSVR---------HRNLVPL 366 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~---------h~niv~l 366 (618)
.++|++.+.||+|+||.||+|+. +|+.||||+++... ...+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 78999999997532 23477889999988885 7777777
Q ss_pred eEEEE------------------------------eCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHH
Q 007088 367 LGFCV------------------------------AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSAR 416 (618)
Q Consensus 367 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 416 (618)
.+++. ..+..++||||+++|++.+.+.. ..+++..++.++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 77643 25788999999999987777743 24899999999999999
Q ss_pred HHHHHH-hCCCCCceecCCCCCCeeeCCCC--------------------ceEEcccCcccccCCCCCcccccccCCCCc
Q 007088 417 GLAWLH-HNCNPRIIHRNISSKCILLDGDF--------------------EPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475 (618)
Q Consensus 417 ~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt 475 (618)
||+||| +. +|+||||||+|||++.++ .+||+|||+|+..... ...||
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------~~~gt 240 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG---------IVVFC 240 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT---------EEECC
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC---------cEEEe
Confidence 999999 88 999999999999999887 8999999999876532 12389
Q ss_pred ccccCCCCCCCCCCCCccchHHHHHH-HHHHHhCCCCCCCCCCCCccccCHHHHHHHH----hcCCccchhccccccCCC
Q 007088 476 LGYVAPEYPRTLVATPKGDVYSFGVV-LLELITGERPTHLTNAPESFKGSLVEWITLL----NTNSSLETAIDKSLLGNG 550 (618)
Q Consensus 476 ~~y~aPE~~~~~~~~~~sDVwS~Gvi-l~elltG~~Pf~~~~~~~~~~~~l~~~~~~~----~~~~~~~~~~d~~l~~~~ 550 (618)
+.|+|||++.+.. +.++||||+|++ .+++++|..||.. ..|.... ....... .......
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~----~~~~~~~ 304 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFK----TKCNTPA 304 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCS----SCCCSHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccC----cccchhh
Confidence 9999999998766 889999998777 7778889988742 1111111 1000000 0000011
Q ss_pred CHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 007088 551 FDGELHQFLRVACNCVLPTPKERHTMFEVY 580 (618)
Q Consensus 551 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl 580 (618)
......++.+++.+||+.| |++|++
T Consensus 305 ~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 305 MKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 2345677888999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.7e-31 Score=289.17 Aligned_cols=183 Identities=18% Similarity=0.049 Sum_probs=128.7
Q ss_pred EeecCCeeEEEEE-eCCCcEEEEEEeccCc-----------cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEEE
Q 007088 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQ-----------HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 314 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 380 (618)
.+.|+.|.+..++ .--|+.|++|++.... ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666666554 3457889999996531 2235699999999999 7999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||++|++|.++|.... +++.. +|+.||+.||+|+|++ |||||||||+|||++.++++||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~~----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTC----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCC----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999997654 36654 5889999999999999 999999999999999999999999999987655
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~P 511 (618)
....... .+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~~~~t----~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSWPTN----LVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHH----HHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCccccC----ceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4333222 348999999999876 467789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-27 Score=259.41 Aligned_cols=187 Identities=17% Similarity=0.163 Sum_probs=145.7
Q ss_pred CCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 309 SKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
...+.||+|+||.||++.. .+..+++|+..... ...+.+.+|++++++++||||+++..++...++.++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 56788888764321 1134589999999999999999777777788888999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 457999999999999999 9999999999999999 99999999999876
Q ss_pred CCCCcccc---cccCCCCcccccCCCCCCC--CCCCCccchHHHHHHHHHHHhCCCCCC
Q 007088 460 PVDTHLST---FVNGEFGDLGYVAPEYPRT--LVATPKGDVYSFGVVLLELITGERPTH 513 (618)
Q Consensus 460 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDVwS~Gvil~elltG~~Pf~ 513 (618)
........ ......||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 53221100 1112348999999999876 567888999999999999988887763
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.93 E-value=6.6e-26 Score=232.31 Aligned_cols=175 Identities=27% Similarity=0.448 Sum_probs=155.8
Q ss_pred cCCcchHHHHHHHHHhccCCCCccccCccCCCCCCCCCCc--ccceecCCCC-CCcEEEEEecCCccee--eCCcCCCCC
Q 007088 31 LATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQ--FTGVDCWHPD-ENKVLNIRLSDMGLKG--QFPRGIERC 105 (618)
Q Consensus 31 ~~~~~~~~~L~~~k~~~~~~~~~l~~~W~~~~~~~~~~c~--w~gv~c~~~~-~~~v~~l~l~~~~l~g--~~p~~~~~l 105 (618)
.|.+.|++||++||+++.||. .+. +|..+ .+||. |.||.|+... .++|+.|+|++|+++| .+|+.++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~-~W~~~----~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l 75 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLS-SWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANL 75 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGT-TCCTT----SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-ccc-CCCCC----CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCC
Confidence 488999999999999998886 444 89743 35787 9999996421 2799999999999999 999999999
Q ss_pred CCCCeEEccC-CcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccccccc
Q 007088 106 TSLTGLDLSS-NNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTF 184 (618)
Q Consensus 106 ~~L~~L~l~~-n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l 184 (618)
++|++|+|++ |++.|.+|..+.. +++|++|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++.+++|++|
T Consensus 76 ~~L~~L~L~~~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 154 (313)
T 1ogq_A 76 PYLNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CCCCeeeCCCCCcccccCChhHhc-CCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeE
Confidence 9999999995 9999999999876 9999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCc-c--ccccccccCCC
Q 007088 185 SVASNLLTGPVPSFAN-V--NFTAEDFANNS 212 (618)
Q Consensus 185 ~l~~N~l~g~ip~~~~-~--~~~~~~~~~n~ 212 (618)
++++|+++|.+|.... . .+..+++++|.
T Consensus 155 ~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~ 185 (313)
T 1ogq_A 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSE
T ss_pred ECcCCcccCcCCHHHhhhhhcCcEEECcCCe
Confidence 9999999999996432 2 45677888874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=214.60 Aligned_cols=142 Identities=13% Similarity=0.138 Sum_probs=116.8
Q ss_pred CHHHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc-------------------CHHHHHHHHHHHhc
Q 007088 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH-------------------SEKEFLSEINTLGS 357 (618)
Q Consensus 297 ~~~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~ 357 (618)
.+..+......|...+.||+|+||.||+|...+|+.||+|.++.... ....+.+|+.++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34555566667778899999999999999997899999999964321 24568899999999
Q ss_pred CCCCCccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 007088 358 VRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437 (618)
Q Consensus 358 l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 437 (618)
++ | +++.+++.. +..++||||+++|+|.+ +... ....++.|++.||.|||+. +|+||||||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~~----------~~~~i~~qi~~~l~~lH~~---giiHrDlkp~ 222 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRVE----------NPDEVLDMILEEVAKFYHR---GIVHGDLSQY 222 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCCS----------CHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cchh----------hHHHHHHHHHHHHHHHHHC---CCEeCCCCHH
Confidence 99 5 666665543 56799999999999998 4321 2346999999999999999 9999999999
Q ss_pred CeeeCCCCceEEcccCcccc
Q 007088 438 CILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 438 NIll~~~~~~kl~DfG~a~~ 457 (618)
|||++ ++.+||+|||+++.
T Consensus 223 NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE
T ss_pred HEEEE-CCcEEEEECCCCeE
Confidence 99999 99999999999973
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-24 Score=245.31 Aligned_cols=174 Identities=19% Similarity=0.271 Sum_probs=150.2
Q ss_pred CCcchHHHHHHHHHhccCCCCccccCccCCC---CCCCCCCcc------------cceecCCCCCCcEEEEEecCCccee
Q 007088 32 ATLNDIECLKSVKNSLEDPFNYLTTSWNFNN---NTEGFICQF------------TGVDCWHPDENKVLNIRLSDMGLKG 96 (618)
Q Consensus 32 ~~~~~~~~L~~~k~~~~~~~~~l~~~W~~~~---~~~~~~c~w------------~gv~c~~~~~~~v~~l~l~~~~l~g 96 (618)
+...|+.||++||+++.+| +|+.++ ..++++|.| .||.|+. .++|+.|+|++++|+|
T Consensus 266 ~~~~d~~ALl~~k~~l~~~------~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~G 337 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK------NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKG 337 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG------GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCEE
T ss_pred cchHHHHHHHHHHHHcCCC------CCCcCCCcccccCCccccccccccccccCcCceEecC--CCCEEEEECccCCCCC
Confidence 4457999999999999877 787654 122334999 9999975 5899999999999999
Q ss_pred eCCcCCCCCCCCCeEEc-cCCcCccc------------------------------------------------------
Q 007088 97 QFPRGIERCTSLTGLDL-SSNNLSGS------------------------------------------------------ 121 (618)
Q Consensus 97 ~~p~~~~~l~~L~~L~l-~~n~l~g~------------------------------------------------------ 121 (618)
.+|++|++|++|++|+| ++|.++|.
T Consensus 338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i 417 (876)
T 4ecn_A 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417 (876)
T ss_dssp EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence 99999999999999999 88877666
Q ss_pred ----------------------cCchhhhcCCCCCEEEeeCCCCcc-----------------cCCCCCc--CCCCCcEE
Q 007088 122 ----------------------IPSDISSRLQYVTSLDLSSNSLSG-----------------EIPSGLA--NCTFLNVL 160 (618)
Q Consensus 122 ----------------------ip~~~~~~l~~L~~L~l~~N~l~g-----------------~ip~~~~--~l~~L~~l 160 (618)
||.++++ |++|+.|+|++|+|+| .||.+++ +|++|+.|
T Consensus 418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~-L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L 496 (876)
T 4ecn_A 418 KKDSRISLKDTQIGNLTNRITFISKAIQR-LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDV 496 (876)
T ss_dssp CCCCCCCCCTTTTTCCSCEEEEECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEE
T ss_pred ccccccchhhceeccccCcccchhHHHhc-CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEE
Confidence 8888876 9999999999999999 4999998 99999999
Q ss_pred EccCcccCCCCCcccccccccccccccccc-ccC-CCCCCCc-c--------ccccccccCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNL-LTG-PVPSFAN-V--------NFTAEDFANNSGL 214 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~-l~g-~ip~~~~-~--------~~~~~~~~~n~~~ 214 (618)
+|++|++.|.+|..++++++|+.|+|++|+ |+| .+|.... + ++..+++++|...
T Consensus 497 ~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 497 ELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp EEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 999999999999999999999999999998 999 8885321 1 4667778887644
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=235.56 Aligned_cols=174 Identities=21% Similarity=0.269 Sum_probs=151.6
Q ss_pred CcchHHHHHHHHHhccCCCCcccc-------CccCCCCCCCCCCcc---cceecCCCCCCcEEEEEecCCcceeeCCcCC
Q 007088 33 TLNDIECLKSVKNSLEDPFNYLTT-------SWNFNNNTEGFICQF---TGVDCWHPDENKVLNIRLSDMGLKGQFPRGI 102 (618)
Q Consensus 33 ~~~~~~~L~~~k~~~~~~~~~l~~-------~W~~~~~~~~~~c~w---~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~~ 102 (618)
...|+.||.++++++.++.+.... +|+.+ .+||.| .||+|+. .++|+.|+|++++++|.+|++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~----~~~c~w~~~~GV~C~~--~~~V~~L~L~~~~l~g~lp~~l 101 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN----KELDMWGAQPGVSLNS--NGRVTGLSLEGFGASGRVPDAI 101 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS----SCGGGTTCCTTEEECT--TCCEEEEECTTSCCEEEECGGG
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC----CCcccccCCCCeEEcC--CCCEEEEEecCcccCCcCChHH
Confidence 346999999999999877544332 68743 568999 9999975 3899999999999999999999
Q ss_pred CCCCCCCeEEccCC------------------------------------------------------------------
Q 007088 103 ERCTSLTGLDLSSN------------------------------------------------------------------ 116 (618)
Q Consensus 103 ~~l~~L~~L~l~~n------------------------------------------------------------------ 116 (618)
++|++|++|+|++|
T Consensus 102 ~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~ 181 (636)
T 4eco_A 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181 (636)
T ss_dssp GGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCC
T ss_pred hcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccccc
Confidence 99999999999988
Q ss_pred ------------cCccccCchhhhcCCCCCEEEeeCCCCccc-----------------CCCCCc--CCCCCcEEEccCc
Q 007088 117 ------------NLSGSIPSDISSRLQYVTSLDLSSNSLSGE-----------------IPSGLA--NCTFLNVLKLNNN 165 (618)
Q Consensus 117 ------------~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~-----------------ip~~~~--~l~~L~~l~l~~N 165 (618)
+|+| ||.+++. +++|++|+|++|+|+|. +|.+++ ++++|++|+|++|
T Consensus 182 ~l~~l~l~~~~n~l~~-ip~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n 259 (636)
T 4eco_A 182 TLKDTQIGQLSNNITF-VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNC 259 (636)
T ss_dssp CCCTTTTTCCSCEEEE-ECGGGGG-CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECC
T ss_pred chhhhhhccccCCCcc-CCHHHhc-ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCC
Confidence 4556 9998876 99999999999999996 999999 9999999999999
Q ss_pred ccCCCCCcccccccccccccccccc-ccC-CCCCCC-c-------cccccccccCCCCC
Q 007088 166 RFTGKIPPQLGLLNRIKTFSVASNL-LTG-PVPSFA-N-------VNFTAEDFANNSGL 214 (618)
Q Consensus 166 ~l~g~~p~~l~~~~~L~~l~l~~N~-l~g-~ip~~~-~-------~~~~~~~~~~n~~~ 214 (618)
++.|.+|..++++++|+.|++++|+ ++| .+|... . .++..+++++|...
T Consensus 260 ~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~ 318 (636)
T 4eco_A 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318 (636)
T ss_dssp TTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred cCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence 9999999999999999999999998 999 888532 1 26777888888644
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.1e-23 Score=237.22 Aligned_cols=174 Identities=30% Similarity=0.365 Sum_probs=144.6
Q ss_pred ccCCcchHHHHHHHHHhccCCCCccccCccCCCCCCCCCCcccceecCCCCCCcEEEEEecCCcceee---CC-------
Q 007088 30 SLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQ---FP------- 99 (618)
Q Consensus 30 ~~~~~~~~~~L~~~k~~~~~~~~~l~~~W~~~~~~~~~~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~---~p------- 99 (618)
+.+...|++||++||+++.||. .+. +|+. +.+||.|.||+|+ .++|+.|+|+++++.|. +|
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~-~W~~----~~~~C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~ 77 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLP-DWSS----NKNPCTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLT 77 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SST-TCCT----TSCGGGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCT
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-ccc-CCCC----CCCCcCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccC
Confidence 3456789999999999999987 554 9973 3469999999996 58999999999999997 44
Q ss_pred ----------------cCCCCCCCCCeEEccCCcCccccCc--hhhhcCCCCCEEEeeCCCCcccCCCCC-cCCCCCcEE
Q 007088 100 ----------------RGIERCTSLTGLDLSSNNLSGSIPS--DISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVL 160 (618)
Q Consensus 100 ----------------~~~~~l~~L~~L~l~~n~l~g~ip~--~~~~~l~~L~~L~l~~N~l~g~ip~~~-~~l~~L~~l 160 (618)
+.++++++|++|||++|.++|.+|. .++. +++|++|+|++|.++|.+|..+ +++++|++|
T Consensus 78 ~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~-l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L 156 (768)
T 3rgz_A 78 GLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGS-CSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156 (768)
T ss_dssp TCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGG-CTTCCEEECCSSEEECCSSCCSCCCCTTCSEE
T ss_pred cccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhC-CCCCCEEECcCCccCCcCCHHHhccCCCCCEE
Confidence 5788889999999999999999998 8875 9999999999999999999876 889999999
Q ss_pred EccCcccCCCCCcc---ccccccccccccccccccCCCCCCCccccccccccCCCC
Q 007088 161 KLNNNRFTGKIPPQ---LGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSG 213 (618)
Q Consensus 161 ~l~~N~l~g~~p~~---l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~ 213 (618)
+|++|+++|.+|.. ++++++|+.|++++|.++|.+|...-.++..+++++|..
T Consensus 157 ~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l 212 (768)
T 3rgz_A 157 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNF 212 (768)
T ss_dssp ECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCC
T ss_pred ECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcC
Confidence 99999999888877 777888888888888888877753223566667777754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=6.4e-22 Score=203.96 Aligned_cols=178 Identities=18% Similarity=0.259 Sum_probs=146.2
Q ss_pred ccCCcchHHHHHHHHHhc-cCCCCccccCccCCCCCCCCCCcccceecCC-------CCCCcEEEEEecCCcceeeCCcC
Q 007088 30 SLATLNDIECLKSVKNSL-EDPFNYLTTSWNFNNNTEGFICQFTGVDCWH-------PDENKVLNIRLSDMGLKGQFPRG 101 (618)
Q Consensus 30 ~~~~~~~~~~L~~~k~~~-~~~~~~l~~~W~~~~~~~~~~c~w~gv~c~~-------~~~~~v~~l~l~~~~l~g~~p~~ 101 (618)
+.+..+++.||++||.++ .++.+.+ .+|...+.....+|.|.|+.|.. ....+|+.|+|++|+++ .+|+.
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~-~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHH-HHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred cccCchHHHHHHHHHHhccCCchhhh-hhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 446678999999999998 4665554 48964444567799999999952 12468999999999998 89999
Q ss_pred CCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccc----
Q 007088 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGL---- 177 (618)
Q Consensus 102 ~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~---- 177 (618)
++++++|++|+|++|+++ .+|..++. +++|++|+|++|+++ .+|..++++++|+.|+|++|++.|.+|..++.
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~-l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~ 176 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGG-GTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-C
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhc-cCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccch
Confidence 999999999999999999 89988875 999999999999999 89999999999999999999999999988765
Q ss_pred -----cccccccccccccccCCCCCCCc-c-ccccccccCCCC
Q 007088 178 -----LNRIKTFSVASNLLTGPVPSFAN-V-NFTAEDFANNSG 213 (618)
Q Consensus 178 -----~~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~ 213 (618)
+++|+.|+|++|+++ .+|.... + ++..+++++|..
T Consensus 177 ~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l 218 (328)
T 4fcg_A 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218 (328)
T ss_dssp CCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCC
T ss_pred hhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCC
Confidence 889999999999998 6775322 1 566677777753
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.7e-21 Score=222.10 Aligned_cols=138 Identities=33% Similarity=0.617 Sum_probs=129.3
Q ss_pred EEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcc
Q 007088 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166 (618)
Q Consensus 87 l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~ 166 (618)
++++.|.++|.+|..++++++|+.|||++|+|+|.||.+++. +++|+.|+|++|+|+|.||.++++|++|+.|||++|+
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~-l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS-MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGG-CTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhc-cccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 456678999999999999999999999999999999999986 9999999999999999999999999999999999999
Q ss_pred cCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCCCCCCCCCCCCCCC
Q 007088 167 FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNSGLCGKPLNPCPGV 225 (618)
Q Consensus 167 l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~~c~~~~~~C~~~ 225 (618)
|+|.||..++.+++|+.|+|++|+|+|.||....+ .+...+|.||+++||.|..+|...
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~ 751 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS 751 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSC
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCC
Confidence 99999999999999999999999999999976543 677889999999999999899754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=8.1e-20 Score=178.12 Aligned_cols=151 Identities=22% Similarity=0.260 Sum_probs=131.6
Q ss_pred CCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 65 EGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
..+.|+|++|.|.... ..+++.|+|++|++++..|..+.++++|++|+|++|+|+ .+|...+..+++|++|
T Consensus 15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L 93 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVL 93 (229)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEE
Confidence 4568999999997532 357899999999999998999999999999999999997 7887766669999999
Q ss_pred EeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCC
Q 007088 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGL 214 (618)
Q Consensus 137 ~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 214 (618)
+|++|+|++..|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.... .++..+++.+|++.
T Consensus 94 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 94 DLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred ECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 99999999655566899999999999999999 8999999999999999999999987765332 26778899999998
Q ss_pred CCC
Q 007088 215 CGK 217 (618)
Q Consensus 215 c~~ 217 (618)
|.+
T Consensus 173 c~c 175 (229)
T 3e6j_A 173 CEC 175 (229)
T ss_dssp TTB
T ss_pred CCc
Confidence 853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.1e-20 Score=182.94 Aligned_cols=145 Identities=14% Similarity=0.101 Sum_probs=109.6
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEe-CCCcE--EEEEEeccCccC-------------------------HHHHHH
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAML-PGGCF--IMIKRLEDSQHS-------------------------EKEFLS 350 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~ 350 (618)
..+.....-|++.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+
T Consensus 40 ~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (258)
T 1zth_A 40 YKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK 119 (258)
T ss_dssp HHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred HHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence 33333333467788999999999999997 78888 999987543111 135789
Q ss_pred HHHHHhcCCCCCc--cceeEEEEeCCeeEEEEeecCC-C----ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHH-
Q 007088 351 EINTLGSVRHRNL--VPLLGFCVAKKERLLVYSYLEN-G----TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH- 422 (618)
Q Consensus 351 E~~~l~~l~h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH- 422 (618)
|+.++.+++|+++ +.++++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.|||
T Consensus 120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHH
Confidence 9999999988864 344432 356899999942 4 44443321 224457789999999999999
Q ss_pred hCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 423 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
+. +|+||||||+|||++. .++|+|||+|....
T Consensus 189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TS---CEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred HC---CEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 88 9999999999999998 99999999997653
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=9.4e-19 Score=167.82 Aligned_cols=152 Identities=24% Similarity=0.265 Sum_probs=128.3
Q ss_pred CCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 65 EGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
..+.|.|.+|.|.... ..+++.|+|++|++++..+..+.++++|++|+|++|+++ .+|...+..+++|++|
T Consensus 3 ~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred CCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEE
Confidence 3467899999997532 347899999999999766677899999999999999999 6777665569999999
Q ss_pred EeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCC
Q 007088 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGL 214 (618)
Q Consensus 137 ~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 214 (618)
+|++|++++..|..++++++|+.|+|++|+|++..|..+..+++|+.|++++|++++..+.... .++..+++++|+..
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 9999999965555689999999999999999977677789999999999999999987775332 26788899999887
Q ss_pred CCC
Q 007088 215 CGK 217 (618)
Q Consensus 215 c~~ 217 (618)
|..
T Consensus 162 ~~~ 164 (208)
T 2o6s_A 162 CTC 164 (208)
T ss_dssp CCT
T ss_pred cCC
Confidence 754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=8.1e-19 Score=169.90 Aligned_cols=151 Identities=23% Similarity=0.310 Sum_probs=130.7
Q ss_pred CCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 65 EGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
..+.|.|..|.|.... ...++.|+|++|++++..+..+..+++|+.|+|++|++++..|..+.+ +++|++|
T Consensus 7 ~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~-l~~L~~L 85 (220)
T 2v9t_B 7 AACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQG-LRSLNSL 85 (220)
T ss_dssp TTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTT-CSSCCEE
T ss_pred CCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhC-CcCCCEE
Confidence 4566889999997532 347899999999999888889999999999999999999766777765 9999999
Q ss_pred EeeCCCCcccCCCC-CcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc-c-ccccccccCCCC
Q 007088 137 DLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-V-NFTAEDFANNSG 213 (618)
Q Consensus 137 ~l~~N~l~g~ip~~-~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~ 213 (618)
+|++|+|+ .+|.. +..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|.... + ++..+++++|++
T Consensus 86 ~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 86 VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred ECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 99999999 56654 68999999999999999998899999999999999999999998886432 2 577889999999
Q ss_pred CCCC
Q 007088 214 LCGK 217 (618)
Q Consensus 214 ~c~~ 217 (618)
.|.+
T Consensus 165 ~c~c 168 (220)
T 2v9t_B 165 ICDC 168 (220)
T ss_dssp ECSG
T ss_pred CCCC
Confidence 8853
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-19 Score=170.43 Aligned_cols=152 Identities=19% Similarity=0.204 Sum_probs=129.6
Q ss_pred CCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCc-CCCCCCCCCeEEccCCcCccccCchhhhcCCCCCE
Q 007088 65 EGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPR-GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTS 135 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~-~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~ 135 (618)
..|.|.|..+.|++.. ...++.|+|++|+|++..|. .+.++++|+.|+|++|++++..|..+. ++++|++
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~-~l~~L~~ 85 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFE-GASGVNE 85 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTT-TCTTCCE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhC-CCCCCCE
Confidence 4566889999997532 23578999999999988664 489999999999999999954444554 5999999
Q ss_pred EEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc-c-ccccccccCCCC
Q 007088 136 LDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-V-NFTAEDFANNSG 213 (618)
Q Consensus 136 L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~ 213 (618)
|+|++|++++..|..++++++|++|+|++|+|++..|..+..+++|+.|+|++|++++.+|.... + ++..+++++|++
T Consensus 86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 99999999977777799999999999999999998899999999999999999999999886443 2 577889999999
Q ss_pred CCCC
Q 007088 214 LCGK 217 (618)
Q Consensus 214 ~c~~ 217 (618)
.|.+
T Consensus 166 ~c~c 169 (220)
T 2v70_A 166 NCNC 169 (220)
T ss_dssp ECSG
T ss_pred cCCC
Confidence 8854
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.76 E-value=4.5e-19 Score=181.40 Aligned_cols=137 Identities=31% Similarity=0.474 Sum_probs=97.7
Q ss_pred EEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEcc
Q 007088 84 VLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163 (618)
Q Consensus 84 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~ 163 (618)
++.|+|++|+++|.+|..++.++ |+.|+|++|++++.+|..+. .+++|+.|+|++|++++.+|. +..+++|+.|+|+
T Consensus 176 L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 176 FTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp CCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCC-TTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred CcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHh-cCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 44444444444444444444443 44444444444444444443 366777777777777765554 6778888999999
Q ss_pred CcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCCCCCCCCCCCCC
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNSGLCGKPLNPCP 223 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~~c~~~~~~C~ 223 (618)
+|+|+|.+|..+..+++|+.|+|++|+++|.+|....+ ++..+++++|+++||.|..+|.
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C~ 313 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCCCCC
Confidence 99999999999999999999999999999999986433 6788899999999999887773
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=164.88 Aligned_cols=152 Identities=21% Similarity=0.259 Sum_probs=113.7
Q ss_pred CCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCc-CCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 66 GFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPR-GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 66 ~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~-~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
.+.|.|..+.|+... ...++.|+|++|++++..+. .++++++|++|+|++|+|++..|..+.. +++|++|
T Consensus 5 ~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L 83 (192)
T 1w8a_A 5 MCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG-ASHIQEL 83 (192)
T ss_dssp TSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEE
T ss_pred CCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCC-cccCCEE
Confidence 456889988886532 23778888888888866654 3788888888888888888766776654 8888888
Q ss_pred EeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCCCCC
Q 007088 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNSGLC 215 (618)
Q Consensus 137 ~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~~c 215 (618)
+|++|++++..|..++++++|+.|+|++|+|++.+|..+..+++|+.|+|++|.+++..|-..- ..+....+.++...|
T Consensus 84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C 163 (192)
T 1w8a_A 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBB
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCC
Confidence 8888888877777788888888888988888888888888888888888888888887763111 012222444555556
Q ss_pred CCC
Q 007088 216 GKP 218 (618)
Q Consensus 216 ~~~ 218 (618)
+.|
T Consensus 164 ~~P 166 (192)
T 1w8a_A 164 GAP 166 (192)
T ss_dssp CSS
T ss_pred CCC
Confidence 544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-17 Score=154.76 Aligned_cols=131 Identities=21% Similarity=0.255 Sum_probs=99.9
Q ss_pred CCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEE
Q 007088 66 GFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLD 137 (618)
Q Consensus 66 ~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~ 137 (618)
.+.|+|.++.|.... ...++.|+|++|++++..+..+.++++|++|+|++|+++ .+|...+..+++|+.|+
T Consensus 4 ~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~ 82 (177)
T 2o6r_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILY 82 (177)
T ss_dssp TCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEE
Confidence 466899999996532 246788888888888666666788888888888888888 56655444588888888
Q ss_pred eeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCC
Q 007088 138 LSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 138 l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
|++|++++..|..++++++|+.|+|++|+|++..+..+..+++|+.|++++|.+++..|.
T Consensus 83 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 83 LHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 888888865555678888888888888888854444567788888888888888887763
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.71 E-value=4e-17 Score=161.33 Aligned_cols=130 Identities=20% Similarity=0.198 Sum_probs=83.1
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|++++..|..+.++++|++|+|++|++++..|..+. ++++|++|+|++|++++..|..++.+++|+.|+
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 113 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFD-DLTELGTLGLANNQLASLPLGVFDHLTQLDKLY 113 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT-TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhc-cCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence 3567777777777776666777777777777777777754443343 377777777777777754445566677777777
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCC-c-cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-N-VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-~-~~~~~~~~~~n~ 212 (618)
|++|+|++..|..+..+++|+.|+|++|++++..|... . .++..+++++|.
T Consensus 114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 77777765444455666666777777666666555322 1 144555555554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.2e-16 Score=165.16 Aligned_cols=146 Identities=13% Similarity=0.101 Sum_probs=106.2
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc---------------CHH--------HHHHHHHHH
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH---------------SEK--------EFLSEINTL 355 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~--------~~~~E~~~l 355 (618)
..+.+.-.-|++.+.||+|++|.||+|...+|+.||||+++.... ... ...+|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 334443344899999999999999999998999999998753210 011 123567777
Q ss_pred hcCCCCCccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 007088 356 GSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNIS 435 (618)
Q Consensus 356 ~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 435 (618)
.++.+.++.-..-+.. ...++||||++|++|.++.... ....++.|++.+|.|||+. ||||||||
T Consensus 168 ~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~~----------~~~~l~~qll~~l~~lH~~---gIVHrDLK 232 (397)
T 4gyi_A 168 KALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSVP----------DPASLYADLIALILRLAKH---GLIHGDFN 232 (397)
T ss_dssp HHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCCS----------CHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred HHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcccH----------HHHHHHHHHHHHHHHHHHC---CCcCCCCC
Confidence 7775554432222211 2347999999998887765321 2356889999999999999 99999999
Q ss_pred CCCeeeCCCC----------ceEEcccCcccccC
Q 007088 436 SKCILLDGDF----------EPKLSDFGLARLMN 459 (618)
Q Consensus 436 p~NIll~~~~----------~~kl~DfG~a~~~~ 459 (618)
|.|||+++++ .+.|+||+-+....
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999998776 38999999876544
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=151.46 Aligned_cols=130 Identities=24% Similarity=0.348 Sum_probs=113.7
Q ss_pred EEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccC
Q 007088 85 LNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164 (618)
Q Consensus 85 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~ 164 (618)
+.|++++|+|+ .+|..+.. +|++|+|++|++++..|..++..+++|++|+|++|++++.+|..++++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 47999999995 89987765 9999999999999544444445599999999999999998899999999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCCCc-c-ccccccccCCCCCCCC
Q 007088 165 NRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-V-NFTAEDFANNSGLCGK 217 (618)
Q Consensus 165 N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~-~~~~~~~~~n~~~c~~ 217 (618)
|+|++..|..+..+++|+.|+|++|++++.+|.... + ++..+++++|++.|.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 999998888899999999999999999999986543 2 6778899999988753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.5e-16 Score=155.50 Aligned_cols=130 Identities=20% Similarity=0.235 Sum_probs=102.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|++++..+..+.++++|++|+|++|+++ .+|..++.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 115 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELR 115 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEE
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEE
Confidence 35778888888888766668888999999999999888 67777666688899999999998865455678888899999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCC-c-cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-N-VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-~-~~~~~~~~~~n~ 212 (618)
|++|++++..|..++.+++|+.|+|++|++++..+... . .++..+++++|.
T Consensus 116 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 168 (270)
T 2o6q_A 116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ 168 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence 99998887777778888888888888888887666432 2 256667777774
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.5e-16 Score=147.28 Aligned_cols=126 Identities=26% Similarity=0.367 Sum_probs=105.9
Q ss_pred EEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcc
Q 007088 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166 (618)
Q Consensus 87 l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~ 166 (618)
+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..+.. +++|+.|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~-l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSN-YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGG-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhc-ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 455667777 6787664 68999999999999 89977765 9999999999999997767789999999999999999
Q ss_pred cCCCCCccccccccccccccccccccCCCCCCC-cc-ccccccccCCCCCCCC
Q 007088 167 FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-NV-NFTAEDFANNSGLCGK 217 (618)
Q Consensus 167 l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-~~-~~~~~~~~~n~~~c~~ 217 (618)
|++..|..|..+++|+.|+|++|++++..+... .+ ++..+++++|++.|.+
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 998878889999999999999999997776533 22 6778899999998854
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.4e-16 Score=147.32 Aligned_cols=129 Identities=22% Similarity=0.255 Sum_probs=110.9
Q ss_pred CCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 65 EGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
..+.|.|..|.|.+.. ...++.|+|++|+++ .+|..+.++++|+.|+|++|++++ +|...+.++++|++|
T Consensus 6 ~~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~-i~~~~f~~l~~L~~L 83 (193)
T 2wfh_A 6 TECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTL 83 (193)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred CCCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCE-eCHhHccCCCCCCEE
Confidence 3456788889996532 357899999999998 899999999999999999999995 554444459999999
Q ss_pred EeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCC
Q 007088 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPV 195 (618)
Q Consensus 137 ~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~i 195 (618)
+|++|++++..|..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|.++..-
T Consensus 84 ~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred ECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence 99999999877778999999999999999999655567899999999999999998643
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.64 E-value=7.7e-16 Score=153.99 Aligned_cols=137 Identities=20% Similarity=0.210 Sum_probs=110.7
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|++++..+..++++++|++|+|++|++++ +|+..+.++++|++|+|++|++++..|..++++++|+.|
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 162 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTEL 162 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCc-cCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEE
Confidence 3578889999999987777778899999999999999985 554443458999999999999996666667889999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCGKP 218 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~~~ 218 (618)
+|++|++++..|..++.+++|+.|++++|++++.+|.... .++..+++++|+..|.+|
T Consensus 163 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 163 DLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999999977777788899999999999999988775432 267778899998877543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=6.2e-16 Score=173.23 Aligned_cols=140 Identities=20% Similarity=0.230 Sum_probs=116.3
Q ss_pred ceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCc
Q 007088 73 GVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS 144 (618)
Q Consensus 73 gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~ 144 (618)
.|.|.... +..++.|+|++|+|++..|.+|.+|++|++|||++|+|+ .||+..+.+|++|++|+|++|+|+
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~-~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCC
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC-CcChhHhcCCCCCCEEEccCCcCC
Confidence 46786432 357899999999999877889999999999999999999 577665556999999999999999
Q ss_pred ccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccC-CCCCCCc--cccccccccCCCC
Q 007088 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN--VNFTAEDFANNSG 213 (618)
Q Consensus 145 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g-~ip~~~~--~~~~~~~~~~n~~ 213 (618)
+..|..|++|++|++|+|++|+|++..|..|+++++|+.|+|++|++++ .+|.+.. .++..+++++|..
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l 185 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 185 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence 6444568999999999999999998767789999999999999999986 4665433 2566777777753
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.5e-16 Score=166.23 Aligned_cols=147 Identities=18% Similarity=0.175 Sum_probs=126.0
Q ss_pred CCCcccc--eecCCCC-------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEE
Q 007088 67 FICQFTG--VDCWHPD-------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLD 137 (618)
Q Consensus 67 ~~c~w~g--v~c~~~~-------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~ 137 (618)
..|.|.+ |.|.+.. +.+++.|+|++|++++..|..++++++|++|+|++|.+.+.+|+..+.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3466555 8886532 357899999999999999999999999999999999999899776556699999999
Q ss_pred eeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcc--ccccccccccccccccccCCCCCC--Cc-cccccccccCCC
Q 007088 138 LSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQ--LGLLNRIKTFSVASNLLTGPVPSF--AN-VNFTAEDFANNS 212 (618)
Q Consensus 138 l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~--l~~~~~L~~l~l~~N~l~g~ip~~--~~-~~~~~~~~~~n~ 212 (618)
|++|++++..|..++++++|++|+|++|++++.+|.. ++.+++|+.|+|++|++++..|.. .. .++..+++++|.
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999877766 899999999999999999998863 22 257778888885
Q ss_pred C
Q 007088 213 G 213 (618)
Q Consensus 213 ~ 213 (618)
.
T Consensus 166 l 166 (455)
T 3v47_A 166 V 166 (455)
T ss_dssp B
T ss_pred c
Confidence 4
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=157.95 Aligned_cols=148 Identities=21% Similarity=0.172 Sum_probs=116.7
Q ss_pred CCCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCC-CCCCCCeEEccCCcCccccCchhhhcCCCCC
Q 007088 64 TEGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIE-RCTSLTGLDLSSNNLSGSIPSDISSRLQYVT 134 (618)
Q Consensus 64 ~~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~ 134 (618)
+..|.|.+..|.|.+.. ...++.|+|++|+|++..+..+. ++++|+.|+|++|+|++ +|+..+.++++|+
T Consensus 13 p~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~-i~~~~~~~l~~L~ 91 (361)
T 2xot_A 13 PANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLR 91 (361)
T ss_dssp CTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCE-ECTTTTTTCTTCC
T ss_pred CCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCc-cChhhccCCCCCC
Confidence 34456788889996532 34578899999999987777787 99999999999999995 5544334599999
Q ss_pred EEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCC-----cccccccccc
Q 007088 135 SLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-----NVNFTAEDFA 209 (618)
Q Consensus 135 ~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-----~~~~~~~~~~ 209 (618)
+|+|++|+|++..|..+.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+... -.++..++++
T Consensus 92 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~ 171 (361)
T 2xot_A 92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS 171 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECC
T ss_pred EEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECC
Confidence 99999999996656678999999999999999998888889999999999999999987554432 1145556666
Q ss_pred CCC
Q 007088 210 NNS 212 (618)
Q Consensus 210 ~n~ 212 (618)
+|.
T Consensus 172 ~N~ 174 (361)
T 2xot_A 172 SNK 174 (361)
T ss_dssp SSC
T ss_pred CCC
Confidence 664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.7e-15 Score=146.41 Aligned_cols=115 Identities=17% Similarity=0.224 Sum_probs=105.5
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|+|++..+..|.++++|++|+|++|++++ +|+..+..+++|++|+|++|++++..|..+.++++|+.|
T Consensus 56 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 134 (220)
T 2v70_A 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCC-CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred CCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCc-cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence 3579999999999998888899999999999999999995 555444459999999999999998889999999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
+|++|+|++..|..+..+++|+.|+|++|.+++..+
T Consensus 135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 999999999889999999999999999999998765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.1e-15 Score=151.00 Aligned_cols=135 Identities=26% Similarity=0.205 Sum_probs=99.8
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|+++ .+|..+..+++|++|+|++|+|+ .+|+..+..+++|++|+|++|++++..|..+..+++|+.|
T Consensus 76 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 356778888888887 67888888888888888888888 4554434458888888888888885545556788888888
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~~c~~ 217 (618)
+|++|+|++..+..+..+++|+.|+|++|+|+...+.... ..+..+++.+|++.|.+
T Consensus 154 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 8888888854444567788888888888888843333322 25677788899888853
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.6e-15 Score=155.91 Aligned_cols=131 Identities=18% Similarity=0.257 Sum_probs=114.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCC---------CCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCc
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIER---------CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLA 152 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~---------l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~ 152 (618)
.+++.|+|++|++.|.+|..++. +++|++|+|++|+++ .+|..+.. +++|++|+|++|++++ +|..++
T Consensus 150 ~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~-l~~L~~L~L~~N~l~~-l~~~l~ 226 (328)
T 4fcg_A 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN-LQNLKSLKIRNSPLSA-LGPAIH 226 (328)
T ss_dssp TTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG-CTTCCEEEEESSCCCC-CCGGGG
T ss_pred cCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC-CCCCCEEEccCCCCCc-Cchhhc
Confidence 57899999999999999988875 999999999999999 89988765 9999999999999994 788899
Q ss_pred CCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCC
Q 007088 153 NCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLC 215 (618)
Q Consensus 153 ~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c 215 (618)
++++|+.|+|++|++.+.+|..++.+++|+.|+|++|++.+.+|.... .++..+++++|...-
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 999999999999999999999999999999999999999999996432 156778888886543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.2e-15 Score=146.73 Aligned_cols=135 Identities=21% Similarity=0.218 Sum_probs=117.0
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|++++..|..+.++++|++|+|++|+++ .+|...+..+++|++|+|++|++++..|..++++++|+.|
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 136 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL 136 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence 367999999999999988888999999999999999999 5665555569999999999999996555567999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCG 216 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~ 216 (618)
+|++|+|++..|..++.+++|+.|+|++|++++..|.... .++..+++++|+..|.
T Consensus 137 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 137 RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred ECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999976666899999999999999999988875432 2677889999998874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.7e-15 Score=147.43 Aligned_cols=135 Identities=20% Similarity=0.216 Sum_probs=78.7
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++..+..+.++++|++|+|++|++++ +|+..+..+++|++|+|++|++++..+..++.+++|+.|+
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 163 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELR 163 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe-eCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeE
Confidence 345566666666664444445666666666666666663 3333333366666666666666643333356666666666
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~~ 217 (618)
|++|++++..|..+..+++|+.|+|++|++++..+.... .++..+++++|++.|.+
T Consensus 164 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 164 LYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred ecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 666666654444566666677777777766655443221 14556677777776643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.5e-15 Score=161.61 Aligned_cols=136 Identities=20% Similarity=0.161 Sum_probs=122.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|++++.+|..++++++|++|+|++|++++..|..+.. +++|++|+|++|++++..|..++++++|+.|+
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG-LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcC-cccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 46899999999999999999999999999999999999777777765 99999999999999987788899999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCGKP 218 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~~~ 218 (618)
|++|++++..|..+..+++|+.|+|++|++++..+.... .++..+++++|+..|.+|
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999999998899999999999999999999987665432 267888999999988654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4e-15 Score=143.81 Aligned_cols=113 Identities=22% Similarity=0.263 Sum_probs=105.2
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|++++..|..|.++++|++|+|++|+|+ .+|..++..+++|++|+|++|++++..|..+.++++|+.|
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 133 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEE
Confidence 357999999999999999999999999999999999999 7888876679999999999999998888999999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
+|++|+|++..|..+..+++|+.|+|++|.++..
T Consensus 134 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9999999987777899999999999999999764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.6e-15 Score=151.72 Aligned_cols=134 Identities=19% Similarity=0.244 Sum_probs=100.9
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCcc-ccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSG-SIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g-~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
.+++.|+|++|.+.+..|..+.++++|++|+|++|.+++ .+|..+.. +++|++|+|++|++++..|..++++++|+.|
T Consensus 126 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 126 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE-LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp TTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhh-CcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 467778888888877777778888888888888888876 46665554 7888888888888887667778888888888
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCc-c--ccccccccCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-V--NFTAEDFANNSGLCG 216 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~--~~~~~~~~~n~~~c~ 216 (618)
+|++|++++..+..+..+++|+.|++++|++++.+|.... . ++..+++++|+..|.
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECS
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecc
Confidence 8888888876666777788888888888888887775332 1 466777888877664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=2.1e-15 Score=151.79 Aligned_cols=133 Identities=23% Similarity=0.266 Sum_probs=74.0
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
+++.|+|++|++++..|..+.++++|++|+|++|+++ .+|...+..+++|++|+|++|++++..+..+..+++|+.|+|
T Consensus 106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 184 (285)
T 1ozn_A 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (285)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEEC
Confidence 4555566666655555555556666666666666665 333332233566666666666666333334556666666666
Q ss_pred cCcccCCCCCccccccccccccccccccccCCCCC-CCc-cccccccccCCCCCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS-FAN-VNFTAEDFANNSGLCG 216 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~-~~~-~~~~~~~~~~n~~~c~ 216 (618)
++|++++..|..+..+++|+.|++++|++++..|. +.. .++..+++++|+..|.
T Consensus 185 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred CCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 66666655566666666666666666666654432 111 1345566666666553
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.9e-15 Score=164.06 Aligned_cols=143 Identities=17% Similarity=0.157 Sum_probs=120.8
Q ss_pred CcccceecCCCCCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC
Q 007088 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148 (618)
Q Consensus 69 c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip 148 (618)
|.+.++.|.. ...++.|+|++|++++..|..++++++|+.|+|++|.++|.+|..++..+++|++|+|++|.|++. |
T Consensus 109 N~l~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~ 185 (487)
T 3oja_A 109 NNISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185 (487)
T ss_dssp SCCCCEEECC--CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred CcCCCCCccc--cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c
Confidence 5666777753 467999999999999999999999999999999999999988988875699999999999999965 4
Q ss_pred CCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCCCCCC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNSGLCG 216 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~~c~ 216 (618)
. +..+++|+.|+|++|+|++ +|+.++.+++|+.|+|++|.|++..+.+.. .++..+++++|+..|+
T Consensus 186 ~-~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 186 G-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp C-CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred c-cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 3 4569999999999999997 556699999999999999999984433332 2677889999998874
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.57 E-value=6.4e-15 Score=136.28 Aligned_cols=108 Identities=23% Similarity=0.247 Sum_probs=90.8
Q ss_pred EEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCc
Q 007088 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165 (618)
Q Consensus 86 ~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N 165 (618)
.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..+.. +++|++|+|++|+|++..|..+.++++|+.|+|++|
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~-l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDR-LTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTT-CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcC-cccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 3556677887 5887774 89999999999999655666654 999999999999999655555789999999999999
Q ss_pred ccCCCCCccccccccccccccccccccCCCCC
Q 007088 166 RFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 166 ~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
+|++..|..+..+++|+.|+|++|.+++..+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 99976666799999999999999999987663
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.56 E-value=6.7e-16 Score=173.28 Aligned_cols=142 Identities=14% Similarity=0.242 Sum_probs=114.8
Q ss_pred CcccceecCCCCCCcEEEEEecCCcceee-----------------CCcCCC--CCCCCCeEEccCCcCccccCchhhhc
Q 007088 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQ-----------------FPRGIE--RCTSLTGLDLSSNNLSGSIPSDISSR 129 (618)
Q Consensus 69 c~w~gv~c~~~~~~~v~~l~l~~~~l~g~-----------------~p~~~~--~l~~L~~L~l~~n~l~g~ip~~~~~~ 129 (618)
+...|+.-.-....+++.|+|++|.++|. +|++++ +|++|++|+|++|++.|.+|..++.
T Consensus 193 n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~- 271 (636)
T 4eco_A 193 NNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA- 271 (636)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTT-
T ss_pred CCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhc-
Confidence 45555432222346788999999999986 999988 9999999999999999999988875
Q ss_pred CCCCCEEEeeCCC-Ccc-cCCCCCcCC------CCCcEEEccCcccCCCCCc--cccccccccccccccccccCCCCCCC
Q 007088 130 LQYVTSLDLSSNS-LSG-EIPSGLANC------TFLNVLKLNNNRFTGKIPP--QLGLLNRIKTFSVASNLLTGPVPSFA 199 (618)
Q Consensus 130 l~~L~~L~l~~N~-l~g-~ip~~~~~l------~~L~~l~l~~N~l~g~~p~--~l~~~~~L~~l~l~~N~l~g~ip~~~ 199 (618)
+++|++|+|++|+ ++| .+|..++++ ++|+.|+|++|+++ .+|. .++++++|+.|++++|+++|.+|.+.
T Consensus 272 l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~ 350 (636)
T 4eco_A 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFG 350 (636)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCE
T ss_pred CCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhC
Confidence 9999999999998 998 889888776 88999999999998 8888 88899999999999999998888433
Q ss_pred cc-ccccccccCCC
Q 007088 200 NV-NFTAEDFANNS 212 (618)
Q Consensus 200 ~~-~~~~~~~~~n~ 212 (618)
.+ ++..+++++|.
T Consensus 351 ~l~~L~~L~L~~N~ 364 (636)
T 4eco_A 351 SEIKLASLNLAYNQ 364 (636)
T ss_dssp EEEEESEEECCSSE
T ss_pred CCCCCCEEECCCCc
Confidence 22 56666777774
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=135.24 Aligned_cols=128 Identities=26% Similarity=0.354 Sum_probs=107.4
Q ss_pred EEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccC
Q 007088 85 LNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164 (618)
Q Consensus 85 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~ 164 (618)
+.+++++++++ .+|..+. ++|+.|+|++|+++ .+|...+.++++|++|+|++|++++..|..++++++|+.|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 47899999998 5776554 79999999999999 56665545599999999999999965555679999999999999
Q ss_pred cccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCC
Q 007088 165 NRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCG 216 (618)
Q Consensus 165 N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~ 216 (618)
|+|++..|..+..+++|+.|++++|++++..+.... .++..+++++|+..|.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 999987777789999999999999999977665432 2678889999988774
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=145.61 Aligned_cols=131 Identities=21% Similarity=0.169 Sum_probs=112.4
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCC-CcccCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS-LSGEIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~-l~g~ip~~~~~l~~L~~ 159 (618)
..+++.|+|++|++++..+..+.++++|++|+|++|.+++..|..+.. +++|++|+|++|+ +++..|..+..+++|+.
T Consensus 31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~ 109 (285)
T 1ozn_A 31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG-LALLEQLDLSDNAQLRSVDPATFHGLGRLHT 109 (285)
T ss_dssp CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT-CTTCCEEECCSCTTCCCCCTTTTTTCTTCCE
T ss_pred CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCC-ccCCCEEeCCCCCCccccCHHHhcCCcCCCE
Confidence 457899999999999888888999999999999999999766777765 9999999999998 77555788999999999
Q ss_pred EEccCcccCCCCCccccccccccccccccccccCCCCCCC-c-cccccccccCCC
Q 007088 160 LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-N-VNFTAEDFANNS 212 (618)
Q Consensus 160 l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-~-~~~~~~~~~~n~ 212 (618)
|+|++|++++..|..+..+++|+.|++++|++++..+... . .++..+++++|.
T Consensus 110 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 164 (285)
T 1ozn_A 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (285)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence 9999999998888889999999999999999998777533 2 257777888884
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.6e-15 Score=136.96 Aligned_cols=112 Identities=20% Similarity=0.263 Sum_probs=99.7
Q ss_pred CcEEEEEecCCcce-eeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLK-GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~-g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
.+++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. ..+. ++++|++|+|++|++++.+|..++++++|+.|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~-~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLP-KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCC-CCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhh-cCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 57889999999999 89999999999999999999999954 4554 49999999999999998888888889999999
Q ss_pred EccCcccCCC-CCccccccccccccccccccccCCCC
Q 007088 161 KLNNNRFTGK-IPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 161 ~l~~N~l~g~-~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
+|++|++++. .|..++.+++|+.|++++|.+++..+
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 130 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence 9999999973 45889999999999999999998766
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-15 Score=139.12 Aligned_cols=130 Identities=19% Similarity=0.195 Sum_probs=102.9
Q ss_pred CCcEEEEEecCCcce-eeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLK-GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~-g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~ 159 (618)
..+++.|+|++|+++ |.+|..+..+++|+.|+|++|.+++ + ..+. .+++|++|+|++|++++.+|..+.++++|+.
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~-~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLP-KLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C-SSCC-CCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h-hhhc-cCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 356888999999998 8888888899999999999999885 4 4454 4889999999999999778877778999999
Q ss_pred EEccCcccCCC-CCccccccccccccccccccccCCCC----CCCcc-ccccccccCCCC
Q 007088 160 LKLNNNRFTGK-IPPQLGLLNRIKTFSVASNLLTGPVP----SFANV-NFTAEDFANNSG 213 (618)
Q Consensus 160 l~l~~N~l~g~-~p~~l~~~~~L~~l~l~~N~l~g~ip----~~~~~-~~~~~~~~~n~~ 213 (618)
|+|++|++++. .+..+..+++|+.|++++|.+++..+ .+..+ ++..+++++|..
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence 99999999863 22678888999999999999988766 22221 456667777653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=2.9e-15 Score=165.12 Aligned_cols=144 Identities=21% Similarity=0.211 Sum_probs=119.4
Q ss_pred CCcccceecCCC----------CCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEE
Q 007088 68 ICQFTGVDCWHP----------DENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLD 137 (618)
Q Consensus 68 ~c~w~gv~c~~~----------~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~ 137 (618)
.|.|.|+ |+.. ...+++.|+|++|++++..|..+.++++|++|+|++|++++..|..+.. +++|++|+
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~ 80 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS-LGSLEHLD 80 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEE
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc-cccCCEEE
Confidence 4888888 7532 1347999999999999999999999999999999999999766666654 99999999
Q ss_pred eeCCCCcccCCCCCcCCCCCcEEEccCcccCC-CCCccccccccccccccccccccCCCCC--CCcc-ccccccccCCCC
Q 007088 138 LSSNSLSGEIPSGLANCTFLNVLKLNNNRFTG-KIPPQLGLLNRIKTFSVASNLLTGPVPS--FANV-NFTAEDFANNSG 213 (618)
Q Consensus 138 l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g-~~p~~l~~~~~L~~l~l~~N~l~g~ip~--~~~~-~~~~~~~~~n~~ 213 (618)
|++|++++..|..++++++|++|+|++|++++ .+|..++++++|+.|++++|++.+.+|. +..+ ++..+++++|..
T Consensus 81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999997666669999999999999999997 4678899999999999999997777763 2222 466677777753
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=5.3e-15 Score=165.17 Aligned_cols=135 Identities=19% Similarity=0.181 Sum_probs=109.1
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccc-cCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS-IPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~-ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
.+++.|+|++|.+++.+|..++++++|++|+|++|.+++. +|..+.. +++|+.|+|++|++++.+|..++++++|+.|
T Consensus 424 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN-TTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc-CCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 4677888888888888888888888888888888888874 5666654 8888888888888888888888888889999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCC-CCcc--ccccccccCCCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS-FANV--NFTAEDFANNSGLCGKP 218 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~-~~~~--~~~~~~~~~n~~~c~~~ 218 (618)
+|++|++++.+|..++.+++|+.|+|++|+++. +|. +... ++..+++++|++.|.++
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCC-EESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCcc-cCHhHhhhcccCcEEEccCCCcccCCc
Confidence 999999888888888888889999999998884 543 3332 36778899999888654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.5e-15 Score=150.95 Aligned_cols=144 Identities=21% Similarity=0.243 Sum_probs=119.5
Q ss_pred CCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCc-CCCCCCCCCeEEccCCcCc--cccCchhhhcCCCCC
Q 007088 66 GFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPR-GIERCTSLTGLDLSSNNLS--GSIPSDISSRLQYVT 134 (618)
Q Consensus 66 ~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~-~~~~l~~L~~L~l~~n~l~--g~ip~~~~~~l~~L~ 134 (618)
.+.|.|.+|.|.... ..+++.|+|++|+++ .+|+ .+.++++|++|+|++|+++ |.+|..+.. +++|+
T Consensus 4 ~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~-~~~L~ 81 (306)
T 2z66_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFG-TTSLK 81 (306)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHS-CSCCC
T ss_pred CCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCccccccc-ccccC
Confidence 466899999997532 357999999999999 5555 4799999999999999998 445777765 99999
Q ss_pred EEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCC-ccccccccccccccccccccCCCCCCCc--cccccccccCC
Q 007088 135 SLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIP-PQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANN 211 (618)
Q Consensus 135 ~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p-~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n 211 (618)
+|+|++|.++ .+|..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+++.+|.... .++..+++++|
T Consensus 82 ~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 9999999999 688889999999999999999997554 5788999999999999999988886432 25667777777
Q ss_pred C
Q 007088 212 S 212 (618)
Q Consensus 212 ~ 212 (618)
.
T Consensus 161 ~ 161 (306)
T 2z66_A 161 S 161 (306)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-14 Score=161.73 Aligned_cols=131 Identities=22% Similarity=0.243 Sum_probs=107.2
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
+.+++.|+|++|++++..|..|.++++|++|+|++|++++..|..+. ++++|++|+|++|++++..|..|++|++|++|
T Consensus 31 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 109 (606)
T 3vq2_A 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH-GLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT-TCTTCCEEECTTCCCCCCCTTSSTTCTTCCEE
T ss_pred CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhh-chhhcCEeECCCCcccccChhhcCCcccCCEE
Confidence 36788999999999988888899999999999999999965565555 49999999999999998778889999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccC-CCCCCCc-c-ccccccccCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN-V-NFTAEDFANNS 212 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g-~ip~~~~-~-~~~~~~~~~n~ 212 (618)
+|++|++++..|..++++++|++|++++|++++ .+|.... + ++..+++++|.
T Consensus 110 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~ 164 (606)
T 3vq2_A 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY 164 (606)
T ss_dssp ECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred EccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence 999999987776788888899999999998886 6675332 1 45666677664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=7.7e-15 Score=164.32 Aligned_cols=135 Identities=19% Similarity=0.243 Sum_probs=120.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccc-cCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS-IPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~-ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+..++++.|.+.+..|..+..+++|+.|+|++|++.+. +|..+. .+++|++|+|++|++++.+|..|++|++|+.|
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~-~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT-ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT-TCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhh-hccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 4678899999999999999999999999999999986544 555554 59999999999999999889999999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCc---cccccccccCCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN---VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~~c~~ 217 (618)
+|++|+|++..|..+..+++|+.|+|++|+|++.+|.... .++..+++++|++.|.+
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 9999999998888999999999999999999999997543 25778899999999965
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.6e-15 Score=154.69 Aligned_cols=135 Identities=22% Similarity=0.176 Sum_probs=113.3
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|+|++..|..|.++++|++|+|++|+|+ .+|...+..+++|+.|+|++|++++..|..+.++++|+.|
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 467999999999999888889999999999999999999 5666555569999999999999998778899999999999
Q ss_pred EccCcccCCCCCccc----cccccccccccccccccCCCCCCCc-c---ccccccccCCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQL----GLLNRIKTFSVASNLLTGPVPSFAN-V---NFTAEDFANNSGLCGK 217 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l----~~~~~L~~l~l~~N~l~g~ip~~~~-~---~~~~~~~~~n~~~c~~ 217 (618)
+|++|+|++ +|..+ ..+++|+.|+|++|+|++..+.... + .+..+++.+|++.|.+
T Consensus 142 ~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 142 YLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp ECCSSCCCS-CCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 999999995 66554 6799999999999999975543221 1 1356889999999864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-14 Score=144.17 Aligned_cols=130 Identities=21% Similarity=0.229 Sum_probs=110.6
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|++++..+..+.++++|++|+|++|++++ +|...+.++++|++|+|++|++++..|..++++++|+.|+
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence 468999999999998888799999999999999999995 5543334599999999999999987778899999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccC-CCCCCCc--cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g-~ip~~~~--~~~~~~~~~~n~ 212 (618)
+++|++++..+..++.+++|+.|++++|++++ .+|.... .++..+++++|.
T Consensus 107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~ 160 (276)
T 2z62_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160 (276)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCC
Confidence 99999998777789999999999999999988 4675432 256777888884
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.5e-15 Score=168.56 Aligned_cols=109 Identities=28% Similarity=0.416 Sum_probs=66.0
Q ss_pred EEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEcc
Q 007088 84 VLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163 (618)
Q Consensus 84 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~ 163 (618)
++.|+|++|.+. .+|..+++|++|++|+|++|.|+ .||..++. |++|++|+|++|+|+ .||.+|++|++|++|+|+
T Consensus 226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKN-LSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGG-GTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhC-CCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 344555555555 55555556666666666666666 56655543 666666666666666 556666666666666666
Q ss_pred CcccCCCCCccccccccccccccccccccCCCCC
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
+|+|+ .||..|+.+++|+.|+|++|.|+|.+|.
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK 334 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence 66665 5565566666666666666666666654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-14 Score=144.85 Aligned_cols=118 Identities=22% Similarity=0.252 Sum_probs=105.3
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|++++..|..++++++|++|+|++|++++ +|+..+.++++|+.|+|++|++++..|..++++++|+.|
T Consensus 108 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 186 (272)
T 3rfs_A 108 LTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL 186 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCc-cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence 3579999999999998777789999999999999999994 555554459999999999999997666678999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA 199 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~ 199 (618)
+|++|++++..|..++.+++|+.|++++|.++|..|...
T Consensus 187 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l~ 225 (272)
T 3rfs_A 187 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIR 225 (272)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred ECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcHHH
Confidence 999999998888888999999999999999999988643
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.1e-14 Score=139.29 Aligned_cols=117 Identities=22% Similarity=0.249 Sum_probs=101.7
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|++++..+..+.++++|++|+|++|+++ .+|...+.++++|++|+|++|++++..|..+.++++|+.|
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 129 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL 129 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence 357999999999999666666899999999999999999 5666654559999999999999996655668999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~ 198 (618)
+|++|++++..+..+..+++|+.|++++|.+++..|..
T Consensus 130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l 167 (208)
T 2o6s_A 130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 167 (208)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTTTT
T ss_pred ECCCCccceeCHHHhccCCCccEEEecCCCeecCCCCH
Confidence 99999999766666899999999999999999988854
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=7.9e-15 Score=161.58 Aligned_cols=110 Identities=27% Similarity=0.318 Sum_probs=103.0
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
.++.|+|++|+|++ +|. +++|++|+.|+|++|+|+ .||..++. |++|+.|+|++|+|++ || .+++|++|+.|+|
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~-l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L 515 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA-LRCLEVLQASDNALEN-VD-GVANLPRLQELLL 515 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc-CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence 47789999999997 776 999999999999999999 99998876 9999999999999996 88 8999999999999
Q ss_pred cCcccCCCC-CccccccccccccccccccccCCCCCC
Q 007088 163 NNNRFTGKI-PPQLGLLNRIKTFSVASNLLTGPVPSF 198 (618)
Q Consensus 163 ~~N~l~g~~-p~~l~~~~~L~~l~l~~N~l~g~ip~~ 198 (618)
++|+|++.+ |..++.+++|+.|+|++|.|++.+|..
T Consensus 516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 999999887 999999999999999999999998854
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.2e-14 Score=160.08 Aligned_cols=141 Identities=18% Similarity=0.117 Sum_probs=121.0
Q ss_pred ccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCC
Q 007088 71 FTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142 (618)
Q Consensus 71 w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~ 142 (618)
+..|.|.... +..++.|+|++|++++..|..|+++++|++|+|++|++.+..|..+.. +++|++|+|++|+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS-QHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTT-CTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccC-ccccCeeeCCCCc
Confidence 4457785432 457899999999999998999999999999999999999766777765 9999999999999
Q ss_pred CcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccC-CCCCCCcc-ccccccccCCC
Q 007088 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG-PVPSFANV-NFTAEDFANNS 212 (618)
Q Consensus 143 l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g-~ip~~~~~-~~~~~~~~~n~ 212 (618)
+++..|..++++++|++|+|++|++++..|..++++++|++|++++|++++ .+|.+... ++..+++++|.
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 164 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSC
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCc
Confidence 998889999999999999999999998668889999999999999999998 55655432 56667777774
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.53 E-value=2.9e-14 Score=143.86 Aligned_cols=127 Identities=25% Similarity=0.252 Sum_probs=98.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|++++..|..+.++++|++|+|++|.++ .+|.. . .+++|++|+|++|+++ .+|..+..+++|+.|+
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~-~-~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~ 106 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-G-TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC-S-CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC-C-CCCcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence 56888999999998888888888888888888888888 45554 3 4888888888888888 6788888888888888
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
|++|+|++..|..|..+++|+.|+|++|++++..|.... .++..+++++|.
T Consensus 107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 888888866667788888888888888888876664322 256666777774
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.2e-14 Score=139.53 Aligned_cols=115 Identities=23% Similarity=0.269 Sum_probs=102.7
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|+|++..+..+.++++|+.|+|++|+|+ .+|...+..+++|++|+|++|+|+ .||..+..+++|+.|
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 140 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEE
Confidence 357999999999997555566899999999999999999 566665556999999999999999 899999999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
+|++|+|++..+..+..+++|+.|+|++|.+++..+.
T Consensus 141 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 177 (229)
T 3e6j_A 141 ALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRD 177 (229)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBGG
T ss_pred ECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcch
Confidence 9999999976667799999999999999999987763
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=2.2e-14 Score=155.29 Aligned_cols=142 Identities=18% Similarity=0.133 Sum_probs=120.1
Q ss_pred cccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCC
Q 007088 70 QFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN 141 (618)
Q Consensus 70 ~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N 141 (618)
.|..|.|.... +..++.|+|++|++++..|..|.++++|++|+|++|.+++..|..+.+ +++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNN-LFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhC-CccCCEEECCCC
Confidence 36788886432 357889999999999988999999999999999999999766777765 999999999999
Q ss_pred CCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 142 SLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 142 ~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
++++..+..++++++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|.... .++..+++++|.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 163 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN 163 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCc
Confidence 99954445589999999999999999998899999999999999999999988775432 156677777774
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.4e-15 Score=171.38 Aligned_cols=143 Identities=13% Similarity=0.165 Sum_probs=115.6
Q ss_pred CcccceecCCCCCCcEEEEEecCCccee-----------------eCCcCCC--CCCCCCeEEccCCcCccccCchhhhc
Q 007088 69 CQFTGVDCWHPDENKVLNIRLSDMGLKG-----------------QFPRGIE--RCTSLTGLDLSSNNLSGSIPSDISSR 129 (618)
Q Consensus 69 c~w~gv~c~~~~~~~v~~l~l~~~~l~g-----------------~~p~~~~--~l~~L~~L~l~~n~l~g~ip~~~~~~ 129 (618)
+...|+.-.-....+++.|+|++|+|+| .+|++++ +|++|++|+|++|++.|.+|..++.
T Consensus 435 N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~- 513 (876)
T 4ecn_A 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD- 513 (876)
T ss_dssp CEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGG-
T ss_pred CcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhC-
Confidence 4455554322234678899999999998 5999988 9999999999999999999988875
Q ss_pred CCCCCEEEeeCCC-Ccc-cCCCCCcCCC-------CCcEEEccCcccCCCCCc--cccccccccccccccccccCCCCCC
Q 007088 130 LQYVTSLDLSSNS-LSG-EIPSGLANCT-------FLNVLKLNNNRFTGKIPP--QLGLLNRIKTFSVASNLLTGPVPSF 198 (618)
Q Consensus 130 l~~L~~L~l~~N~-l~g-~ip~~~~~l~-------~L~~l~l~~N~l~g~~p~--~l~~~~~L~~l~l~~N~l~g~ip~~ 198 (618)
|++|+.|+|++|+ |+| .+|..+++++ +|+.|+|++|+|+ .+|. .++++++|+.|+|++|+++ .+|.+
T Consensus 514 L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~ 591 (876)
T 4ecn_A 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAF 591 (876)
T ss_dssp CSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCC
T ss_pred CCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhh
Confidence 9999999999998 998 8888776665 8999999999999 8888 8999999999999999998 88854
Q ss_pred Ccc-ccccccccCCCCC
Q 007088 199 ANV-NFTAEDFANNSGL 214 (618)
Q Consensus 199 ~~~-~~~~~~~~~n~~~ 214 (618)
..+ ++..+++++|...
T Consensus 592 ~~L~~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 592 GTNVKLTDLKLDYNQIE 608 (876)
T ss_dssp CTTSEESEEECCSSCCS
T ss_pred cCCCcceEEECcCCccc
Confidence 432 5667778877543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.8e-14 Score=167.11 Aligned_cols=140 Identities=19% Similarity=0.186 Sum_probs=111.3
Q ss_pred CcccceecCCCCCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC
Q 007088 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148 (618)
Q Consensus 69 c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip 148 (618)
|.|+.|.+ .+.+++.|+|++|.+++..|..|.+|++|++|+|++|.+.+.|+++.+.++++|++|+|++|++++..|
T Consensus 14 ~~L~~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p 90 (844)
T 3j0a_A 14 CNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90 (844)
T ss_dssp CCSSCCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECT
T ss_pred CCCCCCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCH
Confidence 56888877 357899999999999988888899999999999999988878855444568999999999999988788
Q ss_pred CCCcCCCCCcEEEccCcccCCCCCcc--ccccccccccccccccccCCCCC--CCcc-ccccccccCC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGKIPPQ--LGLLNRIKTFSVASNLLTGPVPS--FANV-NFTAEDFANN 211 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~~p~~--l~~~~~L~~l~l~~N~l~g~ip~--~~~~-~~~~~~~~~n 211 (618)
..+++|++|++|+|++|++++.+|.. ++++++|+.|+|++|.+++..|. +..+ ++..+++++|
T Consensus 91 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N 158 (844)
T 3j0a_A 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158 (844)
T ss_dssp TSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESS
T ss_pred hHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCC
Confidence 88889999999999999988877765 88888888888888888887653 2221 4445555555
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.5e-14 Score=131.06 Aligned_cols=107 Identities=22% Similarity=0.274 Sum_probs=91.6
Q ss_pred EEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC-CCcCCCCCcEEEcc
Q 007088 85 LNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS-GLANCTFLNVLKLN 163 (618)
Q Consensus 85 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~l~l~ 163 (618)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..+. ++++|++|+|++|+|++ +|. .++++++|+.|+|+
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFD-HLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECC
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhc-CCcCCCEEECCCCCCCc-cChhHhCCcchhhEEECC
Confidence 46888999995 8898875 8999999999999976666665 49999999999999996 555 46899999999999
Q ss_pred CcccCCCCCccccccccccccccccccccCCCC
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
+|+|++..|..+..+++|+.|+|++|.++...+
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 999996555569999999999999999986654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=3.2e-14 Score=142.37 Aligned_cols=112 Identities=16% Similarity=0.176 Sum_probs=58.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++..+..+.++++|++|+|++|++++..|..+. ++++|++|+|++|++++..+..++++++|+.|+
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS-GLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT-TCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhc-CCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 3455555555555554444555555555555555555533333333 255555555555555543333455555555555
Q ss_pred ccCcccCC-CCCccccccccccccccccccccCC
Q 007088 162 LNNNRFTG-KIPPQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 162 l~~N~l~g-~~p~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
|++|++++ .+|..++.+++|+.|++++|++++.
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcC
Confidence 55555554 2455555555555555555555543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.50 E-value=8.5e-14 Score=143.25 Aligned_cols=143 Identities=20% Similarity=0.265 Sum_probs=120.3
Q ss_pred CCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEE
Q 007088 66 GFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLD 137 (618)
Q Consensus 66 ~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~ 137 (618)
++.|.|..+.|.... ..+++.|+|++|++++..|..+.++++|++|+|++|++++..|..+.. +++|++|+
T Consensus 30 ~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~ 108 (332)
T 2ft3_A 30 GCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP-LRKLQKLY 108 (332)
T ss_dssp SCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTT-CTTCCEEE
T ss_pred CCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhC-cCCCCEEE
Confidence 455889999996432 347899999999999888889999999999999999999766777765 99999999
Q ss_pred eeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccccccccccccccc--CCCCCC-CccccccccccCCC
Q 007088 138 LSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT--GPVPSF-ANVNFTAEDFANNS 212 (618)
Q Consensus 138 l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~--g~ip~~-~~~~~~~~~~~~n~ 212 (618)
|++|+++ .+|..+. ++|++|+|++|++++..+..+..+++|+.|++++|.++ |..|.. ...++..+++++|.
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~ 183 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSB
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCC
Confidence 9999999 7998876 89999999999999766667999999999999999996 355543 33366777787775
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=6.1e-14 Score=150.26 Aligned_cols=142 Identities=16% Similarity=0.158 Sum_probs=114.1
Q ss_pred ccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCC
Q 007088 71 FTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142 (618)
Q Consensus 71 w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~ 142 (618)
|..|.|.+.. ...++.|+|++|++++..+..|.++++|++|+|++|++++ ++...+.++++|++|+|++|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~-i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE-ECGGGGTTCSSCCEEECCSSC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc-cChhhccCCccCCEEECCCCc
Confidence 5678886532 3568899999999999999999999999999999999995 554444559999999999999
Q ss_pred CcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCC--CCcc-ccccccccCCCC
Q 007088 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS--FANV-NFTAEDFANNSG 213 (618)
Q Consensus 143 l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~--~~~~-~~~~~~~~~n~~ 213 (618)
+++..+..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+..+.+|. +..+ ++..+++++|..
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 197 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence 9955455799999999999999999976667888999999999998766666664 2221 566677777743
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-14 Score=164.87 Aligned_cols=174 Identities=23% Similarity=0.257 Sum_probs=105.7
Q ss_pred CCcchHHHHHHHHHhccCCCCccccCccCCCCCCCCCCcccceecCCC---------------CCCcEEEEEecCCccee
Q 007088 32 ATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHP---------------DENKVLNIRLSDMGLKG 96 (618)
Q Consensus 32 ~~~~~~~~L~~~k~~~~~~~~~l~~~W~~~~~~~~~~c~w~gv~c~~~---------------~~~~v~~l~l~~~~l~g 96 (618)
....+..+|+++..+...+...-...|... ....+.|.++.++.. ....+..++|+.|.|.+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~ 205 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGD---STPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDE 205 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCC---CCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccC
Confidence 345678889888888744322222245322 123456666544321 12344555666655544
Q ss_pred ---------eCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCccc
Q 007088 97 ---------QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRF 167 (618)
Q Consensus 97 ---------~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l 167 (618)
..|..+..++.|+.|+|++|.+. .||..++. +++|++|+|++|+|+ .||..|++|++|++|+|++|+|
T Consensus 206 ~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l 282 (727)
T 4b8c_D 206 DDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK-YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRL 282 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGG-CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCC
T ss_pred ccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC-CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcC
Confidence 34777899999999999999999 89999885 999999999999999 8999999999999999999999
Q ss_pred CCCCCccccccccccccccccccccCCCCCC-Ccc-ccccccccCCCC
Q 007088 168 TGKIPPQLGLLNRIKTFSVASNLLTGPVPSF-ANV-NFTAEDFANNSG 213 (618)
Q Consensus 168 ~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~-~~~-~~~~~~~~~n~~ 213 (618)
+ .||..|+.|++|++|+|++|.|+ .||.. ..+ ++..+++++|..
T Consensus 283 ~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 283 T-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp S-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred C-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence 9 88999999999999999999997 66753 332 567778888864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=6e-14 Score=158.83 Aligned_cols=143 Identities=22% Similarity=0.233 Sum_probs=113.9
Q ss_pred CCcccceecCCC--------CCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEee
Q 007088 68 ICQFTGVDCWHP--------DENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLS 139 (618)
Q Consensus 68 ~c~w~gv~c~~~--------~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~ 139 (618)
.|.++.|.|... -+.+++.|+|++|++++..+..++++++|++|+|++|.+++..|..+.. +++|++|+|+
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~ 81 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQK-LPMLKVLNLQ 81 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHH-CTTCCEEECC
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhc-ccCcCEEECC
Confidence 345555666432 1357899999999999877778999999999999999999766766655 9999999999
Q ss_pred CCCCcccCCC-CCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 140 SNSLSGEIPS-GLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 140 ~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
+|++++ +|. .++++++|++|+|++|++++..|..++++++|++|++++|.+++.+|.... .++..+++++|.
T Consensus 82 ~n~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 156 (680)
T 1ziw_A 82 HNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156 (680)
T ss_dssp SSCCCC-CCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSC
T ss_pred CCccCc-cChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCc
Confidence 999994 555 689999999999999999877778899999999999999999988876432 145666666664
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=4e-14 Score=156.69 Aligned_cols=135 Identities=17% Similarity=0.207 Sum_probs=104.5
Q ss_pred cEEEEEecCCcceeeCC-cCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCc-ccCCCCCcCCCCCcEE
Q 007088 83 KVLNIRLSDMGLKGQFP-RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS-GEIPSGLANCTFLNVL 160 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p-~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~-g~ip~~~~~l~~L~~l 160 (618)
+++.|+|++|.+.+..| ..+.++++|++|+|++|.+.+.+|..+.. +++|+.|+|++|+++ |.+|..++.+++|+.|
T Consensus 397 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L 475 (570)
T 2z63_A 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG-LSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475 (570)
T ss_dssp TCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT-CTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred CCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc-CCcCcEEECcCCcCccccchhhhhcccCCCEE
Confidence 45566666666666555 45778888888888888888777766654 888888888888887 6788888888888888
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCGKP 218 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~~~ 218 (618)
+|++|++++..|..+..+++|+.|++++|++++.+|.... .++..+++++|+..|.++
T Consensus 476 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 8888888887788888888888888888888888775432 256777888888877644
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.6e-14 Score=148.52 Aligned_cols=144 Identities=22% Similarity=0.270 Sum_probs=112.4
Q ss_pred CCCCcccceecCCC----------CCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCE
Q 007088 66 GFICQFTGVDCWHP----------DENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTS 135 (618)
Q Consensus 66 ~~~c~w~gv~c~~~----------~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~ 135 (618)
.+.|.|.|+ |+-. -..+++.|+|++|++++..+..+.++++|++|+|++|++++..|..+.. +++|++
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~ 104 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSS-LGSLEH 104 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCC-CCCCCE
Confidence 356888887 5321 1247899999999999877778999999999999999999655655654 999999
Q ss_pred EEeeCCCCcccCCCC-CcCCCCCcEEEccCcccCCCCCc--ccccccccccccccccc-ccCCCCCCC-cc-cccccccc
Q 007088 136 LDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFTGKIPP--QLGLLNRIKTFSVASNL-LTGPVPSFA-NV-NFTAEDFA 209 (618)
Q Consensus 136 L~l~~N~l~g~ip~~-~~~l~~L~~l~l~~N~l~g~~p~--~l~~~~~L~~l~l~~N~-l~g~ip~~~-~~-~~~~~~~~ 209 (618)
|+|++|++++ +|.. ++++++|++|+|++|++++ +|. .+..+++|+.|++++|+ +++..|... .. ++..++++
T Consensus 105 L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 105 LDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp EECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred EECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 9999999994 6655 8899999999999999994 665 78899999999999995 555545432 21 56677787
Q ss_pred CCCC
Q 007088 210 NNSG 213 (618)
Q Consensus 210 ~n~~ 213 (618)
+|..
T Consensus 183 ~n~l 186 (353)
T 2z80_A 183 ASDL 186 (353)
T ss_dssp ETTC
T ss_pred CCCc
Confidence 7753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=5.5e-14 Score=150.61 Aligned_cols=133 Identities=22% Similarity=0.226 Sum_probs=87.0
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCC-------------------------CCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTS-------------------------LTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~-------------------------L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
.+++.|+|++|++++..+..+.++++ |++|+|++|+++ .+|. +. .+++|+.|
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~-~l~~L~~L 212 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LT-PLIKLDEL 212 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CT-TCSSCCEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cC-CCcccCEE
Confidence 46778888888777554444554444 455555555554 3443 22 25666666
Q ss_pred EeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCC
Q 007088 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGL 214 (618)
Q Consensus 137 ~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~ 214 (618)
+|++|++++..|..+.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+.... .++..+++++|++.
T Consensus 213 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred ECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 6666666665566677777777777777777766677777777777888888887766664332 15667788888888
Q ss_pred CCC
Q 007088 215 CGK 217 (618)
Q Consensus 215 c~~ 217 (618)
|.+
T Consensus 293 CdC 295 (440)
T 3zyj_A 293 CNC 295 (440)
T ss_dssp CSS
T ss_pred CCC
Confidence 864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.48 E-value=5.1e-14 Score=137.79 Aligned_cols=145 Identities=17% Similarity=0.184 Sum_probs=116.0
Q ss_pred CCCCcc-ccee--cCCC-----CCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCc-CccccCchhhhcCCCCCEE
Q 007088 66 GFICQF-TGVD--CWHP-----DENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNN-LSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 66 ~~~c~w-~gv~--c~~~-----~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~-l~g~ip~~~~~~l~~L~~L 136 (618)
.+.|.+ .++. |... .+..++.|+|++|++++..+..+.++++|++|+|++|+ ++ .+|+..+.++++|++|
T Consensus 7 ~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 7 PCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHI 85 (239)
T ss_dssp SCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEE
T ss_pred CCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEE
Confidence 344544 5544 8531 13478999999999998777789999999999999997 77 6776555569999999
Q ss_pred EeeC-CCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccccc---ccccccc-cccCCCCCCC-cc-ccc-cccc
Q 007088 137 DLSS-NSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIK---TFSVASN-LLTGPVPSFA-NV-NFT-AEDF 208 (618)
Q Consensus 137 ~l~~-N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~---~l~l~~N-~l~g~ip~~~-~~-~~~-~~~~ 208 (618)
+|++ |++++..|..+.++++|+.|+|++|++++ +|. ++.+++|+ .|++++| ++++..|... .. ++. .+++
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l 163 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence 9999 99996555678999999999999999996 887 88888888 9999999 8988776533 22 566 7888
Q ss_pred cCCCC
Q 007088 209 ANNSG 213 (618)
Q Consensus 209 ~~n~~ 213 (618)
++|..
T Consensus 164 ~~n~l 168 (239)
T 2xwt_C 164 YNNGF 168 (239)
T ss_dssp CSCCC
T ss_pred CCCCC
Confidence 88853
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=3.2e-14 Score=158.81 Aligned_cols=134 Identities=22% Similarity=0.214 Sum_probs=94.4
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccc-cC--chhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCc
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS-IP--SDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~-ip--~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~ 158 (618)
.+++.|+|++|.+++..|..++.+++|++|+|++|.+.+. +| ..+. .+++|++|+|++|++++..|..++++++|+
T Consensus 425 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 503 (606)
T 3t6q_A 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ-TLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503 (606)
T ss_dssp TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGG-GCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhc-cCCCccEEECCCCccCccChhhhccccCCC
Confidence 3566677777777666666677777777777777777652 22 3343 377777777777777776677777777788
Q ss_pred EEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCCC
Q 007088 159 VLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 159 ~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~~ 217 (618)
.|+|++|++++.+|..+.++++| .|++++|++++.+|.... .++..+++++|++.|.+
T Consensus 504 ~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 504 HVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp EEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred EEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 88888888777777777777777 777888888777765322 15667788888887753
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.48 E-value=1.7e-14 Score=167.35 Aligned_cols=133 Identities=22% Similarity=0.193 Sum_probs=106.1
Q ss_pred CcEEEEEecCCcceeeCCc-CCCCCCCCCeEEccCCcCc-----cccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCC
Q 007088 82 NKVLNIRLSDMGLKGQFPR-GIERCTSLTGLDLSSNNLS-----GSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCT 155 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~-~~~~l~~L~~L~l~~n~l~-----g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~ 155 (618)
.+++.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..+ ..+++|+.|+|++|++++..|..+.+++
T Consensus 426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 504 (844)
T 3j0a_A 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF-EGLSHLQVLYLNHNYLNSLPPGVFSHLT 504 (844)
T ss_dssp TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCS-SCBCCEECCCCCHHHHTTCCTTSSSSCC
T ss_pred CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhh-cCcccccEEECCCCcccccChhHccchh
Confidence 4677788888888765443 3556788888888888886 3333334 3489999999999999988888889999
Q ss_pred CCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCCCCCCCC
Q 007088 156 FLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGLCGKP 218 (618)
Q Consensus 156 ~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~c~~~ 218 (618)
+|+.|+|++|+|++..|..+. ++|+.|+|++|+|+|.+|.... ++..+++++|++.|.++
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~-~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV-SLSVLDITHNKFICECE 564 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS-SCCEEEEEEECCCCSSS
T ss_pred hhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC-CcCEEEecCCCcccccc
Confidence 999999999999976666555 7899999999999999997665 67889999999999654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.48 E-value=5.4e-14 Score=156.68 Aligned_cols=129 Identities=12% Similarity=0.107 Sum_probs=80.4
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
.++.|++++|.+.+..+..+.++++|++|+|++|.+++..|..+.. +++|++|+|++|.+++..|..++++++|++|+|
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAY-AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTT-CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcC-CCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 4556667776666444444566777777777777777544444443 777777777777777655556677777777777
Q ss_pred cCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
++|+|++..|..|+++++|++|+|++|.+++.+|.... .++..+++++|.
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 182 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSC
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCC
Confidence 77777743333456677777777777777766664322 145555666653
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=148.87 Aligned_cols=142 Identities=14% Similarity=0.113 Sum_probs=116.2
Q ss_pred ccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCC
Q 007088 71 FTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142 (618)
Q Consensus 71 w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~ 142 (618)
|..|.|.+.. ..+++.|+|++|++++..|..|.++++|+.|+|++|++++..|..+. ++++|++|+|++|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~-~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN-GLASLNTLELFDNW 134 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhcc-CcccCCEEECCCCc
Confidence 5678886432 35789999999999999999999999999999999999965556555 59999999999999
Q ss_pred CcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCC--CCc-cccccccccCCCC
Q 007088 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS--FAN-VNFTAEDFANNSG 213 (618)
Q Consensus 143 l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~--~~~-~~~~~~~~~~n~~ 213 (618)
+++..|..++++++|+.|+|++|+|++..+..+..+++|+.|++++|+.-+.+|. +.. .++..+++++|..
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 208 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcc
Confidence 9965556699999999999999999976666889999999999999766666664 222 1566777887754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.47 E-value=5.9e-14 Score=133.04 Aligned_cols=125 Identities=14% Similarity=0.279 Sum_probs=76.5
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
+++.|+|++|+++ .+| .+..+++|++|+|++|.+. .+| .+.. +++|++|+|++|++++..|..++.+++|+.|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~-~l~~-l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN-PISG-LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG-GGTT-CTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch-hhhc-CCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 4566666666666 555 4666666666666666554 232 4443 666666666666666666666666666666666
Q ss_pred cCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNS 212 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 212 (618)
++|++++..|..++.+++|+.|++++|.+.+.+|.+..+ ++..+++++|.
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~ 170 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDG 170 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBC
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCC
Confidence 666666666666666666666666666644444433221 34555555553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.47 E-value=4e-14 Score=156.64 Aligned_cols=133 Identities=23% Similarity=0.269 Sum_probs=79.0
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCcc--ccCchhhhcCCCCCEEEeeCCCCcccCCCC-CcCCC---
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSG--SIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCT--- 155 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g--~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~-~~~l~--- 155 (618)
.+++.|+|++|++++.+|..++++++|+.|+|++|++++ .+|..+.. +++|+.|+|++|++++.+|.. +..++
T Consensus 353 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~-l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~ 431 (562)
T 3a79_B 353 SSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN-MSSLETLDVSLNSLNSHAYDRTCAWAESIL 431 (562)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTT-CTTCCEEECTTSCCBSCCSSCCCCCCTTCC
T ss_pred CCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcC-CCCCCEEECCCCcCCCccChhhhcCcccCC
Confidence 456677777777776666666666677777777666664 23333433 666666666666666555543 34444
Q ss_pred -------------------CCcEEEccCcccCCCCCccccccccccccccccccccCCCCC-CCcc-ccccccccCCCCC
Q 007088 156 -------------------FLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS-FANV-NFTAEDFANNSGL 214 (618)
Q Consensus 156 -------------------~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~-~~~~-~~~~~~~~~n~~~ 214 (618)
+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+. +..+ ++..+++++|++.
T Consensus 432 ~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 510 (562)
T 3a79_B 432 VLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD 510 (562)
T ss_dssp EEECCSSCCCGGGGSSCCTTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred EEECCCCCCCcchhhhhcCcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence 5555555555555 4565555666677777777777632222 2221 4555667777766
Q ss_pred CC
Q 007088 215 CG 216 (618)
Q Consensus 215 c~ 216 (618)
|.
T Consensus 511 c~ 512 (562)
T 3a79_B 511 CT 512 (562)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.47 E-value=8e-14 Score=144.38 Aligned_cols=111 Identities=17% Similarity=0.177 Sum_probs=92.4
Q ss_pred CCcccceecCCCCCCcEEEEEecCC-cceeeCCcCCCCCCCCCeEEccC-CcCccccCchhhhcCCCCCEEEeeCCCCcc
Q 007088 68 ICQFTGVDCWHPDENKVLNIRLSDM-GLKGQFPRGIERCTSLTGLDLSS-NNLSGSIPSDISSRLQYVTSLDLSSNSLSG 145 (618)
Q Consensus 68 ~c~w~gv~c~~~~~~~v~~l~l~~~-~l~g~~p~~~~~l~~L~~L~l~~-n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g 145 (618)
.|.|..|.|. ++ +|+ .||. |..+++|+.|+|++ |+|++..|..+. +|++|+.|+|++|+|+|
T Consensus 7 ~C~~~~v~~~-------------~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~ 70 (347)
T 2ifg_A 7 PHGSSGLRCT-------------RDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLR-GLGELRNLTIVKSGLRF 70 (347)
T ss_dssp CSSSSCEECC-------------SSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSC-SCCCCSEEECCSSCCCE
T ss_pred cccCCEEEcC-------------CCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhc-cccCCCEEECCCCccce
Confidence 4888888884 34 677 4898 99999999999996 999954444554 59999999999999999
Q ss_pred cCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCC
Q 007088 146 EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPV 195 (618)
Q Consensus 146 ~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~i 195 (618)
..|..|++|++|+.|+|++|+|++..|..+..++ |+.|+|++|.|...-
T Consensus 71 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp ECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred eCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence 8888899999999999999999965555555555 999999999998643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.47 E-value=2.4e-14 Score=146.13 Aligned_cols=131 Identities=15% Similarity=0.155 Sum_probs=109.7
Q ss_pred CcEEEEEecCCcceeeCCcCC--CCCCCCCeEEccCCcCccccCchhhhcC-----CCCCEEEeeCCCCcccCCCCCcCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGI--ERCTSLTGLDLSSNNLSGSIPSDISSRL-----QYVTSLDLSSNSLSGEIPSGLANC 154 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~--~~l~~L~~L~l~~n~l~g~ip~~~~~~l-----~~L~~L~l~~N~l~g~ip~~~~~l 154 (618)
.+++.|+|++|+++|.+|..+ +.+++|++|+|++|++++. |..+.. + ++|++|+|++|++++..|..++++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~-l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE-LQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH-HHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH-HHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 578999999999999999987 8999999999999999976 877765 6 899999999999998777899999
Q ss_pred CCCcEEEccCcccCCC--CCccc--cccccccccccccccccC--CCCCCC--c-cccccccccCCCCC
Q 007088 155 TFLNVLKLNNNRFTGK--IPPQL--GLLNRIKTFSVASNLLTG--PVPSFA--N-VNFTAEDFANNSGL 214 (618)
Q Consensus 155 ~~L~~l~l~~N~l~g~--~p~~l--~~~~~L~~l~l~~N~l~g--~ip~~~--~-~~~~~~~~~~n~~~ 214 (618)
++|+.|+|++|++.|. +|..+ +.+++|+.|+|++|++++ .+|... . .++..+++++|...
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 241 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 9999999999999886 35555 889999999999999984 333211 1 25777888888643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.1e-14 Score=154.53 Aligned_cols=122 Identities=25% Similarity=0.438 Sum_probs=99.2
Q ss_pred cccce-ecCCCCCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC
Q 007088 70 QFTGV-DCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148 (618)
Q Consensus 70 ~w~gv-~c~~~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip 148 (618)
.|.|+ .|.. ++++.|+|++|+|++ +|..+. ++|+.|+|++|+|+ .|| . .+++|++|+|++|+|++ ||
T Consensus 49 ~~~~l~~C~~---~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip 116 (571)
T 3cvr_A 49 AVSLLKECLI---NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LP 116 (571)
T ss_dssp HHHHHHHHHH---TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CC
T ss_pred hhhhcccccc---CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cc
Confidence 79999 7853 579999999999997 888774 78999999999999 788 2 37889999999999996 88
Q ss_pred CCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 212 (618)
. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|.... ++..+++++|.
T Consensus 117 ~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~-~L~~L~Ls~N~ 171 (571)
T 3cvr_A 117 E-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPT-SLEVLSVRNNQ 171 (571)
T ss_dssp C-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCT-TCCEEECCSSC
T ss_pred h-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCC-CcCEEECCCCC
Confidence 8 665 88999999999987 777 57888888888888887 665322 56777777775
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.8e-14 Score=143.11 Aligned_cols=129 Identities=16% Similarity=0.201 Sum_probs=83.4
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccc--cCchh-hhcCCCCCEEEeeCCCCcccCCC---C-CcCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS--IPSDI-SSRLQYVTSLDLSSNSLSGEIPS---G-LANC 154 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~--ip~~~-~~~l~~L~~L~l~~N~l~g~ip~---~-~~~l 154 (618)
.+++.|+|++|++.+..|..++++++|++|+|++|++.|. +|... ...+++|++|+|++|+++ .+|. . ++++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 4788888888888877778888888888888888887653 32222 123666667777777665 2332 1 3556
Q ss_pred CCCcEEEccCcccCCCCCcccccc---ccccccccccccccCCCCCCCccccccccccCCC
Q 007088 155 TFLNVLKLNNNRFTGKIPPQLGLL---NRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212 (618)
Q Consensus 155 ~~L~~l~l~~N~l~g~~p~~l~~~---~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 212 (618)
++|++|+|++|+|++.+|+.++.+ ++|+.|+|++|+|+ .+|.....++..+++++|.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~ 283 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNR 283 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCc
Confidence 666677777777666666666555 46666677666666 4454332355666666664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.46 E-value=9.6e-14 Score=149.27 Aligned_cols=136 Identities=17% Similarity=0.142 Sum_probs=82.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhc----------------------CCCCCEEEee
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSR----------------------LQYVTSLDLS 139 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~----------------------l~~L~~L~l~ 139 (618)
.+++.|+|++|++++..+..+.++++|+.|+|++|+.-+.+|...+.+ +++|+.|+|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls 226 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMS 226 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCCCCTTCTTCCEEECT
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccccccccccccEEECc
Confidence 478888888888886555455555555555555533333444433333 5555555555
Q ss_pred CCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCCC
Q 007088 140 SNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 140 ~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~~ 217 (618)
+|++++..|..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++..+.... .++..+++++|++.|.+
T Consensus 227 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp TSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 5666555555566666666666666666666666666666677777777777655554322 14566777778777754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.1e-14 Score=154.89 Aligned_cols=109 Identities=26% Similarity=0.252 Sum_probs=73.9
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCcc--ccCchhhhcCCCCCEEEeeCCCCcccCCCC-CcCCCCC
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSG--SIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFL 157 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g--~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~-~~~l~~L 157 (618)
...++.|+|++|.+++.+|..++++++|+.|+|++|++++ .+|..+.. +++|++|+|++|++++.+|.. +..+++|
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~-l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ-MKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTT-CTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhh-CCCCCEEECCCCcCCcccccchhccCccC
Confidence 4567888888888888888888888888888888888885 55666654 888888888888888767754 5556555
Q ss_pred cEEEccCcccCCCCCcccccccccccccccccccc
Q 007088 158 NVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 158 ~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~ 192 (618)
+.|+|++|++++.+|..+. ++|+.|++++|+++
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 5555555555554444332 34444444444444
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.46 E-value=5.9e-14 Score=133.05 Aligned_cols=126 Identities=13% Similarity=0.187 Sum_probs=106.0
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|.++ .++.+..+++|++|+|++|++++..|..+.. +++|++|+|++|++++..|..++.+++|+.|+
T Consensus 66 ~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~-l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTT-CTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcC-CCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 47899999999654 4458999999999999999999888888875 99999999999999988888999999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 212 (618)
|++|++.+.+| .+..+++|+.|++++|++++.. .+..+ ++..+++++|+
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC-
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcc
Confidence 99999555777 6899999999999999998843 33222 57777888885
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.9e-13 Score=140.54 Aligned_cols=144 Identities=19% Similarity=0.215 Sum_probs=119.8
Q ss_pred CCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 65 EGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
.++.|.|..+.|.+.. ...++.|+|++|++++..+..++++++|++|+|++|++++..|..+.. +++|++|
T Consensus 27 ~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L 105 (330)
T 1xku_A 27 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-LVKLERL 105 (330)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT-CTTCCEE
T ss_pred CCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcC-CCCCCEE
Confidence 3456899999997532 347889999999999877779999999999999999999766877765 9999999
Q ss_pred EeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccC--CCCCCCc--cccccccccCCC
Q 007088 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG--PVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 137 ~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g--~ip~~~~--~~~~~~~~~~n~ 212 (618)
+|++|+++ .+|..+. ++|+.|++++|++++..|..+..+++|+.|++++|.++. ..|.... .++..+++++|.
T Consensus 106 ~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 106 YLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp ECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred ECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence 99999999 7898776 799999999999998777789999999999999999964 5554322 156667777774
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=2.2e-13 Score=151.71 Aligned_cols=128 Identities=20% Similarity=0.230 Sum_probs=109.0
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCC-CcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~-~~~l~~L~~l 160 (618)
.+++.|+|++|++++..|..|+++++|++|+|++|.+++..|..++ ++++|++|+|++|.++ .+|.. ++++++|++|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 152 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ-NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 152 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHc-CCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEE
Confidence 4688999999999998888999999999999999999975555454 5999999999999999 45655 6999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 212 (618)
+|++|+|++..|..++.+++|+.|+|++|.+++..+.... ++..+++++|.
T Consensus 153 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~-~L~~L~l~~n~ 203 (597)
T 3oja_B 153 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP-SLFHANVSYNL 203 (597)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCT-TCSEEECCSSC
T ss_pred EeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhh-hhhhhhcccCc
Confidence 9999999998888999999999999999999986443333 45555666663
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.6e-14 Score=143.85 Aligned_cols=130 Identities=15% Similarity=0.083 Sum_probs=74.7
Q ss_pred CcEEEEEecCCcceeeCC----cCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCccc--CC--CCCcC
Q 007088 82 NKVLNIRLSDMGLKGQFP----RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE--IP--SGLAN 153 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p----~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~--ip--~~~~~ 153 (618)
.+++.|+|++|.+++.+| ..+..+++|++|+|++|++.+..|..+. .+++|++|+|++|++.|. +| ..+++
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVR-AFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCC-CCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhc-cCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 456666666666666544 3345566667777777766644444443 366677777777766542 22 22356
Q ss_pred CCCCcEEEccCcccCCCCCc----cccccccccccccccccccCCCCCCC-cc----ccccccccCCCC
Q 007088 154 CTFLNVLKLNNNRFTGKIPP----QLGLLNRIKTFSVASNLLTGPVPSFA-NV----NFTAEDFANNSG 213 (618)
Q Consensus 154 l~~L~~l~l~~N~l~g~~p~----~l~~~~~L~~l~l~~N~l~g~ip~~~-~~----~~~~~~~~~n~~ 213 (618)
+++|++|+|++|+++ .+|. .++.+++|+.|+|++|++++.+|... .. ++..+++++|..
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l 263 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGL 263 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCC
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCC
Confidence 666666777777665 2332 13556666667777777666655321 11 455556666643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=140.94 Aligned_cols=131 Identities=18% Similarity=0.170 Sum_probs=107.5
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|++++..|..++.+++|++|+|++|.+++..|..++..+++|++|+|++|++++ +|. ...+++|+.|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~-~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EEC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccc-ccccccCCEEE
Confidence 4678889999999987788899999999999999999977777776568999999999999995 454 34589999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCC-CCc-cccccccccCCCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS-FAN-VNFTAEDFANNSGLCG 216 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~-~~~-~~~~~~~~~~n~~~c~ 216 (618)
|++|++++ +|+.+..+++|+.|+|++|++++ +|. +.. .++..+++++|+..|+
T Consensus 198 Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp CCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHH
T ss_pred CCCCcCCc-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCc
Confidence 99999995 66668999999999999999996 453 322 2677888999987763
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.43 E-value=6.1e-14 Score=143.07 Aligned_cols=128 Identities=17% Similarity=0.196 Sum_probs=57.3
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccc--cCchh-hhcCCCCCEEEeeCCCCcc--cCCCC-CcCCCC
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS--IPSDI-SSRLQYVTSLDLSSNSLSG--EIPSG-LANCTF 156 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~--ip~~~-~~~l~~L~~L~l~~N~l~g--~ip~~-~~~l~~ 156 (618)
+++.|+|++|++++..|..++++++|++|+|++|++.|. +|..+ +..+++|++|+|++|++++ .+|.. +.++++
T Consensus 150 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~ 229 (312)
T 1wwl_A 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ 229 (312)
T ss_dssp TCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCC
T ss_pred CCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCC
Confidence 444555555555544444555555555555555555443 12222 1224455555555555541 12211 234445
Q ss_pred CcEEEccCcccCCCCC-ccccccccccccccccccccCCCCCCCccccccccccCC
Q 007088 157 LNVLKLNNNRFTGKIP-PQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANN 211 (618)
Q Consensus 157 L~~l~l~~N~l~g~~p-~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n 211 (618)
|+.|+|++|++++.+| ..+..+++|+.|+|++|+++ .+|.....++..+++++|
T Consensus 230 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N 284 (312)
T 1wwl_A 230 LQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYN 284 (312)
T ss_dssp CSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSS
T ss_pred CCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCceEEECCCC
Confidence 5555555555554443 23334445555555555554 344322223444445444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.7e-13 Score=148.32 Aligned_cols=133 Identities=22% Similarity=0.193 Sum_probs=99.0
Q ss_pred EEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEcc
Q 007088 84 VLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163 (618)
Q Consensus 84 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~ 163 (618)
++.|+|++|.+.+.+|+.+....+|+.|+|++|+++ .+|...+.++++|+.|+|++|++++..+..+.++++|+.|+|+
T Consensus 202 L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 280 (477)
T 2id5_A 202 LKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280 (477)
T ss_dssp CCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECC
T ss_pred cceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECC
Confidence 444444444444444444444445666666666776 5665444568899999999999997767778999999999999
Q ss_pred CcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCCC
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~~ 217 (618)
+|++++..|..+..+++|+.|+|++|++++..+.... .++..+++++|++.|.+
T Consensus 281 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp SSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 9999988888999999999999999999987665432 25778899999988864
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=3e-13 Score=124.99 Aligned_cols=106 Identities=25% Similarity=0.229 Sum_probs=93.2
Q ss_pred CCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccc
Q 007088 108 LTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVA 187 (618)
Q Consensus 108 L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~ 187 (618)
.+.|++++|+|. .||..+ .++|++|+|++|++++..|..++++++|+.|+|++|+|++..|..+..+++|+.|+|+
T Consensus 11 ~~~l~~s~n~l~-~ip~~~---~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGI---PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccC---CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 579999999999 799876 4789999999999998878899999999999999999997666678999999999999
Q ss_pred cccccCCCCCCC-c-cccccccccCCCCCCCC
Q 007088 188 SNLLTGPVPSFA-N-VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 188 ~N~l~g~ip~~~-~-~~~~~~~~~~n~~~c~~ 217 (618)
+|+|++..|... . .++..+++++|++.|.+
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 999999887533 3 26788999999998854
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.6e-13 Score=123.74 Aligned_cols=105 Identities=21% Similarity=0.222 Sum_probs=93.3
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcc-cCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG-EIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g-~ip~~~~~l~~L~~ 159 (618)
..+++.|+|++|++++. ..++++++|++|+|++|.+++.+|..+.. +++|++|+|++|++++ ..|..++++++|+.
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~ 117 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEK-CPNLTHLNLSGNKIKDLSTIEPLKKLENLKS 117 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHH-CTTCCEEECTTSCCCSHHHHGGGGGCTTCCE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhh-CCCCCEEECCCCcCCChHHHHHHhhCCCCCE
Confidence 46799999999999976 88999999999999999999878877654 9999999999999997 24588999999999
Q ss_pred EEccCcccCCCCC---cccccccccccccccc
Q 007088 160 LKLNNNRFTGKIP---PQLGLLNRIKTFSVAS 188 (618)
Q Consensus 160 l~l~~N~l~g~~p---~~l~~~~~L~~l~l~~ 188 (618)
|++++|++++..+ ..++.+++|+.|++++
T Consensus 118 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 118 LDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999997655 4789999999999864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.42 E-value=2.6e-13 Score=125.03 Aligned_cols=109 Identities=23% Similarity=0.244 Sum_probs=96.8
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC--CCCcCCCCCcE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP--SGLANCTFLNV 159 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip--~~~~~l~~L~~ 159 (618)
.+++.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.. +++|++|+|++|++++ +| ..++.+++|+.
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~-~~~~~~l~~l~~L~~ 124 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEK-LPNLTHLNLSGNKLKD-ISTLEPLKKLECLKS 124 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHH-CTTCCEEECBSSSCCS-SGGGGGGSSCSCCCE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhh-CCCCCEEeccCCccCc-chhHHHHhcCCCCCE
Confidence 5799999999999976 88999999999999999999777776654 9999999999999995 44 78999999999
Q ss_pred EEccCcccCCCCC---ccccccccccccccccccccCC
Q 007088 160 LKLNNNRFTGKIP---PQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 160 l~l~~N~l~g~~p---~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
|+|++|++++..+ ..+..+++|+.|++++|.+...
T Consensus 125 L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 125 LDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp EECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred EEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 9999999996554 4789999999999999998654
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=3e-13 Score=140.38 Aligned_cols=130 Identities=21% Similarity=0.189 Sum_probs=112.8
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC--CCcCCCCCc
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS--GLANCTFLN 158 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~--~~~~l~~L~ 158 (618)
..+++.|+|++|++++..|..+.++++|++|+|++|+++ .+|...+.++++|++|+|++|+++ .+|. .++++++|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 467999999999999988899999999999999999999 678775556999999999999999 5776 789999999
Q ss_pred EEEccCcc-cCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 159 VLKLNNNR-FTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 159 ~l~l~~N~-l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
.|++++|+ +++..|..++.+++|+.|++++|++++.+|.... .++..+++++|.
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence 99999995 7766677899999999999999999999886443 156677777774
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=3.3e-13 Score=152.76 Aligned_cols=136 Identities=23% Similarity=0.225 Sum_probs=100.5
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccc----cCc---hhhhcCCCCCEEEeeCCCCcccCCC-CCcC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS----IPS---DISSRLQYVTSLDLSSNSLSGEIPS-GLAN 153 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~----ip~---~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~ 153 (618)
.+++.|+|++|++++..|..+..+++|++|+|++|++++. +|. ..+.++++|++|+|++|+++ .||. .+++
T Consensus 480 ~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~ 558 (680)
T 1ziw_A 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKD 558 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTTT
T ss_pred CCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHccc
Confidence 4577778888887766666677788888888888887742 111 11234788888888888888 5665 4788
Q ss_pred CCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc---cccccccccCCCCCCCCC
Q 007088 154 CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN---VNFTAEDFANNSGLCGKP 218 (618)
Q Consensus 154 l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~~c~~~ 218 (618)
+++|+.|+|++|++++..|..+..+++|+.|+|++|++++.+|.... .++..+++++|++.|.++
T Consensus 559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 88888888888888865555577888888888888888887775321 257788999999999765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.41 E-value=5.2e-13 Score=123.84 Aligned_cols=106 Identities=22% Similarity=0.230 Sum_probs=91.9
Q ss_pred CCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccc
Q 007088 108 LTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVA 187 (618)
Q Consensus 108 L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~ 187 (618)
-+.+++++|++. .||..+ .++|+.|+|++|+|++..|..++++++|+.|+|++|+|++..|..+..+++|+.|+|+
T Consensus 14 ~~~l~~~~n~l~-~iP~~~---~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGI---PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SSEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CcEEEeCCCCCC-ccCCCc---CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECC
Confidence 378999999997 899877 3789999999999998888899999999999999999997555567899999999999
Q ss_pred cccccCCCCC-CCcc-ccccccccCCCCCCCC
Q 007088 188 SNLLTGPVPS-FANV-NFTAEDFANNSGLCGK 217 (618)
Q Consensus 188 ~N~l~g~ip~-~~~~-~~~~~~~~~n~~~c~~ 217 (618)
+|+|++..|. +..+ ++..+++++|++.|.+
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 9999987775 3332 6788899999988753
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.40 E-value=3.8e-13 Score=148.75 Aligned_cols=128 Identities=19% Similarity=0.105 Sum_probs=106.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++..|..+.++++|++|+|++|++++..|..+.+ +++|++|+|++|+++ .||.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLF-NQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTT-CTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCC-CCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 67899999999999888889999999999999999999666666654 999999999999999 78987 899999999
Q ss_pred ccCcccCC-CCCccccccccccccccccccccCCCCCC-CccccccccccCCCC
Q 007088 162 LNNNRFTG-KIPPQLGLLNRIKTFSVASNLLTGPVPSF-ANVNFTAEDFANNSG 213 (618)
Q Consensus 162 l~~N~l~g-~~p~~l~~~~~L~~l~l~~N~l~g~ip~~-~~~~~~~~~~~~n~~ 213 (618)
|++|++++ .+|..++++++|+.|++++|++++..... ..+++..+++++|..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence 99999997 56789999999999999999998732221 112236667777753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.7e-13 Score=148.59 Aligned_cols=31 Identities=13% Similarity=-0.007 Sum_probs=25.7
Q ss_pred CHHHHHHHHHHHhcCCCCCccceeEEEEeCC
Q 007088 344 SEKEFLSEINTLGSVRHRNLVPLLGFCVAKK 374 (618)
Q Consensus 344 ~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 374 (618)
..++|..|++.+.+++|+|+|+++|||....
T Consensus 322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 322 GSETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 4668999999999999999999999987653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.6e-13 Score=150.11 Aligned_cols=127 Identities=20% Similarity=0.144 Sum_probs=98.8
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++..|..+.++++|++|+|++|++++..|..+.. +++|++|+|++|+++ .||.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKF-NQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTT-CTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhc-ccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 57888899998888777778888889999999999888666766654 888999999999888 68877 788889999
Q ss_pred ccCcccCC-CCCccccccccccccccccccccCCCCCCCcccc--ccccccCCCC
Q 007088 162 LNNNRFTG-KIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNF--TAEDFANNSG 213 (618)
Q Consensus 162 l~~N~l~g-~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~--~~~~~~~n~~ 213 (618)
|++|++++ .+|..++.+++|+.|++++|++++....... ++ ..+++++|..
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~-~L~L~~L~l~~n~l 150 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA-HLNISKVLLVLGET 150 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGT-TSCEEEEEEEECTT
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccchhhccccc-cceeeEEEeecccc
Confidence 99998887 5788888888888888888888763221111 23 5566666643
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.1e-13 Score=148.82 Aligned_cols=118 Identities=20% Similarity=0.148 Sum_probs=105.3
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcc-cCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSG-EIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g-~ip~~~~~l~~L~~ 159 (618)
..+++.|+|++|++++..|..|+++++|++|+|++|++++..|..+. ++++|++|+|++|++++ .+|..++++++|+.
T Consensus 49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 127 (549)
T 2z81_A 49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG-PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127 (549)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHT-TCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhc-cCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence 46799999999999999999999999999999999999965555465 59999999999999997 57889999999999
Q ss_pred EEccCcccCCCCC-ccccccccccccccccccccCCCCCCC
Q 007088 160 LKLNNNRFTGKIP-PQLGLLNRIKTFSVASNLLTGPVPSFA 199 (618)
Q Consensus 160 l~l~~N~l~g~~p-~~l~~~~~L~~l~l~~N~l~g~ip~~~ 199 (618)
|+|++|++.+.+| ..++.+++|+.|++++|++++.+|...
T Consensus 128 L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 168 (549)
T 2z81_A 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168 (549)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT
T ss_pred EECCCCccccccCHhhhhcccccCeeeccCCcccccChhhh
Confidence 9999999777776 579999999999999999999888643
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.38 E-value=4.7e-13 Score=140.89 Aligned_cols=129 Identities=14% Similarity=0.161 Sum_probs=98.8
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+++++.++...+..+.++++|++|+|++|.+.+..|..+. .+++|++|+|++|++++..|..++++++|++|+
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFA-YAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTT-TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhcc-CCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 4677888888888743333468888999999999998854444554 488999999999999877677788899999999
Q ss_pred ccCcccCCCCCcc-ccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQ-LGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~-l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
|++|+++ .+|.. ++.+++|++|++++|++++..|.... .++..+++++|.
T Consensus 124 L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 176 (390)
T 3o6n_A 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176 (390)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSC
T ss_pred CCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCc
Confidence 9999988 45554 58888999999999999887775332 256677777774
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=138.19 Aligned_cols=128 Identities=20% Similarity=0.230 Sum_probs=108.6
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCC-CcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~-~~~l~~L~~l 160 (618)
.+++.|+|++|++++..+..+.++++|++|+|++|++++..|..+. ++++|++|+|++|+++ .+|.. ++++++|++|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L 146 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ-NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTL 146 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTT-TCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhc-CCCCCCEEECCCCccC-cCCHHHhcCCCCCcEE
Confidence 5789999999999988888999999999999999999965555554 5999999999999999 67766 5899999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 212 (618)
+|++|++++..|..++.+++|+.|++++|++++....... ++..+++++|.
T Consensus 147 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-~L~~L~l~~n~ 197 (390)
T 3o6n_A 147 SMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIP-SLFHANVSYNL 197 (390)
T ss_dssp ECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCT-TCSEEECCSSC
T ss_pred ECCCCccCccChhhccCCCCCCEEECCCCcCCcccccccc-ccceeeccccc
Confidence 9999999988888899999999999999999976333222 45566666663
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=147.56 Aligned_cols=117 Identities=19% Similarity=0.263 Sum_probs=109.9
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCc-cccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLS-GSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~-g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~ 159 (618)
..+++.|+|++|.+.+.+|..+.++++|+.|+|++|.+. |.+|..+.. +++|+.|+|++|++++..|..++++++|+.
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE-LRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT-CTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc-ccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 357899999999999999999999999999999999998 689988765 999999999999999888999999999999
Q ss_pred EEccCcccCCCCCccccccccccccccccccccCCCCCC
Q 007088 160 LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198 (618)
Q Consensus 160 l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~ 198 (618)
|+|++|++++..|..+..+++|+.|++++|.++|.+|..
T Consensus 499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcch
Confidence 999999999988888999999999999999999999864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.37 E-value=4e-13 Score=124.85 Aligned_cols=104 Identities=18% Similarity=0.293 Sum_probs=65.6
Q ss_pred cEEEEEecCCcceeeCCcCCCCCC-CCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCC-cCCCCCcEE
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCT-SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVL 160 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~-~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~-~~l~~L~~l 160 (618)
.++.|+|++|+++ .+|. +..+. +|++|+|++|.+++ + ..+.. +++|++|+|++|+++ .+|+.+ +.+++|+.|
T Consensus 20 ~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~-l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 20 RDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPL-LRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL 93 (176)
T ss_dssp SCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCC-CSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred CceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-ccccc-CCCCCEEECCCCccc-ccCcchhhcCCCCCEE
Confidence 5666777777766 3443 44444 67777777777764 3 33433 667777777777776 345443 667777777
Q ss_pred EccCcccCCCCCc--cccccccccccccccccccC
Q 007088 161 KLNNNRFTGKIPP--QLGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 161 ~l~~N~l~g~~p~--~l~~~~~L~~l~l~~N~l~g 193 (618)
+|++|+|+ .+|. .+..+++|+.|++++|.++.
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~ 127 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 127 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC
Confidence 77777774 4555 56666777777777777663
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.37 E-value=4.8e-13 Score=130.77 Aligned_cols=128 Identities=18% Similarity=0.194 Sum_probs=106.2
Q ss_pred CCcEEEEEecCCc-ceeeCCcCCCCCCCCCeEEccC-CcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCc
Q 007088 81 ENKVLNIRLSDMG-LKGQFPRGIERCTSLTGLDLSS-NNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158 (618)
Q Consensus 81 ~~~v~~l~l~~~~-l~g~~p~~~~~l~~L~~L~l~~-n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~ 158 (618)
..+++.|+|++|+ +++..+..+.++++|++|+|++ |+++ .+|...+.++++|++|+|++|++++ +|. ++.+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~ 130 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTD 130 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCC
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-EcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccc
Confidence 4579999999997 8766666899999999999998 9999 5666555569999999999999996 887 88888888
Q ss_pred ---EEEccCc-ccCCCCCcccccccccc-ccccccccccCCCCCC--CccccccccccCCC
Q 007088 159 ---VLKLNNN-RFTGKIPPQLGLLNRIK-TFSVASNLLTGPVPSF--ANVNFTAEDFANNS 212 (618)
Q Consensus 159 ---~l~l~~N-~l~g~~p~~l~~~~~L~-~l~l~~N~l~g~ip~~--~~~~~~~~~~~~n~ 212 (618)
.|++++| ++++..+..+..+++|+ .|++++|+++ .+|.. ...++..+++++|.
T Consensus 131 ~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 99876666789999999 9999999998 66642 22356777888884
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=133.58 Aligned_cols=127 Identities=20% Similarity=0.240 Sum_probs=80.3
Q ss_pred CcEEEEEecCCcce--eeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcE
Q 007088 82 NKVLNIRLSDMGLK--GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159 (618)
Q Consensus 82 ~~v~~l~l~~~~l~--g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~ 159 (618)
.+++.|+|++|.+. |..+..+.++++|++|+|++|+++ .+|..+ .++|+.|+|++|++++..|..++++++|+.
T Consensus 145 ~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~---~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 220 (330)
T 1xku_A 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAK 220 (330)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred ccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccc---cccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence 46777788777774 366666777777777777777776 466544 256666666666666655666666666666
Q ss_pred EEccCcccCCCCCccccccccccccccccccccCCCCCCC-c-cccccccccCCCC
Q 007088 160 LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-N-VNFTAEDFANNSG 213 (618)
Q Consensus 160 l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-~-~~~~~~~~~~n~~ 213 (618)
|+|++|++++..|..+..+++|+.|++++|+++ .+|... . .++..+++++|..
T Consensus 221 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i 275 (330)
T 1xku_A 221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275 (330)
T ss_dssp EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred EECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence 666666666655556666666666666666666 444322 1 1345556666543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.36 E-value=4.9e-13 Score=124.24 Aligned_cols=107 Identities=21% Similarity=0.230 Sum_probs=95.2
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC--CCcCCCCCcE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS--GLANCTFLNV 159 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~--~~~~l~~L~~ 159 (618)
.+++.|+|++|++++. +.++.+++|++|+|++|+++ .+|+.++..+++|++|+|++|+++ .+|. .++.+++|+.
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 117 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence 3799999999999975 78999999999999999999 577777556999999999999996 7887 8999999999
Q ss_pred EEccCcccCCCCCcc----ccccccccccccccccccC
Q 007088 160 LKLNNNRFTGKIPPQ----LGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 160 l~l~~N~l~g~~p~~----l~~~~~L~~l~l~~N~l~g 193 (618)
|+|++|.++ .+|.. +..+++|+.|++++|.+..
T Consensus 118 L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 118 LCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 999999998 57775 8999999999999998754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.8e-12 Score=131.81 Aligned_cols=127 Identities=16% Similarity=0.252 Sum_probs=109.1
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|++++..|..++++++|++|+|++|++. .+|..++ ++|++|+|++|++++..+..++++++|+.|
T Consensus 77 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L 152 (332)
T 2ft3_A 77 LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCI 152 (332)
T ss_dssp CTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEE
T ss_pred CCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEE
Confidence 467999999999999999999999999999999999999 8998764 789999999999995444568999999999
Q ss_pred EccCcccC--CCCCccccccccccccccccccccCCCCCCCccccccccccCCCC
Q 007088 161 KLNNNRFT--GKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSG 213 (618)
Q Consensus 161 ~l~~N~l~--g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~ 213 (618)
+|++|+++ |..|..+..+ +|+.|++++|++++ +|.....++..+++++|..
T Consensus 153 ~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~i 205 (332)
T 2ft3_A 153 EMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPETLNELHLDHNKI 205 (332)
T ss_dssp ECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSCSSCSCCBCCSSCC
T ss_pred ECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCccccCCCCEEECCCCcC
Confidence 99999996 4778888888 99999999999998 5543333677788888853
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=3e-12 Score=126.96 Aligned_cols=146 Identities=11% Similarity=0.019 Sum_probs=113.7
Q ss_pred HHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEE
Q 007088 301 LMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 301 l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 378 (618)
+......|.....++.|+.+.||++... +..+++|+..... .....+.+|+++++.+. +..+.++++++.+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567877778888888999999864 6789999986522 22345889999998884 6778899999998889999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC--------------------------------- 425 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------- 425 (618)
||||++|.+|.+.+... .....++.+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDE---------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCTT---------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCCc---------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 99999999988764211 123478899999999999820
Q ss_pred -----------------------CCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 426 -----------------------NPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 426 -----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799998774
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.1e-14 Score=138.36 Aligned_cols=124 Identities=20% Similarity=0.272 Sum_probs=82.4
Q ss_pred cEEEEEecCCcceeeCCc------CCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCC
Q 007088 83 KVLNIRLSDMGLKGQFPR------GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTF 156 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~------~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~ 156 (618)
+++.++|++++++|.+|+ .+.++++|++|+|++|++++ +| .+.. +++|++|+|++|+++ .+|..+..+++
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~-l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSG-MENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHH-HTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-cccc-CCCCCEEECCCCCcc-cccchhhcCCc
Confidence 455566666666666665 67777777777777777774 66 5544 777777777777777 67776666777
Q ss_pred CcEEEccCcccCCCCCccccccccccccccccccccCCCC--CCCcc-ccccccccCCC
Q 007088 157 LNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP--SFANV-NFTAEDFANNS 212 (618)
Q Consensus 157 L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip--~~~~~-~~~~~~~~~n~ 212 (618)
|+.|+|++|++++ +| .++.+++|+.|++++|++++..+ .+..+ ++..+++++|+
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~ 151 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCc
Confidence 7777777777775 45 56777777777777777775322 22111 45556666664
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.4e-12 Score=127.82 Aligned_cols=123 Identities=20% Similarity=0.312 Sum_probs=91.8
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++. |+ +.++++|++|+|++|++++ +|.... ++|+.|+|++|++++ +| .++++++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~N~l~~-l~~~~~---~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISDL-SP-LKDLTKLEELSVNRNRLKN-LNGIPS---ACLSRLFLDNNELRD-TD-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCSSCCSC-CTTCCC---SSCCEEECCSSCCSB-SG-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCCC-hh-hccCCCCCEEECCCCccCC-cCcccc---CcccEEEccCCccCC-Ch-hhcCcccccEEE
Confidence 5688888888888854 33 8888888888888888884 665321 778888888888885 44 588888888888
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNSGLC 215 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~~c 215 (618)
|++|++++ +| .++.+++|+.|+|++|++++. +.+..+ ++..+++++|+..+
T Consensus 135 Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 135 IRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp CTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEEC
T ss_pred CCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccC
Confidence 88888885 44 578888888888888888877 433322 56667778776544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.31 E-value=4e-12 Score=139.49 Aligned_cols=94 Identities=29% Similarity=0.438 Sum_probs=46.3
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
+++.|+|++|+|+ .|| ..+++|+.|+|++|+|++ ||. +.. +|++|+|++|+|++ ||. .+++|+.|+|
T Consensus 81 ~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~---~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 81 QITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA---SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT---TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc---CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 4555555555555 455 334555555555555553 554 321 45555555555553 444 3444555555
Q ss_pred cCcccCCCCCccccccccccccccccccccC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g 193 (618)
++|+|++ +|. .+++|+.|+|++|+|++
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~ 174 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTF 174 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCC
Confidence 5555443 443 23444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.30 E-value=3.7e-12 Score=128.41 Aligned_cols=121 Identities=27% Similarity=0.377 Sum_probs=96.8
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++..| +.++++|++|+|++|.+++ +|. +.. +++|++|+|++|++++ + +.++.+++|+.|+
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~-l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKD-LKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTT-CTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hcc-CCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 578899999999986444 8899999999999999984 554 554 8999999999999985 4 4688899999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~ 212 (618)
|++|++++. +.++.+++|+.|++++|++++..| +.. .++..+++++|.
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~ 189 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 189 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCc
Confidence 999999864 568888999999999999988766 322 256677777774
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=3.8e-12 Score=131.70 Aligned_cols=106 Identities=15% Similarity=0.166 Sum_probs=93.4
Q ss_pred CeEEccCC-cCccccCchhhhcCCCCCEEEeeC-CCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccccccccc
Q 007088 109 TGLDLSSN-NLSGSIPSDISSRLQYVTSLDLSS-NSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSV 186 (618)
Q Consensus 109 ~~L~l~~n-~l~g~ip~~~~~~l~~L~~L~l~~-N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l 186 (618)
..+++++| +|+ .||. +.. +++|+.|+|++ |+|++..|..|++|++|+.|+|++|+|+|..|..|+++++|+.|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~-~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCS-CSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCC-CCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 45799998 999 6999 765 99999999996 9999766688999999999999999999998999999999999999
Q ss_pred ccccccCCCCCCC-ccccccccccCCCCCCCC
Q 007088 187 ASNLLTGPVPSFA-NVNFTAEDFANNSGLCGK 217 (618)
Q Consensus 187 ~~N~l~g~ip~~~-~~~~~~~~~~~n~~~c~~ 217 (618)
++|+|++..|... .+.+..+++.+|+..|.+
T Consensus 88 ~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCccceeCHHHcccCCceEEEeeCCCccCCC
Confidence 9999998777544 345788899999998865
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.28 E-value=7.7e-12 Score=124.11 Aligned_cols=122 Identities=21% Similarity=0.279 Sum_probs=102.0
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|+++ .+| .+..+++|+.|+|++|++++ +|+ +. ++++|++|+|++|++++ +|.... ++|+.|+
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~-~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~ 112 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LK-DLTKLEELSVNRNRLKN-LNGIPS--ACLSRLF 112 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GT-TCSSCCEEECCSSCCSC-CTTCCC--SSCCEEE
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hc-cCCCCCEEECCCCccCC-cCcccc--CcccEEE
Confidence 46889999999998 566 79999999999999999995 665 55 49999999999999995 675443 9999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNSGL 214 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~~ 214 (618)
|++|++++ +| .++.+++|+.|+|++|++++. |.+.. .++..+++++|...
T Consensus 113 L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 113 LDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp CCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCC
T ss_pred ccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCc
Confidence 99999996 44 589999999999999999985 43332 25777888888643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.27 E-value=4.5e-12 Score=127.81 Aligned_cols=124 Identities=22% Similarity=0.348 Sum_probs=104.2
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|.+++ +| .+.++++|++|+|++|++++ +| .+.. +++|+.|+|++|++++ + ..++.+++|+.|
T Consensus 89 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~~-~l~~-l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L 161 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVH-LPQLESLYLGNNKITD-I-TVLSRLTKLDTL 161 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CG-GGGG-CTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred CCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-Ch-hhcC-CCCCCEEEccCCcCCc-c-hhhccCCCCCEE
Confidence 4679999999999986 44 49999999999999999995 54 4654 9999999999999996 4 679999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNSGL 214 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~~ 214 (618)
+|++|++++..| +..+++|+.|++++|.+++. |.+..+ ++..+++++|+..
T Consensus 162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEEEEEE
T ss_pred EccCCccccchh--hcCCCccCEEECCCCcCCCC-hhhccCCCCCEEECcCCccc
Confidence 999999997544 89999999999999999874 544332 5777888888643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.27 E-value=4.8e-13 Score=136.75 Aligned_cols=126 Identities=17% Similarity=0.232 Sum_probs=105.2
Q ss_pred CcEEEEEecCCcceeeCCcCCC-CCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIE-RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
.+++.|+|++|.+++..|..+. .+++|++|+|++|+++ .+|... . +++|+.|+|++|+++ .+|..+..+++|+.|
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~-~-l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L 219 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-V-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEECCC-C-CTTCCEEECCSSCCC-EECGGGGGGTTCSEE
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccccc-c-cccCCEEECCCCcCC-cchhhhcccCcccEE
Confidence 5799999999999998888774 8999999999999999 456544 3 899999999999999 577789999999999
Q ss_pred EccCcccCCCCCcccccccccccccccccccc-CCCCCCCcc--ccccccccCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT-GPVPSFANV--NFTAEDFANNS 212 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~-g~ip~~~~~--~~~~~~~~~n~ 212 (618)
+|++|+|+ .+|..+..+++|+.|++++|.++ +.+|.+... ++..+++.+|.
T Consensus 220 ~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~ 273 (317)
T 3o53_A 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273 (317)
T ss_dssp ECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHH
T ss_pred ECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCch
Confidence 99999999 58999999999999999999999 766654321 23444445443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.27 E-value=9.5e-12 Score=126.50 Aligned_cols=121 Identities=28% Similarity=0.458 Sum_probs=75.6
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++ +++ +.++++|++|+|++|++++ +| .+.. +++|+.|+|++|++++ +|. ++.+++|+.|+
T Consensus 63 ~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~-l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKN-VS-AIAG-LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSC-CG-GGTT-CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred CCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCC-ch-hhcC-CCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 456777777777764 333 7777777777777777763 44 3443 7777777777777764 443 66777777777
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~ 212 (618)
|++|++++. |+ ++.+++|+.|++++|++++..| +.. .++..+++++|.
T Consensus 136 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 136 LDLNQITNI-SP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp CCSSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred CCCCccCcC-cc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCc
Confidence 777777643 33 6666777777777777766443 221 144555555553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.27 E-value=6.6e-12 Score=130.13 Aligned_cols=146 Identities=14% Similarity=0.098 Sum_probs=103.5
Q ss_pred CCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCE-EE
Q 007088 67 FICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTS-LD 137 (618)
Q Consensus 67 ~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~-L~ 137 (618)
|-|+|..|.|++.. +..++.|+|++|+|+..-+..|.+|++|++|+|++|++.+.||...+.++++|.. ++
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 44789999996532 2467889999999885444568889999999999998887888877666877764 66
Q ss_pred eeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccc-cccCCCCC-CCcc--ccccccccCCC
Q 007088 138 LSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASN-LLTGPVPS-FANV--NFTAEDFANNS 212 (618)
Q Consensus 138 l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N-~l~g~ip~-~~~~--~~~~~~~~~n~ 212 (618)
+++|++++..|..+.++++|+.|++++|++++..+..+....++..|++.+| ++....+. +... .+..+++++|.
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence 7788888655677888899999999999988665556666667777877664 44433332 2221 23445666663
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.26 E-value=8.3e-12 Score=126.95 Aligned_cols=123 Identities=26% Similarity=0.391 Sum_probs=92.0
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|.+++ + +.+.++++|++|+|++|++++ +|. +. .+++|+.|+|++|++++ +|. ++.+++|+.|
T Consensus 84 l~~L~~L~L~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~~-l~-~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L 156 (308)
T 1h6u_A 84 LTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITD-VTP-LA-GLSNLQVLYLDLNQITN-ISP-LAGLTNLQYL 156 (308)
T ss_dssp CCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCC-CGG-GT-TCTTCCEEECCSSCCCC-CGG-GGGCTTCCEE
T ss_pred CCCCCEEEccCCcCCC-c-hhhcCCCCCCEEECCCCCCCC-chh-hc-CCCCCCEEECCCCccCc-Ccc-ccCCCCccEE
Confidence 3578888888888875 3 368888888888888888884 554 54 48888888888888885 443 7888888888
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNSG 213 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~ 213 (618)
+|++|++++ +|. +..+++|+.|++++|++++..| +.. .++..+++++|..
T Consensus 157 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l 207 (308)
T 1h6u_A 157 SIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQI 207 (308)
T ss_dssp ECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCC
T ss_pred EccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCcc
Confidence 888888885 444 7888888888888888887655 222 2566677777754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.26 E-value=8e-12 Score=138.49 Aligned_cols=106 Identities=28% Similarity=0.399 Sum_probs=55.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|+|++..| +.+|++|+.|+|++|.|++ +| .+.. +++|+.|+|++|++++ + +.+++|++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~-l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKD-LKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTT-CTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhcc-CCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence 345556666666554332 5555555555555555552 33 3332 5555555555555553 2 2355555555555
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
|++|+|++. +.++.+++|+.|+|++|+|++.+|
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 555555542 345555555555555555555444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=5.7e-12 Score=138.77 Aligned_cols=101 Identities=23% Similarity=0.297 Sum_probs=89.4
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccC-CCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEI-PSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~i-p~~~~~l~~L~~l 160 (618)
.+++.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ || .++. |++|+.|+|++|+|++.+ |..+++|++|+.|
T Consensus 463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~-l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L 538 (567)
T 1dce_A 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVAN-LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL 538 (567)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTT-CSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCC-CCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence 57999999999999 999999999999999999999996 88 6765 999999999999999876 9999999999999
Q ss_pred EccCcccCCCCCcc---cccccccccccc
Q 007088 161 KLNNNRFTGKIPPQ---LGLLNRIKTFSV 186 (618)
Q Consensus 161 ~l~~N~l~g~~p~~---l~~~~~L~~l~l 186 (618)
+|++|+|++.+|.. +..+++|+.|++
T Consensus 539 ~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 539 NLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp ECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred EecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999999765532 234778888754
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.25 E-value=8.3e-12 Score=138.34 Aligned_cols=123 Identities=20% Similarity=0.324 Sum_probs=103.1
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|.|++ +| .+..|++|+.|+|++|+|++ +| .+.. |++|+.|+|++|++++. ..++.|++|+.|
T Consensus 86 l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~-l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 158 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTL 158 (605)
T ss_dssp CTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGG-CTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred CCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccC-CCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence 3578999999999986 44 79999999999999999995 55 4554 99999999999999964 678999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNSG 213 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~ 213 (618)
+|++|+|++..| +..+++|+.|+|++|+|++. |.+..+ ++..+++++|+.
T Consensus 159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l 209 (605)
T 1m9s_A 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQEC 209 (605)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEE
T ss_pred ECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcC
Confidence 999999997666 88999999999999999985 544332 577788888864
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.24 E-value=2e-11 Score=131.00 Aligned_cols=117 Identities=21% Similarity=0.340 Sum_probs=78.7
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++ +| +++++++|++|+|++|++++ +|.. ..+|++|+|++|++++ +| .++++++|+.|+
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIY 201 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEE
Confidence 467777777777775 66 57777888888888887774 6653 3467777777777775 66 577777777777
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 212 (618)
+++|++++ +|... ++|+.|++++|+++ .+|.+..+ ++..+++++|.
T Consensus 202 l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~~~~l~~L~~L~l~~N~ 248 (454)
T 1jl5_A 202 ADNNSLKK-LPDLP---LSLESIVAGNNILE-ELPELQNLPFLTTIYADNNL 248 (454)
T ss_dssp CCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSC
T ss_pred CCCCcCCc-CCCCc---CcccEEECcCCcCC-cccccCCCCCCCEEECCCCc
Confidence 77777775 44432 36666667777666 55653332 45556666664
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.24 E-value=2.8e-11 Score=129.97 Aligned_cols=99 Identities=25% Similarity=0.327 Sum_probs=52.4
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
+++.|+|++|+++| +| .++.+++|++|+|++|++++ +| ++. +++|++|+|++|++++ +| ++++++|++|+|
T Consensus 43 ~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~-l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 43 TLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQ-NTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTT-CTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--ccc-CCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 45555555555554 23 45555555555555555553 33 332 5555555555555554 23 555555555555
Q ss_pred cCcccCCCCCccccccccccccccccccccC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g 193 (618)
++|++++ +| ++.+++|+.|++++|++++
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~ 141 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTE 141 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSC
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCccce
Confidence 5555554 33 4555555555555555555
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=8.2e-12 Score=123.32 Aligned_cols=131 Identities=12% Similarity=0.075 Sum_probs=99.1
Q ss_pred EEe-ecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC--ccceeEEEEeCCeeEEEEeecCCCccc
Q 007088 313 IIG-TGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN--LVPLLGFCVAKKERLLVYSYLENGTLY 389 (618)
Q Consensus 313 ~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~ 389 (618)
.++ .|..+.||++...+|..+++|+.... ....+.+|+++++.+.+.+ +.+++++....+..++||||++|.+|.
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 344 45569999998877888999997654 2245778999988885444 566889888888889999999998884
Q ss_pred cccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 007088 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC-------------------------------------------- 425 (618)
Q Consensus 390 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------- 425 (618)
... .+ ...++.++++.|+.||+..
T Consensus 104 --~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 104 --SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp --TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred --cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 211 11 2357788888899998752
Q ss_pred -----------CCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 426 -----------NPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 426 -----------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.1e-11 Score=128.03 Aligned_cols=124 Identities=25% Similarity=0.357 Sum_probs=76.8
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++. |+ +..+++|++|+|++|.+++ +| .+. .+++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus 221 ~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~-~~-~~~-~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~ 293 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDL-SP-LANLSQLTWLEIGTNQISD-IN-AVK-DLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLF 293 (347)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-CG-GGT-TCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEE
T ss_pred CcCCEEEccCCccCCC-cc-hhcCCCCCEEECCCCccCC-Ch-hHh-cCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEE
Confidence 3566666666666643 22 6666777777777776663 43 233 36677777777777764 33 466677777777
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 212 (618)
|++|++++..|..++.+++|+.|++++|++++..|-..-.++..+++++|+
T Consensus 294 L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred CcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence 777777766666667777777777777777766661111145556666664
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.22 E-value=6.3e-14 Score=132.95 Aligned_cols=110 Identities=20% Similarity=0.251 Sum_probs=98.6
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++ +| .+.++++|+.|+|++|+++ .+|..+.. +++|+.|+|++|++++ +| .++++++|+.|+
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~-~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 121 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV-ADTLEELWISYNQIAS-LS-GIEKLVNLRVLY 121 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH-HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc-CCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence 578999999999997 78 8999999999999999999 89987764 8999999999999996 67 689999999999
Q ss_pred ccCcccCCCCC-ccccccccccccccccccccCCCCC
Q 007088 162 LNNNRFTGKIP-PQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 162 l~~N~l~g~~p-~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
|++|++++.-+ ..+..+++|+.|++++|.+++.+|.
T Consensus 122 l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 99999995322 4789999999999999999998775
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.20 E-value=3.3e-11 Score=129.42 Aligned_cols=105 Identities=21% Similarity=0.248 Sum_probs=86.4
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|+..|.+ .++.+++|+.|+|++|++++ +| +. .+++|+.|+|++|++++. .++.+++|+.|
T Consensus 147 l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~-~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L 217 (457)
T 3bz5_A 147 NTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VS-QNKLLNRLNCDTNNITKL---DLNQNIQLTFL 217 (457)
T ss_dssp CTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CT-TCTTCCEEECCSSCCSCC---CCTTCTTCSEE
T ss_pred CCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cc-cCCCCCEEECcCCcCCee---ccccCCCCCEE
Confidence 356888999998777777 47888999999999999985 77 44 488899999999998863 48888899999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
+|++|+|++ +| ++.+++|+.|++++|+++|..+.
T Consensus 218 ~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 218 DCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp ECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred ECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 999999987 66 78888899999999999886653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.20 E-value=6.9e-12 Score=139.27 Aligned_cols=134 Identities=22% Similarity=0.310 Sum_probs=97.1
Q ss_pred CccCCCCCCCCCCcccceecCCC-----CCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCC
Q 007088 57 SWNFNNNTEGFICQFTGVDCWHP-----DENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQ 131 (618)
Q Consensus 57 ~W~~~~~~~~~~c~w~gv~c~~~-----~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~ 131 (618)
.|..+ ..||.|+|..|.-. ....++.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .||. .++
T Consensus 14 ~W~~~----~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~ 81 (622)
T 3g06_A 14 AWRRA----APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPP 81 (622)
T ss_dssp HHHHT----CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC----CCT
T ss_pred HHHhc----CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC----cCC
Confidence 67643 34788876432100 1235788999999988 8888776 78999999999888 6886 278
Q ss_pred CCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCC
Q 007088 132 YVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANN 211 (618)
Q Consensus 132 ~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n 211 (618)
+|++|+|++|+|+ .||. .+++|+.|+|++|+|++ +|. .+++|+.|++++|++++ +|.... ++..+++++|
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l~-~L~~L~Ls~N 151 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLPP-GLQELSVSDN 151 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCCT-TCCEEECCSS
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCCC-CCCEEECcCC
Confidence 8889999999888 5776 67888888888888885 555 45677888888888876 444332 5666777776
Q ss_pred C
Q 007088 212 S 212 (618)
Q Consensus 212 ~ 212 (618)
.
T Consensus 152 ~ 152 (622)
T 3g06_A 152 Q 152 (622)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.19 E-value=2e-11 Score=130.94 Aligned_cols=59 Identities=25% Similarity=0.361 Sum_probs=37.2
Q ss_pred CCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccC--CCCC
Q 007088 131 QYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTG--PVPS 197 (618)
Q Consensus 131 ~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g--~ip~ 197 (618)
++|+.|+|++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|+.|++++|+++| .+|.
T Consensus 317 ~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~ 377 (454)
T 1jl5_A 317 PSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPE 377 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCT
T ss_pred CcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChH
Confidence 456666666666664 5554 356666677777666 3555 35666667777777666 5554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.18 E-value=2.7e-11 Score=130.56 Aligned_cols=104 Identities=24% Similarity=0.378 Sum_probs=58.2
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|.+++..| +..+++|+.|+|++|.+++ +|+ +. .+++|+.|+|++|++++..| ++.+++|+.|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~-~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 315 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LA-GLTALTNLELNENQLEDISP--ISNLKNLTYLT 315 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GT-TCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-cc-CCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence 356666666666665433 5566666666666666663 333 33 25666666666666654322 55556666666
Q ss_pred ccCcccCCCCCccccccccccccccccccccCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
|++|++++..| ++.+++|+.|++++|++++.
T Consensus 316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred CcCCcCCCchh--hccCccCCEeECCCCccCCc
Confidence 66666655433 44555555555555555553
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.16 E-value=5e-11 Score=128.50 Aligned_cols=125 Identities=27% Similarity=0.316 Sum_probs=101.1
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|++++. +.+..+++|+.|+|++|.+++..| +. .+++|+.|+|++|++++. |. ++.+++|+.|
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~-~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L 292 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS-GLTKLTELKLGANQISNI-SP-LAGLTALTNL 292 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT-TCTTCSEEECCSSCCCCC-GG-GTTCTTCSEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh-cCCCCCEEECCCCccCcc-cc-ccCCCccCeE
Confidence 35789999999999863 468899999999999999996544 54 499999999999999964 44 8899999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGL 214 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~ 214 (618)
+|++|++++..| ++.+++|+.|++++|++++..|-..-.++..+++++|...
T Consensus 293 ~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~ 344 (466)
T 1o6v_A 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVS 344 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCC
T ss_pred EcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccC
Confidence 999999997544 7889999999999999999877222225677788888543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.9e-10 Score=118.10 Aligned_cols=141 Identities=15% Similarity=0.216 Sum_probs=107.4
Q ss_pred CCcEEeecCCeeEEEEEeCCCcEEEEEEec--cCc--cCHHHHHHHHHHHhcCC--CCCccceeEEEEeC---CeeEEEE
Q 007088 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLE--DSQ--HSEKEFLSEINTLGSVR--HRNLVPLLGFCVAK---KERLLVY 380 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 380 (618)
..+.|+.|.++.||+....+ ..+++|+.. ... .....+.+|..+++.+. +..+++++.++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999998755 577888876 332 23456888999999886 45688899988776 4589999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC----------------------------------- 425 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------- 425 (618)
||++|.++.+... ..++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999987754221 23678888999999999999999831
Q ss_pred --------------------CCCceecCCCCCCeeeCCCCc--eEEcccCcccc
Q 007088 426 --------------------NPRIIHRNISSKCILLDGDFE--PKLSDFGLARL 457 (618)
Q Consensus 426 --------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~ 457 (618)
.+.++|+|+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.10 E-value=8.1e-11 Score=121.53 Aligned_cols=105 Identities=23% Similarity=0.304 Sum_probs=91.8
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.|+|++|.+++. +.+..+++|++|+|++|++++ +|. +. .+++|+.|+|++|++++..|..++++++|+.|
T Consensus 242 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-~~-~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 242 LSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-ISV-LN-NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CGG-GG-GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred CCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Chh-hc-CCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 46799999999999863 569999999999999999995 553 54 49999999999999999888889999999999
Q ss_pred EccCcccCCCCCcccccccccccccccccccc
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~ 192 (618)
+|++|++++..| +..+++|+.|++++|.++
T Consensus 317 ~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp ECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EccCCccccccC--hhhhhccceeehhhhccc
Confidence 999999997666 889999999999999986
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.09 E-value=8.5e-12 Score=131.06 Aligned_cols=131 Identities=15% Similarity=0.183 Sum_probs=109.4
Q ss_pred CcEEEEEecCCcce-eeCC---cCCCCCCCCCeEEccCCcCc--c---ccCchhhhcCCCCCEEEeeCCCCc----ccCC
Q 007088 82 NKVLNIRLSDMGLK-GQFP---RGIERCTSLTGLDLSSNNLS--G---SIPSDISSRLQYVTSLDLSSNSLS----GEIP 148 (618)
Q Consensus 82 ~~v~~l~l~~~~l~-g~~p---~~~~~l~~L~~L~l~~n~l~--g---~ip~~~~~~l~~L~~L~l~~N~l~----g~ip 148 (618)
.+++.|+|++|+++ +.+| ..+.++++|+.|+|++|+++ | .+|..+.. +++|++|+|++|.++ +.+|
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~-~~~L~~L~Ls~n~l~~~g~~~l~ 237 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAY-CQELKVLDLQDNTFTHLGSSALA 237 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGG-CTTCCEEECCSSCCHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhc-CCCccEEECcCCCCCcHHHHHHH
Confidence 68999999999998 5666 56888999999999999998 4 34545654 999999999999997 7899
Q ss_pred CCCcCCCCCcEEEccCcccCCC----CCccc--cccccccccccccccccC----CCCCCC-c--cccccccccCCCC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGK----IPPQL--GLLNRIKTFSVASNLLTG----PVPSFA-N--VNFTAEDFANNSG 213 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~----~p~~l--~~~~~L~~l~l~~N~l~g----~ip~~~-~--~~~~~~~~~~n~~ 213 (618)
..+..+++|+.|+|++|+|++. +|..+ +.+++|+.|+|++|.+++ .+|... . .++..+++++|+.
T Consensus 238 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 238 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred HHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 9999999999999999999976 67777 448999999999999999 577533 1 2677788888864
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.09 E-value=6.5e-12 Score=129.12 Aligned_cols=107 Identities=21% Similarity=0.324 Sum_probs=69.2
Q ss_pred CcEEEEEecCCcceee-CCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCC-CCccc-CCCCCcCCCCCc
Q 007088 82 NKVLNIRLSDMGLKGQ-FPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSN-SLSGE-IPSGLANCTFLN 158 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~-~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N-~l~g~-ip~~~~~l~~L~ 158 (618)
.+++.|+|++|.+++. +|..+.++++|++|+|++|.+++.+|..+.. +++|++|+|++| .+++. +|..+.++++|+
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~ 171 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAK-NSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 171 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTT-CTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhc-CCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence 4566777777776655 6666666777777777777766666666654 666777777766 56642 555566666666
Q ss_pred EEEccCc-ccCCC-CCccccccc-cccccccccc
Q 007088 159 VLKLNNN-RFTGK-IPPQLGLLN-RIKTFSVASN 189 (618)
Q Consensus 159 ~l~l~~N-~l~g~-~p~~l~~~~-~L~~l~l~~N 189 (618)
.|+|++| ++++. +|..+..++ +|+.|++++|
T Consensus 172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 6666666 66653 455566666 6666666666
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.07 E-value=4.7e-12 Score=133.02 Aligned_cols=131 Identities=21% Similarity=0.352 Sum_probs=108.1
Q ss_pred CcEEEEEecCCccee----eCCcCCCCC---------CCCCeEEccCCcCc-cccC---chhhhcCCCCCEEEeeCCCCc
Q 007088 82 NKVLNIRLSDMGLKG----QFPRGIERC---------TSLTGLDLSSNNLS-GSIP---SDISSRLQYVTSLDLSSNSLS 144 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g----~~p~~~~~l---------~~L~~L~l~~n~l~-g~ip---~~~~~~l~~L~~L~l~~N~l~ 144 (618)
.+++.|+|++|++++ .++..+..+ ++|++|+|++|+++ +.+| ..+. .+++|++|+|++|+++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~-~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ-SHRLLHTVKMVQNGIR 200 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH-HCTTCCEEECCSSCCC
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHH-hCCCcCEEECcCCCCC
Confidence 579999999999963 466777777 89999999999998 6677 3454 4999999999999998
Q ss_pred --c---cCCCCCcCCCCCcEEEccCcccC----CCCCccccccccccccccccccccCC----CCCCC----cccccccc
Q 007088 145 --G---EIPSGLANCTFLNVLKLNNNRFT----GKIPPQLGLLNRIKTFSVASNLLTGP----VPSFA----NVNFTAED 207 (618)
Q Consensus 145 --g---~ip~~~~~l~~L~~l~l~~N~l~----g~~p~~l~~~~~L~~l~l~~N~l~g~----ip~~~----~~~~~~~~ 207 (618)
| .+|..+..+++|+.|+|++|+|+ +.+|..+..+++|+.|+|++|.+++. +|... ..++..++
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 4 46668999999999999999997 77899999999999999999999876 44321 22567778
Q ss_pred ccCCCC
Q 007088 208 FANNSG 213 (618)
Q Consensus 208 ~~~n~~ 213 (618)
+++|..
T Consensus 281 L~~n~i 286 (386)
T 2ca6_A 281 LQYNEI 286 (386)
T ss_dssp CCSSCC
T ss_pred CcCCcC
Confidence 888853
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.06 E-value=1.4e-10 Score=128.79 Aligned_cols=62 Identities=24% Similarity=0.254 Sum_probs=28.7
Q ss_pred CCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCC
Q 007088 130 LQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 130 l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
+++|+.|+|++|+|+ .||. .+++|+.|+|++|+|+ .+|..++++++|+.|+|++|.++|.+|
T Consensus 240 l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~ 301 (622)
T 3g06_A 240 PSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301 (622)
T ss_dssp CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHH
T ss_pred CCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCH
Confidence 344444444444444 3443 3344444444444444 444444444445555555554444444
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.04 E-value=2.5e-11 Score=124.70 Aligned_cols=128 Identities=18% Similarity=0.153 Sum_probs=96.1
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccc-cCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGS-IPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~-ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
.+++.|+|++|.+.+.++. +.++++|++|+|++|.+++. +|..+.. +++|++|+|++|++++.+|..++++++|+.|
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~-~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L 147 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQ-CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 147 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTT-BCCCSEEECTTCBCCHHHHHHHTTCTTCSEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhh-CCCCCEEeCcCcccCHHHHHHHhcCCCCCEE
Confidence 4677788888888876555 66788888888888888765 7766654 8888888888888888888888888888888
Q ss_pred EccCc-ccCCC-CCccccccccccccccccc-cccCC-CCCCCc--c-ccccccccCC
Q 007088 161 KLNNN-RFTGK-IPPQLGLLNRIKTFSVASN-LLTGP-VPSFAN--V-NFTAEDFANN 211 (618)
Q Consensus 161 ~l~~N-~l~g~-~p~~l~~~~~L~~l~l~~N-~l~g~-ip~~~~--~-~~~~~~~~~n 211 (618)
+|++| .+++. +|..+..+++|+.|++++| .+++. +|.... . ++..+++++|
T Consensus 148 ~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 148 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp ECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred ECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 88888 67763 6777788888888888888 88764 332211 1 3555666666
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.02 E-value=3.7e-10 Score=116.90 Aligned_cols=108 Identities=12% Similarity=0.093 Sum_probs=93.9
Q ss_pred EEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC-CCcCCCCCcE-EEcc
Q 007088 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS-GLANCTFLNV-LKLN 163 (618)
Q Consensus 86 ~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~-l~l~ 163 (618)
.++-++++|+ .||..+ .++|++|+|++|+|+ .||+..+.+|++|++|+|++|++.+.||. .|.+|++|.. ++++
T Consensus 13 ~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 13 VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 4678899999 789877 478999999999999 79987666799999999999999888886 4688988765 7778
Q ss_pred CcccCCCCCccccccccccccccccccccCCCCC
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
+|++++..|..+..+++|++|++++|++++..+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~ 122 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV 122 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCC
T ss_pred CCcccccCchhhhhccccccccccccccccCCch
Confidence 8999987788899999999999999999987664
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.8e-11 Score=125.00 Aligned_cols=130 Identities=25% Similarity=0.243 Sum_probs=88.5
Q ss_pred CcEEEEEecCCcceeeCC----cCCCCCC-CCCeEEccCCcCccccCchhhhcC-----CCCCEEEeeCCCCcccCCCCC
Q 007088 82 NKVLNIRLSDMGLKGQFP----RGIERCT-SLTGLDLSSNNLSGSIPSDISSRL-----QYVTSLDLSSNSLSGEIPSGL 151 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p----~~~~~l~-~L~~L~l~~n~l~g~ip~~~~~~l-----~~L~~L~l~~N~l~g~ip~~~ 151 (618)
..++.|+|++|++++..+ ..+.+++ +|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~-~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ-ILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHH-HHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHH-HHhccCCCccEEECcCCcCChHHHHHH
Confidence 357888888888876555 5667777 7888888888888666665554 4 778888888888886655544
Q ss_pred c----CC-CCCcEEEccCcccCCCCCccccc-----cccccccccccccccCCCCCCC-------ccccccccccCCC
Q 007088 152 A----NC-TFLNVLKLNNNRFTGKIPPQLGL-----LNRIKTFSVASNLLTGPVPSFA-------NVNFTAEDFANNS 212 (618)
Q Consensus 152 ~----~l-~~L~~l~l~~N~l~g~~p~~l~~-----~~~L~~l~l~~N~l~g~ip~~~-------~~~~~~~~~~~n~ 212 (618)
+ .+ ++|+.|+|++|+|++..+..++. .++|+.|+|++|.+++..+... ..++..+++++|.
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~ 178 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCC
Confidence 3 33 78888888888887666555443 2578888888888875333110 0146666777764
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.00 E-value=6.2e-11 Score=123.36 Aligned_cols=130 Identities=22% Similarity=0.235 Sum_probs=95.0
Q ss_pred cEEEEEecCCcceeeCCcCCCCC-----CCCCeEEccCCcCccccCchhhhc---C-CCCCEEEeeCCCCcccCCCCC--
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERC-----TSLTGLDLSSNNLSGSIPSDISSR---L-QYVTSLDLSSNSLSGEIPSGL-- 151 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l-----~~L~~L~l~~n~l~g~ip~~~~~~---l-~~L~~L~l~~N~l~g~ip~~~-- 151 (618)
+++.|+|++|++++..+..+..+ ++|++|+|++|.+++..+..++.. + ++|++|+|++|++++..+..+
T Consensus 52 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 131 (362)
T 3goz_A 52 SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ 131 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred ceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH
Confidence 78899999999988777777665 889999999999987666655431 3 789999999999986554443
Q ss_pred --cC-CCCCcEEEccCcccCCCCC----ccccccc-cccccccccccccCCCCCCCc-------cccccccccCCC
Q 007088 152 --AN-CTFLNVLKLNNNRFTGKIP----PQLGLLN-RIKTFSVASNLLTGPVPSFAN-------VNFTAEDFANNS 212 (618)
Q Consensus 152 --~~-l~~L~~l~l~~N~l~g~~p----~~l~~~~-~L~~l~l~~N~l~g~ip~~~~-------~~~~~~~~~~n~ 212 (618)
.. .++|+.|+|++|++++.-+ ..+..++ +|+.|+|++|++++..+.... .++..+++++|.
T Consensus 132 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~ 207 (362)
T 3goz_A 132 AFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL 207 (362)
T ss_dssp HHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSC
T ss_pred HHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCC
Confidence 33 3689999999999986443 3344554 899999999999877652110 156667777774
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=3.9e-10 Score=114.24 Aligned_cols=188 Identities=20% Similarity=0.209 Sum_probs=122.8
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCC--ccceeEEEEeCC---eeEEEEeecC
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRN--LVPLLGFCVAKK---ERLLVYSYLE 384 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~~ 384 (618)
.+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +.+++......+ ..|+|||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4679999999999863 45888886533 33467889999998873 333 345554443333 3479999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC--------------------------------------- 425 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------- 425 (618)
|.++.+... ..++..++..++.++++.++.||+..
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988865322 23677888889999999999999621
Q ss_pred ----------------CCCceecCCCCCCeeeCC--CCceEEcccCcccccCCCCCcccccccC--CCC---------cc
Q 007088 426 ----------------NPRIIHRNISSKCILLDG--DFEPKLSDFGLARLMNPVDTHLSTFVNG--EFG---------DL 476 (618)
Q Consensus 426 ----------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~~--~~g---------t~ 476 (618)
.+.++|+|++|.||++++ ...+.|+||+.+..-.... ........ ..+ .+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHc
Confidence 135899999999999998 4567899999887543211 00000000 000 00
Q ss_pred cccC-CCCCCCCCCCCccchHHHHHHHHHHHhCCCCC
Q 007088 477 GYVA-PEYPRTLVATPKGDVYSFGVVLLELITGERPT 512 (618)
Q Consensus 477 ~y~a-PE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf 512 (618)
++.. |+... ......+.|++|.++|.+.+|+.+|
T Consensus 253 ~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1111 11111 0112368999999999999998775
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.88 E-value=1.2e-10 Score=114.57 Aligned_cols=126 Identities=17% Similarity=0.222 Sum_probs=87.4
Q ss_pred CCcccceecCCCCCCcEEEEEecC---CcceeeCCcC------------------------CCCCCCCCe--EEccCCcC
Q 007088 68 ICQFTGVDCWHPDENKVLNIRLSD---MGLKGQFPRG------------------------IERCTSLTG--LDLSSNNL 118 (618)
Q Consensus 68 ~c~w~gv~c~~~~~~~v~~l~l~~---~~l~g~~p~~------------------------~~~l~~L~~--L~l~~n~l 118 (618)
.|.|.|+.|+. ...+|..+...+ ..+.|.++++ +.....|.. ++++.|+.
T Consensus 77 l~~~~g~i~~~-~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~ 155 (267)
T 3rw6_A 77 LKAVNYKILDR-ENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR 155 (267)
T ss_dssp HHHTTSSCBCT-TSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred HHhcCcEEECC-CCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence 58899999964 334666665544 3444444421 222223333 56667743
Q ss_pred ccccCch---hhhcCCCCCEEEeeCCCCcc--cCCCCCcCCCCCcEEEccCcccCCCCCccccccc--cccccccccccc
Q 007088 119 SGSIPSD---ISSRLQYVTSLDLSSNSLSG--EIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLN--RIKTFSVASNLL 191 (618)
Q Consensus 119 ~g~ip~~---~~~~l~~L~~L~l~~N~l~g--~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~--~L~~l~l~~N~l 191 (618)
. .++.. +..++++|+.|+|++|+|++ .+|..++.+++|+.|+|++|+|++. ..+..+. +|+.|+|++|.+
T Consensus 156 ~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 156 S-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp H-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred H-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence 3 33321 22358999999999999998 6777788999999999999999975 4455555 899999999999
Q ss_pred cCCCCC
Q 007088 192 TGPVPS 197 (618)
Q Consensus 192 ~g~ip~ 197 (618)
++.+|.
T Consensus 233 ~~~~~~ 238 (267)
T 3rw6_A 233 CDTFRD 238 (267)
T ss_dssp GGGCSS
T ss_pred ccccCc
Confidence 998773
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.79 E-value=9.4e-11 Score=125.93 Aligned_cols=112 Identities=16% Similarity=0.155 Sum_probs=62.7
Q ss_pred CcEEEEEecCCcceeeC-----CcCCCCCCCCCeEEccCCcCccc----cCchhhhcCCCCCEEEeeCCCCcccCCCCCc
Q 007088 82 NKVLNIRLSDMGLKGQF-----PRGIERCTSLTGLDLSSNNLSGS----IPSDISSRLQYVTSLDLSSNSLSGEIPSGLA 152 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~-----p~~~~~l~~L~~L~l~~n~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~ 152 (618)
.+++.|+|++|.+++.- +..+..+++|++|+|++|++++. +|..+.. +++|++|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~-~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA-KESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH-CTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhh-CCCcceEECCCCCCchHHHHHHH
Confidence 45666777777665431 12223466666666666666643 5555443 66666666666666543332222
Q ss_pred C-----CCCCcEEEccCcccCCC----CCccccccccccccccccccccCC
Q 007088 153 N-----CTFLNVLKLNNNRFTGK----IPPQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 153 ~-----l~~L~~l~l~~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
. .++|+.|+|++|++++. +|..+..+++|+.|++++|.+++.
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 356 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHH
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccc
Confidence 2 24666666666666644 344555556666666666666554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.74 E-value=4e-10 Score=120.96 Aligned_cols=133 Identities=20% Similarity=0.192 Sum_probs=100.8
Q ss_pred CCcEEEEEecCCcceee----CCcCCCCCCCCCeEEccCCcCccccCchhhh----cCCCCCEEEeeCCCCccc----CC
Q 007088 81 ENKVLNIRLSDMGLKGQ----FPRGIERCTSLTGLDLSSNNLSGSIPSDISS----RLQYVTSLDLSSNSLSGE----IP 148 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~----~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~----~l~~L~~L~l~~N~l~g~----ip 148 (618)
..+++.|+|++|++++. ++..+.++++|++|+|++|.+++.-+..+.. ..++|+.|+|++|.+++. +|
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 334 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS 334 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence 35789999999999865 7777888999999999999997654444443 236899999999998865 56
Q ss_pred CCCcCCCCCcEEEccCcccCCCCCccccc-----cccccccccccccccC----CCCCCCc--cccccccccCCCC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGKIPPQLGL-----LNRIKTFSVASNLLTG----PVPSFAN--VNFTAEDFANNSG 213 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~~p~~l~~-----~~~L~~l~l~~N~l~g----~ip~~~~--~~~~~~~~~~n~~ 213 (618)
..+..+++|+.|+|++|++++..+..+.. .++|+.|++++|++++ .+|.... .++..+++++|..
T Consensus 335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i 410 (461)
T 1z7x_W 335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410 (461)
T ss_dssp HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCC
Confidence 67778889999999999888765555543 5689999999998886 5664321 2566778888753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.69 E-value=2.9e-09 Score=104.66 Aligned_cols=80 Identities=24% Similarity=0.276 Sum_probs=66.6
Q ss_pred CCCCCCCeEEccCCcCcc--ccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCC--CCcEEEccCcccCCCCCc-----
Q 007088 103 ERCTSLTGLDLSSNNLSG--SIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCT--FLNVLKLNNNRFTGKIPP----- 173 (618)
Q Consensus 103 ~~l~~L~~L~l~~n~l~g--~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~--~L~~l~l~~N~l~g~~p~----- 173 (618)
.++++|+.|+|++|+|++ .+|..+.. +++|+.|+|++|+|++. .++..++ +|+.|+|++|.+++.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~-l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~ 243 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQK-APNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYI 243 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHH-STTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhh-CCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHH
Confidence 568899999999999997 66666654 99999999999999964 4556665 999999999999998873
Q ss_pred --cccccccccccc
Q 007088 174 --QLGLLNRIKTFS 185 (618)
Q Consensus 174 --~l~~~~~L~~l~ 185 (618)
.+..+++|+.||
T Consensus 244 ~~il~~~P~L~~LD 257 (267)
T 3rw6_A 244 SAIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHHCTTCCEES
T ss_pred HHHHHHCcccCeEC
Confidence 356788888776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=3.9e-09 Score=109.89 Aligned_cols=131 Identities=21% Similarity=0.184 Sum_probs=86.8
Q ss_pred CcEEEEEecCCcceeeCCcCCC-CCCCCCeEEccCCcCccccCchhhh----cCCCCCEEEeeCCCCcc----cCCCCCc
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIE-RCTSLTGLDLSSNNLSGSIPSDISS----RLQYVTSLDLSSNSLSG----EIPSGLA 152 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~l~~n~l~g~ip~~~~~----~l~~L~~L~l~~N~l~g----~ip~~~~ 152 (618)
..++.|+|++|+++..-...+. .+++|+.|+|++|+|+..-...+.. ..++|+.|+|++|.++. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 4788899998888653333332 3567888888888887433333322 24678888888888864 2444456
Q ss_pred CCCCCcEEEccCcccCCC----CCccccccccccccccccccccCCC----CCCC--ccccccccccCCC
Q 007088 153 NCTFLNVLKLNNNRFTGK----IPPQLGLLNRIKTFSVASNLLTGPV----PSFA--NVNFTAEDFANNS 212 (618)
Q Consensus 153 ~l~~L~~l~l~~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~g~i----p~~~--~~~~~~~~~~~n~ 212 (618)
.+++|++|+|++|+|+.. ++..+...++|+.|+|++|.++..- +... ..++..+++++|.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~ 250 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE 250 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSS
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCC
Confidence 778888888888888742 3555667778888888888887531 1111 1145667777774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=8.1e-07 Score=89.77 Aligned_cols=136 Identities=18% Similarity=0.159 Sum_probs=96.8
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCC---CccceeEEEE-eCCeeEEEEeecCCC
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHR---NLVPLLGFCV-AKKERLLVYSYLENG 386 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~g 386 (618)
.+.++.|....||+. |..+++|+-.. ......+.+|.+++..+.+. .+.+++.+.. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456888888899988 46678887432 23346788999999998642 3567777764 345678999999998
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC----------------------------------------- 425 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------- 425 (618)
++.+... ..++......++.++++.|+.||+..
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8765321 12455566666777777777766531
Q ss_pred ----------------CCCceecCCCCCCeeeCC---CCc-eEEcccCcccc
Q 007088 426 ----------------NPRIIHRNISSKCILLDG---DFE-PKLSDFGLARL 457 (618)
Q Consensus 426 ----------------~~~ivH~Dlkp~NIll~~---~~~-~kl~DfG~a~~ 457 (618)
.+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224699999999999987 455 48999998764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-08 Score=112.38 Aligned_cols=130 Identities=5% Similarity=-0.021 Sum_probs=87.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCC-CCCCCeEEcc----CCcCccc-----cCchhhhcCCCCCEEEeeCC--CCcccCCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIER-CTSLTGLDLS----SNNLSGS-----IPSDISSRLQYVTSLDLSSN--SLSGEIPS 149 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~-l~~L~~L~l~----~n~l~g~-----ip~~~~~~l~~L~~L~l~~N--~l~g~ip~ 149 (618)
.+++.|+|+.+++++..+..++. +++|+.|+|+ .|++++. ++..+. ++++|+.|+|+++ .+++..+.
T Consensus 378 ~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~-~~~~L~~L~L~~~~~~l~~~~~~ 456 (592)
T 3ogk_B 378 QELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI-GCKKLRRFAFYLRQGGLTDLGLS 456 (592)
T ss_dssp TTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHH-HCTTCCEEEEECCGGGCCHHHHH
T ss_pred ccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHH-hCCCCCEEEEecCCCCccHHHHH
Confidence 46778888888888777777765 7888888885 6777752 443343 3788888888743 36665555
Q ss_pred CCcC-CCCCcEEEccCcccCC-CCCccccccccccccccccccccCC-CCCCCc--cccccccccCCC
Q 007088 150 GLAN-CTFLNVLKLNNNRFTG-KIPPQLGLLNRIKTFSVASNLLTGP-VPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 150 ~~~~-l~~L~~l~l~~N~l~g-~~p~~l~~~~~L~~l~l~~N~l~g~-ip~~~~--~~~~~~~~~~n~ 212 (618)
.++. +++|+.|+|++|++++ .+|..+..+++|+.|+|++|.+++. ++.... .++..+++++|.
T Consensus 457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 5543 7778888888888876 3455556778888888888887654 222211 145666777775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=7e-07 Score=88.35 Aligned_cols=135 Identities=17% Similarity=0.137 Sum_probs=98.3
Q ss_pred EEeecCCe-eEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEeecCCCccc
Q 007088 313 IIGTGRTG-ATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYSYLENGTLY 389 (618)
Q Consensus 313 ~lG~G~~g-~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 389 (618)
.+..|..+ .||+... .++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 45566665 6898875 45678899986543 3456788999888774 334778899999999999999999998776
Q ss_pred cccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 007088 390 DKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC-------------------------------------------- 425 (618)
Q Consensus 390 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------------- 425 (618)
+..... ......+..+++..|+.||+..
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 643221 1223456677777777777531
Q ss_pred -----------CCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 426 -----------NPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 426 -----------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01379999999999999877777999998753
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.39 E-value=5.9e-09 Score=108.54 Aligned_cols=131 Identities=18% Similarity=0.141 Sum_probs=95.5
Q ss_pred CcEEEEEecCCcceeeCCcCCC-----CCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCC-----
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIE-----RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL----- 151 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~-----~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~----- 151 (618)
..++.|+|++|+++..-...+. +.++|+.|+|++|.++..-...+...+++|+.|+|++|+++..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 4688999999998864333332 237999999999999865445555558899999999999985433333
Q ss_pred cCCCCCcEEEccCcccCC----CCCccccccccccccccccccccCCC----CCCC--ccccccccccCCC
Q 007088 152 ANCTFLNVLKLNNNRFTG----KIPPQLGLLNRIKTFSVASNLLTGPV----PSFA--NVNFTAEDFANNS 212 (618)
Q Consensus 152 ~~l~~L~~l~l~~N~l~g----~~p~~l~~~~~L~~l~l~~N~l~g~i----p~~~--~~~~~~~~~~~n~ 212 (618)
...++|+.|+|++|+|+. .++..+..+++|++|+|++|.++..- +... ..++..+++++|.
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~ 222 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNG 222 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSC
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCC
Confidence 346889999999999974 34556677899999999999997531 1111 0146677777774
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.33 E-value=5.8e-08 Score=90.51 Aligned_cols=110 Identities=14% Similarity=0.192 Sum_probs=83.6
Q ss_pred CcEEEEEecCC-ccee----eCCcCCCCCCCCCeEEccCCcCccc----cCchhhhcCCCCCEEEeeCCCCccc----CC
Q 007088 82 NKVLNIRLSDM-GLKG----QFPRGIERCTSLTGLDLSSNNLSGS----IPSDISSRLQYVTSLDLSSNSLSGE----IP 148 (618)
Q Consensus 82 ~~v~~l~l~~~-~l~g----~~p~~~~~l~~L~~L~l~~n~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~----ip 148 (618)
..++.|+|++| ++.. .+...+...++|++|+|++|.+... +...+.. .++|++|+|++|.++.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~-n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV-NNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHH-CSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHh-CCCcCEEECcCCcCCHHHHHHHH
Confidence 57889999998 8763 2455677788999999999999632 3333433 67899999999999853 45
Q ss_pred CCCcCCCCCcEEEc--cCcccCCC----CCcccccccccccccccccccc
Q 007088 149 SGLANCTFLNVLKL--NNNRFTGK----IPPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 149 ~~~~~l~~L~~l~l--~~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~ 192 (618)
..+...+.|+.|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 56778889999999 88998854 3344555688999999998874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.3e-06 Score=90.13 Aligned_cols=80 Identities=10% Similarity=0.021 Sum_probs=57.3
Q ss_pred cEE-eecCCeeEEEEEeC-------CCcEEEEEEeccCc---c-CHHHHHHHHHHHhcCC-C--CCccceeEEEEeC---
Q 007088 312 NII-GTGRTGATYIAMLP-------GGCFIMIKRLEDSQ---H-SEKEFLSEINTLGSVR-H--RNLVPLLGFCVAK--- 373 (618)
Q Consensus 312 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 373 (618)
+.| +.|....+|+.... ++..+++|+..... . ....+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 467 78888999998764 26788899875432 1 1245778888888874 2 3577888887665
Q ss_pred CeeEEEEeecCCCccccc
Q 007088 374 KERLLVYSYLENGTLYDK 391 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~ 391 (618)
+..++||||++|.++.+.
T Consensus 106 g~~~~v~e~l~G~~l~~~ 123 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPDV 123 (357)
T ss_dssp SSCEEEEECCCCBCCCBT
T ss_pred CCceEEEEecCCCChhhc
Confidence 356899999998877653
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.26 E-value=1.3e-06 Score=89.18 Aligned_cols=99 Identities=16% Similarity=0.175 Sum_probs=49.8
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCC-EEEeeCCCCcccCC-CCCcCCCCCcEE
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVT-SLDLSSNSLSGEIP-SGLANCTFLNVL 160 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~-~L~l~~N~l~g~ip-~~~~~l~~L~~l 160 (618)
+++.|+|++|+++..-+..|.+|++|+.|+|.+| +. .|+...|.++++|+ .|+|++ +++ .|+ ..|.+|++|+.|
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMGCDNLRYV 302 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTTCTTEEEE
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cce-EEchhhhhCCccCCEE
Confidence 4555555555555333334555555555555555 44 45555554455555 555555 444 232 345555555555
Q ss_pred EccCcccCCCCCccccccccccccc
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFS 185 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~ 185 (618)
+|++|+++..-+..|.++++|+.++
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EeCCCccCccchhhhcCCcchhhhc
Confidence 5555555533333455555555443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.10 E-value=7.4e-06 Score=83.52 Aligned_cols=80 Identities=20% Similarity=0.242 Sum_probs=54.3
Q ss_pred CCCCCEEEeeCCCCcccCCC-CCcCCCCCcEEEccCcccCCCCCcccccccccc-ccccccccccCCCCC-CCcc-cccc
Q 007088 130 LQYVTSLDLSSNSLSGEIPS-GLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIK-TFSVASNLLTGPVPS-FANV-NFTA 205 (618)
Q Consensus 130 l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~-~l~l~~N~l~g~ip~-~~~~-~~~~ 205 (618)
+++|+.|+|++|+++ .||. .|.+|++|+.|+|.+| ++..-+.+|.++++|+ .+++.+ +++..-+. |..+ ++..
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 678888888888888 6665 4788888888888887 6643345678888888 888877 44433222 2222 4555
Q ss_pred ccccCCC
Q 007088 206 EDFANNS 212 (618)
Q Consensus 206 ~~~~~n~ 212 (618)
+++.+|.
T Consensus 302 l~l~~n~ 308 (329)
T 3sb4_A 302 VLATGDK 308 (329)
T ss_dssp EEECSSC
T ss_pred EEeCCCc
Confidence 6665553
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.6e-06 Score=95.96 Aligned_cols=105 Identities=8% Similarity=0.048 Sum_probs=65.9
Q ss_pred CcEEEEEecCCcceee----CCcCCCCCCCCCeEEccCCcCc----cccCchhhhcCCCCCEEEeeCCCCcccCCCCCcC
Q 007088 82 NKVLNIRLSDMGLKGQ----FPRGIERCTSLTGLDLSSNNLS----GSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLAN 153 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~----~p~~~~~l~~L~~L~l~~n~l~----g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~ 153 (618)
.+++.|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+. ++++|+.|+|++|.+.+ +|..+++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~-~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR-NCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH-HCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh-hCCCCcEEeccCccHHH-HHHHHhh
Confidence 4677888888877655 4444566778888888888776 34444443 37788888888887774 6666666
Q ss_pred CCCCcEEEccCcccC---CCCCcccccccccccccccc
Q 007088 154 CTFLNVLKLNNNRFT---GKIPPQLGLLNRIKTFSVAS 188 (618)
Q Consensus 154 l~~L~~l~l~~N~l~---g~~p~~l~~~~~L~~l~l~~ 188 (618)
+++|+.|+++++... +..+..+..+++|+.|++++
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~ 279 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETT
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccc
Confidence 666776666643222 22333445555555555554
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.05 E-value=2.7e-07 Score=102.08 Aligned_cols=129 Identities=9% Similarity=0.028 Sum_probs=93.6
Q ss_pred CcEEEEEecCCcceeeCCcCCC-CCCCCCeEEcc--C----CcCcc-----ccCchhhhcCCCCCEEEeeCCCCcccCCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIE-RCTSLTGLDLS--S----NNLSG-----SIPSDISSRLQYVTSLDLSSNSLSGEIPS 149 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~l~--~----n~l~g-----~ip~~~~~~l~~L~~L~l~~N~l~g~ip~ 149 (618)
.+++.|.+..+++++..+..+. ++++|+.|+|+ + |++++ .++.-+ ..+++|+.|+|++ ++++..+.
T Consensus 372 ~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~-~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIV-EHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHH-HHCTTCCEEECCS-SCCHHHHH
T ss_pred hhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHH-hhCCCccEEeecC-cccHHHHH
Confidence 4678888888999887766665 58999999999 4 56662 122223 3489999999977 77766666
Q ss_pred CCcC-CCCCcEEEccCcccCCCCCccc-cccccccccccccccccCCCCC-CCc--cccccccccCCC
Q 007088 150 GLAN-CTFLNVLKLNNNRFTGKIPPQL-GLLNRIKTFSVASNLLTGPVPS-FAN--VNFTAEDFANNS 212 (618)
Q Consensus 150 ~~~~-l~~L~~l~l~~N~l~g~~p~~l-~~~~~L~~l~l~~N~l~g~ip~-~~~--~~~~~~~~~~n~ 212 (618)
.++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. ... .++..+++++|+
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~ 517 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCS 517 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSC
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCC
Confidence 6665 8899999999999987666555 6689999999999998654432 111 156667777764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.02 E-value=1.9e-05 Score=80.62 Aligned_cols=141 Identities=16% Similarity=0.214 Sum_probs=80.3
Q ss_pred cEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC--CCCccceeE------EEEeCCeeEEEEeec
Q 007088 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR--HRNLVPLLG------FCVAKKERLLVYSYL 383 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lV~e~~ 383 (618)
+.|+.|..+.||+....+|. +++|+.... ..++..|..++..+. .-.+.+++. +....+..++||||+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~-~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGA-VCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTEE-EEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCCC-EEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 34555678899999886665 889988763 234445555555442 112333332 123456789999999
Q ss_pred CCCcccc--------------ccCC----CC-C-C----CcCCCHHHH-------------------------------H
Q 007088 384 ENGTLYD--------------KLHP----AE-H-E----VMHMDWPLR-------------------------------L 408 (618)
Q Consensus 384 ~~gsL~~--------------~l~~----~~-~-~----~~~l~~~~~-------------------------------~ 408 (618)
+|.++.. .++. .. . . ...-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 9866531 0110 00 0 0 001123211 0
Q ss_pred HHHHHHHHHHHHHHh----------CCCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 409 RIAIGSARGLAWLHH----------NCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 409 ~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
.+..++..++.+|+. ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446667763 023489999999999999888889999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.95 E-value=6.1e-05 Score=75.88 Aligned_cols=139 Identities=17% Similarity=0.167 Sum_probs=92.6
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC---CCCccceeEEEEeCCeeEEEEeecCCCc
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR---HRNLVPLLGFCVAKKERLLVYSYLENGT 387 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~gs 387 (618)
.+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+++++.+....+..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46789999999999986 4667888987643 3566889998888873 3678889999888888999999999876
Q ss_pred ccc-----------ccCCCCC-C-----------------CcCCCHHHHH---HHH----------------HHHHHHH-
Q 007088 388 LYD-----------KLHPAEH-E-----------------VMHMDWPLRL---RIA----------------IGSARGL- 418 (618)
Q Consensus 388 L~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~----------------~~i~~~L- 418 (618)
+.. .++.... . ...-+|.... ++. .+++..+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 532 1111110 0 0112454322 111 1111112
Q ss_pred HHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 419 AWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 419 ~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
..|.. ...|.++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 2346899999999999999887 8899974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=2.1e-05 Score=82.31 Aligned_cols=74 Identities=12% Similarity=-0.019 Sum_probs=49.4
Q ss_pred CcEEeecCCeeEEEEEeC-CCcEEEEEEeccCc--------cCHHHHHHHHHHHhcCCC--C-CccceeEEEEeCCeeEE
Q 007088 311 NNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQ--------HSEKEFLSEINTLGSVRH--R-NLVPLLGFCVAKKERLL 378 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 378 (618)
.+.||.|..+.||++... ++..+++|...... .....+..|.++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999753 56889999764321 123456778888887632 3 34455544 4455789
Q ss_pred EEeecCCC
Q 007088 379 VYSYLENG 386 (618)
Q Consensus 379 V~e~~~~g 386 (618)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=1e-06 Score=90.96 Aligned_cols=127 Identities=16% Similarity=0.201 Sum_probs=86.9
Q ss_pred CcEEEEEecCCc-ceeeCCcCCCCCCCCCeEEccCCcCccccCchhh-hcCCCCCEEEeeC--CCCccc--C---CCCC-
Q 007088 82 NKVLNIRLSDMG-LKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS-SRLQYVTSLDLSS--NSLSGE--I---PSGL- 151 (618)
Q Consensus 82 ~~v~~l~l~~~~-l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~-~~l~~L~~L~l~~--N~l~g~--i---p~~~- 151 (618)
.+++.|+|+++. + .+++ + .+.+|+.|+|..+.++...-..+. ..+++|+.|+|+. |...|. + -..+
T Consensus 172 P~L~~L~L~g~~~l--~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL--SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp TTCCEEEEECCBTC--BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCcEEEEeCCCCc--eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 579999998873 3 3444 4 389999999999887654434444 2489999999974 332222 1 1112
Q ss_pred -cCCCCCcEEEccCcccCCCCCcccc---ccccccccccccccccCC----CCCCCc--cccccccccCCC
Q 007088 152 -ANCTFLNVLKLNNNRFTGKIPPQLG---LLNRIKTFSVASNLLTGP----VPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 152 -~~l~~L~~l~l~~N~l~g~~p~~l~---~~~~L~~l~l~~N~l~g~----ip~~~~--~~~~~~~~~~n~ 212 (618)
..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.+++. ++.... .++..+++++|.
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 3589999999999999865554443 578999999999999874 332211 146677777774
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.85 E-value=2.1e-06 Score=94.86 Aligned_cols=105 Identities=18% Similarity=0.178 Sum_probs=62.7
Q ss_pred CcEEEEEecCCcceeeCCcCCC-CCCCCCeEEccCC-cCccc-cCchhhhcCCCCCEEEeeCCCCcccCCCCC----cCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIE-RCTSLTGLDLSSN-NLSGS-IPSDISSRLQYVTSLDLSSNSLSGEIPSGL----ANC 154 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~-~l~~L~~L~l~~n-~l~g~-ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~----~~l 154 (618)
.+++.|+|+++.+++..+..+. ++++|++|+|++| .++.. ++. +..++++|++|+|++|.+++..+..+ ..+
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA-IAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHH-HHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHH-HHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 3567777777777666555554 5677777777776 44432 333 33347777777777777665433333 355
Q ss_pred CCCcEEEccCcccCCCCC-----ccccccccccccccccc
Q 007088 155 TFLNVLKLNNNRFTGKIP-----PQLGLLNRIKTFSVASN 189 (618)
Q Consensus 155 ~~L~~l~l~~N~l~g~~p-----~~l~~~~~L~~l~l~~N 189 (618)
++|+.|+|++|. +.++ ..+..+++|+.|++++|
T Consensus 184 ~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 184 TSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp CCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 677777777775 2222 11234567777777766
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.77 E-value=4.1e-06 Score=77.80 Aligned_cols=98 Identities=14% Similarity=0.184 Sum_probs=74.8
Q ss_pred eeCCcCCCCCCCCCeEEccCC-cCccc----cCchhhhcCCCCCEEEeeCCCCccc----CCCCCcCCCCCcEEEccCcc
Q 007088 96 GQFPRGIERCTSLTGLDLSSN-NLSGS----IPSDISSRLQYVTSLDLSSNSLSGE----IPSGLANCTFLNVLKLNNNR 166 (618)
Q Consensus 96 g~~p~~~~~l~~L~~L~l~~n-~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~----ip~~~~~l~~L~~l~l~~N~ 166 (618)
..+...+...++|++|+|++| .+... +...+.. .++|++|+|++|++... +...+...+.|+.|+|++|+
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~-~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~ 104 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKT-NTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNF 104 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTT-CCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHh-CCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCc
Confidence 344556778899999999999 88732 3333333 68899999999999742 23345566889999999999
Q ss_pred cCCC----CCcccccccccccccc--ccccccCC
Q 007088 167 FTGK----IPPQLGLLNRIKTFSV--ASNLLTGP 194 (618)
Q Consensus 167 l~g~----~p~~l~~~~~L~~l~l--~~N~l~g~ 194 (618)
|+.. +...+...++|+.|+| ++|.++..
T Consensus 105 i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~ 138 (185)
T 1io0_A 105 ISGSGILALVEALQSNTSLIELRIDNQSQPLGNN 138 (185)
T ss_dssp CCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH
T ss_pred CCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHH
Confidence 9853 4566777889999999 88998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00047 Score=69.82 Aligned_cols=160 Identities=11% Similarity=0.073 Sum_probs=93.0
Q ss_pred ccCHHHHHHhhccCCC-----CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCC--Ccccee
Q 007088 295 KMRLSDLMKATNSFSK-----NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHR--NLVPLL 367 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~ 367 (618)
.++.+++......|.. ...++ |....||+....+|+.+++|+..........+..|..++..+... .+++++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 3455556555555532 34566 888899998877787899999875444566777888887776321 244444
Q ss_pred EE-----EEeCCeeEEEEeecCCCccccc--------------cC----CCCC-CCcCCCHHHH----HHH---------
Q 007088 368 GF-----CVAKKERLLVYSYLENGTLYDK--------------LH----PAEH-EVMHMDWPLR----LRI--------- 410 (618)
Q Consensus 368 ~~-----~~~~~~~~lV~e~~~~gsL~~~--------------l~----~~~~-~~~~l~~~~~----~~i--------- 410 (618)
.. ....+..++||+|++|.++... ++ .... ....+++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 2224566889999988654310 11 0000 0111222211 001
Q ss_pred ------HHHHHHHHHHHHhC----CCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 411 ------AIGSARGLAWLHHN----CNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 411 ------~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
...+-..++.+... ..+.++|+|+++.||+++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 233689999999999999 4 899999988754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00017 Score=73.01 Aligned_cols=160 Identities=13% Similarity=0.141 Sum_probs=89.5
Q ss_pred ccCHHHHHHhhccCCCC-----cEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC--cccee
Q 007088 295 KMRLSDLMKATNSFSKN-----NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN--LVPLL 367 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 367 (618)
.++.+++......|... +.|+.|....+|+....+| .+++|+..... ....+..|+.++..+.... +.+++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 35566777766667652 3466688889999987666 57789886521 2234556777766653211 33333
Q ss_pred EE------EEeCCeeEEEEeecCCCccccc--------------cCC----CCCCC-cC---CCHHHHHH----------
Q 007088 368 GF------CVAKKERLLVYSYLENGTLYDK--------------LHP----AEHEV-MH---MDWPLRLR---------- 409 (618)
Q Consensus 368 ~~------~~~~~~~~lV~e~~~~gsL~~~--------------l~~----~~~~~-~~---l~~~~~~~---------- 409 (618)
.. ....+..+++|+|++|..+... ++. ..... .. ..|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1234567899999998654321 110 00000 00 11222110
Q ss_pred --HHHHHHHHHHHHHhC----CCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 410 --IAIGSARGLAWLHHN----CNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 410 --i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
+...+...++++++. ..++++|+|+.+.||+++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455566532 13479999999999999887656899998775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00021 Score=71.05 Aligned_cols=75 Identities=17% Similarity=0.212 Sum_probs=55.1
Q ss_pred CCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCC---CCccceeEEEEeCCeeEEEEeecCC
Q 007088 310 KNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRH---RNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
..+.+|.|..+.||+.+..+|+.|++|+..... .....|..|...|+.+.. -.+.+++++. ..++||||+++
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 356799999999999999999999999876433 233457889998887742 2345555542 34789999987
Q ss_pred Ccc
Q 007088 386 GTL 388 (618)
Q Consensus 386 gsL 388 (618)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.0001 Score=73.99 Aligned_cols=71 Identities=11% Similarity=0.033 Sum_probs=44.9
Q ss_pred CcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCc-cceeEEEEeCCeeEEEEeec-CCCcc
Q 007088 311 NNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNL-VPLLGFCVAKKERLLVYSYL-ENGTL 388 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gsL 388 (618)
.+.|+.|....+|+. ..+++|+.........+..+|..+++.+....+ .+++++ +.+.-++|+||+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 678999999999998 558888876532111123467777776643233 455554 344457899999 65444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00019 Score=75.61 Aligned_cols=79 Identities=11% Similarity=0.058 Sum_probs=48.2
Q ss_pred CCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCC---CCCCccchHHHHHHHH
Q 007088 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL---VATPKGDVYSFGVVLL 503 (618)
Q Consensus 427 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDVwS~Gvil~ 503 (618)
+.++|+|++|.|||++.++ ++++||+.+..-.... ........ -...|.+|+..... ......++......+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3799999999999998876 9999999887543211 10110000 01345666544311 1122355668888888
Q ss_pred HHHhCC
Q 007088 504 ELITGE 509 (618)
Q Consensus 504 elltG~ 509 (618)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00024 Score=73.47 Aligned_cols=143 Identities=15% Similarity=0.089 Sum_probs=85.1
Q ss_pred CcEEeecCCeeEEEEEeC--------CCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEe
Q 007088 311 NNIIGTGRTGATYIAMLP--------GGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 381 (618)
.+.+..|-...+|+.... ++..+++|+..........+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 356777888899999864 2478999987543334566778999988874 3334567766543 29999
Q ss_pred ecCCCccccc-c----------------CCCCC-CCcCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 007088 382 YLENGTLYDK-L----------------HPAEH-EVMHM--DWPLRLRIAIGSAR-------------------GLAWLH 422 (618)
Q Consensus 382 ~~~~gsL~~~-l----------------~~~~~-~~~~l--~~~~~~~i~~~i~~-------------------~L~~LH 422 (618)
|++|.+|..- + +.... -.... -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998666421 1 11110 01112 24555555544322 223332
Q ss_pred ----hC-CCCCceecCCCCCCeeeCCC----CceEEcccCcccc
Q 007088 423 ----HN-CNPRIIHRNISSKCILLDGD----FEPKLSDFGLARL 457 (618)
Q Consensus 423 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~ 457 (618)
.. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 12368999999999999876 6899999988753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.40 E-value=7.7e-05 Score=76.85 Aligned_cols=127 Identities=13% Similarity=0.151 Sum_probs=82.4
Q ss_pred CcEEEEEecCCcc---------eeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCc
Q 007088 82 NKVLNIRLSDMGL---------KGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLA 152 (618)
Q Consensus 82 ~~v~~l~l~~~~l---------~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~ 152 (618)
.+++.|.+.++.. .+.+++.+..+++|+.|+|++|.-. .+|. + . +++|+.|+|..|.++...-..++
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~-~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-P-RPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-B-CTTCSEEEEECSBCCHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-c-CCCCcEEEEecCCCChHHHHHHH
Confidence 4788888876543 2345555677899999999988322 3555 3 3 88999999998887644333343
Q ss_pred --CCCCCcEEEccC--cccCCC-----CCccc--cccccccccccccccccCCCCCC-----CccccccccccCCC
Q 007088 153 --NCTFLNVLKLNN--NRFTGK-----IPPQL--GLLNRIKTFSVASNLLTGPVPSF-----ANVNFTAEDFANNS 212 (618)
Q Consensus 153 --~l~~L~~l~l~~--N~l~g~-----~p~~l--~~~~~L~~l~l~~N~l~g~ip~~-----~~~~~~~~~~~~n~ 212 (618)
.+++|+.|+|+. |...|. +...+ ..+++|+.|+|.+|.+++..+.. ...++..++++.|.
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~ 290 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGV 290 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSC
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCC
Confidence 789999999863 332222 11222 34789999999999987543211 01146667777663
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0004 Score=73.37 Aligned_cols=74 Identities=14% Similarity=0.178 Sum_probs=51.3
Q ss_pred CcEEeecCCeeEEEEEeCC--------CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC-ccceeEEEEeCCeeEEEEe
Q 007088 311 NNIIGTGRTGATYIAMLPG--------GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN-LVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e 381 (618)
.+.|+.|-...+|+....+ +..+++|+.... .....+.+|..++..+...+ ..++++.+.+ .+|+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3568888889999998753 578999988442 22245668998888874333 3567766532 38999
Q ss_pred ecCCCccc
Q 007088 382 YLENGTLY 389 (618)
Q Consensus 382 ~~~~gsL~ 389 (618)
|++|.++.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00033 Score=72.43 Aligned_cols=73 Identities=14% Similarity=0.094 Sum_probs=44.6
Q ss_pred cEEeecCCeeEEEEEeCC---------CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC-ccceeEEEEeCCeeEEEEe
Q 007088 312 NIIGTGRTGATYIAMLPG---------GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN-LVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e 381 (618)
+.|+.|....+|+....+ +..+++|+.........+...|.++++.+...+ +.++++.. . -++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence 457778888999998754 268889987653221112357777777774333 44666554 2 378999
Q ss_pred ecCCCcc
Q 007088 382 YLENGTL 388 (618)
Q Consensus 382 ~~~~gsL 388 (618)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9997654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0012 Score=70.08 Aligned_cols=75 Identities=12% Similarity=0.029 Sum_probs=48.8
Q ss_pred CcEEeecCCeeEEEEEeCC-CcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCc-cceeEEEEeCCeeEEEEeecCCCcc
Q 007088 311 NNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNL-VPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
.+.|+.|-...+|+....+ +..+++|+........-+..+|..++..+...++ .++++++. + .+||||++|.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 4568888889999998765 5788899875432111112578888888864444 56777662 2 359999998665
Q ss_pred c
Q 007088 389 Y 389 (618)
Q Consensus 389 ~ 389 (618)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00058 Score=59.12 Aligned_cols=55 Identities=24% Similarity=0.412 Sum_probs=27.2
Q ss_pred EEecCCcce-eeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCc
Q 007088 87 IRLSDMGLK-GQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS 144 (618)
Q Consensus 87 l~l~~~~l~-g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~ 144 (618)
++.++++|+ ..+|..|. .+|+.|+|++|+|+ .||...+..+++|+.|+|++|.+.
T Consensus 13 v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 13 VDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 344455554 24443321 24555555555555 455555444555555555555443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0013 Score=66.74 Aligned_cols=143 Identities=11% Similarity=0.071 Sum_probs=72.4
Q ss_pred cEEeecCCee-EEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCC--CCccceeEEEEeCCeeEEEEeecCCCcc
Q 007088 312 NIIGTGRTGA-TYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH--RNLVPLLGFCVAKKERLLVYSYLENGTL 388 (618)
Q Consensus 312 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL 388 (618)
+.|+.|.... +|+....++..+++|....... .++..|+.++..+.. -.+.+++.+..+. -+++||++.+.++
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~l 99 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDALF 99 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCBH
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcch
Confidence 3455554444 6677654466777776544320 234456666665532 2356677664333 3789999976555
Q ss_pred ccccCCC---------------------CCC-CcCCCHHHHH-------H-------------HHHHHHHHHHHHHh---
Q 007088 389 YDKLHPA---------------------EHE-VMHMDWPLRL-------R-------------IAIGSARGLAWLHH--- 423 (618)
Q Consensus 389 ~~~l~~~---------------------~~~-~~~l~~~~~~-------~-------------i~~~i~~~L~~LH~--- 423 (618)
.+.+... ... ...++..... . ....+...++.+..
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~ 179 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL 179 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence 4332110 000 0112211100 0 00111122223311
Q ss_pred CCCCCceecCCCCCCeeeCCC----CceEEcccCccccc
Q 007088 424 NCNPRIIHRNISSKCILLDGD----FEPKLSDFGLARLM 458 (618)
Q Consensus 424 ~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~a~~~ 458 (618)
...+.++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123479999999999999874 67999999988653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00092 Score=69.86 Aligned_cols=123 Identities=13% Similarity=0.203 Sum_probs=76.9
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCc----ccCC-CCCcCCCCC
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS----GEIP-SGLANCTFL 157 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~----g~ip-~~~~~l~~L 157 (618)
.++.|+|+++ ++..-...|.+ ++|+.++| .|++. .|+...+.++++|+.++|.+|.+. ..|+ ..|.+|++|
T Consensus 227 ~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 227 QLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CCCEEecCCC-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 5677777653 44222334545 77888888 45566 677777777888888888877764 1233 457778888
Q ss_pred cEEEccCcccCCCCCccccccccccccccccccccCCCC--CCCccccccccccCCC
Q 007088 158 NVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP--SFANVNFTAEDFANNS 212 (618)
Q Consensus 158 ~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip--~~~~~~~~~~~~~~n~ 212 (618)
+.++|. |.++-.-...|.+|++|+.+.|.+| ++ .|+ .|...++..+.+.+|.
T Consensus 303 ~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 303 ARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp CEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTSSSSSCCCEEEECCSS
T ss_pred CeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCC
Confidence 888887 4465333456777788888888555 33 232 2333355666666663
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00074 Score=58.42 Aligned_cols=56 Identities=29% Similarity=0.414 Sum_probs=44.7
Q ss_pred CeEEccCCcCc-cccCchhhhcCCCCCEEEeeCCCCcccCCCC-CcCCCCCcEEEccCcccC
Q 007088 109 TGLDLSSNNLS-GSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVLKLNNNRFT 168 (618)
Q Consensus 109 ~~L~l~~n~l~-g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~-~~~l~~L~~l~l~~N~l~ 168 (618)
+.++.++++|+ ..+|..+ .++|+.|+|++|+|+ .||.. |..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l---p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF---PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC---CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCC---CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 47889999986 5688765 346889999999999 56654 678889999999999875
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0013 Score=68.63 Aligned_cols=108 Identities=13% Similarity=0.136 Sum_probs=85.2
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCc----cccCchhhhcCCCCCEEEeeCCCCcccCC-CCCcCCCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLS----GSIPSDISSRLQYVTSLDLSSNSLSGEIP-SGLANCTF 156 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~----g~ip~~~~~~l~~L~~L~l~~N~l~g~ip-~~~~~l~~ 156 (618)
..++.+.|. ++++..-+..|.+|++|+.++|.+|.+. ..|+...+.++++|+.++|. |+++ .|+ ..|.+|++
T Consensus 248 ~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~-~I~~~aF~~c~~ 324 (401)
T 4fdw_A 248 SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIR-ILGQGLLGGNRK 324 (401)
T ss_dssp CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCC-EECTTTTTTCCS
T ss_pred CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceE-EEhhhhhcCCCC
Confidence 457788884 5576445677999999999999998775 24888888889999999999 5577 566 45889999
Q ss_pred CcEEEccCcccCCCCCccccccccccccccccccccCC
Q 007088 157 LNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 157 L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
|+.++|.+| ++..-+.+|.++ +|+.+++++|.+.-.
T Consensus 325 L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l 360 (401)
T 4fdw_A 325 VTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQV 360 (401)
T ss_dssp CCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBC
T ss_pred ccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCccc
Confidence 999999665 663345678889 999999999976543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0021 Score=65.56 Aligned_cols=31 Identities=16% Similarity=0.212 Sum_probs=27.6
Q ss_pred CCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 427 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.00064 Score=61.84 Aligned_cols=84 Identities=14% Similarity=0.108 Sum_probs=55.3
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCc-CccccCchhhhcC----CCCCEEEeeCCC-CcccCCCCCcCCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNN-LSGSIPSDISSRL----QYVTSLDLSSNS-LSGEIPSGLANCT 155 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~-l~g~ip~~~~~~l----~~L~~L~l~~N~-l~g~ip~~~~~l~ 155 (618)
-+++.|||+++.++..=-..+.+|++|+.|+|+++. ++..==..+.. + ++|++|+|+++. ++-.==..+++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~-~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQ-LENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHT-CHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHh-cccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 468999999887664333456788889999998874 65321122322 2 368888888864 6532123467788
Q ss_pred CCcEEEccCcc
Q 007088 156 FLNVLKLNNNR 166 (618)
Q Consensus 156 ~L~~l~l~~N~ 166 (618)
+|+.|+|++..
T Consensus 140 ~L~~L~L~~c~ 150 (176)
T 3e4g_A 140 NLKYLFLSDLP 150 (176)
T ss_dssp TCCEEEEESCT
T ss_pred CCCEEECCCCC
Confidence 88888888764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0005 Score=62.56 Aligned_cols=93 Identities=14% Similarity=0.127 Sum_probs=63.3
Q ss_pred eCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCC-CcccCCCCCcCC----CCCcEEEccCcc-cCCC
Q 007088 97 QFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS-LSGEIPSGLANC----TFLNVLKLNNNR-FTGK 170 (618)
Q Consensus 97 ~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~-l~g~ip~~~~~l----~~L~~l~l~~N~-l~g~ 170 (618)
.+|.....--.|+.|||+++.++-.==..+. .+++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++. +|..
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~-~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~ 130 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHME-GLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDK 130 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGT-TCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhc-CCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHH
Confidence 3454332335799999999988633223344 49999999999985 663222234553 479999999975 7643
Q ss_pred CCcccccccccccccccccc
Q 007088 171 IPPQLGLLNRIKTFSVASNL 190 (618)
Q Consensus 171 ~p~~l~~~~~L~~l~l~~N~ 190 (618)
==..+..+++|+.|+|++..
T Consensus 131 Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 131 GIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHHGGGCTTCCEEEEESCT
T ss_pred HHHHHhcCCCCCEEECCCCC
Confidence 22457788999999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.015 Score=54.29 Aligned_cols=102 Identities=15% Similarity=0.069 Sum_probs=65.9
Q ss_pred ccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCccc
Q 007088 387 TLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLS 466 (618)
Q Consensus 387 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 466 (618)
||.+.|...+ .+++++++|.++.|.+.+|.-+-.+..+ ..+=+.|..|++..+|.+.+.+ +.+. .
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------~--- 98 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------A--- 98 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------c---
Confidence 7888887665 5799999999999999998876221111 1223346889999999988764 1111 0
Q ss_pred ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCC
Q 007088 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERP 511 (618)
Q Consensus 467 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~P 511 (618)
....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 99 -------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 -------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 123466888763 3456788899999999999864433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.29 E-value=0.0059 Score=63.96 Aligned_cols=142 Identities=8% Similarity=0.059 Sum_probs=84.5
Q ss_pred CcEEeecCCeeEEEEEeCC--------CcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEe
Q 007088 311 NNIIGTGRTGATYIAMLPG--------GCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 381 (618)
.+.+..|-...+|+....+ +..+++|+........-+..+|..+++.+. +.-..++++.+ . -++|||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 3567778888999998753 578999987543211112357888777774 33345666533 2 378999
Q ss_pred ecCCCccccc-cC----------------CC-------CC--CCcCCCHHHHHHHHHHH-------------------HH
Q 007088 382 YLENGTLYDK-LH----------------PA-------EH--EVMHMDWPLRLRIAIGS-------------------AR 416 (618)
Q Consensus 382 ~~~~gsL~~~-l~----------------~~-------~~--~~~~l~~~~~~~i~~~i-------------------~~ 416 (618)
|++|.+|..- +. .. .. ...+.-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998765321 10 00 00 11122344444444322 22
Q ss_pred HHHHHHhC---------------------CCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 417 GLAWLHHN---------------------CNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 417 ~L~~LH~~---------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
.+.+|.+. ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 23333211 1235899999999999 7788999999988754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.59 E-value=0.015 Score=60.33 Aligned_cols=102 Identities=14% Similarity=0.318 Sum_probs=77.1
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC-CCCcCCCCCcEEE
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP-SGLANCTFLNVLK 161 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip-~~~~~l~~L~~l~ 161 (618)
.++.+.+.++-.+ .-...+.+++.|+.+.+. +.+. .|+...+.++++|+.++|..| ++ .|. ..|.+|++|+.+.
T Consensus 266 ~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ 340 (394)
T 4gt6_A 266 YLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIA 340 (394)
T ss_dssp SCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEE
T ss_pred cccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEE
Confidence 4566666544322 334568889999999996 5666 788888888999999999865 56 555 4588999999999
Q ss_pred ccCcccCCCC-Cccccccccccccccccccc
Q 007088 162 LNNNRFTGKI-PPQLGLLNRIKTFSVASNLL 191 (618)
Q Consensus 162 l~~N~l~g~~-p~~l~~~~~L~~l~l~~N~l 191 (618)
|..| ++ .| ..+|.+|++|+.+++.+|..
T Consensus 341 ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 341 IPSS-VT-KIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp ECTT-CC-BCCGGGGTTCTTCCEEEESSCHH
T ss_pred ECcc-cC-EEhHhHhhCCCCCCEEEECCcee
Confidence 9755 65 45 45788999999999988754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.52 E-value=0.035 Score=57.07 Aligned_cols=80 Identities=16% Similarity=0.326 Sum_probs=35.7
Q ss_pred CCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC-CCCcCCCCCcEEEccCcccCCCC-Cccccccc
Q 007088 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP-SGLANCTFLNVLKLNNNRFTGKI-PPQLGLLN 179 (618)
Q Consensus 102 ~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip-~~~~~l~~L~~l~l~~N~l~g~~-p~~l~~~~ 179 (618)
+.++.+|+.+.+..+ +. .|+...+.++++|+.+++.+|.++ .|+ ..|.+|++|+.+.|.+| ++ .| ..+|.+|+
T Consensus 259 F~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~ 333 (379)
T 4h09_A 259 LQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTLPTA-LK-TIQVYAFKNCK 333 (379)
T ss_dssp TTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCT
T ss_pred cceeehhcccccccc-ce-eccccccccccccccccccccccc-eehhhhhcCCCCCCEEEcCcc-cc-EEHHHHhhCCC
Confidence 444444555544322 33 344444444555555555555444 333 23445555555555432 32 22 22344455
Q ss_pred ccccccc
Q 007088 180 RIKTFSV 186 (618)
Q Consensus 180 ~L~~l~l 186 (618)
+|+.+.+
T Consensus 334 ~L~~i~i 340 (379)
T 4h09_A 334 ALSTISY 340 (379)
T ss_dssp TCCCCCC
T ss_pred CCCEEEE
Confidence 5555444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.04 Score=57.04 Aligned_cols=107 Identities=15% Similarity=0.387 Sum_probs=76.3
Q ss_pred CcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC-CCcCCCCCcEEEccCcccCCCCCccccc
Q 007088 99 PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS-GLANCTFLNVLKLNNNRFTGKIPPQLGL 177 (618)
Q Consensus 99 p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~g~~p~~l~~ 177 (618)
...+.+++.|+.+.+.++.. .|+...+.++++|+.+.+. +.++ .|+. .|.+|++|+.++|..| ++-.-..+|.+
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~--~I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVV--SIGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCC--EECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cceeeecccccEEecccccc--eecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 45688999999999976654 4777777779999999996 5566 5664 5788999999999865 55222457889
Q ss_pred cccccccccccccccCCCCC--CCcc-ccccccccCCC
Q 007088 178 LNRIKTFSVASNLLTGPVPS--FANV-NFTAEDFANNS 212 (618)
Q Consensus 178 ~~~L~~l~l~~N~l~g~ip~--~~~~-~~~~~~~~~n~ 212 (618)
|.+|+.+.+..+ ++ .|+. |.+. +++.+.|.+|.
T Consensus 333 C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 333 CEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp CTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCH
T ss_pred CCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCce
Confidence 999999998655 33 3442 2221 45666666653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=95.40 E-value=0.003 Score=58.53 Aligned_cols=83 Identities=14% Similarity=0.199 Sum_probs=42.7
Q ss_pred CcEEEEEecCC-ccee----eCCcCCCCCCCCCeEEccCCcCccc----cCchhhhcCCCCCEEEeeCCCCcccC----C
Q 007088 82 NKVLNIRLSDM-GLKG----QFPRGIERCTSLTGLDLSSNNLSGS----IPSDISSRLQYVTSLDLSSNSLSGEI----P 148 (618)
Q Consensus 82 ~~v~~l~l~~~-~l~g----~~p~~~~~l~~L~~L~l~~n~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~i----p 148 (618)
..++.|+|++| ++.. .|-..+..-+.|+.|+|++|++... |-..+.. -+.|+.|+|++|.++..= =
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~-N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIET-SPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHH-CSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhc-CCccCeEecCCCcCCHHHHHHHH
Confidence 45666777664 4431 1333445556677777777776521 1122222 355677777777766210 1
Q ss_pred CCCcCCCCCcEEEccCc
Q 007088 149 SGLANCTFLNVLKLNNN 165 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N 165 (618)
..+..-+.|+.|+|++|
T Consensus 120 ~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHTTTTCCCSEEECCCC
T ss_pred HHHhhCCceeEEECCCC
Confidence 12333345666666654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.034 Score=57.61 Aligned_cols=85 Identities=18% Similarity=0.218 Sum_probs=66.6
Q ss_pred cCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC-CCCcCCCCCcEEEccCcccCCCCCcccccc
Q 007088 100 RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP-SGLANCTFLNVLKLNNNRFTGKIPPQLGLL 178 (618)
Q Consensus 100 ~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip-~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~ 178 (618)
..+..+++|+.+.+.++ +. .|+...+.++++|+.++|.++ ++ .|+ ..|.+|++|+.++|..| ++-.-..+|.+|
T Consensus 291 ~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C 365 (394)
T 4fs7_A 291 KTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGC 365 (394)
T ss_dssp TTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTBTTC
T ss_pred ccccccccccccccccc-cc-eechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-ccEehHHHhhCC
Confidence 45778999999999765 66 688877777999999999754 66 565 46889999999999877 653234578899
Q ss_pred ccccccccccc
Q 007088 179 NRIKTFSVASN 189 (618)
Q Consensus 179 ~~L~~l~l~~N 189 (618)
.+|+.+++..|
T Consensus 366 ~~L~~i~lp~~ 376 (394)
T 4fs7_A 366 INLKKVELPKR 376 (394)
T ss_dssp TTCCEEEEEGG
T ss_pred CCCCEEEECCC
Confidence 99999988654
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.016 Score=38.87 Aligned_cols=31 Identities=13% Similarity=0.052 Sum_probs=18.0
Q ss_pred CchhHHHHHhhhhhHHHHHHHHhhheeeeec
Q 007088 229 SRAGIIAAAAAAGVTFTALVVGIFLFCFMRG 259 (618)
Q Consensus 229 ~~~~~ii~~v~~~v~~~~lvv~ii~~~~~r~ 259 (618)
+....|++.++.|+++++++++.++++++||
T Consensus 8 s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 8 PKIPSIATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp SCSSSSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCcceEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 4555677777777766665555444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.00 E-value=0.063 Score=55.55 Aligned_cols=97 Identities=14% Similarity=0.151 Sum_probs=70.5
Q ss_pred EEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC-CCCcCCCCCcEEEc
Q 007088 84 VLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP-SGLANCTFLNVLKL 162 (618)
Q Consensus 84 v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip-~~~~~l~~L~~l~l 162 (618)
++.+.+..+... .-...+.++..|+.+.+..+. ||...+..+++|+.+.+..| ++ .|+ ..+.++++|+.++|
T Consensus 255 l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~l 327 (394)
T 4fs7_A 255 LESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSIDL 327 (394)
T ss_dssp CCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEECC
T ss_pred ceeEEcCCCcce-eeccccccccccceeccCcee----eccccccccccccccccccc-cc-eechhhhcCCCCCCEEEe
Confidence 344455443222 334567888999999887763 56666667999999999865 66 565 45889999999999
Q ss_pred cCcccCCCC-Cccccccccccccccccc
Q 007088 163 NNNRFTGKI-PPQLGLLNRIKTFSVASN 189 (618)
Q Consensus 163 ~~N~l~g~~-p~~l~~~~~L~~l~l~~N 189 (618)
.++ ++ .| ..+|.+|++|+.+.+..|
T Consensus 328 p~~-v~-~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 328 PYL-VE-EIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp CTT-CC-EECTTTTTTCTTCCEECCCTT
T ss_pred CCc-cc-EEhHHhccCCCCCCEEEECcc
Confidence 755 65 44 457889999999999766
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.56 E-value=0.049 Score=36.35 Aligned_cols=37 Identities=19% Similarity=0.306 Sum_probs=15.7
Q ss_pred CCCCCCCCchhHHHHHhhhhhHHHHHHHHhhheeeeec
Q 007088 222 CPGVPKKSRAGIIAAAAAAGVTFTALVVGIFLFCFMRG 259 (618)
Q Consensus 222 C~~~~~~~~~~~ii~~v~~~v~~~~lvv~ii~~~~~r~ 259 (618)
|+.....+....++++++. ++++++++++++++++||
T Consensus 2 Cp~~~~~~~~~~Ia~~vVG-vll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 2 CPAEQRASPLTSIISAVVG-ILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp CCCCCCCCSHHHHHHHHHH-HHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCcccchHHHHHH-HHHHHHHHHHHHhheehh
Confidence 5543333444445555444 443333333333333333
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=93.52 E-value=0.019 Score=53.13 Aligned_cols=88 Identities=16% Similarity=0.217 Sum_probs=60.0
Q ss_pred CCCCCCCCCeEEccCC-cCccc----cCchhhhcCCCCCEEEeeCCCCcccCCCC----CcCCCCCcEEEccCcccCCC-
Q 007088 101 GIERCTSLTGLDLSSN-NLSGS----IPSDISSRLQYVTSLDLSSNSLSGEIPSG----LANCTFLNVLKLNNNRFTGK- 170 (618)
Q Consensus 101 ~~~~l~~L~~L~l~~n-~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~ip~~----~~~l~~L~~l~l~~N~l~g~- 170 (618)
-+.+-+.|++|+|++| ++... |-..+.. -+.|+.|+|++|.+...--.. +..-+.|+.|+|++|+|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~-N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACN-SKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTT-CSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhh-CCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 3456688999999986 77521 2223333 468999999999998321122 33457899999999999842
Q ss_pred ---CCccccccccccccccccc
Q 007088 171 ---IPPQLGLLNRIKTFSVASN 189 (618)
Q Consensus 171 ---~p~~l~~~~~L~~l~l~~N 189 (618)
|-..+..-+.|+.|+|++|
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHHHhhCCceeEEECCCC
Confidence 2233444567999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.90 E-value=0.26 Score=51.12 Aligned_cols=29 Identities=24% Similarity=0.299 Sum_probs=24.5
Q ss_pred ceecCCCCCCeee------CCCCceEEcccCcccc
Q 007088 429 IIHRNISSKCILL------DGDFEPKLSDFGLARL 457 (618)
Q Consensus 429 ivH~Dlkp~NIll------~~~~~~kl~DfG~a~~ 457 (618)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999988753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.72 E-value=0.054 Score=36.21 Aligned_cols=32 Identities=25% Similarity=0.299 Sum_probs=18.8
Q ss_pred CCchhHHHHHhhhhhHHHHHHHHhhheeeeec
Q 007088 228 KSRAGIIAAAAAAGVTFTALVVGIFLFCFMRG 259 (618)
Q Consensus 228 ~~~~~~ii~~v~~~v~~~~lvv~ii~~~~~r~ 259 (618)
.+....|++.++.|+++++++++.++++++||
T Consensus 6 ~s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 6 HARTPLIAAGVIGGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCcceEEEeehHHHHHHHHHHHHHHHHhhhh
Confidence 34556677777777776666555444444443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.32 E-value=0.31 Score=49.85 Aligned_cols=86 Identities=13% Similarity=0.218 Sum_probs=58.3
Q ss_pred cCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC-CCcCCCCCcEEEccCcccCCCCCcccccc
Q 007088 100 RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS-GLANCTFLNVLKLNNNRFTGKIPPQLGLL 178 (618)
Q Consensus 100 ~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~g~~p~~l~~~ 178 (618)
..+.+++.|+.+.+..+ +. .|+...+.++.+|+.+.+..+ +. .|+. .+.+|++|+.+.+.+|.++-.-+..|.++
T Consensus 234 ~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c 309 (379)
T 4h09_A 234 GAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDC 309 (379)
T ss_dssp TTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTC
T ss_pred ccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ce-eccccccccccccccccccccccceehhhhhcCC
Confidence 34566777777777655 54 566666666777888887654 44 4443 46778888888888887773334567788
Q ss_pred ccccccccccc
Q 007088 179 NRIKTFSVASN 189 (618)
Q Consensus 179 ~~L~~l~l~~N 189 (618)
.+|+.+.|.+|
T Consensus 310 ~~L~~i~lp~~ 320 (379)
T 4h09_A 310 VKLSSVTLPTA 320 (379)
T ss_dssp TTCCEEECCTT
T ss_pred CCCCEEEcCcc
Confidence 88888877543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.66 E-value=1.4 Score=40.90 Aligned_cols=116 Identities=7% Similarity=0.053 Sum_probs=78.7
Q ss_pred CCCCccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 007088 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKC 438 (618)
Q Consensus 359 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 438 (618)
.||++++. .+-.+.+...+.|+.-+ +...+-. ...++...+++++.+|+....+++.. +|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 68888876 56566666555555433 2332221 13478899999999999888666644 788899999
Q ss_pred eeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 007088 439 ILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTH 513 (618)
Q Consensus 439 Ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~ 513 (618)
|+++.++.+++.-.|+...+.+.. .+...=.-.+=+++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~l~P~~--------------------------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVDPLP--------------------------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBSCCC--------------------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCCCCC--------------------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998877654332211 1111223356778888999988875
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=84.80 E-value=0.77 Score=29.69 Aligned_cols=28 Identities=29% Similarity=0.307 Sum_probs=15.2
Q ss_pred CCchhHHHHHhhhhhHHHHHHHHhhhee
Q 007088 228 KSRAGIIAAAAAAGVTFTALVVGIFLFC 255 (618)
Q Consensus 228 ~~~~~~ii~~v~~~v~~~~lvv~ii~~~ 255 (618)
..+.+.|+++++..++.+++++++.+|+
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~ 34 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFR 34 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHH
Confidence 3455667666666555555555444433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.57 E-value=1.8 Score=40.27 Aligned_cols=115 Identities=13% Similarity=0.123 Sum_probs=75.5
Q ss_pred CCCCccceeEEEEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceecCCCCC
Q 007088 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA-WLHHNCNPRIIHRNISSK 437 (618)
Q Consensus 359 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlkp~ 437 (618)
.||++ -..+-.+.+...+.++.-+++.=...+ ..++...+++++.+|+.... +++. -+|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57887 445556667766666654333222223 23788899999999887766 5554 478889999
Q ss_pred CeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 007088 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTH 513 (618)
Q Consensus 438 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~ 513 (618)
||++|.++.+++.-.|+-..+ +|.-. +..-=.-.+=+++..++.++..|.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l---------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL---------------------PPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB---------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC---------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999887765433 22211 111113356678888888887664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 618 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-46 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-25 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-11 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-54
Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 28/288 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFI-MIKRLEDSQHSEKEFLSEINTLGSVRHRNLV 364
+ IG+G G Y G + M+ + + F +E+ L RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
+G+ + +V + E +LY LH E + + IA +A+G+ +LH
Sbjct: 68 LFMGYST-APQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK 123
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
IIHR++ S I L D K+ DFGLA + + G + ++APE
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF--EQLSGSILWMAPEVI 178
Query: 485 RTLVA---TPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-SLVEWITLLNTNSSLET 540
R + + DVY+FG+VL EL+TG+ P + + + I + L
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLP---------YSNINNRDQIIFMVGRGYLSP 229
Query: 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588
+ K R+ C+ ER ++ + +A
Sbjct: 230 DLSKV-----RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-52
Identities = 64/281 (22%), Positives = 115/281 (40%), Gaps = 26/281 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
+ +G G+ G ++ G + +K L+ S FL+E N + ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L ++ ++ Y+ENG+L D L + + L +A A G+A++
Sbjct: 73 LYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
IHR++ + IL+ K++DFGLARL+ + + + APE
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK---FPIKWTAPEAIN 183
Query: 486 TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545
T K DV+SFG++L E++T R + +L +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------- 229
Query: 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
+ + EL+Q +R C P++R T + +L
Sbjct: 230 VRPDNCPEELYQLMR---LCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-52
Identities = 58/283 (20%), Positives = 116/283 (40%), Gaps = 26/283 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
+ + IG+G+ G ++ + IK + + SE++F+ E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L G C+ + LV+ ++E+G L D L + L + + G + +
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+IHR+++++ L+ + K+SDFG+ R + ST + + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT---KFPVKWASPEVFS 175
Query: 486 TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545
+ K DV+SFGV++ E+ + + + + E + ++T L S
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRLYKPRLAS 228
Query: 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588
++ +C P++R + + L IAE
Sbjct: 229 ----------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-50
Identities = 65/278 (23%), Positives = 108/278 (38%), Gaps = 26/278 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
S +G G G ++ G + IK L+ S + FL E + +RH LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L ++ +V Y+ G+L D L ++ P + +A A G+A++
Sbjct: 77 LYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+HR++ + IL+ + K++DFGLARL+ + G + + APE
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ---GAKFPIKWTAPEAAL 187
Query: 486 TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545
T K DV+SFG++L EL T R + G N + +++
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVP--------YPG---------MVNREVLDQVERG 230
Query: 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583
+ C C P+ER T + L
Sbjct: 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 1e-50
Identities = 59/294 (20%), Positives = 109/294 (37%), Gaps = 24/294 (8%)
Query: 314 IGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV-- 371
IG GR G + G + +K + +EI +RH N++ +
Sbjct: 11 IGKGRFGEVWRGKWRGE-EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 372 --AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC---- 425
+ LV Y E+G+L+D L+ + +++A+ +A GLA LH
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 426 -NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
P I HR++ SK IL+ + ++D GLA + + N G Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 485 RTLV------ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV--EWITLLNTNS 536
+ + + D+Y+ G+V E+ + + LV +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 537 SLETAIDKSLLGNGFDGE-LHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589
E + ++ E L ++ C R T + + L ++++
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-50
Identities = 55/281 (19%), Positives = 107/281 (38%), Gaps = 26/281 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
+ +GTG+ G G + IK +++ SE EF+ E + ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L G C ++ ++ Y+ NG L + L H L + + +L
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
+HR+++++ L++ K+SDFGL+R + + S G + + PE
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV---GSKFPVRWSPPEVLM 174
Query: 486 TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545
+ K D+++FGV++ E+ + + ++ TNS I +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMP--------YERF---------TNSETAEHIAQG 217
Query: 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
L + + +C ER T + + +
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 1e-49
Identities = 65/313 (20%), Positives = 123/313 (39%), Gaps = 41/313 (13%)
Query: 293 VEKMRLSDLMKATNSFSKN---------NIIGTGRTGATYIAMLPG----GCFIMIKRL- 338
++ D +A F+K +IG G G L F+ IK L
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 339 -EDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEH 397
++ ++FLSE + +G H N++ L G +++ ++ENG+L L
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---Q 120
Query: 398 EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457
+ + G A G+ +L +HR+++++ IL++ + K+SDFGL+R
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 458 MNPVDTHLS-TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLT 515
+ + + T G + + APE + T DV+S+G+V+ E+++ GERP
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---- 233
Query: 516 NAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT 575
+ TN + AI++ ++ +C R
Sbjct: 234 -----YWD---------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279
Query: 576 MFEVYQLLRAIAE 588
++ L +
Sbjct: 280 FGQIVNTLDKMIR 292
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 1e-48
Identities = 61/295 (20%), Positives = 117/295 (39%), Gaps = 28/295 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLV 364
+ + +G G+ G Y + + +K L++ +EFL E + ++H NLV
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
LLG C + ++ ++ G L D L E + + L +A + + +L
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
IHR+++++ L+ + K++DFGL+RLM + + APE
Sbjct: 135 ---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK---FPIKWTAPESL 188
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
+ K DV++FGV+L E+ T + G S + ++K
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSP--------YPG---------IDLSQVYELLEK 231
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIM 599
+G + + C P +R + E++Q + + + DE+
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS--DEVE 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-48
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 15/219 (6%)
Query: 304 ATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL--EDSQHSEKEFLSEINTLGSVRH 360
+ F K + +G G G + P G + K + E + + E+ L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
+V G + E + +++ G+L L A + + +++I +GL +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
L +I+HR++ IL++ E KL DFG++ + D+ ++FV G Y++
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFV----GTRSYMS 171
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE 519
PE + + + D++S G+ L+E+ G P +A E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 4e-48
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 30/287 (10%)
Query: 311 NNIIGTGRTGATYIAMLPG----GCFIMIKRL--EDSQHSEKEFLSEINTLGSVRHRNLV 364
N +IG G G Y L +K L +FL+E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 365 PLLGFCV-AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
LLG C+ ++ L+V Y+++G L + + +E + + + A+G+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGM---KF 145
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY 483
+ + +HR+++++ +LD F K++DFGLAR M + G + ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 484 PRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543
+T T K DV+SFGV+L EL+T P + L++ LL + +
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 265
Query: 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590
V C P + R + E+ + AI +
Sbjct: 266 -----------------VMLKCWHPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-46
Identities = 59/282 (20%), Positives = 117/282 (41%), Gaps = 32/282 (11%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
IG G G + G + +K +++ + + FL+E + + +RH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQ 64
Query: 366 LLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
LLG V +K L +V Y+ G+L D L + L+ ++ + +L N
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
+HR+++++ +L+ D K+SDFGL + + + + APE
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-------KLPVKWTAPEAL 172
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
R + K DV+SFG++L E+ + R + + L + + + ++
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPY-------PRIPLKDVVPRVEKGYKMD----- 220
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
+G +++ ++ NC R + ++ + L I
Sbjct: 221 --APDGCPPAVYEVMK---NCWHLDAAMRPSFLQLREQLEHI 257
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-46
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 30/282 (10%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNL 363
+ IGTG G G ++ K L+ +E E +SE+N L ++H N+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 364 VPLLGFCVAKKERLL--VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
V + + L V Y E G L + E ++D LR+ L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 422 H--HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
H + ++HR++ + LDG KL DFGLAR++N + F G Y+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF----VGTPYYM 181
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539
+PE + K D++S G +L EL P F + +
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP---------FTAFSQKELAGKIREGKFR 232
Query: 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ + EL++ + + R ++ E+ +
Sbjct: 233 R------IPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 1e-46
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 31/290 (10%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGG-----CFIMIKRL--EDSQHSEKEFLSEINTLGSV 358
+ ++ +IG G G Y ML + IK L ++ +FL E +G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 359 RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGL 418
H N++ L G K +++ Y+ENG L L + + + G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGM 123
Query: 419 AWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
+ N +HR+++++ IL++ + K+SDFGL+R++ T G + +
Sbjct: 124 ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-GGKIPIRW 179
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538
APE T DV+SFG+V+ E++T + +N +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----------------LSNHEV 222
Query: 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588
AI+ ++ C R ++ +L +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 2e-46
Identities = 62/320 (19%), Positives = 122/320 (38%), Gaps = 50/320 (15%)
Query: 297 RLSDLMKATNSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRL--EDSQHSEKEF 348
+L L N+ IG G G + A PG + +K L E S + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 349 LSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH--------------- 393
E + + N+V LLG C K L++ Y+ G L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 394 -----PAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPK 448
+ + +L IA A G+A+L + +HR+++++ L+ + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 449 LSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITG 508
++DFGL+R + D + + + + ++ PE T + DV+++GVVL E+ +
Sbjct: 181 IADFGLSRNIYSADYYKAD--GNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 509 ERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLP 568
+ G E + + ++ + + + C
Sbjct: 239 GLQ--------PYYGMAHEEVIYYVRDGNILACP---------ENCPLELYNLMRLCWSK 281
Query: 569 TPKERHTMFEVYQLLRAIAE 588
P +R + ++++L+ + E
Sbjct: 282 LPADRPSFCSIHRILQRMCE 301
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 3e-46
Identities = 69/324 (21%), Positives = 127/324 (39%), Gaps = 37/324 (11%)
Query: 301 LMKATNSFSKNNIIGTGRTGATYIAMLPG-----GCFIMIKRL--EDSQHSEKEFLSEIN 353
++K T F K ++G+G G Y + + IK L S + KE L E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 354 TLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIG 413
+ SV + ++ LLG C+ +L+ + G L D + ++ L +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYVR---EHKDNIGSQYLLNWCVQ 119
Query: 414 SARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
A+G+ +L R++HR+++++ +L+ K++DFGLA+L+ + G
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGK 174
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533
+ ++A E + T + DV+S+GV + EL+T + G
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--------PYDG---------I 217
Query: 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA---ERY 590
S + + ++K + C + R E+ +A +RY
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 277
Query: 591 HFTTDDEIMLPSNTGDPNFPDELI 614
DE M + D NF L+
Sbjct: 278 LVIQGDERMHLPSPTDSNFYRALM 301
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 54/282 (19%), Positives = 111/282 (39%), Gaps = 34/282 (12%)
Query: 310 KNNIIGTGRTGATYIAMLPG---GCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRNL 363
++ +G+G G + +K L++ + E L+E N + + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
V ++G C + +LV E G L L + H+ + + + G+ +L
Sbjct: 71 VRMIGICE-AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY 483
+ +HR+++++ +LL K+SDFGL++ + + + +G + + APE
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG-KWPVKWYAPEC 181
Query: 484 PRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542
+ K DV+SFGV++ E + G++P ++G S + +
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP---------YRGM---------KGSEVTAML 223
Query: 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584
+K G + + C + R V LR
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-44
Identities = 57/294 (19%), Positives = 115/294 (39%), Gaps = 33/294 (11%)
Query: 300 DLMKATNSFSKNNI-IGTGRTGATYIAML---PGGCFIMIKRL--EDSQHSEKEFLSEIN 353
L ++ +I +G G G+ + + IK L + +E + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 354 TLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIG 413
+ + + +V L+G C A+ +LV G L+ L + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQ 117
Query: 414 SARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
+ G+ +L +HR+++++ +LL K+SDFGL++ + D++ + G+
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK- 173
Query: 474 GDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLL 532
L + APE + + DV+S+GV + E ++ G++P P E + +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFI 225
Query: 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
+E EL+ + +C + ++R V Q +RA
Sbjct: 226 EQGKRME-------CPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 68/313 (21%), Positives = 120/313 (38%), Gaps = 45/313 (14%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIM---IKRLED--SQHSEKEFLSEINTLGSV-R 359
N ++IG G G A + M IKR+++ S+ ++F E+ L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 360 HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH------------PAEHEVMHMDWPLR 407
H N++ LLG C + L Y +G L D L A +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 408 LRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLST 467
L A ARG+ + + IHR+++++ IL+ ++ K++DFGL+R
Sbjct: 130 LHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 468 FVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-SLV 526
+ ++A E V T DV+S+GV+L E+++ + G +
Sbjct: 187 -----RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--------PYCGMTCA 233
Query: 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
E L LE ++ D E++ +R C P ER + ++ L +
Sbjct: 234 ELYEKLPQGYRLEKPLN-------CDDEVYDLMR---QCWREKPYERPSFAQILVSLNRM 283
Query: 587 AERYHFTTDDEIM 599
E + +
Sbjct: 284 LEERKTYVNTTLY 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 58/275 (21%), Positives = 100/275 (36%), Gaps = 33/275 (12%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
+G G G Y A K ++ S+ ++++ EI+ L S H N+V LL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
+ ++ + G + + E + + + L +LH N +IIH
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 432 RNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY-----PRT 486
R++ + IL D + KL+DFG++ +F+ G ++APE +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCETSKD 189
Query: 487 LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSL 546
K DV+S G+ L+E+ E P H N L S
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS---------- 239
Query: 547 LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ FL+ C+ R T ++ Q
Sbjct: 240 ---RWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-42
Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-FLSEINTLGSVRHRNLVP 365
+++ IG G +G Y AM + G + I+++ Q +KE ++EI + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L + E +V YL G+L D + MD + + L +LH N
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
++IHR+I S ILL D KL+DFG + P + ST V G ++APE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVT 189
Query: 486 TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-SLVEWITLLNTNSSLETAIDK 544
PK D++S G++ +E+I GE P + + + + L+ TN + E +
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP---------YLNENPLRALYLIATNGTPELQNPE 240
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
L FL C+ ++R + E+ Q
Sbjct: 241 KL-----SAIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 5e-42
Identities = 61/282 (21%), Positives = 107/282 (37%), Gaps = 40/282 (14%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL----EDSQHSEKEFLSEINTLGSVRHRN 362
FS IG G GA Y A + + IK++ + S ++ + E+ L +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
+ G + + LV Y + + + G+ +GLA+LH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 132
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
+ +IHR++ + ILL KL DFG A +M P ++ + T ++APE
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT--------PYWMAPE 181
Query: 483 YPRTL---VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539
+ K DV+S G+ +EL + P NA + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------------HIA 227
Query: 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+L + F+ +C+ P++R T + +
Sbjct: 228 QNESPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-42
Identities = 66/307 (21%), Positives = 113/307 (36%), Gaps = 45/307 (14%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRL--EDSQHSEKEFLSEINTLGS 357
N S +G G G A G + +K L + +SE+ L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 358 V-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH--------------PAEHEVMHM 402
+ H N+V LLG C L++ Y G L + L E + + +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 403 DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462
D L + A+G+A+L IHR+++++ ILL K+ DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
++ + ++APE V T + DV+S+G+ L EL +
Sbjct: 200 NYVVK--GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----------- 246
Query: 523 GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582
+ +S I + + + + C P +R T ++ QL
Sbjct: 247 -----PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 583 L-RAIAE 588
+ + I+E
Sbjct: 302 IEKQISE 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 2e-41
Identities = 53/308 (17%), Positives = 110/308 (35%), Gaps = 49/308 (15%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRL--EDSQHSEKEFLSEINTLGS 357
+ ++G+G G A G + +K L + + +SE+ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 358 V-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH-------------------PAEH 397
+ H N+V LLG C L++ Y G L + L E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 398 EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457
++ + + L A A+G+ +L +HR+++++ +L+ K+ DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNA 517
+ + + ++APE + T K DV+S+G++L E+ +
Sbjct: 214 IMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----- 266
Query: 518 PESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMF 577
+ G + +++ I + + + +C ++R +
Sbjct: 267 ---YPG--------IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 578 EVYQLLRA 585
+ L
Sbjct: 316 NLTSFLGC 323
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-41
Identities = 57/280 (20%), Positives = 100/280 (35%), Gaps = 37/280 (13%)
Query: 311 NNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKE---FLSEINTLGSVRHRNLVPL 366
+ IG G Y + + L+D + ++ E F E L ++H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 367 LGFCVA----KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
+ KK +LV + +GTL L M + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 423 HNCNPRIIHRNISSKCILLDG-DFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
P IIHR++ I + G K+ D GLA L + + G ++AP
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVI----GTPEFMAP 182
Query: 482 EYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541
E DVY+FG+ +LE+ T E P + + +
Sbjct: 183 EMYEEKY-DESVDVYAFGMCMLEMATSEYP---------YSECQNAAQIYRR----VTSG 228
Query: 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ + E+ + + C+ ER+++ ++
Sbjct: 229 VKPASFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 3e-40
Identities = 59/279 (21%), Positives = 104/279 (37%), Gaps = 37/279 (13%)
Query: 308 FSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHS----EKEFLSEINTLGSVRHRN 362
F +G G+ G Y+A + +K L +Q E + E+ +RH N
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
++ L G+ L+ Y GT+Y +L ++ D A L++ H
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCH 123
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
R+IHR+I + +LL E K++DFG + + +T G L Y+ PE
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLC----GTLDYLPPE 174
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAI 542
+ K D++S GV+ E + G+ P F+ + + S +E
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP---------FEAN--TYQETYKRISRVEFTF 223
Query: 543 DKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ + + P +R + EV +
Sbjct: 224 PDFV-----TEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-39
Identities = 63/278 (22%), Positives = 101/278 (36%), Gaps = 29/278 (10%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL--EDSQHSEKEFLSEINTLGSVRHRNLV 364
+ +G G G +A+ + +K + + + + EI + H N+V
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
G + L Y G L+D++ P M P R G+ +LH
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
I HR+I + +LLD K+SDFGLA + + +N G L YVAPE
Sbjct: 123 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELL 177
Query: 485 RTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543
+ DV+S G+VL ++ GE P + E T LN +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----- 232
Query: 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
D L ++ P R T+ ++ +
Sbjct: 233 --------DSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 57/283 (20%), Positives = 104/283 (36%), Gaps = 35/283 (12%)
Query: 313 IIGTGRTGATYIAMLPG----GCFIMIKRLED--SQHSEKEFLSEINTLGSVRHRNLVPL 366
IG G+ G + + + IK ++ S ++FL E T+ H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
+G + ++ G L L +D + A + LA+L
Sbjct: 74 IGVIT-ENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
R +HR+I+++ +L+ + KL DFGL+R M + ++ ++APE
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMAPESINF 183
Query: 487 LVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545
T DV+ FGV + E++ G +P + ++ I ++
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRI----------ENGERL 228
Query: 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588
+ L+ + C P R E+ L I E
Sbjct: 229 PMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-39
Identities = 60/282 (21%), Positives = 101/282 (35%), Gaps = 34/282 (12%)
Query: 314 IGTGRTGATYIAMLPG----GCFIMIKRLE----DSQHSEKEFLSEINTLGSVRHRNLVP 365
+G G G + +K L+ + +F+ E+N + S+ HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 366 LLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC 425
L G + ++ V G+L D+L H R A+ A G+ +L
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 426 NPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR 485
IHR+++++ +LL K+ DFGL R + D H + APE +
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAPESLK 187
Query: 486 TLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
T + D + FGV L E+ T G+ P N + ++ I +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-----ILHKIDKEGERLPRPEDCPQ 242
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586
+ V C P++R T + L
Sbjct: 243 DI------------YNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (364), Expect = 7e-39
Identities = 59/280 (21%), Positives = 108/280 (38%), Gaps = 30/280 (10%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE-FLSEINTLGSVRHRNL 363
+ + + +GTG G + G K + S+KE EI T+ +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
V L E +++Y ++ G L++K+ E M + +GL +H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 424 NCNPRIIHRNISSKCILL--DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
N +H ++ + I+ E KL DFGL ++P + T G + AP
Sbjct: 143 NN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-----TGTAEFAAP 194
Query: 482 EYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541
E D++S GV+ L++G P N E+ + + + + +++ +
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR-------NVKSCDWNMDDS 247
Query: 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
G + F+R +L P R T+ + +
Sbjct: 248 AFS-----GISEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 9e-39
Identities = 60/297 (20%), Positives = 115/297 (38%), Gaps = 36/297 (12%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRL--EDSQHSEKEFLSEINTLGS 357
+ + +G G G Y + G + IK + S EFL+E + +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 358 VRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMH------MDWPLRLRIA 411
++V LLG + L++ + G L L + + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 412 IGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNG 471
A G+A+L+ N + +HR+++++ ++ DF K+ DFG+ R + D +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--GK 194
Query: 472 EFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531
+ +++PE + V T DV+SFGVVL E+ T ++G
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--------YQG-------- 238
Query: 532 LNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588
+N + + + L + D + C PK R + E+ ++ E
Sbjct: 239 -LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 6e-38
Identities = 51/225 (22%), Positives = 83/225 (36%), Gaps = 14/225 (6%)
Query: 303 KATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLE----DSQHSEKEFLSEINTLGS 357
K F I+G G +A L IK LE ++ E + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 358 VRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARG 417
+ H V L ++ SY +NG L + D
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSA 120
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L +LH IIHR++ + ILL+ D +++DFG A++++P N G
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ--ARANSFVGTAQ 175
Query: 478 YVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
YV+PE A D+++ G ++ +L+ G P N F+
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 61/304 (20%), Positives = 123/304 (40%), Gaps = 45/304 (14%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG--------GCFIMIKRL--EDSQHSEKEFLSEINTL 355
+ +G G G +A G + +K L + ++ + +SE+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 356 GSV-RHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLH------------PAEHEVMHM 402
+ +H+N++ LLG C ++ Y G L + L P+ + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 403 DWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462
+ A ARG+ + + + IHR+++++ +L+ D K++DFGLAR ++ +D
Sbjct: 133 SSKDLVSCAYQVARGM---EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 463 THLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
+ T + ++APE + T + DV+SFGV+L E+ T +
Sbjct: 190 YYKKTTNG--RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--------YP 239
Query: 523 GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582
G VE + L + + + ++ + +C P +R T ++ +
Sbjct: 240 GVPVEELFKL---------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 583 LRAI 586
L I
Sbjct: 291 LDRI 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 137 bits (347), Expect = 2e-36
Identities = 54/272 (19%), Positives = 103/272 (37%), Gaps = 30/272 (11%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLE-DSQHSEKEFLSEINTLGSVRHRNLVPLLGFCV 371
+G+G G + + G + K + + +EI+ + + H L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 372 AKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIH 431
K E +L+ +L G L+D++ E M + + GL +H + I+H
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 432 RNISSKCILLDGDFEP--KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA 489
+I + I+ + K+ DFGLA +NP V + APE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNP-----DEIVKVTTATAEFAAPEIVDREPV 205
Query: 490 TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGN 549
D+++ GV+ L++G P F G + + L + D+ +
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSP---------FAGE--DDLETLQNVKRCDWEFDEDAF-S 253
Query: 550 GFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
E F++ N + P++R T+ + +
Sbjct: 254 SVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (337), Expect = 1e-35
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 33/283 (11%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL--EDSQHSEKEFLSEINTLGSVRHR 361
+ + +++GTG +A + IK + + + E +EI L ++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
N+V L + L+ + G L+D++ E R+ + +L
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLDAVKYL 123
Query: 422 HHNCNPRIIHRNISSKCILL---DGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
H I+HR++ + +L D D + +SDFGL+++ +P + LST G GY
Sbjct: 124 HDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTAC----GTPGY 175
Query: 479 VAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538
VAPE + D +S GV+ L+ G P + N + F+ +L
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE-------QILKAEYEF 228
Query: 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
++ + F+R + + P++R T + Q
Sbjct: 229 DSPYWDDI-----SDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 49/271 (18%), Positives = 101/271 (37%), Gaps = 29/271 (10%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
+G G G + + M K ++ + EI+ L RHRN++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR 432
+E ++++ ++ ++++++ ++ + L +LH + I H
Sbjct: 73 MEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 433 NISSKCILLD--GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVAT 490
+I + I+ K+ +FG AR + P D F Y APE + V +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL-----FTAPEYYAPEVHQHDVVS 181
Query: 491 PKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNG 550
D++S G ++ L++G P + + ++N + + K +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIE-------NIMNAEYTFDEEAFKEI---- 230
Query: 551 FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
E F+ ++ K R T E Q
Sbjct: 231 -SIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 3e-34
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 43/305 (14%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRL--EDSQHSEKEFLSEINTLGS 357
+ +G G G A G + +K L + + +SE+ L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 358 VRHR-NLVPLLGFCVAKKERL-LVYSYLENGTLYDKLHPAEHEVM------------HMD 403
+ H N+V LLG C L ++ + + G L L +E + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 404 WPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463
+ + A+G+ +L + IHR+++++ ILL K+ DFGLAR +
Sbjct: 133 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG 523
++ L ++APE V T + DV+SFGV+L E+ + P
Sbjct: 190 YVRK--GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVK 241
Query: 524 SLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLL 583
E+ L + + + E++Q + +C P +R T E+ + L
Sbjct: 242 IDEEFCRRLKEGTRMR-------APDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 291
Query: 584 RAIAE 588
+ +
Sbjct: 292 GNLLQ 296
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (325), Expect = 4e-34
Identities = 52/304 (17%), Positives = 96/304 (31%), Gaps = 25/304 (8%)
Query: 302 MKATNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH 360
++ N + IG+G G Y+ + G + IK + + E ++
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-CVKTKHPQLHIESKIYKMMQG 61
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
+P + +C A+ + ++ L +L D + L +A + +
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN---FCSRKFSLKTVLLLADQMISRIEY 118
Query: 421 LHHNCNPRIIHRNISSKCIL---LDGDFEPKLSDFGLARLMNPVDTHLSTFV---NGEFG 474
+H IHR++ L + DFGLA+ TH G
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 475 DLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534
Y + + + + D+ S G VL+ G P A
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--------TKRQKYER 227
Query: 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTT 594
S + + +L G+ E +L C ++ + QL R + R F+
Sbjct: 228 ISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
Query: 595 DDEI 598
D
Sbjct: 285 DYVF 288
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 125 bits (315), Expect = 5e-33
Identities = 60/296 (20%), Positives = 105/296 (35%), Gaps = 35/296 (11%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL----EDSQHSEKEFLSEINTLGSVR 359
++ + I+G G ++A L + +K L F E ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 360 HRNLVPLLGFCVAKKERL----LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSA 415
H +V + A+ +V Y++ TL D +H M + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADAC 121
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
+ L + H N IIHR++ I++ K+ DFG+AR + + T G
Sbjct: 122 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGT 177
Query: 476 LGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535
Y++PE R + DVYS G VL E++TGE P + +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---------- 227
Query: 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591
E I S G +L + + P+ R+ ++ + R H
Sbjct: 228 --REDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAA--EMRADL-VRVH 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 58/301 (19%), Positives = 109/301 (36%), Gaps = 37/301 (12%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE--KEFLSEINTLGSVRHR 361
++ + IG G G A + IK++ +H + L EI L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 362 NLVPLLGFCVAK----KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARG 417
N++ + A + + + ++L LY L H+ RG
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRG 121
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L ++H ++HR++ +LL+ + K+ DFGLAR+ +P H + F+
Sbjct: 122 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-TGFLTEYVATRW 177
Query: 478 YVAPEY-PRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536
Y APE + T D++S G +L E+++ + + + +L + S
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN----HILGILGSPS 233
Query: 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPT----------------PKERHTMFEVY 580
+ +L + L +V N + P P +R + +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 581 Q 581
Sbjct: 294 A 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (307), Expect = 1e-31
Identities = 43/292 (14%), Positives = 85/292 (29%), Gaps = 27/292 (9%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
IG G G + L + IK + + E T + +P + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFE-PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 71
Query: 373 KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHR 432
+ ++ L +L D L A + +H +++R
Sbjct: 72 EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125
Query: 433 NISSKCILLDGDFEP-----KLSDFGLARLMNPVDTHLSTFV---NGEFGDLGYVAPEYP 484
+I L+ + DFG+ + T G Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544
+ + D+ + G V + + G P A + + E I ++ L
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEKKQSTPLRE---- 239
Query: 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDD 596
L GF E ++++ + L + ER + T D+
Sbjct: 240 --LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTEDE 286
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 122 bits (306), Expect = 1e-31
Identities = 56/292 (19%), Positives = 107/292 (36%), Gaps = 45/292 (15%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL----------EDSQHSEKEFLSEINTLG 356
+ I+G G + + P +K + E+ Q + L E++ L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 357 SVR-HRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSA 415
V H N++ L LV+ ++ G L+D L E + + +I
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALL 120
Query: 416 RGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGD 475
+ LH I+HR++ + ILLD D KL+DFG + ++P L G
Sbjct: 121 EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREVC----GT 172
Query: 476 LGYVAPEYPRTLVA------TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWI 529
Y+APE + + D++S GV++ L+ G P F +
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP---------FWHRKQMLM 223
Query: 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ + + + + + + + + ++ P++R+T E
Sbjct: 224 LRMIMSGNYQFGSPEW---DDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 123 bits (310), Expect = 2e-31
Identities = 50/226 (22%), Positives = 84/226 (37%), Gaps = 22/226 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLE----DSQHSEKEFLSE---INTLGS 357
N FS + IIG G G Y G +K L+ + E L+E ++ + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 358 VRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARG 417
+V + + + + G L+ L + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 418 LAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLG 477
L +H+ +++R++ ILLD ++SD GLA + H S G G
Sbjct: 120 LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS------VGTHG 170
Query: 478 YVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
Y+APE + VA D +S G +L +L+ G P + +
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 216
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (301), Expect = 5e-31
Identities = 54/287 (18%), Positives = 105/287 (36%), Gaps = 31/287 (10%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHRNLVPLLG 368
IG G G Y A G +K++ ++ + + EI+ L ++H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 369 FCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR 428
KK +LV+ +L+ ++ + G+A+ H R
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 429 IIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE-YPRTL 487
++HR++ + +L++ + E K++DFGLAR + + L Y AP+ +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSK 176
Query: 488 VATPKGDVYSFGVVLLELITGERP-------------THLTNAPESFKGSLVEWITLLNT 534
+ D++S G + E++ G + P S V + +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
N ++ + G D L + P +R T + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 5e-31
Identities = 46/216 (21%), Positives = 90/216 (41%), Gaps = 19/216 (8%)
Query: 312 NIIGTGRTGATYIAM-LPGGCFIMIKRLE----DSQHSEKEFLSEINTLGSVRHRNLVPL 366
+GTG G ++ G + +K L+ + E L V H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 367 LGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCN 426
G ++ ++ Y+E G L+ L ++ + + L + +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC-------LALEYLHS 122
Query: 427 PRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT 486
II+R++ + ILLD + K++DFG A+ + V L G Y+APE T
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-------GTPDYIAPEVVST 175
Query: 487 LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
D +SFG+++ E++ G P + +N ++++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 64/297 (21%), Positives = 104/297 (35%), Gaps = 37/297 (12%)
Query: 307 SFSKNNIIGTGRTGATYIAMLPG-GCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVP 365
S++ +IG G G Y A L G + IK++ ++ E+ + + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNRELQIMRKLDHCNIVR 77
Query: 366 LLGFCVAKKER------LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLA 419
L F + E+ LV Y+ H + + + R LA
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 420 WLHHNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGY 478
++H I HR+I + +LLD D KL DFG A+ + + ++S + Y
Sbjct: 137 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-----YY 188
Query: 479 VAP-EYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL-------VEWIT 530
AP T DV+S G VL EL+ G+ + + + E I
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 531 LLNTN------SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+N N ++ + E + TP R T E
Sbjct: 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 58/292 (19%), Positives = 101/292 (34%), Gaps = 31/292 (10%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRNL 363
F K IG G G Y A G + +K++ +E + EI+ L + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
V LL + + LV+ +L + + PL +GLA+ H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDA---SALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE- 482
+ ++HR++ + +L++ + KL+DFGLAR + V L Y APE
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV----VTLWYRAPEI 173
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERP-------------THLTNAPESFKGSLVEWI 529
+ D++S G + E++T P+ V +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ D S + D + L + P +R +
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 4e-30
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 17/221 (7%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE----FLSEINTLG-SVRHR 361
F + ++G G G ++A F IK L+ + + E L + H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
L + K+ V YL G L + D A GL +L
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFL 119
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
H I++R++ ILLD D K++DFG+ + D +TF G Y+AP
Sbjct: 120 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC----GTPDYIAP 172
Query: 482 EYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
E D +SFGV+L E++ G+ P H + E F
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 52/297 (17%), Positives = 98/297 (32%), Gaps = 26/297 (8%)
Query: 303 KATNSFSKNNIIGTGRTGATYIA--MLPGGCFIMIKRL---EDSQHSEKEFLSEIN---T 354
+A + IG G G + A + GG F+ +KR+ + + E+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 355 LGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMH--MDWPLRLRIAI 412
L + H N+V L C + L + L +V + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 413 GSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGE 472
RGL +LH + ++HR++ + IL+ + KL+DFGLAR+ + S
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---- 176
Query: 473 FGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK--------GS 524
L Y APE D++S G + E+ + ++ +
Sbjct: 177 -VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 525 LVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+W + + + + C+ P +R + +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 55/295 (18%), Positives = 103/295 (34%), Gaps = 48/295 (16%)
Query: 308 FSKNNI---------IGTGRTGATYIAM-LPGGCFIMIKRL-------EDSQHSEKEFLS 350
F + N+ +G+G+ G K + S ++
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 351 EINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRI 410
E++ L ++H N++ L K + +L+ + G L+D E +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEF 118
Query: 411 AIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP----KLSDFGLARLMNPVDTHLS 466
G+ +LH I H ++ + I+L P K+ DFGLA ++ +
Sbjct: 119 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-- 173
Query: 467 TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV 526
FG +VAPE + D++S GV+ L++G P E +
Sbjct: 174 ---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----TL 225
Query: 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
++ +N E + F+R ++ PK+R T+ + Q
Sbjct: 226 ANVSAVNYEFEDE-------YFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 5e-29
Identities = 54/287 (18%), Positives = 102/287 (35%), Gaps = 28/287 (9%)
Query: 312 NIIGTGRTGATYIAMLPG-GCFIMIKRL------EDSQHSEKEFLSEINTLGSVRHRNLV 364
+ +G G+ Y A + IK++ E + L EI L + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 365 PLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHN 424
LL K LV+ ++E + + + + + +GL +LH +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 425 CNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
I+HR++ +LLD + KL+DFGLA+ + + V Y APE
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV----VTRWYRAPELL 172
Query: 485 RTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFK--------GSLVEWITLLNTN 535
+ D+++ G +L EL+ + + + +W + +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 536 SSLET-AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ + L + F L + L P R T + +
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 3e-28
Identities = 52/305 (17%), Positives = 95/305 (31%), Gaps = 39/305 (12%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHR 361
+ + K IG G G + A G + +K++ + + L EI L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 362 NLVPLLGFCVAKKER--------LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIG 413
N+V L+ C K LV+ + E+ + + R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--FTLSEIKRVMQML- 126
Query: 414 SARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEF 473
L L++ +I+HR++ + +L+ D KL+DFGLAR +
Sbjct: 127 ----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 474 GDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFK---------- 522
L Y PE P D++ G ++ E+ T
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 523 ------GSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTM 576
E L + + L D + ++ P +R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDS 299
Query: 577 FEVYQ 581
+
Sbjct: 300 DDALN 304
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 6e-28
Identities = 48/278 (17%), Positives = 92/278 (33%), Gaps = 34/278 (12%)
Query: 313 IIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFC- 370
++G G G +K L+D + +E + ++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRAS---QCPHIVRIVDVYE 75
Query: 371 ---VAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNP 427
+K L+V L+ G L+ ++ + I + +LH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLHSI--- 130
Query: 428 RIIHRNISSKCILLDGDFEP---KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYP 484
I HR++ + +L KL+DFG A+ ++ + YVAPE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT-----PYYVAPEVL 185
Query: 485 RTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG-SLVEWITLLNTNSSLETAID 543
D++S GV++ L+ G P F + + T +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP---------FYSNHGLAISPGMKTRIRMGQYEF 236
Query: 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ + E+ +R N + P +R T+ E
Sbjct: 237 PNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 46/222 (20%), Positives = 77/222 (34%), Gaps = 16/222 (7%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE----FLSEINTLGSVRH 360
N F ++G G G + G + +K L K+ ++E L + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
L L V Y G L+ L L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSAL-- 118
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
+ + +++R+I + ++LD D K++DFGL + + TF G Y+A
Sbjct: 119 -EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC----GTPEYLA 173
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
PE D + GVV+ E++ G P + + F+
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 53/289 (18%), Positives = 98/289 (33%), Gaps = 25/289 (8%)
Query: 308 FSKNNIIGTGRTGATYIAM-LPGGCFIMIKRL---EDSQHSEKEFLSEINTLGSVRHRNL 363
+ K IG G G + A + +KR+ +D + L EI L ++H+N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 364 VPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH 423
V L + K+ LV+ + + +D + +GL + H
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHS 119
Query: 424 NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEY 483
++HR++ + +L++ + E KL++FGLAR S V +
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW---YRPPDVL 173
Query: 484 PRTLVATPKGDVYSFGVVLLELITGERP-----------THLTNAPESFKGSLVEWITLL 532
+ + D++S G + EL RP + + +T L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ L N + N + P +R + E Q
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-26
Identities = 52/281 (18%), Positives = 92/281 (32%), Gaps = 49/281 (17%)
Query: 313 IIGTGRTGATYIAM-LPGGCFIMIKRL-------EDSQHSEKEFLSEINTLGSVR--HRN 362
++G+G G+ Y + + + IK + + E+ L V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 363 LVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
++ LL + +L+ E E + L + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCH 127
Query: 423 HNCNPRIIHRNISSKCILLDGD-FEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
+ ++HR+I + IL+D + E KL DFG L+ DT + F G Y P
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFD----GTRVYSPP 178
Query: 482 EYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540
E+ R V+S G++L +++ G+ P F+ E
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------FEH-------------DEEI 216
Query: 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ E +R C+ P +R T E+
Sbjct: 217 IRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 6e-25
Identities = 52/293 (17%), Positives = 105/293 (35%), Gaps = 27/293 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHR 361
+ +G+G GA A+ G + IK+L SE K E+ L +RH
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 362 NLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
N++ LL + + + + + +GL ++
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 422 HHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAP 481
H HR++ + ++ D E K+ DFGLAR D+ ++ +V Y AP
Sbjct: 138 HAAGII---HRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYV----VTRWYRAP 187
Query: 482 E-YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPE----------SFKGSLVEWIT 530
E + T D++S G ++ E+ITG+ ++ + + V+ +
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 531 LLNTNSSLET--AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
+ ++ ++K + + + ++ ++R T E
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 1e-24
Identities = 42/211 (19%), Positives = 78/211 (36%), Gaps = 19/211 (9%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKE----FLSEINTLGSVRH 360
+ F + +GTG G + G +K L+ + + + L+E L +V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
LV L +V Y+ G ++ L + P A +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEY 156
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
LH +I+R++ + +L+D +++DFG A+ + L G +A
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-------CGTPEALA 206
Query: 481 PEYPRTLVATPKGDVYSFGVVLLELITGERP 511
PE + D ++ GV++ E+ G P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 1e-23
Identities = 53/251 (21%), Positives = 93/251 (37%), Gaps = 29/251 (11%)
Query: 284 IKVSAFEKSVEKMRLSDLMKATNSFSKNNIIGTGRTGATYIAMLPG----GCFIMIKRL- 338
++ + EK+ + + F ++GTG G ++ G +K L
Sbjct: 9 LRTANLTGHAEKVGIEN-------FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK 61
Query: 339 ----EDSQHSEKEFLSEINTLGSVRHR-NLVPLLGFCVAKKERLLVYSYLENGTLYDKLH 393
+ + +E L +R LV L + + L+ Y+ G L+ L
Sbjct: 62 KATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS 121
Query: 394 PAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453
+ + I + L H II+R+I + ILLD + L+DFG
Sbjct: 122 -------QRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 174
Query: 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA--TPKGDVYSFGVVLLELITGERP 511
L++ +T G + Y+AP+ R + D +S GV++ EL+TG P
Sbjct: 175 LSKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
Query: 512 THLTNAPESFK 522
+ S
Sbjct: 232 FTVDGEKNSQA 242
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 91.4 bits (226), Expect = 8e-21
Identities = 37/212 (17%), Positives = 77/212 (36%), Gaps = 23/212 (10%)
Query: 306 NSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNL 363
+ + +G G+ + A+ + +++K L +K+ EI L ++R N+
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKKKIKREIKILENLRGGPNI 92
Query: 364 VPLLGFCVAKKERL--LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWL 421
+ L R LV+ ++ N + + L +
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYC 145
Query: 422 HHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
H I+HR++ +++D + + +L D+GLA +P + N +
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-----NVRVASRYFKG 197
Query: 481 PEYPRTLVA-TPKGDVYSFGVVLLELITGERP 511
PE D++S G +L +I + P
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 9e-21
Identities = 43/220 (19%), Positives = 77/220 (35%), Gaps = 25/220 (11%)
Query: 313 IIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRHRNLVPLLG 368
IG+G G A + IK+L ++ K E+ + V H+N++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 369 FCVAKK------ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLH 422
+K + LV ++ +D + G+ LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH 136
Query: 423 HNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPE 482
IHR++ I++ D K+ DFGLAR S + Y APE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPE 188
Query: 483 YPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFK 522
+ D++S G ++ E++ + + + +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.1 bits (225), Expect = 1e-20
Identities = 55/294 (18%), Positives = 96/294 (32%), Gaps = 27/294 (9%)
Query: 305 TNSFSKNNIIGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSE---KEFLSEINTLGSVRH 360
+ + +G+G G+ A G + +K+L S K E+ L ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
N++ LL + L + + + RGL +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVA 480
+H HR++ + ++ D E K+ DFGLAR + T Y A
Sbjct: 137 IHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG-------YVATRWYRA 186
Query: 481 PE-YPRTLVATPKGDVYSFGVVLLELITGERP----THLTNAPESFKGSLVEWITLLNTN 535
PE + D++S G ++ EL+TG H+ + LL
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 536 SSLE--------TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581
SS T + K N F G + + ++ +R T +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 89.7 bits (221), Expect = 6e-20
Identities = 35/212 (16%), Positives = 69/212 (32%), Gaps = 18/212 (8%)
Query: 314 IGTGRTGATYIAM-LPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA 372
+G G ++A + + +K + + + EI L V +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 373 KKERLL-VYSYLENGTLYDKLHPAEHEVMH-----------MDWPLRLRIAIGSARGLAW 420
+LL +++ ++ + + +I+ GL +
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 421 LHHNCNPRIIHRNISSKCILLD-GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYV 479
+H C IIH +I + +L++ D L +A L N Y
Sbjct: 141 MHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYR 196
Query: 480 APEYPRTLVATPKGDVYSFGVVLLELITGERP 511
+PE D++S ++ ELITG+
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.5 bits (177), Expect = 3e-15
Identities = 27/156 (17%), Positives = 52/156 (33%), Gaps = 22/156 (14%)
Query: 312 NIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEK-----------EFLSEINTLGSVRH 360
++G G+ A + ++K + S K F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 361 RNLVPLLGFCVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAW 420
R L L G V K Y++ N L + + E + ++ P + I +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMI--LEEVAK 118
Query: 421 LHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456
+H I+H ++S +L+ + + DF +
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 5e-14
Identities = 27/71 (38%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 153 NCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANN 211
LN L L NNR G +P L L + + +V+ N L G +P N+ F +ANN
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 212 SGLCGKPLNPC 222
LCG PL C
Sbjct: 302 KCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 26/128 (20%), Positives = 44/128 (34%), Gaps = 3/128 (2%)
Query: 45 NSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIER 104
N L + N + +
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT-QKIHLAKNSLAFDLGKVGL 242
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
+L GLDL +N + G++P ++ L+++ SL++S N+L GEIP N +V N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQ-LKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYAN 300
Query: 165 NRFTGKIP 172
N+ P
Sbjct: 301 NKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.8 bits (138), Expect = 1e-09
Identities = 20/98 (20%), Positives = 31/98 (31%), Gaps = 4/98 (4%)
Query: 58 WNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNN 117
+ + L + + G P+G+ + L L++S NN
Sbjct: 220 DKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 118 LSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCT 155
L G IP LQ ++N P L CT
Sbjct: 280 LCGEIPQ--GGNLQRFDVSAYANNKCLCGSP--LPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 49.7 bits (117), Expect = 5e-07
Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 7/166 (4%)
Query: 35 NDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDC-WHPDENKVLNIRLSDMG 93
D + L +K L +P +SW + + GV C +V N+ LS +
Sbjct: 6 QDKQALLQIKKDLGNP--TTLSSWLPTTDCCN--RTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 94 LKGQF--PRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL 151
L + P + L L + N ++L + L ++ ++SG IP L
Sbjct: 62 LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFL 121
Query: 152 ANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197
+ L L + N +G +PP + L + + N ++G +P
Sbjct: 122 SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 1e-11
Identities = 38/160 (23%), Positives = 57/160 (35%), Gaps = 11/160 (6%)
Query: 34 LNDIECLKSVKN--SLEDPFNYLTTSWNFNNNT--EGFICQFTGVDCWHPDENKVLNIRL 89
L DI L S+ N L+ N ++ + T + P L
Sbjct: 231 LKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNL 290
Query: 90 SDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS 149
+ + I +LT L L NN+S P S L + L ++N +S S
Sbjct: 291 ELNENQLEDISPISNLKNLTYLTLYFNNISDISPV---SSLTKLQRLFFANNKVSD--VS 345
Query: 150 GLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASN 189
LAN T +N L +N+ + P L L RI +
Sbjct: 346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 6e-08
Identities = 32/169 (18%), Positives = 54/169 (31%), Gaps = 48/169 (28%)
Query: 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISS 128
Q + + N + + L+ LK + T+LT LDL++N +S P +
Sbjct: 207 NQISDITPLGILTN-LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 263
Query: 129 RLQYV-----------------------------------------TSLDLSSNSLSGEI 147
+L + T L L N++S
Sbjct: 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS 323
Query: 148 PSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196
P +++ T L L NN+ + L L I S N ++ P
Sbjct: 324 P--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 12/62 (19%), Positives = 23/62 (37%), Gaps = 5/62 (8%)
Query: 111 LDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGK 170
L N++ ++ + L VT+L + G+ L + +NN+ T
Sbjct: 27 TVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDI 81
Query: 171 IP 172
P
Sbjct: 82 TP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 13/95 (13%)
Query: 77 WHPDEN--KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDIS--SRLQY 132
D + + L + +T L + I L
Sbjct: 15 IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI-----KSIDGVEYLNN 67
Query: 133 VTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRF 167
+T ++ S+N L+ P L N T L + +NNN+
Sbjct: 68 LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 34/157 (21%), Positives = 52/157 (33%), Gaps = 7/157 (4%)
Query: 67 FICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDI 126
V L + + T+L L L+ N L +
Sbjct: 180 LDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTL 237
Query: 127 SSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSV 186
+S L +T LDL++N +S P L+ T L LKL N+ + P L L + +
Sbjct: 238 AS-LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 292
Query: 187 ASNLLTGPVPSFANVNFTAEDFANNSGLCGKPLNPCP 223
N L P N T N+ P++
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLT 329
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.1 bits (151), Expect = 5e-11
Identities = 25/141 (17%), Positives = 47/141 (33%), Gaps = 12/141 (8%)
Query: 57 SWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSN 116
E ++ N RL D G++ + + L L L+
Sbjct: 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379
Query: 117 NLSGSIPSDISS---RLQYVTSLDLSSNSLSGEIPSGLA-----NCTFLNVLKLNNNRFT 168
++S S S +++ + LDLS+N L L L L L + ++
Sbjct: 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439
Query: 169 GKIPPQLGLL----NRIKTFS 185
++ +L L ++ S
Sbjct: 440 EEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.8 bits (145), Expect = 2e-10
Identities = 15/74 (20%), Positives = 25/74 (33%), Gaps = 4/74 (5%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE----IPSGLANCTFLNVLKL 162
+ LD+ LS + +++ LQ + L L+ I S L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 163 NNNRFTGKIPPQLG 176
+N +
Sbjct: 63 RSNELGDVGVHCVL 76
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 19/86 (22%), Positives = 29/86 (33%), Gaps = 10/86 (11%)
Query: 83 KVLNI---RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY---VTSL 136
+ L+I LSD P + L L+ + DISS L+ + L
Sbjct: 5 QSLDIQCEELSDARWAELLPL----LQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 137 DLSSNSLSGEIPSGLANCTFLNVLKL 162
+L SN L + K+
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.001
Identities = 13/66 (19%), Positives = 24/66 (36%), Gaps = 8/66 (12%)
Query: 83 KVLNIR---LSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQY----VTS 135
+V+ + L++ K + +L L+L SN L + LQ +
Sbjct: 30 QVVRLDDCGLTEARCK-DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQK 88
Query: 136 LDLSSN 141
L L +
Sbjct: 89 LSLQNC 94
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.4 bits (137), Expect = 1e-09
Identities = 21/97 (21%), Positives = 35/97 (36%), Gaps = 5/97 (5%)
Query: 103 ERCT-SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
RC L + S L +P D+ LDL +N ++ N L+ L
Sbjct: 6 FRCQCHLRVVQCSDLGLE-KVPKDLPPDTAL---LDLQNNKITEIKDGDFKNLKNLHTLI 61
Query: 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSF 198
L NN+ + P L +++ ++ N L
Sbjct: 62 LINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM 98
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 29/191 (15%), Positives = 63/191 (32%), Gaps = 5/191 (2%)
Query: 23 FCGNVRLSLATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFICQFTGVDCWHPDEN 82
+ A L +E L KN L++ + + E I + ++
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS 142
V+ + + + G + L+ + ++ N++ +IP + L L L N
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTE---LHLDGNK 182
Query: 143 LSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVAS-NLLTGPVPSFANV 201
++ + L L L L+ N + L ++ + + L+ P +
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 202 NFTAEDFANNS 212
NN+
Sbjct: 243 YIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 24/165 (14%), Positives = 48/165 (29%), Gaps = 13/165 (7%)
Query: 69 CQFTGVDCWH----------PDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNL 118
C V C P + +L+ L + + + +L L L +N +
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLD--LQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 119 SGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLL 178
S P + L + L LS N L L V + + + L +
Sbjct: 68 SKISPGAF-APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 179 NRIKTFSVASNLLTGPVPSFANVNFTAEDFANNSGLCGKPLNPCP 223
++ + +F + + ++ + P P
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPP 171
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 1e-08
Identities = 19/125 (15%), Positives = 37/125 (29%), Gaps = 11/125 (8%)
Query: 57 SWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSN 116
+ + +++ + + SL L++S+N
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNN 294
Query: 117 NLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTG--KIPPQ 174
L +P+ + L S N L+ E+P N L+ + N IP
Sbjct: 295 KLI-ELPALPPR----LERLIASFNHLA-EVPELPQNLKQLH---VEYNPLREFPDIPES 345
Query: 175 LGLLN 179
+ L
Sbjct: 346 VEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 6e-05
Identities = 18/69 (26%), Positives = 27/69 (39%), Gaps = 6/69 (8%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
L+L++ LS S+P + SL S NSL+ E+P + L V N
Sbjct: 36 LDRQAHELELNNLGLS-SLPELPPH----LESLVASCNSLT-ELPELPQSLKSLLVDNNN 89
Query: 164 NNRFTGKIP 172
+ P
Sbjct: 90 LKALSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 23/136 (16%), Positives = 38/136 (27%), Gaps = 8/136 (5%)
Query: 58 WNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNN 117
+ N + D L I S +L N
Sbjct: 211 ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLN 270
Query: 118 LSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGL 177
S + + + L++S+N L E+P+ L L + N ++P L
Sbjct: 271 ASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPE---L 322
Query: 178 LNRIKTFSVASNLLTG 193
+K V N L
Sbjct: 323 PQNLKQLHVEYNPLRE 338
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 7e-08
Identities = 15/66 (22%), Positives = 25/66 (37%), Gaps = 4/66 (6%)
Query: 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161
+ + S ++ NL+ ++P D+ L LS N L + L T L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKDTTI---LHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 162 LNNNRF 167
L+
Sbjct: 62 LDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 20/110 (18%), Positives = 34/110 (30%), Gaps = 1/110 (0%)
Query: 58 WNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNN 117
+ + T + L P G+ T +NN
Sbjct: 99 LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158
Query: 118 LSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRF 167
+P+ + + L+ + +L L NSL IP G L L+ N +
Sbjct: 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 17/80 (21%), Positives = 29/80 (36%), Gaps = 1/80 (1%)
Query: 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSS 140
V+ R + + +DLS++ + S I S+ + +L L
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 141 NSLSGEIPSGLANCTFLNVL 160
LS I + LA + L L
Sbjct: 81 LRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 19/99 (19%), Positives = 37/99 (37%), Gaps = 7/99 (7%)
Query: 91 DMGLKGQFPRGIERCTS--LTGLDLSSNNLSGSIPSDISS-RLQYVTSLDLSSNSLSGE- 146
D+ K P R S + + + + S R+Q+ +DLS++ +
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQH---MDLSNSVIEVST 62
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFS 185
+ L+ C+ L L L R + I L + + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 13/90 (14%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 109 TGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFT 168
LDL+ NL + + S+ V + + + + + + + L+N+
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIE 59
Query: 169 GK-IPPQLGLLNRIKTFSVASNLLTGPVPS 197
+ L ++++ S+ L+ P+ +
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVN 89
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 1e-05
Identities = 15/105 (14%), Positives = 34/105 (32%), Gaps = 2/105 (1%)
Query: 87 IRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE 146
+R + G + +LT L + + + L + +L + + L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 147 IPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLL 191
P L+ L L+ N + + ++ ++ N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (99), Expect = 2e-05
Identities = 13/120 (10%), Positives = 33/120 (27%), Gaps = 4/120 (3%)
Query: 104 RCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGL-ANCTFLNVLKL 162
+GL + + + + +T L + + + L L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPG-AENLTELYIENQQHLQHLELRDLRGLGELRNLTI 63
Query: 163 NNNRFTGKIPPQLGLLNRIKTFSVASN-LLTGPVPSFANVNFTAEDFANNSGLCGKPLNP 221
+ P R+ +++ N L + + ++ + N C L
Sbjct: 64 VKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 1e-05
Identities = 12/54 (22%), Positives = 19/54 (35%), Gaps = 3/54 (5%)
Query: 120 GSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPP 173
+P+D+ LD+S + GL N L N + K+P
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 7e-05
Identities = 11/71 (15%), Positives = 20/71 (28%), Gaps = 5/71 (7%)
Query: 105 CT-SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLN 163
C S + ++ IPSD+ L L + L ++++
Sbjct: 6 CHCSNRVFLCQESKVT-EIPSDLPRNAIE---LRFVLTKLRVIQKGAFSGFGDLEKIEIS 61
Query: 164 NNRFTGKIPPQ 174
N I
Sbjct: 62 QNDVLEVIEAD 72
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 3e-04
Identities = 12/93 (12%), Positives = 31/93 (33%), Gaps = 5/93 (5%)
Query: 58 WNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGI-ERCTSLTGLDLSSN 116
+ + + ++ + LSD + P + + LD+S
Sbjct: 152 SFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT 211
Query: 117 NLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS 149
+ S+PS L+ + + + ++P+
Sbjct: 212 RIH-SLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 7e-05
Identities = 11/68 (16%), Positives = 27/68 (39%), Gaps = 7/68 (10%)
Query: 107 SLTGLDLSSNNLSGSIPSDISSRLQY---VTSLDLSSNSLSGE----IPSGLANCTFLNV 159
S+ G L + ++ + + L V + LS N++ E + +A+ L +
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 160 LKLNNNRF 167
+ ++
Sbjct: 64 AEFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 13/90 (14%), Positives = 24/90 (26%), Gaps = 5/90 (5%)
Query: 81 ENKVLNI-RLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL--- 136
E K L + ++ K + S+ + LS N + +S + L
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 137 DLSSNSLSGEIPSGLANCTFLNVLKLNNNR 166
+ S L L +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPK 94
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 19/122 (15%), Positives = 33/122 (27%), Gaps = 10/122 (8%)
Query: 57 SWNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSN 116
N G+ + L ++ +L L L+
Sbjct: 194 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC 253
Query: 117 NLSGSIPSDISSRLQYV-----TSLDLSSNSLSGEIPSGLA-----NCTFLNVLKLNNNR 166
LS + + + +L L N + + L L L+LN NR
Sbjct: 254 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 313
Query: 167 FT 168
F+
Sbjct: 314 FS 315
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 9e-05
Identities = 26/105 (24%), Positives = 37/105 (35%), Gaps = 25/105 (23%)
Query: 111 LDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS--------------------- 149
L L+ +L+ + + +L VT LDLS N L P+
Sbjct: 3 LHLAHKDLT--VLCHLE-QLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 150 GLANCTFLNVLKLNNNRFTG-KIPPQLGLLNRIKTFSVASNLLTG 193
G+AN L L L NNR L R+ ++ N L
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 12/65 (18%), Positives = 22/65 (33%), Gaps = 5/65 (7%)
Query: 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
+L L L+ N ++ SS+ + +P LA ++ +L
Sbjct: 224 LRALQYLRLNDNPWVCDC--RARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAA 278
Query: 165 NRFTG 169
N G
Sbjct: 279 NDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.001
Identities = 13/76 (17%), Positives = 22/76 (28%), Gaps = 8/76 (10%)
Query: 103 ERCT----SLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLN 158
C L ++P I + Q + L N +S + C L
Sbjct: 4 GACVCYNEPKVTTSCPQQGLQ-AVPVGIPAASQR---IFLHGNRISHVPAASFRACRNLT 59
Query: 159 VLKLNNNRFTGKIPPQ 174
+L L++N
Sbjct: 60 ILWLHSNVLARIDAAA 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 21/107 (19%), Positives = 36/107 (33%), Gaps = 5/107 (4%)
Query: 58 WNFNNNTEGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNN 117
+N + + P LS + + + LT L N
Sbjct: 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184
Query: 118 LSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164
+S P + L + + L +N +S P LAN + L ++ L N
Sbjct: 185 ISDISPL---ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 618 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.52 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.5 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.46 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.38 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.34 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.34 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.34 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.31 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.28 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.22 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.21 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.19 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.07 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.03 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.03 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.98 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.97 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.85 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.83 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.7 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.66 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.55 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.18 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.18 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.16 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.07 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.04 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 97.86 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.86 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.8 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.58 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.36 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.02 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.53 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.75 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 93.74 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=422.33 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=204.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|+..+.||+|+||.||+|++.+++.||||+++......++|.+|++++++++|||||+++|++.+++..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 46788899999999999999998899999999988777888999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 85 g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 99999986554 4589999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||+|+..|+..... ..+...........
T Consensus 159 ---~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~~------- 221 (263)
T d1sm2a_ 159 ---STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFRL------- 221 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCCC-------
T ss_pred ---ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCCC-------
Confidence 1223489999999999999999999999999999999995545433211 11222222111110
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..+.....++.+++.+||+.||++|||++||++.|+++++.
T Consensus 222 ---~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 ---YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 01112234677788899999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=418.19 Aligned_cols=257 Identities=25% Similarity=0.360 Sum_probs=209.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecC
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLE 384 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 384 (618)
.++|++.+.||+|+||.||+|.+++++.||||+++......++|.+|++++++++|||||++++++.+ +..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 35788899999999999999999889999999998877778899999999999999999999998754 56799999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++..... ..+++..+++|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 91 NGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999998865543 4599999999999999999999999 9999999999999999999999999999987543322
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
. .....||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+..........
T Consensus 166 ~---~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~------- 228 (272)
T d1qpca_ 166 A---REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYR------- 228 (272)
T ss_dssp C---CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCC-------
T ss_pred c---ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCC-------
Confidence 1 2234488999999999988999999999999999999997666543221 1111111111110
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
...+......+.+++.+||+.||++|||++||++.|+++-
T Consensus 229 ---~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 ---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 0111222345777888999999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-53 Score=425.85 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=215.2
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC-CCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP-GGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.++|+..+.||+|+||.||+|+.. +++.||||+++.+....++|.+|++++++++|||||++++++.+++..++||||+
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 467888999999999999999964 5889999999887777889999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++..... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 96 ~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 96 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999865433 5699999999999999999999999 999999999999999999999999999987655333
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
... ....|++.|+|||++.+..++.++|||||||++|||++|..||..... ...........
T Consensus 171 ~~~---~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~~~i~~~-------- 232 (287)
T d1opja_ 171 TAH---AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKD-------- 232 (287)
T ss_dssp EEE---TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTT--------
T ss_pred eee---ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHHHHHhcC--------
Confidence 222 223378899999999999999999999999999999998777654322 11111111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
.....+......+.+++.+||+.||++|||++||++.|+.+.++-
T Consensus 233 --~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 233 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred --CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 111112223456778888999999999999999999999886543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-52 Score=421.44 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=197.7
Q ss_pred cCCCCcEEeecCCeeEEEEEeC-CC---cEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAMLP-GG---CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+|++.++||+|+||.||+|... ++ ..||||.+.... ...++|.+|++++++++|||||++++++.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4556689999999999999964 22 368999986543 34567999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... ..+++.+++.++.||++||+|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 107 Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp ECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999887644 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcc-cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 461 VDTHL-STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 461 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
..... .....+..||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+..........
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~~~- 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQDYR- 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC-
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCC-
Confidence 32221 111223347899999999999999999999999999999998 8999975432 112222211111
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
...+.+....+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 252 ---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 ---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111222345677888899999999999999999999998763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=412.99 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=200.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999995 578999999986543 3345689999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999997543 499999999999999999999999 99999999999999999999999999998764332
Q ss_pred CcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchh
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETA 541 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 541 (618)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... ...... .......
T Consensus 158 ~~--~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~-~~~~~~~-- 226 (271)
T d1nvra_ 158 RE--RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDW-KEKKTYL-- 226 (271)
T ss_dssp EE--CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHH-HTTCTTS--
T ss_pred cc--ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHHHH-hcCCCCC--
Confidence 21 12234569999999999988776 578999999999999999999997543211 111111 1110000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 542 IDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 542 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.........+.+++.+||+.||++|||++|+++
T Consensus 227 -------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112245567777999999999999999854
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=410.39 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=202.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccC---ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDS---QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.+.||+|+||.||+|+.++ .||||+++.. ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4678899999999999999998644 5999999653 3345779999999999999999999998754 56899999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+++|+|.+++.... ..+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 999999999996544 3599999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRT---LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+...+.........
T Consensus 158 ~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 158 SGS--HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD----QIIFMVGRGYLSPDL 231 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHHTSCCCCG
T ss_pred CCc--ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCCCCCcc
Confidence 221 11223458999999998864 357899999999999999999999997643211 111111110000000
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
. ......+..+.+++.+||+.||++|||++||++.|+.+++..
T Consensus 232 ~---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 S---------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp G---------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred h---------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 0 011123356777888999999999999999999999998753
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=408.66 Aligned_cols=254 Identities=20% Similarity=0.322 Sum_probs=213.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|+..++||+|+||+||+|+.++++.||||+++......++|.+|++++++++||||+++++++.+++..++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 57889999999999999999998999999999998877888999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... ..+++..+++++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 84 g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 84 GCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 99999976554 4589999999999999999999999 99999999999999999999999999998765433222
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +..........
T Consensus 158 ---~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~------- 219 (258)
T d1k2pa_ 158 ---SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLR------- 219 (258)
T ss_dssp ---CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCC-------
T ss_pred ---ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCC-------
Confidence 223458999999999999999999999999999999998 89999754321 11111211111
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
...+......+.+++.+||+.||++|||++|+++.|.+|
T Consensus 220 ---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 ---LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ---CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 011122234677788899999999999999999998754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=403.52 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=203.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4689999999999999999996 46899999998642 345677899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 9999999999997543 499999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+. .+..........
T Consensus 159 ~~~------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~--- 221 (263)
T d2j4za1 159 SRR------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEF--- 221 (263)
T ss_dssp CCC------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCC---
T ss_pred Ccc------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCC---
Confidence 322 123489999999999999999999999999999999999999975321 111111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ +.....++.+++.+||+.||++|||++|+++
T Consensus 222 ----~~----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 ----TF----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CC----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 01 1112245666777999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=411.80 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=203.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
++|++.+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4799999999999999999994 679999999986543 45677999999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++... .+++.++..++.||+.||+|||++ ||+||||||+|||++.++++||+|||+|+.......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999987543 489999999999999999999999 999999999999999999999999999987754332
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
.. ....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............
T Consensus 172 ~~----~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--------~~~~~~~~~~~~----- 234 (293)
T d1yhwa1 172 KR----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--------RALYLIATNGTP----- 234 (293)
T ss_dssp CB----CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHHCSC-----
T ss_pred cc----cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCC-----
Confidence 22 2345999999999999999999999999999999999999999753321 111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ ..+......+.+++.+||+.||++|||++|+++
T Consensus 235 -~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 235 -EL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -CC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 011122345667777999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=411.71 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=192.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEe--CCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVA--KKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 379 (618)
++|++.+.||+|+||.||+|+. .+|+.||+|+++.... ..+.+.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6799999999999999999995 5789999999976432 34568899999999999999999999865 4567999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC--NPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
|||+++|+|.+++.........+++..++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998754333356999999999999999999999871 11399999999999999999999999999988
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+. .+........ .
T Consensus 164 ~~~~~~~~----~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~-~ 230 (269)
T d2java1 164 LNHDTSFA----KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREG-K 230 (269)
T ss_dssp C---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHT-C
T ss_pred cccCCCcc----ccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcC-C
Confidence 75432221 234589999999999999999999999999999999999999975322 1111111111 1
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .+ +.....++.+++.+||+.||++|||++|+++
T Consensus 231 ~~-----~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 FR-----RI----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC-----CC----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 10 11 1112235667777999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=407.06 Aligned_cols=260 Identities=20% Similarity=0.313 Sum_probs=207.4
Q ss_pred ccCCCCc-EEeecCCeeEEEEEeC---CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNN-IIGTGRTGATYIAMLP---GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|...+ +||+|+||.||+|... ++..||||+++... ...++|.+|++++++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455566 4999999999999853 45689999997543 345679999999999999999999999865 568999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999986543 3599999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +..........
T Consensus 161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~- 230 (285)
T d1u59a_ 161 ADDSYY-TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR- 230 (285)
T ss_dssp TCSCEE-CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCC-
T ss_pred cccccc-ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC-
Confidence 543222 11223458899999999998999999999999999999998 99999764321 11111111111
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
...+...+.++.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 231 ---------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 231 ---------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp ---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 01112233567788889999999999999999999998765543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=406.17 Aligned_cols=260 Identities=22% Similarity=0.344 Sum_probs=201.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCC-----cEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGG-----CFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
+.|+..++||+|+||.||+|.+++. ..||||+++... ....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999996432 479999996543 334578999999999999999999999999999999
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
||||+.+|++.+++.... ..+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999999998876543 3599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
....... .......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ..+........
T Consensus 161 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~--- 229 (283)
T d1mqba_ 161 EDDPEAT-YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKAINDG--- 229 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHHHHTT---
T ss_pred cCCCccc-eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHHHHHhcc---
Confidence 5432221 112233489999999999999999999999999999999997666654321 11112211111
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.....+...+..+.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 230 -------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11112223345677888899999999999999999999998763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=405.93 Aligned_cols=256 Identities=25% Similarity=0.340 Sum_probs=205.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++|++.+.||+|+||.||+|+.++++.||||+++......+.|.+|+.++++++|||||++++++. .+..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCC
Confidence 578999999999999999999988889999999887777889999999999999999999999985 4568999999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|..++..... ..++|.+++.++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++.........
T Consensus 96 g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 96 GSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp CBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999998875432 4599999999999999999999999 99999999999999999999999999998765433221
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKS 545 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 545 (618)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+..... ..+..........
T Consensus 171 ---~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~~-------- 232 (285)
T d1fmka3 171 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYR-------- 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCC--------
T ss_pred ---eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCC--------
Confidence 1223489999999999999999999999999999999997777654322 1222222221111
Q ss_pred ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 546 LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 546 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
.........++.+++.+||+.||++|||+++|++.|+++.
T Consensus 233 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred --CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 1111223346777888999999999999999999888764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=416.08 Aligned_cols=199 Identities=22% Similarity=0.384 Sum_probs=177.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.++|++.++||+|+||+||+|+. .+|+.||+|+++... ...+++.+|+.++++++|||||+++++|.++++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999995 578999999997532 335678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
|+++|+|.+++.... .+++..+..++.|++.||.|||+ + +|+||||||+|||++.++++||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999997543 49999999999999999999996 5 899999999999999999999999999986543
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTN 516 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~ 516 (618)
.. ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+
T Consensus 158 ~~------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 158 SM------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HT------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred Cc------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 21 123459999999999999999999999999999999999999997654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=408.39 Aligned_cols=250 Identities=22% Similarity=0.285 Sum_probs=201.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC-ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS-QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
+.|++.+.||+|+||.||+|+. .+++.||+|+++.. ....+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4588899999999999999995 57899999999653 344567899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++.... .++++.++..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999876533 3599999999999999999999999 99999999999999999999999999997653211
Q ss_pred cccccccCCCCcccccCCCCCC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPR-----TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
.......||+.|+|||++. +..|+.++|||||||++|||+||+.||......+ .+... ......
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~~i----~~~~~~ 233 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLLKI----AKSEPP 233 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHH----HHSCCC
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH----HHHHH----HcCCCC
Confidence 1122345999999999873 5568999999999999999999999997644321 11111 111100
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+ ..+.....++.+++.+||+.||++|||++|+++
T Consensus 234 ------~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 ------TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ------CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 011222345677777999999999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-50 Score=402.13 Aligned_cols=249 Identities=21% Similarity=0.315 Sum_probs=198.1
Q ss_pred cEEeecCCeeEEEEEeC---CCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeecCC
Q 007088 312 NIIGTGRTGATYIAMLP---GGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYLEN 385 (618)
Q Consensus 312 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 385 (618)
++||+|+||.||+|.+. .++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999853 35789999996532 234679999999999999999999999865 457899999999
Q ss_pred CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCcc
Q 007088 386 GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHL 465 (618)
Q Consensus 386 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 465 (618)
|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999987543 499999999999999999999999 99999999999999999999999999998765433322
Q ss_pred cccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhccc
Q 007088 466 STFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDK 544 (618)
Q Consensus 466 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 544 (618)
. ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... .+..........
T Consensus 165 ~-~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~------- 228 (277)
T d1xbba_ 165 K-AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGER------- 228 (277)
T ss_dssp E-C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCC-------
T ss_pred c-cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcCCC-------
Confidence 1 1223458999999999999999999999999999999998 8999975332 111111111111
Q ss_pred cccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 007088 545 SLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIA 587 (618)
Q Consensus 545 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 587 (618)
...+...+.++.+|+.+||+.||++|||++||++.|+...
T Consensus 229 ---~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 ---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1111223356777888999999999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=396.71 Aligned_cols=243 Identities=22% Similarity=0.310 Sum_probs=192.1
Q ss_pred CCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEe----CCeeEEEE
Q 007088 309 SKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVA----KKERLLVY 380 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 380 (618)
...++||+|+||+||+|+. .+++.||+|.+.... ...+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4456899999999999995 468899999986543 334568999999999999999999999875 34578999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCeeeC-CCCceEEcccCcccc
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPR--IIHRNISSKCILLD-GDFEPKLSDFGLARL 457 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~ 457 (618)
||+++|+|.+++.... .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999997543 499999999999999999999998 6 99999999999996 578999999999986
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
...... ....||+.|+|||++.+ +++.++|||||||++|||++|+.||..... .............
T Consensus 165 ~~~~~~------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 165 KRASFA------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVK 230 (270)
T ss_dssp CCTTSB------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCC
T ss_pred ccCCcc------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHHHHcCCC
Confidence 543221 23359999999998865 699999999999999999999999975332 1111122211111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...++ ... ..++.+++.+||+.||++|||++|+++
T Consensus 231 -~~~~~-----~~~---~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 -PASFD-----KVA---IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -CGGGG-----GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CcccC-----ccC---CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00111 111 234667777999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=405.68 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=202.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999996 57899999999642 345567999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 9999999999887554 499999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .+......... .
T Consensus 161 ~~~~~--~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~-~-- 227 (288)
T d1uu3a_ 161 ESKQA--RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLE-Y-- 227 (288)
T ss_dssp -----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTC-C--
T ss_pred CCccc--ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCC-C--
Confidence 32211 12234599999999999999999999999999999999999999975322 11111111111 0
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQL 582 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 582 (618)
.+ +.....++.+++.+||+.||++|||++|+++.
T Consensus 228 ----~~----p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ----DF----PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ----CC----CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ----CC----CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 01 11122356677779999999999999998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-50 Score=406.89 Aligned_cols=250 Identities=21% Similarity=0.291 Sum_probs=188.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
.+.|++.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35689999999999999999995 468999999996543 334568899999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC---CCCceEEcccCccccc
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD---GDFEPKLSDFGLARLM 458 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~ 458 (618)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhccc----CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999997543 499999999999999999999999 999999999999994 5789999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 161 ~~~~~-----~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~- 226 (307)
T d1a06a_ 161 DPGSV-----LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND--------AKLFEQILKAEY- 226 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHTTCC-
T ss_pred cCCCe-----eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHhccCC-
Confidence 54322 1234599999999999999999999999999999999999999975322 111111111110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.............+.+++.+||+.||++|||++|+++
T Consensus 227 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 ------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0001111122345667777999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=409.53 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=203.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC------CcEEEEEEeccC--ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG------GCFIMIKRLEDS--QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
++|++.+.||+|+||.||+|+..+ ...||+|++... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578899999999999999998532 247999998653 23446789999999998 899999999999999999
Q ss_pred EEEEeecCCCccccccCCCCC-------------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 007088 377 LLVYSYLENGTLYDKLHPAEH-------------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSK 437 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 437 (618)
++||||+++|+|.+++..... ....+++..++.++.||++||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999975432 123589999999999999999999999 9999999999
Q ss_pred CeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCC
Q 007088 438 CILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTN 516 (618)
Q Consensus 438 NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~ 516 (618)
||+++.++++||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSE--EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccccccCCeEEEeeccccccccCCCcee--eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999998765433221 1122347999999999999999999999999999999998 899997644
Q ss_pred CCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 007088 517 APESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLR 584 (618)
Q Consensus 517 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 584 (618)
..+ .+.+.+. .. ...+.+......+.+|+.+||+.||++|||++||++.|.
T Consensus 272 ~~~----~~~~~~~---~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA----NFYKLIQ---NG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH----HHHHHHH---TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH----HHHHHHh---cC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 321 1111111 11 111111223346777888999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=404.01 Aligned_cols=244 Identities=25% Similarity=0.333 Sum_probs=197.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc----CHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH----SEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
+.|+..+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3588899999999999999994 5789999999975432 2356889999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+++|+|..++... .++++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999997766443 3599999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCcccccccCCCCcccccCCCCCCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRT---LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
.. ...||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... .+.........
T Consensus 168 ~~--------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~~~- 230 (309)
T d1u5ra_ 168 AN--------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE- 230 (309)
T ss_dssp BC--------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSC-
T ss_pred CC--------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCC-
Confidence 21 2349999999998753 4689999999999999999999999975321 11111111111
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.+.+.....+ ..+.+++.+||+.||++|||++|+++
T Consensus 231 -----~~~~~~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 -----SPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----CCCCSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCCCCCCC---HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111112223 35666777999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=393.62 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=198.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEe-CCeeEEEEeecC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVA-KKERLLVYSYLE 384 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 384 (618)
++|+..+.||+|+||.||+|.. .|+.||||+++.+. ..+++.+|++++++++||||++++|++.+ .+..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 4677889999999999999998 47889999997653 45679999999999999999999999865 456899999999
Q ss_pred CCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCCc
Q 007088 385 NGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDTH 464 (618)
Q Consensus 385 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 464 (618)
+|+|.+++..... ..+++..+++|+.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++.......
T Consensus 85 ~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~- 158 (262)
T d1byga_ 85 KGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 158 (262)
T ss_dssp TEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCc-
Confidence 9999999975432 3589999999999999999999999 999999999999999999999999999987543221
Q ss_pred ccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 465 LSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 465 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
...+|..|+|||++.+..++.++|||||||++|||+| |++||..... ..+..++. ..
T Consensus 159 ------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~i~---~~-------- 216 (262)
T d1byga_ 159 ------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVE---KG-------- 216 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHT---TT--------
T ss_pred ------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHH---cC--------
Confidence 1237889999999998999999999999999999998 6777765322 12222221 11
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
...+.+......+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 217 --~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 217 --YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 1111122223466778889999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-49 Score=407.98 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=204.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.++++++|||||++++++.+.+..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45899999999999999999995 579999999997643 3456789999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC--CCCceEEcccCcccccCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD--GDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~~~~ 460 (618)
+++|+|.+++.... ..+++..+..|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+....
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999986543 3599999999999999999999999 999999999999996 467899999999988765
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC-ccc
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS-SLE 539 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~-~~~ 539 (618)
..... ...||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .+......... ...
T Consensus 179 ~~~~~-----~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~ 245 (350)
T d1koaa2 179 KQSVK-----VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMD 245 (350)
T ss_dssp TSCEE-----EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCSC
T ss_pred ccccc-----eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 43321 23489999999999999999999999999999999999999975322 11121111111 100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. .........+.+++.+||+.||++|||++|+++
T Consensus 246 ~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 246 D--------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp C--------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred c--------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 001112345667777999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5e-49 Score=406.68 Aligned_cols=251 Identities=19% Similarity=0.280 Sum_probs=204.6
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
.++|++.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999995 579999999997643 3455688999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC--CCCceEEcccCcccccCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD--GDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~a~~~~~ 460 (618)
+++|+|.+++.... .++++.+++.|+.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998876543 3599999999999999999999999 999999999999998 678999999999998765
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
..... ...||+.|+|||++.+..++.++||||+||++|||+||+.||..... .+.........
T Consensus 182 ~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~---- 244 (352)
T d1koba_ 182 DEIVK-----VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCD---- 244 (352)
T ss_dssp TSCEE-----EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCC----
T ss_pred CCcee-----eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC----
Confidence 43221 23489999999999999999999999999999999999999975332 11111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.............++.+++.+||+.||.+|||++|+++
T Consensus 245 ---~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 245 ---WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ---CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ---CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111111222345667778999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-49 Score=402.22 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=211.8
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEE
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFC 370 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~ 370 (618)
.+++-..++|++.+.||+|+||.||+|+.. +++.||||+++... ...++|.+|++++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344445678999999999999999999853 45789999997543 3356799999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCccccccCCCCC--------------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 007088 371 VAKKERLLVYSYLENGTLYDKLHPAEH--------------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRII 430 (618)
Q Consensus 371 ~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 430 (618)
.+.+..++||||+++|+|.+++..... ....+++..++.|+.|++.||+|||++ +|+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 999999999999999999998853221 124589999999999999999999999 999
Q ss_pred ecCCCCCCeeeCCCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCC-
Q 007088 431 HRNISSKCILLDGDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE- 509 (618)
Q Consensus 431 H~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~- 509 (618)
||||||+|||+|.++.+||+|||+|+......... ......||+.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK--ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCcccc--ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 99999999999999999999999998765432221 122344889999999999999999999999999999999986
Q ss_pred CCCCCCCCCCccccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 510 RPTHLTNAPESFKGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 510 ~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
+||..... .+........ ... ..+...+.++.+|+.+||+.||++||||.||+++|++|.+
T Consensus 241 ~p~~~~~~--------~e~~~~v~~~-~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 241 QPYYGMAH--------EEVIYYVRDG-NIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp CTTTTSCH--------HHHHHHHHTT-CCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCCH--------HHHHHHHHcC-CCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 56654322 1112222111 111 1112233467788889999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=393.83 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=196.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCC----CcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPG----GCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.+.||+|+||.||+|+... +..||||.++... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578889999999999999998532 4578999986533 33567999999999999999999999985 4678999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 86 ~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999876543 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCcc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSSL 538 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~ 538 (618)
....... ....||+.|+|||.+.+..++.++|||||||++|||+| |.+||...... .+...+. .....
T Consensus 160 ~~~~~~~---~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-----~~~~~i~---~~~~~ 228 (273)
T d1mp8a_ 160 DSTYYKA---SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGRIE---NGERL 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----GHHHHHH---TTCCC
T ss_pred CCcceec---cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-----HHHHHHH---cCCCC
Confidence 4332221 12347899999999999999999999999999999998 89998764432 1222111 11110
Q ss_pred chhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 539 ETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 539 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..+......+.+++.+||+.||++|||++||++.|+.+.++
T Consensus 229 ----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 ----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11122334677788899999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=395.09 Aligned_cols=274 Identities=21% Similarity=0.287 Sum_probs=206.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----eeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK----ERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e 381 (618)
++|...+.||+|+||.||+|+. +|+.||||+++...........|+..+.+++||||+++++++.+.+ ..++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 5677788999999999999997 6789999999765433333444555667789999999999998754 5789999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC-----NPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
|+++|+|.++++.. .++|..+++++.|++.||+|||+.. .++|+||||||+|||++.++++||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999753 4899999999999999999999731 2389999999999999999999999999998
Q ss_pred ccCCCCCcccccccCCCCcccccCCCCCCCC------CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccc-------c
Q 007088 457 LMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL------VATPKGDVYSFGVVLLELITGERPTHLTNAPESFK-------G 523 (618)
Q Consensus 457 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~-------~ 523 (618)
.................||+.|+|||++.+. .++.++|||||||++|||+||..||......+... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 8755443333333445699999999987754 36779999999999999999998876433222111 1
Q ss_pred CHHHHHHHHhcCCccchhccccccCCC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhc
Q 007088 524 SLVEWITLLNTNSSLETAIDKSLLGNG-FDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERY 590 (618)
Q Consensus 524 ~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 590 (618)
......... ..... ++.+.... ..+....+.+++.+||+.||++|||+.||++.|+++.++-
T Consensus 237 ~~~~~~~~~-~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 237 SVEEMRKVV-CEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHH-TTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHH-hcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 111111111 11111 11111111 2245667889999999999999999999999999997654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=393.50 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=207.4
Q ss_pred CcEEeecCCeeEEEEEeCCC----cEEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeC-CeeEEEEeec
Q 007088 311 NNIIGTGRTGATYIAMLPGG----CFIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK-KERLLVYSYL 383 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 383 (618)
.++||+|+||+||+|++.++ ..||||+++.. ....++|.+|++++++++||||++++|++.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 36899999753 23456799999999999999999999998764 5789999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVDT 463 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~ 463 (618)
++|+|.+++.... ..+++..+++++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999887654 3578899999999999999999999 999999999999999999999999999998765443
Q ss_pred cccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccchhcc
Q 007088 464 HLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLETAID 543 (618)
Q Consensus 464 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 543 (618)
..........||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ..+..++ ......
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~~~~~i---~~g~~~----- 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYL---LQGRRL----- 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHH---HTTCCC-----
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----HHHHHHH---HcCCCC-----
Confidence 3333333456899999999999999999999999999999999988887653321 1111221 111110
Q ss_pred ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 007088 544 KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTT 594 (618)
Q Consensus 544 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~ 594 (618)
..+......+.+++.+||+.||++||++.||++.|+++.+.+..+.
T Consensus 254 -----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 254 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred -----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 0111223467778889999999999999999999999988765543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-48 Score=388.61 Aligned_cols=248 Identities=20% Similarity=0.272 Sum_probs=202.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|++.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999996 578999999986421 24678999999999999999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC----ceEEcccC
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF----EPKLSDFG 453 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 453 (618)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999997543 499999999999999999999999 999999999999998776 49999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
+|+........ ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .+......
T Consensus 163 ~a~~~~~~~~~-----~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~ 229 (293)
T d1jksa_ 163 LAHKIDFGNEF-----KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVS 229 (293)
T ss_dssp TCEECTTSCBC-----SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred hhhhcCCCccc-----cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHH
Confidence 99876543322 233489999999999999999999999999999999999999975432 11111111
Q ss_pred cC-CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TN-SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. ........ ......+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 AVNYEFEDEYF--------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTCCCCCHHHH--------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hcCCCCCchhc--------CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 01010000 112245667788999999999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=398.74 Aligned_cols=247 Identities=20% Similarity=0.259 Sum_probs=203.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 379 (618)
.++|++.+.||+|+||.||+|+. .+|+.||||++++. ....+.+.+|+.+|++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35799999999999999999995 67999999999753 24567789999999999999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999987654 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ...+||+.|+|||++.+..|+.++||||+||++|||++|++||...+. .+.........
T Consensus 157 ~~~~~~----~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~--- 221 (337)
T d1o6la_ 157 SDGATM----KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEE--- 221 (337)
T ss_dssp CTTCCB----CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC---
T ss_pred cCCccc----ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCC---
Confidence 433222 234599999999999999999999999999999999999999976432 11111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
..+. ...+ .++.+++.+||+.||.+||+ ++|+++
T Consensus 222 ----~~~p-~~~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 ----IRFP-RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----CCCC-TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCC-ccCC---HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0011 1122 34566777999999999995 777765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=398.25 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=202.8
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCc----EEEEEEeccC--ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGC----FIMIKRLEDS--QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 378 (618)
.+|++.++||+|+||+||+|... +|+ +||+|+++.. ....++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35889999999999999999853 443 6899988643 35577899999999999999999999999875 5678
Q ss_pred EEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCccccc
Q 007088 379 VYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLM 458 (618)
Q Consensus 379 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 458 (618)
++||+.+|+|.+++.... ..+++..+++++.||+.||+|||++ +|+||||||+|||++.++++||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999998876544 4699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
........ .....||+.|+|||++.++.++.++|||||||++|||+| |++||...... .+...+.. ...
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----~~~~~i~~---~~~ 231 (317)
T d1xkka_ 162 GAEEKEYH--AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EISSILEK---GER 231 (317)
T ss_dssp TTTCC----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----GHHHHHHH---TCC
T ss_pred cccccccc--ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHc---CCC
Confidence 54333221 122348999999999999999999999999999999999 78888654321 12222211 110
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
...+......+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 232 ----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 ----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----------CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111122335677888899999999999999999999988653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=393.54 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=205.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC-CCc--EEEEEEeccC--ccCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP-GGC--FIMIKRLEDS--QHSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.++||+|+||.||+|++. +|. .||||+++.. ....++|.+|+++++++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888899999999999999964 443 5788887543 23456799999999999 799999999999999999999
Q ss_pred EeecCCCccccccCCCC------------CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCce
Q 007088 380 YSYLENGTLYDKLHPAE------------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEP 447 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 447 (618)
|||+++|+|.++++... .....+++..+++++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997542 2235699999999999999999999999 99999999999999999999
Q ss_pred EEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCC-CCCCCCCCCccccCHH
Q 007088 448 KLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGER-PTHLTNAPESFKGSLV 526 (618)
Q Consensus 448 kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~-Pf~~~~~~~~~~~~l~ 526 (618)
||+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||...+ ..
T Consensus 167 kl~DfG~a~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~ 233 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK-----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CA 233 (309)
T ss_dssp EECCTTCEESSCEECCC---------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HH
T ss_pred EEccccccccccccccc-----cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HH
Confidence 99999999865432221 12338999999999999999999999999999999999765 554322 11
Q ss_pred HHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcC
Q 007088 527 EWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYH 591 (618)
Q Consensus 527 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 591 (618)
+.......... ...+.....++.+++.+||+.||++||||+||++.|+++.++..
T Consensus 234 ~~~~~i~~~~~----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 234 ELYEKLPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HHHHHGGGTCC----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHhcCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 22222211111 11112233467777889999999999999999999999987543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-48 Score=389.63 Aligned_cols=260 Identities=23% Similarity=0.296 Sum_probs=200.5
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----e
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK----E 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 375 (618)
.++|++.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36799999999999999999995 579999999997543 23456899999999999999999999997654 3
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 789999999999999886543 499999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
......... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..... .+........
T Consensus 159 ~~~~~~~~~-~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~ 229 (277)
T d1o6ya_ 159 RAIADSGNS-VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVRE 229 (277)
T ss_dssp EECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHC
T ss_pred hhhcccccc-ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHHHHHHhc
Confidence 765433221 1122334599999999999999999999999999999999999999975332 1111111111
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhh
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-TMFEVYQLLRAIA 587 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 587 (618)
.... +...... ....+.+++.+||+.||.+|| |++++++.|.++.
T Consensus 230 ~~~~----~~~~~~~---~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 230 DPIP----PSARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCC----GGGTSSS---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCC----CchhccC---CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1110 1111111 224566777799999999999 8999999988774
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=396.24 Aligned_cols=250 Identities=19% Similarity=0.254 Sum_probs=204.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEeec
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
.++|++.+.||+|+||+||+|.. .+++.||||+++........+.+|+++|++++|||||++++++.+++..|+||||+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46799999999999999999995 57899999999877666677899999999999999999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCC--CceEEcccCcccccCCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGD--FEPKLSDFGLARLMNPV 461 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~a~~~~~~ 461 (618)
++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999997654 3599999999999999999999999 99999999999999854 57999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC-ccch
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS-SLET 540 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~-~~~~ 540 (618)
.... ...+|+.|+|||...+..++.++||||+||++|||++|+.||..... .+......... ....
T Consensus 158 ~~~~-----~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~ 224 (321)
T d1tkia_ 158 DNFR-----LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDE 224 (321)
T ss_dssp CEEE-----EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCH
T ss_pred Cccc-----ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCh
Confidence 3221 22379999999999999999999999999999999999999976432 11111111111 1110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...+ ....++.+++.+||..||++|||++|+++
T Consensus 225 ~~~~--------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAFK--------EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHT--------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhcc--------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 11234667777999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-48 Score=392.63 Aligned_cols=243 Identities=21% Similarity=0.291 Sum_probs=202.0
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|+. .+|+.||||+++.. ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999995 56999999999643 245677999999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||++||+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccccc----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 9999999999887654 388999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .+..........
T Consensus 157 ~~-------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~--- 218 (316)
T d1fota_ 157 VT-------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAEL--- 218 (316)
T ss_dssp CB-------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCC---
T ss_pred cc-------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcCCC---
Confidence 22 124599999999999999999999999999999999999999975332 111111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
.. +.....++.+++.+||+.||.+|| |++|+++
T Consensus 219 ----~~----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ----RF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----CC----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CC----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 00 111223466777799999999996 8999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=392.77 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=197.1
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC-
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK- 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 374 (618)
.++|++.++||+|+||.||+|... +++.||||+++... ...+.+.+|...+.++ +|+||+.+++++...+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367999999999999999999842 34789999997543 3345678888888777 6899999999987654
Q ss_pred eeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
..++||||+++|+|.+++..... ....+++.+++.++.||++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 67999999999999999865432 123589999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE-RPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~-~Pf~~~~~~~~~ 521 (618)
.++++||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+||. +||......+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-- 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYV--RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSC--CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred CCCcEEEccCcchhhcccccccc--ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999998765433221 122345899999999999999999999999999999999975 5665433211
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
.+...+. .... ...+.....++.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 245 --~~~~~~~---~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 --EFCRRLK---EGTR----------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp --HHHHHHH---HTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHh---cCCC----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1111111 1110 111122334677888899999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=388.54 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=196.1
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC--C--CcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP--G--GCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|++.+.||+|+||.||+|+.. + ...||||+++.. ....++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 2 247899998653 2334679999999999999999999999966 4678
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++|++.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999998876543 4599999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
......... ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||...+. .+.........
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~~ 231 (273)
T d1u46a_ 161 LPQNDDHYV-MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEG 231 (273)
T ss_dssp CCC-CCEEE-C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSC
T ss_pred cccCCCcce-ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhCC
Confidence 755433221 1223347889999999999999999999999999999998 8999975332 11112221111
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAI 586 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 586 (618)
. ..+........+.+++.+||+.||++|||+.||++.|++.
T Consensus 232 ~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 E---------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 0111122234677788899999999999999999998875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.5e-48 Score=384.18 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=200.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc----------CHHHHHHHHHHHhcCC-CCCccceeEEEEeC
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH----------SEKEFLSEINTLGSVR-HRNLVPLLGFCVAK 373 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 373 (618)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999995 5789999999865321 1245889999999997 99999999999999
Q ss_pred CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccC
Q 007088 374 KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFG 453 (618)
Q Consensus 374 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 453 (618)
+..|+||||+++|+|.+++.... ++++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999997543 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPR------TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVE 527 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~ 527 (618)
+++........ ....||+.|+|||++. ...++.++||||+||++|||++|+.||...... .
T Consensus 156 ~a~~~~~~~~~-----~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~--------~ 222 (277)
T d1phka_ 156 FSCQLDPGEKL-----REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------L 222 (277)
T ss_dssp TCEECCTTCCB-----CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------H
T ss_pred heeEccCCCce-----eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH--------H
Confidence 99887643221 2345899999999764 345788999999999999999999999764321 1
Q ss_pred HHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 528 WITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 528 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.......... ............++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 MLRMIMSGNY-------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHHHTCC-------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhCCC-------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111110 0011111223345677778999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=389.67 Aligned_cols=260 Identities=23% Similarity=0.358 Sum_probs=203.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEeC--------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCC
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLP--------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKK 374 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 374 (618)
++|++.+.||+|+||.||+|+.. ++..||||+++... ....++.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 57888999999999999999842 23579999997644 3346788999999888 8999999999999999
Q ss_pred eeEEEEeecCCCccccccCCCCC------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEH------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
..++||||+++|+|.+++..... ....+++.+++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999965532 124589999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELIT-GERPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~ellt-G~~Pf~~~~~~~~~ 521 (618)
.++.+||+|||+++......... ......+|+.|+|||.+.++.|+.++|||||||++|||++ |++||......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYK--KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTC--CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred CCCCeEeccchhhcccccccccc--ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---
Confidence 99999999999998765433221 1223458999999999999999999999999999999998 68887643211
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAE 588 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 588 (618)
.+.+ ....... ...+......+.+++.+||+.||.+|||+.||++.|+++.+
T Consensus 245 --~~~~---~i~~~~~----------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 --ELFK---LLKEGHR----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp --HHHH---HHHTTCC----------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHH---HHHcCCC----------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111 1111111 11111223457788889999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=392.15 Aligned_cols=252 Identities=18% Similarity=0.238 Sum_probs=196.9
Q ss_pred hccCCCCc-EEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcC-CCCCccceeEEEEe----CCeeE
Q 007088 305 TNSFSKNN-IIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSV-RHRNLVPLLGFCVA----KKERL 377 (618)
Q Consensus 305 ~~~y~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~ 377 (618)
.++|.+.+ .||+|+||.||+|+. .+++.||||+++.. +.+.+|++++.++ +|||||+++++|.+ ....|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 45788765 599999999999995 67899999999653 4577899987654 89999999999876 35689
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC---CCceEEcccCc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG---DFEPKLSDFGL 454 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~ 454 (618)
+|||||+||+|.+++..... ..+++.++..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 99999999999999976433 4699999999999999999999999 9999999999999985 56799999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
|+........ ....||+.|+|||++.+..|+.++|||||||++|||+||+.||......+.... ......
T Consensus 161 a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-----~~~~i~ 230 (335)
T d2ozaa1 161 AKETTSHNSL-----TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-----MKTRIR 230 (335)
T ss_dssp CEECCCCCCC-----CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCC
T ss_pred eeeccCCCcc-----ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----HHHHHh
Confidence 9876543322 234599999999999999999999999999999999999999976543221100 000000
Q ss_pred CCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .............++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 231 MGQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCS------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 00001111223456778888999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=389.87 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=208.5
Q ss_pred ccCCCCcEEeecCCeeEEEEEe------CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcC-CCCCccceeEEEEeCCee
Q 007088 306 NSFSKNNIIGTGRTGATYIAML------PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSV-RHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 376 (618)
++|+..+.||+|+||.||+|++ .+++.||||+++... ....++.+|+.+++++ +|||||++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5788899999999999999984 346799999997643 3445689999999999 699999999999999999
Q ss_pred EEEEeecCCCccccccCCCCC--------------CCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC
Q 007088 377 LLVYSYLENGTLYDKLHPAEH--------------EVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD 442 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 442 (618)
++||||+++|+|.+++..... ....+++..+..++.||++||+|||++ +++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 999999999999999865431 224689999999999999999999999 999999999999999
Q ss_pred CCCceEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCCCCcc
Q 007088 443 GDFEPKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITG-ERPTHLTNAPESF 521 (618)
Q Consensus 443 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG-~~Pf~~~~~~~~~ 521 (618)
.++.+|++|||.++......... ......||+.|+|||.+.+..++.++|||||||++|||+|+ .+||......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~--- 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--- 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSE--ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS---
T ss_pred ccCcccccccchheeccCCCcce--EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999998765433222 22334589999999999999999999999999999999995 4444433221
Q ss_pred ccCHHHHHHHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 522 KGSLVEWITLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 522 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
..+.+.+.. .............+.+|+.+||+.||++|||++||+++|+++..+
T Consensus 255 -~~~~~~i~~-------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 -SKFYKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -HHHHHHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHhc-------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 111122111 111111122335677888899999999999999999999987554
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.6e-47 Score=393.35 Aligned_cols=247 Identities=20% Similarity=0.225 Sum_probs=196.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc----cCHHHHH---HHHHHHhcCCCCCccceeEEEEeCCeeE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ----HSEKEFL---SEINTLGSVRHRNLVPLLGFCVAKKERL 377 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~~ 377 (618)
++|++.+.||+|+||.||+|+. .+|+.||||++.... .....+. +|+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999995 569999999986422 2233343 4477788889999999999999999999
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999997543 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
...... ....||+.|+|||++. +..++.++|||||||++|||+||+.||......+ ......... ..
T Consensus 157 ~~~~~~------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~-~~ 224 (364)
T d1omwa3 157 FSKKKP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTL-TM 224 (364)
T ss_dssp CSSSCC------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSS-SC
T ss_pred cCCCcc------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcc-cC
Confidence 654322 2235999999999886 4568999999999999999999999997644321 111111111 00
Q ss_pred ccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 537 SLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 537 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
. . ..+.....++.+++.+||+.||++||| ++|+++
T Consensus 225 ~------~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 A------V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp C------C----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C------C----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 0 0 001112235667777999999999999 677764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-47 Score=393.20 Aligned_cols=243 Identities=18% Similarity=0.212 Sum_probs=201.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVY 380 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 380 (618)
++|++.+.||+|+||.||+|+. .+|+.||||++... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999995 57999999998642 244567899999999999999999999999999999999
Q ss_pred eecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCC
Q 007088 381 SYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 381 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 460 (618)
||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+|||++.++++||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 9999999999987553 499999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccch
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLET 540 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 540 (618)
.. ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+. ............
T Consensus 194 ~~-------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~--- 255 (350)
T d1rdqe_ 194 RT-------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKV--- 255 (350)
T ss_dssp CB-------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC---
T ss_pred cc-------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCCC---
Confidence 22 123489999999999999999999999999999999999999975321 111111111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 007088 541 AIDKSLLGNGFDGELHQFLRVACNCVLPTPKERH-----TMFEVYQ 581 (618)
Q Consensus 541 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 581 (618)
. .+.....++.+++.+||+.||.+|+ |++|+++
T Consensus 256 ----~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 ----R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----C----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0 0111234566777799999999994 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=390.09 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=199.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccC----ccCHHHHHHHHHHHh-cCCCCCccceeEEEEeCCeeEEE
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDS----QHSEKEFLSEINTLG-SVRHRNLVPLLGFCVAKKERLLV 379 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 379 (618)
++|++.+.||+|+||+||+|+. .+++.||||++++. ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5789999999999999999995 57899999999653 234456777777765 68999999999999999999999
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccC
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMN 459 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 459 (618)
|||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 99999999999997554 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCccc
Q 007088 460 PVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSSLE 539 (618)
Q Consensus 460 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~~~ 539 (618)
...... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.. +.........
T Consensus 155 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~--- 219 (320)
T d1xjda_ 155 LGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDN--- 219 (320)
T ss_dssp CTTCCB----CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC---
T ss_pred cccccc----cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCC---
Confidence 433222 2345999999999999999999999999999999999999999754321 1111111111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 007088 540 TAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMF-EVY 580 (618)
Q Consensus 540 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 580 (618)
+.. +......+.+++.+||+.||++||++. |++
T Consensus 220 ----~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 220 ----PFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp ----CCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 001 111224566777799999999999995 674
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=380.12 Aligned_cols=257 Identities=23% Similarity=0.276 Sum_probs=192.9
Q ss_pred CCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccC------HHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 310 KNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHS------EKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 310 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
..++||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999995 56899999999653321 24588999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
++++++..+.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9998877766543 3488899999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC--Cccc
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN--SSLE 539 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~--~~~~ 539 (618)
... ....||+.|+|||++.+ ..++.++||||+||++|||++|++||......+ .+.......... ....
T Consensus 155 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 155 RAY----THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp CCC----CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTTSS
T ss_pred ccc----cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH----HHHHHHHhcCCCChhhcc
Confidence 221 23458999999998764 457999999999999999999999997543211 111111111000 0000
Q ss_pred hh------cc-ccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 540 TA------ID-KSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 540 ~~------~d-~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .. ....... .......+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00 00 0000000 0112346778888999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=386.06 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=209.4
Q ss_pred hccCCCCcEEeecCCeeEEEEEeC------CCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCee
Q 007088 305 TNSFSKNNIIGTGRTGATYIAMLP------GGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKER 376 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 376 (618)
.++|+..+.||+|+||.||+|.+. +++.||||+++... .....|.+|++++++++||||+++++++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 367888999999999999999853 35789999997643 3335689999999999999999999999999999
Q ss_pred EEEEeecCCCccccccCCCC------CCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEc
Q 007088 377 LLVYSYLENGTLYDKLHPAE------HEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLS 450 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 450 (618)
++||||+++|+|.+++.... .....+++..+.+++.|+++||.|||++ +|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999886432 1124579999999999999999999999 99999999999999999999999
Q ss_pred ccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCCCCccccCHHHHH
Q 007088 451 DFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGE-RPTHLTNAPESFKGSLVEWI 529 (618)
Q Consensus 451 DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~-~Pf~~~~~~~~~~~~l~~~~ 529 (618)
|||+|+........ .......||+.|+|||.+.+..++.++||||||+++|||+||. .||... ...+..
T Consensus 176 DFGla~~~~~~~~~--~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------~~~~~~ 245 (308)
T d1p4oa_ 176 DFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------SNEQVL 245 (308)
T ss_dssp CTTCCCGGGGGGCE--EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------CHHHHH
T ss_pred ecccceeccCCcce--eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------CHHHHH
Confidence 99999876543322 1122345899999999999999999999999999999999985 556432 222333
Q ss_pred HHHhcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhh
Q 007088 530 TLLNTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAER 589 (618)
Q Consensus 530 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 589 (618)
........ . ..+......+.+++.+||+.||++|||++||++.|++..+.
T Consensus 246 ~~i~~~~~-~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 246 RFVMEGGL-L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHTTCC-C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHhCCC-C---------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 32222111 0 11122234677888899999999999999999999887553
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=376.90 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=196.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ...+++.+|++++++++|||||++++++.++++.|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999995 679999999996543 234678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
|+.++ +.+++..... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.|+.....
T Consensus 82 ~~~~~-~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99764 4444432222 4599999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCcccccccCCCCcccccCCCCCCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC-Ccc-
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLV-ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN-SSL- 538 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~-~~~- 538 (618)
.... ....||+.|+|||...... ++.++||||+||++|||++|+.||...+..+ .+.......... ...
T Consensus 156 ~~~~----~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 156 VRTY----THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp SBCT----TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTS
T ss_pred cccc----eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH----HHHHHHHhcCCCchhhc
Confidence 3222 2334899999999876655 5789999999999999999999997543211 111111111000 000
Q ss_pred chhc---c--cc---ccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 ETAI---D--KS---LLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 ~~~~---d--~~---l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... + .. ..... ......++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000 0 00 00000 0112245677888999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-46 Score=377.85 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=198.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEee
Q 007088 306 NSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYSY 382 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 382 (618)
++|++.++||+|+||+||+|+..+|+.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5799999999999999999999899999999996532 3357899999999999999999999999999999999999
Q ss_pred cCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCCC
Q 007088 383 LENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPVD 462 (618)
Q Consensus 383 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~ 462 (618)
+.++.+..+.... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9887777776544 3499999999999999999999999 99999999999999999999999999998765433
Q ss_pred CcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC--Ccc-
Q 007088 463 THLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN--SSL- 538 (618)
Q Consensus 463 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~--~~~- 538 (618)
... ....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.......... ...
T Consensus 155 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 155 RKY----THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRILGTPNSKNWP 226 (286)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTST
T ss_pred ccc----ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH----HHHHHHHhhCCCChhhcc
Confidence 222 12347899999998765 456899999999999999999999997543211 111111110000 000
Q ss_pred --chh--ccccc-------cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 539 --ETA--IDKSL-------LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 539 --~~~--~d~~l-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... .+... ...........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000 00001112345677788999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=371.94 Aligned_cols=238 Identities=20% Similarity=0.296 Sum_probs=191.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc-------cCHHHHHHHHHHHhcCC--CCCccceeEEEEeCCe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ-------HSEKEFLSEINTLGSVR--HRNLVPLLGFCVAKKE 375 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 375 (618)
++|++.++||+|+||.||+|+. .+|+.||||+++... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999995 578999999986432 11234678999999986 8999999999999999
Q ss_pred eEEEEeecCC-CccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-CCceEEcccC
Q 007088 376 RLLVYSYLEN-GTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-DFEPKLSDFG 453 (618)
Q Consensus 376 ~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 453 (618)
.++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 5777777544 3499999999999999999999999 9999999999999985 4799999999
Q ss_pred cccccCCCCCcccccccCCCCcccccCCCCCCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHH
Q 007088 454 LARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVA-TPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLL 532 (618)
Q Consensus 454 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~ 532 (618)
+|+....... ....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... +. .
T Consensus 157 ~a~~~~~~~~------~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i---~ 217 (273)
T d1xwsa_ 157 SGALLKDTVY------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI---I 217 (273)
T ss_dssp TCEECCSSCB------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HH---H
T ss_pred cceecccccc------cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HH---h
Confidence 9987543221 23459999999999887665 567999999999999999999996421 00 0
Q ss_pred hcCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 533 NTNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 533 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... +. ...+ .++.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~--------~~-~~~s---~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 218 RGQVF--------FR-QRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HCCCC--------CS-SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcccC--------CC-CCCC---HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00000 11 1122 34666777999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=376.96 Aligned_cols=262 Identities=20% Similarity=0.259 Sum_probs=192.7
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CC-CcEEEEEEeccCc---cCHHHHHHHHHHHhcC---CCCCccceeEEEEe----
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PG-GCFIMIKRLEDSQ---HSEKEFLSEINTLGSV---RHRNLVPLLGFCVA---- 372 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 372 (618)
.++|++.++||+|+||+||+|+. .+ ++.||||+++... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999995 34 6789999986422 2223456777776655 89999999999864
Q ss_pred -CCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcc
Q 007088 373 -KKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSD 451 (618)
Q Consensus 373 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 451 (618)
....+++|||++++++........ ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 246789999999877654443322 4589999999999999999999999 999999999999999999999999
Q ss_pred cCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 452 FGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 452 fG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+ .+......
T Consensus 160 fg~~~~~~~~~-----~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~----~~~~i~~~ 230 (305)
T d1blxa_ 160 FGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDV 230 (305)
T ss_dssp CCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred hhhhhhhcccc-----cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH----HHHHHHHh
Confidence 99987654322 2234559999999999999999999999999999999999999997643211 11111111
Q ss_pred HhcCCc--------cchhccccc----cCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 532 LNTNSS--------LETAIDKSL----LGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 532 ~~~~~~--------~~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
...... ......... ...........+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 100000 000000000 00001112245667777999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.9e-44 Score=363.96 Aligned_cols=277 Identities=14% Similarity=0.114 Sum_probs=217.7
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCC-CCccceeEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRH-RNLVPLLGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~ 383 (618)
++|++.++||+|+||.||+|+. .+|+.||||++.... ..+.+.+|++.++.++| +|++.+++++......++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 5799999999999999999995 578999999886532 23457789999999965 89999999999999999999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCC-----CCceEEcccCccccc
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDG-----DFEPKLSDFGLARLM 458 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~a~~~ 458 (618)
+|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+..
T Consensus 84 -~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 84 -GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp -CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred -CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 679999886544 3589999999999999999999999 9999999999999974 578999999999876
Q ss_pred CCCCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcC
Q 007088 459 NPVDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTN 535 (618)
Q Consensus 459 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~ 535 (618)
........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......... .......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-~~~~i~~~~~-~ 234 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQ-S 234 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHH-H
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-HHHHHHhccC-C
Confidence 54322111 11223469999999999999999999999999999999999999997644322110 1111110000 0
Q ss_pred CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCC
Q 007088 536 SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLP 601 (618)
Q Consensus 536 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 601 (618)
.... .+... .+.++.+++..|++.+|++||+++.+.+.|+++.++.....++.+||.
T Consensus 235 ~~~~-----~l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 235 TPLR-----ELCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp SCHH-----HHTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred CChH-----HhcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 0000 11111 124567777799999999999999999999999999999999888885
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-44 Score=365.57 Aligned_cols=277 Identities=18% Similarity=0.172 Sum_probs=208.3
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccce-eEEEEeCCeeEEEEeec
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPL-LGFCVAKKERLLVYSYL 383 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lV~e~~ 383 (618)
++|++.+.||+|+||.||+|+. .+|+.||||++.... ..+++..|++++++++|+|++.. .+++.+.+..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 5799999999999999999995 568999999886543 23457899999999987765554 55567778889999999
Q ss_pred CCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeC---CCCceEEcccCcccccCC
Q 007088 384 ENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLD---GDFEPKLSDFGLARLMNP 460 (618)
Q Consensus 384 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~a~~~~~ 460 (618)
. |++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+....
T Consensus 86 ~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 86 G-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-Cchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 5 46666554333 3599999999999999999999999 999999999999985 455799999999998754
Q ss_pred CCCccc---ccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc
Q 007088 461 VDTHLS---TFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS 537 (618)
Q Consensus 461 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~ 537 (618)
...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......... ....+........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMSTP- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSC-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHHhhcccCCCC-
Confidence 332211 12233469999999999999999999999999999999999999998654432211 1111111111100
Q ss_pred cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCcccCC
Q 007088 538 LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQLLRAIAERYHFTTDDEIMLP 601 (618)
Q Consensus 538 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 601 (618)
. +.+. ...+.++.+++.+|++.||++||+++++.+.|+.+..+-....++.++|.
T Consensus 237 ~-----~~~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 237 I-----EVLC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp H-----HHHT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred h-----hHhc----cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 0 0000 11224567777799999999999999999999999887777777777764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-44 Score=363.92 Aligned_cols=266 Identities=20% Similarity=0.229 Sum_probs=194.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeC-------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------- 373 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 373 (618)
.++|++.++||+|+||+||+|+. .+|+.||||++.... ...+++.+|+++|++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999995 579999999985432 3456788999999999999999999998653
Q ss_pred -CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEccc
Q 007088 374 -KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDF 452 (618)
Q Consensus 374 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 452 (618)
+..++||||++++.+....... ..++...++.++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 4578999999887776554433 3489999999999999999999999 9999999999999999999999999
Q ss_pred CcccccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHH
Q 007088 453 GLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITL 531 (618)
Q Consensus 453 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~ 531 (618)
|+++.................||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... .+......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~i~~~ 237 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQL 237 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHHHHHHh
Confidence 99987664433333333345699999999988754 68999999999999999999999997533211 11111111
Q ss_pred HhcC-Cccchhcc---------ccccCC-CCHH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 532 LNTN-SSLETAID---------KSLLGN-GFDG------ELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 532 ~~~~-~~~~~~~d---------~~l~~~-~~~~------~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.... .......+ ...... ...+ ....+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1000 00000000 000000 0111 1235567888999999999999999974
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-44 Score=360.18 Aligned_cols=261 Identities=22% Similarity=0.242 Sum_probs=200.6
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc---cCHHHHHHHHHHHhcCCCCCccceeEEEEeCCeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ---HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 381 (618)
++|++.+.||+|+||+||+|+. .+++.||||+++... ...+++.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 678999999986533 335678999999999999999999999999999999999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccccCCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARLMNPV 461 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 461 (618)
++.+++|..++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988876553 489999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCcccccccCCCCcccccCCCCCCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCCc---
Q 007088 462 DTHLSTFVNGEFGDLGYVAPEYPRTLV-ATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNSS--- 537 (618)
Q Consensus 462 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~~--- 537 (618)
..... ...++..|+|||.+.+.. ++.++||||+||++|||++|+.||........ .+.. +........
T Consensus 155 ~~~~~----~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~---~~~~-~~~~~~~~~~~~ 226 (292)
T d1unla_ 155 VRCYS----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKR-IFRLLGTPTEEQ 226 (292)
T ss_dssp CSCCC----SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHH-HHHHHCCCCTTT
T ss_pred Cccce----eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH---HHHH-HHhhcCCCChhh
Confidence 32221 223678899999887655 68999999999999999999999865332111 1111 111111000
Q ss_pred c---chhcc--------cc-ccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 538 L---ETAID--------KS-LLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 538 ~---~~~~d--------~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
. ....+ .. -...........+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 00 000011122345667778999999999999999865
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=366.15 Aligned_cols=263 Identities=21% Similarity=0.264 Sum_probs=193.9
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCc--cCHHHHHHHHHHHhcCCCCCccceeEEEEeCC----eeE
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQ--HSEKEFLSEINTLGSVRHRNLVPLLGFCVAKK----ERL 377 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 377 (618)
+.+|++.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999984 689999999997543 33467889999999999999999999997653 235
Q ss_pred EEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 378 LVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 378 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 556677799999998643 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCcccccccCCCCcccccCCCCCC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhcCC
Q 007088 458 MNPVDTHLSTFVNGEFGDLGYVAPEYPR-TLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNTNS 536 (618)
Q Consensus 458 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~~~ 536 (618)
........ .......||+.|+|||.+. +..++.++||||+||++|||++|+.||......+. ....... ....
T Consensus 159 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~----~~~~~~~-~~~~ 232 (345)
T d1pmea_ 159 ADPDHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ----LNHILGI-LGSP 232 (345)
T ss_dssp CCGGGCBC-CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHH-HCSC
T ss_pred ccCCCccc-eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH----HHHHhhh-ccCC
Confidence 65432221 1223456899999999875 45678999999999999999999999976432110 0000000 0000
Q ss_pred ccc-----------hhc--cccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 537 SLE-----------TAI--DKSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 537 ~~~-----------~~~--d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
... ... .+...... ......++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000 00000000 0011235677888999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=372.37 Aligned_cols=259 Identities=25% Similarity=0.248 Sum_probs=189.7
Q ss_pred cCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCccceeEEEEeC------CeeEEE
Q 007088 307 SFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNLVPLLGFCVAK------KERLLV 379 (618)
Q Consensus 307 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~lV 379 (618)
+|+..++||+|+||+||+|+. .+|+.||||++...... ..+|++++++++||||+++++++... .+.++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 578889999999999999996 56999999999764422 34799999999999999999998653 246899
Q ss_pred EeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccCccccc
Q 007088 380 YSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLM 458 (618)
Q Consensus 380 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~ 458 (618)
|||++++.+..+.. .......+++..++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 98 ~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99998754333322 111224699999999999999999999999 999999999999999775 8999999999876
Q ss_pred CCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHH-------
Q 007088 459 NPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWIT------- 530 (618)
Q Consensus 459 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~------- 530 (618)
...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.....
T Consensus 174 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~----~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 174 VRGEPN-----VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLGTPTR 244 (350)
T ss_dssp CTTSCC-----CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHCCCCH
T ss_pred cCCccc-----ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH----HHHHHHHHhCCChH
Confidence 543322 22358999999998664 578999999999999999999999997643211 1111111
Q ss_pred ----HHhcC---CccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 531 ----LLNTN---SSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 531 ----~~~~~---~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..... ..........+..........++.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10000 0000000000000001122345677778999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.6e-43 Score=361.00 Aligned_cols=259 Identities=16% Similarity=0.213 Sum_probs=195.4
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeC--CeeEEEEe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAK--KERLLVYS 381 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 381 (618)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 5799999999999999999995 67999999999754 3567899999999995 99999999999754 46899999
Q ss_pred ecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCC-ceEEcccCcccccCC
Q 007088 382 YLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDF-EPKLSDFGLARLMNP 460 (618)
Q Consensus 382 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~ 460 (618)
|+++|+|.++. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999998764 2489999999999999999999999 999999999999998655 699999999987654
Q ss_pred CCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHH---------HHHH
Q 007088 461 VDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLV---------EWIT 530 (618)
Q Consensus 461 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~---------~~~~ 530 (618)
.... ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||............+. .+..
T Consensus 183 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 183 GQEY-----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp TCCC-----CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred CCcc-----cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 3321 233489999999987765 479999999999999999999999976443111000000 0111
Q ss_pred HHhcCCc--cchhcc--------ccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 531 LLNTNSS--LETAID--------KSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 531 ~~~~~~~--~~~~~d--------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
....... ...... .............++.+|+.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1000000 000000 00001111122345777888999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=362.72 Aligned_cols=251 Identities=23% Similarity=0.269 Sum_probs=197.9
Q ss_pred ccCCCCcEEeecCCeeEEEEEe----CCCcEEEEEEeccCc-----cCHHHHHHHHHHHhcCCC-CCccceeEEEEeCCe
Q 007088 306 NSFSKNNIIGTGRTGATYIAML----PGGCFIMIKRLEDSQ-----HSEKEFLSEINTLGSVRH-RNLVPLLGFCVAKKE 375 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 375 (618)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999984 247899999986432 344568899999999976 899999999999999
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.++||||+.+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 999999999999999987654 378899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL--VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
+......... .....|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+... .......
T Consensus 177 ~~~~~~~~~~---~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~----~i~~~~~ 249 (322)
T d1vzoa_ 177 KEFVADETER---AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA----EISRRIL 249 (322)
T ss_dssp EECCGGGGGG---GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH----HHHHHHH
T ss_pred hhhccccccc---ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHHhcc
Confidence 8765432221 2233489999999988654 46889999999999999999999998765432221 1111111
Q ss_pred cCCccchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 007088 534 TNSSLETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHT-----MFEVYQ 581 (618)
Q Consensus 534 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 581 (618)
... . ..+.....++.+++.+||+.||++||| ++|+++
T Consensus 250 ~~~-------~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 KSE-------P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HCC-------C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCC-------C----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 110 0 011123346667777999999999994 778754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=362.16 Aligned_cols=256 Identities=22% Similarity=0.281 Sum_probs=189.0
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeCC------
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAKK------ 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 374 (618)
.++|++.++||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45799999999999999999995 5699999999975432 3456889999999999999999999997654
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
+.|+||||+ +++|..++.. ..+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 469999999 5577776643 3499999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHh
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRT-LVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLN 533 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~ 533 (618)
|+...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+... .+........
T Consensus 168 a~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~----~~~~~~~~~~ 236 (346)
T d1cm8a_ 168 ARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTG 236 (346)
T ss_dssp CEECCSSC-------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHC
T ss_pred eeccCCcc-------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH----HHHHHHhccC
Confidence 98765422 23448999999998765 456899999999999999999999997643211 1111111000
Q ss_pred cC-------Cc----------cchhccccccCCCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 534 TN-------SS----------LETAIDKSLLGNGFDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 534 ~~-------~~----------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. .. ..+.....+ ..........+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCcHHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 00 000000000 0001112235667788999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=357.30 Aligned_cols=262 Identities=19% Similarity=0.232 Sum_probs=188.8
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeC------C
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAK------K 374 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 374 (618)
.++|++.++||+|+||+||+|.. .+|+.||||+++.... ..+++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36799999999999999999995 4699999999976432 335688999999999999999999999643 5
Q ss_pred eeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCc
Q 007088 375 ERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGL 454 (618)
Q Consensus 375 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 454 (618)
+.|+||||+.++.+. .+. ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~l~~-~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDANLCQ-VIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEEHHH-HHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchHHHH-hhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 789999999775544 443 2489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCH---------
Q 007088 455 ARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSL--------- 525 (618)
Q Consensus 455 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l--------- 525 (618)
++....... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||...+........+
T Consensus 166 ~~~~~~~~~-----~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 166 ARTAGTSFM-----MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhccccccc-----cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 886554322 123348999999999999999999999999999999999999997543211000000
Q ss_pred ------HHHHHHHhcCCc-----cchhccccccCCC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 526 ------VEWITLLNTNSS-----LETAIDKSLLGNG---FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 526 ------~~~~~~~~~~~~-----~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
..+......... ............. .......+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 0001111111111 1234567888999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-42 Score=353.25 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=191.3
Q ss_pred hccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCcc---CHHHHHHHHHHHhcCCCCCccceeEEEEeC-----Ce
Q 007088 305 TNSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQH---SEKEFLSEINTLGSVRHRNLVPLLGFCVAK-----KE 375 (618)
Q Consensus 305 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 375 (618)
.++|++.++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56799999999999999999994 6799999999976432 345688999999999999999999998643 33
Q ss_pred eEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEEcccCcc
Q 007088 376 RLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKLSDFGLA 455 (618)
Q Consensus 376 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 455 (618)
.+++++|+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 46777888899999998643 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCcccccccCCCCcccccCCCCCCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCCCCccccCHHHHHHHHhc
Q 007088 456 RLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTL-VATPKGDVYSFGVVLLELITGERPTHLTNAPESFKGSLVEWITLLNT 534 (618)
Q Consensus 456 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~~l~~~~~~~~~ 534 (618)
...... .....||+.|+|||...+. .++.++||||+||++|+|++|+.||...+.... ..........
T Consensus 169 ~~~~~~-------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~----~~~i~~~~~~ 237 (348)
T d2gfsa1 169 RHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ----LKLILRLVGT 237 (348)
T ss_dssp -CCTGG-------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCC
T ss_pred cccCcc-------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcCC
Confidence 765322 2234589999999986654 468999999999999999999999976432111 0000000000
Q ss_pred CC-------c---cchhcc--ccccCCC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 007088 535 NS-------S---LETAID--KSLLGNG----FDGELHQFLRVACNCVLPTPKERHTMFEVYQ 581 (618)
Q Consensus 535 ~~-------~---~~~~~d--~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 581 (618)
.. . ...... ....... .......+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00 0 000000 0000000 0112245677888999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-38 Score=329.39 Aligned_cols=265 Identities=18% Similarity=0.156 Sum_probs=190.2
Q ss_pred ccCCCCcEEeecCCeeEEEEEe-CCCcEEEEEEeccCccCHHHHHHHHHHHhcCC-----------CCCccceeEEEEeC
Q 007088 306 NSFSKNNIIGTGRTGATYIAML-PGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR-----------HRNLVPLLGFCVAK 373 (618)
Q Consensus 306 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 373 (618)
++|++.++||+|+||+||+|+. .+|+.||||+++......+.+.+|+.++++++ |+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 3599999999999999999995 67999999999877655677888999888775 57899999988653
Q ss_pred --CeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCeeeCCCCc----
Q 007088 374 --KERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHH-NCNPRIIHRNISSKCILLDGDFE---- 446 (618)
Q Consensus 374 --~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~---- 446 (618)
...+++|+++..+......... .....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence 4566777776554432222111 112458899999999999999999998 6 8999999999999986653
Q ss_pred --eEEcccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCCCCcccc-
Q 007088 447 --PKLSDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVLLELITGERPTHLTNAPESFKG- 523 (618)
Q Consensus 447 --~kl~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil~elltG~~Pf~~~~~~~~~~~- 523 (618)
++++|||.+....... ....||+.|+|||++.+..++.++||||+||+++||++|+.||...........
T Consensus 169 ~~~kl~dfg~s~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EEEEECCCTTCEETTBCC-------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred ceeeEeeccccccccccc-------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 9999999997654321 233489999999999999999999999999999999999999975433211110
Q ss_pred -CHHHHHHHHhc--------CCccchhcc---------c----------cccCCCCHHHHHHHHHHHhhccCCCCCCCCC
Q 007088 524 -SLVEWITLLNT--------NSSLETAID---------K----------SLLGNGFDGELHQFLRVACNCVLPTPKERHT 575 (618)
Q Consensus 524 -~l~~~~~~~~~--------~~~~~~~~d---------~----------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 575 (618)
.+......... ........+ . .............+.+++.+||+.||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111111100 000000000 0 0012234566788999999999999999999
Q ss_pred HHHHHH
Q 007088 576 MFEVYQ 581 (618)
Q Consensus 576 ~~evl~ 581 (618)
++|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999864
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2.1e-30 Score=263.39 Aligned_cols=186 Identities=33% Similarity=0.530 Sum_probs=153.8
Q ss_pred cCCcchHHHHHHHHHhccCCCCccccCccCCCCCCCCCC--cccceecCCC-CCCcEEEEEecCCccee--eCCcCCCCC
Q 007088 31 LATLNDIECLKSVKNSLEDPFNYLTTSWNFNNNTEGFIC--QFTGVDCWHP-DENKVLNIRLSDMGLKG--QFPRGIERC 105 (618)
Q Consensus 31 ~~~~~~~~~L~~~k~~~~~~~~~l~~~W~~~~~~~~~~c--~w~gv~c~~~-~~~~v~~l~l~~~~l~g--~~p~~~~~l 105 (618)
.|.++|++||++||+++.||. .+. +|..+ ++|| .|.||+|+.. ...||+.|+|++++++| .+|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~-sW~~~----~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L 75 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLS-SWLPT----TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANL 75 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGT-TCCTT----SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGC
T ss_pred CCCHHHHHHHHHHHHHCCCCC-cCC-CCCCC----CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcC
Confidence 589999999999999999885 454 89743 4588 5999999753 24589999999999998 689999999
Q ss_pred CCCCeEEccC-CcCccccCchhhhcCCCCCEEEeeCCCCccc--------------------------------------
Q 007088 106 TSLTGLDLSS-NNLSGSIPSDISSRLQYVTSLDLSSNSLSGE-------------------------------------- 146 (618)
Q Consensus 106 ~~L~~L~l~~-n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~-------------------------------------- 146 (618)
++|++|+|++ |+|+|.||.+++. |++|++|+|++|++.|.
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~~i~~-L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp TTCSEEEEEEETTEESCCCGGGGG-CTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred cccccccccccccccccccccccc-ccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 9999999997 8999999999875 77777777776555432
Q ss_pred ----------CCC-------------------------------------------------------------------
Q 007088 147 ----------IPS------------------------------------------------------------------- 149 (618)
Q Consensus 147 ----------ip~------------------------------------------------------------------- 149 (618)
+|.
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred eccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 221
Q ss_pred ----CCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCCCCCCCCCCCCC
Q 007088 150 ----GLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNSGLCGKPLNPCP 223 (618)
Q Consensus 150 ----~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~~~c~~~~~~C~ 223 (618)
+++.+++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.||.+..+ ++..+++.+|+.+||.|.++|.
T Consensus 235 ~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp CBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred ccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 1222334778899999999999999999999999999999999999986543 6788899999999999998883
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=4.3e-24 Score=200.11 Aligned_cols=168 Identities=12% Similarity=0.096 Sum_probs=121.0
Q ss_pred CCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCcc-------------------CHHHHHHHHHHHhcCCCCCccceeEE
Q 007088 309 SKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQH-------------------SEKEFLSEINTLGSVRHRNLVPLLGF 369 (618)
Q Consensus 309 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~~~ 369 (618)
.+.++||+|+||.||+|+..+|+.||||+++.... .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999988999999998753210 01234568889999999999988766
Q ss_pred EEeCCeeEEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCeeeCCCCceEE
Q 007088 370 CVAKKERLLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNCNPRIIHRNISSKCILLDGDFEPKL 449 (618)
Q Consensus 370 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 449 (618)
. ..+++|||++++.+.+ ++......++.|++.+++|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2379999998765543 23334567999999999999999 99999999999999965 5899
Q ss_pred cccCcccccCCCCCcccccccCCCCcccccCCCCCCCCCCCCccchHHHHHHH
Q 007088 450 SDFGLARLMNPVDTHLSTFVNGEFGDLGYVAPEYPRTLVATPKGDVYSFGVVL 502 (618)
Q Consensus 450 ~DfG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDVwS~Gvil 502 (618)
+|||.|........... ... .... -.|.+ .+.|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~~~--l~r---d~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREI--LER---DVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHH--HHH---HHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHH--HHH---HHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 99999987653321110 000 0000 00111 35678899999976444
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=2.3e-17 Score=153.76 Aligned_cols=136 Identities=26% Similarity=0.374 Sum_probs=98.7
Q ss_pred CCCCCcccceecCCCCCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCc
Q 007088 65 EGFICQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLS 144 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~ 144 (618)
.+|-|+|..|.|+ +++|+ .||..|. +++++|+|++|+|++.++...+.++++|+.|+|++|++.
T Consensus 4 ~~C~C~~~~v~Cs-------------~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~ 67 (192)
T d1w8aa_ 4 AMCHCEGTTVDCT-------------GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67 (192)
T ss_dssp TTSEEETTEEECT-------------TSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC
T ss_pred CCCEEcCCEEEEe-------------CCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc
Confidence 3455777777774 45666 6776663 677888888888876676666556888888888888888
Q ss_pred ccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCCCCCC
Q 007088 145 GEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNSGLCG 216 (618)
Q Consensus 145 g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~~~c~ 216 (618)
+..+..+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..+. .++..+++++|++.|.
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence 77777777888888888888888866666777888888888888888877775432 1566777788877664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.56 E-value=6.3e-15 Score=136.97 Aligned_cols=115 Identities=21% Similarity=0.248 Sum_probs=100.3
Q ss_pred CCcEEEEEecCCcceeeCC-cCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcE
Q 007088 81 ENKVLNIRLSDMGLKGQFP-RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNV 159 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p-~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~ 159 (618)
+..++.|+|++|.|++.++ ..+.++++|+.|+|++|++.+..+..+ ..+++|++|+|++|++++..|..|.++++|++
T Consensus 28 p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~-~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~ 106 (192)
T d1w8aa_ 28 PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF-EGASHIQELQLGENKIKEISNKMFLGLHQLKT 106 (192)
T ss_dssp CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT-TTCTTCCEEECCSCCCCEECSSSSTTCTTCCE
T ss_pred CCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc-ccccccceeeeccccccccCHHHHhCCCcccc
Confidence 3578899999999998665 557899999999999999996555555 45999999999999999655667899999999
Q ss_pred EEccCcccCCCCCccccccccccccccccccccCCCC
Q 007088 160 LKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 160 l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
|+|++|+|++..|..|..+++|++|+|++|.+....+
T Consensus 107 L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 107 LNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp EECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 9999999998778889999999999999999987654
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=7.8e-15 Score=125.79 Aligned_cols=103 Identities=28% Similarity=0.360 Sum_probs=91.1
Q ss_pred EEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCc
Q 007088 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNN 165 (618)
Q Consensus 86 ~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N 165 (618)
.|+|++|+++ .+| .+.++++|++|+|++|+|+ .+|+.+.. +++|+.|++++|+++ .+| .++++++|+.|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~-l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAA-LRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGG-CTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhh-hhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 5899999998 565 4999999999999999999 79988865 999999999999999 566 5999999999999999
Q ss_pred ccCCCC-CccccccccccccccccccccCC
Q 007088 166 RFTGKI-PPQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 166 ~l~g~~-p~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
+++..- +..++.+++|+.|++++|.++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 998532 25688999999999999999864
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.52 E-value=4.4e-15 Score=149.19 Aligned_cols=110 Identities=27% Similarity=0.410 Sum_probs=99.4
Q ss_pred EEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccC
Q 007088 85 LNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN 164 (618)
Q Consensus 85 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~ 164 (618)
..++++++.+.|.+|..++.+++|+.|++++|.++|.+| +++. +++|+.|+|++|+|+|.||.+|++|++|++|+|++
T Consensus 200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~-~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGL-SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCC-CTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred ccccccccccccccccccccccccccccccccccccccc-cccc-ccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 357888888889999999999999999999999998776 4554 89999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccccccccc-ccCC-CCC
Q 007088 165 NRFTGKIPPQLGLLNRIKTFSVASNL-LTGP-VPS 197 (618)
Q Consensus 165 N~l~g~~p~~l~~~~~L~~l~l~~N~-l~g~-ip~ 197 (618)
|+|+|.||. ++++++|+.+++++|+ ++|. +|+
T Consensus 278 N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp~ 311 (313)
T d1ogqa_ 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLPA 311 (313)
T ss_dssp SEEEEECCC-STTGGGSCGGGTCSSSEEESTTSSC
T ss_pred CcccccCCC-cccCCCCCHHHhCCCccccCCCCCC
Confidence 999999985 6899999999999997 7885 665
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=3.3e-14 Score=139.19 Aligned_cols=133 Identities=27% Similarity=0.257 Sum_probs=95.6
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|++++ ++..+.++++|+.|+|++|.+. .++...+..+.+|+.|++++|.+++..|..+..+++|+.|+
T Consensus 77 ~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccc-cccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccchhcc
Confidence 345556666665553 3445566666666666666665 34433334467777777777777754445567889999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCC-CCc-cccccccccCCCCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS-FAN-VNFTAEDFANNSGLCGK 217 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~-~~~-~~~~~~~~~~n~~~c~~ 217 (618)
+++|+|++..|..+..+++|+.|+|++|+|+ .+|. +.. ..+..++++|||+.|.+
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 9999999877788999999999999999999 6774 332 25778899999999964
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.9e-14 Score=140.97 Aligned_cols=134 Identities=22% Similarity=0.246 Sum_probs=117.8
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++.+..+..+..+.+|+.+++++|+|+ .||+..+..+++|+.|+|++|++++..|..+.++++|+.|+
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~ 183 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence 57899999999998777888899999999999999999 67766666699999999999999976677889999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCC-c-cccccccccCCCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA-N-VNFTAEDFANNSGLCG 216 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~-~-~~~~~~~~~~n~~~c~ 216 (618)
+++|++++..|..|..+++|++|++++|++++..|... . .++..+++++|++.|.
T Consensus 184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 99999999889999999999999999999999887432 2 2578889999999885
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=4.6e-13 Score=130.87 Aligned_cols=127 Identities=25% Similarity=0.252 Sum_probs=96.7
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.|+|++|+|++..+..|.++++|++|+|++|+|+ .+|.. . .+++|++|+|++|+++ .+|..+.++++|+.|+
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~-~-~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~ 106 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-G-TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD 106 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC-S-CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccccc-c-cccccccccccccccc-cccccccccccccccc
Confidence 46899999999999776678999999999999999998 78763 3 4999999999999999 4677888889999988
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
+++|++.+..+..+..+.+++.|++++|.+++..|.... ..+..+++++|.
T Consensus 107 l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 888888766566666666677777777766655543322 134445555553
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=1.3e-12 Score=116.37 Aligned_cols=99 Identities=15% Similarity=0.105 Sum_probs=80.1
Q ss_pred CCcceeeCCcCCCCCCCCCeEEccCC-cCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCC
Q 007088 91 DMGLKGQFPRGIERCTSLTGLDLSSN-NLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTG 169 (618)
Q Consensus 91 ~~~l~g~~p~~~~~l~~L~~L~l~~n-~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g 169 (618)
++++. .+|..+..+++|++|+|++| .++ .||...+.++++|+.|+|++|+|+..-|..|..+++|++|+|++|+|+
T Consensus 17 ~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~- 93 (156)
T d2ifga3 17 RDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE- 93 (156)
T ss_dssp SSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-
T ss_pred CCCCc-cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-
Confidence 44454 56788889999999999866 477 788776667999999999999999544666899999999999999999
Q ss_pred CCCcccccccccccccccccccc
Q 007088 170 KIPPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 170 ~~p~~l~~~~~L~~l~l~~N~l~ 192 (618)
.+|.......+|+.|+|++|.|.
T Consensus 94 ~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 94 SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccChhhhccccccccccCCCccc
Confidence 67666555557889999998874
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=6.8e-13 Score=130.91 Aligned_cols=115 Identities=20% Similarity=0.174 Sum_probs=104.1
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
...+..+++++|+|++..+..+..+++|+.|+|++|+|+ .+|+..+.++++|+.|++++|++++..|..|.++++|++|
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCccc-ccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 356889999999999766778999999999999999999 5666565669999999999999999889999999999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
|+++|++++..|..++.+++|++|++++|.+.+.-+
T Consensus 207 ~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999998888899999999999999999998654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=4.6e-13 Score=120.30 Aligned_cols=106 Identities=17% Similarity=0.217 Sum_probs=78.4
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCC-CcCCCCCcEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSG-LANCTFLNVL 160 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~-~~~l~~L~~l 160 (618)
.++..|+|++|+++ .||..+..+++|+.|||++|+++ .++. +. .+++|++|+|++|+++ .+|.. +..+++|+.|
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~-~~-~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FP-LLRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL 92 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECC-CC-CCSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCC-cc-cCcchhhhhccccccc-CCCccccccccccccc
Confidence 46778888888887 55666677888888888888888 6653 43 4888888888888888 45554 3568888888
Q ss_pred EccCcccCCCCC--ccccccccccccccccccccC
Q 007088 161 KLNNNRFTGKIP--PQLGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 161 ~l~~N~l~g~~p--~~l~~~~~L~~l~l~~N~l~g 193 (618)
+|++|+++. ++ ..+..+++|++|++++|.++.
T Consensus 93 ~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 93 ILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp ECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred eeccccccc-cccccccccccccchhhcCCCcccc
Confidence 888888873 44 356777888888888887754
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.31 E-value=1.4e-12 Score=111.39 Aligned_cols=99 Identities=25% Similarity=0.380 Sum_probs=83.9
Q ss_pred CeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccccccccccc
Q 007088 109 TGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVAS 188 (618)
Q Consensus 109 ~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~ 188 (618)
|.|||++|+++ .+|. +. .+++|++|+|++|+++ .+|+.++.+++|+.|++++|+|++ +| .++.+++|+.|++++
T Consensus 1 R~L~Ls~n~l~-~l~~-l~-~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LE-QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCCC-GG-GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCC-CCcc-cc-cCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCC
Confidence 68999999999 7875 65 4999999999999999 799999999999999999999994 66 489999999999999
Q ss_pred ccccCCCC--CCCcc-ccccccccCCCC
Q 007088 189 NLLTGPVP--SFANV-NFTAEDFANNSG 213 (618)
Q Consensus 189 N~l~g~ip--~~~~~-~~~~~~~~~n~~ 213 (618)
|+++...+ .+... ++..+++++|+.
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCcC
Confidence 99986432 22222 577788999974
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.28 E-value=6.6e-12 Score=124.94 Aligned_cols=146 Identities=20% Similarity=0.217 Sum_probs=94.6
Q ss_pred CCCCCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEE
Q 007088 65 EGFICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSL 136 (618)
Q Consensus 65 ~~~~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L 136 (618)
..|-|.|.+|.|.+.. +..++.|+|++|+|+...+.+|.++++|++|++++|.+....|..+ .++++|++|
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f-~~l~~L~~L 84 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF-APLVKLERL 84 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT-TTCTTCCEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhh-hCCCccCEe
Confidence 3456889999997531 3568889999999985444578888888888888888884334444 447777777
Q ss_pred EeeCCCCcccCCCCC------------------------------------------------cC---------------
Q 007088 137 DLSSNSLSGEIPSGL------------------------------------------------AN--------------- 153 (618)
Q Consensus 137 ~l~~N~l~g~ip~~~------------------------------------------------~~--------------- 153 (618)
+|++|+++ .+|..+ ..
T Consensus 85 ~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 85 YLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp ECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred cccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 77777665 333211 11
Q ss_pred ------CCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc--cccccccccCCC
Q 007088 154 ------CTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN--VNFTAEDFANNS 212 (618)
Q Consensus 154 ------l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~ 212 (618)
+++|+.|++++|.+++.+|..+..++.++.|++++|.+++..|.... .++..+++++|.
T Consensus 164 ~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~ 230 (305)
T d1xkua_ 164 TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230 (305)
T ss_dssp SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSC
T ss_pred ccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccc
Confidence 22345555555555555566666667777777777777776664332 145566666663
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=5.2e-12 Score=113.22 Aligned_cols=110 Identities=19% Similarity=0.167 Sum_probs=88.2
Q ss_pred cCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccc
Q 007088 100 RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLN 179 (618)
Q Consensus 100 ~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~ 179 (618)
+.+.++..|++|||++|+++ .||... ..+++|++|||++|+++ .++ .+..+++|++|+|++|+++...|..+..++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~-~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLG-ATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGG-GGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccc-cccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccc
Confidence 34668889999999999999 788644 45999999999999999 675 589999999999999999964444567899
Q ss_pred cccccccccccccCC--CCCCCc-cccccccccCCCC
Q 007088 180 RIKTFSVASNLLTGP--VPSFAN-VNFTAEDFANNSG 213 (618)
Q Consensus 180 ~L~~l~l~~N~l~g~--ip~~~~-~~~~~~~~~~n~~ 213 (618)
+|+.|++++|+++.. +..+.. .++..+++++|+.
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred ccccceeccccccccccccccccccccchhhcCCCcc
Confidence 999999999999753 222222 1567778888863
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.21 E-value=1.8e-11 Score=121.65 Aligned_cols=129 Identities=26% Similarity=0.352 Sum_probs=107.1
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
..++.+++++|+++ .+|..+ +++|+.|++++|..++..|..+.. ++.++.|++++|++++..|..+.++++|++|+
T Consensus 150 ~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~-~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~ 225 (305)
T d1xkua_ 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKG-LNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225 (305)
T ss_dssp TTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTT-CTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred cccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhc-cccccccccccccccccccccccccccceeee
Confidence 46788999999987 566654 689999999999999887777654 99999999999999987788899999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCC--------ccccccccccCCCCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFA--------NVNFTAEDFANNSGLC 215 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~--------~~~~~~~~~~~n~~~c 215 (618)
|++|+|+ .+|..+..+++|+.|+|++|+++..-.... ..++..+++++|++.+
T Consensus 226 L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 9999998 689999999999999999999985422211 1246677899998764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=2.2e-11 Score=108.34 Aligned_cols=113 Identities=12% Similarity=0.118 Sum_probs=93.9
Q ss_pred CCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCC-CcccCC-CCCcCCCCCcEEEccCcccCCCCCccccccc
Q 007088 102 IERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNS-LSGEIP-SGLANCTFLNVLKLNNNRFTGKIPPQLGLLN 179 (618)
Q Consensus 102 ~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~-l~g~ip-~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~ 179 (618)
...+...+.++.+++++. .+|..+.. +++|+.|+|++|+ ++ .|| ..|.++++|+.|+|++|+|+..-|.+|..++
T Consensus 4 ~C~c~~~~~l~c~~~~~~-~~p~~l~~-l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~ 80 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGAL-DSLHHLPG-AENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80 (156)
T ss_dssp SSCCSSSSCEECCSSCCC-TTTTTSCS-CSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS
T ss_pred CCCcCCCCeEEecCCCCc-cCcccccC-ccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccc
Confidence 345556678999999998 78888865 9999999998764 88 565 5699999999999999999977788899999
Q ss_pred cccccccccccccCCCCCCC-ccccccccccCCCCCCCC
Q 007088 180 RIKTFSVASNLLTGPVPSFA-NVNFTAEDFANNSGLCGK 217 (618)
Q Consensus 180 ~L~~l~l~~N~l~g~ip~~~-~~~~~~~~~~~n~~~c~~ 217 (618)
+|+.|+|++|+|+...+... ..++..+++++|++.|.+
T Consensus 81 ~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred cccceeccCCCCcccChhhhccccccccccCCCcccCCc
Confidence 99999999999996555433 346778999999998853
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.07 E-value=1.7e-10 Score=107.00 Aligned_cols=121 Identities=27% Similarity=0.404 Sum_probs=92.5
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|++++. ++ ++++++|++|++++|.+. .+|. +. ++++|+.|++++|.+.. + ..+..+++|+.|+
T Consensus 62 ~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~-~~~~-l~-~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~ 134 (199)
T d2omxa2 62 NNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP-LA-NLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GT-TCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEE
T ss_pred CCcCcCccccccccCc-cc-ccCCcccccccccccccc-cccc-cc-ccccccccccccccccc-c-cccchhhhhHHhh
Confidence 5788899999988864 33 888999999999999887 5664 44 48889999998888874 3 3477888899999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~ 212 (618)
+++|++.. +| .+..+++|+.|++++|++++..| +.. .++..+++++|.
T Consensus 135 l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~-l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 135 LSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKP-LANLTTLERLDISSNK 183 (199)
T ss_dssp CCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred hhhhhhcc-cc-cccccccccccccccccccCCcc-ccCCCCCCEEECCCCC
Confidence 99998873 44 57788889999999998887543 222 256777888874
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.03 E-value=2.6e-10 Score=106.72 Aligned_cols=121 Identities=26% Similarity=0.374 Sum_probs=90.9
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|+|++|.+++ ++ .+++|++|+.|+|++|+++ .+|. +.. +++|+.|++++|.+. .++ .+..++.|+.++
T Consensus 68 ~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~~-l~~-l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLSS-LKD-LKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGGG-GTT-CTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCEEeCCCccccC-cc-ccccCcccccccccccccc-cccc-ccc-ccccccccccccccc-ccc-cccccccccccc
Confidence 478889999998886 44 3678889999999999988 5774 544 888999999888887 343 577888888888
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCcc-ccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANV-NFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~-~~~~~~~~~n~ 212 (618)
+++|.+++ +..+..+++|+.+++++|++++..| +..+ ++..+++++|.
T Consensus 141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNH 189 (210)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred cccccccc--ccccccccccccccccccccccccc-ccCCCCCCEEECCCCC
Confidence 88888874 3456778888888888888886433 3222 56677777774
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.03 E-value=2.9e-10 Score=105.40 Aligned_cols=121 Identities=25% Similarity=0.445 Sum_probs=97.5
Q ss_pred CcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEE
Q 007088 82 NKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLK 161 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~ 161 (618)
.+++.|++++++++ .++ .+..|++|++|+|++|++++ +++ +.+ +++|++|++++|.+. .+| .+++++.|+.|+
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~-l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKN-LTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTT-CTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccC-Ccccccccccccccc-ccc-cccccccccccc
Confidence 46889999999988 454 48899999999999999995 554 554 999999999999998 566 489999999999
Q ss_pred ccCcccCCCCCccccccccccccccccccccCCCCCCCc-cccccccccCCC
Q 007088 162 LNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAEDFANNS 212 (618)
Q Consensus 162 l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~ 212 (618)
+++|.+... ..+..+++|+.|++++|+++. +|.+.. .++..+++.+|.
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc-ccccccccccccccccccc
Confidence 999999853 347889999999999999975 343322 255666777764
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.00 E-value=1.7e-12 Score=120.68 Aligned_cols=88 Identities=22% Similarity=0.297 Sum_probs=45.6
Q ss_pred cCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccc
Q 007088 100 RGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLN 179 (618)
Q Consensus 100 ~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~ 179 (618)
.++..|++|++|+|++|+++ .|+. +.. +++|+.|+|++|.++ .+|.....+++|+.|++++|+++. ++ .+..++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~~-l~~-l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~ 115 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KISS-LSG-MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV 115 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCCC-HHH-HTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHH
T ss_pred hHHhcccccceeECcccCCC-Cccc-ccC-CccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccc
Confidence 34555555555555555555 4442 333 555555555555555 444433444455555555555552 22 244555
Q ss_pred cccccccccccccC
Q 007088 180 RIKTFSVASNLLTG 193 (618)
Q Consensus 180 ~L~~l~l~~N~l~g 193 (618)
+|+.|++++|+++.
T Consensus 116 ~L~~L~L~~N~i~~ 129 (198)
T d1m9la_ 116 NLRVLYMSNNKITN 129 (198)
T ss_dssp HSSEEEESEEECCC
T ss_pred cccccccccchhcc
Confidence 55555555555543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.98 E-value=3.4e-10 Score=115.64 Aligned_cols=63 Identities=29% Similarity=0.365 Sum_probs=34.5
Q ss_pred CCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCC
Q 007088 130 LQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 130 l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
+++++.|+|++|++++ ++ .+..+++|+.|+|++|+|++ +| .++++++|+.|++++|++++.+|
T Consensus 306 ~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 306 LKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred hcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 4455555555555553 22 25555666666666666653 33 35556666666666666665444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.97 E-value=6.3e-10 Score=103.98 Aligned_cols=121 Identities=21% Similarity=0.280 Sum_probs=98.8
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
.++.|++++++++. ++ .+..+++|++|+|++|++++ +|+ +. ++++|++|+|++|+++ .+| .+.++++|+.|++
T Consensus 47 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~~-~~-~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IKP-LA-NLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSL 119 (210)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CGG-GT-TCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEEC
T ss_pred CccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-ccc-cc-cCcccccccccccccc-ccc-ccccccccccccc
Confidence 57889999999985 44 48899999999999999995 664 44 4999999999999999 466 5899999999999
Q ss_pred cCcccCCCCCccccccccccccccccccccCCCCCCCccccccccccCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFANVNFTAEDFANNS 212 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~ 212 (618)
++|.+. .+ +.+..+++|+.+++++|.+++..+...-.++..+++++|.
T Consensus 120 ~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp TTSCCC-CC-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSC
T ss_pred cccccc-cc-cccccccccccccccccccccccccccccccccccccccc
Confidence 999987 34 4588999999999999999875432211256777777774
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.92 E-value=1.1e-11 Score=115.10 Aligned_cols=110 Identities=20% Similarity=0.265 Sum_probs=93.9
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
-.+++.|+|++|+++ .++ .+..|++|+.|+|++|+++ .||..... +++|+.|++++|+++ .++ .+.++++|+.|
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~-~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L 120 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAV-ADTLEELWISYNQIA-SLS-GIEKLVNLRVL 120 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHH-HHHCCEEECSEEECC-CHH-HHHHHHHSSEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccc-ccccccccccccccc-ccc-ccccccccccc
Confidence 357899999999998 565 5999999999999999998 78865543 778999999999999 454 48899999999
Q ss_pred EccCcccCCCCC--ccccccccccccccccccccCCCCC
Q 007088 161 KLNNNRFTGKIP--PQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 161 ~l~~N~l~g~~p--~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
+|++|+++. ++ ..+..+++|+.|++++|.++...+.
T Consensus 121 ~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 121 YMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred ccccchhcc-ccccccccCCCccceeecCCCccccCccc
Confidence 999999984 44 4688999999999999998876654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.88 E-value=1.1e-09 Score=111.80 Aligned_cols=82 Identities=32% Similarity=0.404 Sum_probs=71.7
Q ss_pred CCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCcccccccc
Q 007088 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNR 180 (618)
Q Consensus 101 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~ 180 (618)
.+..+.+|+.|+|++|++++ +++ +. .+++|+.|+|++|++++ +| .+++|++|++|+|++|+|++..| +.++++
T Consensus 302 ~~~~~~~l~~L~ls~n~l~~-l~~-l~-~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~ 374 (384)
T d2omza2 302 PISNLKNLTYLTLYFNNISD-ISP-VS-SLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTR 374 (384)
T ss_dssp GGGGCTTCSEEECCSSCCSC-CGG-GG-GCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTT
T ss_pred ccchhcccCeEECCCCCCCC-Ccc-cc-cCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCC
Confidence 46778899999999999995 553 54 49999999999999994 55 69999999999999999997544 889999
Q ss_pred ccccccccc
Q 007088 181 IKTFSVASN 189 (618)
Q Consensus 181 L~~l~l~~N 189 (618)
|+.|+|++|
T Consensus 375 L~~L~L~~N 383 (384)
T d2omza2 375 ITQLGLNDQ 383 (384)
T ss_dssp CSEEECCCE
T ss_pred CCEeeCCCC
Confidence 999999998
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=2.5e-09 Score=101.97 Aligned_cols=101 Identities=18% Similarity=0.241 Sum_probs=54.2
Q ss_pred CCcccceecCCCC--------CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEee
Q 007088 68 ICQFTGVDCWHPD--------ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLS 139 (618)
Q Consensus 68 ~c~w~gv~c~~~~--------~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~ 139 (618)
-|.+..|.|.+.. +..++.|+|++|.++...+..|.++++|++|+|++|.+...+|...+.++++++.|++.
T Consensus 7 ~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 7 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp EECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 3566667775321 12455566666665533333455566666666666655545555444445555555554
Q ss_pred -CCCCcccCCCCCcCCCCCcEEEccCcccC
Q 007088 140 -SNSLSGEIPSGLANCTFLNVLKLNNNRFT 168 (618)
Q Consensus 140 -~N~l~g~ip~~~~~l~~L~~l~l~~N~l~ 168 (618)
.|++....|..+.++++|+.|++++|++.
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred ccccccccccccccccccccccccchhhhc
Confidence 34555444444555666666666666554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.83 E-value=4.3e-09 Score=99.35 Aligned_cols=132 Identities=27% Similarity=0.440 Sum_probs=78.2
Q ss_pred CcccceecCCCCCCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCC
Q 007088 69 CQFTGVDCWHPDENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIP 148 (618)
Q Consensus 69 c~w~gv~c~~~~~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip 148 (618)
.++.|+.. ..+++.|+|++|.+++..| +..+++|+.|++++|.++ .++. +.. +++|+.|++++|...+..+
T Consensus 54 ~~l~~l~~----l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~~-l~~-l~~L~~l~l~~~~~~~~~~ 124 (227)
T d1h6ua2 54 TTIEGVQY----LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVSA-IAG-LQSIKTLDLTSTQITDVTP 124 (227)
T ss_dssp CCCTTGGG----CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCGG-GTT-CTTCCEEECTTSCCCCCGG
T ss_pred CcchhHhc----CCCCcEeecCCceeecccc--cccccccccccccccccc-cccc-ccc-cccccccccccccccccch
Confidence 34555533 3578888888888875433 677777777777777776 5553 333 6666666666655543221
Q ss_pred --------------------CCCcCCCCCcEEEccCcccCCCCCccccccccccccccccccccCCCCCCCc-ccccccc
Q 007088 149 --------------------SGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPSFAN-VNFTAED 207 (618)
Q Consensus 149 --------------------~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~ 207 (618)
..+.++++|+.|++++|++++.. .++++++|+.|+|++|++++ +|.+.. .++..++
T Consensus 125 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~ 201 (227)
T d1h6ua2 125 LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVH 201 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEE
T ss_pred hccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcCCCCCCEEE
Confidence 11344556677777777666322 26666777777777777765 332222 1455566
Q ss_pred ccCCC
Q 007088 208 FANNS 212 (618)
Q Consensus 208 ~~~n~ 212 (618)
+++|.
T Consensus 202 Ls~N~ 206 (227)
T d1h6ua2 202 LKNNQ 206 (227)
T ss_dssp CTTSC
T ss_pred CcCCc
Confidence 66664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=9.4e-09 Score=97.79 Aligned_cols=107 Identities=12% Similarity=0.153 Sum_probs=91.2
Q ss_pred EEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCC-CCcCCCCCcEEEcc-
Q 007088 86 NIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPS-GLANCTFLNVLKLN- 163 (618)
Q Consensus 86 ~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~l~l~- 163 (618)
.++.++.+++ .+|+.+. +++++|+|++|++. .||...+.++++|++|+|++|.+...+|. .+.++++++.|++.
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 5777888888 8998774 68999999999998 78887666699999999999999877765 57889999999986
Q ss_pred CcccCCCCCccccccccccccccccccccCCCC
Q 007088 164 NNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 164 ~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
.|++....|..+..+++|+.|++++|.+....+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~ 120 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCC
T ss_pred cccccccccccccccccccccccchhhhccccc
Confidence 478887778889999999999999999976443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.70 E-value=1.1e-08 Score=96.47 Aligned_cols=107 Identities=21% Similarity=0.326 Sum_probs=84.7
Q ss_pred CCcEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEE
Q 007088 81 ENKVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVL 160 (618)
Q Consensus 81 ~~~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l 160 (618)
..+++.++++++...+. ..+.....++.+.++++.+.+..+ +.. .++|+.|++++|.+++. + .++++++|+.|
T Consensus 106 l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--~~~-~~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L 178 (227)
T d1h6ua2 106 LQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--LAG-LTNLQYLSIGNAQVSDL-T-PLANLSKLTTL 178 (227)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--GGG-CTTCCEEECCSSCCCCC-G-GGTTCTTCCEE
T ss_pred ccccccccccccccccc--chhccccchhhhhchhhhhchhhh--hcc-ccccccccccccccccc-h-hhcccccceec
Confidence 35678899998887753 336678899999999999885433 333 88999999999998853 3 38899999999
Q ss_pred EccCcccCCCCCccccccccccccccccccccCCCC
Q 007088 161 KLNNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 161 ~l~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip 196 (618)
+|++|++++ +|+ ++++++|++|+|++|++++..|
T Consensus 179 ~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 179 KADDNKISD-ISP-LASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp ECCSSCCCC-CGG-GGGCTTCCEEECTTSCCCBCGG
T ss_pred ccCCCccCC-Chh-hcCCCCCCEEECcCCcCCCCcc
Confidence 999999985 554 8889999999999999986543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.66 E-value=2.5e-08 Score=99.81 Aligned_cols=100 Identities=26% Similarity=0.339 Sum_probs=83.8
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEc
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKL 162 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l 162 (618)
+++.|+|++++|+ .+|+. +++|++|+|++|+|+ .||.. +.+|+.|++++|+++ .|+.- .+.|++|+|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 5778999999998 68864 468999999999999 89964 457999999999998 66642 146999999
Q ss_pred cCcccCCCCCccccccccccccccccccccCCCCC
Q 007088 163 NNNRFTGKIPPQLGLLNRIKTFSVASNLLTGPVPS 197 (618)
Q Consensus 163 ~~N~l~g~~p~~l~~~~~L~~l~l~~N~l~g~ip~ 197 (618)
++|+++ .+|. ++.+++|+.|++++|.+++..+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~ 138 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL 138 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC
T ss_pred cccccc-cccc-hhhhccceeeccccccccccccc
Confidence 999998 6775 68899999999999999876654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.55 E-value=1.9e-07 Score=89.52 Aligned_cols=149 Identities=11% Similarity=0.025 Sum_probs=101.0
Q ss_pred HHHHHhhccCCCCcEEeecCCeeEEEEEeCCCcEEEEEEeccCc-cCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCee
Q 007088 299 SDLMKATNSFSKNNIIGTGRTGATYIAMLPGGCFIMIKRLEDSQ-HSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKER 376 (618)
Q Consensus 299 ~~l~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 376 (618)
.|+.+..+.|+..+..+-++.+.||+... ++..+++|+..... .....+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35556566666544433334468999875 44556778775432 33345678888877663 44467888888888899
Q ss_pred EEEEeecCCCccccccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 007088 377 LLVYSYLENGTLYDKLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC------------------------------- 425 (618)
Q Consensus 377 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------- 425 (618)
++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred EEEEEecccccccccccccc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999988765442211 12345666777777777531
Q ss_pred -------------------------CCCceecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 426 -------------------------NPRIIHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 426 -------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
.+.++|+|+.|.||++++++..-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01378999999999999876667999997753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.18 E-value=2.2e-07 Score=82.27 Aligned_cols=81 Identities=22% Similarity=0.257 Sum_probs=41.9
Q ss_pred CCCCCCCeEEccCCcCccccCc--hhhhcCCCCCEEEeeCCCCcccCCC-CCcCCCCCcEEEccCcccCCCCCcc-----
Q 007088 103 ERCTSLTGLDLSSNNLSGSIPS--DISSRLQYVTSLDLSSNSLSGEIPS-GLANCTFLNVLKLNNNRFTGKIPPQ----- 174 (618)
Q Consensus 103 ~~l~~L~~L~l~~n~l~g~ip~--~~~~~l~~L~~L~l~~N~l~g~ip~-~~~~l~~L~~l~l~~N~l~g~~p~~----- 174 (618)
..+++|++|+|++|+++ .++. ..+..+++|+.|+|++|+++ .++. ......+|+.|+|++|.++......
T Consensus 62 ~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~ 139 (162)
T d1koha1 62 ENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYIS 139 (162)
T ss_dssp HHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHH
T ss_pred HhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHH
Confidence 34566666666666666 3321 12223666666666666666 3433 1122334666666666666544321
Q ss_pred --ccccccccccc
Q 007088 175 --LGLLNRIKTFS 185 (618)
Q Consensus 175 --l~~~~~L~~l~ 185 (618)
+..+++|+.||
T Consensus 140 ~i~~~~P~L~~LD 152 (162)
T d1koha1 140 AIRERFPKLLRLD 152 (162)
T ss_dssp HHHTTSTTCCEET
T ss_pred HHHHHCCCCCEEC
Confidence 33455555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.18 E-value=2.4e-06 Score=84.82 Aligned_cols=94 Identities=29% Similarity=0.319 Sum_probs=73.2
Q ss_pred CCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccCcccCCCCCccccccccccccc
Q 007088 106 TSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNNNRFTGKIPPQLGLLNRIKTFS 185 (618)
Q Consensus 106 ~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~N~l~g~~p~~l~~~~~L~~l~ 185 (618)
.+|+.|||++|.++ ++|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .++|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~----~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL----PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC----CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC----CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccc
Confidence 47899999999998 79963 578999999999999 899765 57889999999998 55532 24699999
Q ss_pred cccccccCCCCCCCcc-ccccccccCCCC
Q 007088 186 VASNLLTGPVPSFANV-NFTAEDFANNSG 213 (618)
Q Consensus 186 l~~N~l~g~ip~~~~~-~~~~~~~~~n~~ 213 (618)
+++|.++. +|....+ ++..+++++|..
T Consensus 105 L~~n~l~~-lp~~~~l~~L~~L~l~~~~~ 132 (353)
T d1jl5a_ 105 VSNNQLEK-LPELQNSSFLKIIDVDNNSL 132 (353)
T ss_dssp CCSSCCSS-CCCCTTCTTCCEEECCSSCC
T ss_pred cccccccc-ccchhhhccceeeccccccc
Confidence 99999985 5654332 456666666643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=1.1e-07 Score=98.57 Aligned_cols=110 Identities=20% Similarity=0.270 Sum_probs=84.6
Q ss_pred cEEEEEecCCcceee-CCcCCCCCCCCCeEEccCCcCcc----ccCchhhhcCCCCCEEEeeCCCCcc----cCCCCCc-
Q 007088 83 KVLNIRLSDMGLKGQ-FPRGIERCTSLTGLDLSSNNLSG----SIPSDISSRLQYVTSLDLSSNSLSG----EIPSGLA- 152 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~-~p~~~~~l~~L~~L~l~~n~l~g----~ip~~~~~~l~~L~~L~l~~N~l~g----~ip~~~~- 152 (618)
++++|||++|++++. +..-+..+++|+.|+|++|.++- .|...+. .+++|+.|||++|+++. .+...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~-~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALR-VNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHH-TCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHh-cCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 689999999999863 23345668999999999999872 3444454 48999999999999862 1222333
Q ss_pred CCCCCcEEEccCcccCCC----CCccccccccccccccccccccC
Q 007088 153 NCTFLNVLKLNNNRFTGK----IPPQLGLLNRIKTFSVASNLLTG 193 (618)
Q Consensus 153 ~l~~L~~l~l~~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~g 193 (618)
...+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 235799999999999854 46677889999999999999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=2.4e-06 Score=81.19 Aligned_cols=129 Identities=13% Similarity=0.082 Sum_probs=88.2
Q ss_pred EeecCC-eeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCC--CCCccceeEEEEeCCeeEEEEeecCCCcccc
Q 007088 314 IGTGRT-GATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVR--HRNLVPLLGFCVAKKERLLVYSYLENGTLYD 390 (618)
Q Consensus 314 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 390 (618)
+..|.. +.||+...+++..+++|....... ..+..|...++.+. .-.+.+++.+..+++..++||+|++|.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 444543 578999988888899998765432 24567777776663 3346778888888888999999999876644
Q ss_pred ccCCCCCCCcCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 007088 391 KLHPAEHEVMHMDWPLRLRIAIGSARGLAWLHHNC--------------------------------------------- 425 (618)
Q Consensus 391 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------------- 425 (618)
.. ... ...+.++++.|+-||+..
T Consensus 96 ~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 96 SH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp SC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 21 111 122334444555555320
Q ss_pred ----------CCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 426 ----------NPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 426 ----------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
.+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1137999999999999987667899998765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=3e-07 Score=89.47 Aligned_cols=57 Identities=23% Similarity=0.334 Sum_probs=31.9
Q ss_pred cEEEEEecCCcceeeCCcCCCCCCCCCeEEccC-CcCccc-cCchhhhcCCCCCEEEeeC
Q 007088 83 KVLNIRLSDMGLKGQFPRGIERCTSLTGLDLSS-NNLSGS-IPSDISSRLQYVTSLDLSS 140 (618)
Q Consensus 83 ~v~~l~l~~~~l~g~~p~~~~~l~~L~~L~l~~-n~l~g~-ip~~~~~~l~~L~~L~l~~ 140 (618)
+++.|+|+++++++..+..++.+++|++|+|++ +.++.. +.. +..++++|++|+|++
T Consensus 72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~-l~~~~~~L~~L~ls~ 130 (284)
T d2astb2 72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT-LLSSCSRLDELNLSW 130 (284)
T ss_dssp CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHH-HHHHCTTCCEEECCC
T ss_pred CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccch-hhHHHHhcccccccc
Confidence 456666666666655556666666666666666 344421 111 223366666666665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.04 E-value=1.5e-07 Score=83.37 Aligned_cols=93 Identities=17% Similarity=0.130 Sum_probs=67.2
Q ss_pred CCCCCCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCccc--CCCCCcCCCCCcEEEccCcccCCCCCc-cccc
Q 007088 101 GIERCTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGE--IPSGLANCTFLNVLKLNNNRFTGKIPP-QLGL 177 (618)
Q Consensus 101 ~~~~l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~--ip~~~~~l~~L~~l~l~~N~l~g~~p~-~l~~ 177 (618)
.+..+..+..|++.+|... .++ .+..++++|++|+|++|+++.- ++..+..+++|+.|+|++|+++. +++ ....
T Consensus 37 ~l~~~~~~~~l~~~~~~~~-~l~-~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~ 113 (162)
T d1koha1 37 DLVAQNIDVVLNRRSSMAA-TLR-IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIK 113 (162)
T ss_dssp TTTTTTCCCCTTSHHHHHH-HHH-HHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHT
T ss_pred hhhhccchhhcchhhhHhh-hhH-HHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhh
Confidence 3555556666666655444 444 4445699999999999999942 23446789999999999999994 543 3333
Q ss_pred cccccccccccccccCCCC
Q 007088 178 LNRIKTFSVASNLLTGPVP 196 (618)
Q Consensus 178 ~~~L~~l~l~~N~l~g~ip 196 (618)
..+|+.|++++|.+++...
T Consensus 114 ~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 114 GLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp TCCCSSCCCTTSTTSSSSS
T ss_pred ccccceeecCCCCcCcCcc
Confidence 4578999999999987654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=1.6e-06 Score=84.20 Aligned_cols=84 Identities=23% Similarity=0.227 Sum_probs=38.4
Q ss_pred CCCCCeEEccCCcCccccCchhhhcCCCCCEEEeeCCCCcccCCCCCcCCCCCcEEEccC-cccCCC-CCcccccccccc
Q 007088 105 CTSLTGLDLSSNNLSGSIPSDISSRLQYVTSLDLSSNSLSGEIPSGLANCTFLNVLKLNN-NRFTGK-IPPQLGLLNRIK 182 (618)
Q Consensus 105 l~~L~~L~l~~n~l~g~ip~~~~~~l~~L~~L~l~~N~l~g~ip~~~~~l~~L~~l~l~~-N~l~g~-~p~~l~~~~~L~ 182 (618)
..+|++|||+++.+++.....++.++++|++|+|+++.+++..+..++.+++|+.|+|++ +.++.. +..-...+++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 344555555555544333233333455555555555555544444455555555555555 233311 111123345555
Q ss_pred cccccc
Q 007088 183 TFSVAS 188 (618)
Q Consensus 183 ~l~l~~ 188 (618)
.|++++
T Consensus 125 ~L~ls~ 130 (284)
T d2astb2 125 ELNLSW 130 (284)
T ss_dssp EEECCC
T ss_pred cccccc
Confidence 555544
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.86 E-value=4.6e-07 Score=93.68 Aligned_cols=113 Identities=19% Similarity=0.251 Sum_probs=79.5
Q ss_pred CcEEEEEecCCcceeeCCcC-----CCCCCCCCeEEccCCcCccccCchh---hhcCCCCCEEEeeCCCCccc----CCC
Q 007088 82 NKVLNIRLSDMGLKGQFPRG-----IERCTSLTGLDLSSNNLSGSIPSDI---SSRLQYVTSLDLSSNSLSGE----IPS 149 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g~~p~~-----~~~l~~L~~L~l~~n~l~g~ip~~~---~~~l~~L~~L~l~~N~l~g~----ip~ 149 (618)
..+..+++++|.+...-... ......|+.+++++|.++..-...+ ....++|+.|+|++|+++.. ++.
T Consensus 283 ~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~ 362 (460)
T d1z7xw1 283 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 362 (460)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhh
Confidence 56788999999876422211 1234679999999998875432222 22367899999999998742 333
Q ss_pred CCc-CCCCCcEEEccCcccCC----CCCccccccccccccccccccccCC
Q 007088 150 GLA-NCTFLNVLKLNNNRFTG----KIPPQLGLLNRIKTFSVASNLLTGP 194 (618)
Q Consensus 150 ~~~-~l~~L~~l~l~~N~l~g----~~p~~l~~~~~L~~l~l~~N~l~g~ 194 (618)
.+. ..+.|+.|+|++|+|+. .++..+..+++|++|+|++|+++..
T Consensus 363 ~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~ 412 (460)
T d1z7xw1 363 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred hhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence 443 45679999999999974 2455667778999999999998753
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.80 E-value=1.4e-06 Score=86.95 Aligned_cols=111 Identities=14% Similarity=0.174 Sum_probs=68.7
Q ss_pred CcEEEEEecCCccee----eCCcCCCCCCCCCeEEccCCcCccc-----cCchhhhcCCCCCEEEeeCCCCccc----CC
Q 007088 82 NKVLNIRLSDMGLKG----QFPRGIERCTSLTGLDLSSNNLSGS-----IPSDISSRLQYVTSLDLSSNSLSGE----IP 148 (618)
Q Consensus 82 ~~v~~l~l~~~~l~g----~~p~~~~~l~~L~~L~l~~n~l~g~-----ip~~~~~~l~~L~~L~l~~N~l~g~----ip 148 (618)
..+..|++++|.+.- .+...+..+..|+.|+|++|+++.. +...+ ..+++|+.|+|++|.++.. +.
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l-~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL-AYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTG-GGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhh-cchhhhccccccccccccccccccc
Confidence 456677777776642 2334455667788888888877521 22223 2367788888888877532 33
Q ss_pred CCCcCCCCCcEEEccCcccCCCCCccc----cc--cccccccccccccccC
Q 007088 149 SGLANCTFLNVLKLNNNRFTGKIPPQL----GL--LNRIKTFSVASNLLTG 193 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~~p~~l----~~--~~~L~~l~l~~N~l~g 193 (618)
..+..+++|+.|+|++|+|++.-...+ .. ..+|+.|++++|+++.
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~ 287 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCCh
Confidence 446677778888888887765322222 21 2467788888887754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.58 E-value=3.4e-06 Score=84.08 Aligned_cols=130 Identities=18% Similarity=0.315 Sum_probs=91.0
Q ss_pred CcEEEEEecCCcce--e--eC---------CcCCCCCCCCCeEEccCCcCcc----ccCchhhhcCCCCCEEEeeCCCCc
Q 007088 82 NKVLNIRLSDMGLK--G--QF---------PRGIERCTSLTGLDLSSNNLSG----SIPSDISSRLQYVTSLDLSSNSLS 144 (618)
Q Consensus 82 ~~v~~l~l~~~~l~--g--~~---------p~~~~~l~~L~~L~l~~n~l~g----~ip~~~~~~l~~L~~L~l~~N~l~ 144 (618)
..++.|+|++|.+. | .+ .........|+.|++++|+++- .+...+. ..+.|+.|+|++|+++
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~-~~~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ-SHRLLHTVKMVQNGIR 199 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHH-HCTTCCEEECCSSCCC
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhh-hhhhhccccccccccc
Confidence 46889999998752 0 11 1112456789999999998862 2333333 3789999999999987
Q ss_pred cc-----CCCCCcCCCCCcEEEccCcccCCC----CCccccccccccccccccccccCCC--------CCCCcccccccc
Q 007088 145 GE-----IPSGLANCTFLNVLKLNNNRFTGK----IPPQLGLLNRIKTFSVASNLLTGPV--------PSFANVNFTAED 207 (618)
Q Consensus 145 g~-----ip~~~~~l~~L~~l~l~~N~l~g~----~p~~l~~~~~L~~l~l~~N~l~g~i--------p~~~~~~~~~~~ 207 (618)
.. +...+..+++|+.|+|++|.|+.. +...+..+++|+.|+|++|.+++.- +......+..++
T Consensus 200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ 279 (344)
T d2ca6a1 200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 279 (344)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEE
Confidence 32 345578889999999999998643 4456778899999999999987631 111122466678
Q ss_pred ccCCC
Q 007088 208 FANNS 212 (618)
Q Consensus 208 ~~~n~ 212 (618)
+++|.
T Consensus 280 ls~N~ 284 (344)
T d2ca6a1 280 LQYNE 284 (344)
T ss_dssp CCSSC
T ss_pred CCCCc
Confidence 88774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=0.0001 Score=74.46 Aligned_cols=76 Identities=13% Similarity=0.026 Sum_probs=48.2
Q ss_pred CcEEeecCCeeEEEEEeC-CCcEEEEEEeccC--------ccCHHHHHHHHHHHhcCC-C--CCccceeEEEEeCCeeEE
Q 007088 311 NNIIGTGRTGATYIAMLP-GGCFIMIKRLEDS--------QHSEKEFLSEINTLGSVR-H--RNLVPLLGFCVAKKERLL 378 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 378 (618)
.+.||.|....||+.... +++.|++|.-... .....+...|.+.|..+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 346899999999999854 4678899965321 112234556777776652 2 345556544 4556789
Q ss_pred EEeecCCCcc
Q 007088 379 VYSYLENGTL 388 (618)
Q Consensus 379 V~e~~~~gsL 388 (618)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999986543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.36 E-value=0.00034 Score=68.50 Aligned_cols=137 Identities=9% Similarity=0.027 Sum_probs=81.8
Q ss_pred CeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCCc--ccee-----EEEEeCCeeEEEEeecCCCccccc
Q 007088 319 TGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRNL--VPLL-----GFCVAKKERLLVYSYLENGTLYDK 391 (618)
Q Consensus 319 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~e~~~~gsL~~~ 391 (618)
--.||++..++|+.|++|+.+......+++..|...+..|....+ +..+ ..+...+..+.++++++|..+...
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 358999999999999999998776677888899988877742222 1111 122345667899999987543210
Q ss_pred ------------------cCCCC-CCCcCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCCCc
Q 007088 392 ------------------LHPAE-HEVMHMDWPL-------------------RLRIAIGSARGLAWLHH----NCNPRI 429 (618)
Q Consensus 392 ------------------l~~~~-~~~~~l~~~~-------------------~~~i~~~i~~~L~~LH~----~~~~~i 429 (618)
..... .....+++.. +..+...+.+.++.+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00000 0011122111 11122222223333322 223478
Q ss_pred eecCCCCCCeeeCCCCceEEcccCcccc
Q 007088 430 IHRNISSKCILLDGDFEPKLSDFGLARL 457 (618)
Q Consensus 430 vH~Dlkp~NIll~~~~~~kl~DfG~a~~ 457 (618)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 56899998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.16 E-value=4.8e-05 Score=67.02 Aligned_cols=107 Identities=12% Similarity=0.130 Sum_probs=61.3
Q ss_pred CcEEEEEecCC-cceee----CCcCCCCCCCCCeEEccCCcCccccC----chhhhcCCCCCEEEeeCCCCcccC----C
Q 007088 82 NKVLNIRLSDM-GLKGQ----FPRGIERCTSLTGLDLSSNNLSGSIP----SDISSRLQYVTSLDLSSNSLSGEI----P 148 (618)
Q Consensus 82 ~~v~~l~l~~~-~l~g~----~p~~~~~l~~L~~L~l~~n~l~g~ip----~~~~~~l~~L~~L~l~~N~l~g~i----p 148 (618)
..++.|+|+++ .+... +-..+...+.|+.|+|++|.+...-. ..+. ..+.|+.|+|++|.++..- =
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~-~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIE-TSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHH-HCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhh-hcccccceeeehhhcchHHHHHHH
Confidence 46777888764 34321 33346666778888888887763211 1222 3567888888888777321 1
Q ss_pred CCCcCCCCCcEEEccCcccCCC-------CCccccccccccccccccc
Q 007088 149 SGLANCTFLNVLKLNNNRFTGK-------IPPQLGLLNRIKTFSVASN 189 (618)
Q Consensus 149 ~~~~~l~~L~~l~l~~N~l~g~-------~p~~l~~~~~L~~l~l~~N 189 (618)
..+...+.|+.|+|++|++... +...+...++|+.|+++.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 2355667788888887765521 2223333455666655443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.08 E-value=0.00065 Score=66.01 Aligned_cols=160 Identities=12% Similarity=0.063 Sum_probs=86.1
Q ss_pred ccCHHHHHHhhccCCCCcEEe-----ecCCeeEEEEEeCCCcEEEEEEeccCccCHHHHHHHHHHHhcCCCCC--cccee
Q 007088 295 KMRLSDLMKATNSFSKNNIIG-----TGRTGATYIAMLPGGCFIMIKRLEDSQHSEKEFLSEINTLGSVRHRN--LVPLL 367 (618)
Q Consensus 295 ~~~~~~l~~~~~~y~~~~~lG-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~ 367 (618)
.++.+|+.....+|...+... .|---+.|+.+..+|+ +++|++.... ..+++..|++++..+...+ +...+
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccc
Confidence 356788888888998765543 4555778999987765 7889886532 2334556676666663222 11111
Q ss_pred E------EEEeCCeeEEEEeecCCCccccccC------------------CCCCC-CcCCCHH-----------------
Q 007088 368 G------FCVAKKERLLVYSYLENGTLYDKLH------------------PAEHE-VMHMDWP----------------- 405 (618)
Q Consensus 368 ~------~~~~~~~~~lV~e~~~~gsL~~~l~------------------~~~~~-~~~l~~~----------------- 405 (618)
. +.........++.++.+......-. ..... .......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1222345667777776643322100 00000 0000000
Q ss_pred -HHHHHHHHHHHHHHHHHhC-CCCCceecCCCCCCeeeCCCCceEEcccCccc
Q 007088 406 -LRLRIAIGSARGLAWLHHN-CNPRIIHRNISSKCILLDGDFEPKLSDFGLAR 456 (618)
Q Consensus 406 -~~~~i~~~i~~~L~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 456 (618)
.....+..+...+...+.. ...++||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222222221 22379999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.02 E-value=0.00094 Score=67.17 Aligned_cols=74 Identities=12% Similarity=0.141 Sum_probs=51.3
Q ss_pred CcEEeecCCeeEEEEEeCC--------CcEEEEEEeccCccCHHHHHHHHHHHhcCC-CCCccceeEEEEeCCeeEEEEe
Q 007088 311 NNIIGTGRTGATYIAMLPG--------GCFIMIKRLEDSQHSEKEFLSEINTLGSVR-HRNLVPLLGFCVAKKERLLVYS 381 (618)
Q Consensus 311 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 381 (618)
.+.|+-|-.-.+|++...+ ...|++++.... .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4568888889999998654 356777777633 33445668888888874 4334577777643 68999
Q ss_pred ecCCCccc
Q 007088 382 YLENGTLY 389 (618)
Q Consensus 382 ~~~~gsL~ 389 (618)
|++|.++.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99875553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.53 E-value=0.00029 Score=61.79 Aligned_cols=89 Identities=15% Similarity=0.188 Sum_probs=61.5
Q ss_pred CCCCCCCeEEccCC-cCccc----cCchhhhcCCCCCEEEeeCCCCcccCCC----CCcCCCCCcEEEccCcccCCCC--
Q 007088 103 ERCTSLTGLDLSSN-NLSGS----IPSDISSRLQYVTSLDLSSNSLSGEIPS----GLANCTFLNVLKLNNNRFTGKI-- 171 (618)
Q Consensus 103 ~~l~~L~~L~l~~n-~l~g~----ip~~~~~~l~~L~~L~l~~N~l~g~ip~----~~~~l~~L~~l~l~~N~l~g~~-- 171 (618)
.+.++|++|+|+++ .++.. +=..+. ..++|+.|+|++|.+...-.. .+...+.|+.|+|++|.|+..-
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~-~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~ 90 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAAC-NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 90 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHT-TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHh-hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHH
Confidence 35688999999974 56522 111222 357799999999998733222 2445688999999999998531
Q ss_pred --Ccccccccccccccccccccc
Q 007088 172 --PPQLGLLNRIKTFSVASNLLT 192 (618)
Q Consensus 172 --p~~l~~~~~L~~l~l~~N~l~ 192 (618)
-..+...++|+.|++++|.++
T Consensus 91 ~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 91 RLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHHhCCcCCEEECCCCcCC
Confidence 224556678999999888654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.75 E-value=0.00059 Score=59.58 Aligned_cols=110 Identities=15% Similarity=0.192 Sum_probs=68.1
Q ss_pred CcEEEEEecC-Cccee----eCCcCCCCCCCCCeEEccCCcCccccCchh---hhcCCCCCEEEeeCCCCccc----CCC
Q 007088 82 NKVLNIRLSD-MGLKG----QFPRGIERCTSLTGLDLSSNNLSGSIPSDI---SSRLQYVTSLDLSSNSLSGE----IPS 149 (618)
Q Consensus 82 ~~v~~l~l~~-~~l~g----~~p~~~~~l~~L~~L~l~~n~l~g~ip~~~---~~~l~~L~~L~l~~N~l~g~----ip~ 149 (618)
..++.|+|++ +.++. .+-..+...++|++|+|++|.++..--..+ ....++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 4677888886 34432 133445677888889999888864322212 12367888888888887633 123
Q ss_pred CCcCCCCCcEEEc--cCcccCC----CCCccccccccccccccccccc
Q 007088 150 GLANCTFLNVLKL--NNNRFTG----KIPPQLGLLNRIKTFSVASNLL 191 (618)
Q Consensus 150 ~~~~l~~L~~l~l--~~N~l~g----~~p~~l~~~~~L~~l~l~~N~l 191 (618)
.+...++|+.++| ++|.+.. .+...+...++|+.|+++.|..
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 4566777877555 4566643 2334455677788887765543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.74 E-value=0.0083 Score=51.82 Aligned_cols=90 Identities=14% Similarity=0.170 Sum_probs=58.6
Q ss_pred CCCCCCCCeEEccC-CcCccccCchhh---hcCCCCCEEEeeCCCCcccCCC----CCcCCCCCcEEEccCcccCCC---
Q 007088 102 IERCTSLTGLDLSS-NNLSGSIPSDIS---SRLQYVTSLDLSSNSLSGEIPS----GLANCTFLNVLKLNNNRFTGK--- 170 (618)
Q Consensus 102 ~~~l~~L~~L~l~~-n~l~g~ip~~~~---~~l~~L~~L~l~~N~l~g~ip~----~~~~l~~L~~l~l~~N~l~g~--- 170 (618)
..+.+.|++|+|++ |.++...=..++ ...++|+.|+|++|.++..--. .+...++|+.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34678999999997 566522111122 2378899999999988743221 245678899999999998743
Q ss_pred -CCcccccccccccccc--ccccc
Q 007088 171 -IPPQLGLLNRIKTFSV--ASNLL 191 (618)
Q Consensus 171 -~p~~l~~~~~L~~l~l--~~N~l 191 (618)
+-..+...++|+.++| ++|.+
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCC
T ss_pred HHHHHHHhCccccEEeeccCCCcC
Confidence 2244566677776444 45555
|